0000950170-24-052097.txt : 20240502 0000950170-24-052097.hdr.sgml : 20240502 20240502160817 ACCESSION NUMBER: 0000950170-24-052097 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 85 CONFORMED PERIOD OF REPORT: 20240331 FILED AS OF DATE: 20240502 DATE AS OF CHANGE: 20240502 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ZIMMER BIOMET HOLDINGS, INC. CENTRAL INDEX KEY: 0001136869 STANDARD INDUSTRIAL CLASSIFICATION: ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 134151777 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-16407 FILM NUMBER: 24908236 BUSINESS ADDRESS: STREET 1: 345 EAST MAIN STREET CITY: WARSAW STATE: IN ZIP: 46580 BUSINESS PHONE: 5742676131 MAIL ADDRESS: STREET 1: 345 EAST MAIN STREET CITY: WARSAW STATE: IN ZIP: 46580 FORMER COMPANY: FORMER CONFORMED NAME: ZIMMER HOLDINGS INC DATE OF NAME CHANGE: 20010315 10-Q 1 zbh-20240331.htm 10-Q 10-Q
--12-31falseQ10001136869falsehttp://fasb.org/us-gaap/2023#ProductMemberhttp://fasb.org/us-gaap/2023#ProductMemberhttp://fasb.org/us-gaap/2023#ProductMemberhttp://fasb.org/us-gaap/2023#ProductMemberhttp://fasb.org/us-gaap/2023#ProductMemberhttp://fasb.org/us-gaap/2023#ProductMemberhttp://fasb.org/us-gaap/2023#ProductMemberhttp://fasb.org/us-gaap/2023#ProductMemberhttp://fasb.org/us-gaap/2023#AssetsCurrent http://fasb.org/us-gaap/2023#OtherAssetsNoncurrenthttp://fasb.org/us-gaap/2023#AssetsCurrent http://fasb.org/us-gaap/2023#OtherAssetsNoncurrenthttp://fasb.org/us-gaap/2023#AssetsCurrent http://fasb.org/us-gaap/2023#OtherAssetsNoncurrenthttp://fasb.org/us-gaap/2023#AssetsCurrent http://fasb.org/us-gaap/2023#OtherAssetsNoncurrenthttp://fasb.org/us-gaap/2023#AssetsCurrent http://fasb.org/us-gaap/2023#OtherAssetsNoncurrenthttp://fasb.org/us-gaap/2023#AssetsCurrent http://fasb.org/us-gaap/2023#OtherAssetsNoncurrenthttp://fasb.org/us-gaap/2023#OtherLiabilitiesCurrent http://fasb.org/us-gaap/2023#OtherLiabilitiesNoncurrenthttp://fasb.org/us-gaap/2023#OtherLiabilitiesCurrent http://fasb.org/us-gaap/2023#OtherLiabilitiesNoncurrenthttp://fasb.org/us-gaap/2023#OtherLiabilitiesCurrent http://fasb.org/us-gaap/2023#OtherLiabilitiesNoncurrenthttp://fasb.org/us-gaap/2023#OtherLiabilitiesCurrent http://fasb.org/us-gaap/2023#OtherLiabilitiesNoncurrenthttp://fasb.org/us-gaap/2023#OtherLiabilitiesCurrent http://fasb.org/us-gaap/2023#OtherLiabilitiesNoncurrenthttp://fasb.org/us-gaap/2023#OtherLiabilitiesCurrent http://fasb.org/us-gaap/2023#OtherLiabilitiesNoncurrenthttp://fasb.org/us-gaap/2023#OtherLiabilitiesCurrent http://fasb.org/us-gaap/2023#OtherLiabilitiesNoncurrenthttp://fasb.org/us-gaap/2023#OtherLiabilitiesCurrent http://fasb.org/us-gaap/2023#OtherLiabilitiesNoncurrenthttp://fasb.org/us-gaap/2023#AssetsCurrent http://fasb.org/us-gaap/2023#OtherAssetsNoncurrenthttp://fasb.org/us-gaap/2023#AssetsCurrent http://fasb.org/us-gaap/2023#OtherAssetsNoncurrenthttp://fasb.org/us-gaap/2023#AssetsCurrent http://fasb.org/us-gaap/2023#OtherAssetsNoncurrenthttp://fasb.org/us-gaap/2023#AssetsCurrent http://fasb.org/us-gaap/2023#OtherAssetsNoncurrenthttp://fasb.org/us-gaap/2023#AssetsCurrent http://fasb.org/us-gaap/2023#OtherAssetsNoncurrenthttp://fasb.org/us-gaap/2023#AssetsCurrent http://fasb.org/us-gaap/2023#OtherAssetsNoncurrenthttp://fasb.org/us-gaap/2023#OtherLiabilitiesCurrent http://fasb.org/us-gaap/2023#OtherLiabilitiesNoncurrenthttp://fasb.org/us-gaap/2023#OtherLiabilitiesCurrent http://fasb.org/us-gaap/2023#OtherLiabilitiesNoncurrenthttp://fasb.org/us-gaap/2023#OtherLiabilitiesCurrent http://fasb.org/us-gaap/2023#OtherLiabilitiesNoncurrenthttp://fasb.org/us-gaap/2023#OtherLiabilitiesCurrent http://fasb.org/us-gaap/2023#OtherLiabilitiesNoncurrenthttp://fasb.org/us-gaap/2023#OtherLiabilitiesCurrent http://fasb.org/us-gaap/2023#OtherLiabilitiesNoncurrenthttp://fasb.org/us-gaap/2023#OtherLiabilitiesCurrent http://fasb.org/us-gaap/2023#OtherLiabilitiesNoncurrenthttp://fasb.org/us-gaap/2023#OtherLiabilitiesCurrent http://fasb.org/us-gaap/2023#OtherLiabilitiesNoncurrenthttp://fasb.org/us-gaap/2023#OtherLiabilitiesCurrent http://fasb.org/us-gaap/2023#OtherLiabilitiesNoncurrenthttp://www.zimmerbiomet.com/20240331#AcquisitionIntegrationDivestitureAndRelatedExpenseshttp://fasb.org/us-gaap/2023#CostOfGoodsAndServicesSoldhttp://fasb.org/us-gaap/2023#CostOfGoodsAndServicesSoldhttp://fasb.org/us-gaap/2023#InterestIncomeExpenseNethttp://fasb.org/us-gaap/2023#InterestIncomeExpenseNethttp://fasb.org/us-gaap/2023#CostOfGoodsAndServicesSoldhttp://fasb.org/us-gaap/2023#InterestIncomeExpenseNethttp://fasb.org/us-gaap/2023#CostOfGoodsAndServicesSoldhttp://fasb.org/us-gaap/2023#InterestIncomeExpenseNethttp://fasb.org/us-gaap/2023#AssetsCurrenthttp://fasb.org/us-gaap/2023#AssetsCurrenthttp://fasb.org/us-gaap/2023#OtherAssetsNoncurrenthttp://fasb.org/us-gaap/2023#OtherAssetsNoncurrenthttp://fasb.org/us-gaap/2023#AssetsCurrenthttp://fasb.org/us-gaap/2023#AssetsCurrenthttp://fasb.org/us-gaap/2023#OtherLiabilitiesCurrenthttp://fasb.org/us-gaap/2023#OtherLiabilitiesCurrenthttp://fasb.org/us-gaap/2023#OtherLiabilitiesNoncurrenthttp://fasb.org/us-gaap/2023#OtherLiabilitiesNoncurrenthttp://fasb.org/us-gaap/2023#OtherLiabilitiesCurrenthttp://fasb.org/us-gaap/2023#OtherLiabilitiesCurrent0001136869zbh:HipsMember2023-01-012023-03-310001136869zbh:UncommittedCreditFacilityMember2023-12-310001136869us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:OtherCurrentAssetsMemberus-gaap:ForeignExchangeForwardMember2023-12-310001136869zbh:ShortTermTermLoanMember2023-01-012023-03-310001136869us-gaap:LandMember2024-03-310001136869us-gaap:NondesignatedMemberus-gaap:ForeignExchangeContractMembersrt:MaximumMember2024-03-310001136869us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMemberus-gaap:ForeignExchangeForwardMemberus-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2023-01-012023-03-310001136869us-gaap:SeniorNotesMemberzbh:FivePointThreeFiveZeroPercentageMemberzbh:TwoThousandTwentyEightMember2023-12-310001136869us-gaap:CostOfSalesMember2023-01-012023-03-310001136869zbh:TwoThousandThirtyMemberus-gaap:SeniorNotesMemberzbh:ThreePointFiveFiveZeroPercentageMember2023-12-310001136869us-gaap:CashFlowHedgingMember2023-01-012023-03-310001136869us-gaap:CostOfSalesMember2024-03-310001136869us-gaap:InterestRateSwapMemberus-gaap:InterestExpenseMember2023-01-012023-03-310001136869zbh:CorporateItemsMember2024-01-012024-03-310001136869zbh:AprilAcquisitionMembersrt:MaximumMember2023-04-2800011368692024-03-310001136869country:US2023-01-012023-03-310001136869us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMemberus-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMemberzbh:AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditAndUnrecognizedActuarialGainLossMember2024-01-012024-03-310001136869us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:ForeignExchangeForwardMember2023-12-310001136869zbh:OthersCountriesMember2024-01-012024-03-310001136869us-gaap:SeniorNotesMemberzbh:OnePointFourFiveZeroPercentageMemberzbh:TwoThousandTwentyFourMember2024-03-310001136869us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-03-310001136869us-gaap:NondesignatedMember2023-12-310001136869zbh:EmbodyIncMember2023-02-142023-02-140001136869us-gaap:CashFlowHedgingMember2023-12-310001136869country:US2024-01-012024-03-310001136869us-gaap:CommonStockMember2023-03-310001136869zbh:FourPointFourFiveZeroPercentageMemberus-gaap:SeniorNotesMemberzbh:TwoThousandFortyFiveMember2023-12-310001136869srt:AmericasMember2023-01-012023-03-310001136869zbh:CashFlowHedgesOneMember2023-12-310001136869us-gaap:AdditionalPaidInCapitalMember2023-03-310001136869zbh:EuroNotesMemberzbh:OnePointOneSixFourPercentageMemberzbh:TwoThousandTwentySevenMember2024-03-310001136869us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:InterestRateSwapMemberus-gaap:OtherLiabilitiesMember2023-12-310001136869us-gaap:OtherRestructuringMemberzbh:TwoThousandTwentyOneRestructuringPlanMember2023-12-310001136869us-gaap:FairValueMeasurementsRecurringMember2024-03-310001136869us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMemberus-gaap:ForeignExchangeForwardMemberus-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2024-01-012024-03-310001136869zbh:LongTermDebtNoncurrentMemberzbh:CumulativeFairValueHedgingAdjustmentCarryingAmountOfHedgedLiabilitiesMember2023-12-310001136869us-gaap:CashFlowHedgingMember2024-01-012024-03-310001136869zbh:AprilAcquisitionMember2023-04-282023-04-280001136869zbh:TwoThousandTwentyThreeRestructuringPlanMemberzbh:EmployeeTerminationBenefitsMember2024-03-310001136869us-gaap:NondesignatedMemberus-gaap:OtherCurrentAssetsMemberus-gaap:ForeignExchangeForwardMember2024-03-310001136869us-gaap:CustomerRelationshipsMember2023-01-012023-12-310001136869us-gaap:RetainedEarningsMember2023-03-310001136869zbh:CarryingAmountOfHedgedLiabilitiesMember2023-12-310001136869srt:MaximumMemberzbh:OctoberTwoThousandTwentyThreeAcquisitionMember2023-10-060001136869zbh:TwoThousandTwentyOneRestructuringPlanMemberus-gaap:OtherRestructuringMember2024-03-310001136869us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:FairValueInputsLevel2Memberus-gaap:InterestRateSwapMemberus-gaap:FairValueMeasurementsRecurringMember2024-03-310001136869us-gaap:SeniorNotesMemberzbh:TwoThousandTwentySixMemberzbh:ThreePointZeroFiveZeroPercentageMember2024-03-310001136869zbh:TwoThousandTwentyThreeThreeSixtyFourDayRevolvingCreditAgreementMember2024-01-012024-03-310001136869us-gaap:TreasuryStockCommonMember2023-01-012023-03-310001136869zbh:EmbodyIncMemberus-gaap:CommonStockMember2023-02-142023-02-140001136869srt:MaximumMemberzbh:TwoThousandTwentyThreeFiveYearCreditAgreementMember2024-03-310001136869zbh:TwoThousandTwentyThreeMemberus-gaap:SeniorNotesMemberzbh:ThreePointSevenZeroPercentageSeniorNotesDue2023Member2023-03-310001136869zbh:TwoThousandTwentyThreeThreeSixtyFourDayRevolvingCreditAgreementMembersrt:MinimumMember2024-03-310001136869zbh:MultiCurrencyRevolvingFacilityMemberzbh:TwoThousandTwentyTwoFiveYearCreditAgreementMember2022-08-192022-08-190001136869us-gaap:CommonStockMember2024-03-310001136869us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:OtherCurrentLiabilitiesMemberus-gaap:ForeignExchangeForwardMember2024-03-310001136869us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMemberus-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2023-01-012023-03-310001136869us-gaap:SeniorNotesMemberzbh:OnePointFourFiveZeroPercentageMemberzbh:TwoThousandTwentyFourMember2023-12-310001136869us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-01-012024-03-310001136869us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-12-310001136869us-gaap:TreasuryStockCommonMember2023-03-310001136869zbh:TwoThousandTwentyOneRestructuringPlanMemberzbh:EmployeeTerminationBenefitsMember2023-12-310001136869us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMemberzbh:AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditAndUnrecognizedActuarialGainLossMemberus-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2023-01-012023-03-310001136869zbh:EuroNotesMember2023-01-012023-03-310001136869zbh:OnePointOneSixFourPercentageNotesDueTwoThousandTwentySevenMember2024-01-012024-03-310001136869us-gaap:TrademarksAndTradeNamesMember2023-01-012023-12-310001136869us-gaap:InterestExpenseMember2024-01-012024-03-310001136869us-gaap:InterestRateSwapMemberus-gaap:CashFlowHedgingMember2023-01-012023-03-310001136869zbh:EmbodyIncMember2023-02-140001136869us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CrossCurrencyInterestRateContractMemberus-gaap:OtherAssetsMember2023-12-310001136869us-gaap:RetainedEarningsMember2023-01-012023-03-310001136869us-gaap:AdditionalPaidInCapitalMember2022-12-310001136869us-gaap:RetainedEarningsMember2023-12-310001136869us-gaap:ContractTerminationMemberzbh:TwoThousandNineteenRestructuringPlanMember2024-01-012024-03-310001136869us-gaap:CrossCurrencyInterestRateContractMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:OtherAssetsMember2024-03-310001136869zbh:FourPointFourFiveZeroPercentageMemberus-gaap:SeniorNotesMemberzbh:TwoThousandFortyFiveMember2024-01-012024-03-310001136869zbh:TwoThousandTwentyThreeRestructuringPlanMember2024-03-310001136869us-gaap:TrademarksAndTradeNamesMemberzbh:TwoThousandTwentyThreeAcquisitionsMember2023-12-310001136869us-gaap:NoncontrollingInterestMember2024-01-012024-03-310001136869zbh:ForwardStartingInterestRateSwapsMemberus-gaap:CashFlowHedgingMember2024-01-012024-03-310001136869zbh:TwoThousandTwentyTwoFiveYearCreditAgreementMembersrt:MinimumMember2024-03-310001136869us-gaap:CashFlowHedgingMemberus-gaap:ForeignExchangeForwardMember2023-01-012023-03-310001136869zbh:UncommittedCreditFacilityMember2023-08-280001136869us-gaap:CashFlowHedgingMember2024-03-310001136869us-gaap:OtherRestructuringMemberzbh:TwoThousandNineteenRestructuringPlanMember2023-12-310001136869us-gaap:CrossCurrencyInterestRateContractMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:FairValueMeasurementsRecurringMember2023-12-310001136869zbh:EmbodyIncMemberus-gaap:CommonStockMember2024-03-310001136869zbh:TwoThousandTwentyThreeAcquisitionsMember2024-01-012024-03-310001136869us-gaap:CrossCurrencyInterestRateContractMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:OtherCurrentAssetsMember2024-03-310001136869zbh:TwoThousandTwentyThreeAcquisitionsMemberus-gaap:DevelopedTechnologyRightsMember2023-12-310001136869us-gaap:CrossCurrencyInterestRateContractMember2024-01-012024-03-3100011368692022-12-310001136869zbh:TwoPointFourTwoFivePercentageMemberzbh:EuroNotesMemberzbh:TwoThousandTwentySixMember2023-12-310001136869zbh:CorporateItemsMember2023-01-012023-03-310001136869zbh:TwoThousandTwentyOneRestructuringPlanMember2024-03-310001136869zbh:SETMember2023-01-012023-03-310001136869us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CrossCurrencyInterestRateContractMemberus-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2023-12-310001136869us-gaap:SeniorNotesMemberzbh:FivePointThreeFiveZeroPercentageMemberzbh:TwoThousandTwentyEightMember2024-03-310001136869us-gaap:CommonStockMember2023-01-012023-03-310001136869zbh:TwoThousandTwentyThreeMemberus-gaap:SeniorNotesMemberzbh:ThreePointSevenZeroPercentageSeniorNotesDue2023Member2023-01-012023-03-310001136869us-gaap:FairValueMeasurementsRecurringMember2023-12-310001136869us-gaap:OperatingSegmentsMembersrt:AsiaPacificMember2023-01-012023-03-310001136869zbh:TwoThousandThirtyNineMemberus-gaap:SeniorNotesMemberzbh:FivePointSevenFiveZeroPercentageMember2024-03-310001136869us-gaap:OperatingSegmentsMemberus-gaap:EMEAMember2024-01-012024-03-310001136869zbh:TwoThousandTwentyThreeAcquisitionsMemberus-gaap:InProcessResearchAndDevelopmentMember2023-12-3100011368692023-01-012023-12-310001136869us-gaap:NondesignatedMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:ForeignExchangeForwardMember2024-03-310001136869zbh:OctoberTwoThousandTwentyThreeAcquisitionMember2023-10-060001136869us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2023-12-310001136869us-gaap:ConstructionInProgressMember2023-12-3100011368692023-03-310001136869zbh:TwoThousandTwentyThreeFiveYearCreditAgreementMembersrt:MinimumMember2024-03-310001136869zbh:KneesMember2023-01-012023-03-310001136869zbh:MultiCurrencyRevolvingFacilityMemberzbh:TwoThousandTwentyTwoFiveYearCreditAgreementMember2022-08-190001136869us-gaap:ContractTerminationMemberzbh:TwoThousandTwentyOneRestructuringPlanMember2023-12-310001136869us-gaap:NondesignatedMemberus-gaap:OtherCurrentAssetsMemberus-gaap:ForeignExchangeForwardMember2023-12-310001136869us-gaap:InterestExpenseMember2024-03-310001136869us-gaap:InterestRateSwapMemberus-gaap:InterestExpenseMember2024-01-012024-03-310001136869zbh:UncommittedCreditFacilityMember2024-03-310001136869zbh:EuroNotesMember2024-01-012024-03-310001136869zbh:FourPointTwoFiveZeroPercentageMemberus-gaap:SeniorNotesMemberzbh:TwoThousandThirtyFiveMember2024-03-310001136869zbh:TwoThousandTwentyFiveMemberus-gaap:SeniorNotesMemberzbh:ThreePointFiveFiveZeroPercentageMember2024-03-310001136869us-gaap:AccumulatedTranslationAdjustmentMember2024-01-012024-03-310001136869us-gaap:NondesignatedMemberus-gaap:OtherCurrentLiabilitiesMemberus-gaap:ForeignExchangeForwardMember2023-12-310001136869us-gaap:CrossCurrencyInterestRateContractMember2024-03-310001136869zbh:TwoThousandTwentyOneRestructuringPlanMember2024-01-012024-03-310001136869zbh:TwoThousandNineteenRestructuringPlanMember2019-12-310001136869us-gaap:CommonStockMember2023-12-310001136869us-gaap:CashFlowHedgingMemberus-gaap:ForeignExchangeForwardMember2024-01-012024-03-310001136869zbh:InstrumentsMember2024-03-310001136869us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:FairValueInputsLevel2Memberus-gaap:InterestRateSwapMemberus-gaap:FairValueMeasurementsRecurringMember2023-12-310001136869zbh:TwoThousandTwentyOneRestructuringPlanMemberzbh:EmployeeTerminationBenefitsMember2024-03-310001136869us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMemberzbh:ForwardStartingInterestRateSwapsMemberus-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2023-01-012023-03-310001136869zbh:ShortTermTermLoanMemberus-gaap:CashMember2023-01-012023-03-310001136869us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2024-01-012024-03-310001136869us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2024-01-012024-03-310001136869zbh:TwoPointSixZeroPercentageMemberus-gaap:SeniorNotesMemberzbh:TwoThousandThirtyOneMember2024-03-310001136869zbh:FourPointTwoFiveZeroPercentageMemberus-gaap:SeniorNotesMemberzbh:TwoThousandThirtyFiveMember2023-12-310001136869us-gaap:DevelopedTechnologyRightsMember2023-01-012023-12-310001136869zbh:NovemberTwoThousandTwentyThreeAcquisitionMember2023-11-152023-11-150001136869zbh:HipsMember2024-01-012024-03-310001136869zbh:TwoThousandNineteenRestructuringPlanMember2024-03-310001136869us-gaap:CrossCurrencyInterestRateContractMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:OtherLiabilitiesMember2023-12-3100011368692024-04-220001136869zbh:EmbodyIncMemberus-gaap:CommonStockMember2024-01-012024-03-310001136869us-gaap:CommonStockMember2024-01-012024-03-310001136869zbh:EuroNotesMemberzbh:OnePointOneSixFourPercentageMemberzbh:TwoThousandTwentySevenMember2023-12-310001136869us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMemberus-gaap:ForeignExchangeForwardMemberus-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2023-01-012023-03-310001136869zbh:TwoThousandTwentyThreeRestructuringPlanMemberus-gaap:ContractTerminationMember2024-01-012024-03-310001136869us-gaap:OperatingSegmentsMembersrt:AsiaPacificMember2024-01-012024-03-310001136869zbh:TwoThousandTwentyThreeThreeSixtyFourDayRevolvingCreditAgreementMember2024-03-310001136869us-gaap:CostOfSalesMember2024-01-012024-03-3100011368692024-01-012024-03-310001136869zbh:TwoPointFourTwoFivePercentageNotesDueTwoThousandTwentySixMember2024-01-012024-03-310001136869us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:InterestRateSwapMemberus-gaap:FairValueMeasurementsRecurringMember2023-12-310001136869zbh:CrossCurrencyInterestRateContractMaturedMember2023-01-012023-03-310001136869us-gaap:TreasuryStockCommonMember2022-12-310001136869zbh:OthersCountriesMember2023-01-012023-03-310001136869srt:MaximumMemberzbh:NovemberTwoThousandTwentyThreeAcquisitionMember2023-11-150001136869us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2023-12-3100011368692023-12-310001136869zbh:EmbodyIncMemberus-gaap:InProcessResearchAndDevelopmentMember2023-03-310001136869us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMemberus-gaap:ForeignExchangeForwardMemberus-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2024-01-012024-03-310001136869us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:OtherAssetsMemberus-gaap:ForeignExchangeForwardMember2023-12-310001136869us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:OtherAssetsMemberus-gaap:ForeignExchangeForwardMember2024-03-310001136869zbh:TwoThousandTwentyOneRestructuringPlanMemberzbh:EmployeeTerminationBenefitsMember2024-01-012024-03-310001136869us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMemberus-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2024-01-012024-03-310001136869us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:ForeignExchangeForwardMemberus-gaap:OtherLiabilitiesMember2023-12-310001136869zbh:TwoThousandTwentyTwoThreeSixtyFourDayRevolvingCreditAgreementMember2022-08-190001136869zbh:BuildingsAndEquipmentMember2023-12-310001136869us-gaap:NoncontrollingInterestMember2023-12-310001136869zbh:TwoThousandNineteenRestructuringPlanMember2024-01-012024-03-310001136869zbh:FourPointFourFiveZeroPercentageMemberus-gaap:SeniorNotesMemberzbh:TwoThousandFortyFiveMember2024-03-310001136869us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CrossCurrencyInterestRateContractMemberus-gaap:OtherCurrentAssetsMember2023-12-310001136869zbh:EuroNotesMember2024-03-310001136869zbh:TwoThousandTwentyOneRestructuringPlanMember2021-12-310001136869zbh:TwoThousandTwentyOneRestructuringPlanMember2023-12-310001136869zbh:TwoPointSixZeroPercentageMemberus-gaap:SeniorNotesMemberzbh:TwoThousandThirtyOneMember2023-12-310001136869us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CrossCurrencyInterestRateContractMemberus-gaap:OtherCurrentLiabilitiesMember2023-12-310001136869zbh:CrossCurrencyInterestRateContractMaturedMember2023-03-310001136869us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-03-310001136869us-gaap:CommonStockMember2022-12-310001136869us-gaap:AccumulatedTranslationAdjustmentMember2023-12-310001136869us-gaap:NondesignatedMemberus-gaap:OtherNonoperatingIncomeExpenseMemberus-gaap:ForeignExchangeForwardMember2023-01-012023-03-310001136869us-gaap:NondesignatedMemberus-gaap:OtherCurrentLiabilitiesMemberus-gaap:ForeignExchangeForwardMember2024-03-310001136869us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:ForeignExchangeForwardMemberus-gaap:OtherLiabilitiesMember2024-03-310001136869us-gaap:CrossCurrencyInterestRateContractMemberus-gaap:NetInvestmentHedgingMemberus-gaap:InterestExpenseMember2024-01-012024-03-310001136869zbh:LongTermDebtNoncurrentMemberzbh:CumulativeFairValueHedgingAdjustmentCarryingAmountOfHedgedLiabilitiesMember2024-03-310001136869us-gaap:NoncontrollingInterestMember2022-12-310001136869us-gaap:CrossCurrencyInterestRateContractMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:OtherLiabilitiesMember2024-03-310001136869zbh:OctoberTwoThousandTwentyThreeAcquisitionMember2023-10-062023-10-060001136869us-gaap:DesignatedAsHedgingInstrumentMember2023-12-310001136869us-gaap:NondesignatedMember2024-03-310001136869srt:MaximumMemberzbh:EmbodyIncMemberus-gaap:CommonStockMember2023-02-140001136869us-gaap:SeniorNotesMemberzbh:TwoThousandTwentySixMemberzbh:ThreePointZeroFiveZeroPercentageMember2023-12-310001136869us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-01-012023-03-310001136869zbh:TwoThousandTwentyThreeAcquisitionsMemberus-gaap:CustomerRelationshipsMember2023-12-310001136869zbh:TwoThousandNineteenRestructuringPlanMember2023-12-310001136869us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2024-03-310001136869zbh:CarryingAmountOfHedgedLiabilitiesMember2024-03-310001136869us-gaap:SoftwareAndSoftwareDevelopmentCostsMember2023-12-310001136869zbh:TwoPointFourTwoFivePercentageMemberzbh:EuroNotesMemberzbh:TwoThousandTwentySixMember2024-03-310001136869us-gaap:ContractTerminationMemberzbh:TwoThousandTwentyThreeRestructuringPlanMember2024-03-310001136869us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:OtherCurrentLiabilitiesMemberus-gaap:ForeignExchangeForwardMember2023-12-310001136869us-gaap:NondesignatedMemberus-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:ForeignExchangeForwardMember2024-03-310001136869us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:InterestRateSwapMemberus-gaap:OtherLiabilitiesMember2024-03-310001136869us-gaap:AdditionalPaidInCapitalMember2023-12-310001136869us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2023-12-310001136869us-gaap:NondesignatedMemberus-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:ForeignExchangeForwardMember2023-12-310001136869us-gaap:ContractTerminationMemberzbh:TwoThousandTwentyOneRestructuringPlanMember2024-01-012024-03-310001136869zbh:OtherProductCategoryMember2023-01-012023-03-310001136869zbh:SETMember2024-01-012024-03-310001136869zbh:TwoThousandThirtyNineMemberus-gaap:SeniorNotesMemberzbh:FivePointSevenFiveZeroPercentageMember2023-12-310001136869us-gaap:LandMember2023-12-310001136869us-gaap:ContractTerminationMemberzbh:TwoThousandTwentyOneRestructuringPlanMember2024-03-310001136869zbh:TwoThousandTwentyThreeRestructuringPlanMemberzbh:EmployeeTerminationBenefitsMember2023-12-310001136869srt:AmericasMember2024-01-012024-03-310001136869us-gaap:AdditionalPaidInCapitalMember2024-01-012024-03-310001136869us-gaap:OtherRestructuringMemberzbh:TwoThousandNineteenRestructuringPlanMember2024-03-310001136869us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:ForeignExchangeForwardMember2024-03-310001136869us-gaap:ForeignExchangeContractMembercurrency:CHF2024-03-310001136869us-gaap:NondesignatedMemberus-gaap:ForeignExchangeContractMembersrt:MinimumMember2024-03-310001136869us-gaap:AccumulatedTranslationAdjustmentMember2024-03-310001136869zbh:TwoThousandTwentyThreeRestructuringPlanMemberus-gaap:OtherRestructuringMember2024-03-310001136869us-gaap:NondesignatedMemberus-gaap:OtherNonoperatingIncomeExpenseMemberus-gaap:ForeignExchangeForwardMember2024-01-012024-03-310001136869zbh:OtherContingenciesMember2024-03-310001136869zbh:TwoThousandTwentyTwoFiveYearCreditAgreementMember2023-07-070001136869us-gaap:NoncontrollingInterestMember2023-03-310001136869zbh:TwoThousandTwentyThreeAcquisitionsMember2023-12-310001136869zbh:InstrumentsMember2023-12-310001136869zbh:CrossCurrencyInterestRateContractMaturedMember2024-03-310001136869us-gaap:AdditionalPaidInCapitalMember2023-01-012023-03-310001136869zbh:TwoThousandTwentyThreeRestructuringPlanMember2024-01-012024-03-310001136869us-gaap:InterestExpenseMember2023-01-012023-03-310001136869zbh:TwoThousandTwentyThreeRestructuringPlanMember2023-12-310001136869zbh:TwoThousandTwentyFiveMemberus-gaap:SeniorNotesMemberzbh:ThreePointFiveFiveZeroPercentageMember2023-12-310001136869us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2024-01-012024-03-310001136869us-gaap:SoftwareAndSoftwareDevelopmentCostsMember2024-03-310001136869us-gaap:NondesignatedMemberus-gaap:ForeignExchangeForwardMember2023-12-310001136869us-gaap:ContractTerminationMemberzbh:TwoThousandNineteenRestructuringPlanMember2023-12-310001136869us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMemberus-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2024-01-012024-03-310001136869zbh:MultiCurrencyRevolvingFacilityMemberzbh:TwoThousandTwentyThreeFiveYearCreditAgreementMember2023-07-070001136869us-gaap:CrossCurrencyInterestRateContractMemberus-gaap:NetInvestmentHedgingMemberus-gaap:InterestExpenseMember2023-01-012023-03-310001136869us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CrossCurrencyInterestRateContractMemberus-gaap:OtherCurrentLiabilitiesMember2024-03-310001136869us-gaap:OperatingSegmentsMemberus-gaap:EMEAMember2023-01-012023-03-310001136869zbh:TwoThousandTwentyOneRestructuringPlanMemberus-gaap:OtherRestructuringMember2024-01-012024-03-310001136869us-gaap:InterestRateSwapMemberus-gaap:CashFlowHedgingMember2024-01-012024-03-310001136869us-gaap:CrossCurrencyInterestRateContractMember2023-01-012023-03-310001136869us-gaap:ContractTerminationMemberzbh:TwoThousandNineteenRestructuringPlanMember2024-03-310001136869us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-12-310001136869us-gaap:RetainedEarningsMember2022-12-310001136869us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:ForeignExchangeForwardMember2023-12-310001136869zbh:OtherProductCategoryMember2024-01-012024-03-310001136869zbh:NovemberTwoThousandTwentyThreeAcquisitionMember2023-11-150001136869zbh:TwoThousandTwentyThreeRestructuringPlanMemberus-gaap:OtherRestructuringMember2023-12-310001136869us-gaap:NoncontrollingInterestMember2023-01-012023-03-310001136869zbh:KneesMember2024-01-012024-03-310001136869zbh:TwoThousandTwentyThreeRestructuringPlanMemberzbh:EmployeeTerminationBenefitsMember2024-01-012024-03-310001136869zbh:MultiCurrencyRevolvingFacilityMemberzbh:TwoThousandTwentyThreeFiveYearCreditAgreementMember2023-07-072023-07-070001136869us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2024-03-310001136869us-gaap:DesignatedAsHedgingInstrumentMember2024-03-310001136869us-gaap:TreasuryStockCommonMember2024-03-310001136869zbh:EmployeeTerminationBenefitsMemberzbh:TwoThousandNineteenRestructuringPlanMember2024-03-310001136869us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:OtherCurrentAssetsMemberus-gaap:ForeignExchangeForwardMember2024-03-3100011368692023-01-012023-03-310001136869us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMemberzbh:ForwardStartingInterestRateSwapsMemberus-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2024-01-012024-03-310001136869us-gaap:NondesignatedMemberus-gaap:ForeignExchangeForwardMember2024-03-310001136869us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:InterestRateSwapMemberus-gaap:FairValueMeasurementsRecurringMember2024-03-310001136869us-gaap:NondesignatedMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:ForeignExchangeForwardMember2023-12-310001136869srt:MaximumMemberzbh:TwoThousandTwentyThreeThreeSixtyFourDayRevolvingCreditAgreementMember2024-03-310001136869zbh:BuildingsAndEquipmentMember2024-03-310001136869zbh:EmployeeTerminationBenefitsMemberzbh:TwoThousandNineteenRestructuringPlanMember2024-01-012024-03-310001136869zbh:EmployeeTerminationBenefitsMemberzbh:TwoThousandNineteenRestructuringPlanMember2023-12-310001136869us-gaap:RetainedEarningsMember2024-03-310001136869us-gaap:NoncontrollingInterestMember2024-03-310001136869us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2024-03-310001136869us-gaap:CrossCurrencyInterestRateContractMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:FairValueMeasurementsRecurringMember2024-03-310001136869zbh:CashFlowHedgesOneMember2024-03-310001136869us-gaap:RetainedEarningsMember2024-01-012024-03-310001136869us-gaap:CommonStockMember2024-01-012024-03-310001136869us-gaap:TreasuryStockCommonMember2023-12-310001136869us-gaap:AdditionalPaidInCapitalMember2024-03-310001136869us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2023-01-012023-03-310001136869zbh:TwoThousandTwentyThreeRestructuringPlanMemberus-gaap:OtherRestructuringMember2024-01-012024-03-310001136869zbh:TwoThousandThirtyMemberus-gaap:SeniorNotesMemberzbh:ThreePointFiveFiveZeroPercentageMember2024-03-310001136869us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:ForeignExchangeForwardMember2024-03-310001136869zbh:ForwardStartingInterestRateSwapsMemberus-gaap:CashFlowHedgingMember2023-01-012023-03-310001136869us-gaap:ConstructionInProgressMember2024-03-310001136869us-gaap:TreasuryStockCommonMember2024-01-012024-03-310001136869currency:USDus-gaap:ForeignExchangeContractMember2024-03-310001136869us-gaap:OtherRestructuringMemberzbh:TwoThousandNineteenRestructuringPlanMember2024-01-012024-03-310001136869zbh:EmbodyIncMemberus-gaap:CommonStockMember2023-02-140001136869us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMemberus-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2023-01-012023-03-310001136869us-gaap:CrossCurrencyInterestRateContractMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2024-03-31iso4217:EURiso4217:USDxbrli:sharesxbrli:pureiso4217:JPYxbrli:sharesiso4217:CHFzbh:Segmentiso4217:USD

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

FORM 10-Q

 

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE

SECURITIES EXCHANGE ACT OF 1934

FOR THE QUARTERLY PERIOD ENDED March 31, 2024

Commission File Number 001-16407

 

ZIMMER BIOMET HOLDINGS, INC.

(Exact name of registrant as specified in its charter)

 

Delaware

13-4151777

(State or other jurisdiction of

incorporation or organization)

(IRS Employer

Identification No.)

345 East Main Street, Warsaw, IN 46580

(Address of principal executive offices)

Telephone: (574) 373-3333

 

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

Trading Symbol(s)

Name of each exchange on which registered

Common Stock, $0.01 par value

ZBH

New York Stock Exchange

2.425% Notes due 2026

ZBH 26

New York Stock Exchange

1.164% Notes due 2027

ZBH 27

New York Stock Exchange

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer

☒

 

 

Accelerated filer

☐

 

 

 

 

 

Non-accelerated filer

☐

Smaller reporting company

☐

 

 

 

 

Emerging growth company

☐

 

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

As of April 22, 2024, 205,728,398 shares of the registrant’s $.01 par value common stock were outstanding.

 

 

 

ZIMMER BIOMET HOLDINGS, INC.

INDEX TO FORM 10-Q

March 31, 2024

 

 

 

 

Page

 

 

 

Part I - Financial Information

 

 

 

 

 

 

 

Item 1.

 

Financial Statements (unaudited)

 

3

 

 

Condensed Consolidated Statements of Earnings for the Three Months Ended March 31, 2024 and 2023

 

3

 

 

Condensed Consolidated Statements of Comprehensive Income for the Three Months Ended March 31, 2024 and 2023

 

4

 

 

Condensed Consolidated Balance Sheets as of March 31, 2024 and December 31, 2023

 

5

 

 

Condensed Consolidated Statements of Stockholders’ Equity for the Three Months Ended March 31, 2024 and 2023

 

6

 

 

Condensed Consolidated Statements of Cash Flows for the Three Months Ended March 31, 2024 and 2023

 

7

 

 

Notes to Interim Condensed Consolidated Financial Statements

 

8

 

 

 

 

 

Item 2.

 

Management’s Discussion and Analysis of Financial Condition and Results of Operations

 

26

 

 

 

 

 

Item 3.

 

Quantitative and Qualitative Disclosures About Market Risk

 

33

 

 

 

 

 

Item 4.

 

Controls and Procedures

 

33

 

 

 

Part II - Other Information

 

 

 

 

 

 

 

Item 1.

 

Legal Proceedings

 

34

 

 

 

 

 

Item 1A.

 

Risk Factors

 

34

 

 

 

 

 

Item 2.

 

Unregistered Sales of Equity Securities and Use of Proceeds

 

34

 

 

 

 

 

Item 3.

 

Defaults Upon Senior Securities

 

34

 

 

 

 

 

Item 4.

 

Mine Safety Disclosures

 

34

 

 

 

 

 

Item 5.

 

Other Information

 

34

 

 

 

 

 

Item 6.

 

Exhibits

 

36

 

 

 

Signatures

 

37

 

2

 

Part I – Financial Information

Item 1. Financial Statements

ZIMMER BIOMET HOLDINGS, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF EARNINGS

(in millions, except per share amounts, unaudited)

 

 

Three Months Ended

 

 

 

March 31,

 

 

 

2024

 

 

2023

 

Net Sales

 

$

1,889.2

 

 

$

1,831.0

 

Cost of products sold, excluding intangible asset amortization

 

 

512.3

 

 

 

500.8

 

Intangible asset amortization

 

 

142.1

 

 

 

133.4

 

Research and development

 

 

107.9

 

 

 

110.4

 

Selling, general and administrative

 

 

736.2

 

 

 

715.9

 

Restructuring and other cost reduction initiatives

 

 

124.4

 

 

 

41.8

 

Acquisition, integration, divestiture and related

 

 

0.4

 

 

 

1.3

 

Operating expenses

 

 

1,623.3

 

 

 

1,503.7

 

Operating Profit

 

 

265.9

 

 

 

327.3

 

Other (expense) income, net

 

 

(0.1

)

 

 

7.7

 

Interest expense, net

 

 

(50.7

)

 

 

(48.2

)

Earnings before income taxes

 

 

215.1

 

 

 

286.8

 

Provision for income taxes

 

 

42.3

 

 

 

54.1

 

Net Earnings

 

 

172.8

 

 

 

232.8

 

Less: Net earnings attributable to noncontrolling interest

 

 

0.4

 

 

 

0.2

 

Net Earnings of Zimmer Biomet Holdings, Inc.

 

$

172.4

 

 

$

232.5

 

 

 

 

 

 

 

Earnings Per Common Share

 

 

 

 

 

 

Basic

 

$

0.84

 

 

$

1.11

 

Diluted

 

$

0.84

 

 

$

1.11

 

Weighted Average Common Shares Outstanding

 

 

 

 

 

 

Basic

 

 

205.2

 

 

 

209.4

 

Diluted

 

 

206.2

 

 

 

210.4

 

The accompanying notes are an integral part of these condensed consolidated financial statements.

3

 

ZIMMER BIOMET HOLDINGS, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME

(in millions, unaudited)

 

 

Three Months Ended

 

 

 

March 31,

 

 

 

2024

 

 

2023

 

Net Earnings of Zimmer Biomet Holdings, Inc.

 

$

172.4

 

 

$

232.5

 

Other Comprehensive Income (Loss):

 

 

 

 

 

 

Foreign currency cumulative translation adjustments, net of tax

 

 

(35.8

)

 

 

12.4

 

Unrealized cash flow hedge gains, net of tax

 

 

34.7

 

 

 

8.8

 

Reclassification adjustments on hedges, net of tax

 

 

(18.0

)

 

 

(19.0

)

Adjustments to prior service cost and unrecognized actuarial assumptions, net of tax

 

 

(1.1

)

 

 

(0.9

)

Total Other Comprehensive (Loss) Income

 

 

(20.2

)

 

 

1.3

 

Comprehensive Income Attributable to

 

 

 

 

 

 

Zimmer Biomet Holdings, Inc.

 

$

152.2

 

 

$

233.8

 

The accompanying notes are an integral part of these condensed consolidated financial statements.

4

 

ZIMMER BIOMET HOLDINGS, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS

(in millions, except share amounts, unaudited)

 

 

March 31,

 

 

December 31,

 

 

 

2024

 

 

2023

 

ASSETS

 

 

 

 

 

 

Current Assets:

 

 

 

 

 

 

Cash and cash equivalents

 

$

393.0

 

 

$

415.8

 

Accounts receivable, less allowance for credit losses

 

 

1,446.4

 

 

 

1,442.4

 

Inventories

 

 

2,388.2

 

 

 

2,385.2

 

Prepaid expenses and other current assets

 

 

403.8

 

 

 

366.1

 

Total Current Assets

 

 

4,631.5

 

 

 

4,609.5

 

Property, plant and equipment, net

 

 

2,090.9

 

 

 

2,060.4

 

Goodwill

 

 

8,791.5

 

 

 

8,818.5

 

Intangible assets, net

 

 

4,734.1

 

 

 

4,856.4

 

Other assets

 

 

1,204.4

 

 

 

1,152.1

 

Total Assets

 

$

21,452.4

 

 

$

21,496.9

 

LIABILITIES AND STOCKHOLDERS' EQUITY

 

 

 

 

 

 

Current Liabilities:

 

 

 

 

 

 

Accounts payable

 

$

370.3

 

 

$

410.6

 

Income taxes payable

 

 

70.3

 

 

 

61.2

 

Other current liabilities

 

 

1,386.3

 

 

 

1,485.7

 

Current portion of long-term debt

 

 

970.0

 

 

 

900.0

 

Total Current Liabilities

 

 

2,797.0

 

 

 

2,857.4

 

Deferred income taxes, net

 

 

370.4

 

 

 

357.6

 

Long-term income tax payable

 

 

275.8

 

 

 

273.7

 

Other long-term liabilities

 

 

577.0

 

 

 

652.1

 

Long-term debt

 

 

4,826.2

 

 

 

4,867.9

 

Total Liabilities

 

 

8,846.4

 

 

 

9,008.7

 

Commitments and Contingencies (Note 15)

 

 

 

 

 

 

Stockholders' Equity:

 

 

 

 

 

 

Zimmer Biomet Holdings, Inc. Stockholders' Equity:

 

 

 

 

 

 

Common stock, $0.01 par value, one billion shares authorized, 317.2 million shares as of March 31, 2024 (316.2 million as of December 31, 2023) issued

 

 

3.2

 

 

 

3.2

 

Paid-in capital

 

 

9,945.9

 

 

 

9,846.1

 

Retained earnings

 

 

10,509.0

 

 

 

10,384.5

 

Accumulated other comprehensive loss

 

 

(211.2

)

 

 

(191.0

)

Treasury stock, 111.5 million shares as of March 31, 2024 (110.6 million as of December 31, 2023)

 

 

(7,648.9

)

 

 

(7,562.3

)

Total Zimmer Biomet Holdings, Inc. stockholders' equity

 

 

12,598.0

 

 

 

12,480.5

 

Noncontrolling interest

 

 

8.1

 

 

 

7.7

 

Total Stockholders' Equity

 

 

12,606.0

 

 

 

12,488.1

 

Total Liabilities and Stockholders' Equity

 

$

21,452.4

 

 

$

21,496.9

 

The accompanying notes are an integral part of these condensed consolidated financial statements.

5

 

ZIMMER BIOMET HOLDINGS, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY

(in millions, except per share amounts, unaudited)

 

 

 

Zimmer Biomet Holdings, Inc. Stockholders

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Accumulated

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Other

 

 

 

 

 

 

 

 

 

 

 

Total

 

 

 

Common Shares

 

 

Paid-in

 

 

Retained

 

 

Comprehensive

 

 

Treasury Shares

 

 

Noncontrolling

 

 

Stockholders'

 

 

 

Number

 

 

Amount

 

 

Capital

 

 

Earnings

 

 

(Loss) Income

 

 

Number

 

 

Amount

 

 

Interest

 

 

Equity

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balance January 1, 2024

 

 

316.2

 

 

$

3.2

 

 

$

9,846.1

 

 

$

10,384.5

 

 

$

(191.0

)

 

 

(110.6

)

 

$

(7,562.3

)

 

$

7.7

 

 

$

12,488.1

 

Net earnings

 

 

-

 

 

 

-

 

 

 

-

 

 

 

172.4

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

0.4

 

 

 

172.8

 

Other comprehensive loss

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(20.2

)

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(20.2

)

Cash dividends declared
($0.24 per share)

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(49.3

)

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(49.3

)

Stock compensation plans

 

 

0.8

 

 

 

-

 

 

 

76.4

 

 

 

1.4

 

 

 

-

 

 

 

-

 

 

 

1.4

 

 

 

-

 

 

 

79.2

 

Embody, Inc. acquisition consideration

 

 

0.2

 

 

 

-

 

 

 

23.4

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

23.4

 

Share repurchases

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(0.9

)

 

 

(88.0

)

 

 

-

 

 

 

(88.0

)

Balance March 31, 2024

 

 

317.2

 

 

$

3.2

 

 

$

9,945.9

 

 

$

10,509.0

 

 

$

(211.2

)

 

 

(111.5

)

 

$

(7,648.9

)

 

$

8.1

 

 

$

12,606.0

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balance January 1, 2023

 

 

313.8

 

 

$

3.1

 

 

$

9,504.4

 

 

$

9,559.3

 

 

$

(179.3

)

 

 

(104.8

)

 

$

(6,867.2

)

 

$

6.7

 

 

$

12,027.0

 

Net earnings

 

 

-

 

 

 

-

 

 

 

-

 

 

 

232.5

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

0.2

 

 

 

232.8

 

Other comprehensive income

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

1.3

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

1.3

 

Cash dividends declared
($0.24 per share)

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(50.4

)

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(50.4

)

Stock compensation plans

 

 

0.5

 

 

 

-

 

 

 

55.4

 

 

 

0.3

 

 

 

-

 

 

 

-

 

 

 

0.3

 

 

 

-

 

 

 

56.0

 

Embody, Inc. acquisition consideration

 

 

1.1

 

 

 

0.1

 

 

 

134.9

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

135.0

 

Share repurchases

 

 

-

 

 

 

-

 

 

 

(2.3

)

 

 

-

 

 

 

-

 

 

 

(2.1

)

 

 

(241.7

)

 

 

-

 

 

 

(244.0

)

Balance March 31, 2023

 

 

315.4

 

 

$

3.2

 

 

$

9,692.4

 

 

$

9,741.7

 

 

$

(178.0

)

 

 

(106.9

)

 

$

(7,108.6

)

 

$

6.9

 

 

$

12,157.6

 

 

The accompanying notes are an integral part of these condensed consolidated financial statements.

6

 

ZIMMER BIOMET HOLDINGS, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(in millions, unaudited)

 

 

 

 

 

 

For the Three Months Ended March 31,

 

 

 

2024

 

 

2023

 

Cash flows provided by (used in) operating activities:

 

 

 

 

 

 

Net earnings

 

$

172.8

 

 

$

232.8

 

Adjustments to reconcile net earnings to cash provided
   by operating activities:

 

 

 

 

 

 

Depreciation and amortization

 

 

238.6

 

 

 

231.8

 

Share-based compensation

 

 

29.0

 

 

 

25.0

 

Changes in operating assets and liabilities, net of acquired assets and liabilities

 

 

 

 

 

 

Income taxes

 

 

(8.6

)

 

 

21.5

 

Receivables

 

 

(22.7

)

 

 

8.6

 

Inventories

 

 

(55.3

)

 

 

(94.2

)

Accounts payable and accrued liabilities

 

 

(119.4

)

 

 

(91.8

)

Other assets and liabilities

 

 

(6.4

)

 

 

(26.0

)

       Net cash provided by operating activities

 

 

228.0

 

 

 

307.7

 

Cash flows provided by (used in) investing activities:

 

 

 

 

 

 

Additions to instruments

 

 

(82.0

)

 

 

(82.8

)

Additions to other property, plant and equipment

 

 

(55.1

)

 

 

(46.7

)

Net investment hedge settlements

 

 

10.2

 

 

 

13.4

 

Acquisition of intellectual property rights

 

 

(12.5

)

 

 

(14.0

)

Business combination investments, net of acquired cash

 

 

-

 

 

 

(18.9

)

Other investing activities

 

 

(55.6

)

 

 

(0.3

)

              Net cash used in investing activities

 

 

(195.0

)

 

 

(149.4

)

Cash flows provided by (used in) financing activities:

 

 

 

 

 

 

Net proceeds from revolving facilities

 

 

70.0

 

 

 

210.0

 

Redemption of senior notes

 

 

-

 

 

 

(86.3

)

Payment on term loan

 

 

-

 

 

 

(33.9

)

Dividends paid to stockholders

 

 

(49.4

)

 

 

(50.3

)

Proceeds from employee stock compensation plans

 

 

56.4

 

 

 

36.0

 

Business combination contingent consideration payments

 

 

(1.5

)

 

 

(9.6

)

Deferred business combination payments

 

 

(1.5

)

 

 

-

 

Repurchase of common stock

 

 

(113.6

)

 

 

(267.6

)

Other financing activities

 

 

(10.5

)

 

 

(5.1

)

               Net cash used in financing activities

 

 

(50.1

)

 

 

(206.7

)

Effect of exchange rates on cash and cash equivalents

 

 

(5.7

)

 

 

2.9

 

                      Change in cash and cash equivalents

 

 

(22.7

)

 

 

(45.5

)

Cash and cash equivalents, beginning of year

 

 

415.8

 

 

 

375.7

 

Cash and cash equivalents, end of period

 

$

393.0

 

 

$

330.2

 

 

The accompanying notes are an integral part of these condensed consolidated financial statements.

7

 

ZIMMER BIOMET HOLDINGS, INC. AND SUBSIDIARIES

NOTES TO INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

1. Basis of Presentation

The financial data presented herein is unaudited and should be read in conjunction with the consolidated financial statements and accompanying notes included in our Annual Report on Form 10-K for the year ended December 31, 2023.

In our opinion, the accompanying unaudited condensed consolidated financial statements include all adjustments, consisting of only normal recurring adjustments, necessary for a fair statement of the financial position, results of operations and cash flows for the interim periods presented. The December 31, 2023 condensed consolidated balance sheet data was derived from audited financial statements, but does not include all disclosures required by accounting principles generally accepted in the United States of America (“GAAP”). Results for interim periods should not be considered indicative of results for the full year.

 

Amounts reported in millions within this Quarterly Report on Form 10-Q are computed based on the actual amounts. As a result, the sum of the components may not equal the total amount reported in millions due to rounding. In addition, certain columns and rows within tables may not sum to the totals due to the use of rounded numbers. Percentages presented are calculated from the underlying unrounded amounts.

 

The words “we,” “us,” “our” and similar words, “Zimmer Biomet” and “the Company” refer to Zimmer Biomet Holdings, Inc. and its subsidiaries. “Zimmer Biomet Holdings” refers to the parent company only.

2. Significant Accounting Policies

Use of Estimates - The accompanying unaudited condensed consolidated financial statements are prepared in conformity with GAAP, which requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. We have made our best estimates, as appropriate under GAAP, in the recognition of our assets and liabilities. Actual results could differ materially from these estimates.

 

Accounting Pronouncements Not Yet Adopted - In November 2023, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2023-07, Improvements to Reportable Segment Disclosures, which is an amendment to ASC Topic 280 - Segment Reporting. The ASU requires more detailed and disaggregated segment information, including the disclosure of significant segment expense categories and amounts for each reportable segment. The ASU also requires certain annual disclosures to also be made in interim periods. The ASU is effective for fiscal years beginning after December 15, 2023, and interim periods for fiscal years beginning after December 15, 2024. The guidance will be applied retrospectively unless retrospective adoption is impracticable. Early adoption of this ASU is permitted. We are currently evaluating the impact this ASU will have on our financial statements and disclosures.

 

In December 2023, the FASB issued ASU 2023-09, Improvements to Income Tax Disclosures, which is an amendment to ASC Topic 740 - Income Taxes. The ASU improves the transparency of income tax disclosures by requiring greater disaggregated information about an entity’s effective tax rate reconciliation and requiring additional disclosures and disaggregation of income taxes, among other amendments to improve the effectiveness of income tax disclosures. The ASU is effective for fiscal years beginning after December 15, 2024. The guidance will be applied prospectively with an option to apply the guidance retrospectively. Early adoption of this ASU is permitted. We are currently evaluating the impact this ASU will have on our financial statements and disclosures.

3. Revenue

Net sales by geography are as follows (in millions):

 

 

 

Three Months Ended

 

 

 

March 31,

 

 

 

2024

 

 

2023

 

United States

 

$

1,099.2

 

 

$

1,060.4

 

International

 

 

790.0

 

 

 

770.6

 

Total

 

$

1,889.2

 

 

$

1,831.0

 

 

Net sales by product category are as follows (in millions):

8

 

 

 

 

Three Months Ended

 

 

 

March 31,

 

 

 

2024

 

 

2023

 

Knees

 

$

788.1

 

 

$

762.5

 

Hips

 

 

491.2

 

 

 

492.8

 

S.E.T.

 

 

452.6

 

 

 

433.4

 

Other

 

 

157.3

 

 

 

142.3

 

Total

 

$

1,889.2

 

 

$

1,831.0

 

 

S.E.T. includes sales from our Sports Medicine, Extremities, Trauma, Craniomaxillofacial and Thoracic ("CMFT") product categories. Other includes sales from our Technology, Surgical and Bone Cement product categories.

 

This net sales presentation differs from our reportable operating segments, which are based upon our senior management organizational structure and how we allocate resources toward achieving operating profit goals. Each of our reportable operating segments sells all the product categories noted above. Accordingly, the only difference from the presentation above and our reportable operating segments are the geographic groupings.

 

4. Restructuring

 

In December 2023, our management approved a new global restructuring program (the “2023 Restructuring Plan”) intended to optimize our cost structure and drive greater efficiencies throughout the company. The 2023 Restructuring Plan is expected to result in total pre-tax restructuring charges of approximately $120 million. The pre-tax restructuring charges consist of employee termination benefits; contract terminations for sales agents; and other charges, such as consulting fees. The expenses incurred under our 2023 Restructuring Plan are reported in our “Restructuring and other cost reduction initiatives” financial statement line item. The charges incurred in the three-month period ended March 31, 2024 were primarily the result of finalizing, obtaining approval and, where applicable, communicating certain restructuring plans. The following table summarizes the liabilities recognized related to the 2023 Restructuring Plan (in millions):

 

 

 

Employee

 

 

 

 

 

 

 

 

 

 

 

 

Termination

 

 

Contract

 

 

 

 

 

 

 

 

 

Benefits

 

 

Terminations

 

 

Other

 

 

Total

 

Balance, December 31, 2023

 

$

9.2

 

 

$

-

 

 

$

5.0

 

 

$

14.2

 

Expenses incurred in the three months ended March 31, 2024

 

 

71.0

 

 

 

1.8

 

 

 

6.8

 

 

 

79.6

 

Cash payments

 

 

(23.5

)

 

 

-

 

 

 

(1.3

)

 

 

(24.8

)

Foreign currency exchange rate changes

 

 

(0.4

)

 

 

-

 

 

 

-

 

 

 

(0.4

)

Non-cash activity

 

 

-

 

 

 

-

 

 

 

1.2

 

 

 

1.2

 

Balance, March 31, 2024

 

$

56.3

 

 

$

1.8

 

 

$

11.7

 

 

$

69.8

 

 

 

 

 

 

 

 

 

 

 

 

 

Expense incurred since the start of the 2023 Restructuring Plan

 

$

80.2

 

 

$

1.8

 

 

$

10.4

 

 

$

92.4

 

 

 

 

 

 

 

 

 

 

 

 

 

Expense estimated to be recognized for the 2023 Restructuring Plan

 

$

90.0

 

 

$

10.0

 

 

$

20.0

 

 

$

120.0

 

 

9

 

In December 2021, our management approved a global restructuring program (the “2021 Restructuring Plan”) intended to further reduce costs and to reorganize our global operations in preparation for the spinoff of ZimVie. The 2021 Restructuring Plan is expected to result in total pre-tax restructuring charges of approximately $180 million. The pre-tax restructuring charges consist of employee termination benefits; contract terminations for sales agents; and other charges, such as consulting fees and project management expenses. The expenses incurred under our 2021 Restructuring Plan are reported in our “Restructuring and other cost reduction initiatives” financial statement line item. The following table summarizes the liabilities recognized related to the 2021 Restructuring Plan (in millions):

 

 

 

Employee

 

 

 

 

 

 

 

 

 

 

 

 

Termination

 

 

Contract

 

 

 

 

 

 

 

 

 

Benefits

 

 

Terminations

 

 

Other

 

 

Total

 

Balance, December 31, 2023

 

$

4.2

 

 

$

17.6

 

 

$

2.9

 

 

$

24.7

 

Expenses incurred in the three months ended March 31, 2024

 

 

(0.4

)

 

 

-

 

 

 

1.3

 

 

 

0.9

 

Cash payments

 

 

(0.8

)

 

 

(7.3

)

 

 

(1.5

)

 

 

(9.6

)

Foreign currency exchange rate changes

 

 

(0.1

)

 

 

(0.4

)

 

 

-

 

 

 

(0.5

)

Balance, March 31, 2024

 

$

2.9

 

 

$

9.9

 

 

$

2.7

 

 

$

15.5

 

 

 

 

 

 

 

 

 

 

 

 

 

Expense incurred since the start of the 2021 Restructuring Plan

 

$

58.7

 

 

$

73.8

 

 

$

37.5

 

 

$

170.0

 

 

 

 

 

 

 

 

 

 

 

 

 

Expense estimated to be recognized for the 2021 Restructuring Plan

 

$

60.0

 

 

$

80.0

 

 

$

40.0

 

 

$

180.0

 

 

In December 2019, our Board of Directors approved, and we initiated, a global restructuring program (the “2019 Restructuring Plan”) with an objective of reducing structural costs to allow us to further invest in higher priority growth opportunities. The 2019 Restructuring Plan is expected to result in total pre-tax restructuring charges of approximately $370 million. The pre-tax restructuring charges consist of employee termination benefits; contract terminations for facilities and sales agents; and other charges, such as consulting fees, project management expenses and relocation costs, including costs to close a manufacturing facility.

 

The following table summarizes the location on our condensed consolidated statement of earnings and type of cost for our 2019 Restructuring Plan (in millions):

 

 

 

 

 

Three Months Ended March 31, 2024

 

 

 

Employee

 

 

 

 

 

 

 

 

 

 

 

 

Termination

 

 

Contract

 

 

 

 

 

 

 

 

 

Benefits

 

 

Terminations

 

 

Other

 

 

Total

 

Cost of products sold, excluding intangible asset amortization

 

$

-

 

 

$

-

 

 

$

0.5

 

 

$

0.5

 

Restructuring and other cost reduction initiatives

 

 

14.7

 

 

 

-

 

 

 

1.8

 

 

 

16.5

 

 

 

$

14.7

 

 

$

-

 

 

$

2.3

 

 

$

17.0

 

 

The following table summarizes the liabilities recognized related to the 2019 Restructuring Plan (in millions):

 

 

 

Employee

 

 

 

 

 

 

 

 

 

 

 

 

Termination

 

 

Contract

 

 

 

 

 

 

 

 

 

Benefits

 

 

Terminations

 

 

Other

 

 

Total

 

Balance, December 31, 2023

 

$

43.8

 

 

$

5.6

 

 

$

2.9

 

 

$

52.3

 

Expenses incurred in the three months ended March 31, 2024

 

 

14.7

 

 

 

-

 

 

 

2.3

 

 

 

17.0

 

Cash payments

 

 

-

 

 

 

(0.5

)

 

 

(3.5

)

 

 

(4.0

)

Foreign currency exchange rate changes

 

 

(0.5

)

 

 

-

 

 

 

-

 

 

 

(0.5

)

Balance, March 31, 2024

 

$

58.0

 

 

$

5.1

 

 

$

1.7

 

 

$

64.8

 

 

 

 

 

 

 

 

 

 

 

 

 

Expense incurred since the start of the 2019 Restructuring Plan

 

$

140.4

 

 

$

35.0

 

 

$

161.0

 

 

$

336.4

 

 

 

 

 

 

 

 

 

 

 

 

 

Expense estimated to be recognized for the 2019 Restructuring Plan

 

$

155.0

 

 

$

35.0

 

 

$

180.0

 

 

$

370.0

 

 

We do not include restructuring charges in the operating profit of our reportable segments. We report the expenses for other cost reduction and optimization initiatives in our “Restructuring and other cost reduction initiatives” financial statement line item because

10

 

these activities also have the goal of reducing costs across the organization. However, since the cost reduction initiative expenses are not considered restructuring, they have been excluded from the amounts presented in this note.

 

5. Inventories

 

 

March 31,

 

 

December 31,

 

 

 

2024

 

 

2023

 

 

 

(in millions)

 

Finished goods

 

$

1,846.7

 

 

$

1,831.2

 

Work in progress

 

 

226.7

 

 

 

246.5

 

Raw materials

 

 

314.8

 

 

 

307.5

 

Inventories

 

$

2,388.2

 

 

$

2,385.2

 

 

6. Property, Plant and Equipment

 

 

March 31,

 

 

December 31,

 

 

 

2024

 

 

2023

 

 

 

(in millions)

 

Land

 

$

18.8

 

 

$

18.9

 

Buildings and equipment

 

 

2,254.1

 

 

 

2,245.9

 

Capitalized software costs

 

 

555.2

 

 

 

552.2

 

Instruments

 

 

3,814.6

 

 

 

3,748.6

 

Construction in progress

 

 

206.4

 

 

 

200.6

 

 

 

 

6,849.1

 

 

 

6,766.2

 

Accumulated depreciation

 

 

(4,758.2

)

 

 

(4,705.8

)

Property, plant and equipment, net

 

$

2,090.9

 

 

$

2,060.4

 

We had $25.3 million and $30.8 million of property, plant and equipment included in accounts payable as of March 31, 2024 and December 31, 2023, respectively.

 

7. Acquisitions

 

On February 14, 2023, we completed the acquisition of all the outstanding shares of Embody, Inc. ("Embody"), a medical device company focused on soft tissue healing, that expands our portfolio for the sports medicine market. The initial consideration consisted of the issuance of 1.1 million shares of our common stock valued at $135.0 million and $19.5 million of cash for a total value of $154.5 million. The fair value of our common stock was determined to be $127.34 per share, which represented the average of our high and low stock prices on the acquisition date. The Embody acquisition includes additional consideration of up to $120.0 million in fair value of our common shares and cash, subject to achieving a future regulatory milestone after closing and commercial milestones based on sales growth over a three-year period. We assigned a fair value of $94.0 million for this contingent consideration as of the acquisition date. The estimated fair value of the contingent consideration liability was calculated based on the probability of achieving the specified regulatory milestone and by simulating numerous potential outcomes for the commercial milestones and discounting to present value the estimated payments.

On April 28, 2023, we completed the acquisition of all the outstanding shares of a privately held orthopedics medical device company that expands our portfolio in the orthopedics market ("April 2023 acquisition"). The initial consideration consisted of $15.0 million of cash and includes consideration of up to $8.0 million in cash, subject to achieving future regulatory milestones.

 

On October 6, 2023, we completed the acquisition of all the outstanding shares of a privately held orthopedics medical device company that provides us new surgical technology that can be used in procedures across multiple product categories (“October 2023 acquisition”). The initial consideration consisted of $42.2 million of cash and includes additional consideration of up to $33.0 million in cash contingent upon achieving certain commercial milestones based on sales growth over a three-year period. We assigned a fair value of $21.5 million for this contingent consideration as of the acquisition date. The estimated fair value of the contingent liability was calculated based on the probability of achieving the commercial milestones and discounting to present value the estimated payments.

 

On November 15, 2023, we completed the acquisition of a privately held technology company by acquiring certain assets, liabilities and employees of the technology company (“November 2023 acquisition”). The November 2023 acquisition expands our

11

 

technology and data capabilities and solutions across multiple product categories to better serve our customers. The initial consideration consisted of $60.7 million of cash and includes additional consideration of up to $20.0 million in cash contingent upon achieving a commercial milestone based on a certain sales target which must be achieved by December 31, 2025. We assigned a fair value of $15.0 million for this contingent consideration as of the acquisition date. The estimated fair value of the contingent liability was calculated based on the probability of achieving the commercial milestone and discounting to present value the estimated payment.

 

These acquisitions are collectively referred to in this report as the “2023 acquisitions”. Refer to Note 10 for information regarding the issuance of common stock and cash payments related to the contingent consideration liabilities that have occurred subsequent to the acquisition dates.

 

The goodwill related to the 2023 acquisitions represents the excess of the consideration transferred over the fair value of the net assets acquired. The goodwill related to the 2023 acquisitions is generated from the operational synergies and cross-selling opportunities we expect to achieve from the technologies acquired. A portion of the goodwill is expected to be deductible for U.S. income tax purposes. The goodwill related to the Embody, the October 2023 and the November 2023 acquisitions is included in the Americas operating segment and the Americas Orthopedics reporting unit. The goodwill related to the April 2023 acquisition is included in the Asia Pacific operating segment and reporting unit. The goodwill related to the Embody acquisition was the only significant activity related to our consolidated goodwill balance in the three-month period ended March 31, 2023, other than changes related to foreign currency exchange rate translation adjustments. Foreign currency exchange translations adjustments were the only significant activity impacting goodwill for the three-month period ended March 31, 2024.

 

The purchase price allocation for the Embody acquisition was final as of March 31, 2024. The purchase price allocations for the other 2023 acquisitions are preliminary as of March 31, 2024. We need additional time to evaluate the tax attributes of those transactions, which may change the recognized tax assets and liabilities. There may be differences between the preliminary estimates of fair value and the final acquisition accounting. The final estimates of fair value are expected to be completed as soon as possible, but no later than one year after the respective acquisition dates.

 

The following table summarizes the estimates of fair value of the assets acquired and liabilities assumed related to the 2023 acquisitions (in millions):

 

Current assets

 

$

13.1

 

Intangible assets subject to amortization:

 

 

 

   Technology

 

 

144.0

 

   Trademarks and trade names

 

 

3.5

 

   Customer relationships

 

 

40.1

 

Intangible assets not subject to amortization:

 

 

 

   In-process research and development (IPR&D)

 

 

36.3

 

Goodwill

 

 

215.0

 

Other assets

 

 

4.8

 

Total assets acquired

 

 

456.8

 

Current liabilities

 

 

8.2

 

Deferred income taxes

 

 

37.7

 

Total liabilities assumed

 

 

45.9

 

Net assets acquired

 

$

410.9

 

 

The weighted average amortization periods selected for technology, customer relationships and trademarks and trade names were 15 years, 8 years and 13 years, respectively. Upon receiving regulatory approval subsequent to the Embody acquisition date, the $36.3 million of IPR&D was reclassified to a definite-lived intangible asset and began amortizing over the applicable estimated useful life.

 

In the three-month period ended March 31, 2024, there were no material adjustments to the preliminary values of the 2023 acquisitions.

 

We have not included pro forma information and certain other information under GAAP for these acquisitions because they did not have a material impact on our financial position or results of operations.

 

12

 

8. Debt

Our debt consisted of the following (in millions):

 

 

March 31,

 

 

December 31,

 

 

 

2024

 

 

2023

 

Current portion of long-term debt

 

 

 

 

 

 

Uncommitted Credit Facility

 

$

120.0

 

 

$

50.0

 

1.450% Senior Notes due 2024

 

 

850.0

 

 

 

850.0

 

Total current portion of long-term debt

 

$

970.0

 

 

$

900.0

 

Long-term debt

 

 

 

 

 

 

3.550% Senior Notes due 2025

 

$

863.0

 

 

$

863.0

 

3.050% Senior Notes due 2026

 

 

600.0

 

 

 

600.0

 

5.350% Senior Notes due 2028

 

 

500.0

 

 

 

500.0

 

3.550% Senior Notes due 2030

 

 

257.5

 

 

 

257.5

 

2.600% Senior Notes due 2031

 

 

750.0

 

 

 

750.0

 

4.250% Senior Notes due 2035

 

 

253.4

 

 

 

253.4

 

5.750% Senior Notes due 2039

 

 

317.8

 

 

 

317.8

 

4.450% Senior Notes due 2045

 

 

395.4

 

 

 

395.4

 

2.425% Euro Notes due 2026

 

 

540.1

 

 

 

552.3

 

1.164% Euro Notes due 2027

 

 

540.1

 

 

 

552.3

 

Debt discount and issuance costs

 

 

(27.4

)

 

 

(29.1

)

Adjustment related to interest rate swaps

 

 

(163.7

)

 

 

(144.7

)

Total long-term debt

 

$

4,826.2

 

 

$

4,867.9

 

At March 31, 2024, our total current and non-current debt of $5.8 billion consisted of $5.9 billion aggregate principal amount of our senior notes, which included €1.0 billion Euro-denominated senior notes (“Euro Notes”), and $120.0 million of outstanding borrowings under the Uncommitted Credit Facility (defined below), partially offset by debt discount and issuance costs of $27.4 million and fair value adjustments related to interest rate swaps totaling $163.7 million.

 

In the three-month period ended March 31, 2023, we redeemed $83.0 million outstanding principal amount on a short-term term loan by paying $33.9 million in cash and by transferring all our common shares we owned of a publicly traded company we previously spun-off. The transfer of the common shares as part of the settlement resulted in a $49.1 million noncash financing activity. In the three-month period ended March 31, 2023 we also redeemed $86.3 million outstanding principal amount of our 3.700% Senior Notes due 2023.

 

On August 28, 2023, we entered into an uncommitted facility letter (the "Uncommitted Credit Facility"), which provides that from time to time, we may request, and the lender in its absolute and sole discretion may provide, short-term loans. Borrowings under the Uncommitted Credit Facility may be used only for general corporate and working capital purposes. The Uncommitted Credit Facility provides that the aggregate principal amount of outstanding borrowings at any time shall not exceed $300.0 million. Each borrowing under the Uncommitted Credit Facility will mature on the maturity date specified by the lender at the time of the advance, which will be no more than 90 days following the date of the advance. The Uncommitted Credit Facility and borrowings thereunder are unsecured. Borrowings under the Uncommitted Credit Facility bear interest at floating rates, based upon either an adjusted term secured overnight financing rate (“Term SOFR”) for the applicable interest period, the prime rate, or lender’s cost of funds, in each case, plus an applicable margin determined at the time of each borrowing. The Uncommitted Credit Facility includes customary affirmative and negative covenants and events of default for unsecured uncommitted financing arrangements. We were in compliance with all covenants under the Uncommitted Credit Facility as of March 31, 2024. As of March 31, 2024, there were outstanding borrowings of $120.0 million under the Uncommitted Credit Facility.

 

On July 7, 2023, we entered into a new five-year revolving credit agreement (the “2023 Five-Year Credit Agreement”) and a new 364-day revolving credit agreement (the “2023 364-Day Revolving Credit Agreement”), as described below. Borrowings under these credit agreements will be used for general corporate purposes.

 

The 2023 Five-Year Credit Agreement contains a five-year unsecured revolving facility of $1.5 billion (the “2023 Five-Year Revolving Facility”). The 2023 Five-Year Credit Agreement replaced the previous revolving credit agreement entered into on August 19, 2022 (the “2022 Five-Year Credit Agreement”), which contained a five-year unsecured revolving facility of $1.5 billion (the “2022 Five-Year Revolving Facility”). There was approximately $520.0 million in aggregate outstanding borrowings under the 2022 Five-Year Credit Agreement at the time it was terminated, which borrowings were repaid in full through borrowings under the 2023 Five-Year Credit Agreement on July 7, 2023 in the same amount and on the same interest rate and margin terms.

 

13

 

The 2023 Five-Year Credit Agreement will mature on July 7, 2028, with two one-year extensions exercisable at our discretion and subject to required lender consent. The 2023 Five-Year Credit Agreement also includes an uncommitted incremental feature allowing us to request an increase of the facility by an aggregate amount of up to $500.0 million.

 

Borrowings under the 2023 Five-Year Credit Agreement bear interest at floating rates, based upon either an adjusted Term SOFR for the applicable interest period or an alternate base rate, in each case, plus an applicable margin determined by reference to our senior unsecured long-term debt credit rating. We pay a facility fee on the aggregate amount of the 2023 Five-Year Revolving Facility at a rate determined by reference to our senior unsecured long-term debt credit rating. The 2023 Five-Year Credit Agreement contains customary affirmative and negative covenants and events of default for unsecured financing arrangements, including, among other things, limitations on consolidations, mergers, and sales of assets. The 2023 Five-Year Credit Agreement also requires us to maintain a consolidated indebtedness to consolidated EBITDA ratio of no greater than 4.5 to 1.0 as of the last day of any period of four consecutive fiscal quarters (with such ratio subject to increase to 5.0 to 1.0 for a period of time in connection with a qualified material acquisition and certain other restrictions). We were in compliance with all covenants under the 2023 Five-Year Credit Agreement as of March 31, 2024. As of March 31, 2024, there were no outstanding borrowings under the 2023 Five-Year Credit Agreement.

 

The 2023 364-Day Revolving Credit Agreement is an unsecured revolving credit facility in the principal amount of $1.0 billion (the “2023 364-Day Revolving Facility”). The 2023 364-Day Revolving Credit Agreement replaced a credit agreement entered into on August 19, 2022, which was also a 364- day unsecured revolving credit facility of $1.0 billion (the “2022 364-Day Revolving Facility”). There were no borrowings outstanding under the 2022 364-Day Revolving Facility when it was terminated.

 

The 2023 364-Day Revolving Facility will mature on July 5, 2024. Borrowings under the 2023 364-Day Revolving Credit Agreement bear interest at floating rates based upon either an adjusted Term SOFR for the applicable interest period or an alternate base rate, in each case, plus an applicable margin determined by reference to our senior unsecured long-term debt credit rating. We pay a facility fee on the aggregate amount of the 2023 364-Day Revolving Facility at a rate determined by reference to our senior unsecured long-term debt credit rating. The 2023 364-Day Revolving Credit Agreement contains customary affirmative and negative covenants and events of default for an unsecured financing arrangement including, among other things, limitations on consolidations, mergers, and sales of assets. The 2023 364-Day Revolving Credit Agreement also requires us to maintain a consolidated indebtedness to consolidated EBITDA ratio of no greater than 4.5 to 1.0 as of the last day of any period of four consecutive fiscal quarters (with such ratio subject to increase to 5.0 to 1.0 in connection with a qualified material acquisition and certain other restrictions). We were in compliance with all covenants under the 2023 364-Day Revolving Credit Agreement as of March 31, 2024. As of March 31, 2024, there were no outstanding borrowings under the 2023 364-Day Revolving Credit Agreement.

 

Borrowings under our revolving credit facilities have been executed with underlying notes that have maturities of three months or less. At maturity of the underlying note, we elect to either repay the note, borrow the same amount, or some combination thereof. On our condensed consolidated statements of cash flows, we present the borrowings and repayments of these underlying notes as net cash inflows or outflows due to their short-term nature.

 

The estimated fair value of our senior notes, which includes our Euro notes, as of March 31, 2024, based on quoted prices for the specific securities from transactions in over-the-counter markets (Level 2), was $5,553.8 million. The carrying value of the outstanding $120.0 million principal balance of the Uncommitted Credit Facility approximates its fair value as it bears interest at short-term market rates.

 

9. Accumulated Other Comprehensive Income

Accumulated other comprehensive income (loss) (“AOCI”) refers to certain gains and losses that under GAAP are included in comprehensive income but are excluded from net earnings as these amounts are initially recorded as an adjustment to stockholders’ equity. Amounts in AOCI may be reclassified to net earnings upon the occurrence of certain events.

Our AOCI is comprised of foreign currency translation adjustments, unrealized gains and losses on cash flow hedges and unrecognized prior service costs and gains and losses in actuarial assumptions related to our defined benefit plans. Foreign currency translation adjustments are reclassified to net earnings upon sale or upon a complete or substantially complete liquidation of an investment in a foreign entity. Unrealized gains and losses on cash flow hedges are reclassified to net earnings when the hedged item affects net earnings. Amounts related to defined benefit plans that are in AOCI are reclassified over the service periods of employees in the plan.

14

 

The following table shows the changes in the components of AOCI gains (losses), net of tax (in millions):

 

 

Foreign

 

 

Cash

 

 

Defined

 

 

 

 

 

 

Currency

 

 

Flow

 

 

Benefit

 

 

Total

 

 

 

Translation

 

 

Hedges

 

 

Plan Items

 

 

AOCI

 

Balance at December 31, 2023

 

$

(159.4

)

 

$

63.3

 

 

$

(94.9

)

 

$

(191.0

)

AOCI before reclassifications

 

 

(35.8

)

 

 

34.7

 

 

 

-

 

 

 

(1.1

)

Reclassifications to statements of earnings

 

 

-

 

 

 

(18.0

)

 

 

(1.1

)

 

 

(19.1

)

Balance at March 31, 2024

 

$

(195.2

)

 

$

80.0

 

 

$

(96.0

)

 

$

(211.2

)

The following table shows the reclassification adjustments from AOCI (in millions):

 

 

Amount of Gain (Loss)

 

 

 

Reclassified from AOCI

 

 

 

Three Months Ended

 

 

 

 

 

March 31,

 

 

Location on

Component of AOCI

 

2024

 

 

2023

 

 

Statements of Earnings

Cash flow hedges

 

 

 

 

 

 

 

 

Foreign exchange forward contracts

 

$

22.0

 

 

$

23.1

 

 

Cost of products sold

Forward starting interest rate swaps

 

 

(0.2

)

 

 

(0.2

)

 

Interest expense, net

 

 

 

21.8

 

 

 

22.9

 

 

Total before tax

 

 

3.8

 

 

 

3.9

 

 

Provision for income taxes

 

 

$

18.0

 

 

$

19.0

 

 

Net of tax

Defined benefit plans

 

 

 

 

 

 

 

 

Prior service cost and unrecognized actuarial loss

 

$

0.8

 

 

$

1.0

 

 

Other (expense) income, net

 

 

(0.3

)

 

 

0.1

 

 

Provision for income taxes

 

 

$

1.1

 

 

$

0.9

 

 

Net of tax

Total reclassifications

 

$

19.1

 

 

$

19.9

 

 

Net of tax

 

The following table shows the tax effects on each component of AOCI recognized in our condensed consolidated statements of comprehensive income (in millions):

 

 

Three Months Ended March 31, 2024

 

 

 

Before Tax

 

 

Tax

 

 

Net of Tax

 

Foreign currency cumulative translation adjustments

 

$

(19.2

)

 

 

16.6

 

 

$

(35.8

)

Unrealized cash flow hedge gains

 

 

43.4

 

 

 

8.7

 

 

 

34.7

 

Reclassification adjustments on cash flow hedges

 

 

(21.8

)

 

 

(3.8

)

 

 

(18.0

)

Adjustments to prior service cost and unrecognized actuarial assumptions

 

 

(0.8

)

 

 

0.3

 

 

 

(1.1

)

Total Other Comprehensive Income (Loss)

 

$

1.6

 

 

$

21.8

 

 

$

(20.2

)

 

 

 

Three Months Ended March 31, 2023

 

 

 

Before Tax

 

 

Tax

 

 

Net of Tax

 

Foreign currency cumulative translation adjustments

 

$

7.5

 

 

$

(4.9

)

 

$

12.4

 

Unrealized cash flow hedge gains

 

 

11.1

 

 

 

2.3

 

 

 

8.8

 

Reclassification adjustments on cash flow hedges

 

 

(22.9

)

 

 

(3.9

)

 

 

(19.0

)

Adjustments to prior service cost and unrecognized actuarial assumptions

 

 

(1.0

)

 

 

(0.1

)

 

 

(0.9

)

Total Other Comprehensive Income (Loss)

 

$

(5.3

)

 

$

(6.6

)

 

$

1.3

 

15

 

10. Fair Value Measurement of Assets and Liabilities

The following financial assets and liabilities are recorded at fair value on a recurring basis (in millions):

 

 

As of March 31, 2024

 

 

 

 

 

 

Fair Value Measurements at Reporting Date Using:

 

Description

 

Recorded
Balance

 

 

Quoted Prices
in Active
Markets for
Identical
Assets
(Level 1)

 

 

Significant
Other
Observable
Inputs
(Level 2)

 

 

Significant
Unobservable
Inputs
(Level 3)

 

Assets

 

 

 

 

 

 

 

 

 

 

 

 

Derivatives designated as hedges, current and long-term

 

 

 

 

 

 

 

 

 

 

 

 

Foreign currency forward contracts

 

$

74.4

 

 

$

-

 

 

$

74.4

 

 

$

-

 

Cross-currency interest rate swaps

 

 

27.3

 

 

 

-

 

 

 

27.3

 

 

 

-

 

Derivatives not designated as hedges, current and long-term

 

 

 

 

 

 

 

 

 

 

 

 

Foreign currency forward contracts

 

 

2.4

 

 

 

-

 

 

 

2.4

 

 

 

-

 

Total Assets

 

$

104.1

 

 

$

-

 

 

$

104.1

 

 

$

-

 

 

 

 

 

 

 

 

 

 

 

 

 

Liabilities

 

 

 

 

 

 

 

 

 

 

 

 

Derivatives designated as hedges, current and long-term

 

 

 

 

 

 

 

 

 

 

 

 

Foreign currency forward contracts

 

$

1.7

 

 

$

-

 

 

$

1.7

 

 

$

-

 

Cross-currency interest rate swaps

 

 

43.8

 

 

 

-

 

 

 

43.8

 

 

 

-

 

Interest rate swaps

 

 

163.8

 

 

 

-

 

 

 

163.8

 

 

 

-

 

Derivatives not designated as hedges, current and long-term

 

 

 

 

 

 

 

 

 

 

 

 

Foreign currency forward contracts

 

 

1.5

 

 

 

-

 

 

 

1.5

 

 

 

-

 

Contingent consideration related to acquisitions

 

 

115.2

 

 

 

-

 

 

 

-

 

 

 

115.2

 

Total Liabilities

 

$

326.0

 

 

$

-

 

 

$

210.8

 

 

$

115.2

 

 

16

 

 

 

As of December 31, 2023

 

 

 

 

 

 

Fair Value Measurements at Reporting Date Using:

 

Description

 

Recorded
Balance

 

 

Quoted Prices
in Active
Markets for
Identical
Assets
(Level 1)

 

 

Significant
Other
Observable
Inputs
(Level 2)

 

 

Significant
Unobservable
Inputs
(Level 3)

 

Assets

 

 

 

 

 

 

 

 

 

 

 

 

Derivatives designated as hedges, current and long-term

 

 

 

 

 

 

 

 

 

 

 

 

Foreign currency forward contracts

 

$

54.4

 

 

$

-

 

 

$

54.4

 

 

$

-

 

Cross-currency interest rate swaps

 

 

5.4

 

 

 

-

 

 

 

5.4

 

 

 

-

 

Derivatives not designated as hedges, current and long-term

 

 

 

 

 

 

 

 

 

 

 

 

Foreign currency forward contracts

 

 

0.4

 

 

 

-

 

 

 

0.4

 

 

 

-

 

Total Assets

 

$

60.2

 

 

$

-

 

 

$

60.2

 

 

$

-

 

 

 

 

 

 

 

 

 

 

 

 

 

Liabilities

 

 

 

 

 

 

 

 

 

 

 

 

Derivatives designated as hedges, current and long-term

 

 

 

 

 

 

 

 

 

 

 

 

Foreign currency forward contracts

 

$

3.7

 

 

$

-

 

 

$

3.7

 

 

$

-

 

Cross-currency interest rate swaps

 

 

68.1

 

 

 

-

 

 

 

68.1

 

 

 

-

 

Interest rate swaps

 

 

144.7

 

 

 

-

 

 

 

144.7

 

 

 

-

 

Derivatives not designated as hedges, current and long-term

 

 

 

 

 

 

 

 

 

 

 

 

Foreign currency forward contracts

 

 

1.6

 

 

 

-

 

 

 

1.6

 

 

 

-

 

Contingent consideration related to acquisitions

 

 

141.7

 

 

 

-

 

 

 

-

 

 

 

141.7

 

Total Liabilities

 

$

359.8

 

 

$

-

 

 

$

218.1

 

 

$

141.7

 

We value our foreign currency forward contracts using a market approach based on foreign currency exchange rates obtained from active markets, and we perform ongoing assessments of counterparty credit risk.

We value our interest rate swaps using a market approach based on publicly available market yield curves and the terms of our swaps, and we perform ongoing assessments of counterparty credit risk. The valuation of our cross-currency interest rate swaps also includes consideration of foreign currency exchange rates.

Contingent payments related to acquisitions consist of sales-based payments and regulatory milestones, and are valued using discounted cash flow techniques. The fair value of sales-based payments is based upon significant unobservable inputs such as probability-weighted future revenue estimates and simulating the numerous potential outcomes, and changes as revenue estimates increase or decrease. The fair value of the regulatory milestones is based on the probability of success in obtaining the specified regulatory approval.

Contingent payments related to the Embody acquisition are to be settled by issuance of our common stock and cash payments. The Embody acquisition is discussed in Note 7. During the three-month period ended March 31, 2024, we issued 0.2 million shares of our common stock valued at $23.4 million and paid $1.5 million of cash for a commercial milestone related to the Embody acquisition. The fair value of common stock was determined to be $123.87 per share, which represented the average of our high and low stock prices on the settlement date. To minimize dilution from issuing shares for the milestone settlement, we repurchased 0.2 million shares of our common stock in February of 2024.

The following table provides a reconciliation of the beginning and ending balances of items measured at fair value on a recurring basis in the tables above that used significant unobservable inputs (Level 3) (in millions):

 

 

 

Level 3 - Liabilities

 

Contingent payments related to acquisitions

 

 

 

Beginning balance December 31, 2023

 

$

141.7

 

Change in estimates

 

 

(1.6

)

Settlements

 

 

(24.9

)

Ending balance March 31, 2024

 

$

115.2

 

 

17

 

Changes in estimates for contingent payments related to acquisitions are recognized in the Acquisition, integration, divestiture and related line item on our condensed consolidated statements of earnings.

11. Derivative Instruments and Hedging Activities

We are exposed to certain market risks relating to our ongoing business operations, including foreign currency exchange rate risk, commodity price risk, interest rate risk and credit risk. We manage our exposure to these and other market risks through regular operating and financing activities. Currently, the only risks that we manage through the use of derivative instruments are interest rate risk and foreign currency exchange rate risk.

Interest Rate Risk

Derivatives Designated as Fair Value Hedges

We currently use fixed-to-variable interest rate swaps to manage our exposure to interest rate risk from our cash investments and debt portfolio. These derivative instruments are designated as fair value hedges under GAAP. Changes in the fair value of the derivative instrument are recorded in current earnings and are offset by gains or losses on the underlying debt instrument.

As of March 31, 2024 and December 31, 2023, the following amounts were recorded on our condensed consolidated balance sheets related to cumulative basis adjustments for fair value hedges (in millions):

 

 

 

Carrying Amount of the Hedged Liabilities

 

 

 

Cumulative Amount of Fair Value Hedging Adjustment Included in the Carrying Amount of the Hedged Liabilities

 

Balance Sheet Line Item

 

March 31, 2024

 

 

December 31, 2023

 

 

 

March 31, 2024

 

 

December 31, 2023

 

Long-term debt

 

$

832.3

 

 

$

851.3

 

 

 

$

(163.7

)

 

$

(144.7

)

 

Derivatives Designated as Cash Flow Hedges

In 2014, we entered into forward starting interest rate swaps that were designated as cash flow hedges of our thirty-year tranche of senior notes due 2045 we expected to issue in 2015. The forward starting interest rate swaps mitigated the risk of changes in interest rates prior to the completion of the notes offering. The interest rate swaps were settled, and the remaining loss to be recognized at March 31, 2024 was $23.7 million, which will be recognized using the effective interest rate method over the remaining maturity period of the hedged notes.

Foreign Currency Exchange Rate Risk

We operate on a global basis and are exposed to the risk that our financial condition, results of operations and cash flows could be adversely affected by changes in foreign currency exchange rates. To reduce the potential effects of foreign currency exchange rate movements on net earnings, we enter into derivative financial instruments in the form of foreign currency exchange forward contracts with major financial institutions. We also designated our Euro Notes as net investment hedges of investments in foreign subsidiaries. We are primarily exposed to foreign currency exchange rate risk with respect to transactions and net assets denominated in Euros, Swiss Francs, Japanese Yen, British Pounds, Chinese Renmimbi, Canadian Dollars, Australian Dollars, Korean Won, Swedish Krona, Czech Koruna, Thai Baht, Taiwan Dollars, South African Rand, Russian Rubles, Indian Rupees, Turkish Lira, Polish Zloty, Danish Krone, and Norwegian Krone. We do not use derivative financial instruments for trading or speculative purposes.

Derivatives Designated as Net Investment Hedges

We are exposed to the impact of foreign exchange rate fluctuations in the investments in our wholly-owned foreign subsidiaries that are denominated in currencies other than the U.S. Dollar. In order to mitigate the volatility in foreign exchange rates, we issued Euro Notes in December 2016 and November 2019 and designated 100 percent of the Euro Notes to hedge our net investment in certain wholly-owned foreign subsidiaries that have a functional currency of the Euro. All changes in the fair value of a hedging instrument designated as a net investment hedge are recorded as a component of AOCI in the condensed consolidated balance sheets.

At March 31, 2024, we had receive-fixed-rate, pay-fixed-rate cross-currency interest swaps with notional amounts outstanding of Euro 700 million, Japanese Yen 54.1 billion and Swiss Franc 125 million. These transactions further hedge our net investment in certain wholly-owned foreign subsidiaries that have a functional currency of Euro, Japanese Yen and Swiss Franc. All changes in the fair value of a derivative instrument designated as a net investment hedge are recorded as a component of AOCI in the condensed consolidated balance sheets. The portion of this change related to the excluded component will be amortized into earnings over the life of the derivative while the remainder will be recorded in AOCI until the hedged net investment is sold or substantially liquidated. We recognize the excluded component in interest expense, net on our condensed consolidated statements of earnings. The net cash received related to the receive-fixed-rate, pay-fixed-rate component of the cross-currency interest rate swaps is reflected in investing cash flows in our condensed consolidated statements of cash flows. In the three-month period ended March 31, 2023, Euro 100

18

 

million and Swiss Franc 50 million of these cross-currency interest rate swaps matured at a gain of $6.0 million and loss of $3.0 million, respectively. The settlement of these gains and losses with the counterparties is reflected in investing cash flows in our condensed consolidated statements of cash flows and will remain in AOCI on our condensed consolidated balance sheet until the hedged net investment is sold or substantially liquidated. No cross-currency interest rate swaps matured in the three-month period ended March 31, 2024.

Derivatives Designated as Cash Flow Hedges

Our revenues are generated in various currencies throughout the world. However, a significant amount of our inventory is produced in U.S. Dollars. Therefore, movements in foreign currency exchange rates may have different proportional effects on our revenues compared to our cost of products sold. To minimize the effects of foreign currency exchange rate movements on cash flows, we hedge intercompany sales of inventory expected to occur within the next 30 months with foreign currency exchange forward contracts. We designate these derivative instruments as cash flow hedges.

We perform quarterly assessments of hedge effectiveness by verifying and documenting the critical terms of the hedge instrument and confirming that forecasted transactions have not changed significantly. We also assess on a quarterly basis whether there have been adverse developments regarding the risk of a counterparty default. For derivatives which qualify as hedges of future cash flows, the gains and losses are temporarily recorded in AOCI and then recognized in cost of products sold when the hedged item affects net earnings. On our condensed consolidated statements of cash flows, the settlements of these cash flow hedges are recognized in operating cash flows.

For foreign currency exchange forward contracts and options outstanding at March 31, 2024, we had obligations to purchase U.S. Dollars and sell Euros, Japanese Yen, British Pounds, Canadian Dollars, Australian Dollars, Korean Won, Swedish Krona, Czech Koruna, Thai Baht, Taiwan Dollars, South African Rand, Indian Rupees, Polish Zloty, Danish Krone, and Norwegian Krone and obligations to purchase Swiss Francs and sell U.S. Dollars. These derivatives mature at dates ranging from April 2024 through August 2026. As of March 31, 2024, the notional amounts of outstanding forward contracts and options entered into with third parties to purchase U.S. Dollars were $1,526.7 million. As of March 31, 2024, the notional amounts of outstanding forward contracts and options entered into with third parties to purchase Swiss Francs were $435.4 million.

Derivatives Not Designated as Hedging Instruments

We enter into foreign currency forward exchange contracts with terms of one to three months to manage currency exposures for monetary assets and liabilities denominated in a currency other than an entity’s functional currency. As a result, any foreign currency remeasurement gains/losses recognized in earnings are generally offset with gains/losses on the foreign currency forward exchange contracts in the same reporting period. The net amount of these offsetting gains/losses is recorded in other (expense) income, net. Any outstanding contracts are recorded on the balance sheet at fair value as of the end of the reporting period. The notional amounts of these contracts are typically in a range of $1.25 billion to $1.75 billion per quarter.

Income Statement Presentation

Derivatives Designated as Cash Flow Hedges

Derivative instruments designated as cash flow hedges had the following effects, before taxes, on AOCI and net earnings on our condensed consolidated statements of earnings, condensed consolidated statements of comprehensive income and condensed consolidated balance sheets (in millions):

 

 

Amount of Gain

 

 

 

 

Amount of Gain (Loss)

 

 

 

Recognized in AOCI

 

 

 

 

Reclassified from AOCI

 

 

 

Three Months Ended

 

 

 

 

Three Months Ended

 

 

 

March 31,

 

 

Location on

 

March 31,

 

Derivative Instrument

 

2024

 

 

2023

 

 

Statements of Earnings

 

2024

 

 

2023

 

Foreign exchange
   forward contracts

 

$

43.4

 

 

$

11.1

 

 

Cost of products sold

 

$

22.0

 

 

$

23.1

 

Forward starting
   interest rate swaps

 

 

-

 

 

 

-

 

 

Interest expense, net

 

 

(0.2

)

 

 

(0.2

)

 

 

$

43.4

 

 

$

11.1

 

 

 

 

$

21.8

 

 

$

22.9

 

19

 

The fair value of outstanding derivative instruments designated as cash flow hedges and recorded on our condensed consolidated balance sheet at March 31, 2024, together with settled derivatives where the hedged item has not yet affected earnings, was a net unrealized gain of $93.1 million, or $79.9 million after taxes, which is deferred in AOCI. A gain of $75.2 million, or $62.0 million after taxes, is expected to be reclassified to earnings in cost of products sold and a loss of $0.7 million, or $0.5 million after taxes, is expected to be reclassified to earnings in interest expense, net over the next twelve months.

 

The following table presents the effect of fair value, cash flow and net investment hedge accounting on our condensed consolidated statements of earnings (in millions):

 

 

 

Location and Amount of Gain/(Loss) Recognized in Income on Fair Value, Cash Flow and Net Investment Hedging Relationships

 

 

 

Three Months Ended

 

 

Three Months Ended

 

 

 

March 31, 2024

 

 

March 31, 2023

 

 

 

Cost of

 

 

Interest

 

 

Cost of

 

 

Interest

 

 

 

Products

 

 

Expense,

 

 

Products

 

 

Expense,

 

 

 

Sold

 

 

Net

 

 

Sold

 

 

Net

 

Total amounts of income and expense line items presented in the statements of earnings in which the effects of fair value, cash flow and net investment hedges are recorded

 

$

512.3

 

 

$

(50.7

)

 

$

500.8

 

 

$

(48.2

)

        The effects of fair value, cash flow and net investment hedging:

 

 

 

 

 

 

 

 

 

 

             Gain (loss) on fair value hedging
                  relationships

 

 

 

 

 

 

 

 

 

 

 

 

                       Interest rate swaps

 

 

-

 

 

 

(10.6

)

 

 

-

 

 

 

(8.2

)

             Gain (loss) on cash flow hedging
                  relationships

 

 

 

 

 

 

 

 

 

 

 

 

                       Foreign exchange forward contracts

 

 

22.0

 

 

 

-

 

 

 

23.1

 

 

 

-

 

                       Forward starting interest rate swaps

 

 

-

 

 

 

(0.2

)

 

 

-

 

 

 

(0.2

)

             Gain on net investment hedging
                  relationships

 

 

 

 

 

 

 

 

 

 

 

 

                       Cross-currency interest rate swaps

 

 

-

 

 

 

8.2

 

 

 

-

 

 

 

9.0

 

 

Derivatives Not Designated as Hedging Instruments

The following gains / (losses) from these derivative instruments were recognized on our condensed consolidated statements of earnings (in millions):

 

 

 

 

Three Months Ended

 

 

 

Location on

 

March 31,

 

Derivative Instrument

 

Statements of Earnings

 

2024

 

 

2023

 

Foreign exchange forward contracts

 

Other (expense) income, net

 

$

8.4

 

 

$

(3.6

)

These gains / (losses) do not reflect offsetting losses of $12.2 million in the three-month period ended March 31, 2024, and offsetting gains of $0.4 in the three-month period ended March 31, 2023, recognized in other income (expense), net as a result of foreign currency remeasurement of monetary assets and liabilities denominated in a currency other than an entity’s functional currency.

20

 

Balance Sheet Presentation

As of March 31, 2024 and December 31, 2023, all derivatives designated as fair value hedges, cash flow hedges and net investment hedges are recorded at fair value on our condensed consolidated balance sheets. On our condensed consolidated balance sheets, we recognize individual forward contracts with the same counterparty on a net asset/liability basis if we have a master netting agreement with the counterparty. Under these master netting agreements, we are able to settle derivative instrument assets and liabilities with the same counterparty in a single transaction, instead of settling each derivative instrument separately. We have master netting agreements with substantially all of our counterparties. The fair value of derivative instruments on a gross basis is as follows (in millions):

 

 

As of March 31, 2024

 

 

As of December 31, 2023

 

 

 

Balance

 

 

 

 

Balance

 

 

 

 

 

Sheet

 

Fair

 

 

Sheet

 

Fair

 

 

 

Location

 

Value

 

 

Location

 

Value

 

Asset Derivatives Designated as Hedges

 

 

 

 

 

 

 

 

 

 

Foreign exchange forward contracts

 

Other current assets

 

$

66.3

 

 

Other current assets

 

$

58.4

 

Cross-currency interest rate swaps

 

Other current assets

 

 

-

 

 

Other current assets

 

 

-

 

Foreign exchange forward contracts

 

Other assets

 

 

21.2

 

 

Other assets

 

 

17.2

 

Cross-currency interest rate swaps

 

Other assets

 

 

27.3

 

 

Other assets

 

 

5.4

 

Total asset derivatives

 

 

 

$

114.8

 

 

 

 

$

81.0

 

 

 

 

 

 

 

 

 

 

 

Asset Derivatives Not Designated as Hedges

 

 

 

 

 

 

 

 

 

 

Foreign exchange forward contracts

 

Other current assets

 

$

3.7

 

 

Other current assets

 

$

1.2

 

 

 

 

 

 

 

 

 

 

 

Liability Derivatives Designated as Hedges

 

 

 

 

 

 

 

 

 

 

Foreign exchange forward contracts

 

Other current liabilities

 

$

8.5

 

 

Other current liabilities

 

$

13.9

 

Cross-currency interest rate swaps

 

Other current liabilities

 

 

35.0

 

 

Other current liabilities

 

 

33.3

 

Foreign exchange forward contracts

 

Other long-term liabilities

 

 

6.3

 

 

Other long-term liabilities

 

 

11.0

 

Cross-currency interest rate swaps

 

Other long-term liabilities

 

 

8.8

 

 

Other long-term liabilities

 

 

34.8

 

Interest rate swaps

 

Other long-term liabilities

 

 

163.8

 

 

Other long-term liabilities

 

 

144.7

 

Total liability derivatives

 

 

 

$

222.4

 

 

 

 

$

237.7

 

 

 

 

 

 

 

 

 

 

 

Liability Derivatives Not Designated as Hedges

 

 

 

 

 

 

 

 

 

 

Foreign exchange forward contracts

 

Other current liabilities

 

$

2.8

 

 

Other current liabilities

 

$

2.4

 

The table below presents the effects of our master netting agreements on our condensed consolidated balance sheets (in millions):

 

 

 

 

As of March 31, 2024

 

 

As of December 31, 2023

 

Description

 

Location

 

Gross
Amount

 

 

Offset

 

 

Net Amount in
Balance Sheet

 

 

Gross
Amount

 

 

Offset

 

 

Net Amount in
Balance Sheet

 

Asset Derivatives

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cash flow hedges

 

Other current assets

 

$

66.3

 

 

$

8.4

 

 

$

57.9

 

 

$

58.4

 

 

$

13.0

 

 

$

45.4

 

Cash flow hedges

 

Other assets

 

 

21.2

 

 

 

4.7

 

 

 

16.5

 

 

 

17.2

 

 

 

8.2

 

 

 

9.0

 

Derivatives Not Designated as Hedges

 

Other current assets

 

 

3.7

 

 

 

1.3

 

 

 

2.4

 

 

 

1.2

 

 

 

0.8

 

 

 

0.4

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Liability Derivatives

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cash flow hedges

 

Other current liabilities

 

 

8.5

 

 

 

8.4

 

 

 

0.1

 

 

 

13.9

 

 

 

13.0

 

 

 

0.9

 

Cash flow hedges

 

Other long-term liabilities

 

 

6.3

 

 

 

4.7

 

 

 

1.6

 

 

 

11.0

 

 

 

8.2

 

 

 

2.8

 

Derivatives Not Designated as Hedges

 

Other current liabilities

 

 

2.8

 

 

 

1.3

 

 

 

1.5

 

 

 

2.4

 

 

 

0.8

 

 

 

1.6

 

21

 

The following net investment hedge gains (losses) were recognized on our condensed consolidated statements of comprehensive income (in millions):

 

 

Amount of Gain (Loss)

 

 

 

Recognized in AOCI

 

 

 

Three Months Ended

 

 

 

March 31,

 

Derivative Instrument

 

2024

 

 

2023

 

Euro Notes

 

$

24.4

 

 

$

(19.2

)

Cross-currency interest rate swaps

 

 

46.1

 

 

 

(4.5

)

 

 

$

70.5

 

 

$

(23.7

)

 

 

12. Income Taxes

We operate on a global basis and are subject to numerous and complex tax laws and regulations. Additionally, tax laws continue to undergo rapid changes in both application and interpretation by various countries, including state aid interpretations and initiatives led by the Organisation for Economic Cooperation and Development ("OECD"). Our income tax filings are subject to examinations by taxing authorities throughout the world. Income tax audits may require an extended period of time to reach resolution and may result in significant income tax adjustments when interpretation of tax laws or allocation of company profits is disputed. Although ultimate timing is uncertain, the net amount of tax liability for unrecognized tax benefits may change within the next twelve months due to changes in audit status, expiration of statutes of limitations, settlements of tax assessments and other events. Management’s best estimate of such change is within the range of a $270 million decrease to a $20 million increase.

We are under continuous audit by the IRS and have disputes with the IRS and other foreign taxing authorities in the jurisdictions where we operate. In addition, some jurisdictions in which we operate require payment of disputed taxes to petition a court or taxing authority, or we may elect to make such payments prior to final resolution. We record any prepayments as income tax receivables when we believe our position is more likely than not to be upheld. We assess our position on these disputes at each reporting period. During the course of these audits and disputes, we receive proposed adjustments from taxing authorities that may be material. Therefore, there is a possibility that an adverse outcome in these audits or disputes could have a material effect on our results of operations and financial condition. Our U.S. federal income tax returns have been audited through 2019.

The IRS has proposed adjustments for tax years 2010-2012, primarily related to reallocating profits between certain U.S. and foreign subsidiaries, which remain unsettled. We have disputed these adjustments and intend to continue to vigorously defend our positions as we pursue resolution through the administrative process with the IRS Independent Office of Appeals.

The IRS has proposed adjustments for tax years 2013-2015, primarily related to transfer pricing involving our cost sharing agreement between the U.S. and Switzerland affiliated companies and the reallocation of profits between certain of our U.S. and foreign subsidiaries. This includes a proposed increase to our U.S. federal taxable income, which would result in additional tax expense related to 2013 of approximately $370 million, subject to interest and penalties. We strongly believe that the position of the IRS, with regard to this matter, is inconsistent with the applicable U.S. Treasury Regulations governing our cost sharing agreement. We intend to vigorously contest the adjustment, and we will pursue all available administrative and, if necessary, judicial remedies. If we pursue judicial remedies in the U.S. Tax Court for years 2013-2015, a number of years will likely elapse before such matters are finally resolved. No payment of any amount related to this matter is required to be made, if at all, until all applicable proceedings have been completed.

The IRS has proposed adjustments for tax years 2016-2019, primarily related to the U.S. taxation of foreign earnings and profits, which could result in additional material tax expense if we are unsuccessful in defending our position. We disagree with the proposed adjustments and intend to continue to vigorously contest the adjustments. We do not expect a final resolution of these issues in the next 12 months. No payment of any amount related to his matter is required to be made, if at all, until all applicable proceedings have been completed.

In the three-month period ended March 31, 2024, our effective tax rate (“ETR”) was 19.7 percent compared to 18.9 percent for the three-month period ended March 31, 2023. The 19.7 percent and 18.9 percent ETR in the three-month periods ended March 31, 2024 and 2023, respectively, were primarily driven by our mix of earnings between U.S. and foreign locations. Absent discrete tax events, we expect our future ETR will be lower than the U.S. corporate income tax rate of 21.0 percent due to our mix of earnings between U.S. and foreign locations, which generally have lower corporate income tax rates. Our ETR in future periods could also potentially be impacted by: changes in our mix of pre-tax earnings; changes in tax rates, tax laws or their interpretation; including the European Union adoption of Pillar Two proposals which began to take effect in 2024; the outcome of various federal, state and foreign audits, appeals, and litigation; and the expiration of certain statutes of limitations. Currently, we cannot reasonably estimate the impact of these items on our financial results.

 

22

 

13. Earnings Per Share

The following is a reconciliation of weighted average shares for the basic and diluted shares computations (in millions):

 

 

Three Months Ended

 

 

 

March 31,

 

 

 

2024

 

 

2023

 

Weighted average shares outstanding for basic net earnings per share

 

 

205.2

 

 

 

209.4

 

Effect of dilutive stock options and other equity awards

 

 

1.0

 

 

 

1.0

 

Weighted average shares outstanding for diluted net earnings per share

 

 

206.2

 

 

 

210.4

 

During the three-month periods ended March 31, 2024 and 2023, an average of 1.6 million options and 2.0 million options, respectively, to purchase shares of common stock were not included in the computation of diluted earnings per share because the effect would have been antidilutive.

14. Segment Information

We design, manufacture and market orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; craniomaxillofacial and thoracic products (“CMFT”); surgical products; and a suite of integrated digital and robotic technologies that leverage data, data analytics and artificial intelligence. Our chief operating decision maker (“CODM”) allocates resources to achieve our operating profit goals through three operating segments. These operating segments, which also constitute our reportable segments, are Americas; EMEA; and Asia Pacific.

Our CODM evaluates performance based upon segment operating profit exclusive of operating expenses and income pertaining to intangible asset amortization, certain inventory and manufacturing-related charges, restructuring and other cost reduction initiatives, acquisition, integration, divestiture and related, litigation, certain European Union Medical Device Regulation (“EU MDR”) expenses, other charges and corporate functions (collectively referred to as “Corporate items”). Corporate functions include finance, corporate legal, information technology, human resources and other corporate departments as well as stock-based compensation and certain operations, distribution, quality assurance, regulatory assurance, research and development ("R&D") and marketing expenses. Intercompany transactions have been eliminated from segment operating profit.

Our Americas operating segment is comprised principally of the U.S. and includes other North, Central and South American markets. Our EMEA operating segment is comprised principally of Europe and includes the Middle East and African markets. Our Asia Pacific operating segment is comprised principally of Japan, China and Australia and includes other Asian and Pacific markets. The Americas, EMEA and Asia Pacific operating segments include the commercial operations as well as regional headquarter expenses to operate in those markets. Our operating segments do not include many centralized, product category expenses such as R&D and global marketing that benefit all regions.

In the three-month period ended March 31, 2024, the segment operating profit measures our CODM reviews were revised. Certain product category headquarter costs, primarily R&D and marketing, that were previously in our Americas operating segment are now included in Corporate items. In addition, certain support function costs from our operating segments are now included in Corporate items. We have reclassified these product category headquarter and support function expenses in the prior period to conform to the current period presentation.

Net sales and operating profit by segment are as follows (in millions):

 

 

 

Net Sales

 

 

Operating Profit

 

 

 

Three Months Ended

 

 

Three Months Ended

 

 

 

March 31,

 

 

March 31,

 

 

 

2024

 

 

2023

 

 

2024

 

 

2023

 

Americas

 

$

1,186.5

 

 

$

1,141.3

 

 

$

639.3

 

 

$

608.9

 

EMEA

 

 

444.8

 

 

 

425.6

 

 

 

153.0

 

 

 

149.5

 

Asia Pacific

 

 

258.0

 

 

 

264.1

 

 

 

93.3

 

 

 

90.2

 

Total

 

$

1,889.2

 

 

$

1,831.0

 

 

 

 

 

 

 

Corporate items

 

 

 

 

 

 

 

 

(477.6

)

 

 

(387.9

)

Intangible asset amortization

 

 

 

 

 

 

 

 

(142.1

)

 

 

(133.4

)

Operating profit

 

 

 

 

 

 

 

$

265.9

 

 

$

327.3

 

 

23

 

15. Commitments and Contingencies

From time to time, we are involved in various legal proceedings, including product liability, intellectual property, stockholder matters, tax disputes, commercial disputes, employment matters, whistleblower and qui tam claims and investigations, governmental proceedings and investigations, and other legal matters that arise in the normal course of our business, including those described below. On a quarterly and annual basis, we review relevant information with respect to loss contingencies and update our accruals, disclosures and estimates of reasonably possible losses or ranges of loss based on such reviews. We establish liabilities for loss contingencies on an undiscounted basis when it is probable that a loss has been incurred and the amount of the loss can be reasonably estimated. If the reasonable estimate of a known or probable loss is a range, and no amount within the range is a better estimate than any other, the minimum amount of the range is accrued. For matters where a loss is believed to be reasonably possible, but not probable, or if no reasonable estimate of known or probable loss is available, no accrual has been made.

When determining the estimated loss or range of loss, significant judgment is required. Estimates of probable losses resulting from litigation and other contingencies are inherently difficult to predict, particularly when the matters are in early procedural stages with incomplete facts or legal discovery, involve unsubstantiated or indeterminate claims for damages, and/or potentially involve penalties, fines or punitive damages. In addition to the matters described herein, we remain subject to the risk of future governmental, regulatory and legal actions. Governmental and regulatory actions may lead to product recalls, injunctions and other restrictions on our operations and monetary sanctions, which may include substantial civil or criminal penalties. Actions involving intellectual property could result in a loss of patent protection or the ability to market products, which could lead to significant sales reductions or cost increases, or otherwise materially affect the results of our operations.

We recognize litigation-related charges and gains in Selling, general and administrative expense on our condensed consolidated statement of earnings. During the three-month periods ended March 31, 2024 and 2023, we recognized $1.0 million and $3.3 million, respectively, of net litigation-related charges. At March 31, 2024 and December 31, 2023, accrued litigation liabilities were $226.5 million and $244.1 million, respectively. These litigation-related charges and accrued liabilities reflect all of our litigation-related contingencies and not just the matters discussed below. The ultimate cost of litigation could be materially different than the amount of the current estimates and accruals and could have a material adverse impact on our financial condition and results of operations.

Litigation

Durom Cup-related claims: On July 22, 2008, we temporarily suspended marketing and distribution of the Durom Cup in the U.S. Subsequently, a number of product liability lawsuits were filed against us in various U.S. and foreign jurisdictions. The plaintiffs seek damages for personal injury, and they generally allege that the Durom Cup contains defects that result in complications and revision of the device. We have settled the majority of these claims in the U.S., but other lawsuits are pending in various foreign jurisdictions and additional claims may be asserted in the future. The majority of claims outside the U.S. are pending in Germany, Netherlands and Italy.

We rely on significant estimates in determining the provisions for Durom Cup-related claims, including our estimate of the number of claims that we will receive and the average amount we will pay per claim. The actual number of claims and the actual amount we pay per claim may differ from our estimates. For various reasons, we cannot reasonably estimate the possible loss or range of loss that may result from Durom Cup-related claims in excess of the losses we have accrued. Although we are vigorously defending these lawsuits, their ultimate resolution is uncertain. We accrued a litigation-related charge in this matter based on an estimate of the reasonably possible loss, as discussed above.

Zimmer M/L Taper, M/L Taper with Kinectiv Technology, and Versys Femoral Head-related claims (“Metal Reaction” claims): We are a defendant in a number of product liability lawsuits relating to our M/L Taper and M/L Taper with Kinectiv Technology hip stems, and Versys Femoral Head implants. The plaintiffs seek damages for personal injury, alleging that defects in the products lead to corrosion at the head/stem junction resulting in, among other things, pain, inflammation and revision surgery.

The majority of the cases are consolidated in an MDL that was created on October 3, 2018 in the U.S. District Court for the Southern District of New York (In Re: Zimmer M/L Taper Hip Prosthesis or M/L Taper Hip Prosthesis with Kinectiv Technology and Versys Femoral Head Products Liability Litigation). Most of the cases in the MDL have been resolved. Other related cases are pending in various state and federal courts and in courts in Canada, and additional claims may be asserted in the future. Although we are vigorously defending these lawsuits, their ultimate resolution is uncertain. We accrued a litigation-related charge in this matter based on an estimate of the reasonably possible loss, as discussed above.

Biomet metal-on-metal hip implant claims: Biomet is a defendant in a number of product liability lawsuits relating to metal-on-metal hip implants, most of which involve the M2a-Magnum hip system. Cases were originally consolidated in an MDL in the U.S. District Court for the Northern District of Indiana (In Re: Biomet M2a Magnum Hip Implant Product Liability Litigation), but the majority of the claims in the U.S. have been settled. Trials may still occur in the future, and although each case will be tried on its particular facts, a verdict and subsequent final judgment for the plaintiff in one or more of these cases could have a substantial impact on our potential liability. Lawsuits are pending in various foreign jurisdictions and additional claims are expected to be asserted. We continue to refine our estimates of the potential liability to resolve the remaining claims and lawsuits. Although we are vigorously

24

 

defending these lawsuits, their ultimate resolution is uncertain. We accrued a litigation-related charge in this matter based on an estimate of the reasonably possible loss, as discussed above.

Other Contingencies

Contractual obligations: We have entered into development, distribution and other contractual arrangements that may result in future payments dependent upon various events such as the achievement of certain product R&D milestones, sales milestones, or, at our discretion, maintenance of exclusive rights to distribute a product. Since there is uncertainty on the timing or whether such payments will have to be made, they have not been recognized on our condensed consolidated balance sheets. These estimated payments could range from $0 to approximately $405 million.

 

25

 

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

The following discussion and analysis should be read in conjunction with the interim condensed consolidated financial statements and corresponding notes included elsewhere in this Form 10-Q. Amounts reported in millions within this Quarterly Report on Form 10-Q are computed based on the actual amounts. As a result, the sum of the components may not equal the total amount reported in millions due to rounding. In addition, certain columns and rows within tables may not sum to the totals due to the use of rounded numbers. Percentages presented are calculated from the underlying unrounded amounts.

Executive Level Overview

Results for the Three-Month Period ended March 31, 2024

In the three-month period ended March 31, 2024, our net sales increased 3.2 percent when compared to the same prior year period. Net sales growth was driven by a combination of market growth, new product introductions and commercial execution across the organization. These favorable items were tempered by a negative 1.2 percent effect from changes in foreign currency exchange rates.

Our net earnings were $172.4 million in the three-month period ended March 31, 2024 compared to $232.5 million in the same prior year period. The decline in earnings was primarily related to charges from our 2023 Restructuring Plan which was instituted at the end of 2023 and continued into 2024, including $71.0 million in employee termination benefits-related charges recognized in the three-month period ended March 31, 2024.

2024 Outlook

We expect year-over-year revenue growth of mid-single digits in 2024 to be driven by a combination of market growth, new product introductions, commercial execution and continued improvements in product supply. Based on recent foreign currency exchange rates, we expect foreign currency to negatively affect year-over-year net sales by approximately 0.5 percent. We estimate operating profit will increase in 2024 when compared to 2023 due to higher net sales, leverage from fixed operating expenses and savings from our restructuring plans. However, we estimate these favorable items may be partially offset by higher intangible asset amortization and increased restructuring-related costs to implement our plans. We estimate our net interest expense will increase slightly due to higher interest rates. We expect our provision for income taxes will increase in 2024 when compared to 2023 due to the non-reoccurrence of favorable tax settlements.

 

Results of Operations

We review sales by two geographies, the United States and International, and by the following product categories: Knees; Hips; S.E.T. (Sports Medicine, Extremities, Trauma, Craniomaxillofacial and Thoracic); and Other. This sales analysis differs from our reportable operating segments, which are based upon our senior management organizational structure and how we allocate resources toward achieving operating profit goals. We review sales by these geographies because the underlying market trends in any particular geography tend to be similar across product categories, because we primarily sell the same products in all geographies and many of our competitors publicly report in this manner. Our business is seasonal in nature to some extent, as many of our products are used in elective surgical procedures, which typically decline during the summer months and can increase at the end of the year once annual deductibles have been met on health insurance plans.

Net Sales by Geography

The following table presents our net sales by geography and the percentage changes (dollars in millions):

 

 

Three Months Ended

 

 

 

 

 

 

 

March 31,

 

 

 

 

 

 

 

2024

 

 

2023

 

 

% Inc

 

 

United States

 

$

1,099.2

 

 

$

1,060.4

 

 

 

3.7

 

 %

International

 

 

790.0

 

 

 

770.6

 

 

 

2.5

 

 

Total

 

$

1,889.2

 

 

$

1,831.0

 

 

 

3.2

 

 

 

 

 

 

 

 

 

 

 

 

 

 

26

 

Net Sales by Product Category

The following table presents our net sales by product category and the percentage changes (dollars in millions):

 

 

Three Months Ended

 

 

 

 

 

 

 

March 31,

 

 

 

 

 

 

 

2024

 

 

2023

 

 

% Inc / (Dec)

 

 

Knees

 

$

788.1

 

 

$

762.5

 

 

 

3.4

 

 %

Hips

 

 

491.2

 

 

 

492.8

 

 

 

(0.3

)

 

S.E.T.

 

 

452.6

 

 

 

433.4

 

 

 

4.4

 

 

Other

 

 

157.3

 

 

 

142.3

 

 

 

10.6

 

 

Total

 

$

1,889.2

 

 

$

1,831.0

 

 

 

3.2

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

The following table presents our net sales by geography for our Knees and Hips product categories, which represent our most significant product categories (dollars in millions):

 

 

Three Months Ended March 31,

 

 

 

 

 

 

 

2024

 

 

2023

 

 

% Inc / (Dec)

 

 

Knees

 

 

 

 

 

 

 

 

 

 

United States

 

$

458.0

 

 

$

448.2

 

 

 

2.2

 

%

International

 

 

330.1

 

 

 

314.3

 

 

 

5.0

 

 

Total

 

$

788.1

 

 

$

762.5

 

 

 

3.4

 

 

Hips

 

 

 

 

 

 

 

 

 

 

United States

 

$

254.9

 

 

$

252.3

 

 

 

1.0

 

%

International

 

 

236.3

 

 

 

240.5

 

 

 

(1.7

)

 

Total

 

$

491.2

 

 

$

492.8

 

 

 

(0.3

)

 

Demand (Volume and Mix) Trends

 

Changes in volume and mix of product sales had a positive effect of 4.2 percent on year-over-year sales during the three-month period ended March 31, 2024. Market growth and new product introductions contributed positively to volume and mix trends.

Pricing Trends

Global selling prices had a positive effect of 0.2 percent on year-over-year sales during the three-month period ended March 31, 2024. The majority of countries in which we operate continue to experience pricing pressure from local hospitals, health systems, and governmental healthcare cost containment efforts. However, we have had success in offsetting negative effects of pricing pressure due to internal initiatives and being able to pass some inflationary impacts on to customers.

Foreign Currency Exchange Rates

For the three-month period ended March 31, 2024, changes in foreign currency exchange rates had a negative effect of 1.2 percent on year-over-year sales. If foreign currency exchange rates remain at levels consistent with recent rates, we estimate there will be a negative impact of approximately 0.5 percent on full-year 2024 sales.

Geography

The 3.7 percent net sales growth in the U.S. in the three-month period ended March 31, 2024 was driven by market growth and sales of our ROSA® Robot. Internationally, net sales increased by 2.5 percent during the three-month period ended March 31, 2024 when compared to the same prior year period. This increase was similarly driven by market growth in most of our international markets. Our International sales were negatively affected by 2.9 percent due to changes in foreign currency exchange rates in the three-month period ended March 31, 2024.

Product Categories

Knees and Hips net sales grew 3.4 percent and declined 0.3 percent, respectively, in the three-month period ended March 31, 2024, when compared to the same prior year period. The net sales of Knees and Hips benefited from market growth and new product

27

 

introductions. However, overall Hips net sales declined in the three-month period ended March 31, 2024 when compared to the same prior year period primarily due to the negative effects of foreign currency. Knees and Hips net sales were negatively affected by 0.9 percent and 1.8 percent, respectively, in the three-month period ended March 31, 2024 due to changes in foreign currency exchange rates. The 4.4 percent increase in S.E.T. net sales for the three-month period ended March 31, 2024 was the result of growth in our sports medicine, upper extremities, and craniomaxillofacial and thoracic products, partially offset by lower volumes in other S.E.T. products. Other net sales grew 10.6 percent in the three-month period ended March 31, 2024 driven by net sales for our ROSA Robot.

Expenses as a Percentage of Net Sales

 

 

Three Months Ended

 

 

 

 

 

 

 

 

March 31,

 

 

 

% Inc /

 

 

 

 

2024

 

 

 

2023

 

 

 

(Dec)

 

 

Cost of products sold, excluding intangible asset amortization

 

 

27.1

 

%

 

 

27.4

 

%

 

 

(0.3

)

%

Intangible asset amortization

 

 

7.5

 

 

 

 

7.3

 

 

 

 

0.2

 

 

Research and development

 

 

5.7

 

 

 

 

6.0

 

 

 

 

(0.3

)

 

Selling, general and administrative

 

 

39.0

 

 

 

 

39.1

 

 

 

 

(0.1

)

 

Restructuring and other cost reduction initiatives

 

 

6.6

 

 

 

 

2.3

 

 

 

 

4.3

 

 

Acquisition, integration, divestiture and related

 

 

-

 

 

 

 

0.1

 

 

 

 

(0.1

)

 

Operating profit

 

 

14.1

 

 

 

 

17.9

 

 

 

 

(3.8

)

 

 

Cost of products sold, excluding intangible asset amortization as a percentage of net sales decreased in the three-month period ended March 31, 2024 when compared to the same prior year period, primarily due to lower royalty expense. The reduction in royalty expense was partially the result of agreements we entered into in 2023 to acquire intellectual property through the buyout of certain licensing arrangements, which are recognized as intangible assets and result in additional intangible asset amortization expense instead of royalty expense. The lower royalty expense was partially offset by higher manufacturing costs.

Intangible asset amortization expense increased in the three-month period ended March 31, 2024 compared to the same prior year period due to the 2023 acquisitions and the buyout of certain royalty-related licensing agreements as described above.

R&D expenses decreased in amount and as a percentage of net sales in the three-month period ended March 31, 2024 when compared to the same prior year period. The decreases were driven by lower spending on our initial compliance with the European Union Medical Device Regulation as we continue to make progress on the approvals of our products, but were partially offset by higher personnel-related costs.

Selling, general and administrative (“SG&A”) expenses increased in amount, but slightly decreased as a percentage of net sales in the three-month period ended March 31, 2024 when compared to the same prior year period. The increase in expenses was due to selling and distribution costs that are variable expenses which increase as net sales increase. Additionally, instrument-related costs were higher due to new product introductions, share-based compensation was higher due to timing of awards, and we recognized higher charges on various strategic initiatives. These higher costs were partially offset by savings from our 2023 Restructuring Plan.

In December of 2023, 2021 and 2019, we initiated global restructuring programs. We also have other cost reduction and optimization initiatives that have the goal of reducing costs across the organization. We recognized expenses of $124.4 million and $41.8 million in the three-month periods ended March 31, 2024 and 2023, respectively, primarily related to employee termination benefits, sales agent contract terminations, and consulting and project management expenses associated with these programs. The expenses were higher in the 2024 period when compared to the 2023 period primarily due to additional expenses related to the 2023 Restructuring Plan that had just been initiated at the end of 2023. For more information regarding these expenses, see Note 4 to our interim condensed consolidated financial statements included in Part I, Item 1 of this report.

Acquisition, integration, divestiture and related expenses decreased in amount and as a percentage of net sales in the three-month period ended March 31, 2024 when compared to the same prior year period, primarily due to gains recognized from changes in the fair value of contingent consideration.

28

 

Other (Expense) Income, Net, Interest Expense, Net, and Income Taxes

In the three-month period ended March 31, 2024, we recognized expense of $0.1 million in our other (expense) income, net financial statement line item compared to a gain of $7.7 million in the same prior year period. The year-over-year change was primarily due to declines in fair value in our equity investments.

Interest expense, net, increased in the three-month period ended March 31, 2024 when compared to the same prior year period, primarily from increased losses incurred on our fixed-to-variable interest rate swaps in the current year period.

In the three-month period ended March 31, 2024, our effective tax rate (“ETR”) was 19.7 percent compared to 18.9 percent for the three-month period ended March 31, 2023. The 19.7 percent and 18.9 percent ETR in the three-month periods ended March 31, 2024 and 2023, respectively, were primarily driven by our mix of earnings between U.S. and foreign locations. Absent discrete tax events, we expect our future ETR will be lower than the U.S. corporate income tax rate of 21.0 percent due to our mix of earnings between U.S. and foreign locations, which generally have lower corporate income tax rates. Our ETR in future periods could also potentially be impacted by: changes in our mix of pre-tax earnings; changes in tax rates, tax laws or their interpretation, including the European Union adoption of Pillar Two proposals which began to take effect in 2024; the outcome of various federal, state and foreign audits, appeals, and litigation; and the expiration of certain statutes of limitations. Currently, we cannot reasonably estimate the impact of these items on our financial results.

Segment Operating Profit

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Operating Profit as a

 

 

 

 

Net Sales

 

 

Operating Profit

 

 

Percentage of Net Sales

 

 

 

 

Three Months Ended

 

 

Three Months Ended

 

 

Three Months Ended

 

 

 

 

March 31,

 

 

March 31,

 

 

March 31,

 

 

(dollars in millions)

 

2024

 

 

2023

 

 

2024

 

 

2023

 

 

2024

 

 

2023

 

 

Americas

 

$

1,186.5

 

 

$

1,141.3

 

 

$

639.3

 

 

$

608.9

 

 

 

53.9

 

%

 

53.4

 

%

EMEA

 

 

444.8

 

 

 

425.6

 

 

 

153.0

 

 

 

149.5

 

 

 

34.4

 

 

 

35.1

 

 

Asia Pacific

 

 

258.0

 

 

 

264.1

 

 

 

93.3

 

 

 

90.2

 

 

 

36.2

 

 

 

34.2

 

 

 

Americas

In the Americas, operating profit and operating profit as a percentage of net sales increased in the three-month period ended March 31, 2024 when compared to the same prior year period. The increases were primarily due to higher net sales driven by market growth and new product introductions, coupled with lower royalty expense as a result of agreements we entered into in 2023 to acquire intellectual property through the buyout of certain licensing arrangements.

 

EMEA

In EMEA, operating profit increased, but operating profit as a percentage of net sales decreased, in the three-month period ended March 31, 2024 when compared to the same prior year period. The increase in operating profit was due to higher net sales driven by market growth and improved pricing. However, operating profit as a percentage of net sales decreased due to higher manufacturing costs and a higher mix of profits from countries with lower operating profit margins.

 

Asia Pacific

In Asia Pacific, operating profit and operating profit as a percentage of net sales increased in the three-month period ended March 31, 2024 when compared to the same prior year period. In Asia Pacific, changes in foreign currency exchange rates have had a larger impact on our results than in our other operating segments. While net sales declined in the three-month period ended March 31, 2024 when compared to the same prior year period due to changes in foreign currency exchange rates, the negative net sales impact was partially offset by higher hedge gains recognized in the current year period from our hedging program. As a result, net sales volume growth, lower royalty expense as a result of agreements we entered into in 2023 to acquire intellectual property through the buyout of certain licensing arrangements, and savings from our restructuring programs resulted in higher operating profit and operating profit as a percentage of sales in Asia Pacific in the 2024 period.

 

 

29

 

Liquidity and Capital Resources

 

As of March 31, 2024, we had $393.0 million in cash and cash equivalents. In addition, we had $1.0 billion available to borrow under our 2023 364-Day Credit Agreement, and $1.5 billion available under our 2023 Five-Year Revolving Facility. The terms of the 2023 364-Day Credit Agreement and the 2023 Five-Year Revolving Facility are described further in Note 8 to our interim condensed consolidated financial statements included in Part I, Item 1 of this report.

 

We believe that cash flows from operations, our cash and cash equivalents on hand, and available borrowings under our revolving credit facilities will be sufficient to meet our ongoing liquidity requirements for at least the next twelve months. However, it is possible our needs may change. Further, there can be no assurance that, if needed, we will be able to secure additional financing on terms favorable to us, if at all.

 

Sources of Liquidity

Cash flows provided by operating activities were $228.0 million in the three-month period ended March 31, 2024, compared to $307.7 million in the same prior year period. The decrease in the 2024 period was driven by higher bonus, income tax and restructuring-related payments in the 2024 period. In addition, the timing of accounts payable payments made in the 2024 period compared to the 2023 period also resulted in a decline in operating cash flows.

Cash flows used in investing activities were $195.0 million in the three-month period ended March 31, 2024, compared to $149.4 million in the same prior year period. Instrument and property, plant and equipment additions reflected ongoing investments in our product portfolio, including new product introductions, optimization of our manufacturing and logistics networks, and investments in enterprise resource planning software. In addition, in the three-month period ended March 31, 2024 we invested in a debt security as well as other intangible assets.

Cash flows used in financing activities were $50.1 million in the three-month period ended March 31, 2024, compared to $206.7 million in the same prior year period. In the 2024 period, we borrowed a net $70.0 million under our Uncommitted Credit Facility and used those proceeds, along with cash on hand, to repurchase $113.6 million of our common stock. In the 2023 period, we borrowed a net $210.0 million under our revolving credit facilities and used those proceeds, along with cash on hand, to repurchase $267.6 million of our common stock. We also repaid $120.2 million of other debt obligations that were due in the first quarter of 2023.

We place our cash and cash equivalents in highly-rated financial institutions and limit the amount of credit exposure to any one entity. We invest only in high-quality financial instruments in accordance with our internal investment policy.

As of March 31, 2024, $350.6 million of our cash and cash equivalents were held in jurisdictions outside of the U.S. Of this amount, $31.5 million is denominated in U.S. Dollars and, therefore, bears no foreign currency translation risk. The remaining amount is denominated in currencies of the various countries where we operate. We generally intend to limit distributions from foreign subsidiaries earnings that were previously taxed in the U.S., as a result of the transition tax or tax on Global Intangible Low-Taxed Income (“GILTI”). These previously taxed earnings would not be subject to further U.S. federal tax.

Our concentrations of credit risks with respect to trade accounts receivable are limited due to the large number of customers and their dispersion across a number of geographic areas and by frequent monitoring of the creditworthiness of the customers to whom credit is granted in the normal course of business. Substantially all of our trade receivables are concentrated in the public and private hospital and healthcare industry in the U.S. and internationally or with distributors or dealers who operate in international markets and, accordingly, are exposed to their respective business, economic and country-specific variables.

Material Cash Requirements from Known Contractual and Other Obligations

At March 31, 2024, we had outstanding debt of $5,796.2 million, of which $970.0 million was classified as current debt. Of our current debt, $850.0 million of senior notes mature on November 22, 2024, and the remaining $120.0 million was outstanding under our Uncommitted Credit Facility which we expect to repay during 2024. We believe we can satisfy these debt obligations with cash generated from our operations, by issuing new debt and/or by borrowing on our committed revolving credit facilities.

For additional information on our debt, including types of debt, maturity dates, interest rates, debt covenants and available revolving credit facilities, see Note 8 to our interim condensed consolidated financial statements included in Part I, Item 1 of this report.

30

 

In February 2024, our Board of Directors declared a quarterly cash dividend of $0.24 per share. We expect to continue paying cash dividends on a quarterly basis; however, future dividends are subject to approval of the Board of Directors and may be adjusted as business needs or market conditions change.

In February 2016, our Board of Directors authorized a $1.0 billion share repurchase program effective March 1, 2016, with no expiration date. In the three-month period ended March 31, 2024, we repurchased approximately 0.7 million shares for $88.0 million. As of March 31, 2024, $67.8 million remained authorized under this program.

As discussed in Note 4 to our interim condensed consolidated financial statements in Part I, Item 1 of this report, we are executing on a 2023 Restructuring Plan, a 2021 Restructuring Plan and a 2019 Restructuring Plan. The 2023 Restructuring Plan along with other related initiatives is expected to result in total pre-tax charges of $120 million to $135 million by the end of 2025, of which approximately $92 million was incurred through March 31, 2024. We expect to reduce gross annual pre-tax operating expenses by $175 million to $200 million relative to the 2023 baseline expenses by the end of 2025 as program benefits under the 2023 Restructuring Plan are realized. The 2021 Restructuring Plan is expected to result in total pre-tax restructuring charges of approximately $180 million by the end of 2024, of which approximately $170 million was incurred through March 31, 2024. We expect to reduce gross annual pre-tax operating expenses by approximately $190 million relative to the 2021 baseline expenses by the end of 2024 as program benefits under the 2021 Restructuring Plan are realized. The 2019 Restructuring Plan is expected to result in total pre-tax restructuring charges of approximately $370 million by the end of 2025, of which approximately $336 million was incurred through March 31, 2024. In our original estimates, we expected to reduce gross annual pre-tax operating expenses by approximately $180 million to $280 million relative to the 2019 baseline expenses by the end of 2023 as benefits under the 2019 Restructuring Plan were realized. Our latest estimates indicate that we will be near the low end of that range, and the full benefits will not be realized until we complete the closure of a manufacturing facility, which is expected to occur in 2025.

As discussed in Note 12 to our interim condensed consolidated financial statements included in Part I, Item 1 of this report, the IRS has issued proposed adjustments for years 2010 through 2012, for years 2013 through 2015, and for years 2016 through 2019. We have disputed these proposed adjustments and intend to continue to vigorously defend our positions. Although the ultimate timing for resolution of the disputed tax issues is uncertain, future payments may be significant to our operating cash flows.

As discussed in Note 15 to our interim condensed consolidated financial statements included in Part I, Item 1 of this report, we are involved in various litigation matters. We estimate the total liabilities for all litigation matters was $226.5 million as of March 31, 2024. However, litigation is inherently uncertain, and upon resolution of any of these uncertainties, we may incur charges in excess of these estimates, and may in the future incur other material judgments or enter into other material settlements of claims. We expect to pay these liabilities over the next few years. Additionally, we have entered into development, distribution and other contractual arrangements that may result in future payments dependent upon various events such as the achievement of certain product R&D milestones, sales milestones, or, at our discretion, maintenance of exclusive rights to distribute a product. Since there is uncertainty on the timing or whether such payments will have to be made, they have not been recognized on our condensed consolidated balance sheets. These estimated payments could range from $0 to approximately $405 million.

Recent Accounting Pronouncements

Information pertaining to recent accounting pronouncements can be found in Note 2 to our interim condensed consolidated financial statements included in Part I, Item 1 of this report.

Critical Accounting Estimates

The preparation of our financial statements is affected by the selection and application of accounting policies and methods, and also requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Critical accounting estimates are those that involve a significant level of estimation uncertainty and have had or are reasonably likely to have a material impact on our financial condition and results of operations. There were no changes in the three-month period ended March 31, 2024 to our critical accounting estimates as described in our Annual Report on Form 10-K for the year ended December 31, 2023.

31

 

Cautionary Note Regarding Forward-Looking Statements and Factors That May Affect Future Results

This quarterly report contains certain statements that are forward-looking statements within the meaning of federal securities laws. Forward-looking statements can be identified by the fact that they do not relate strictly to historical or current facts. When used in this report, the words “may,” “will,” “can,” “should,” “would,” “could,” “anticipate,” “expect,” “plan,” “seek,” “believe,” “are confident that,” “look forward to,” “predict,” “estimate,” “potential,” “project,” “target,” “forecast,” “see,” “intend,” “design,” “strive,” “strategy,” “future,” “opportunity,” “assume,” “guide,” “position,” “continue” and similar expressions are intended to identify forward-looking statements. Forward-looking statements are based on current beliefs, expectations and assumptions of management and are subject to significant risks, uncertainties and changes in circumstances that could cause actual results to differ materially from such forward-looking statements. These risks, uncertainties and changes in circumstances include, but are not limited to:

•
competition;
•
pricing pressures;
•
dependence on new product development, technological advances and innovation;
•
changes in customer demand for our products and services caused by demographic changes, obsolescence, development of different therapies or other factors;
•
shifts in the product category or regional sales mix of our products and services;
•
the effects of business disruptions, either alone or in combination with other risks on our business and operations;
•
the risks and uncertainties related to our ability to successfully execute our restructuring plans;
•
control of costs and expenses;
•
our ability to attract, retain and develop the highly skilled employees, senior management, independent agents and distributors we need to support our business;
•
the possibility that the anticipated synergies and other benefits from mergers and acquisitions will not be realized, or will not be realized within the expected time periods;
•
the risks and uncertainties related to our ability to successfully integrate the operations, products, employees and distributors of acquired companies;
•
the effect of the potential disruption of management’s attention from ongoing business operations due to integration matters related to mergers and acquisitions; the effect of mergers and acquisitions on our relationships with customers, suppliers and lenders and on our operating results and businesses generally;
•
the ability to form and implement alliances;
•
dependence on a limited number of suppliers for key raw materials and other inputs and for outsourced activities;
•
the risk of disruptions in the supply of materials and components used in manufacturing or sterilizing our products;
•
breaches or failures of our information technology systems or products, including by cyberattack, unauthorized access or theft;
•
challenges relating to changes in and compliance with governmental laws and regulations affecting our U.S. and international businesses, including regulations of the U.S. Food and Drug Administration (“FDA”) and other government regulators, such as more stringent requirements for regulatory clearance of products;
•
the outcome of government investigations;
•
the impact of healthcare reform and cost containment measures, including efforts sponsored by government agencies, legislative bodies, the private sector and healthcare purchasing organizations, through reductions in reimbursement levels, repayment demands and otherwise;
•
the impact of substantial indebtedness on our ability to service our debt obligations and/or refinance amounts outstanding under our debt obligations at maturity on terms favorable to us, or at all;
•
changes in tax obligations arising from examinations by tax authorities and from changes in tax laws in jurisdictions where we do business, including as a result of the “base erosion and profit shifting” project undertaken by the Organisation for Economic Co-operation and Development and otherwise;
•
challenges to the tax-free nature of the ZimVie spinoff transaction and the subsequent liquidation of our retained interest in ZimVie;
•
the risk of additional tax liability due to the recategorization of our independent agents and distributors to employees;

32

 

•
the risk that material impairment of the carrying value of our intangible assets, including goodwill, could negatively affect our operating results;
•
changes in general domestic and international economic conditions, including interest rate and currency exchange rate fluctuations;
•
changes in general industry and market conditions, including domestic and international growth, inflation and currency exchange rates;
•
the domestic and international business impact of political, social and economic instability, tariffs, trade restrictions and embargoes, sanctions, wars, disputes and other conflicts, including on our ability to operate in, export from or collect accounts receivable in affected countries;
•
challenges relating to changes in and compliance with governmental laws and regulations affecting our U.S. and international businesses, including regulations of the FDA and other government regulators relating to medical products, healthcare fraud and abuse laws and data privacy and security laws;
•
the success of our quality and operational excellence initiatives;
•
the ability to remediate matters identified in inspectional observations or warning letters issued by the FDA and other regulators, while continuing to satisfy the demand for our products;
•
product liability, intellectual property and commercial litigation losses; and
•
the ability to obtain and maintain adequate intellectual property protection.

Our Annual Report on Form 10-K for the year ended December 31, 2023 contains detailed discussions of these and other important factors under the heading “Risk Factors.” You should understand that it is not possible to predict or identify all factors that could cause actual results to differ materially from forward-looking statements. Consequently, you should not consider any list or discussion of such factors to be a complete set of all potential risks or uncertainties.

Forward-looking statements speak only as of the date they are made and we expressly disclaim any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. You are advised, however, to consult any further disclosures we make on related subjects in our Quarterly Reports on Form 10-Q and Current Reports on Form 8-K.

Readers of this report are cautioned not to rely on these forward-looking statements since there can be no assurance that these forward-looking statements will prove to be accurate. This cautionary statement is applicable to all forward-looking statements contained in this report.

Item 3. Quantitative and Qualitative Disclosures About Market Risk

There have been no material changes from the information provided in our Annual Report on Form 10-K for the year ended December 31, 2023.

Item 4. Controls and Procedures

Evaluation of Disclosure Controls and Procedures. We maintain disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (“Exchange Act”)) that are designed to provide reasonable assurance that information required to be disclosed in the reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosures. Because of inherent limitations, disclosure controls and procedures, no matter how well designed and operated, can provide only reasonable, and not absolute, assurance that the objectives of disclosure controls and procedures are met.

Our management, with the participation of our Chief Executive Officer and Chief Financial Officer, evaluated the effectiveness of our disclosure controls and procedures as of the end of the period covered by this report. Based on that evaluation, our Chief Executive Officer and Chief Financial Officer concluded that, as of the end of the period covered by this report, our disclosure controls and procedures were effective at a reasonable assurance level.

Changes in Internal Control Over Financial Reporting. There were no changes in our internal control over financial reporting that occurred during the quarter ended March 31, 2024 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

33

 

Part II – Other Information

Information pertaining to legal proceedings can be found in Note 15 to our interim condensed consolidated financial statements included in Part I, Item 1 of this report and is incorporated herein by reference.

Item 1A. Risk Factors

You should carefully consider the factors discussed in Part I, Item 1A “Risk Factors” of our Annual Report on Form 10-K for the year ended December 31, 2023 (“2023 Form 10-K”), which could materially affect our business, financial condition and results of operations. The risks described in our 2023 Form 10-K are not the only risks we face. Additional risks and uncertainties not currently known to us or that we currently deem to be immaterial may also materially adversely affect our business, financial condition or results of operations.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

 

Unregistered Sales of Equity Securities

During the three-month period ended March 31, 2024, we issued 0.2 million shares of our common stock valued at $23.4 million upon the achievement of a commercial milestone related to the Embody acquisition. The shares were issued to the former Embody shareholders whom we reasonably believed to be accredited investors in a private transaction exempt from registration under Section 4(a)(2) and Regulation D under the Securities Act. To minimize dilution from issuing shares for the milestone settlement, we repurchased 0.2 million shares of our common stock in February 2024.

 

Issuer Purchases of Equity Securities

 

The following table summarizes repurchases of common stock settled during the three-month period ended March 31, 2024:

 

Period

 

Total Number of Shares Purchased

 

 

Average Price Paid per Share

 

 

Total Number of Shares Purchased as a Part of Publicly Announced Program(1)

 

 

Maximum Approximate Dollar Value of Shares that may yet be
Purchased Under the Program(1)

 

January 2024

 

 

530,017

 

 

$

120.94

 

 

 

530,017

 

 

$

91,702,916

 

February 2024

 

 

192,737

 

 

 

123.87

 

 

 

192,737

 

 

 

67,828,222

 

March 2024

 

 

-

 

 

 

-

 

 

 

-

 

 

 

67,828,222

 

Total

 

 

722,754

 

 

$

121.72

 

 

 

722,754

 

 

$

67,828,222

 

 

(1) In February 2016, our Board of Directors authorized a $1.0 billion share repurchase program effective March 1, 2016, with no expiration date.

Item 3. Defaults Upon Senior Securities

None

Item 4. Mine Safety Disclosures

Not applicable

Item 5. Other Information

During the three-month period ended March 31, 2024, the Audit Committee of our Board of Directors approved the engagement of PricewaterhouseCoopers LLP, our independent registered public accounting firm, to perform certain audit-related and tax services. This disclosure is made pursuant to Section 10A(i)(2) of the Exchange Act, as added by Section 202 of the Sarbanes-Oxley Act of 2002.

During the three-month period ended March 31, 2024, no members of our Board of Directors or officers (as defined in Rule 16a-1(f) of the Exchange Act) adopted, amended or terminated any contract, instruction or written plan for the purchase or sale of our

34

 

securities intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) of the Exchange Act or any non-Rule 10b5-1 trading arrangement, as defined in rules of the Securities and Exchange Commission.

35

 

Item 6. Exhibits

The following exhibits are filed or furnished as part of this report:

3.1

 

Restated Certificate of Incorporation of Zimmer Biomet Holdings, Inc., dated May 17, 2021 (incorporated by reference to Exhibit 3.2 to the Registrant’s Current Report on Form 8-K filed May 20, 2021)

 

 

 

3.2

 

Restated Bylaws of Zimmer Biomet Holdings, Inc., effective December 14, 2022 (incorporated by reference to Exhibit 3.2 to the Registrant’s Annual Report on Form 10-K filed February 24, 2023)

 

 

 

10.1

 

Form of Amendment to Change in Control Severance Agreement with Ivan Tornos, Suketu Upadhyay, Rachel Ellingson, Lori Winkler and Paul Stellato (incorporated by reference to Exhibit 10.51 to the Registrant's Annual Report on Form 10-K filed February 23, 2024)

 

 

 

10.2

 

Amendment to Change in Control Severance Agreement dated February 19, 2024 between Zimmer GmbH and Wilfred van Zuilen (incorporated by reference to Exhibit 10.52 to the Registrant's Annual Report on Form 10-K filed February 23, 2024)

 

 

 

10.3

 

Deed of Amendment dated February 19, 2024 between Zimmer Asia (HK) Limited and Sang-Uk Yi (incorporated by reference to Exhibit 10.53 to the Registrant's Annual Report on Form 10-K filed February 23, 2024)

 

 

 

10.4

 

Form of Change in Control Severance Agreement with Mark Bezjak (incorporated by reference to Exhibit 10.54 to the Registrant's Annual Report on Form 10-K filed February 23, 2024)

 

 

 

 21

 

List of Subsidiaries of Zimmer Biomet Holdings, Inc.

 

 

 

 31.1

 

Certification pursuant to Rule 13a-14(a)/15d-14(a) of the Securities Exchange Act of 1934 of the Chief Executive Officer, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

 

 

 

 31.2

 

Certification pursuant to Rule 13a-14(a)/15d-14(a) of the Securities Exchange Act of 1934 of the Chief Financial Officer, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

 

 

 

 32

 

Certification pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

 

 

 

101

 

Inline XBRL Instance Document – the instance document does not appear in the Interactive Data File because XBRL tags are embedded within the Inline XBRL document.

 

 

 

101.SCH

 

Inline XBRL Taxonomy Extension Schema Document

 

 

 

104

 

Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)

 

 

 

 

36

 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

 

 

ZIMMER BIOMET HOLDINGS, INC.

 

 

(Registrant)

 

 

 

 

 

Date: May 2, 2024

 

By:

 

/s/ Suketu Upadhyay

 

 

 

 

Suketu Upadhyay

 

 

 

 

Chief Financial Officer and Executive Vice President - Finance, Operations and Supply Chain

 

 

 

 

(Principal Financial Officer)

 

 

 

 

 

Date: May 2, 2024

 

By:

 

/s/ Paul Stellato

 

 

 

 

Paul Stellato

 

 

 

 

Vice President, Controller and Chief Accounting Officer

 

 

 

 

(Principal Accounting Officer)

 

 

 

 

 

 

 

 

 

 

 

 

37

 EX-21 2 zbh-ex21.htm EX-21 EX-21

 

Exhibit 21

 

 

Subsidiaries of Zimmer Biomet Holdings, Inc.

As of March 31, 2024

 

Name of Subsidiary1

Jurisdiction of Formation

Domestic subsidiaries:

 

 

A&E Advanced Closure Systems, LLC

Delaware

 

A&E Medical Corp.

New Jersey

 

Alto Development Corp.

New Jersey

 

Avitus Orthopaedics, Inc.

Delaware

 

Biomet Biologics, LLC

Indiana

 

Biomet CV Holdings, LLC

Delaware

 

Biomet Fair Lawn LLC

Indiana

 

Biomet International, Inc.

Delaware

 

Biomet Manufacturing, LLC

Indiana

 

Biomet Microfixation, LLC

Florida

 

dba Zimmer Biomet CMF and Thoracic

 

 

Biomet Orthopedics, LLC

Indiana

 

Biomet Sports Medicine, LLC

Indiana

 

dba Biomet Sports Medicine Limited Liability Company (Forced)

 

 

Biomet Trauma, LLC

Indiana

 

Biomet U.S. Reconstruction, LLC

Indiana

 

Biomet, Inc.

Indiana

 

dba Zimmer Biomet

 

 

Cayenne Medical, Inc.

Delaware

 

CD Diagnostics, Inc.

Delaware

 

CD Laboratories, Inc.

Maryland

 

Citra Labs, LLC

Indiana

 

dba Biomet Citra Labs, LLC (Forced)

 

 

Dornoch Medical Systems, Inc.

Illinois

 

Embody, Inc.

Virginia

 

ETEX Corporation

Massachusetts

 

dba Zimmer ETEX

 

 

dba Zimmer Biomet ETEX

 

 

ETEX Holdings, Inc.

Delaware

 

dba Zimmer ETEX

 

 

dba Zimmer Biomet ETEX

 

 

Interpore Cross International, LLC

California

 

dba Zimmer Biomet Irvine

 

 

Jace Medical, LLC

Indiana

 

LVB Acquisition, Inc.

Delaware

 

Medtech Surgical, Inc.

Delaware

 

ReLign Corporation

Delaware

 

Synvasive Technology, Inc.

California

 

VSC Medical Holdings Inc.

Delaware

 

ZB EMEA US UK LLC

Delaware

 

ZB Manufacturing, LLC

Delaware

 

Zimmer Biomet Americas Holding LLC

Delaware

 

Zimmer Biomet Distribution LLC

Delaware

 

Zimmer Biomet Integrations LLC

Delaware

 

Zimmer Biomet Leasing LLC

Delaware

 

 

 

Zimmer Caribe, LLC

Delaware

 

Zimmer CEP USA, Inc.

Delaware

 

Zimmer Co-op Holdings, LLC

Delaware

 

Zimmer CV, Inc.

Delaware

 

Zimmer Knee Creations, Inc.

Delaware

 

Zimmer Orthobiologics, Inc.

New Jersey

 

Zimmer Production, Inc.

Delaware

 

Zimmer Spine Next, Inc.

Delaware

 

Zimmer Surgical, Inc.

Delaware

 

Zimmer Trabecular Metal Technology, Inc.

New Jersey

 

Zimmer US, Inc.

Delaware

 

dba Zimmer Biomet

 

 

dba Zimmer Biomet Bay Area

 

 

dba Zimmer Biomet Mid-Atlantic

 

 

dba Zimmer Biomet North Texas

 

 

dba Zimmer Biomet Southern California

 

 

dba Zimmer US Cooperative

 

 

dba Compression Therapy Concepts

 

 

dba CTC Inc.

 

 

Zimmer, Inc.

Delaware

 

dba Zimmer Biomet

 

 

dba Zimmer Biomet Corporate Services (Forced)

 

 

dba Z Hotel

 

 

dba CD Diagnostics

 

 

dba CD Laboratories

 

 

 

 

Foreign subsidiaries:

 

 

Biomet Argentina SA

Argentina

 

OSSIS Australia Pty Limited

Australia

 

Zimmer Australia Holding Pty. Ltd.

Australia

 

Zimmer Biomet Pty Ltd.

Australia

 

Zimmer Biomet Austria GmbH

Austria

 

ZH2LX Barbados Branch (branch)

Barbados

 

Zimmer Biomet Finance Srl

Barbados

 

Zimmer Biomet BV

Belgium

 

Biomet Insurance Ltd.

Bermuda

 

Biomet Brazil Medical Device Ltda.

Brazil

 

WM World Medical Importacao e Exportacao Ltda.

Brazil

 

Zimmer Biomet Brasil Ltda.

Brazil

 

ORTHOsoft ULC

Canada

 

dba Zimmer CAS

 

 

Zimmer Biomet Canada, Inc.

Canada

 

ZB Cayman (Asia) Holding Ltd.

Cayman Islands

 

Biomet Chile SA

Chile

 

Beijing Montagne Medical Device Co. Ltd.

China

 

Biomet China Co., Ltd.

China

 

Changzhou Biomet Medical Devices Co. Ltd.

China

 

Shanghai Biomet Business Consulting Co. Ltd.

China

 

Zhejiang Biomet Medical Products Co. Ltd.

China

 

Zimmer Biomet CBT

China

 

Zimmer (Shanghai) Medical International Trading Co., Ltd.

China

 

Zimmer (Shanghai) Medical International Trading Co., Ltd. - Beijing Branch (branch)

China

 

Zimmer Biomet Colombia SAS

Colombia

 

Zimmer Biomet Centroamerica SA

Costa Rica

 

Zimmer Czech sro

Czech Republic

 

 

 

Zimmer Biomet Denmark ApS

Denmark

 

Zimmer Biomet Finland Oy

Finland

 

Biomet France Sarl

France

 

Medtech SAS

France

 

Neosteo SAS

France

 

Zimmer Biomet France SAS

France

 

Zimmer Biomet France Holdings SAS

France

 

Biomet Deutschland GmbH

Germany

 

Zimmer Biomet Healthcare Management GmbH

Germany

 

Zimmer Biomet Deutschland GmbH

Germany

 

Zimmer Germany Holdings GmbH

Germany

 

Zimmer International Logistics GmbH

Germany

 

Zimmer Biomet Hellas SA

Greece

 

Biomet Hong Kong Holding Ltd.

Hong Kong

 

ZB Hong Kong Holding Ltd.

Hong Kong

 

ZB Hong Kong Ltd.

Hong Kong

 

Zimmer Asia (HK) Ltd.

Hong Kong

 

Zimmer India Private Ltd.

India

 

Zimmer Biomet Ireland Holdings Limited

Ireland

 

Zimmer Biomet Ireland Limited

Ireland

 

Zimmer Orthopedics Manufacturing Limited

Ireland

 

D.S. Comp Ltd.

Israel

 

Zimmer Biomet Comp Ltd.

Israel

 

Zimmer Biomet Medical Israel Ltd.

Israel

 

Zimmer Biomet Italia Srl

Italy

 

Zimmer Biomet GK

Japan

 

Zimmer Biomet Kikaku G.K.

Japan

 

Zimmer Biomet Korea Ltd.

Korea

 

Zimmer GmbH, Representative Office Lebanon (branch)

Lebanon

 

Zimmer Biomet OUS Holdings AG

Liechtenstein

 

Zimmer Luxembourg Sarl

Luxembourg

 

Zimmer Luxembourg II Sarl

Luxembourg

 

Zimmer Medical Malaysia SDN BHD

Malaysia

 

Biomet Mexico S.A. de C.V.

Mexico

 

Representaciones Zimmer Inc., S. de R.L. de C.V.

Mexico

 

A&E Medical Europe BV

Netherlands

 

A&E Medical Europe Cooperatief U.A.

Netherlands

 

Biomet C.V.

Netherlands

 

Biomet Global Supply Chain Center B.V.

Netherlands

 

Biomet Holdings B.V.

Netherlands

 

Medical Concepts Holding B.V.

Netherlands

 

ZB COOP C.V.

Netherlands

 

Zimmer Biomet Asia Holding B.V.

Netherlands

 

Zimmer Biomet Nederland B.V.

Netherlands

 

Zimmer Manufacturing B.V.

Netherlands

 

OSSIS Corporation

New Zealand

 

Zimmer Biomet New Zealand Company

New Zealand

 

Zimmer Biomet NZ Holdings Corporation

New Zealand

 

Zimmer Biomet Norway AS

Norway

 

Zimmer Biomet Polska Sp. z.o.o

Poland

 

Zimmer Biomet Portugal Unipessoal, Lda

Portugal

 

Biomet Orthopedics Puerto Rico, Inc.

Puerto Rico

 

Zimmer Manufacturing B.V. (branch)

Puerto Rico

 

Zimmer Biomet Romania S.R.L.

Romania

 

Zimmer CIS Ltd.

Russia

 

 

 

Zimmer Biomet Asel Alarabiya Limited Company

Saudi Arabia

 

Zimmer GmbH, Zimmer Biomet Regional Headquarters (branch)

Saudi Arabia

 

Zimmer Biomet Asia Holdings Pte. Ltd.

Singapore

 

Zimmer Pte. Ltd.

Singapore

 

Zimmer Slovakia sro

Slovakia

 

Zimmer Biomet South Africa (Pty) Ltd.

South Africa

 

Biomet Spain Orthopaedics S.L.

Spain

 

Zimmer Biomet Spain S.L.

Spain

 

Biomet Cementing Technologies AB

Sweden

 

Scandimed Holding AB

Sweden

 

Zimmer Biomet Sweden AB

Sweden

 

Zimmer Biomet Global Holdings Switzerland GmbH

Switzerland

 

Zimmer Biomet OUS Holdings 1 GmbH

Switzerland

 

Zimmer GmbH

Switzerland

 

Zimmer GmbH, Euro IP Branch (branch)

Switzerland

 

Zimmer GmbH, Distribution (branch)

Switzerland

 

Zimmer GmbH, Zug Branch (branch)

Switzerland

 

Zimmer Surgical SA

Switzerland

 

Zimmer Switzerland Holdings LLC

Switzerland

 

Zimmer Switzerland Manufacturing GmbH

Switzerland

 

Zimmer Biomet Taiwan Co., Ltd.

Taiwan

 

Zimmer Biomet (Thailand) Co., Ltd.

Thailand

 

Zimmer Biomet Tibbi Cihazlar Sanayi ve Ticaret Anonim Sirketi

Turkey

 

Zimmer Gulf FZ LLC

United Arab Emirates

 

Biomet UK Ltd.

United Kingdom

 

Biomet UK Healthcare Ltd.

United Kingdom

 

ZB EMEA 1 LP

United Kingdom

 

ZB EMEA Finance UK 1 Ltd.

United Kingdom

 

ZB EMEA Finance UK 2 Ltd.

United Kingdom

 

ZB EMEA Finance UK 3 Ltd.

United Kingdom

 

ZB UK Group Holdings Limited

United Kingdom

 

ZB UK Plant Holdings Limited

United Kingdom

 

Zimmer Biomet UK Ltd.

United Kingdom

 

Zimmer Trustee Ltd.

United Kingdom

 

Zimmer Pte. Ltd., The Representative Office of Zimmer Pte. Ltd. in Hanoi City (branch)

Vietnam

 

1 Excludes certain entities that have de minimis activity or are in the process of being liquidated or dissolved and that, if considered in the aggregate as a single subsidiary, would not constitute a significant subsidiary.

 

 EX-31.1 3 zbh-ex31_1.htm EX-31.1 EX-31.1

 

EXHIBIT 31.1

CERTIFICATION PURSUANT TO RULE 13a-14(a)/15d-14(a) OF THE SECURITIES EXCHANGE ACT OF 1934, AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Ivan Tornos, certify that:

1.
I have reviewed this quarterly report on Form 10-Q of Zimmer Biomet Holdings, Inc.;
2.
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.
The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d‑15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
(a)
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
(b)
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
(c)
Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
(d)
Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and
5.
The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors:
(a)
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and
(b)
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Date: May 2, 2024

 

/s/ Ivan Tornos

Ivan Tornos

President and Chief Executive Officer

 

 

 EX-31.2 4 zbh-ex31_2.htm EX-31.2 EX-31.2

 

EXHIBIT 31.2

CERTIFICATION PURSUANT TO RULE 13a-14(a)/15d-14(a) OF THE SECURITIES EXCHANGE ACT OF 1934, AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Suketu Upadhyay, certify that:

1.
I have reviewed this quarterly report on Form 10-Q of Zimmer Biomet Holdings, Inc.;
2.
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.
The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d‑15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
(a)
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
(b)
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
(c)
Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
(d)
Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and
5.
The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors:
(a)
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and
(b)
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Date: May 2, 2024

 

/s/ Suketu Upadhyay

Suketu Upadhyay

Chief Financial Officer and Executive Vice President - Finance, Operations and Supply Chain

 

 

 

 EX-32 5 zbh-ex32.htm EX-32 EX-32

 

Exhibit 32

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES‑OXLEY ACT OF 2002

In connection with the Quarterly Report on Form 10-Q of Zimmer Biomet Holdings, Inc. (the "Company") for the period ended March 31, 2024 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), each of the undersigned certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:

(1)
The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2)
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

/s/ Ivan Tornos

Ivan Tornos

President and Chief Executive Officer

May 2, 2024

 

/s/ Suketu Upadhyay

Suketu Upadhyay

Chief Financial Officer and Executive Vice President - Finance, Operations and Supply Chain

May 2, 2024

 

 

 EX-101.SCH 6 zbh-20240331.xsd XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT 100000 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink 100010 - Statement - Condensed Consolidated Statements of Earnings (unaudited) link:presentationLink link:calculationLink link:definitionLink 100020 - Statement - Condensed Consolidated Statements of Comprehensive Income (unaudited) link:presentationLink link:calculationLink link:definitionLink 100030 - Statement - Condensed Consolidated Balance Sheets (unaudited) link:presentationLink link:calculationLink link:definitionLink 100040 - Statement - Condensed Consolidated Balance Sheets (unaudited) (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 100050 - Statement - Condensed Consolidated Statements of Stockholders' Equity (unaudited) link:presentationLink link:calculationLink link:definitionLink 100060 - Statement - Condensed Consolidated Statements of Stockholders' Equity (Parenthetical) (unaudited) link:presentationLink link:calculationLink link:definitionLink 100070 - Statement - Condensed Consolidated Statements of Cash Flows (unaudited) link:presentationLink link:calculationLink link:definitionLink 995455 - Disclosure - Basis of Presentation link:presentationLink link:calculationLink link:definitionLink 995465 - Disclosure - Discontinued Operations and Related ZimVie Matters link:presentationLink link:calculationLink link:definitionLink 995475 - Disclosure - Significant Accounting Policies link:presentationLink link:calculationLink link:definitionLink 995485 - Disclosure - Revenue link:presentationLink link:calculationLink link:definitionLink 995495 - Disclosure - Restructuring link:presentationLink link:calculationLink link:definitionLink 995505 - Disclosure - Inventories link:presentationLink link:calculationLink link:definitionLink 995515 - Disclosure - Property, Plant and Equipment link:presentationLink link:calculationLink link:definitionLink 995525 - Disclosure - Acquisitions link:presentationLink link:calculationLink link:definitionLink 995535 - Disclosure - Debt link:presentationLink link:calculationLink link:definitionLink 995545 - Disclosure - Accumulated Other Comprehensive Income link:presentationLink link:calculationLink link:definitionLink 995555 - Disclosure - Fair Value Measurement of Assets and Liabilities link:presentationLink link:calculationLink link:definitionLink 995565 - Disclosure - Derivative Instruments and Hedging Activities link:presentationLink link:calculationLink link:definitionLink 995575 - Disclosure - Income Taxes link:presentationLink link:calculationLink link:definitionLink 995585 - Disclosure - Earnings Per Share link:presentationLink link:calculationLink link:definitionLink 995595 - Disclosure - Segment Information link:presentationLink link:calculationLink link:definitionLink 995605 - Disclosure - Commitments and Contingencies link:presentationLink link:calculationLink link:definitionLink 995615 - Disclosure - Significant Accounting Policies (Policies) link:presentationLink link:calculationLink link:definitionLink 995625 - Disclosure - Discontinued Operations and Related ZimVie Matters (Tables) link:presentationLink link:calculationLink link:definitionLink 995635 - Disclosure - Revenue (Tables) link:presentationLink link:calculationLink link:definitionLink 995645 - Disclosure - Restructuring (Tables) link:presentationLink link:calculationLink link:definitionLink 995655 - Disclosure - Inventories (Tables) link:presentationLink link:calculationLink link:definitionLink 995665 - Disclosure - Property, Plant and Equipment (Tables) link:presentationLink link:calculationLink link:definitionLink 995675 - Disclosure - Acquisitions (Tables) link:presentationLink link:calculationLink link:definitionLink 995685 - Disclosure - Debt (Tables) link:presentationLink link:calculationLink link:definitionLink 995695 - Disclosure - Accumulated Other Comprehensive Income (Tables) link:presentationLink link:calculationLink link:definitionLink 995705 - Disclosure - Fair Value Measurement of Assets and Liabilities (Tables) link:presentationLink link:calculationLink link:definitionLink 995715 - Disclosure - Derivative Instruments and Hedging Activities (Tables) link:presentationLink link:calculationLink link:definitionLink 995725 - Disclosure - Earnings Per Share (Tables) link:presentationLink link:calculationLink link:definitionLink 995735 - Disclosure - Segment Information (Tables) link:presentationLink link:calculationLink link:definitionLink 995745 - Disclosure - Basis of Presentation - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 995755 - Disclosure - Discontinued Operations and Related ZimVie Matters - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 995765 - Disclosure - Discontinued Operations and Related ZimVie Matters - Summary of Details of Loss from Discontinued Operations Included in Condensed Consolidated Statements of Earnings (Details) link:presentationLink link:calculationLink link:definitionLink 995775 - Disclosure - Discontinued Operations and Related ZimVie Matters - Summary of Details of Assets and Liabilities of Discontinued Operation (Details) link:presentationLink link:calculationLink link:definitionLink 995785 - Disclosure - Significant Accounting Policies - Additional Information (Detail) link:presentationLink link:calculationLink link:definitionLink 995795 - Disclosure - Revenue - Schedule of Net Sales by Geography (Detail) link:presentationLink link:calculationLink link:definitionLink 995805 - Disclosure - Revenue - Schedule of Net Sales by Product Category (Detail) link:presentationLink link:calculationLink link:definitionLink 995815 - Disclosure - Restructuring - Additional Information (Detail) link:presentationLink link:calculationLink link:definitionLink 995825 - Disclosure - Restructuring - Summary of Liabilities Recognized Related to Restructuring Plan (Detail) link:presentationLink link:calculationLink link:definitionLink 995835 - Disclosure - Restructuring - Summary of Location on Condensed Consolidated Statement of Earnings and Type of Cost for Restructuring Plan (Detail) link:presentationLink link:calculationLink link:definitionLink 995845 - Disclosure - Inventories - Summary of Inventories (Detail) link:presentationLink link:calculationLink link:definitionLink 995855 - Disclosure - Property, Plant and Equipment - Summary of Property, Plant and Equipment (Detail) link:presentationLink link:calculationLink link:definitionLink 995865 - Disclosure - Property, Plant and Equipment - Additional Information (Detail) link:presentationLink link:calculationLink link:definitionLink 995875 - Disclosure - Acquisitions - Additional Information (Detail) link:presentationLink link:calculationLink link:definitionLink 995885 - Disclosure - Acquisitions - Summary of Estimates of Fair Value of Assets Acquired and Liabilities Assumed (Details) link:presentationLink link:calculationLink link:definitionLink 995895 - Disclosure - Debt - Summary of Debt Instruments (Detail) link:presentationLink link:calculationLink link:definitionLink 995905 - Disclosure - Debt - Summary of Debt Instruments (Parenthetical) (Detail) link:presentationLink link:calculationLink link:definitionLink 995915 - Disclosure - Accumulated Other Comprehensive Income - Reclassification Adjustments from Accumulated Other Comprehensive Income (Detail) 2 link:presentationLink link:calculationLink link:definitionLink 995925 - Disclosure - Debt - Additional Information (Detail) link:presentationLink link:calculationLink link:definitionLink 995935 - Disclosure - Accumulated Other Comprehensive Income - Changes in Components of Accumulated Other Comprehensive Income, Net of Tax (Detail) link:presentationLink link:calculationLink link:definitionLink 995945 - Disclosure - Accumulated Other Comprehensive Income - Reclassification Adjustments from Accumulated Other Comprehensive Income (Detail) link:presentationLink link:calculationLink link:definitionLink 995955 - Disclosure - Accumulated Other Comprehensive Income - Tax Effects on Each Component of Accumulated Other Comprehensive Income Recognized in Statements of Comprehensive Income (Detail) link:presentationLink link:calculationLink link:definitionLink 995965 - Disclosure - Fair Value Measurement of Assets and Liabilities - Schedule of Fair Value Measurement of Asset and Liabilities (Detail) link:presentationLink link:calculationLink link:definitionLink 995975 - Disclosure - Fair Value Measurement of Assets and Liabilities - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 995985 - Disclosure - Fair Value Measurement of Assets and Liabilities - Schedule of Fair Value Liabilities Measured on Recurring Basis (Detail) link:presentationLink link:calculationLink link:definitionLink 995995 - Disclosure - Derivative Instruments and Hedging Activities - Schedule of Amounts Recorded On Balance Sheet Related To Cumulative Basis Adjustments For Fair Value Hedges (Detail) link:presentationLink link:calculationLink link:definitionLink 996005 - Disclosure - Derivative Instruments and Hedging Activities - Additional Information (Detail) link:presentationLink link:calculationLink link:definitionLink 996015 - Disclosure - Derivative Instruments and Hedging Activities - Gross Unrealized Losses from Derivative Instruments (Detail) link:presentationLink link:calculationLink link:definitionLink 996025 - Disclosure - Derivative Instruments and Hedging Activities - Effects of Fair Value, Cash Flow and Net Investment Hedge Accounting on Condensed Consolidated Statements of Earnings (Detail) link:presentationLink link:calculationLink link:definitionLink 996035 - Disclosure - Derivative Instruments and Hedging Activities - Derivative Instruments Not Designated as Hedging Instruments (Detail) link:presentationLink link:calculationLink link:definitionLink 996045 - Disclosure - Derivative Instruments and Hedging Activities - Fair Value of Derivative Instruments on Gross Basis (Detail) link:presentationLink link:calculationLink link:definitionLink 996055 - Disclosure - Derivative Instruments and Hedging Activities - Schedule of Effects of Master Netting Agreements on Condensed Consolidated Balance Sheets (Detail) link:presentationLink link:calculationLink link:definitionLink 996065 - Disclosure - Derivative Instruments and Hedging Activities - Net Investment Hedge Gains (Losses) Recognized on Condensed Consolidated Statements of Comprehensive Income (Detail) link:presentationLink link:calculationLink link:definitionLink 996075 - Disclosure - Income Taxes - Additional Information (Detail) link:presentationLink link:calculationLink link:definitionLink 996085 - Disclosure - Earnings Per Share - Reconciliation of Weighted Average Shares for Basic and Diluted Shares Computations (Detail) link:presentationLink link:calculationLink link:definitionLink 996095 - Disclosure - Earnings Per Share - Additional Information (Detail) link:presentationLink link:calculationLink link:definitionLink 996105 - Disclosure - Segment Information - Additional Information (Detail) link:presentationLink link:calculationLink link:definitionLink 996115 - Disclosure - Segment Information - Summary of Net Sales and Operating Profit by Segment (Detail) link:presentationLink link:calculationLink link:definitionLink 996125 - Disclosure - Commitments and Contingencies - Additional Information (Detail) link:presentationLink link:calculationLink link:definitionLink Collaborative Arrangement and Arrangement Other than Collaborative [Domain] Document Transition Report Document Transition Report Disposal Group, Including Discontinued Operation, Assets, Current Current assets of discontinued operations Total Current Assets of Discontinued Operations United States of America, Dollars U.S. Dollars [Member] Consolidated EBITDA ratio thereafter. Consolidated E B I T D A Ratio Thereafter Consolidated EBITDA ratio thereafter Other comprehensive income (loss). Other Comprehensive Income Loss [Line Items] Other Comprehensive Income Loss [Line Items] Restructuring Cost and Reserve [Line Items] Restructuring Cost And Reserve [Line Items] Two Thousand Thirty Five [Member] Two Thousand Thirty Five [Member] Due in 2035 [Member] Geographical [Axis] Geographical Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block] Fair Value Liabilities Measured on Recurring Basis Noncontrolling Interest [Member] Noncontrolling Interest [Member] Other Current Assets [Member] Other Current Assets [Member] Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, after Tax Unrealized cash flow hedge gains, net of tax Other Liabilities, Noncurrent Other long-term liabilities Other Liabilities, Noncurrent, Total Short-Term Debt [Abstract] Other Assets [Member] Other Assets [Member] Fair Value, Inputs, Level 1 [Member] Fair Value Measurements at Reporting Date Using: Quoted Prices in Active Markets for Identical Assets (Level 1) [Member] Three point seven zero percentage. Three Point Seven Zero Percentage [Member] 3.700% Senior Notes due 2023 3.700% [Member] AOCI, Cash Flow Hedge, Cumulative Gain (Loss), after Tax Fair value of outstanding derivative instruments, unrealized gain net of taxes deferred in accumulated other comprehensive income Increase (Decrease) in Other Operating Assets and Liabilities, Net Other assets and liabilities Increase (Decrease) in Other Operating Assets and Liabilities, Net, Total Document Information [Table] Document Information [Table] Fair Value Disclosures [Text Block] Fair Value Measurement of Assets and Liabilities Japan Term Loan B. Japan Term Loan B [Member] Japan Term Loan B [Member] Revenue from Contract with Customer, Excluding Assessed Tax Net Sales Revenue from Contract with Customer, Excluding Assessed Tax, Total Two thousand twenty seven. Two Thousand Twenty Seven [Member] Due in 2027 [Member] Schedule of Cash Flow Hedges Included in Accumulated Other Comprehensive Income (Loss) [Table Text Block] Gross Unrealized Losses from Derivative Instruments Short-Term Debt, Type [Axis] Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block] Fair Value of Derivative Instruments on Gross Basis Schedule of Business Acquisitions, by Acquisition [Table] Knees. Knees [Member] Knees [Member] Two thousand twenty one restructuring plan. Two Thousand Twenty One Restructuring Plan [Member] 2021 Restructuring Plan [Member] Acquisition, integration, divestiture and related discontinued operation. Acquisition Integration Divestiture And Related Discontinued Operation Acquisition, integration, divestiture and related Interest Income (Expense), Net Interest expense, net Interest Income (Expense), Net, Total Summary of Estimates of Fair Value of Assets Acquired and Liabilities Assumed Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block] Hedged Liability, Fair Value Hedge, Cumulative Increase (Decrease) Long-term debt Multi Currency Revolving Facility [Member] Multi Currency Revolving Facility [Member] Multicurrency Revolving Facility [Member] Short-Term Term Loan and Forward Exchange Agreement [Member] Short-term term loan and forward exchange agreement. Short Term Term Loan And Forward Exchange Agreement Cross Currency Interest Rate Swap Terminated [Member] Cross Currency Interest Rate Contract Terminated Member Cross currency interest rate contract terminated. Net sales and operating profit information. Net Sales And Operating Profit Information [Line Items] Net Sales And Operating Profit Information [Line Items] Five year revolving facility member. Five Year Revolving Facility [Member] Five Year Revolving Facility Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block] Fair Value Measurement of Asset and Liabilities Revenue from External Customers by Products and Services [Table Text Block] Schedule of Net Sales by Product Category Shares of common stock repurchased Stock Repurchased During Period, Shares Disposal Groups, Including Discontinued Operations [Table] Income Statement Balance Sheet And Additional Disclosures By Disposal Groups Including Discontinued Operations [Table] Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent [Member] Cash Flow Hedges [Member] Balance Sheet Location [Axis] Balance Sheet Location Assets, Current Total Current Assets SET. S E T [Member] S.E.T [Member] Extinguishment of Debt, Type [Domain] Extinguishment of Debt, Type Currency [Axis] Currency Unsecured Long-Term Debt, Noncurrent Term loan Term loan Liabilities and Equity Total Liabilities and Stockholders' Equity Entity Address, State or Province Entity Address, State or Province Derivative Instruments and Hedging Activities Disclosure [Text Block] Derivative Instruments and Hedging Activities Non-Rule 10b5-1 Arrangement Amended Non-Rule 10b5-1 Arr Amended [Flag] Non-Rule 10b5-1 arr amended. Disposal Group, Including Discontinued Operation, Liabilities, Noncurrent Noncurrent liabilities of discontinued operations Total Noncurrent Liabilities of Discontinued Operations Acquisition date Acquisition Date for Second Quarter Acquisition Business Acquisition, Effective Date of Acquisition Comprehensive Income (Loss), Net of Tax, Attributable to Parent Comprehensive Income Attributable to Zimmer Biomet Holdings, Inc. Inventory Disclosure [Text Block] Inventories Acquisition integration divestiture and related expenses Acquisition Integration Divestiture And Related Expenses Acquisition, integration, divestiture and related 2022 five-year revolving facility member. Two Thousand Twenty Two Five-Year Revolving Facility [Member] 2022 Five-Year Revolving Facility Trading Symbol Trading Symbol Debt Instrument, Redemption, Period [Axis] Debt Instrument, Redemption, Period Common Stock, Shares, Issued Common stock, shares issued Common Stock, Shares, Issued, Total Cross Currency Interest Rate Contract [Member] Cross-currency Interest Rate Swaps [Member] Prepaid Expense and Other Assets, Current Prepaid expenses and other current assets Schedule of Long-Term Debt Instruments [Table] Debt Instrument [Table] AOCI Attributable to Parent [Member] Accumulated Other Comprehensive (Loss) Income [Member] Total AOCI [Member] Business Combination Disclosure [Text Block] Acquisitions Total Other Comprehensive Income (Loss) Other Comprehensive Income (Loss), Net of Tax Total Other Comprehensive Income (Loss) Long-Term Debt, Current Maturities Current portion of long-term debt Long-term Debt, Current Maturities, Total Total current portion of long-term debt Entity Address, City or Town Entity Address, City or Town Increase (Decrease) in Income Taxes Payable Income taxes Debt Disclosure [Text Block] Debt Property, Plant and Equipment [Table Text Block] Summary of Property, Plant and Equipment Payments of Ordinary Dividends, Common Stock Dividends paid to stockholders Derivative Instruments Not Designated as Hedging Instruments, Gain (Loss), Net Gains/(losses) from derivative instruments not designated as hedging instruments Derivative Instruments Not Designated as Hedging Instruments, Gain (Loss), Net, Total Due in 2028 [Member] Two Thousand Twenty Eight [Member] Two thousand twenty eight. Equity Interest Issued or Issuable, Type [Domain] Additional Paid-in Capital [Member] Paid-in Capital [Member] Deferred payments timeframe. Deferred Payments Timeframe Deferred payments timeframe Business Combination, Consideration Transferred, Liabilities Incurred Deferred business combination payments Buildings and equipment. Buildings And Equipment [Member] Buildings And Equipment [Member] Liabilities, Current [Abstract] Current Liabilities: Non-cash activity Restructuring Reserve, Settled without Cash Assets, Current [Abstract] Current Assets: Statement of Stockholders' Equity [Abstract] Reclassification out of Accumulated Other Comprehensive Income [Axis] Reclassification out of Accumulated Other Comprehensive Income Net Litigation Related Gain (Charges) Gain (Loss) Related to Litigation Settlement Debt Instrument, Maturity Date Maturity date of debt instrument Long-Term Debt Long-term debt Long-term Debt, Total Derivative Contract [Domain] Derivative Contract Property, Plant and Equipment, Net Property, plant and equipment, net Property, plant and equipment, net Property, Plant and Equipment, Net, Beginning Balance Property, Plant and Equipment, Net, Ending Balance Class of Stock [Domain] Class of Stock Income Taxes Disclosure [Line Items] Income Taxes Disclosure [Line Items] Income Taxes Disclosure [Line Items] Employee termination benefits. Employee Termination Benefits [Member] Employee Termination Benefits [Member] The effect of master netting arrangements in offsetting derivative instrument assets and liabilities. Derivative Offset Offset Accumulated defined benefit plans adjustment net prior service cost credit and unrecognized actuarial gain loss. Accumulated Defined Benefit Plans Adjustment Net Prior Service Cost Credit And Unrecognized Actuarial Gain Loss [Member] Prior Service Cost and Unrecognized Actuarial Gain Loss [Member] Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Indefinite-Lived Intangible Assets Intangible assets not subject to amortization Revenue from External Customer [Line Items] Entity Wide Information Revenue From External Customer [Line Items] Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent U.S. corporate income tax rate Contingent consideration related to acquisitions Business Combination, Contingent Consideration, Liability Business Combination, Contingent Consideration, Liability, Total New contingent payments related to the Embody acquisition Statement of Comprehensive Income [Abstract] Collaborative Arrangement and Arrangement Other than Collaborative [Axis] Treasury stock, shares Treasury Stock, Common, Shares Entity Central Index Key Entity Central Index Key Other Intangible Assets [Member] Unrealized gain Unrealized Gain (Loss) on Derivatives Assets, Fair Value Disclosure Total Assets Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements Settlements Liabilities, Current Total Current Liabilities Entity Tax Identification Number Entity Tax Identification Number Earnings before income taxes Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Inventory, Finished Goods, Net of Reserves Finished goods Corporate Items [Member] Corporate Items [Member] Corporate items. Increase (Decrease) in Operating Capital [Abstract] Changes in operating assets and liabilities, net of acquired assets and liabilities Additions to instruments, which are hand-held devices used by surgeons during total joint replacement and other surgical procedures. Additions To Instruments Additions to instruments Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table] Fair Values Derivatives Balance Sheet Location By Derivative Contract Type By Hedging Designation [Table] Two thousand twenty four. Two Thousand Twenty Four [Member] Due in 2024 [Member] Restructuring and other cost reduction initiatives . Restructuring And Other Cost Reduction Initiatives Restructuring and other cost reduction initiatives Debt Instrument, Term Hedged senior notes maturity period Debt instrument, term Construction in Progress [Member] Construction in Progress [Member] Three Point One Five Zero Percentage [Member] Three Point One Five Zero Percentage [Member] 3.150% [Member] Disposal Group, Including Discontinued Operation, Accounts, Notes and Loans Receivable, Net Accounts receivable, less allowance for credit losses Other Liabilities [Member] Other Long-term Liabilities [Member] 2022 Five-Year Credit Agreement [Member] Two Thousand Twenty Two Five-Year Credit Agreement [Member] Two thousand twenty two five-year credit agreement. Derivative Instrument [Axis] Derivative Instrument Geographical [Domain] Geographical Assets Total Assets UNITED STATES US [Member] Short-Term Term Loan Short-Term Bank Loans and Notes Payable Offsetting Assets [Table Text Block] Schedule of Effects of Master Netting Agreements on Condensed Consolidated Balance Sheets Entity Registrant Name Entity Registrant Name Carrying amount of hedged liabilities. Carrying Amount Of Hedged Liabilities [Member] Carrying Amount of Hedged Liabilities [Member] Two Thousand Twenty One Five-Year Credit Agreement [Member]. Two Thousand Twenty One Five Year Credit Agreement [Member] 2021 Five-Year Credit Agreement [Member] Equity Interest Type [Axis] Retained Earnings (Accumulated Deficit) Retained earnings Retained Earnings (Accumulated Deficit), Total Retained Earnings (Accumulated Deficit), Beginning Balance Retained Earnings (Accumulated Deficit), Ending Balance Retained Earnings [Member] Retained Earnings [Member] Class of Stock [Axis] Class of Stock Inventory, Raw Materials, Net of Reserves Raw materials Equity, Including Portion Attributable to Noncontrolling Interest Balance Balance Total Stockholders' Equity Deferred Income Tax Liabilities, Net Deferred income taxes, net Deferred Income Tax Liabilities, Net, Total Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, Tax Unrealized cash flow hedge gains, tax Disposal Group, Including Discontinued Operation, Liabilities, Current Current liabilities of discontinued operations Total Current Liabilities of Discontinued Operations Minimum [Member] Minimum [Member] Minimum [Member] Number of unregistered common shares retained in spinoff Number of Unregistered Common Shares Retained in Spinoff Number of Unregistered Common Shares Retained in Spinoff Decrease in Unrecognized Tax Benefits is Reasonably Possible Decrease in unrecognized tax benefits within the next twelve months Significant Accounting Policies [Text Block] Significant Accounting Policies Derivative Instruments and Hedging Activities Disclosure [Abstract] Foreign Exchange Forward [Member] Foreign Exchange Forward Contracts [Member] Accrued Income Taxes, Current Income taxes payable Disaggregation of Revenue [Abstract] Equity Component [Domain] Equity Component Income (Loss) from Continuing Operations, Net of Tax, Attributable to Noncontrolling Interest Less: Net earnings attributable to noncontrolling interest Land [Member] Land [Member] Other Nonoperating Income (Expense) [Member] Other (expense) income, net [Member] Other income (expense), net [Member] Adjustments to reconcile net earnings to cash provided by operating activities: Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net Debt discount and issuance costs Debt discount and issuance costs Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net, Total Spinoff [Member] Spinoff [Member] Spinoff [Member] Measurement Frequency [Axis] Fair Value, Measurements, Recurring [Member] ZimVie to Zimmer Biomet. Zim Vie To Zimmer Biomet [Member] ZimVie to Zimmer Biomet Debt Disclosure [Abstract] Entity Current Reporting Status Entity Current Reporting Status Proceeds from (Payments for) Other Financing Activities Other financing activities Common Stock, Shares Authorized Common stock, shares authorized Interest Rate Cash Flow Hedge Gain (Loss) to be Reclassified During Next 12 Months, Net Fair value of outstanding derivative instruments, loss, expected to be reclassified to earnings Long-Term Debt, Fair Value Estimated fair value Disposal Groups, Including Discontinued Operations, Disclosure [Text Block] Discontinued Operations and Related ZimVie Matters Assets [Abstract] ASSETS Discontinued operation amortization of intangible assets. Discontinued Operation Amortization Of Intangible Assets Intangible asset amortization Hedging Relationship [Axis] Hedging Relationship Amortization of Intangible Assets Intangible asset amortization Intangible asset amortization Amortization of Intangible Assets, Total Derivative income expense effects of cash flow hedges. Derivative Income Expense Effects Of Cash Flow Hedges Total amounts of income and expense line items presented in the statements of earnings in which the effects of fair value, cash flow and net investment hedges are recorded Common stock, $0.01 par value, one billion shares authorized, 317.2 million shares as of March 31, 2024 (316.2 million as of December 31, 2023) issued Common Stock, Value, Issued Common Stock, Value, Issued, Total Common Stock, Value, Issued, Beginning Balance Common Stock, Value, Issued, Ending Balance Repayments of Long-Term Debt Redemption of outstanding principal amount Repayments of Long-term Debt, Total Two Thousand Nineteen Credit Agreement Two Thousand Nineteen Credit Agreement [Member] 2019 Credit Agreement [Member] Benefit for income taxes from discontinued operations Discontinued Operation, Tax Effect of Discontinued Operation (Benefit) Provision for income taxes from discontinued operations Discontinued Operation, Tax Effect of Discontinued Operation, Total Restructuring Reserve Ending Balance Beginning Balance Restructuring Reserve, Total Revenue Recognition [Abstract] Current Fiscal Year End Date Current Fiscal Year End Date Percentage of outstanding common shares retained. Percentage Of Outstanding Common Shares Retained Percentage of outstanding common shares retained Share-Based Payment Arrangement, Noncash Expense Share-based compensation Share-based Payment Arrangement, Noncash Expense, Total Operating Income (Loss) Operating Profit Operating Profit Payment on term loan Repayments of Debt Business Acquisition, Equity Interest Issued or Issuable, Number of Shares Issuance of common stock for acquisition Five year credit agreement. Five Year Credit Agreement [Member] Five-Year Credit Agreement [Member] Net investment hedge gain /loss at termination Net Investment Hedge Gain Loss At Termination Net investment hedge gain loss at termination. Total consideration transferred at the acquisition dates Business Combination, Consideration Transferred, Total Business Combination, Consideration Transferred Provision for income taxes Tax benefit related to Swiss Agreement Provision (benefit) for income taxes Income Tax Expense (Benefit), Total Net investment hedge loss at maturity. Net Investment Hedge Loss at Maturity Net investment hedge loss at maturity Embody, Inc. acquisition consideration, shares Stock Issued During Period, Shares, Acquisitions Cash Cash on hand from dividend Cash, Beginning Balance Cash, Ending Balance Business combination contingent consideration payments Payment for Contingent Consideration Liability, Financing Activities Business combination contingent consideration payments Payments for Restructuring Cash payments Two point four two five percentage. Two Point Four Two Five Percentage [Member] 2.425% [Member] Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax Reclassifications to statements of earnings Reclassifications to statements of earnings Accumulated Net Gain (Loss) from Cash Flow Hedges Attributable to Parent [Member] Defined Benefit Plan Items [Member] Summary of Details of Loss from Discontinued operation Disposal Groups, Including Discontinued Operations [Table Text Block] Schedule of Segment Reporting Information, by Segment [Table Text Block] Summary of Net sales and Operating Profit by Segment Disposal Group, Including Discontinued Operation, Other Assets, Noncurrent Other assets Revenue from Contract with Customer [Text Block] Revenue Incremental feature line of credit. Incremental Feature Line Of Credit Uncommitted incremental feature Forward starting interest rate swaps. Forward Starting Interest Rate Swaps [Member] Forward Starting Interest Rate Swaps [Member] Amount of potential additional income tax expenses related to IRS notice of proposed adjustment subject to interest and penalties. Amount Of Potential Additional Income Tax Expenses Related To I R S Notice Of Proposed Adjustment Subject To Interest And Penalties Amount of potential additional income tax expense related to an IRS notice of proposed adjustment subject to interest and penalties. Other Comprehensive Income (Loss), Net of Tax [Abstract] Other Comprehensive Income (Loss): Euro notes. Euro Notes [Member] Euro Notes [Member] Aggregate principal amount Aggregate principal amount Senior Notes due Hedging Relationship [Domain] Hedging Relationship Repayments of Short-Term Debt, Total Repayments of Short-Term Debt Payments to settle debt Redemption of outstanding principal amount Other (expense) income, net Other Nonoperating Income (Expense) Other Nonoperating Income (Expense), Total Other income (expense), net Sales Information [Table] Sales Information [Table] Sales Information [Table] Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings Change in estimates Property, Plant and Equipment [Abstract] Revenue from External Customers by Geographic Areas [Table Text Block] Schedule of Net Sales by Geography Three Point seven zero Percentage Senior Notes Due 2023. Three Point seven zero Percentage Senior Notes Due 2023 [Member] 3.700% Senior Notes due 2023 Long-Term Debt, Type [Domain] Long-term Debt, Type Stockholders equity spin off percentage. Stockholders Equity Spin Off Percentage Spin-off percentage Derivative Instruments and Hedging Activities Disclosures [Table] Derivative Instruments And Hedging Activities Disclosures [Table] Other expense, net Disposal group including discontinued operation other expense (income). Disposal Group Including Discontinued Operation Other Expense Income Other (income) expense, net One point four one four percentage. One Point Four One Four Percentage [Member] 1.414% [Member] Derivative Instruments, Gain (Loss) [Table] Derivative Instruments Gain Loss By Hedging Relationship By Income Statement Location By Derivative Instrument Risk [Table] Commitments and Contingencies Disclosure [Abstract] Other Assets, Noncurrent Other assets Other Assets, Noncurrent, Total Disposal Group, Including Discontinued Operation, Revenue Net Sales Cumulative fair value hedging adjustment carrying amount of hedged liabilities. Cumulative Fair Value Hedging Adjustment Carrying Amount Of Hedged Liabilities [Member] Cumulative Amount of Fair Value Hedging Adjustment Included in Carrying Amount of Hedged Liabilities [Member] Two thousand twenty one three sixty four day-revolving credit agreement member. Two Thousand Twenty One Three Sixty Four Day Revolving Credit Agreement [Member] 2021 364-Day Revolving Credit Agreement [Member] Asia Pacific [Member] Two Thousand Thirty Nine [Member] Two Thousand Thirty Nine [Member] Due in 2039 [Member] Disposal Group, Including Discontinued Operation, Accounts Payable, Current Accounts payable Extinguishment of Debt [Axis] Extinguishment of Debt Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Accumulated change, before taxes, in accumulated gains and losses from derivative instruments designated and qualifying as the effective portion of cash flow hedges. Fair Value Of Outstanding Derivative Instruments Net Unrealized Gain Loss Deferred In Other Comprehensive Income Fair value of outstanding derivative instruments, net unrealized gain deferred in accumulated other comprehensive income Secured Debt [Member] Term Loan Fair value measurement with unobservable inputs reconciliation recurring basis liability increase decrease foreign currency. Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Increase Decrease Foreign Currency Foreign currency impact Developed Technology Rights [Member] Technology [Member] Entity [Domain] Entity Loss Contingency Nature [Axis] Loss Contingency Nature Restructuring and Related Cost, Expected Cost Pre-tax restructuring charges Expense estimated to be recognized for the Restructuring Plan Restructuring and Related Cost, Expected Cost, Total Debt instrument ZimVie revolving credit agreement Uncommitted credit facility Cost of Goods and Services Sold Cost of products sold, excluding intangible asset amortization Cost of products sold Cost of Goods and Services Sold, Total Earnings Per Common Share Earnings Per Share [Abstract] Loss Contingencies [Table] Loss Contingencies [Table] Accounting Policies [Abstract] In Process Research and Development [Member] In-process Research and Development (IPR&D) [Member] Other Comprehensive Income (Loss), before Reclassifications, Net of Tax AOCI before reclassifications Forward starting interest rate swap cash flow hedge remaining to be amortized. Forward Starting Interest Rate Swap Cash Flow Hedge Remaining To Be Amortized Forward starting interest rate swap cash flow hedge to be amortized Long term debt Noncurrent. Long Term Debt Noncurrent [Member] Long Term Debt Noncurrent [Member] Disposal Group, Including Discontinued Operation, Accrued Income Tax Payable, Current Income taxes payable Cross Currency Interest Rate Contract Matured [Member]. Cross Currency Interest Rate Contract Matured [Member] Cross-Currency Interest Rate Swaps Matured [Member] Equity, Including Portion Attributable to Noncontrolling Interest [Abstract] Stockholders' Equity: Revolving Credit Facility [Member] Revolving Loans 2023 Acquisitions [Member] Two Thousand Twenty Three Acquisitions Member 2023 acquisition. Basic Earnings Per Share, Basic Net Earnings Per Common Share - Basic Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block] Changes in Components of Accumulated Other Comprehensive Income, Net of Tax Commitments and Contingencies (Note 15) Commitments and Contingencies Business Combinations [Abstract] Income Statement [Abstract] Property, Plant and Equipment Disclosure [Text Block] Property, Plant and Equipment Impact on accounts receivable Error Corrections And Prior Period Adjustments Accounts Receivable and Equity Error corrections and prior period adjustments accounts receivable and equity. Debt, Current Term loan Debt, Current, Total Increase (Decrease) in Accounts Payable and Accrued Liabilities Accounts payable and accrued liabilities Increase (Decrease) in Accounts Payable and Accrued Liabilities, Total Business And Significant Accounting Policies [Line Items] Business And Significant Accounting Policies [Line Items] Business And Significant Accounting Policies [Line Items] Gain (Loss) on Fair Value Hedges Recognized in Earnings Gain (loss) on fair value hedging relationships Gain (Loss) on Fair Value Hedges Recognized in Earnings, Total Restructuring Type [Axis] Restructuring Type Statistical Measurement [Domain] Statistical Measurement Loss Contingencies [Line Items] Loss Contingencies [Line Items] Net cash provided by operating activities Net Cash Provided by (Used in) Operating Activities Proceeds from Other Debt ZimVie term loan credit agreement Accrued Income Taxes, Noncurrent Long-term income tax payable 5.350% [Member] Five Point Three Five Zero Percentage [Member] Five point three five zero percentage. Derivative Asset, Subject to Master Netting Arrangement, before Offset Derivative Assets Gross Amount Derivative Asset, Fair Value, Gross Asset, Total 2023 Restructuring Plan [Member] Two Thousand Twenty Three Restructuring Plan [Member] Two thousand twenty three restructuring plan. Document Period End Date Document Period End Date Statistical Measurement [Axis] Statistical Measurement Commitments and Contingencies Disclosure [Text Block] Commitments and Contingencies Restructuring and Related Cost, Incurred Cost Expenses Restructuring and Related Costs, Incurred Cost, Total Total Diluted Earnings Per Share, Diluted Net Earnings Per Common Share - Diluted Product and Service [Domain] Product and Service EMEA [Member] Cost of Sales [Member] Cost of Products Sold [Member] Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, Tax Reclassification adjustments on cash flow hedges, tax Debt Instrument, Name [Domain] Debt Instrument, Name Other Restructuring [Member] Other Restructuring [Member] Derivative Liability Derivatives, current and long-term Net Amount in Balance Sheet Fair Value Hierarchy and NAV [Domain] Fair Value Hierarchy and NAV Loss Contingency, Nature [Domain] Loss Contingency, Nature Fair Value, Recurring [Member] Fair Value, Measurements, Recurring [Member] Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member] Defined Benefit Plan Items [Member] Disposal Group, Including Discontinued Operation, Property, Plant and Equipment, Noncurrent Property, plant and equipment, net Additional Paid in Capital, Common Stock Paid-in capital Additional Paid in Capital, Common Stock, Beginning Balance Additional Paid in Capital, Common Stock, Ending Balance Restructuring Reserve, Foreign Currency Translation Gain (Loss) Foreign currency exchange rate changes Estimated Litigation Liability Accrued litigation liabilities Segment Reconciling Items [Member] Segment Reconciling Items Gain (Loss), Foreign Currency Transaction, before Tax Gains (losses) on derivatives Foreign Currency Transaction Gain (Loss), before Tax, Total Equity Securities, FV-NI, Current Investment in ZimVie Payments for Repurchase of Common Stock Repurchase of common stock Reclassification out of Accumulated Other Comprehensive Income [Table Text Block] Reclassification Adjustments from Accumulated Other Comprehensive Income Tax Reform and AHV Financing [Member] Swiss Federal Tax Administration (FTA) [Member] Equity, Attributable to Noncontrolling Interest Noncontrolling interest Stockholders' Equity Attributable to Noncontrolling Interest, Total Stockholders' Equity Attributable to Noncontrolling Interest, Beginning Balance Stockholders' Equity Attributable to Noncontrolling Interest, Ending Balance Schedule of Restructuring and Related Costs [Table] Schedule Of Restructuring And Related Costs [Table] Finite-Lived Intangible Assets, Major Class Name [Domain] Liabilities and Equity [Abstract] LIABILITIES AND STOCKHOLDERS' EQUITY Business combination, shares of common stock repurchased. Business Combination, Shares of Common Stock Repurchased Business combination, shares of common stock repurchased Embody, Inc. acquisition consideration Stock Issued During Period, Value, Acquisitions Entity Address, Postal Zip Code Entity Address, Postal Zip Code Cash flow hedges. Cash flow hedges one [member] Cash Flow Hedges [Member] Entity Interactive Data Current Entity Interactive Data Current Issuance of common stock for contingent consideration liability, valued Stock Issued Noncash financing activity Revenue, Product and Service [Extensible Enumeration] Type of Revenue [Extensible List] Credit Facility [Domain] Credit Facility Restatement Adjustment Revision of Prior Period, Adjustment [Member] Adjustment Four Point Four Five Zero Percentage [Member] Four Point Four Five Zero Percentage [Member] 4.450% [Member] Equity [Abstract] Disposal Group, Including Discontinued Operation, Goodwill, Noncurrent Goodwill October 2023 acquisition [Member] October Two Thousand Twenty Three Acquisition [Member] October two thousand twenty three acquisition. Switzerland, Francs Swiss Francs [Member] Net proceeds from revolving facilities Proceeds from (Repayments of) Lines of Credit Senior Notes [Member] Senior Notes [Member] Revision of Prior Period [Axis] Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Derivative Instruments, Gain (Loss) [Line Items] Derivative Instruments Gain Loss [Line Items] The estimated net amount of unrealized gains or losses on foreign currency cash flow hedges at the reporting date expected to be reclassified to earnings within the next 12 months, after taxes. Fair Value Of Outstanding Derivative Instruments Unrealized Gain Loss Net Of Taxes Expected To Be Reclassified To Earnings Fair value of outstanding derivative instruments, gain (loss), net of taxes expected to be reclassified to earnings Issuance of common stock for contingent consideration liability Number Of Shares Issued For Contingent Consideration Liability Number of shares issued for contingent consideration liability. Derivatives, Fair Value [Line Items] Derivatives, Fair Value [Line Items] Equity Components [Axis] Equity Components Schedule of Derivatives Instruments Statements of Financial Performance and Financial Position, Location [Table Text Block] Effects of Fair Value, Cash Flow and Net Investment Hedge Accounting on Consolidated Statements of Earnings Long-Term Debt, by Current and Noncurrent [Abstract] Long-term debt Restructuring and Related Activities [Abstract] Changes in estimates related to contingent payment liabilities included in discontinued operations. Changes In Estimates Related To Contingent Payment Liabilities Included In Discontinued Operations Changes in estimates related to contingent payment liabilities included in discontinued operations Line of credit facility maturity description. Line of Credit Facility Maturity Description Line of credit facility maturity description Inventory Disclosure [Abstract] Payments to Acquire Businesses, Gross Cash payments to acquire businesses Initial cash consideration Other Comprehensive Income Loss [Table] Other Comprehensive Income Loss [Table] Other Comprehensive Income Loss [Table] Financial Liabilities Fair Value Disclosure Total Liabilities Contract Termination [Member] Contract Termination [Member] Local Phone Number Local Phone Number Property, Plant and Equipment [Line Items] Property, Plant and Equipment [Line Items] Designated as Hedging Instrument [Member] Derivatives Designated as Hedges [Member] Disposal Group, Including Discontinued Operation, Inventory, Current Inventories Goodwill Goodwill Goodwill, Total Goodwill, Beginning Balance Goodwill, Ending Balance OCI, Foreign Currency Transaction and Translation Gain (Loss), Arising During Period, Tax Foreign currency cumulative translation adjustments, tax Statement of Cash Flows [Abstract] Stockholders' Equity Note, Spinoff Transaction Spinoff of ZimVie Inc. One point one six four percentage notes due two thousand twenty seven member. One Point One Six Four Percentage Notes Due Two Thousand Twenty Seven [Member] 1.164% Notes due 2027 [Member] ZimVie term loan maximum borrowing capacity. Zim Vie Term Loan Maximum Borrowing Capacity ZimVie term loan credit agreement Income Tax Authority [Domain] Organization, Consolidation and Presentation of Financial Statements [Abstract] Accumulated Other Comprehensive Income (Loss), Net of Tax Accumulated other comprehensive loss Accumulated Other Comprehensive Income (Loss), Net of Tax, Total Accumulated Foreign Currency Adjustment Attributable to Parent [Member] Foreign Currency Translation [Member] Discontinued operation research and development. Discontinued Operation Research And Development Research and development Contract Termination [Member] Contract Termination1 [Member] Contract termination. Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax Amount of Gain / (Loss) Recognized in AOCI Unrealized cash flow hedge gains, before tax Common Stock, Par or Stated Value Per Share Common stock, par value Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations Effect of exchange rates on cash and cash equivalents Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations, Total Debt Instrument, Interest Rate, Stated Percentage Interest rate Long-Lived Tangible Asset [Axis] Long-Lived Tangible Asset September 2020 credit agreement September2020 Credit Agreement [Member] September 2020 Credit Agreement [Member] Loss from discontinued operations before income taxes Discontinued Operation, Income (Loss) from Discontinued Operation, before Income Tax Intellectual Property [Member] Maximum [Member] Maximum Discontinued operation, restructuring and other cost reduction initiatives. Discontinued Operation Restructuring And Other Cost Reduction Initiatives Restructuring and other cost reduction initiatives One Point Six Four Percentage [Member] One Point One Six Four Percentage [Member] 1.164% [Member] Two Thousand Twenty Five [Member] Two Thousand Twenty Five [Member] Due in 2025 [Member] April Acquisition [Member] April acquisition. Consolidation Items [Domain] Consolidation Items IPR&D Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles Intangible assets subject to amortization Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block] Basis of Presentation Reclassification out of Accumulated Other Comprehensive Income [Domain] Reclassification out of Accumulated Other Comprehensive Income Fair Value, Inputs, Level 3 [Member] Fair Value Measurements at Reporting Date Using: Significant Unobservable Inputs (Level 3) [Member] Fair Value, Recurring and Nonrecurring [Table] Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Table] Short-Term Debt, Type [Domain] Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Change in cash and cash equivalents Inventory, Work in Process, Net of Reserves Work in progress Payments for (Proceeds from) Other Investing Activities Other investing activities Interest Expense [Member] Interest Expense [Member] Incremental Common Shares Attributable to Dilutive Effect of Share-Based Payment Arrangements Effect of dilutive stock options and other equity awards Incremental Common Shares Attributable to Share-based Payment Arrangements, Total Operating Segments [Member] Operating Segments Five Point Seven Five Zero Percentage [Member] Five Point Seven Five Zero Percentage [Member] 5.750% [Member] Schedule of Inventory, Current [Table Text Block] Summary of Inventories Comprehensive Income (Loss) [Table Text Block] Tax Effects on Each Component of Accumulated Other Comprehensive Income Recognized in Statements of Comprehensive Income Segment Reporting Disclosure [Text Block] Segment Information City Area Code City Area Code Inventory, Net Inventories Inventories Cash flows provided by (used in) operating activities: Net Cash Provided by (Used in) Operating Activities [Abstract] Total Other Comprehensive Income (Loss) Other Comprehensive Income (Loss), before Tax Consolidation Items [Axis] Consolidation Items Document Information [Line Items] Document Information [Line Items] Adjustment related to interest rate swaps Long Debt Hedged By Interest Rate Swap Change in fair value of debt hedged by interest rate swaps. Business Acquisition [Line Items] (Gain) loss on investment in ZimVie Inc. Gain (Loss) on Investments Gain (Loss) on Investments, Total Gain (loss) on investment in ZimVie Other Comprehensive (Income) Loss, Defined Benefit Plan, Reclassification Adjustment from AOCI, before Tax Adjustments to prior service cost and unrecognized actuarial assumptions, before tax Other Comprehensive (Income) Loss, Defined Benefit Plan, Reclassification Adjustment from AOCI, before Tax, Total Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment Accumulated depreciation Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment, Total Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment, Beginning Balance Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment, Ending Balance Weighted Average Number of Shares Outstanding, Basic Basic Weighted average shares outstanding for basic net earnings per share Weighted Average Number of Shares Outstanding, Basic, Total Deferred business combination payments made Deferred business combination payments Payments of Merger Related Costs, Financing Activities Three point zero five zero percentage member. Three Point Zero Five Zero Percentage [Member] 3.050% [Member] Restructuring and Related Costs [Table Text Block] Summary of Liabilities Recognized Related to Restructuring Plan Prepaid taxes Prepaid Taxes Total amounts of income and expense line items presented in the statements of earnings in which the effects of fair value, cash flow and net investment hedges are recorded Derivative Income Expense Effects Of Fair Value Cash Flow And Net Investment Hedges Derivative income expense effects of fair value, cash flow and net investment hedges. Cash flows provided by (used in) financing activities: Net Cash Provided by (Used in) Financing Activities [Abstract] Restructuring and Related Cost, Cost Incurred to Date Expense incurred since the start of the Restructuring Plan Statement [Table] Statement [Table] Interest rate swaps. Interest Rate Swaps [Member] Interest Rate Swaps [Member] Floating rate notes. Floating Rate Notes [Member] Floating Rate Notes [Member] Document Fiscal Period Focus Document Fiscal Period Focus Impact on retained earnings Error Corrections And Prior Period Adjustments Retained Earnings Accumulated Deficit Error Corrections And Prior Period Adjustments Retained Earnings Accumulated Deficit Not Designated as Hedging Instrument [Member] Derivatives Not Designated as Hedges [Member] Research and Development Expense (Excluding Acquired in Process Cost) Research and development Statement [Line Items] Statement [Line Items] Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net Net assets acquired Shares pledged as collateral Shares pledged as collateral. Increase in Unrecognized Tax Benefits is Reasonably Possible Increase in unrecognized tax benefits within the next twelve months Two thousand nineteen restructuring plan. Two Thousand Nineteen Restructuring Plan [Member] 2019 Restructuring Plan [Member] Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Options to purchase shares of common stock not included in the computation of diluted earnings per share Ending balance March 31, 2024 Beginning balance December 31, 2023 Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value Software and Software Development Costs [Member] Capitalized Software Costs [Member] Four Point Two Five Zero Percentage [Member] Four Point Two Five Zero Percentage [Member] 4.250% [Member] November 2023 acquisition [Member] November Two Thousand Twenty Three Acquisition [Member] November two thousand twenty three acquisition. Accounts Receivable, after Allowance for Credit Loss, Current Accounts receivable, less allowance for credit losses Accounts Receivable, after Allowance for Credit Loss, Current, Total Common Stock [Member] Common Stock [Member] Japan Term Loan A and Japan Term Loan B. Japan Term Loan A And Japan Term Loan B [Member] Japan Term Loan A and Japan Term Loan B [Member] Debt Instrument [Line Items] Debt Instrument [Line Items] Payments to Acquire Business Two, Net of Cash Acquired Business combination investments, net of acquired cash Business combination investments, net of acquired cash Two thousand twenty six. Two Thousand Twenty Six [Member] Due in 2026 [Member] Equity Method Investments And Cost Method Investments [Abstract] Equity Method Investments And Cost Method Investments [Abstract] Net investment hedge gain at maturity. Net Investment Hedge Gain At Maturity Net investment hedge gain at maturity Cash and Cash Equivalents, at Carrying Value Cash and cash equivalents Cash and Cash Equivalents, at Carrying Value, Total Cash and Cash Equivalents, at Carrying Value, Beginning Balance Cash and Cash Equivalents, at Carrying Value, Ending Balance Entity Common Stock, Shares Outstanding Entity Common Stock, Shares Outstanding Loss Contingency Accrual Loss Contingency Accrual Loss Contingency Accrual, Beginning Balance Loss Contingency Accrual, Ending Balance Schedule of Debt [Table Text Block] Summary of Debt Instruments Cash [Member] Cash [Member] Treasury stock, 111.5 million shares as of March 31, 2024 (110.6 million as of December 31, 2023) Treasury Stock, Value Treasury Stock, Value, Total Treasury Stock, Value, Beginning Balance Treasury Stock, Value, Ending Balance Treasury stock, 106.9 million shares (104.8 million shares in 2022) Hips. Hips [Member] Hips [Member] Discontinued Operations and Disposal Groups [Abstract] Cover [Abstract] Short-Term Term Loan [Member] Short-Term Term Loan Short-Term Term Loan [Member] Short-term term loan. Selling, General and Administrative Expense Selling, general and administrative Selling, General and Administrative Expense, Total Derivative Asset, Statement of Financial Position [Extensible Enumeration] Document Fiscal Year Focus Document Fiscal Year Focus Comprehensive Income (Loss) Note [Text Block] Accumulated Other Comprehensive Income Business combination contingent consideration payments Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Contingent Liability Contingent consideration Derivative Instrument, Gain (Loss) Reclassified from AOCI into Income, Effective Portion, Statement of Income or Comprehensive Income [Extensible Enumeration] Litigation Settlement, Expense Net Litigation Related Charges Rule 10b5-1 Arrangement Amended Rule 10b5-1 Arr Amended Flag Rule 10b5-1 arr amended flag. Instruments. Instruments [Member] Instruments [Member] Reclassification out of Accumulated Other Comprehensive Income [Member] Reclassification out of Accumulated Other Comprehensive Income [Member] Restructuring Plan [Domain] Restructuring Plan Proceeds, Issuance of Shares, Share-Based Payment Arrangement, Including Option Exercised Proceeds from employee stock compensation plans Proceeds, Issuance of Shares, Share-based Payment Arrangement, Including Option Exercised, Total Segment Reporting [Abstract] Security Exchange Name Security Exchange Name Total Other Comprehensive (Loss) Income Other comprehensive income (loss) Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent Other comprehensive loss 3.150% Senior notes due 2022. Three Point One Five Zero Percentage Senior Notes Due2022 [Member] 3.150% Senior Notes Due 2022 New Accounting Pronouncements, Policy [Policy Text Block] Accounting Pronouncements Not Yet Adopted Other Contingencies. Other Contingencies [Member] Other Contingencies [Member] Customer Relationships [Member] Derivative Liability, Subject to Master Netting Arrangement, before Offset Derivative Liabilities Gross Amount Derivative Liability, Fair Value, Gross Liability, Total Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, before Tax Foreign currency cumulative translation adjustments, before tax Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, before Tax, Total Property, Plant and Equipment, Gross Property, plant and equipment, Gross Property, Plant and Equipment, Gross, Total Property, Plant and Equipment, Gross, Beginning Balance Property, Plant and Equipment, Gross, Ending Balance Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Percent Minimum tax rate Hedging Designation [Domain] Hedging Designation Shares of common stock repurchased Treasury Stock, Shares, Acquired Share repurchases, Shares Business Acquisition, Acquiree [Domain] Total Other Comprehensive Income (Loss), tax Other Comprehensive Income (Loss), Tax Legal Entity [Axis] Legal Entity Weighted Average Number of Shares Outstanding, Diluted [Abstract] Weighted Average Common Shares Outstanding Entity Emerging Growth Company Entity Emerging Growth Company Sales Information [Line Items] Sales Information [Line Items] Sales Information [Line Items] Amendment Flag Amendment Flag Foreign Currency Cash Flow Hedge Gain (Loss) to be Reclassified During Next 12 Months Fair value of outstanding derivative instruments, gain, expected to be reclassified to earnings Fair value of common stock at the settlement date Stock price at the acquisition date. Stock Price at the Acquisition Date Fair value of common stock at the acquisition date Disposal Group, Including Discontinued Operation, Assets, Noncurrent Noncurrent assets of discontinued operations Total Noncurrent Assets of Discontinued Operations Schedule of Weighted Average Number of Shares [Table Text Block] Reconciliation of Weighted Average Shares for Basic and Diluted Shares Computations Net sales and operating profit information. Net Sales And Operating Profit Information [Table] Net Sales And Operating Profit Information [Table] Acquisition of intellectual property rights Payments to Acquire Intangible Assets Restructuring and Related Activities Disclosure [Text Block] Restructuring Net proceeds from revolving facilities Proceeds from Lines of Credit Proceeds from Lines of Credit, Total Proceeds from revolving facility Loss Contingency, Range of Possible Loss, Portion Not Accrued Loss Contingency, Range of Possible Loss, Portion Not Accrued Effect on Future Earnings, Offset Amount Reduction in annual pre-tax operating expenses Long term debt fair value adjustments. Long Term Debt Fair Value Adjustments Other debt and fair value adjustments, total Derivatives Not Designated as Hedging Instruments [Table Text Block] Derivative Instruments Not Designated as Hedging Instruments One Point Four Five Zero Percentage [Member] One Point Four Five Zero Percentage [Member] 1.450% [Member] Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net Amount of Gain / (Loss) Reclassified from AOCI Gain (loss) on cash flow hedging relationships Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net, Total Schedule of Restructuring Reserve by Type of Cost [Table Text Block] Summary of Location on Condensed Consolidated Statement of Earnings and Type of Cost for Restructuring Plan Disposal Group, Including Discontinued Operation, Other Liabilities, Noncurrent Other long-term liabilities Securities Act File Number Entity File Number Outstanding common shares retained Outstanding common shares retained Restructuring program benefits realized period.. Restructuring Program Benefits Realized Period Restructuring program benefits realized period Two thousand and twenty two five-year credit agreement member. Two Thousand and Twenty Two Five-Year Credit Agreement [Member] 2022 Five-Year Credit Agreement [Member] Other Comprehensive Income (Loss), Net Investment Hedge, Gain (Loss), Reclassification, before Tax Reclassifications of net investment hedges Long-Term Debt, Excluding Current Maturities Long-term debt Total long-term debt Long-Term Debt, Current Maturities [Abstract] Current portion of long-term debt Percentage of debt designated as net investment hedges. Percentage Of Debt Designated As Net Investment Hedges Percentage of debt designated as net investment hedges Sternal closure company. Sternal Closure Company [Member] Sternal Closure Company [Member] Sternal closure company [Member] Loss from discontinued operations, net of tax Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest Shares of common stock repurchased Business combination common stock shares repurchased. Business Combination Common Stock Shares Repurchased Business combination, shares of common stock repurchased Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities Total liabilities assumed Dividends, Common Stock, Cash Cash dividends declared Accounts Payable, Current Accounts payable Accounts Payable, Current, Total Debt Instrument [Axis] Debt Instrument Americas [Member] Costs and Expenses Operating expenses Business Acquisition, Equity Interest Issued or Issuable, Value Assigned Issuance of common stock for acquisition, valued Interest expense net. Interest Expense Net [Member] Interest Expense [Member] Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax Adjustments to prior service cost and unrecognized actuarial assumptions, net of tax Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax, Total Entity Small Business Entity Small Business Amounts Reclassified Out Of Accumulated Other Comprehensive Income Loss [Abstract] Amounts Reclassified Out Of Accumulated Other Comprehensive Income Loss [Abstract] Entity Shell Company Entity Shell Company Number of Operating Segments Number of operating segments Debt, Long-Term and Short-Term, Combined Amount Debt, long-term and short-term, combined amount Debt, Long-term and Short-term, Combined Amount, Total Percentage of outstanding common stock distributed. Percentage Of Outstanding Common Stock Distributed Percentage of outstanding common stock distributed Earnings Per Share [Text Block] Earnings Per Share Two Thousand Twenty Two [Member] Two Thousand Twenty Two [Member] Due in 2022 [Member] Trademarks And Trade Names [Member] Trademarks and Trade Names [Member] Entity Address, Address Line One Entity Address, Address Line One Amount of Gain (Loss) Recognized in AOCI Gain (Loss) on Derivative Used in Net Investment Hedge, after Tax Gain on net investment hedging relationships Maturities of Senior Debt Redemption of senior notes Other Liabilities, Current Other current liabilities Other Liabilities, Current, Total Two point four two five percentage notes due two thousand twenty six. Two Point Four Two Five Percentage Notes Due Two Thousand Twenty Six [Member] 2.425% Notes due 2026 [Member] Intangible assets subject to amortization Finite-Lived Intangible Assets, Gross Finite-Lived Intangible Assets, Gross, Total Forward Exchange Agreement [Member] Forward Exchange Agreement [Member] Forward Exchange Agreement. Forward Exchange Agreement Loss Contingency Minimum Loss Contingency Minimum Loss contingency minimum. Income Statement Location [Axis] Income Statement Location Pillar two minimum tax rate. Pillar Two Minimum Tax Rate Pillar two minimum tax rate Cost, Product and Service [Extensible Enumeration] Type of Cost, Good or Service [Extensible List] New contingent consideration related to the 2023 acquisitions Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Purchases Long-Term Debt, Type [Axis] Long-term Debt, Type Line of Credit Facility, Fair Value of Amount Outstanding Line of credit fair value Net Earnings Net Income (Loss), Including Portion Attributable to Noncontrolling Interest Net earnings IPR&D I P R & D and Reclassified IPR&D and reclassified. Fair Value, Inputs, Level 2 [Member] Fair Value Measurements at Reporting Date Using: Significant Other Observable Inputs (Level 2) [Member] Fair value of common stock at the settlement date Stock Price At The Settlement Date Stock price at the settlement date. Long-Term Debt, Gross Outstanding principal balance Depreciation, Depletion and Amortization Depreciation and amortization Depreciation, Depletion and Amortization, Total Product and Service [Axis] Product and Service Treasury Stock, Value, Acquired, Cost Method Share repurchases Title of 12(b) Security Title of 12(b) Security Common Stock Shares Forward Exchange Agreement Common stock shares forward exchange agreement. Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture Stock compensation plans Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture, Total Schedule of Net Investment Hedges, Statements of Financial Performance and Financial Position, Location [Table Text Block] Net Investment Hedge Gains Recognized on Condensed Consolidated Statements of Comprehensive Income All Currencies [Domain] All Currencies Spin off percentage retained. Spin Off Percentage Retained Spin-off percentage retained Schedule of Fair Value Hedging Instruments, Statements of Financial Performance and Financial Position, Location [Table Text Block] Schedule of Amounts Recorded On Balance Sheet Related To Cumulative Basis Adjustments For Fair Value Hedges Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Noncurrent Assets Other assets Foreign Exchange Contract [Member] Foreign Exchange Contract [Member] Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, before Tax Reclassification adjustments on cash flow hedges, before tax Revenue from External Customers by Products and Services [Table] Schedule Of Entity Wide Information Revenue From External Customers By Products And Services [Table] Treasury Shares [Member] Treasury Stock, Common [Member] Entity Address, Country Entity Address, Country Other expense (income) net. Other Expense Income Net Policy [Text Block] Other Expense (Income), Net Cash flows provided by (used in) investing activities: Net Cash Provided by (Used in) Investing Activities [Abstract] Embody, Inc. member. Embody, Inc. [Member] Embody, Inc. Interest Rate Swap [Member] Interest Rate Swap [Member] Interest Rate Swaps [Member] Long-Term Line of Credit Outstanding borrowings Long-term Line of Credit, Total Uncommitted Credit Facility Long-Lived Tangible Asset [Domain] Long-Lived Tangible Asset Fair Value, Liability, Recurring Basis, Unobservable Input Reconciliation, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration] Common Stock, Dividends, Per Share, Declared Cash dividend declared per share Disposal Group, Including Discontinued Operation, Cash and Cash Equivalents Cash and cash equivalents Increase (Decrease) in Inventories Inventories Increase (Decrease) in Inventories, Total Consolidated EBITDA ratio. Consolidated E B I T D A Ratio Consolidated EBITDA ratio 2023 Five-Year Credit Agreement [Member] Two Thousand Twenty Three Five Year Credit Agreement [Member] Two Thousand Twenty Three Five Year Credit Agreement. Net Investment Hedging [Member] Net Investment Hedging [Member] Two point six zero percentage. Two Point Six Zero Percentage [Member] 2.600% [Member] Cash and Cash Equivalents [Axis] Goodwill and Intangible Asset Impairment, Total Goodwill and Intangible Asset Impairment Intangible asset impairment Intangible asset impairment Restructuring Plan [Axis] Restructuring Plan Common Stock, Shares, Outstanding Balance, shares Balance, shares Net investment hedge gain/loss at maturity that remains in AOCI. Net Investment Hedge Gain Loss At Maturity Net investment hedge gain/loss at maturity Income Statement Location [Domain] Income Statement Location Two Thousand Forty Five [Member] Two Thousand Forty Five [Member] Due in 2045 [Member] Business And Significant Accounting Policies [Table] Business And Significant Accounting Policies [Table] Business And Significant Accounting Policies [Table] Document Type Document Type Japan Term Loan A. Japan Term Loan A [Member] Japan Term Loan A [Member] Disposal Group, Including Discontinued Operation, Classified Balance Sheet Disclosures [Abstract] Net cash used in investing activities Net Cash Provided by (Used in) Investing Activities Document Quarterly Report Document Quarterly Report Disposal Group, Including Discontinued Operation, Costs of Goods Sold Cost of products sold, excluding intangible asset amortization Derivative, Notional Amount Derivative notional amount, Total Net Income (Loss) Available to Common Stockholders, Basic Net of tax Net cash used in financing activities Net Cash Provided by (Used in) Financing Activities Debt Instrument, Redemption, Period [Domain] Debt Instrument, Redemption, Period Income Taxes Disclosure [Table] Income Taxes Disclosure [Table] Income Taxes Disclosure [Table] 2022 364-Day Revolving Credit Agreement [Member] Two thousand twenty two three sixty four-day revolving credit agreement member Two thousand twenty two three sixty four-day revolving credit agreement. Entity Filer Category Entity Filer Category 2023 364-Day Revolving Credit Agreement [Member] Two Thousand Twenty Three Three Sixty Four Day Revolving Credit Agreement [Member] Two Thousand Twenty Three Three Sixty Four Day Revolving Credit Agreement . Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss) Arising During Period, Net of Tax Foreign currency cumulative translation adjustments, net of tax Balance Sheet Location [Domain] Balance Sheet Location Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, after Tax Reclassification adjustments on hedges, net of tax Reclassification adjustments on cash flow hedges, net of tax Capital Expenditures Incurred but Not yet Paid Property plant and equipment included in accounts payable Liabilities Total Liabilities Derivative Instruments and Hedging Activities Disclosures [Line Items] Derivative Instruments and Hedging Activities Disclosures [Line Items] Property, Plant and Equipment [Table] Schedule Of Property Plant And Equipment [Table] Two thousand twenty three five year revolving facility. Two Thousand Twenty Three Five Year Revolving Facility [Member] 2023 Five-Year Revolving Facility Other Current Liabilities [Member] Other Current Liabilities [Member] Equity, Attributable to Parent Stockholders equity, ending balance Stockholders equity, beginning balance Total Zimmer Biomet Holdings, Inc. stockholders' equity Weighted average amortization period of intangible assets Acquired Finite-Lived Intangible Assets, Weighted Average Useful Life Disposal Group, Including Discontinued Operation, General and Administrative Expense Selling, general and administrative Intangible Assets, Net (Excluding Goodwill) Intangible assets, net Intangible Assets, Net (Excluding Goodwill), Total Schedule of Error Corrections and Prior Period Adjustments [Table Text Block] Summary of Changes in Segment Operating Profit Jace Medical, LLC. Jace [Member] Jace [Member] Net earnings Net Earnings of Zimmer Biomet Holdings, Inc. Uncommitted credit facility. Uncommitted Credit Facility [Member] Cash and Cash Equivalents [Domain] Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Total Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets Current assets Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities Deferred income taxes Other product category. Other Product Category [Member] Other [Member] Statement of Financial Position [Abstract] Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture Stock compensation plans, shares Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture, Total Two thousand thirty member. Two Thousand Thirty [Member] Due in 2030 [Member] Derivative Liability, Statement of Financial Position [Extensible Enumeration] Weighted Average Number of Shares Outstanding, Diluted Diluted Weighted average shares outstanding for diluted net earnings per share Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Total Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities Current liabilities Increase (Decrease) in Receivables Receivables Increase (Decrease) in Receivables, Total Others countries. Others Countries [Member] International [Member] Credit Facility [Axis] Credit Facility Two Thousand Twenty One [Member] Two Thousand Twenty One [Member] Due in 2021 [Member] Effective Income Tax Rate Reconciliation, Percent Effective tax rate Effective Income Tax Rate Reconciliation, Percent, Total Offsetting [Abstract] Transfer from Investments Noncash financing activity Use of Estimates, Policy [Policy Text Block] Use of Estimates Two thousand thirty one. Two Thousand Thirty One [Member] Due in 2031 [Member] Income Tax Disclosure [Text Block] Income Taxes Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets Total assets acquired Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items] Income Statement Balance Sheet And Additional Disclosures By Disposal Groups Including Discontinued Operations [Line Items] Disposal Group, Including Discontinued Operation, Prepaid and Other Assets, Current Prepaid expenses and other current assets Two thousand twenty three. Two Thousand Twenty Three [Member] Due in 2023 [Member] Due in 2023 [Member] Fair value of forward exchange agreement Derivative Asset Derivatives, current and long-term Net Amount in Balance Sheet Three Point Five Five Zero Percentage [Member] Three Point Five Five Zero Percentage [Member] 3.550% [Member] Income Tax Authority [Axis] Fair Value Disclosures [Abstract] Disposal Group, Including Discontinued Operation, Deferred Tax Liabilities Deferred income taxes, net Fair Value Hierarchy and NAV [Axis] Fair Value Hierarchy and NAV Measurement Frequency [Domain] Measurement Frequency Disposal Group, Including Discontinued Operation, Intangible Assets, Noncurrent Intangible assets, net Payments for (Proceeds from) Hedge, Investing Activities Net investment hedge settlements Payments for (Proceeds from) Hedge, Investing Activities, Total Hedging Designation [Axis] Hedging Designation Payments to Acquire Property, Plant, and Equipment Additions to other property, plant and equipment Payments to Acquire Property, Plant, and Equipment, Total Other Comprehensive (Income) Loss, Defined Benefit Plan, Reclassification Adjustment from AOCI, Tax Adjustments to prior service cost and unrecognized actuarial assumptions, tax Other Comprehensive (Income) Loss, Defined Benefit Plan, Reclassification Adjustment from AOCI, Tax, Total Type of Restructuring [Domain] Type of Restructuring Revision of Prior Period [Domain] Disposal Group, Including Discontinued Operation, Other Liabilities, Current Other current liabilities Business Acquisition [Axis] Cash and cash equivalents, beginning of year Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations, Total Cash and cash equivalents, end of period Discontinued interest rate swaps. Discontinued Interest Rate Swaps [Member] Discontinued Interest Rate Swaps [Member] Income Tax Disclosure [Abstract] Finite-Lived Intangible Assets by Major Class [Axis] Cash Flow Hedging [Member] Cash Flow Hedges [Member] Liability Derivatives Offset Liability Derivatives Offset Offset Dividend paid on separation. Dividend Paid On Separation Dividend paid on separation Maximum Length of Time, Foreign Currency Cash Flow Hedge Expected months of hedging of inter company sales of inventory to minimize the effects of foreign exchange rate movements XML 8 R1.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Document and Entity Information - shares
 3 Months Ended
Mar. 31, 2024
Apr. 22, 2024
Document Information [Line Items]    
Document Type 10-Q  
Amendment Flag false  
Document Period End Date Mar. 31, 2024  
Document Fiscal Year Focus 2024  
Document Fiscal Period Focus Q1  
Entity Registrant Name ZIMMER BIOMET HOLDINGS, INC.  
Entity Central Index Key 0001136869  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Current Fiscal Year End Date --12-31  
Entity Filer Category Large Accelerated Filer  
Entity Common Stock, Shares Outstanding   205,728,398
Entity Small Business false  
Entity Emerging Growth Company false  
Entity Shell Company false  
Entity File Number 001-16407  
Entity Incorporation, State or Country Code DE  
Entity Tax Identification Number 13-4151777  
Entity Address, Address Line One 345 East Main Street  
Entity Address, City or Town Warsaw  
Entity Address, State or Province IN  
Entity Address, Postal Zip Code 46580  
City Area Code 574  
Local Phone Number 373-3333  
Document Quarterly Report true  
Document Transition Report false  
Common Stock [Member]    
Document Information [Line Items]    
Trading Symbol ZBH  
Security Exchange Name NYSE  
Title of 12(b) Security Common Stock, $0.01 par value  
2.425% Notes due 2026 [Member]    
Document Information [Line Items]    
Trading Symbol ZBH 26  
Security Exchange Name NYSE  
Title of 12(b) Security 2.425% Notes due 2026  
1.164% Notes due 2027 [Member]    
Document Information [Line Items]    
Trading Symbol ZBH 27  
Security Exchange Name NYSE  
Title of 12(b) Security 1.164% Notes due 2027  
XML 9 R2.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Condensed Consolidated Statements of Earnings (unaudited) - USD ($)
shares in Millions, $ in Millions
 3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Income Statement [Abstract]    
Net Sales $ 1,889.2 $ 1,831.0
Type of Revenue [Extensible List] us-gaap:ProductMember us-gaap:ProductMember
Cost of products sold, excluding intangible asset amortization $ 512.3 $ 500.8
Type of Cost, Good or Service [Extensible List] us-gaap:ProductMember us-gaap:ProductMember
Intangible asset amortization $ 142.1 $ 133.4
Research and development 107.9 110.4
Selling, general and administrative 736.2 715.9
Restructuring and other cost reduction initiatives 124.4 41.8
Acquisition, integration, divestiture and related 0.4 1.3
Operating expenses 1,623.3 1,503.7
Operating Profit 265.9 327.3
Other (expense) income, net (0.1) 7.7
Interest expense, net (50.7) (48.2)
Earnings before income taxes 215.1 286.8
Provision for income taxes 42.3 54.1
Net Earnings 172.8 232.8
Less: Net earnings attributable to noncontrolling interest 0.4 0.2
Net Earnings of Zimmer Biomet Holdings, Inc. $ 172.4 $ 232.5
Earnings Per Common Share    
Basic $ 0.84 $ 1.11
Diluted $ 0.84 $ 1.11
Weighted Average Common Shares Outstanding    
Basic 205.2 209.4
Diluted 206.2 210.4
XML 10 R3.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Condensed Consolidated Statements of Comprehensive Income (unaudited) - USD ($)
$ in Millions
 3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Statement of Comprehensive Income [Abstract]    
Net earnings $ 172.4 $ 232.5
Other Comprehensive Income (Loss):    
Foreign currency cumulative translation adjustments, net of tax (35.8) 12.4
Unrealized cash flow hedge gains, net of tax 34.7 8.8
Reclassification adjustments on hedges, net of tax (18.0) (19.0)
Adjustments to prior service cost and unrecognized actuarial assumptions, net of tax (1.1) (0.9)
Total Other Comprehensive (Loss) Income (20.2) 1.3
Comprehensive Income Attributable to Zimmer Biomet Holdings, Inc. $ 152.2 $ 233.8
XML 11 R4.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Condensed Consolidated Balance Sheets (unaudited) - USD ($)
$ in Millions
Mar. 31, 2024
Dec. 31, 2023
Current Assets:    
Cash and cash equivalents $ 393.0 $ 415.8
Accounts receivable, less allowance for credit losses 1,446.4 1,442.4
Inventories 2,388.2 2,385.2
Prepaid expenses and other current assets 403.8 366.1
Total Current Assets 4,631.5 4,609.5
Property, plant and equipment, net 2,090.9 2,060.4
Goodwill 8,791.5 8,818.5
Intangible assets, net 4,734.1 4,856.4
Other assets 1,204.4 1,152.1
Total Assets 21,452.4 21,496.9
Current Liabilities:    
Accounts payable 370.3 410.6
Income taxes payable 70.3 61.2
Other current liabilities 1,386.3 1,485.7
Current portion of long-term debt 970.0 900.0
Total Current Liabilities 2,797.0 2,857.4
Deferred income taxes, net 370.4 357.6
Long-term income tax payable 275.8 273.7
Other long-term liabilities 577.0 652.1
Long-term debt 4,826.2 4,867.9
Total Liabilities 8,846.4 9,008.7
Commitments and Contingencies (Note 15)
Stockholders' Equity:    
Common stock, $0.01 par value, one billion shares authorized, 317.2 million shares as of March 31, 2024 (316.2 million as of December 31, 2023) issued 3.2 3.2
Paid-in capital 9,945.9 9,846.1
Retained earnings 10,509.0 10,384.5
Accumulated other comprehensive loss (211.2) (191.0)
Treasury stock, 111.5 million shares as of March 31, 2024 (110.6 million as of December 31, 2023) (7,648.9) (7,562.3)
Total Zimmer Biomet Holdings, Inc. stockholders' equity 12,598.0 12,480.5
Noncontrolling interest 8.1 7.7
Total Stockholders' Equity 12,606.0 12,488.1
Total Liabilities and Stockholders' Equity $ 21,452.4 $ 21,496.9
XML 12 R5.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Condensed Consolidated Balance Sheets (unaudited) (Parenthetical) - $ / shares
Mar. 31, 2024
Dec. 31, 2023
Statement of Financial Position [Abstract]    
Common stock, par value $ 0.01 $ 0.01
Common stock, shares authorized 1,000,000,000 1,000,000,000
Common stock, shares issued 317,200,000 316,200,000
Treasury stock, shares 111,500,000 110,600,000
XML 13 R6.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Condensed Consolidated Statements of Stockholders' Equity (unaudited) - USD ($)
$ in Millions
Total
Common Stock [Member]
Paid-in Capital [Member]
Retained Earnings [Member]
Accumulated Other Comprehensive (Loss) Income [Member]
Treasury Shares [Member]
Noncontrolling Interest [Member]
Balance at Dec. 31, 2022 $ 12,027.0 $ 3.1 $ 9,504.4 $ 9,559.3 $ (179.3) $ (6,867.2) $ 6.7
Balance, shares at Dec. 31, 2022   313,800,000       (104,800,000)  
Net earnings 232.8     232.5     0.2
Other comprehensive income (loss) 1.3       1.3    
Cash dividends declared (50.4)     (50.4)      
Stock compensation plans 56.0   55.4 0.3   $ 0.3  
Stock compensation plans, shares   500,000          
Embody, Inc. acquisition consideration 135.0 $ 0.1 134.9        
Embody, Inc. acquisition consideration, shares   1,100,000          
Share repurchases (244.0)   (2.3)     $ (241.7)  
Share repurchases, Shares           (2,100,000)  
Balance at Mar. 31, 2023 12,157.6 $ 3.2 9,692.4 9,741.7 (178.0) $ (7,108.6) 6.9
Balance, shares at Mar. 31, 2023   315,400,000       (106,900,000)  
Balance at Dec. 31, 2023 12,488.1 $ 3.2 9,846.1 10,384.5 (191.0) $ (7,562.3) 7.7
Balance, shares at Dec. 31, 2023   316,200,000       (110,600,000)  
Net earnings 172.8     172.4     0.4
Other comprehensive income (loss) (20.2)       (20.2)    
Cash dividends declared (49.3)     (49.3)      
Stock compensation plans 79.2   76.4 1.4   $ 1.4  
Stock compensation plans, shares   800,000          
Embody, Inc. acquisition consideration 23.4   23.4        
Embody, Inc. acquisition consideration, shares   200,000          
Share repurchases (88.0)         $ (88.0)  
Share repurchases, Shares           (0.9)  
Balance at Mar. 31, 2024 $ 12,606.0 $ 3.2 $ 9,945.9 $ 10,509.0 $ (211.2) $ (7,648.9) $ 8.1
Balance, shares at Mar. 31, 2024   317,200,000       (111,500,000)  
XML 14 R7.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Condensed Consolidated Statements of Stockholders' Equity (Parenthetical) (unaudited) - $ / shares
 3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Statement of Stockholders' Equity [Abstract]    
Cash dividend declared per share $ 0.24 $ 0.24
XML 15 R8.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Condensed Consolidated Statements of Cash Flows (unaudited) - USD ($)
$ in Millions
 3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Cash flows provided by (used in) operating activities:    
Net earnings $ 172.8 $ 232.8
Adjustments to reconcile net earnings to cash provided by operating activities:    
Depreciation and amortization 238.6 231.8
Share-based compensation 29.0 25.0
Changes in operating assets and liabilities, net of acquired assets and liabilities    
Income taxes (8.6) 21.5
Receivables (22.7) 8.6
Inventories (55.3) (94.2)
Accounts payable and accrued liabilities (119.4) (91.8)
Other assets and liabilities (6.4) (26.0)
Net cash provided by operating activities 228.0 307.7
Cash flows provided by (used in) investing activities:    
Additions to instruments (82.0) (82.8)
Additions to other property, plant and equipment (55.1) (46.7)
Net investment hedge settlements 10.2 13.4
Acquisition of intellectual property rights (12.5) (14.0)
Business combination investments, net of acquired cash 0.0 (18.9)
Other investing activities (55.6) (0.3)
Net cash used in investing activities (195.0) (149.4)
Cash flows provided by (used in) financing activities:    
Net proceeds from revolving facilities 70.0 210.0
Redemption of senior notes 0.0 (86.3)
Payment on term loan 0.0 (33.9)
Dividends paid to stockholders (49.4) (50.3)
Proceeds from employee stock compensation plans 56.4 36.0
Business combination contingent consideration payments (1.5) (9.6)
Deferred business combination payments (1.5) 0.0
Repurchase of common stock (113.6) (267.6)
Other financing activities (10.5) (5.1)
Net cash used in financing activities (50.1) (206.7)
Effect of exchange rates on cash and cash equivalents (5.7) 2.9
Change in cash and cash equivalents (22.7) (45.5)
Cash and cash equivalents, beginning of year 415.8 375.7
Cash and cash equivalents, end of period $ 393.0 $ 330.2
XML 16 R9.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Pay vs Performance Disclosure - USD ($)
$ in Millions
 3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Pay vs Performance Disclosure    
Net Income (Loss) $ 172.4 $ 232.5
XML 17 R10.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Insider Trading Arrangements
 3 Months Ended
Mar. 31, 2024
Trading Arrangements, by Individual  
Rule 10b5-1 Arrangement Adopted false
Non-Rule 10b5-1 Arrangement Adopted false
Rule 10b5-1 Arrangement Terminated false
Non-Rule 10b5-1 Arrangement Terminated false
Rule 10b5-1 Arrangement Amended false
Non-Rule 10b5-1 Arrangement Amended false
XML 18 R11.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Basis of Presentation
 3 Months Ended
Mar. 31, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Basis of Presentation

1. Basis of Presentation

The financial data presented herein is unaudited and should be read in conjunction with the consolidated financial statements and accompanying notes included in our Annual Report on Form 10-K for the year ended December 31, 2023.

In our opinion, the accompanying unaudited condensed consolidated financial statements include all adjustments, consisting of only normal recurring adjustments, necessary for a fair statement of the financial position, results of operations and cash flows for the interim periods presented. The December 31, 2023 condensed consolidated balance sheet data was derived from audited financial statements, but does not include all disclosures required by accounting principles generally accepted in the United States of America (“GAAP”). Results for interim periods should not be considered indicative of results for the full year.

 

Amounts reported in millions within this Quarterly Report on Form 10-Q are computed based on the actual amounts. As a result, the sum of the components may not equal the total amount reported in millions due to rounding. In addition, certain columns and rows within tables may not sum to the totals due to the use of rounded numbers. Percentages presented are calculated from the underlying unrounded amounts.

 

The words “we,” “us,” “our” and similar words, “Zimmer Biomet” and “the Company” refer to Zimmer Biomet Holdings, Inc. and its subsidiaries. “Zimmer Biomet Holdings” refers to the parent company only.
XML 19 R12.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Significant Accounting Policies
 3 Months Ended
Mar. 31, 2024
Accounting Policies [Abstract]  
Significant Accounting Policies

2. Significant Accounting Policies

Use of Estimates - The accompanying unaudited condensed consolidated financial statements are prepared in conformity with GAAP, which requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. We have made our best estimates, as appropriate under GAAP, in the recognition of our assets and liabilities. Actual results could differ materially from these estimates.

 

Accounting Pronouncements Not Yet Adopted - In November 2023, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2023-07, Improvements to Reportable Segment Disclosures, which is an amendment to ASC Topic 280 - Segment Reporting. The ASU requires more detailed and disaggregated segment information, including the disclosure of significant segment expense categories and amounts for each reportable segment. The ASU also requires certain annual disclosures to also be made in interim periods. The ASU is effective for fiscal years beginning after December 15, 2023, and interim periods for fiscal years beginning after December 15, 2024. The guidance will be applied retrospectively unless retrospective adoption is impracticable. Early adoption of this ASU is permitted. We are currently evaluating the impact this ASU will have on our financial statements and disclosures.

 

In December 2023, the FASB issued ASU 2023-09, Improvements to Income Tax Disclosures, which is an amendment to ASC Topic 740 - Income Taxes. The ASU improves the transparency of income tax disclosures by requiring greater disaggregated information about an entity’s effective tax rate reconciliation and requiring additional disclosures and disaggregation of income taxes, among other amendments to improve the effectiveness of income tax disclosures. The ASU is effective for fiscal years beginning after December 15, 2024. The guidance will be applied prospectively with an option to apply the guidance retrospectively. Early adoption of this ASU is permitted. We are currently evaluating the impact this ASU will have on our financial statements and disclosures.
XML 20 R13.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Revenue
 3 Months Ended
Mar. 31, 2024
Revenue Recognition [Abstract]  
Revenue

3. Revenue

Net sales by geography are as follows (in millions):

 

 

 

Three Months Ended

 

 

 

March 31,

 

 

 

2024

 

 

2023

 

United States

 

$

1,099.2

 

 

$

1,060.4

 

International

 

 

790.0

 

 

 

770.6

 

Total

 

$

1,889.2

 

 

$

1,831.0

 

 

Net sales by product category are as follows (in millions):

 

 

 

Three Months Ended

 

 

 

March 31,

 

 

 

2024

 

 

2023

 

Knees

 

$

788.1

 

 

$

762.5

 

Hips

 

 

491.2

 

 

 

492.8

 

S.E.T.

 

 

452.6

 

 

 

433.4

 

Other

 

 

157.3

 

 

 

142.3

 

Total

 

$

1,889.2

 

 

$

1,831.0

 

 

S.E.T. includes sales from our Sports Medicine, Extremities, Trauma, Craniomaxillofacial and Thoracic ("CMFT") product categories. Other includes sales from our Technology, Surgical and Bone Cement product categories.

 

This net sales presentation differs from our reportable operating segments, which are based upon our senior management organizational structure and how we allocate resources toward achieving operating profit goals. Each of our reportable operating segments sells all the product categories noted above. Accordingly, the only difference from the presentation above and our reportable operating segments are the geographic groupings.

XML 21 R14.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Restructuring
 3 Months Ended
Mar. 31, 2024
Restructuring and Related Activities [Abstract]  
Restructuring

4. Restructuring

 

In December 2023, our management approved a new global restructuring program (the “2023 Restructuring Plan”) intended to optimize our cost structure and drive greater efficiencies throughout the company. The 2023 Restructuring Plan is expected to result in total pre-tax restructuring charges of approximately $120 million. The pre-tax restructuring charges consist of employee termination benefits; contract terminations for sales agents; and other charges, such as consulting fees. The expenses incurred under our 2023 Restructuring Plan are reported in our “Restructuring and other cost reduction initiatives” financial statement line item. The charges incurred in the three-month period ended March 31, 2024 were primarily the result of finalizing, obtaining approval and, where applicable, communicating certain restructuring plans. The following table summarizes the liabilities recognized related to the 2023 Restructuring Plan (in millions):

 

 

 

Employee

 

 

 

 

 

 

 

 

 

 

 

 

Termination

 

 

Contract

 

 

 

 

 

 

 

 

 

Benefits

 

 

Terminations

 

 

Other

 

 

Total

 

Balance, December 31, 2023

 

$

9.2

 

 

$

-

 

 

$

5.0

 

 

$

14.2

 

Expenses incurred in the three months ended March 31, 2024

 

 

71.0

 

 

 

1.8

 

 

 

6.8

 

 

 

79.6

 

Cash payments

 

 

(23.5

)

 

 

-

 

 

 

(1.3

)

 

 

(24.8

)

Foreign currency exchange rate changes

 

 

(0.4

)

 

 

-

 

 

 

-

 

 

 

(0.4

)

Non-cash activity

 

 

-

 

 

 

-

 

 

 

1.2

 

 

 

1.2

 

Balance, March 31, 2024

 

$

56.3

 

 

$

1.8

 

 

$

11.7

 

 

$

69.8

 

 

 

 

 

 

 

 

 

 

 

 

 

Expense incurred since the start of the 2023 Restructuring Plan

 

$

80.2

 

 

$

1.8

 

 

$

10.4

 

 

$

92.4

 

 

 

 

 

 

 

 

 

 

 

 

 

Expense estimated to be recognized for the 2023 Restructuring Plan

 

$

90.0

 

 

$

10.0

 

 

$

20.0

 

 

$

120.0

 

 

In December 2021, our management approved a global restructuring program (the “2021 Restructuring Plan”) intended to further reduce costs and to reorganize our global operations in preparation for the spinoff of ZimVie. The 2021 Restructuring Plan is expected to result in total pre-tax restructuring charges of approximately $180 million. The pre-tax restructuring charges consist of employee termination benefits; contract terminations for sales agents; and other charges, such as consulting fees and project management expenses. The expenses incurred under our 2021 Restructuring Plan are reported in our “Restructuring and other cost reduction initiatives” financial statement line item. The following table summarizes the liabilities recognized related to the 2021 Restructuring Plan (in millions):

 

 

 

Employee

 

 

 

 

 

 

 

 

 

 

 

 

Termination

 

 

Contract

 

 

 

 

 

 

 

 

 

Benefits

 

 

Terminations

 

 

Other

 

 

Total

 

Balance, December 31, 2023

 

$

4.2

 

 

$

17.6

 

 

$

2.9

 

 

$

24.7

 

Expenses incurred in the three months ended March 31, 2024

 

 

(0.4

)

 

 

-

 

 

 

1.3

 

 

 

0.9

 

Cash payments

 

 

(0.8

)

 

 

(7.3

)

 

 

(1.5

)

 

 

(9.6

)

Foreign currency exchange rate changes

 

 

(0.1

)

 

 

(0.4

)

 

 

-

 

 

 

(0.5

)

Balance, March 31, 2024

 

$

2.9

 

 

$

9.9

 

 

$

2.7

 

 

$

15.5

 

 

 

 

 

 

 

 

 

 

 

 

 

Expense incurred since the start of the 2021 Restructuring Plan

 

$

58.7

 

 

$

73.8

 

 

$

37.5

 

 

$

170.0

 

 

 

 

 

 

 

 

 

 

 

 

 

Expense estimated to be recognized for the 2021 Restructuring Plan

 

$

60.0

 

 

$

80.0

 

 

$

40.0

 

 

$

180.0

 

 

In December 2019, our Board of Directors approved, and we initiated, a global restructuring program (the “2019 Restructuring Plan”) with an objective of reducing structural costs to allow us to further invest in higher priority growth opportunities. The 2019 Restructuring Plan is expected to result in total pre-tax restructuring charges of approximately $370 million. The pre-tax restructuring charges consist of employee termination benefits; contract terminations for facilities and sales agents; and other charges, such as consulting fees, project management expenses and relocation costs, including costs to close a manufacturing facility.

 

The following table summarizes the location on our condensed consolidated statement of earnings and type of cost for our 2019 Restructuring Plan (in millions):

 

 

 

 

 

Three Months Ended March 31, 2024

 

 

 

Employee

 

 

 

 

 

 

 

 

 

 

 

 

Termination

 

 

Contract

 

 

 

 

 

 

 

 

 

Benefits

 

 

Terminations

 

 

Other

 

 

Total

 

Cost of products sold, excluding intangible asset amortization

 

$

-

 

 

$

-

 

 

$

0.5

 

 

$

0.5

 

Restructuring and other cost reduction initiatives

 

 

14.7

 

 

 

-

 

 

 

1.8

 

 

 

16.5

 

 

 

$

14.7

 

 

$

-

 

 

$

2.3

 

 

$

17.0

 

 

The following table summarizes the liabilities recognized related to the 2019 Restructuring Plan (in millions):

 

 

 

Employee

 

 

 

 

 

 

 

 

 

 

 

 

Termination

 

 

Contract

 

 

 

 

 

 

 

 

 

Benefits

 

 

Terminations

 

 

Other

 

 

Total

 

Balance, December 31, 2023

 

$

43.8

 

 

$

5.6

 

 

$

2.9

 

 

$

52.3

 

Expenses incurred in the three months ended March 31, 2024

 

 

14.7

 

 

 

-

 

 

 

2.3

 

 

 

17.0

 

Cash payments

 

 

-

 

 

 

(0.5

)

 

 

(3.5

)

 

 

(4.0

)

Foreign currency exchange rate changes

 

 

(0.5

)

 

 

-

 

 

 

-

 

 

 

(0.5

)

Balance, March 31, 2024

 

$

58.0

 

 

$

5.1

 

 

$

1.7

 

 

$

64.8

 

 

 

 

 

 

 

 

 

 

 

 

 

Expense incurred since the start of the 2019 Restructuring Plan

 

$

140.4

 

 

$

35.0

 

 

$

161.0

 

 

$

336.4

 

 

 

 

 

 

 

 

 

 

 

 

 

Expense estimated to be recognized for the 2019 Restructuring Plan

 

$

155.0

 

 

$

35.0

 

 

$

180.0

 

 

$

370.0

 

 

We do not include restructuring charges in the operating profit of our reportable segments. We report the expenses for other cost reduction and optimization initiatives in our “Restructuring and other cost reduction initiatives” financial statement line item because

these activities also have the goal of reducing costs across the organization. However, since the cost reduction initiative expenses are not considered restructuring, they have been excluded from the amounts presented in this note.
XML 22 R15.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Inventories
 3 Months Ended
Mar. 31, 2024
Inventory Disclosure [Abstract]  
Inventories

5. Inventories

 

 

March 31,

 

 

December 31,

 

 

 

2024

 

 

2023

 

 

 

(in millions)

 

Finished goods

 

$

1,846.7

 

 

$

1,831.2

 

Work in progress

 

 

226.7

 

 

 

246.5

 

Raw materials

 

 

314.8

 

 

 

307.5

 

Inventories

 

$

2,388.2

 

 

$

2,385.2

 
XML 23 R16.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Property, Plant and Equipment
 3 Months Ended
Mar. 31, 2024
Property, Plant and Equipment [Abstract]  
Property, Plant and Equipment

6. Property, Plant and Equipment

 

 

March 31,

 

 

December 31,

 

 

 

2024

 

 

2023

 

 

 

(in millions)

 

Land

 

$

18.8

 

 

$

18.9

 

Buildings and equipment

 

 

2,254.1

 

 

 

2,245.9

 

Capitalized software costs

 

 

555.2

 

 

 

552.2

 

Instruments

 

 

3,814.6

 

 

 

3,748.6

 

Construction in progress

 

 

206.4

 

 

 

200.6

 

 

 

 

6,849.1

 

 

 

6,766.2

 

Accumulated depreciation

 

 

(4,758.2

)

 

 

(4,705.8

)

Property, plant and equipment, net

 

$

2,090.9

 

 

$

2,060.4

 

We had $25.3 million and $30.8 million of property, plant and equipment included in accounts payable as of March 31, 2024 and December 31, 2023, respectively.
XML 24 R17.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Acquisitions
 3 Months Ended
Mar. 31, 2024
Business Combinations [Abstract]  
Acquisitions

7. Acquisitions

 

On February 14, 2023, we completed the acquisition of all the outstanding shares of Embody, Inc. ("Embody"), a medical device company focused on soft tissue healing, that expands our portfolio for the sports medicine market. The initial consideration consisted of the issuance of 1.1 million shares of our common stock valued at $135.0 million and $19.5 million of cash for a total value of $154.5 million. The fair value of our common stock was determined to be $127.34 per share, which represented the average of our high and low stock prices on the acquisition date. The Embody acquisition includes additional consideration of up to $120.0 million in fair value of our common shares and cash, subject to achieving a future regulatory milestone after closing and commercial milestones based on sales growth over a three-year period. We assigned a fair value of $94.0 million for this contingent consideration as of the acquisition date. The estimated fair value of the contingent consideration liability was calculated based on the probability of achieving the specified regulatory milestone and by simulating numerous potential outcomes for the commercial milestones and discounting to present value the estimated payments.

On April 28, 2023, we completed the acquisition of all the outstanding shares of a privately held orthopedics medical device company that expands our portfolio in the orthopedics market ("April 2023 acquisition"). The initial consideration consisted of $15.0 million of cash and includes consideration of up to $8.0 million in cash, subject to achieving future regulatory milestones.

 

On October 6, 2023, we completed the acquisition of all the outstanding shares of a privately held orthopedics medical device company that provides us new surgical technology that can be used in procedures across multiple product categories (“October 2023 acquisition”). The initial consideration consisted of $42.2 million of cash and includes additional consideration of up to $33.0 million in cash contingent upon achieving certain commercial milestones based on sales growth over a three-year period. We assigned a fair value of $21.5 million for this contingent consideration as of the acquisition date. The estimated fair value of the contingent liability was calculated based on the probability of achieving the commercial milestones and discounting to present value the estimated payments.

 

On November 15, 2023, we completed the acquisition of a privately held technology company by acquiring certain assets, liabilities and employees of the technology company (“November 2023 acquisition”). The November 2023 acquisition expands our

technology and data capabilities and solutions across multiple product categories to better serve our customers. The initial consideration consisted of $60.7 million of cash and includes additional consideration of up to $20.0 million in cash contingent upon achieving a commercial milestone based on a certain sales target which must be achieved by December 31, 2025. We assigned a fair value of $15.0 million for this contingent consideration as of the acquisition date. The estimated fair value of the contingent liability was calculated based on the probability of achieving the commercial milestone and discounting to present value the estimated payment.

 

These acquisitions are collectively referred to in this report as the “2023 acquisitions”. Refer to Note 10 for information regarding the issuance of common stock and cash payments related to the contingent consideration liabilities that have occurred subsequent to the acquisition dates.

 

The goodwill related to the 2023 acquisitions represents the excess of the consideration transferred over the fair value of the net assets acquired. The goodwill related to the 2023 acquisitions is generated from the operational synergies and cross-selling opportunities we expect to achieve from the technologies acquired. A portion of the goodwill is expected to be deductible for U.S. income tax purposes. The goodwill related to the Embody, the October 2023 and the November 2023 acquisitions is included in the Americas operating segment and the Americas Orthopedics reporting unit. The goodwill related to the April 2023 acquisition is included in the Asia Pacific operating segment and reporting unit. The goodwill related to the Embody acquisition was the only significant activity related to our consolidated goodwill balance in the three-month period ended March 31, 2023, other than changes related to foreign currency exchange rate translation adjustments. Foreign currency exchange translations adjustments were the only significant activity impacting goodwill for the three-month period ended March 31, 2024.

 

The purchase price allocation for the Embody acquisition was final as of March 31, 2024. The purchase price allocations for the other 2023 acquisitions are preliminary as of March 31, 2024. We need additional time to evaluate the tax attributes of those transactions, which may change the recognized tax assets and liabilities. There may be differences between the preliminary estimates of fair value and the final acquisition accounting. The final estimates of fair value are expected to be completed as soon as possible, but no later than one year after the respective acquisition dates.

 

The following table summarizes the estimates of fair value of the assets acquired and liabilities assumed related to the 2023 acquisitions (in millions):

 

Current assets

 

$

13.1

 

Intangible assets subject to amortization:

 

 

 

   Technology

 

 

144.0

 

   Trademarks and trade names

 

 

3.5

 

   Customer relationships

 

 

40.1

 

Intangible assets not subject to amortization:

 

 

 

   In-process research and development (IPR&D)

 

 

36.3

 

Goodwill

 

 

215.0

 

Other assets

 

 

4.8

 

Total assets acquired

 

 

456.8

 

Current liabilities

 

 

8.2

 

Deferred income taxes

 

 

37.7

 

Total liabilities assumed

 

 

45.9

 

Net assets acquired

 

$

410.9

 

 

The weighted average amortization periods selected for technology, customer relationships and trademarks and trade names were 15 years, 8 years and 13 years, respectively. Upon receiving regulatory approval subsequent to the Embody acquisition date, the $36.3 million of IPR&D was reclassified to a definite-lived intangible asset and began amortizing over the applicable estimated useful life.

 

In the three-month period ended March 31, 2024, there were no material adjustments to the preliminary values of the 2023 acquisitions.

 

We have not included pro forma information and certain other information under GAAP for these acquisitions because they did not have a material impact on our financial position or results of operations.

XML 25 R18.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Debt
 3 Months Ended
Mar. 31, 2024
Debt Disclosure [Abstract]  
Debt . Debt

Our debt consisted of the following (in millions):

 

 

March 31,

 

 

December 31,

 

 

 

2024

 

 

2023

 

Current portion of long-term debt

 

 

 

 

 

 

Uncommitted Credit Facility

 

$

120.0

 

 

$

50.0

 

1.450% Senior Notes due 2024

 

 

850.0

 

 

 

850.0

 

Total current portion of long-term debt

 

$

970.0

 

 

$

900.0

 

Long-term debt

 

 

 

 

 

 

3.550% Senior Notes due 2025

 

$

863.0

 

 

$

863.0

 

3.050% Senior Notes due 2026

 

 

600.0

 

 

 

600.0

 

5.350% Senior Notes due 2028

 

 

500.0

 

 

 

500.0

 

3.550% Senior Notes due 2030

 

 

257.5

 

 

 

257.5

 

2.600% Senior Notes due 2031

 

 

750.0

 

 

 

750.0

 

4.250% Senior Notes due 2035

 

 

253.4

 

 

 

253.4

 

5.750% Senior Notes due 2039

 

 

317.8

 

 

 

317.8

 

4.450% Senior Notes due 2045

 

 

395.4

 

 

 

395.4

 

2.425% Euro Notes due 2026

 

 

540.1

 

 

 

552.3

 

1.164% Euro Notes due 2027

 

 

540.1

 

 

 

552.3

 

Debt discount and issuance costs

 

 

(27.4

)

 

 

(29.1

)

Adjustment related to interest rate swaps

 

 

(163.7

)

 

 

(144.7

)

Total long-term debt

 

$

4,826.2

 

 

$

4,867.9

 

At March 31, 2024, our total current and non-current debt of $5.8 billion consisted of $5.9 billion aggregate principal amount of our senior notes, which included €1.0 billion Euro-denominated senior notes (“Euro Notes”), and $120.0 million of outstanding borrowings under the Uncommitted Credit Facility (defined below), partially offset by debt discount and issuance costs of $27.4 million and fair value adjustments related to interest rate swaps totaling $163.7 million.

 

In the three-month period ended March 31, 2023, we redeemed $83.0 million outstanding principal amount on a short-term term loan by paying $33.9 million in cash and by transferring all our common shares we owned of a publicly traded company we previously spun-off. The transfer of the common shares as part of the settlement resulted in a $49.1 million noncash financing activity. In the three-month period ended March 31, 2023 we also redeemed $86.3 million outstanding principal amount of our 3.700% Senior Notes due 2023.

 

On August 28, 2023, we entered into an uncommitted facility letter (the "Uncommitted Credit Facility"), which provides that from time to time, we may request, and the lender in its absolute and sole discretion may provide, short-term loans. Borrowings under the Uncommitted Credit Facility may be used only for general corporate and working capital purposes. The Uncommitted Credit Facility provides that the aggregate principal amount of outstanding borrowings at any time shall not exceed $300.0 million. Each borrowing under the Uncommitted Credit Facility will mature on the maturity date specified by the lender at the time of the advance, which will be no more than 90 days following the date of the advance. The Uncommitted Credit Facility and borrowings thereunder are unsecured. Borrowings under the Uncommitted Credit Facility bear interest at floating rates, based upon either an adjusted term secured overnight financing rate (“Term SOFR”) for the applicable interest period, the prime rate, or lender’s cost of funds, in each case, plus an applicable margin determined at the time of each borrowing. The Uncommitted Credit Facility includes customary affirmative and negative covenants and events of default for unsecured uncommitted financing arrangements. We were in compliance with all covenants under the Uncommitted Credit Facility as of March 31, 2024. As of March 31, 2024, there were outstanding borrowings of $120.0 million under the Uncommitted Credit Facility.

 

On July 7, 2023, we entered into a new five-year revolving credit agreement (the “2023 Five-Year Credit Agreement”) and a new 364-day revolving credit agreement (the “2023 364-Day Revolving Credit Agreement”), as described below. Borrowings under these credit agreements will be used for general corporate purposes.

 

The 2023 Five-Year Credit Agreement contains a five-year unsecured revolving facility of $1.5 billion (the “2023 Five-Year Revolving Facility”). The 2023 Five-Year Credit Agreement replaced the previous revolving credit agreement entered into on August 19, 2022 (the “2022 Five-Year Credit Agreement”), which contained a five-year unsecured revolving facility of $1.5 billion (the “2022 Five-Year Revolving Facility”). There was approximately $520.0 million in aggregate outstanding borrowings under the 2022 Five-Year Credit Agreement at the time it was terminated, which borrowings were repaid in full through borrowings under the 2023 Five-Year Credit Agreement on July 7, 2023 in the same amount and on the same interest rate and margin terms.

 

The 2023 Five-Year Credit Agreement will mature on July 7, 2028, with two one-year extensions exercisable at our discretion and subject to required lender consent. The 2023 Five-Year Credit Agreement also includes an uncommitted incremental feature allowing us to request an increase of the facility by an aggregate amount of up to $500.0 million.

 

Borrowings under the 2023 Five-Year Credit Agreement bear interest at floating rates, based upon either an adjusted Term SOFR for the applicable interest period or an alternate base rate, in each case, plus an applicable margin determined by reference to our senior unsecured long-term debt credit rating. We pay a facility fee on the aggregate amount of the 2023 Five-Year Revolving Facility at a rate determined by reference to our senior unsecured long-term debt credit rating. The 2023 Five-Year Credit Agreement contains customary affirmative and negative covenants and events of default for unsecured financing arrangements, including, among other things, limitations on consolidations, mergers, and sales of assets. The 2023 Five-Year Credit Agreement also requires us to maintain a consolidated indebtedness to consolidated EBITDA ratio of no greater than 4.5 to 1.0 as of the last day of any period of four consecutive fiscal quarters (with such ratio subject to increase to 5.0 to 1.0 for a period of time in connection with a qualified material acquisition and certain other restrictions). We were in compliance with all covenants under the 2023 Five-Year Credit Agreement as of March 31, 2024. As of March 31, 2024, there were no outstanding borrowings under the 2023 Five-Year Credit Agreement.

 

The 2023 364-Day Revolving Credit Agreement is an unsecured revolving credit facility in the principal amount of $1.0 billion (the “2023 364-Day Revolving Facility”). The 2023 364-Day Revolving Credit Agreement replaced a credit agreement entered into on August 19, 2022, which was also a 364- day unsecured revolving credit facility of $1.0 billion (the “2022 364-Day Revolving Facility”). There were no borrowings outstanding under the 2022 364-Day Revolving Facility when it was terminated.

 

The 2023 364-Day Revolving Facility will mature on July 5, 2024. Borrowings under the 2023 364-Day Revolving Credit Agreement bear interest at floating rates based upon either an adjusted Term SOFR for the applicable interest period or an alternate base rate, in each case, plus an applicable margin determined by reference to our senior unsecured long-term debt credit rating. We pay a facility fee on the aggregate amount of the 2023 364-Day Revolving Facility at a rate determined by reference to our senior unsecured long-term debt credit rating. The 2023 364-Day Revolving Credit Agreement contains customary affirmative and negative covenants and events of default for an unsecured financing arrangement including, among other things, limitations on consolidations, mergers, and sales of assets. The 2023 364-Day Revolving Credit Agreement also requires us to maintain a consolidated indebtedness to consolidated EBITDA ratio of no greater than 4.5 to 1.0 as of the last day of any period of four consecutive fiscal quarters (with such ratio subject to increase to 5.0 to 1.0 in connection with a qualified material acquisition and certain other restrictions). We were in compliance with all covenants under the 2023 364-Day Revolving Credit Agreement as of March 31, 2024. As of March 31, 2024, there were no outstanding borrowings under the 2023 364-Day Revolving Credit Agreement.

 

Borrowings under our revolving credit facilities have been executed with underlying notes that have maturities of three months or less. At maturity of the underlying note, we elect to either repay the note, borrow the same amount, or some combination thereof. On our condensed consolidated statements of cash flows, we present the borrowings and repayments of these underlying notes as net cash inflows or outflows due to their short-term nature.

 

The estimated fair value of our senior notes, which includes our Euro notes, as of March 31, 2024, based on quoted prices for the specific securities from transactions in over-the-counter markets (Level 2), was $5,553.8 million. The carrying value of the outstanding $120.0 million principal balance of the Uncommitted Credit Facility approximates its fair value as it bears interest at short-term market rates.

XML 26 R19.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Accumulated Other Comprehensive Income
 3 Months Ended
Mar. 31, 2024
Equity [Abstract]  
Accumulated Other Comprehensive Income

9. Accumulated Other Comprehensive Income

Accumulated other comprehensive income (loss) (“AOCI”) refers to certain gains and losses that under GAAP are included in comprehensive income but are excluded from net earnings as these amounts are initially recorded as an adjustment to stockholders’ equity. Amounts in AOCI may be reclassified to net earnings upon the occurrence of certain events.

Our AOCI is comprised of foreign currency translation adjustments, unrealized gains and losses on cash flow hedges and unrecognized prior service costs and gains and losses in actuarial assumptions related to our defined benefit plans. Foreign currency translation adjustments are reclassified to net earnings upon sale or upon a complete or substantially complete liquidation of an investment in a foreign entity. Unrealized gains and losses on cash flow hedges are reclassified to net earnings when the hedged item affects net earnings. Amounts related to defined benefit plans that are in AOCI are reclassified over the service periods of employees in the plan.

The following table shows the changes in the components of AOCI gains (losses), net of tax (in millions):

 

 

Foreign

 

 

Cash

 

 

Defined

 

 

 

 

 

 

Currency

 

 

Flow

 

 

Benefit

 

 

Total

 

 

 

Translation

 

 

Hedges

 

 

Plan Items

 

 

AOCI

 

Balance at December 31, 2023

 

$

(159.4

)

 

$

63.3

 

 

$

(94.9

)

 

$

(191.0

)

AOCI before reclassifications

 

 

(35.8

)

 

 

34.7

 

 

 

-

 

 

 

(1.1

)

Reclassifications to statements of earnings

 

 

-

 

 

 

(18.0

)

 

 

(1.1

)

 

 

(19.1

)

Balance at March 31, 2024

 

$

(195.2

)

 

$

80.0

 

 

$

(96.0

)

 

$

(211.2

)

The following table shows the reclassification adjustments from AOCI (in millions):

 

 

Amount of Gain (Loss)

 

 

 

Reclassified from AOCI

 

 

 

Three Months Ended

 

 

 

 

 

March 31,

 

 

Location on

Component of AOCI

 

2024

 

 

2023

 

 

Statements of Earnings

Cash flow hedges

 

 

 

 

 

 

 

 

Foreign exchange forward contracts

 

$

22.0

 

 

$

23.1

 

 

Cost of products sold

Forward starting interest rate swaps

 

 

(0.2

)

 

 

(0.2

)

 

Interest expense, net

 

 

 

21.8

 

 

 

22.9

 

 

Total before tax

 

 

3.8

 

 

 

3.9

 

 

Provision for income taxes

 

 

$

18.0

 

 

$

19.0

 

 

Net of tax

Defined benefit plans

 

 

 

 

 

 

 

 

Prior service cost and unrecognized actuarial loss

 

$

0.8

 

 

$

1.0

 

 

Other (expense) income, net

 

 

(0.3

)

 

 

0.1

 

 

Provision for income taxes

 

 

$

1.1

 

 

$

0.9

 

 

Net of tax

Total reclassifications

 

$

19.1

 

 

$

19.9

 

 

Net of tax

 

The following table shows the tax effects on each component of AOCI recognized in our condensed consolidated statements of comprehensive income (in millions):

 

 

Three Months Ended March 31, 2024

 

 

 

Before Tax

 

 

Tax

 

 

Net of Tax

 

Foreign currency cumulative translation adjustments

 

$

(19.2

)

 

 

16.6

 

 

$

(35.8

)

Unrealized cash flow hedge gains

 

 

43.4

 

 

 

8.7

 

 

 

34.7

 

Reclassification adjustments on cash flow hedges

 

 

(21.8

)

 

 

(3.8

)

 

 

(18.0

)

Adjustments to prior service cost and unrecognized actuarial assumptions

 

 

(0.8

)

 

 

0.3

 

 

 

(1.1

)

Total Other Comprehensive Income (Loss)

 

$

1.6

 

 

$

21.8

 

 

$

(20.2

)

 

 

 

Three Months Ended March 31, 2023

 

 

 

Before Tax

 

 

Tax

 

 

Net of Tax

 

Foreign currency cumulative translation adjustments

 

$

7.5

 

 

$

(4.9

)

 

$

12.4

 

Unrealized cash flow hedge gains

 

 

11.1

 

 

 

2.3

 

 

 

8.8

 

Reclassification adjustments on cash flow hedges

 

 

(22.9

)

 

 

(3.9

)

 

 

(19.0

)

Adjustments to prior service cost and unrecognized actuarial assumptions

 

 

(1.0

)

 

 

(0.1

)

 

 

(0.9

)

Total Other Comprehensive Income (Loss)

 

$

(5.3

)

 

$

(6.6

)

 

$

1.3

 

XML 27 R20.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Fair Value Measurement of Assets and Liabilities
 3 Months Ended
Mar. 31, 2024
Fair Value Disclosures [Abstract]  
Fair Value Measurement of Assets and Liabilities

10. Fair Value Measurement of Assets and Liabilities

The following financial assets and liabilities are recorded at fair value on a recurring basis (in millions):

 

 

As of March 31, 2024

 

 

 

 

 

 

Fair Value Measurements at Reporting Date Using:

 

Description

 

Recorded
Balance

 

 

Quoted Prices
in Active
Markets for
Identical
Assets
(Level 1)

 

 

Significant
Other
Observable
Inputs
(Level 2)

 

 

Significant
Unobservable
Inputs
(Level 3)

 

Assets

 

 

 

 

 

 

 

 

 

 

 

 

Derivatives designated as hedges, current and long-term

 

 

 

 

 

 

 

 

 

 

 

 

Foreign currency forward contracts

 

$

74.4

 

 

$

-

 

 

$

74.4

 

 

$

-

 

Cross-currency interest rate swaps

 

 

27.3

 

 

 

-

 

 

 

27.3

 

 

 

-

 

Derivatives not designated as hedges, current and long-term

 

 

 

 

 

 

 

 

 

 

 

 

Foreign currency forward contracts

 

 

2.4

 

 

 

-

 

 

 

2.4

 

 

 

-

 

Total Assets

 

$

104.1

 

 

$

-

 

 

$

104.1

 

 

$

-

 

 

 

 

 

 

 

 

 

 

 

 

 

Liabilities

 

 

 

 

 

 

 

 

 

 

 

 

Derivatives designated as hedges, current and long-term

 

 

 

 

 

 

 

 

 

 

 

 

Foreign currency forward contracts

 

$

1.7

 

 

$

-

 

 

$

1.7

 

 

$

-

 

Cross-currency interest rate swaps

 

 

43.8

 

 

 

-

 

 

 

43.8

 

 

 

-

 

Interest rate swaps

 

 

163.8

 

 

 

-

 

 

 

163.8

 

 

 

-

 

Derivatives not designated as hedges, current and long-term

 

 

 

 

 

 

 

 

 

 

 

 

Foreign currency forward contracts

 

 

1.5

 

 

 

-

 

 

 

1.5

 

 

 

-

 

Contingent consideration related to acquisitions

 

 

115.2

 

 

 

-

 

 

 

-

 

 

 

115.2

 

Total Liabilities

 

$

326.0

 

 

$

-

 

 

$

210.8

 

 

$

115.2

 

 

 

 

As of December 31, 2023

 

 

 

 

 

 

Fair Value Measurements at Reporting Date Using:

 

Description

 

Recorded
Balance

 

 

Quoted Prices
in Active
Markets for
Identical
Assets
(Level 1)

 

 

Significant
Other
Observable
Inputs
(Level 2)

 

 

Significant
Unobservable
Inputs
(Level 3)

 

Assets

 

 

 

 

 

 

 

 

 

 

 

 

Derivatives designated as hedges, current and long-term

 

 

 

 

 

 

 

 

 

 

 

 

Foreign currency forward contracts

 

$

54.4

 

 

$

-

 

 

$

54.4

 

 

$

-

 

Cross-currency interest rate swaps

 

 

5.4

 

 

 

-

 

 

 

5.4

 

 

 

-

 

Derivatives not designated as hedges, current and long-term

 

 

 

 

 

 

 

 

 

 

 

 

Foreign currency forward contracts

 

 

0.4

 

 

 

-

 

 

 

0.4

 

 

 

-

 

Total Assets

 

$

60.2

 

 

$

-

 

 

$

60.2

 

 

$

-

 

 

 

 

 

 

 

 

 

 

 

 

 

Liabilities

 

 

 

 

 

 

 

 

 

 

 

 

Derivatives designated as hedges, current and long-term

 

 

 

 

 

 

 

 

 

 

 

 

Foreign currency forward contracts

 

$

3.7

 

 

$

-

 

 

$

3.7

 

 

$

-

 

Cross-currency interest rate swaps

 

 

68.1

 

 

 

-

 

 

 

68.1

 

 

 

-

 

Interest rate swaps

 

 

144.7

 

 

 

-

 

 

 

144.7

 

 

 

-

 

Derivatives not designated as hedges, current and long-term

 

 

 

 

 

 

 

 

 

 

 

 

Foreign currency forward contracts

 

 

1.6

 

 

 

-

 

 

 

1.6

 

 

 

-

 

Contingent consideration related to acquisitions

 

 

141.7

 

 

 

-

 

 

 

-

 

 

 

141.7

 

Total Liabilities

 

$

359.8

 

 

$

-

 

 

$

218.1

 

 

$

141.7

 

We value our foreign currency forward contracts using a market approach based on foreign currency exchange rates obtained from active markets, and we perform ongoing assessments of counterparty credit risk.

We value our interest rate swaps using a market approach based on publicly available market yield curves and the terms of our swaps, and we perform ongoing assessments of counterparty credit risk. The valuation of our cross-currency interest rate swaps also includes consideration of foreign currency exchange rates.

Contingent payments related to acquisitions consist of sales-based payments and regulatory milestones, and are valued using discounted cash flow techniques. The fair value of sales-based payments is based upon significant unobservable inputs such as probability-weighted future revenue estimates and simulating the numerous potential outcomes, and changes as revenue estimates increase or decrease. The fair value of the regulatory milestones is based on the probability of success in obtaining the specified regulatory approval.

Contingent payments related to the Embody acquisition are to be settled by issuance of our common stock and cash payments. The Embody acquisition is discussed in Note 7. During the three-month period ended March 31, 2024, we issued 0.2 million shares of our common stock valued at $23.4 million and paid $1.5 million of cash for a commercial milestone related to the Embody acquisition. The fair value of common stock was determined to be $123.87 per share, which represented the average of our high and low stock prices on the settlement date. To minimize dilution from issuing shares for the milestone settlement, we repurchased 0.2 million shares of our common stock in February of 2024.

The following table provides a reconciliation of the beginning and ending balances of items measured at fair value on a recurring basis in the tables above that used significant unobservable inputs (Level 3) (in millions):

 

 

 

Level 3 - Liabilities

 

Contingent payments related to acquisitions

 

 

 

Beginning balance December 31, 2023

 

$

141.7

 

Change in estimates

 

 

(1.6

)

Settlements

 

 

(24.9

)

Ending balance March 31, 2024

 

$

115.2

 

 

Changes in estimates for contingent payments related to acquisitions are recognized in the Acquisition, integration, divestiture and related line item on our condensed consolidated statements of earnings.

XML 28 R21.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Derivative Instruments and Hedging Activities
 3 Months Ended
Mar. 31, 2024
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Derivative Instruments and Hedging Activities

11. Derivative Instruments and Hedging Activities

We are exposed to certain market risks relating to our ongoing business operations, including foreign currency exchange rate risk, commodity price risk, interest rate risk and credit risk. We manage our exposure to these and other market risks through regular operating and financing activities. Currently, the only risks that we manage through the use of derivative instruments are interest rate risk and foreign currency exchange rate risk.

Interest Rate Risk

Derivatives Designated as Fair Value Hedges

We currently use fixed-to-variable interest rate swaps to manage our exposure to interest rate risk from our cash investments and debt portfolio. These derivative instruments are designated as fair value hedges under GAAP. Changes in the fair value of the derivative instrument are recorded in current earnings and are offset by gains or losses on the underlying debt instrument.

As of March 31, 2024 and December 31, 2023, the following amounts were recorded on our condensed consolidated balance sheets related to cumulative basis adjustments for fair value hedges (in millions):

 

 

 

Carrying Amount of the Hedged Liabilities

 

 

 

Cumulative Amount of Fair Value Hedging Adjustment Included in the Carrying Amount of the Hedged Liabilities

 

Balance Sheet Line Item

 

March 31, 2024

 

 

December 31, 2023

 

 

 

March 31, 2024

 

 

December 31, 2023

 

Long-term debt

 

$

832.3

 

 

$

851.3

 

 

 

$

(163.7

)

 

$

(144.7

)

 

Derivatives Designated as Cash Flow Hedges

In 2014, we entered into forward starting interest rate swaps that were designated as cash flow hedges of our thirty-year tranche of senior notes due 2045 we expected to issue in 2015. The forward starting interest rate swaps mitigated the risk of changes in interest rates prior to the completion of the notes offering. The interest rate swaps were settled, and the remaining loss to be recognized at March 31, 2024 was $23.7 million, which will be recognized using the effective interest rate method over the remaining maturity period of the hedged notes.

Foreign Currency Exchange Rate Risk

We operate on a global basis and are exposed to the risk that our financial condition, results of operations and cash flows could be adversely affected by changes in foreign currency exchange rates. To reduce the potential effects of foreign currency exchange rate movements on net earnings, we enter into derivative financial instruments in the form of foreign currency exchange forward contracts with major financial institutions. We also designated our Euro Notes as net investment hedges of investments in foreign subsidiaries. We are primarily exposed to foreign currency exchange rate risk with respect to transactions and net assets denominated in Euros, Swiss Francs, Japanese Yen, British Pounds, Chinese Renmimbi, Canadian Dollars, Australian Dollars, Korean Won, Swedish Krona, Czech Koruna, Thai Baht, Taiwan Dollars, South African Rand, Russian Rubles, Indian Rupees, Turkish Lira, Polish Zloty, Danish Krone, and Norwegian Krone. We do not use derivative financial instruments for trading or speculative purposes.

Derivatives Designated as Net Investment Hedges

We are exposed to the impact of foreign exchange rate fluctuations in the investments in our wholly-owned foreign subsidiaries that are denominated in currencies other than the U.S. Dollar. In order to mitigate the volatility in foreign exchange rates, we issued Euro Notes in December 2016 and November 2019 and designated 100 percent of the Euro Notes to hedge our net investment in certain wholly-owned foreign subsidiaries that have a functional currency of the Euro. All changes in the fair value of a hedging instrument designated as a net investment hedge are recorded as a component of AOCI in the condensed consolidated balance sheets.

At March 31, 2024, we had receive-fixed-rate, pay-fixed-rate cross-currency interest swaps with notional amounts outstanding of Euro 700 million, Japanese Yen 54.1 billion and Swiss Franc 125 million. These transactions further hedge our net investment in certain wholly-owned foreign subsidiaries that have a functional currency of Euro, Japanese Yen and Swiss Franc. All changes in the fair value of a derivative instrument designated as a net investment hedge are recorded as a component of AOCI in the condensed consolidated balance sheets. The portion of this change related to the excluded component will be amortized into earnings over the life of the derivative while the remainder will be recorded in AOCI until the hedged net investment is sold or substantially liquidated. We recognize the excluded component in interest expense, net on our condensed consolidated statements of earnings. The net cash received related to the receive-fixed-rate, pay-fixed-rate component of the cross-currency interest rate swaps is reflected in investing cash flows in our condensed consolidated statements of cash flows. In the three-month period ended March 31, 2023, Euro 100

million and Swiss Franc 50 million of these cross-currency interest rate swaps matured at a gain of $6.0 million and loss of $3.0 million, respectively. The settlement of these gains and losses with the counterparties is reflected in investing cash flows in our condensed consolidated statements of cash flows and will remain in AOCI on our condensed consolidated balance sheet until the hedged net investment is sold or substantially liquidated. No cross-currency interest rate swaps matured in the three-month period ended March 31, 2024.

Derivatives Designated as Cash Flow Hedges

Our revenues are generated in various currencies throughout the world. However, a significant amount of our inventory is produced in U.S. Dollars. Therefore, movements in foreign currency exchange rates may have different proportional effects on our revenues compared to our cost of products sold. To minimize the effects of foreign currency exchange rate movements on cash flows, we hedge intercompany sales of inventory expected to occur within the next 30 months with foreign currency exchange forward contracts. We designate these derivative instruments as cash flow hedges.

We perform quarterly assessments of hedge effectiveness by verifying and documenting the critical terms of the hedge instrument and confirming that forecasted transactions have not changed significantly. We also assess on a quarterly basis whether there have been adverse developments regarding the risk of a counterparty default. For derivatives which qualify as hedges of future cash flows, the gains and losses are temporarily recorded in AOCI and then recognized in cost of products sold when the hedged item affects net earnings. On our condensed consolidated statements of cash flows, the settlements of these cash flow hedges are recognized in operating cash flows.

For foreign currency exchange forward contracts and options outstanding at March 31, 2024, we had obligations to purchase U.S. Dollars and sell Euros, Japanese Yen, British Pounds, Canadian Dollars, Australian Dollars, Korean Won, Swedish Krona, Czech Koruna, Thai Baht, Taiwan Dollars, South African Rand, Indian Rupees, Polish Zloty, Danish Krone, and Norwegian Krone and obligations to purchase Swiss Francs and sell U.S. Dollars. These derivatives mature at dates ranging from April 2024 through August 2026. As of March 31, 2024, the notional amounts of outstanding forward contracts and options entered into with third parties to purchase U.S. Dollars were $1,526.7 million. As of March 31, 2024, the notional amounts of outstanding forward contracts and options entered into with third parties to purchase Swiss Francs were $435.4 million.

Derivatives Not Designated as Hedging Instruments

We enter into foreign currency forward exchange contracts with terms of one to three months to manage currency exposures for monetary assets and liabilities denominated in a currency other than an entity’s functional currency. As a result, any foreign currency remeasurement gains/losses recognized in earnings are generally offset with gains/losses on the foreign currency forward exchange contracts in the same reporting period. The net amount of these offsetting gains/losses is recorded in other (expense) income, net. Any outstanding contracts are recorded on the balance sheet at fair value as of the end of the reporting period. The notional amounts of these contracts are typically in a range of $1.25 billion to $1.75 billion per quarter.

Income Statement Presentation

Derivatives Designated as Cash Flow Hedges

Derivative instruments designated as cash flow hedges had the following effects, before taxes, on AOCI and net earnings on our condensed consolidated statements of earnings, condensed consolidated statements of comprehensive income and condensed consolidated balance sheets (in millions):

 

 

Amount of Gain

 

 

 

 

Amount of Gain (Loss)

 

 

 

Recognized in AOCI

 

 

 

 

Reclassified from AOCI

 

 

 

Three Months Ended

 

 

 

 

Three Months Ended

 

 

 

March 31,

 

 

Location on

 

March 31,

 

Derivative Instrument

 

2024

 

 

2023

 

 

Statements of Earnings

 

2024

 

 

2023

 

Foreign exchange
   forward contracts

 

$

43.4

 

 

$

11.1

 

 

Cost of products sold

 

$

22.0

 

 

$

23.1

 

Forward starting
   interest rate swaps

 

 

-

 

 

 

-

 

 

Interest expense, net

 

 

(0.2

)

 

 

(0.2

)

 

 

$

43.4

 

 

$

11.1

 

 

 

 

$

21.8

 

 

$

22.9

 

The fair value of outstanding derivative instruments designated as cash flow hedges and recorded on our condensed consolidated balance sheet at March 31, 2024, together with settled derivatives where the hedged item has not yet affected earnings, was a net unrealized gain of $93.1 million, or $79.9 million after taxes, which is deferred in AOCI. A gain of $75.2 million, or $62.0 million after taxes, is expected to be reclassified to earnings in cost of products sold and a loss of $0.7 million, or $0.5 million after taxes, is expected to be reclassified to earnings in interest expense, net over the next twelve months.

 

The following table presents the effect of fair value, cash flow and net investment hedge accounting on our condensed consolidated statements of earnings (in millions):

 

 

 

Location and Amount of Gain/(Loss) Recognized in Income on Fair Value, Cash Flow and Net Investment Hedging Relationships

 

 

 

Three Months Ended

 

 

Three Months Ended

 

 

 

March 31, 2024

 

 

March 31, 2023

 

 

 

Cost of

 

 

Interest

 

 

Cost of

 

 

Interest

 

 

 

Products

 

 

Expense,

 

 

Products

 

 

Expense,

 

 

 

Sold

 

 

Net

 

 

Sold

 

 

Net

 

Total amounts of income and expense line items presented in the statements of earnings in which the effects of fair value, cash flow and net investment hedges are recorded

 

$

512.3

 

 

$

(50.7

)

 

$

500.8

 

 

$

(48.2

)

        The effects of fair value, cash flow and net investment hedging:

 

 

 

 

 

 

 

 

 

 

             Gain (loss) on fair value hedging
                  relationships

 

 

 

 

 

 

 

 

 

 

 

 

                       Interest rate swaps

 

 

-

 

 

 

(10.6

)

 

 

-

 

 

 

(8.2

)

             Gain (loss) on cash flow hedging
                  relationships

 

 

 

 

 

 

 

 

 

 

 

 

                       Foreign exchange forward contracts

 

 

22.0

 

 

 

-

 

 

 

23.1

 

 

 

-

 

                       Forward starting interest rate swaps

 

 

-

 

 

 

(0.2

)

 

 

-

 

 

 

(0.2

)

             Gain on net investment hedging
                  relationships

 

 

 

 

 

 

 

 

 

 

 

 

                       Cross-currency interest rate swaps

 

 

-

 

 

 

8.2

 

 

 

-

 

 

 

9.0

 

 

Derivatives Not Designated as Hedging Instruments

The following gains / (losses) from these derivative instruments were recognized on our condensed consolidated statements of earnings (in millions):

 

 

 

 

Three Months Ended

 

 

 

Location on

 

March 31,

 

Derivative Instrument

 

Statements of Earnings

 

2024

 

 

2023

 

Foreign exchange forward contracts

 

Other (expense) income, net

 

$

8.4

 

 

$

(3.6

)

These gains / (losses) do not reflect offsetting losses of $12.2 million in the three-month period ended March 31, 2024, and offsetting gains of $0.4 in the three-month period ended March 31, 2023, recognized in other income (expense), net as a result of foreign currency remeasurement of monetary assets and liabilities denominated in a currency other than an entity’s functional currency.

Balance Sheet Presentation

As of March 31, 2024 and December 31, 2023, all derivatives designated as fair value hedges, cash flow hedges and net investment hedges are recorded at fair value on our condensed consolidated balance sheets. On our condensed consolidated balance sheets, we recognize individual forward contracts with the same counterparty on a net asset/liability basis if we have a master netting agreement with the counterparty. Under these master netting agreements, we are able to settle derivative instrument assets and liabilities with the same counterparty in a single transaction, instead of settling each derivative instrument separately. We have master netting agreements with substantially all of our counterparties. The fair value of derivative instruments on a gross basis is as follows (in millions):

 

 

As of March 31, 2024

 

 

As of December 31, 2023

 

 

 

Balance

 

 

 

 

Balance

 

 

 

 

 

Sheet

 

Fair

 

 

Sheet

 

Fair

 

 

 

Location

 

Value

 

 

Location

 

Value

 

Asset Derivatives Designated as Hedges

 

 

 

 

 

 

 

 

 

 

Foreign exchange forward contracts

 

Other current assets

 

$

66.3

 

 

Other current assets

 

$

58.4

 

Cross-currency interest rate swaps

 

Other current assets

 

 

-

 

 

Other current assets

 

 

-

 

Foreign exchange forward contracts

 

Other assets

 

 

21.2

 

 

Other assets

 

 

17.2

 

Cross-currency interest rate swaps

 

Other assets

 

 

27.3

 

 

Other assets

 

 

5.4

 

Total asset derivatives

 

 

 

$

114.8

 

 

 

 

$

81.0

 

 

 

 

 

 

 

 

 

 

 

Asset Derivatives Not Designated as Hedges

 

 

 

 

 

 

 

 

 

 

Foreign exchange forward contracts

 

Other current assets

 

$

3.7

 

 

Other current assets

 

$

1.2

 

 

 

 

 

 

 

 

 

 

 

Liability Derivatives Designated as Hedges

 

 

 

 

 

 

 

 

 

 

Foreign exchange forward contracts

 

Other current liabilities

 

$

8.5

 

 

Other current liabilities

 

$

13.9

 

Cross-currency interest rate swaps

 

Other current liabilities

 

 

35.0

 

 

Other current liabilities

 

 

33.3

 

Foreign exchange forward contracts

 

Other long-term liabilities

 

 

6.3

 

 

Other long-term liabilities

 

 

11.0

 

Cross-currency interest rate swaps

 

Other long-term liabilities

 

 

8.8

 

 

Other long-term liabilities

 

 

34.8

 

Interest rate swaps

 

Other long-term liabilities

 

 

163.8

 

 

Other long-term liabilities

 

 

144.7

 

Total liability derivatives

 

 

 

$

222.4

 

 

 

 

$

237.7

 

 

 

 

 

 

 

 

 

 

 

Liability Derivatives Not Designated as Hedges

 

 

 

 

 

 

 

 

 

 

Foreign exchange forward contracts

 

Other current liabilities

 

$

2.8

 

 

Other current liabilities

 

$

2.4

 

The table below presents the effects of our master netting agreements on our condensed consolidated balance sheets (in millions):

 

 

 

 

As of March 31, 2024

 

 

As of December 31, 2023

 

Description

 

Location

 

Gross
Amount

 

 

Offset

 

 

Net Amount in
Balance Sheet

 

 

Gross
Amount

 

 

Offset

 

 

Net Amount in
Balance Sheet

 

Asset Derivatives

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cash flow hedges

 

Other current assets

 

$

66.3

 

 

$

8.4

 

 

$

57.9

 

 

$

58.4

 

 

$

13.0

 

 

$

45.4

 

Cash flow hedges

 

Other assets

 

 

21.2

 

 

 

4.7

 

 

 

16.5

 

 

 

17.2

 

 

 

8.2

 

 

 

9.0

 

Derivatives Not Designated as Hedges

 

Other current assets

 

 

3.7

 

 

 

1.3

 

 

 

2.4

 

 

 

1.2

 

 

 

0.8

 

 

 

0.4

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Liability Derivatives

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cash flow hedges

 

Other current liabilities

 

 

8.5

 

 

 

8.4

 

 

 

0.1

 

 

 

13.9

 

 

 

13.0

 

 

 

0.9

 

Cash flow hedges

 

Other long-term liabilities

 

 

6.3

 

 

 

4.7

 

 

 

1.6

 

 

 

11.0

 

 

 

8.2

 

 

 

2.8

 

Derivatives Not Designated as Hedges

 

Other current liabilities

 

 

2.8

 

 

 

1.3

 

 

 

1.5

 

 

 

2.4

 

 

 

0.8

 

 

 

1.6

 

The following net investment hedge gains (losses) were recognized on our condensed consolidated statements of comprehensive income (in millions):

 

 

Amount of Gain (Loss)

 

 

 

Recognized in AOCI

 

 

 

Three Months Ended

 

 

 

March 31,

 

Derivative Instrument

 

2024

 

 

2023

 

Euro Notes

 

$

24.4

 

 

$

(19.2

)

Cross-currency interest rate swaps

 

 

46.1

 

 

 

(4.5

)

 

 

$

70.5

 

 

$

(23.7

)
XML 29 R22.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Income Taxes
 3 Months Ended
Mar. 31, 2024
Income Tax Disclosure [Abstract]  
Income Taxes

12. Income Taxes

We operate on a global basis and are subject to numerous and complex tax laws and regulations. Additionally, tax laws continue to undergo rapid changes in both application and interpretation by various countries, including state aid interpretations and initiatives led by the Organisation for Economic Cooperation and Development ("OECD"). Our income tax filings are subject to examinations by taxing authorities throughout the world. Income tax audits may require an extended period of time to reach resolution and may result in significant income tax adjustments when interpretation of tax laws or allocation of company profits is disputed. Although ultimate timing is uncertain, the net amount of tax liability for unrecognized tax benefits may change within the next twelve months due to changes in audit status, expiration of statutes of limitations, settlements of tax assessments and other events. Management’s best estimate of such change is within the range of a $270 million decrease to a $20 million increase.

We are under continuous audit by the IRS and have disputes with the IRS and other foreign taxing authorities in the jurisdictions where we operate. In addition, some jurisdictions in which we operate require payment of disputed taxes to petition a court or taxing authority, or we may elect to make such payments prior to final resolution. We record any prepayments as income tax receivables when we believe our position is more likely than not to be upheld. We assess our position on these disputes at each reporting period. During the course of these audits and disputes, we receive proposed adjustments from taxing authorities that may be material. Therefore, there is a possibility that an adverse outcome in these audits or disputes could have a material effect on our results of operations and financial condition. Our U.S. federal income tax returns have been audited through 2019.

The IRS has proposed adjustments for tax years 2010-2012, primarily related to reallocating profits between certain U.S. and foreign subsidiaries, which remain unsettled. We have disputed these adjustments and intend to continue to vigorously defend our positions as we pursue resolution through the administrative process with the IRS Independent Office of Appeals.

The IRS has proposed adjustments for tax years 2013-2015, primarily related to transfer pricing involving our cost sharing agreement between the U.S. and Switzerland affiliated companies and the reallocation of profits between certain of our U.S. and foreign subsidiaries. This includes a proposed increase to our U.S. federal taxable income, which would result in additional tax expense related to 2013 of approximately $370 million, subject to interest and penalties. We strongly believe that the position of the IRS, with regard to this matter, is inconsistent with the applicable U.S. Treasury Regulations governing our cost sharing agreement. We intend to vigorously contest the adjustment, and we will pursue all available administrative and, if necessary, judicial remedies. If we pursue judicial remedies in the U.S. Tax Court for years 2013-2015, a number of years will likely elapse before such matters are finally resolved. No payment of any amount related to this matter is required to be made, if at all, until all applicable proceedings have been completed.

The IRS has proposed adjustments for tax years 2016-2019, primarily related to the U.S. taxation of foreign earnings and profits, which could result in additional material tax expense if we are unsuccessful in defending our position. We disagree with the proposed adjustments and intend to continue to vigorously contest the adjustments. We do not expect a final resolution of these issues in the next 12 months. No payment of any amount related to his matter is required to be made, if at all, until all applicable proceedings have been completed.

In the three-month period ended March 31, 2024, our effective tax rate (“ETR”) was 19.7 percent compared to 18.9 percent for the three-month period ended March 31, 2023. The 19.7 percent and 18.9 percent ETR in the three-month periods ended March 31, 2024 and 2023, respectively, were primarily driven by our mix of earnings between U.S. and foreign locations. Absent discrete tax events, we expect our future ETR will be lower than the U.S. corporate income tax rate of 21.0 percent due to our mix of earnings between U.S. and foreign locations, which generally have lower corporate income tax rates. Our ETR in future periods could also potentially be impacted by: changes in our mix of pre-tax earnings; changes in tax rates, tax laws or their interpretation; including the European Union adoption of Pillar Two proposals which began to take effect in 2024; the outcome of various federal, state and foreign audits, appeals, and litigation; and the expiration of certain statutes of limitations. Currently, we cannot reasonably estimate the impact of these items on our financial results.
XML 30 R23.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Earnings Per Share
 3 Months Ended
Mar. 31, 2024
Earnings Per Share [Abstract]  
Earnings Per Share

13. Earnings Per Share

The following is a reconciliation of weighted average shares for the basic and diluted shares computations (in millions):

 

 

Three Months Ended

 

 

 

March 31,

 

 

 

2024

 

 

2023

 

Weighted average shares outstanding for basic net earnings per share

 

 

205.2

 

 

 

209.4

 

Effect of dilutive stock options and other equity awards

 

 

1.0

 

 

 

1.0

 

Weighted average shares outstanding for diluted net earnings per share

 

 

206.2

 

 

 

210.4

 

During the three-month periods ended March 31, 2024 and 2023, an average of 1.6 million options and 2.0 million options, respectively, to purchase shares of common stock were not included in the computation of diluted earnings per share because the effect would have been antidilutive.
XML 31 R24.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Segment Information
 3 Months Ended
Mar. 31, 2024
Segment Reporting [Abstract]  
Segment Information

14. Segment Information

We design, manufacture and market orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; craniomaxillofacial and thoracic products (“CMFT”); surgical products; and a suite of integrated digital and robotic technologies that leverage data, data analytics and artificial intelligence. Our chief operating decision maker (“CODM”) allocates resources to achieve our operating profit goals through three operating segments. These operating segments, which also constitute our reportable segments, are Americas; EMEA; and Asia Pacific.

Our CODM evaluates performance based upon segment operating profit exclusive of operating expenses and income pertaining to intangible asset amortization, certain inventory and manufacturing-related charges, restructuring and other cost reduction initiatives, acquisition, integration, divestiture and related, litigation, certain European Union Medical Device Regulation (“EU MDR”) expenses, other charges and corporate functions (collectively referred to as “Corporate items”). Corporate functions include finance, corporate legal, information technology, human resources and other corporate departments as well as stock-based compensation and certain operations, distribution, quality assurance, regulatory assurance, research and development ("R&D") and marketing expenses. Intercompany transactions have been eliminated from segment operating profit.

Our Americas operating segment is comprised principally of the U.S. and includes other North, Central and South American markets. Our EMEA operating segment is comprised principally of Europe and includes the Middle East and African markets. Our Asia Pacific operating segment is comprised principally of Japan, China and Australia and includes other Asian and Pacific markets. The Americas, EMEA and Asia Pacific operating segments include the commercial operations as well as regional headquarter expenses to operate in those markets. Our operating segments do not include many centralized, product category expenses such as R&D and global marketing that benefit all regions.

In the three-month period ended March 31, 2024, the segment operating profit measures our CODM reviews were revised. Certain product category headquarter costs, primarily R&D and marketing, that were previously in our Americas operating segment are now included in Corporate items. In addition, certain support function costs from our operating segments are now included in Corporate items. We have reclassified these product category headquarter and support function expenses in the prior period to conform to the current period presentation.

Net sales and operating profit by segment are as follows (in millions):

 

 

 

Net Sales

 

 

Operating Profit

 

 

 

Three Months Ended

 

 

Three Months Ended

 

 

 

March 31,

 

 

March 31,

 

 

 

2024

 

 

2023

 

 

2024

 

 

2023

 

Americas

 

$

1,186.5

 

 

$

1,141.3

 

 

$

639.3

 

 

$

608.9

 

EMEA

 

 

444.8

 

 

 

425.6

 

 

 

153.0

 

 

 

149.5

 

Asia Pacific

 

 

258.0

 

 

 

264.1

 

 

 

93.3

 

 

 

90.2

 

Total

 

$

1,889.2

 

 

$

1,831.0

 

 

 

 

 

 

 

Corporate items

 

 

 

 

 

 

 

 

(477.6

)

 

 

(387.9

)

Intangible asset amortization

 

 

 

 

 

 

 

 

(142.1

)

 

 

(133.4

)

Operating profit

 

 

 

 

 

 

 

$

265.9

 

 

$

327.3

 

XML 32 R25.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Commitments and Contingencies
 3 Months Ended
Mar. 31, 2024
Commitments and Contingencies Disclosure [Abstract]  
Commitments and Contingencies

15. Commitments and Contingencies

From time to time, we are involved in various legal proceedings, including product liability, intellectual property, stockholder matters, tax disputes, commercial disputes, employment matters, whistleblower and qui tam claims and investigations, governmental proceedings and investigations, and other legal matters that arise in the normal course of our business, including those described below. On a quarterly and annual basis, we review relevant information with respect to loss contingencies and update our accruals, disclosures and estimates of reasonably possible losses or ranges of loss based on such reviews. We establish liabilities for loss contingencies on an undiscounted basis when it is probable that a loss has been incurred and the amount of the loss can be reasonably estimated. If the reasonable estimate of a known or probable loss is a range, and no amount within the range is a better estimate than any other, the minimum amount of the range is accrued. For matters where a loss is believed to be reasonably possible, but not probable, or if no reasonable estimate of known or probable loss is available, no accrual has been made.

When determining the estimated loss or range of loss, significant judgment is required. Estimates of probable losses resulting from litigation and other contingencies are inherently difficult to predict, particularly when the matters are in early procedural stages with incomplete facts or legal discovery, involve unsubstantiated or indeterminate claims for damages, and/or potentially involve penalties, fines or punitive damages. In addition to the matters described herein, we remain subject to the risk of future governmental, regulatory and legal actions. Governmental and regulatory actions may lead to product recalls, injunctions and other restrictions on our operations and monetary sanctions, which may include substantial civil or criminal penalties. Actions involving intellectual property could result in a loss of patent protection or the ability to market products, which could lead to significant sales reductions or cost increases, or otherwise materially affect the results of our operations.

We recognize litigation-related charges and gains in Selling, general and administrative expense on our condensed consolidated statement of earnings. During the three-month periods ended March 31, 2024 and 2023, we recognized $1.0 million and $3.3 million, respectively, of net litigation-related charges. At March 31, 2024 and December 31, 2023, accrued litigation liabilities were $226.5 million and $244.1 million, respectively. These litigation-related charges and accrued liabilities reflect all of our litigation-related contingencies and not just the matters discussed below. The ultimate cost of litigation could be materially different than the amount of the current estimates and accruals and could have a material adverse impact on our financial condition and results of operations.

Litigation

Durom Cup-related claims: On July 22, 2008, we temporarily suspended marketing and distribution of the Durom Cup in the U.S. Subsequently, a number of product liability lawsuits were filed against us in various U.S. and foreign jurisdictions. The plaintiffs seek damages for personal injury, and they generally allege that the Durom Cup contains defects that result in complications and revision of the device. We have settled the majority of these claims in the U.S., but other lawsuits are pending in various foreign jurisdictions and additional claims may be asserted in the future. The majority of claims outside the U.S. are pending in Germany, Netherlands and Italy.

We rely on significant estimates in determining the provisions for Durom Cup-related claims, including our estimate of the number of claims that we will receive and the average amount we will pay per claim. The actual number of claims and the actual amount we pay per claim may differ from our estimates. For various reasons, we cannot reasonably estimate the possible loss or range of loss that may result from Durom Cup-related claims in excess of the losses we have accrued. Although we are vigorously defending these lawsuits, their ultimate resolution is uncertain. We accrued a litigation-related charge in this matter based on an estimate of the reasonably possible loss, as discussed above.

Zimmer M/L Taper, M/L Taper with Kinectiv Technology, and Versys Femoral Head-related claims (“Metal Reaction” claims): We are a defendant in a number of product liability lawsuits relating to our M/L Taper and M/L Taper with Kinectiv Technology hip stems, and Versys Femoral Head implants. The plaintiffs seek damages for personal injury, alleging that defects in the products lead to corrosion at the head/stem junction resulting in, among other things, pain, inflammation and revision surgery.

The majority of the cases are consolidated in an MDL that was created on October 3, 2018 in the U.S. District Court for the Southern District of New York (In Re: Zimmer M/L Taper Hip Prosthesis or M/L Taper Hip Prosthesis with Kinectiv Technology and Versys Femoral Head Products Liability Litigation). Most of the cases in the MDL have been resolved. Other related cases are pending in various state and federal courts and in courts in Canada, and additional claims may be asserted in the future. Although we are vigorously defending these lawsuits, their ultimate resolution is uncertain. We accrued a litigation-related charge in this matter based on an estimate of the reasonably possible loss, as discussed above.

Biomet metal-on-metal hip implant claims: Biomet is a defendant in a number of product liability lawsuits relating to metal-on-metal hip implants, most of which involve the M2a-Magnum hip system. Cases were originally consolidated in an MDL in the U.S. District Court for the Northern District of Indiana (In Re: Biomet M2a Magnum Hip Implant Product Liability Litigation), but the majority of the claims in the U.S. have been settled. Trials may still occur in the future, and although each case will be tried on its particular facts, a verdict and subsequent final judgment for the plaintiff in one or more of these cases could have a substantial impact on our potential liability. Lawsuits are pending in various foreign jurisdictions and additional claims are expected to be asserted. We continue to refine our estimates of the potential liability to resolve the remaining claims and lawsuits. Although we are vigorously

defending these lawsuits, their ultimate resolution is uncertain. We accrued a litigation-related charge in this matter based on an estimate of the reasonably possible loss, as discussed above.

Other Contingencies

Contractual obligations: We have entered into development, distribution and other contractual arrangements that may result in future payments dependent upon various events such as the achievement of certain product R&D milestones, sales milestones, or, at our discretion, maintenance of exclusive rights to distribute a product. Since there is uncertainty on the timing or whether such payments will have to be made, they have not been recognized on our condensed consolidated balance sheets. These estimated payments could range from $0 to approximately $405 million.
XML 33 R26.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Significant Accounting Policies (Policies)
 3 Months Ended
Mar. 31, 2024
Accounting Policies [Abstract]  
Use of Estimates

Use of Estimates - The accompanying unaudited condensed consolidated financial statements are prepared in conformity with GAAP, which requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. We have made our best estimates, as appropriate under GAAP, in the recognition of our assets and liabilities. Actual results could differ materially from these estimates.
Accounting Pronouncements Not Yet Adopted

Accounting Pronouncements Not Yet Adopted - In November 2023, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2023-07, Improvements to Reportable Segment Disclosures, which is an amendment to ASC Topic 280 - Segment Reporting. The ASU requires more detailed and disaggregated segment information, including the disclosure of significant segment expense categories and amounts for each reportable segment. The ASU also requires certain annual disclosures to also be made in interim periods. The ASU is effective for fiscal years beginning after December 15, 2023, and interim periods for fiscal years beginning after December 15, 2024. The guidance will be applied retrospectively unless retrospective adoption is impracticable. Early adoption of this ASU is permitted. We are currently evaluating the impact this ASU will have on our financial statements and disclosures.

 

In December 2023, the FASB issued ASU 2023-09, Improvements to Income Tax Disclosures, which is an amendment to ASC Topic 740 - Income Taxes. The ASU improves the transparency of income tax disclosures by requiring greater disaggregated information about an entity’s effective tax rate reconciliation and requiring additional disclosures and disaggregation of income taxes, among other amendments to improve the effectiveness of income tax disclosures. The ASU is effective for fiscal years beginning after December 15, 2024. The guidance will be applied prospectively with an option to apply the guidance retrospectively. Early adoption of this ASU is permitted. We are currently evaluating the impact this ASU will have on our financial statements and disclosures.
XML 34 R27.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Revenue (Tables)
 3 Months Ended
Mar. 31, 2024
Revenue Recognition [Abstract]  
Schedule of Net Sales by Geography

Net sales by geography are as follows (in millions):

 

 

 

Three Months Ended

 

 

 

March 31,

 

 

 

2024

 

 

2023

 

United States

 

$

1,099.2

 

 

$

1,060.4

 

International

 

 

790.0

 

 

 

770.6

 

Total

 

$

1,889.2

 

 

$

1,831.0

 
Schedule of Net Sales by Product Category

Net sales by product category are as follows (in millions):

 

 

 

Three Months Ended

 

 

 

March 31,

 

 

 

2024

 

 

2023

 

Knees

 

$

788.1

 

 

$

762.5

 

Hips

 

 

491.2

 

 

 

492.8

 

S.E.T.

 

 

452.6

 

 

 

433.4

 

Other

 

 

157.3

 

 

 

142.3

 

Total

 

$

1,889.2

 

 

$

1,831.0

 
XML 35 R28.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Restructuring (Tables)
 3 Months Ended
Mar. 31, 2024
Restructuring and Related Activities [Abstract]  
Summary of Liabilities Recognized Related to Restructuring Plan The following table summarizes the liabilities recognized related to the 2023 Restructuring Plan (in millions):

 

 

 

Employee

 

 

 

 

 

 

 

 

 

 

 

 

Termination

 

 

Contract

 

 

 

 

 

 

 

 

 

Benefits

 

 

Terminations

 

 

Other

 

 

Total

 

Balance, December 31, 2023

 

$

9.2

 

 

$

-

 

 

$

5.0

 

 

$

14.2

 

Expenses incurred in the three months ended March 31, 2024

 

 

71.0

 

 

 

1.8

 

 

 

6.8

 

 

 

79.6

 

Cash payments

 

 

(23.5

)

 

 

-

 

 

 

(1.3

)

 

 

(24.8

)

Foreign currency exchange rate changes

 

 

(0.4

)

 

 

-

 

 

 

-

 

 

 

(0.4

)

Non-cash activity

 

 

-

 

 

 

-

 

 

 

1.2

 

 

 

1.2

 

Balance, March 31, 2024

 

$

56.3

 

 

$

1.8

 

 

$

11.7

 

 

$

69.8

 

 

 

 

 

 

 

 

 

 

 

 

 

Expense incurred since the start of the 2023 Restructuring Plan

 

$

80.2

 

 

$

1.8

 

 

$

10.4

 

 

$

92.4

 

 

 

 

 

 

 

 

 

 

 

 

 

Expense estimated to be recognized for the 2023 Restructuring Plan

 

$

90.0

 

 

$

10.0

 

 

$

20.0

 

 

$

120.0

 

 

The following table summarizes the liabilities recognized related to the 2021 Restructuring Plan (in millions):

 

 

 

Employee

 

 

 

 

 

 

 

 

 

 

 

 

Termination

 

 

Contract

 

 

 

 

 

 

 

 

 

Benefits

 

 

Terminations

 

 

Other

 

 

Total

 

Balance, December 31, 2023

 

$

4.2

 

 

$

17.6

 

 

$

2.9

 

 

$

24.7

 

Expenses incurred in the three months ended March 31, 2024

 

 

(0.4

)

 

 

-

 

 

 

1.3

 

 

 

0.9

 

Cash payments

 

 

(0.8

)

 

 

(7.3

)

 

 

(1.5

)

 

 

(9.6

)

Foreign currency exchange rate changes

 

 

(0.1

)

 

 

(0.4

)

 

 

-

 

 

 

(0.5

)

Balance, March 31, 2024

 

$

2.9

 

 

$

9.9

 

 

$

2.7

 

 

$

15.5

 

 

 

 

 

 

 

 

 

 

 

 

 

Expense incurred since the start of the 2021 Restructuring Plan

 

$

58.7

 

 

$

73.8

 

 

$

37.5

 

 

$

170.0

 

 

 

 

 

 

 

 

 

 

 

 

 

Expense estimated to be recognized for the 2021 Restructuring Plan

 

$

60.0

 

 

$

80.0

 

 

$

40.0

 

 

$

180.0

 

The following table summarizes the liabilities recognized related to the 2019 Restructuring Plan (in millions):

 

 

 

Employee

 

 

 

 

 

 

 

 

 

 

 

 

Termination

 

 

Contract

 

 

 

 

 

 

 

 

 

Benefits

 

 

Terminations

 

 

Other

 

 

Total

 

Balance, December 31, 2023

 

$

43.8

 

 

$

5.6

 

 

$

2.9

 

 

$

52.3

 

Expenses incurred in the three months ended March 31, 2024

 

 

14.7

 

 

 

-

 

 

 

2.3

 

 

 

17.0

 

Cash payments

 

 

-

 

 

 

(0.5

)

 

 

(3.5

)

 

 

(4.0

)

Foreign currency exchange rate changes

 

 

(0.5

)

 

 

-

 

 

 

-

 

 

 

(0.5

)

Balance, March 31, 2024

 

$

58.0

 

 

$

5.1

 

 

$

1.7

 

 

$

64.8

 

 

 

 

 

 

 

 

 

 

 

 

 

Expense incurred since the start of the 2019 Restructuring Plan

 

$

140.4

 

 

$

35.0

 

 

$

161.0

 

 

$

336.4

 

 

 

 

 

 

 

 

 

 

 

 

 

Expense estimated to be recognized for the 2019 Restructuring Plan

 

$

155.0

 

 

$

35.0

 

 

$

180.0

 

 

$

370.0

 
Summary of Location on Condensed Consolidated Statement of Earnings and Type of Cost for Restructuring Plan

The following table summarizes the location on our condensed consolidated statement of earnings and type of cost for our 2019 Restructuring Plan (in millions):

 

 

 

 

 

Three Months Ended March 31, 2024

 

 

 

Employee

 

 

 

 

 

 

 

 

 

 

 

 

Termination

 

 

Contract

 

 

 

 

 

 

 

 

 

Benefits

 

 

Terminations

 

 

Other

 

 

Total

 

Cost of products sold, excluding intangible asset amortization

 

$

-

 

 

$

-

 

 

$

0.5

 

 

$

0.5

 

Restructuring and other cost reduction initiatives

 

 

14.7

 

 

 

-

 

 

 

1.8

 

 

 

16.5

 

 

 

$

14.7

 

 

$

-

 

 

$

2.3

 

 

$

17.0

 
XML 36 R29.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Inventories (Tables)
 3 Months Ended
Mar. 31, 2024
Inventory Disclosure [Abstract]  
Summary of Inventories

 

 

March 31,

 

 

December 31,

 

 

 

2024

 

 

2023

 

 

 

(in millions)

 

Finished goods

 

$

1,846.7

 

 

$

1,831.2

 

Work in progress

 

 

226.7

 

 

 

246.5

 

Raw materials

 

 

314.8

 

 

 

307.5

 

Inventories

 

$

2,388.2

 

 

$

2,385.2

 
XML 37 R30.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Property, Plant and Equipment (Tables)
 3 Months Ended
Mar. 31, 2024
Property, Plant and Equipment [Abstract]  
Summary of Property, Plant and Equipment

 

 

March 31,

 

 

December 31,

 

 

 

2024

 

 

2023

 

 

 

(in millions)

 

Land

 

$

18.8

 

 

$

18.9

 

Buildings and equipment

 

 

2,254.1

 

 

 

2,245.9

 

Capitalized software costs

 

 

555.2

 

 

 

552.2

 

Instruments

 

 

3,814.6

 

 

 

3,748.6

 

Construction in progress

 

 

206.4

 

 

 

200.6

 

 

 

 

6,849.1

 

 

 

6,766.2

 

Accumulated depreciation

 

 

(4,758.2

)

 

 

(4,705.8

)

Property, plant and equipment, net

 

$

2,090.9

 

 

$

2,060.4

 
XML 38 R31.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Acquisitions (Tables)
 3 Months Ended
Mar. 31, 2024
2023 Acquisitions [Member]  
Business Acquisition [Line Items]  
Summary of Estimates of Fair Value of Assets Acquired and Liabilities Assumed

The following table summarizes the estimates of fair value of the assets acquired and liabilities assumed related to the 2023 acquisitions (in millions):

 

Current assets

 

$

13.1

 

Intangible assets subject to amortization:

 

 

 

   Technology

 

 

144.0

 

   Trademarks and trade names

 

 

3.5

 

   Customer relationships

 

 

40.1

 

Intangible assets not subject to amortization:

 

 

 

   In-process research and development (IPR&D)

 

 

36.3

 

Goodwill

 

 

215.0

 

Other assets

 

 

4.8

 

Total assets acquired

 

 

456.8

 

Current liabilities

 

 

8.2

 

Deferred income taxes

 

 

37.7

 

Total liabilities assumed

 

 

45.9

 

Net assets acquired

 

$

410.9

 
XML 39 R32.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Debt (Tables)
 3 Months Ended
Mar. 31, 2024
Debt Disclosure [Abstract]  
Summary of Debt Instruments

Our debt consisted of the following (in millions):

 

 

March 31,

 

 

December 31,

 

 

 

2024

 

 

2023

 

Current portion of long-term debt

 

 

 

 

 

 

Uncommitted Credit Facility

 

$

120.0

 

 

$

50.0

 

1.450% Senior Notes due 2024

 

 

850.0

 

 

 

850.0

 

Total current portion of long-term debt

 

$

970.0

 

 

$

900.0

 

Long-term debt

 

 

 

 

 

 

3.550% Senior Notes due 2025

 

$

863.0

 

 

$

863.0

 

3.050% Senior Notes due 2026

 

 

600.0

 

 

 

600.0

 

5.350% Senior Notes due 2028

 

 

500.0

 

 

 

500.0

 

3.550% Senior Notes due 2030

 

 

257.5

 

 

 

257.5

 

2.600% Senior Notes due 2031

 

 

750.0

 

 

 

750.0

 

4.250% Senior Notes due 2035

 

 

253.4

 

 

 

253.4

 

5.750% Senior Notes due 2039

 

 

317.8

 

 

 

317.8

 

4.450% Senior Notes due 2045

 

 

395.4

 

 

 

395.4

 

2.425% Euro Notes due 2026

 

 

540.1

 

 

 

552.3

 

1.164% Euro Notes due 2027

 

 

540.1

 

 

 

552.3

 

Debt discount and issuance costs

 

 

(27.4

)

 

 

(29.1

)

Adjustment related to interest rate swaps

 

 

(163.7

)

 

 

(144.7

)

Total long-term debt

 

$

4,826.2

 

 

$

4,867.9

 
XML 40 R33.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Accumulated Other Comprehensive Income (Tables)
 3 Months Ended
Mar. 31, 2024
Equity [Abstract]  
Changes in Components of Accumulated Other Comprehensive Income, Net of Tax

The following table shows the changes in the components of AOCI gains (losses), net of tax (in millions):

 

 

Foreign

 

 

Cash

 

 

Defined

 

 

 

 

 

 

Currency

 

 

Flow

 

 

Benefit

 

 

Total

 

 

 

Translation

 

 

Hedges

 

 

Plan Items

 

 

AOCI

 

Balance at December 31, 2023

 

$

(159.4

)

 

$

63.3

 

 

$

(94.9

)

 

$

(191.0

)

AOCI before reclassifications

 

 

(35.8

)

 

 

34.7

 

 

 

-

 

 

 

(1.1

)

Reclassifications to statements of earnings

 

 

-

 

 

 

(18.0

)

 

 

(1.1

)

 

 

(19.1

)

Balance at March 31, 2024

 

$

(195.2

)

 

$

80.0

 

 

$

(96.0

)

 

$

(211.2

)

Reclassification Adjustments from Accumulated Other Comprehensive Income

The following table shows the reclassification adjustments from AOCI (in millions):

 

 

Amount of Gain (Loss)

 

 

 

Reclassified from AOCI

 

 

 

Three Months Ended

 

 

 

 

 

March 31,

 

 

Location on

Component of AOCI

 

2024

 

 

2023

 

 

Statements of Earnings

Cash flow hedges

 

 

 

 

 

 

 

 

Foreign exchange forward contracts

 

$

22.0

 

 

$

23.1

 

 

Cost of products sold

Forward starting interest rate swaps

 

 

(0.2

)

 

 

(0.2

)

 

Interest expense, net

 

 

 

21.8

 

 

 

22.9

 

 

Total before tax

 

 

3.8

 

 

 

3.9

 

 

Provision for income taxes

 

 

$

18.0

 

 

$

19.0

 

 

Net of tax

Defined benefit plans

 

 

 

 

 

 

 

 

Prior service cost and unrecognized actuarial loss

 

$

0.8

 

 

$

1.0

 

 

Other (expense) income, net

 

 

(0.3

)

 

 

0.1

 

 

Provision for income taxes

 

 

$

1.1

 

 

$

0.9

 

 

Net of tax

Total reclassifications

 

$

19.1

 

 

$

19.9

 

 

Net of tax
Tax Effects on Each Component of Accumulated Other Comprehensive Income Recognized in Statements of Comprehensive Income

The following table shows the tax effects on each component of AOCI recognized in our condensed consolidated statements of comprehensive income (in millions):

 

 

Three Months Ended March 31, 2024

 

 

 

Before Tax

 

 

Tax

 

 

Net of Tax

 

Foreign currency cumulative translation adjustments

 

$

(19.2

)

 

 

16.6

 

 

$

(35.8

)

Unrealized cash flow hedge gains

 

 

43.4

 

 

 

8.7

 

 

 

34.7

 

Reclassification adjustments on cash flow hedges

 

 

(21.8

)

 

 

(3.8

)

 

 

(18.0

)

Adjustments to prior service cost and unrecognized actuarial assumptions

 

 

(0.8

)

 

 

0.3

 

 

 

(1.1

)

Total Other Comprehensive Income (Loss)

 

$

1.6

 

 

$

21.8

 

 

$

(20.2

)

 

 

 

Three Months Ended March 31, 2023

 

 

 

Before Tax

 

 

Tax

 

 

Net of Tax

 

Foreign currency cumulative translation adjustments

 

$

7.5

 

 

$

(4.9

)

 

$

12.4

 

Unrealized cash flow hedge gains

 

 

11.1

 

 

 

2.3

 

 

 

8.8

 

Reclassification adjustments on cash flow hedges

 

 

(22.9

)

 

 

(3.9

)

 

 

(19.0

)

Adjustments to prior service cost and unrecognized actuarial assumptions

 

 

(1.0

)

 

 

(0.1

)

 

 

(0.9

)

Total Other Comprehensive Income (Loss)

 

$

(5.3

)

 

$

(6.6

)

 

$

1.3

 
XML 41 R34.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Fair Value Measurement of Assets and Liabilities (Tables)
 3 Months Ended
Mar. 31, 2024
Fair Value Disclosures [Abstract]  
Fair Value Measurement of Asset and Liabilities

The following financial assets and liabilities are recorded at fair value on a recurring basis (in millions):

 

 

As of March 31, 2024

 

 

 

 

 

 

Fair Value Measurements at Reporting Date Using:

 

Description

 

Recorded
Balance

 

 

Quoted Prices
in Active
Markets for
Identical
Assets
(Level 1)

 

 

Significant
Other
Observable
Inputs
(Level 2)

 

 

Significant
Unobservable
Inputs
(Level 3)

 

Assets

 

 

 

 

 

 

 

 

 

 

 

 

Derivatives designated as hedges, current and long-term

 

 

 

 

 

 

 

 

 

 

 

 

Foreign currency forward contracts

 

$

74.4

 

 

$

-

 

 

$

74.4

 

 

$

-

 

Cross-currency interest rate swaps

 

 

27.3

 

 

 

-

 

 

 

27.3

 

 

 

-

 

Derivatives not designated as hedges, current and long-term

 

 

 

 

 

 

 

 

 

 

 

 

Foreign currency forward contracts

 

 

2.4

 

 

 

-

 

 

 

2.4

 

 

 

-

 

Total Assets

 

$

104.1

 

 

$

-

 

 

$

104.1

 

 

$

-

 

 

 

 

 

 

 

 

 

 

 

 

 

Liabilities

 

 

 

 

 

 

 

 

 

 

 

 

Derivatives designated as hedges, current and long-term

 

 

 

 

 

 

 

 

 

 

 

 

Foreign currency forward contracts

 

$

1.7

 

 

$

-

 

 

$

1.7

 

 

$

-

 

Cross-currency interest rate swaps

 

 

43.8

 

 

 

-

 

 

 

43.8

 

 

 

-

 

Interest rate swaps

 

 

163.8

 

 

 

-

 

 

 

163.8

 

 

 

-

 

Derivatives not designated as hedges, current and long-term

 

 

 

 

 

 

 

 

 

 

 

 

Foreign currency forward contracts

 

 

1.5

 

 

 

-

 

 

 

1.5

 

 

 

-

 

Contingent consideration related to acquisitions

 

 

115.2

 

 

 

-

 

 

 

-

 

 

 

115.2

 

Total Liabilities

 

$

326.0

 

 

$

-

 

 

$

210.8

 

 

$

115.2

 

 

 

 

As of December 31, 2023

 

 

 

 

 

 

Fair Value Measurements at Reporting Date Using:

 

Description

 

Recorded
Balance

 

 

Quoted Prices
in Active
Markets for
Identical
Assets
(Level 1)

 

 

Significant
Other
Observable
Inputs
(Level 2)

 

 

Significant
Unobservable
Inputs
(Level 3)

 

Assets

 

 

 

 

 

 

 

 

 

 

 

 

Derivatives designated as hedges, current and long-term

 

 

 

 

 

 

 

 

 

 

 

 

Foreign currency forward contracts

 

$

54.4

 

 

$

-

 

 

$

54.4

 

 

$

-

 

Cross-currency interest rate swaps

 

 

5.4

 

 

 

-

 

 

 

5.4

 

 

 

-

 

Derivatives not designated as hedges, current and long-term

 

 

 

 

 

 

 

 

 

 

 

 

Foreign currency forward contracts

 

 

0.4

 

 

 

-

 

 

 

0.4

 

 

 

-

 

Total Assets

 

$

60.2

 

 

$

-

 

 

$

60.2

 

 

$

-

 

 

 

 

 

 

 

 

 

 

 

 

 

Liabilities

 

 

 

 

 

 

 

 

 

 

 

 

Derivatives designated as hedges, current and long-term

 

 

 

 

 

 

 

 

 

 

 

 

Foreign currency forward contracts

 

$

3.7

 

 

$

-

 

 

$

3.7

 

 

$

-

 

Cross-currency interest rate swaps

 

 

68.1

 

 

 

-

 

 

 

68.1

 

 

 

-

 

Interest rate swaps

 

 

144.7

 

 

 

-

 

 

 

144.7

 

 

 

-

 

Derivatives not designated as hedges, current and long-term

 

 

 

 

 

 

 

 

 

 

 

 

Foreign currency forward contracts

 

 

1.6

 

 

 

-

 

 

 

1.6

 

 

 

-

 

Contingent consideration related to acquisitions

 

 

141.7

 

 

 

-

 

 

 

-

 

 

 

141.7

 

Total Liabilities

 

$

359.8

 

 

$

-

 

 

$

218.1

 

 

$

141.7

 
Fair Value Liabilities Measured on Recurring Basis

The following table provides a reconciliation of the beginning and ending balances of items measured at fair value on a recurring basis in the tables above that used significant unobservable inputs (Level 3) (in millions):

 

 

 

Level 3 - Liabilities

 

Contingent payments related to acquisitions

 

 

 

Beginning balance December 31, 2023

 

$

141.7

 

Change in estimates

 

 

(1.6

)

Settlements

 

 

(24.9

)

Ending balance March 31, 2024

 

$

115.2

 

 
XML 42 R35.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Derivative Instruments and Hedging Activities (Tables)
 3 Months Ended
Mar. 31, 2024
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Schedule of Amounts Recorded On Balance Sheet Related To Cumulative Basis Adjustments For Fair Value Hedges

As of March 31, 2024 and December 31, 2023, the following amounts were recorded on our condensed consolidated balance sheets related to cumulative basis adjustments for fair value hedges (in millions):

 

 

 

Carrying Amount of the Hedged Liabilities

 

 

 

Cumulative Amount of Fair Value Hedging Adjustment Included in the Carrying Amount of the Hedged Liabilities

 

Balance Sheet Line Item

 

March 31, 2024

 

 

December 31, 2023

 

 

 

March 31, 2024

 

 

December 31, 2023

 

Long-term debt

 

$

832.3

 

 

$

851.3

 

 

 

$

(163.7

)

 

$

(144.7

)
Gross Unrealized Losses from Derivative Instruments

Derivative instruments designated as cash flow hedges had the following effects, before taxes, on AOCI and net earnings on our condensed consolidated statements of earnings, condensed consolidated statements of comprehensive income and condensed consolidated balance sheets (in millions):

 

 

Amount of Gain

 

 

 

 

Amount of Gain (Loss)

 

 

 

Recognized in AOCI

 

 

 

 

Reclassified from AOCI

 

 

 

Three Months Ended

 

 

 

 

Three Months Ended

 

 

 

March 31,

 

 

Location on

 

March 31,

 

Derivative Instrument

 

2024

 

 

2023

 

 

Statements of Earnings

 

2024

 

 

2023

 

Foreign exchange
   forward contracts

 

$

43.4

 

 

$

11.1

 

 

Cost of products sold

 

$

22.0

 

 

$

23.1

 

Forward starting
   interest rate swaps

 

 

-

 

 

 

-

 

 

Interest expense, net

 

 

(0.2

)

 

 

(0.2

)

 

 

$

43.4

 

 

$

11.1

 

 

 

 

$

21.8

 

 

$

22.9

 

Effects of Fair Value, Cash Flow and Net Investment Hedge Accounting on Consolidated Statements of Earnings

The following table presents the effect of fair value, cash flow and net investment hedge accounting on our condensed consolidated statements of earnings (in millions):

 

 

 

Location and Amount of Gain/(Loss) Recognized in Income on Fair Value, Cash Flow and Net Investment Hedging Relationships

 

 

 

Three Months Ended

 

 

Three Months Ended

 

 

 

March 31, 2024

 

 

March 31, 2023

 

 

 

Cost of

 

 

Interest

 

 

Cost of

 

 

Interest

 

 

 

Products

 

 

Expense,

 

 

Products

 

 

Expense,

 

 

 

Sold

 

 

Net

 

 

Sold

 

 

Net

 

Total amounts of income and expense line items presented in the statements of earnings in which the effects of fair value, cash flow and net investment hedges are recorded

 

$

512.3

 

 

$

(50.7

)

 

$

500.8

 

 

$

(48.2

)

        The effects of fair value, cash flow and net investment hedging:

 

 

 

 

 

 

 

 

 

 

             Gain (loss) on fair value hedging
                  relationships

 

 

 

 

 

 

 

 

 

 

 

 

                       Interest rate swaps

 

 

-

 

 

 

(10.6

)

 

 

-

 

 

 

(8.2

)

             Gain (loss) on cash flow hedging
                  relationships

 

 

 

 

 

 

 

 

 

 

 

 

                       Foreign exchange forward contracts

 

 

22.0

 

 

 

-

 

 

 

23.1

 

 

 

-

 

                       Forward starting interest rate swaps

 

 

-

 

 

 

(0.2

)

 

 

-

 

 

 

(0.2

)

             Gain on net investment hedging
                  relationships

 

 

 

 

 

 

 

 

 

 

 

 

                       Cross-currency interest rate swaps

 

 

-

 

 

 

8.2

 

 

 

-

 

 

 

9.0

 
Derivative Instruments Not Designated as Hedging Instruments

The following gains / (losses) from these derivative instruments were recognized on our condensed consolidated statements of earnings (in millions):

 

 

 

 

Three Months Ended

 

 

 

Location on

 

March 31,

 

Derivative Instrument

 

Statements of Earnings

 

2024

 

 

2023

 

Foreign exchange forward contracts

 

Other (expense) income, net

 

$

8.4

 

 

$

(3.6

)

Fair Value of Derivative Instruments on Gross Basis The fair value of derivative instruments on a gross basis is as follows (in millions):

 

 

As of March 31, 2024

 

 

As of December 31, 2023

 

 

 

Balance

 

 

 

 

Balance

 

 

 

 

 

Sheet

 

Fair

 

 

Sheet

 

Fair

 

 

 

Location

 

Value

 

 

Location

 

Value

 

Asset Derivatives Designated as Hedges

 

 

 

 

 

 

 

 

 

 

Foreign exchange forward contracts

 

Other current assets

 

$

66.3

 

 

Other current assets

 

$

58.4

 

Cross-currency interest rate swaps

 

Other current assets

 

 

-

 

 

Other current assets

 

 

-

 

Foreign exchange forward contracts

 

Other assets

 

 

21.2

 

 

Other assets

 

 

17.2

 

Cross-currency interest rate swaps

 

Other assets

 

 

27.3

 

 

Other assets

 

 

5.4

 

Total asset derivatives

 

 

 

$

114.8

 

 

 

 

$

81.0

 

 

 

 

 

 

 

 

 

 

 

Asset Derivatives Not Designated as Hedges

 

 

 

 

 

 

 

 

 

 

Foreign exchange forward contracts

 

Other current assets

 

$

3.7

 

 

Other current assets

 

$

1.2

 

 

 

 

 

 

 

 

 

 

 

Liability Derivatives Designated as Hedges

 

 

 

 

 

 

 

 

 

 

Foreign exchange forward contracts

 

Other current liabilities

 

$

8.5

 

 

Other current liabilities

 

$

13.9

 

Cross-currency interest rate swaps

 

Other current liabilities

 

 

35.0

 

 

Other current liabilities

 

 

33.3

 

Foreign exchange forward contracts

 

Other long-term liabilities

 

 

6.3

 

 

Other long-term liabilities

 

 

11.0

 

Cross-currency interest rate swaps

 

Other long-term liabilities

 

 

8.8

 

 

Other long-term liabilities

 

 

34.8

 

Interest rate swaps

 

Other long-term liabilities

 

 

163.8

 

 

Other long-term liabilities

 

 

144.7

 

Total liability derivatives

 

 

 

$

222.4

 

 

 

 

$

237.7

 

 

 

 

 

 

 

 

 

 

 

Liability Derivatives Not Designated as Hedges

 

 

 

 

 

 

 

 

 

 

Foreign exchange forward contracts

 

Other current liabilities

 

$

2.8

 

 

Other current liabilities

 

$

2.4

 
Schedule of Effects of Master Netting Agreements on Condensed Consolidated Balance Sheets

The table below presents the effects of our master netting agreements on our condensed consolidated balance sheets (in millions):

 

 

 

 

As of March 31, 2024

 

 

As of December 31, 2023

 

Description

 

Location

 

Gross
Amount

 

 

Offset

 

 

Net Amount in
Balance Sheet

 

 

Gross
Amount

 

 

Offset

 

 

Net Amount in
Balance Sheet

 

Asset Derivatives

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cash flow hedges

 

Other current assets

 

$

66.3

 

 

$

8.4

 

 

$

57.9

 

 

$

58.4

 

 

$

13.0

 

 

$

45.4

 

Cash flow hedges

 

Other assets

 

 

21.2

 

 

 

4.7

 

 

 

16.5

 

 

 

17.2

 

 

 

8.2

 

 

 

9.0

 

Derivatives Not Designated as Hedges

 

Other current assets

 

 

3.7

 

 

 

1.3

 

 

 

2.4

 

 

 

1.2

 

 

 

0.8

 

 

 

0.4

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Liability Derivatives

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cash flow hedges

 

Other current liabilities

 

 

8.5

 

 

 

8.4

 

 

 

0.1

 

 

 

13.9

 

 

 

13.0

 

 

 

0.9

 

Cash flow hedges

 

Other long-term liabilities

 

 

6.3

 

 

 

4.7

 

 

 

1.6

 

 

 

11.0

 

 

 

8.2

 

 

 

2.8

 

Derivatives Not Designated as Hedges

 

Other current liabilities

 

 

2.8

 

 

 

1.3

 

 

 

1.5

 

 

 

2.4

 

 

 

0.8

 

 

 

1.6

 
Net Investment Hedge Gains Recognized on Condensed Consolidated Statements of Comprehensive Income

The following net investment hedge gains (losses) were recognized on our condensed consolidated statements of comprehensive income (in millions):

 

 

Amount of Gain (Loss)

 

 

 

Recognized in AOCI

 

 

 

Three Months Ended

 

 

 

March 31,

 

Derivative Instrument

 

2024

 

 

2023

 

Euro Notes

 

$

24.4

 

 

$

(19.2

)

Cross-currency interest rate swaps

 

 

46.1

 

 

 

(4.5

)

 

 

$

70.5

 

 

$

(23.7

)
XML 43 R36.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Earnings Per Share (Tables)
 3 Months Ended
Mar. 31, 2024
Earnings Per Share [Abstract]  
Reconciliation of Weighted Average Shares for Basic and Diluted Shares Computations

The following is a reconciliation of weighted average shares for the basic and diluted shares computations (in millions):

 

 

Three Months Ended

 

 

 

March 31,

 

 

 

2024

 

 

2023

 

Weighted average shares outstanding for basic net earnings per share

 

 

205.2

 

 

 

209.4

 

Effect of dilutive stock options and other equity awards

 

 

1.0

 

 

 

1.0

 

Weighted average shares outstanding for diluted net earnings per share

 

 

206.2

 

 

 

210.4

 
XML 44 R37.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Segment Information (Tables)
 3 Months Ended
Mar. 31, 2024
Segment Reporting [Abstract]  
Summary of Net sales and Operating Profit by Segment

Net sales and operating profit by segment are as follows (in millions):

 

 

 

Net Sales

 

 

Operating Profit

 

 

 

Three Months Ended

 

 

Three Months Ended

 

 

 

March 31,

 

 

March 31,

 

 

 

2024

 

 

2023

 

 

2024

 

 

2023

 

Americas

 

$

1,186.5

 

 

$

1,141.3

 

 

$

639.3

 

 

$

608.9

 

EMEA

 

 

444.8

 

 

 

425.6

 

 

 

153.0

 

 

 

149.5

 

Asia Pacific

 

 

258.0

 

 

 

264.1

 

 

 

93.3

 

 

 

90.2

 

Total

 

$

1,889.2

 

 

$

1,831.0

 

 

 

 

 

 

 

Corporate items

 

 

 

 

 

 

 

 

(477.6

)

 

 

(387.9

)

Intangible asset amortization

 

 

 

 

 

 

 

 

(142.1

)

 

 

(133.4

)

Operating profit

 

 

 

 

 

 

 

$

265.9

 

 

$

327.3

 
XML 45 R38.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Discontinued Operations and Related ZimVie Matters - Additional Information (Details) - USD ($)
Mar. 31, 2024
Dec. 31, 2023
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]    
Aggregate principal amount $ 5,900,000,000  
Accounts receivable, less allowance for credit losses 1,446,400,000 $ 1,442,400,000
Retained earnings $ 10,509,000,000 $ 10,384,500,000
XML 46 R39.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Revenue - Schedule of Net Sales by Geography (Detail) - USD ($)
$ in Millions
 3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Sales Information [Line Items]    
Net Sales $ 1,889.2 $ 1,831.0
US [Member]    
Sales Information [Line Items]    
Net Sales 1,099.2 1,060.4
International [Member]    
Sales Information [Line Items]    
Net Sales $ 790.0 $ 770.6
XML 47 R40.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Revenue - Schedule of Net Sales by Product Category (Detail) - USD ($)
$ in Millions
 3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Entity Wide Information Revenue From External Customer [Line Items]    
Net Sales $ 1,889.2 $ 1,831.0
Knees [Member]    
Entity Wide Information Revenue From External Customer [Line Items]    
Net Sales 788.1 762.5
Hips [Member]    
Entity Wide Information Revenue From External Customer [Line Items]    
Net Sales 491.2 492.8
S.E.T [Member]    
Entity Wide Information Revenue From External Customer [Line Items]    
Net Sales 452.6 433.4
Other [Member]    
Entity Wide Information Revenue From External Customer [Line Items]    
Net Sales $ 157.3 $ 142.3
XML 48 R41.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Restructuring - Additional Information (Detail) - USD ($)
$ in Millions
Mar. 31, 2024
Dec. 31, 2023
Dec. 31, 2021
Dec. 31, 2019
2023 Restructuring Plan [Member]        
Restructuring Cost And Reserve [Line Items]        
Pre-tax restructuring charges $ 120.0 $ 120.0    
2021 Restructuring Plan [Member]        
Restructuring Cost And Reserve [Line Items]        
Pre-tax restructuring charges 180.0   $ 180.0  
2019 Restructuring Plan [Member]        
Restructuring Cost And Reserve [Line Items]        
Pre-tax restructuring charges $ 370.0     $ 370.0
XML 49 R42.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Restructuring - Summary of Liabilities Recognized Related to Restructuring Plan (Detail) - USD ($)
$ in Millions
 3 Months Ended
Mar. 31, 2024
Dec. 31, 2023
Dec. 31, 2021
Dec. 31, 2019
2023 Restructuring Plan [Member]        
Restructuring Cost And Reserve [Line Items]        
Beginning Balance $ 14.2      
Expenses 79.6      
Cash payments (24.8)      
Foreign currency exchange rate changes (0.4)      
Non-cash activity 1.2      
Ending Balance 69.8      
Expense incurred since the start of the Restructuring Plan 92.4      
Expense estimated to be recognized for the Restructuring Plan 120.0 $ 120.0    
2023 Restructuring Plan [Member] | Employee Termination Benefits [Member]        
Restructuring Cost And Reserve [Line Items]        
Beginning Balance 9.2      
Expenses 71.0      
Cash payments (23.5)      
Foreign currency exchange rate changes (0.4)      
Ending Balance 56.3      
Expense incurred since the start of the Restructuring Plan 80.2      
Expense estimated to be recognized for the Restructuring Plan 90.0      
2023 Restructuring Plan [Member] | Contract Termination [Member]        
Restructuring Cost And Reserve [Line Items]        
Expenses 1.8      
Ending Balance 1.8      
Expense incurred since the start of the Restructuring Plan 1.8      
Expense estimated to be recognized for the Restructuring Plan 10.0      
2023 Restructuring Plan [Member] | Other Restructuring [Member]        
Restructuring Cost And Reserve [Line Items]        
Beginning Balance 5.0      
Expenses 6.8      
Cash payments (1.3)      
Non-cash activity 1.2      
Ending Balance 11.7      
Expense incurred since the start of the Restructuring Plan 10.4      
Expense estimated to be recognized for the Restructuring Plan 20.0      
2021 Restructuring Plan [Member]        
Restructuring Cost And Reserve [Line Items]        
Beginning Balance 24.7      
Expenses 0.9      
Cash payments (9.6)      
Foreign currency exchange rate changes (0.5)      
Ending Balance 15.5      
Expense incurred since the start of the Restructuring Plan 170.0      
Expense estimated to be recognized for the Restructuring Plan 180.0   $ 180.0  
2021 Restructuring Plan [Member] | Employee Termination Benefits [Member]        
Restructuring Cost And Reserve [Line Items]        
Beginning Balance 4.2      
Expenses (0.4)      
Cash payments (0.8)      
Foreign currency exchange rate changes (0.1)      
Ending Balance 2.9      
Expense incurred since the start of the Restructuring Plan 58.7      
Expense estimated to be recognized for the Restructuring Plan 60.0      
2021 Restructuring Plan [Member] | Contract Termination [Member]        
Restructuring Cost And Reserve [Line Items]        
Beginning Balance 17.6      
Cash payments (7.3)      
Foreign currency exchange rate changes (0.4)      
Ending Balance 9.9      
Expense incurred since the start of the Restructuring Plan 73.8      
Expense estimated to be recognized for the Restructuring Plan 80.0      
2021 Restructuring Plan [Member] | Other Restructuring [Member]        
Restructuring Cost And Reserve [Line Items]        
Beginning Balance 2.9      
Expenses 1.3      
Cash payments (1.5)      
Ending Balance 2.7      
Expense incurred since the start of the Restructuring Plan 37.5      
Expense estimated to be recognized for the Restructuring Plan 40.0      
2019 Restructuring Plan [Member]        
Restructuring Cost And Reserve [Line Items]        
Beginning Balance 52.3      
Expenses 17.0      
Cash payments (4.0)      
Foreign currency exchange rate changes (0.5)      
Ending Balance 64.8      
Expense incurred since the start of the Restructuring Plan 336.4      
Expense estimated to be recognized for the Restructuring Plan 370.0     $ 370.0
2019 Restructuring Plan [Member] | Employee Termination Benefits [Member]        
Restructuring Cost And Reserve [Line Items]        
Beginning Balance 43.8      
Expenses 14.7      
Foreign currency exchange rate changes (0.5)      
Ending Balance 58.0      
Expense incurred since the start of the Restructuring Plan 140.4      
Expense estimated to be recognized for the Restructuring Plan 155.0      
2019 Restructuring Plan [Member] | Contract Termination [Member]        
Restructuring Cost And Reserve [Line Items]        
Beginning Balance 5.6      
Cash payments (0.5)      
Ending Balance 5.1      
Expense incurred since the start of the Restructuring Plan 35.0      
Expense estimated to be recognized for the Restructuring Plan 35.0      
2019 Restructuring Plan [Member] | Other Restructuring [Member]        
Restructuring Cost And Reserve [Line Items]        
Beginning Balance 2.9      
Expenses 2.3      
Cash payments (3.5)      
Ending Balance 1.7      
Expense incurred since the start of the Restructuring Plan 161.0      
Expense estimated to be recognized for the Restructuring Plan $ 180.0      
XML 50 R43.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Restructuring - Summary of Location on Condensed Consolidated Statement of Earnings and Type of Cost for Restructuring Plan (Detail) - USD ($)
$ in Millions
 3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Restructuring Cost and Reserve [Line Items]    
Cost of products sold, excluding intangible asset amortization $ 512.3 $ 500.8
Type of Cost, Good or Service [Extensible List] us-gaap:ProductMember us-gaap:ProductMember
Restructuring and other cost reduction initiatives $ 124.4 $ 41.8
2019 Restructuring Plan [Member]    
Restructuring Cost and Reserve [Line Items]    
Cost of products sold, excluding intangible asset amortization $ 0.5  
Type of Cost, Good or Service [Extensible List] us-gaap:ProductMember  
Restructuring and other cost reduction initiatives $ 16.5  
Total 17.0  
Employee Termination Benefits [Member] | 2019 Restructuring Plan [Member]    
Restructuring Cost and Reserve [Line Items]    
Restructuring and other cost reduction initiatives 14.7  
Total 14.7  
Other Restructuring [Member] | 2019 Restructuring Plan [Member]    
Restructuring Cost and Reserve [Line Items]    
Cost of products sold, excluding intangible asset amortization $ 0.5  
Type of Cost, Good or Service [Extensible List] us-gaap:ProductMember  
Restructuring and other cost reduction initiatives $ 1.8  
Total $ 2.3  
XML 51 R44.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Inventories - Summary of Inventories (Detail) - USD ($)
$ in Millions
Mar. 31, 2024
Dec. 31, 2023
Inventory Disclosure [Abstract]    
Finished goods $ 1,846.7 $ 1,831.2
Work in progress 226.7 246.5
Raw materials 314.8 307.5
Inventories $ 2,388.2 $ 2,385.2
XML 52 R45.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Property, Plant and Equipment - Summary of Property, Plant and Equipment (Detail) - USD ($)
$ in Millions
Mar. 31, 2024
Dec. 31, 2023
Property, Plant and Equipment [Line Items]    
Property, plant and equipment, Gross $ 6,849.1 $ 6,766.2
Accumulated depreciation (4,758.2) (4,705.8)
Property, plant and equipment, net 2,090.9 2,060.4
Land [Member]    
Property, Plant and Equipment [Line Items]    
Property, plant and equipment, Gross 18.8 18.9
Buildings And Equipment [Member]    
Property, Plant and Equipment [Line Items]    
Property, plant and equipment, Gross 2,254.1 2,245.9
Capitalized Software Costs [Member]    
Property, Plant and Equipment [Line Items]    
Property, plant and equipment, Gross 555.2 552.2
Instruments [Member]    
Property, Plant and Equipment [Line Items]    
Property, plant and equipment, Gross 3,814.6 3,748.6
Construction in Progress [Member]    
Property, Plant and Equipment [Line Items]    
Property, plant and equipment, Gross $ 206.4 $ 200.6
XML 53 R46.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Property, Plant and Equipment - Additional Information (Detail) - USD ($)
$ in Millions
 3 Months Ended 12 Months Ended
Mar. 31, 2024
Dec. 31, 2023
Property, Plant and Equipment [Abstract]    
Property plant and equipment included in accounts payable $ 25.3 $ 30.8
XML 54 R47.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Acquisitions - Additional Information (Detail) - USD ($)
$ / shares in Units, shares in Millions, $ in Millions
 3 Months Ended 12 Months Ended
Nov. 15, 2023
Oct. 06, 2023
Apr. 28, 2023
Feb. 14, 2023
Mar. 31, 2024
Mar. 31, 2023
Dec. 31, 2023
Business Acquisition [Line Items]              
Deferred business combination payments made         $ 1.5 $ 0.0  
Technology [Member]              
Business Acquisition [Line Items]              
Weighted average amortization period of intangible assets             15 years
Customer Relationships [Member]              
Business Acquisition [Line Items]              
Weighted average amortization period of intangible assets             8 years
Trademarks And Trade Names [Member]              
Business Acquisition [Line Items]              
Weighted average amortization period of intangible assets             13 years
Embody, Inc.              
Business Acquisition [Line Items]              
Acquisition date       Feb. 14, 2023      
Cash payments to acquire businesses       $ 19.5      
Total consideration transferred at the acquisition dates       154.5      
Contingent consideration       $ 94.0      
Embody, Inc. | Common Stock [Member]              
Business Acquisition [Line Items]              
Issuance of common stock for acquisition       1.1      
Issuance of common stock for acquisition, valued       $ 135.0      
Fair value of common stock at the acquisition date       $ 127.34      
Embody, Inc. | Common Stock [Member] | Maximum              
Business Acquisition [Line Items]              
Contingent consideration       $ 120.0      
Embody, Inc. | In-process Research and Development (IPR&D) [Member]              
Business Acquisition [Line Items]              
IPR&D           $ 36.3  
2023 Acquisitions [Member] | Technology [Member]              
Business Acquisition [Line Items]              
Intangible assets subject to amortization             $ 144.0
2023 Acquisitions [Member] | Customer Relationships [Member]              
Business Acquisition [Line Items]              
Intangible assets subject to amortization             40.1
2023 Acquisitions [Member] | Trademarks And Trade Names [Member]              
Business Acquisition [Line Items]              
Intangible assets subject to amortization             $ 3.5
April Acquisition [Member]              
Business Acquisition [Line Items]              
Acquisition date     Apr. 28, 2023        
Cash payments to acquire businesses     $ 15.0        
April Acquisition [Member] | Maximum              
Business Acquisition [Line Items]              
Contingent consideration     $ 8.0        
October 2023 acquisition [Member]              
Business Acquisition [Line Items]              
Acquisition date   Oct. 06, 2023          
Cash payments to acquire businesses   $ 42.2          
Contingent consideration   21.5          
October 2023 acquisition [Member] | Maximum              
Business Acquisition [Line Items]              
Contingent consideration   $ 33.0          
November 2023 acquisition [Member]              
Business Acquisition [Line Items]              
Acquisition date Nov. 15, 2023            
Cash payments to acquire businesses $ 60.7            
Contingent consideration 15.0            
November 2023 acquisition [Member] | Maximum              
Business Acquisition [Line Items]              
Contingent consideration $ 20.0            
XML 55 R48.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Acquisitions - Summary of Estimates of Fair Value of Assets Acquired and Liabilities Assumed (Details) - USD ($)
$ in Millions
Mar. 31, 2024
Dec. 31, 2023
Business Acquisition [Line Items]    
Goodwill $ 8,791.5 $ 8,818.5
2023 Acquisitions [Member]    
Business Acquisition [Line Items]    
Current assets   13.1
Goodwill   215.0
Other assets   4.8
Total assets acquired   456.8
Current liabilities   8.2
Deferred income taxes   37.7
Total liabilities assumed   45.9
Net assets acquired   410.9
2023 Acquisitions [Member] | Technology [Member]    
Business Acquisition [Line Items]    
Intangible assets subject to amortization   144.0
2023 Acquisitions [Member] | Trademarks and Trade Names [Member]    
Business Acquisition [Line Items]    
Intangible assets subject to amortization   3.5
2023 Acquisitions [Member] | Customer Relationships [Member]    
Business Acquisition [Line Items]    
Intangible assets subject to amortization   40.1
2023 Acquisitions [Member] | In-process Research and Development (IPR&D) [Member]    
Business Acquisition [Line Items]    
Intangible assets not subject to amortization   $ 36.3
XML 56 R49.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Debt - Summary of Debt Instruments (Detail)
€ in Billions
Mar. 31, 2024
USD ($)
Mar. 31, 2024
EUR (€)
Dec. 31, 2023
USD ($)
Current portion of long-term debt      
Total current portion of long-term debt $ 970,000,000   $ 900,000,000
Long-term debt      
Senior Notes due 5,900,000,000    
Debt discount and issuance costs (27,400,000)   (29,100,000)
Adjustment related to interest rate swaps (163,700,000)   (144,700,000)
Total long-term debt 4,826,200,000   4,867,900,000
Uncommitted Credit Facility [Member]      
Current portion of long-term debt      
Outstanding borrowings 120,000,000   50,000,000
Senior Notes [Member] | 1.450% [Member] | Due in 2024 [Member]      
Long-term debt      
Senior Notes due 850,000,000   850,000,000
Senior Notes [Member] | 3.550% [Member] | Due in 2025 [Member]      
Long-term debt      
Senior Notes due 863,000,000   863,000,000
Senior Notes [Member] | 3.550% [Member] | Due in 2030 [Member]      
Long-term debt      
Senior Notes due 257,500,000   257,500,000
Senior Notes [Member] | 3.050% [Member] | Due in 2026 [Member]      
Long-term debt      
Senior Notes due 600,000,000   600,000,000
Senior Notes [Member] | 5.350% [Member] | Due in 2028 [Member]      
Long-term debt      
Senior Notes due 500,000,000   500,000,000
Senior Notes [Member] | 2.600% [Member] | Due in 2031 [Member]      
Long-term debt      
Senior Notes due 750,000,000   750,000,000
Senior Notes [Member] | 4.250% [Member] | Due in 2035 [Member]      
Long-term debt      
Senior Notes due 253,400,000   253,400,000
Senior Notes [Member] | 5.750% [Member] | Due in 2039 [Member]      
Long-term debt      
Senior Notes due 317,800,000   317,800,000
Senior Notes [Member] | 4.450% [Member] | Due in 2045 [Member]      
Long-term debt      
Senior Notes due 395,400,000   395,400,000
Euro Notes [Member]      
Long-term debt      
Term loan | €   € 1.0  
Euro Notes [Member] | 2.425% [Member] | Due in 2026 [Member]      
Long-term debt      
Term loan 540,100,000   552,300,000
Euro Notes [Member] | 1.164% [Member] | Due in 2027 [Member]      
Long-term debt      
Term loan $ 540,100,000   $ 552,300,000
XML 57 R50.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Debt - Summary of Debt Instruments (Parenthetical) (Detail)
Mar. 31, 2024
Dec. 31, 2023
1.450% [Member] | Due in 2024 [Member] | Senior Notes [Member]    
Debt Instrument [Line Items]    
Interest rate 1.45% 1.45%
3.550% [Member] | Due in 2025 [Member] | Senior Notes [Member]    
Debt Instrument [Line Items]    
Interest rate 3.55% 3.55%
3.550% [Member] | Due in 2030 [Member] | Senior Notes [Member]    
Debt Instrument [Line Items]    
Interest rate 3.55% 3.55%
3.050% [Member] | Due in 2026 [Member] | Senior Notes [Member]    
Debt Instrument [Line Items]    
Interest rate 3.05% 3.05%
5.350% [Member] | Due in 2028 [Member] | Senior Notes [Member]    
Debt Instrument [Line Items]    
Interest rate 5.35% 5.35%
2.600% [Member] | Due in 2031 [Member] | Senior Notes [Member]    
Debt Instrument [Line Items]    
Interest rate 2.60% 2.60%
4.250% [Member] | Due in 2035 [Member] | Senior Notes [Member]    
Debt Instrument [Line Items]    
Interest rate 4.25% 4.25%
5.750% [Member] | Due in 2039 [Member] | Senior Notes [Member]    
Debt Instrument [Line Items]    
Interest rate 5.75% 5.75%
4.450% [Member] | Due in 2045 [Member] | Senior Notes [Member]    
Debt Instrument [Line Items]    
Interest rate 4.45% 4.45%
2.425% [Member] | Due in 2026 [Member] | Euro Notes [Member]    
Debt Instrument [Line Items]    
Interest rate 2.425% 2.425%
1.164% [Member] | Due in 2027 [Member] | Euro Notes [Member]    
Debt Instrument [Line Items]    
Interest rate 1.164% 1.164%
XML 58 R51.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Debt - Additional Information (Detail)
€ in Billions
 3 Months Ended
Jul. 07, 2023
USD ($)
Aug. 19, 2022
USD ($)
Mar. 31, 2024
USD ($)
Mar. 31, 2023
USD ($)
Mar. 31, 2024
EUR (€)
Dec. 31, 2023
USD ($)
Aug. 28, 2023
USD ($)
Debt Instrument [Line Items]              
Debt, long-term and short-term, combined amount     $ 5,800,000,000        
Aggregate principal amount     5,900,000,000        
Other debt and fair value adjustments, total     163,700,000        
Debt discount and issuance costs     $ 27,400,000     $ 29,100,000  
Line of credit facility maturity description     underlying notes that have maturities of three months or less        
Estimated fair value     $ 5,553,800,000        
2022 Five-Year Credit Agreement [Member]              
Debt Instrument [Line Items]              
Outstanding borrowings $ 520,000,000            
2022 Five-Year Credit Agreement [Member] | Minimum [Member]              
Debt Instrument [Line Items]              
Consolidated EBITDA ratio thereafter     1.00%   1.00%    
2023 Five-Year Credit Agreement [Member] | Maximum [Member]              
Debt Instrument [Line Items]              
Consolidated EBITDA ratio     4.50%   4.50%    
Consolidated EBITDA ratio thereafter     5.00%   5.00%    
2023 Five-Year Credit Agreement [Member] | Minimum [Member]              
Debt Instrument [Line Items]              
Consolidated EBITDA ratio     1.00%   1.00%    
2022 364-Day Revolving Credit Agreement [Member]              
Debt Instrument [Line Items]              
Outstanding borrowings   $ 0          
Debt instrument   1,000,000,000          
2023 364-Day Revolving Credit Agreement [Member]              
Debt Instrument [Line Items]              
Outstanding borrowings     $ 0        
Maturity date of debt instrument     Jul. 05, 2024        
Debt instrument     $ 1,000,000,000        
2023 364-Day Revolving Credit Agreement [Member] | Maximum [Member]              
Debt Instrument [Line Items]              
Consolidated EBITDA ratio     4.50%   4.50%    
Consolidated EBITDA ratio thereafter     5.00%   5.00%    
2023 364-Day Revolving Credit Agreement [Member] | Minimum [Member]              
Debt Instrument [Line Items]              
Consolidated EBITDA ratio     1.00%   1.00%    
Consolidated EBITDA ratio thereafter     1.00%   1.00%    
Uncommitted Credit Facility [Member]              
Debt Instrument [Line Items]              
Outstanding borrowings     $ 120,000,000     $ 50,000,000  
Debt instrument             $ 300,000,000
Line of credit fair value     $ 120,000,000        
Euro Notes [Member]              
Debt Instrument [Line Items]              
Term loan | €         € 1.0    
Senior Notes [Member] | 3.700% Senior Notes due 2023 | Due in 2023 [Member]              
Debt Instrument [Line Items]              
Redemption of outstanding principal amount       $ 86,300,000      
Interest rate       3.70%      
Multicurrency Revolving Facility [Member] | 2022 Five-Year Credit Agreement [Member]              
Debt Instrument [Line Items]              
Debt instrument   $ 1,500,000,000          
Debt instrument, term   5 years          
Multicurrency Revolving Facility [Member] | 2023 Five-Year Credit Agreement [Member]              
Debt Instrument [Line Items]              
Maturity date of debt instrument Jul. 07, 2028            
Debt instrument $ 1,500,000,000            
Debt instrument, term 5 years            
Uncommitted incremental feature $ 500,000,000            
Short-Term Term Loan [Member]              
Debt Instrument [Line Items]              
Redemption of outstanding principal amount       $ 83,000,000      
Noncash financing activity       49,100,000      
Short-Term Term Loan [Member] | Cash [Member]              
Debt Instrument [Line Items]              
Redemption of outstanding principal amount       $ 33,900,000      
XML 59 R52.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Accumulated Other Comprehensive Income - Changes in Components of Accumulated Other Comprehensive Income, Net of Tax (Detail)
$ in Millions
 3 Months Ended
Mar. 31, 2024
USD ($)
Other Comprehensive Income Loss [Line Items]  
Stockholders equity, beginning balance $ 12,480.5
AOCI before reclassifications (1.1)
Reclassifications to statements of earnings (19.1)
Stockholders equity, ending balance 12,598.0
Cash Flow Hedges [Member]  
Other Comprehensive Income Loss [Line Items]  
Stockholders equity, beginning balance 63.3
AOCI before reclassifications 34.7
Reclassifications to statements of earnings (18.0)
Stockholders equity, ending balance 80.0
Foreign Currency Translation [Member]  
Other Comprehensive Income Loss [Line Items]  
Stockholders equity, beginning balance (159.4)
AOCI before reclassifications (35.8)
Stockholders equity, ending balance (195.2)
Defined Benefit Plan Items [Member]  
Other Comprehensive Income Loss [Line Items]  
Stockholders equity, beginning balance (94.9)
Reclassifications to statements of earnings (1.1)
Stockholders equity, ending balance (96.0)
Total AOCI [Member]  
Other Comprehensive Income Loss [Line Items]  
Stockholders equity, beginning balance (191.0)
Stockholders equity, ending balance $ (211.2)
XML 60 R53.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Accumulated Other Comprehensive Income - Reclassification Adjustments from Accumulated Other Comprehensive Income (Detail) - USD ($)
$ in Millions
 3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Other Comprehensive Income Loss [Line Items]    
Cost of products sold $ 512.3 $ 500.8
Type of Cost, Good or Service [Extensible List] us-gaap:ProductMember us-gaap:ProductMember
Interest expense, net $ (50.7) $ (48.2)
Other (expense) income, net (0.1) 7.7
Earnings before income taxes 215.1 286.8
Provision (benefit) for income taxes 42.3 54.1
Reclassification out of Accumulated Other Comprehensive Income [Member]    
Other Comprehensive Income Loss [Line Items]    
Net of tax $ 19.1 $ 19.9
Reclassification out of Accumulated Other Comprehensive Income [Member] | Cash Flow Hedges [Member] | Foreign Exchange Forward Contracts [Member]    
Other Comprehensive Income Loss [Line Items]    
Type of Cost, Good or Service [Extensible List] us-gaap:ProductMember us-gaap:ProductMember
Reclassification out of Accumulated Other Comprehensive Income [Member] | Defined Benefit Plan Items [Member]    
Other Comprehensive Income Loss [Line Items]    
Provision (benefit) for income taxes $ 3.8 $ 3.9
Net of tax 1.1 0.9
Reclassification out of Accumulated Other Comprehensive Income [Member] | Defined Benefit Plan Items [Member] | Prior Service Cost and Unrecognized Actuarial Gain Loss [Member]    
Other Comprehensive Income Loss [Line Items]    
Other (expense) income, net 0.8 1.0
Reclassification out of Accumulated Other Comprehensive Income [Member] | Defined Benefit Plan Items [Member]    
Other Comprehensive Income Loss [Line Items]    
Earnings before income taxes 21.8 22.9
Provision (benefit) for income taxes (0.3) 0.1
Net of tax 18.0 19.0
Reclassification out of Accumulated Other Comprehensive Income [Member] | Defined Benefit Plan Items [Member] | Foreign Exchange Forward Contracts [Member]    
Other Comprehensive Income Loss [Line Items]    
Cost of products sold 22.0 23.1
Reclassification out of Accumulated Other Comprehensive Income [Member] | Defined Benefit Plan Items [Member] | Forward Starting Interest Rate Swaps [Member]    
Other Comprehensive Income Loss [Line Items]    
Interest expense, net $ (0.2) $ (0.2)
XML 61 R54.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Accumulated Other Comprehensive Income - Tax Effects on Each Component of Accumulated Other Comprehensive Income Recognized in Statements of Comprehensive Income (Detail) - USD ($)
$ in Millions
 3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Statement of Comprehensive Income [Abstract]    
Foreign currency cumulative translation adjustments, before tax $ (19.2) $ 7.5
Unrealized cash flow hedge gains, before tax 43.4 11.1
Reclassification adjustments on cash flow hedges, before tax (21.8) (22.9)
Adjustments to prior service cost and unrecognized actuarial assumptions, before tax (0.8) (1.0)
Total Other Comprehensive Income (Loss) 1.6 (5.3)
Foreign currency cumulative translation adjustments, tax 16.6 (4.9)
Unrealized cash flow hedge gains, tax 8.7 2.3
Reclassification adjustments on cash flow hedges, tax (3.8) (3.9)
Adjustments to prior service cost and unrecognized actuarial assumptions, tax 0.3 (0.1)
Total Other Comprehensive Income (Loss), tax 21.8 (6.6)
Foreign currency cumulative translation adjustments, net of tax (35.8) 12.4
Unrealized cash flow hedge gains, net of tax 34.7 8.8
Reclassification adjustments on cash flow hedges, net of tax (18.0) (19.0)
Adjustments to prior service cost and unrecognized actuarial assumptions, net of tax (1.1) (0.9)
Total Other Comprehensive Income (Loss) $ (20.2) $ 1.3
XML 62 R55.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Fair Value Measurement of Assets and Liabilities - Schedule of Fair Value Measurement of Asset and Liabilities (Detail) - USD ($)
$ in Millions
Mar. 31, 2024
Dec. 31, 2023
Derivatives Not Designated as Hedges [Member]    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Derivatives, current and long-term $ 1.5 $ 1.6
Derivative Liability, Statement of Financial Position [Extensible Enumeration] Other Liabilities, Current Other Liabilities, Current
Foreign Exchange Forward [Member] | Derivatives Not Designated as Hedges [Member]    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Derivatives, current and long-term $ 2.4 $ 0.4
Derivative Asset, Statement of Financial Position [Extensible Enumeration] Assets, Current Assets, Current
Fair Value, Measurements, Recurring [Member]    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Total Assets $ 104.1 $ 60.2
Contingent consideration related to acquisitions 115.2 141.7
Total Liabilities 326.0 359.8
Fair Value, Measurements, Recurring [Member] | Fair Value Measurements at Reporting Date Using: Significant Other Observable Inputs (Level 2) [Member]    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Total Assets 104.1 60.2
Total Liabilities 210.8 218.1
Fair Value, Measurements, Recurring [Member] | Fair Value Measurements at Reporting Date Using: Significant Unobservable Inputs (Level 3) [Member]    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Contingent consideration related to acquisitions 115.2 141.7
Total Liabilities 115.2 141.7
Fair Value, Measurements, Recurring [Member] | Cross-currency Interest Rate Swaps [Member] | Derivatives Designated as Hedges [Member]    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Derivatives, current and long-term $ 27.3 $ 5.4
Derivative Asset, Statement of Financial Position [Extensible Enumeration] Assets, Current, Other Assets, Noncurrent Assets, Current, Other Assets, Noncurrent
Derivatives, current and long-term $ 43.8 $ 68.1
Derivative Liability, Statement of Financial Position [Extensible Enumeration] Other Liabilities, Current, Other Liabilities, Noncurrent Other Liabilities, Current, Other Liabilities, Noncurrent
Fair Value, Measurements, Recurring [Member] | Cross-currency Interest Rate Swaps [Member] | Fair Value Measurements at Reporting Date Using: Significant Other Observable Inputs (Level 2) [Member] | Derivatives Designated as Hedges [Member]    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Derivatives, current and long-term $ 27.3 $ 5.4
Derivative Asset, Statement of Financial Position [Extensible Enumeration] Assets, Current, Other Assets, Noncurrent Assets, Current, Other Assets, Noncurrent
Derivatives, current and long-term $ 43.8 $ 68.1
Derivative Liability, Statement of Financial Position [Extensible Enumeration] Other Liabilities, Current, Other Liabilities, Noncurrent Other Liabilities, Current, Other Liabilities, Noncurrent
Fair Value, Measurements, Recurring [Member] | Interest Rate Swaps [Member] | Derivatives Designated as Hedges [Member]    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Derivatives, current and long-term $ 163.8 $ 144.7
Derivative Liability, Statement of Financial Position [Extensible Enumeration] Other Liabilities, Current, Other Liabilities, Noncurrent Other Liabilities, Current, Other Liabilities, Noncurrent
Fair Value, Measurements, Recurring [Member] | Interest Rate Swaps [Member] | Fair Value Measurements at Reporting Date Using: Significant Other Observable Inputs (Level 2) [Member] | Derivatives Designated as Hedges [Member]    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Derivatives, current and long-term $ 163.8 $ 144.7
Derivative Liability, Statement of Financial Position [Extensible Enumeration] Other Liabilities, Current, Other Liabilities, Noncurrent Other Liabilities, Current, Other Liabilities, Noncurrent
Fair Value, Measurements, Recurring [Member] | Foreign Exchange Forward [Member] | Derivatives Designated as Hedges [Member]    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Derivatives, current and long-term $ 74.4 $ 54.4
Derivative Asset, Statement of Financial Position [Extensible Enumeration] Assets, Current, Other Assets, Noncurrent Assets, Current, Other Assets, Noncurrent
Derivatives, current and long-term $ 1.7 $ 3.7
Derivative Liability, Statement of Financial Position [Extensible Enumeration] Other Liabilities, Current, Other Liabilities, Noncurrent Other Liabilities, Current, Other Liabilities, Noncurrent
Fair Value, Measurements, Recurring [Member] | Foreign Exchange Forward [Member] | Derivatives Not Designated as Hedges [Member]    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Derivatives, current and long-term $ 2.4 $ 0.4
Derivative Asset, Statement of Financial Position [Extensible Enumeration] Assets, Current, Other Assets, Noncurrent Assets, Current, Other Assets, Noncurrent
Derivatives, current and long-term $ 1.5 $ 1.6
Derivative Liability, Statement of Financial Position [Extensible Enumeration] Other Liabilities, Current, Other Liabilities, Noncurrent Other Liabilities, Current, Other Liabilities, Noncurrent
Fair Value, Measurements, Recurring [Member] | Foreign Exchange Forward [Member] | Fair Value Measurements at Reporting Date Using: Significant Other Observable Inputs (Level 2) [Member] | Derivatives Designated as Hedges [Member]    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Derivatives, current and long-term $ 74.4 $ 54.4
Derivative Asset, Statement of Financial Position [Extensible Enumeration] Assets, Current, Other Assets, Noncurrent Assets, Current, Other Assets, Noncurrent
Derivatives, current and long-term $ 1.7 $ 3.7
Derivative Liability, Statement of Financial Position [Extensible Enumeration] Other Liabilities, Current, Other Liabilities, Noncurrent Other Liabilities, Current, Other Liabilities, Noncurrent
Fair Value, Measurements, Recurring [Member] | Foreign Exchange Forward [Member] | Fair Value Measurements at Reporting Date Using: Significant Other Observable Inputs (Level 2) [Member] | Derivatives Not Designated as Hedges [Member]    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Derivatives, current and long-term $ 2.4 $ 0.4
Derivative Asset, Statement of Financial Position [Extensible Enumeration] Assets, Current, Other Assets, Noncurrent Assets, Current, Other Assets, Noncurrent
Derivatives, current and long-term $ 1.5 $ 1.6
Derivative Liability, Statement of Financial Position [Extensible Enumeration] Other Liabilities, Current, Other Liabilities, Noncurrent Other Liabilities, Current, Other Liabilities, Noncurrent
XML 63 R56.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Fair Value Measurement of Assets and Liabilities - Additional Information (Details) - USD ($)
$ / shares in Units, shares in Millions, $ in Millions
 3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Business combination contingent consideration payments $ 1.5 $ 9.6
Common Stock [Member] | Embody, Inc.    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Issuance of common stock for contingent consideration liability 0.2  
Issuance of common stock for contingent consideration liability, valued $ 23.4  
Business combination contingent consideration payments $ 1.5  
Fair value of common stock at the settlement date $ 123.87  
Shares of common stock repurchased 0.2  
XML 64 R57.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Fair Value Measurement of Assets and Liabilities - Schedule of Fair Value Liabilities Measured on Recurring Basis (Detail)
$ in Millions
 3 Months Ended
Mar. 31, 2024
USD ($)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]  
Fair Value, Liability, Recurring Basis, Unobservable Input Reconciliation, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration] Acquisition Integration Divestiture And Related Expenses
Fair Value Measurements at Reporting Date Using: Significant Unobservable Inputs (Level 3) [Member] | Fair Value, Measurements, Recurring [Member]  
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]  
Beginning balance December 31, 2023 $ 141.7
Change in estimates (1.6)
Settlements (24.9)
Ending balance March 31, 2024 $ 115.2
XML 65 R58.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Derivative Instruments and Hedging Activities - Schedule of Amounts Recorded On Balance Sheet Related To Cumulative Basis Adjustments For Fair Value Hedges (Detail) - USD ($)
$ in Millions
Mar. 31, 2024
Dec. 31, 2023
Carrying Amount of Hedged Liabilities [Member]    
Derivative Instruments, Gain (Loss) [Line Items]    
Long-term debt $ 832.3 $ 851.3
Cumulative Amount of Fair Value Hedging Adjustment Included in Carrying Amount of Hedged Liabilities [Member] | Long Term Debt Noncurrent [Member]    
Derivative Instruments, Gain (Loss) [Line Items]    
Long-term debt $ (163.7) $ (144.7)
XML 66 R59.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Derivative Instruments and Hedging Activities - Additional Information (Detail)
€ in Millions, SFr in Millions, ¥ in Billions
 3 Months Ended
Mar. 31, 2024
USD ($)
Mar. 31, 2023
USD ($)
Mar. 31, 2024
EUR (€)
Mar. 31, 2024
JPY (¥)
Mar. 31, 2024
CHF (SFr)
Mar. 31, 2023
EUR (€)
Mar. 31, 2023
CHF (SFr)
Derivative Instruments Gain Loss [Line Items]              
Forward starting interest rate swap cash flow hedge to be amortized $ 23,700,000            
Percentage of debt designated as net investment hedges 100.00%            
Expected months of hedging of inter company sales of inventory to minimize the effects of foreign exchange rate movements 30 months            
Fair value of outstanding derivative instruments, net unrealized gain deferred in accumulated other comprehensive income $ 93,100,000            
Gains (losses) on derivatives (12,200,000) $ 400,000          
Cost of Products Sold [Member]              
Derivative Instruments Gain Loss [Line Items]              
Fair value of outstanding derivative instruments, gain, expected to be reclassified to earnings 75,200,000            
Fair value of outstanding derivative instruments, gain (loss), net of taxes expected to be reclassified to earnings 62,000,000            
Interest Expense [Member]              
Derivative Instruments Gain Loss [Line Items]              
Fair value of outstanding derivative instruments, gain (loss), net of taxes expected to be reclassified to earnings (500,000)            
Fair value of outstanding derivative instruments, loss, expected to be reclassified to earnings (700,000)            
Cash Flow Hedges [Member]              
Derivative Instruments Gain Loss [Line Items]              
Fair value of outstanding derivative instruments, unrealized gain net of taxes deferred in accumulated other comprehensive income 79,900,000            
Cross-currency Interest Rate Swaps [Member]              
Derivative Instruments Gain Loss [Line Items]              
Derivative notional amount, Total     € 700 ¥ 54.1 SFr 125    
Cross-Currency Interest Rate Swaps Matured [Member]              
Derivative Instruments Gain Loss [Line Items]              
Derivative notional amount, Total 0         € 100 SFr 50
Net investment hedge gain at maturity   6,000,000          
Net investment hedge loss at maturity   $ 3,000,000          
Derivatives Not Designated as Hedges [Member] | Foreign Exchange Contract [Member] | Minimum [Member]              
Derivative Instruments Gain Loss [Line Items]              
Derivative notional amount, Total 1,250,000,000            
Derivatives Not Designated as Hedges [Member] | Foreign Exchange Contract [Member] | Maximum [Member]              
Derivative Instruments Gain Loss [Line Items]              
Derivative notional amount, Total 1,750,000,000            
U.S. Dollars [Member] | Foreign Exchange Contract [Member]              
Derivative Instruments Gain Loss [Line Items]              
Derivative notional amount, Total 1,526,700,000            
Swiss Francs [Member] | Foreign Exchange Contract [Member]              
Derivative Instruments Gain Loss [Line Items]              
Derivative notional amount, Total $ 435,400,000            
4.450% [Member] | Senior Notes [Member] | Due in 2045 [Member]              
Derivative Instruments Gain Loss [Line Items]              
Hedged senior notes maturity period 30 years            
XML 67 R60.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Derivative Instruments and Hedging Activities - Gross Unrealized Losses from Derivative Instruments (Detail) - USD ($)
$ in Millions
 3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Derivative Instruments Gain Loss [Line Items]    
Amount of Gain / (Loss) Recognized in AOCI $ 43.4 $ 11.1
Cash Flow Hedges [Member]    
Derivative Instruments Gain Loss [Line Items]    
Amount of Gain / (Loss) Recognized in AOCI 43.4 11.1
Amount of Gain / (Loss) Reclassified from AOCI 21.8 22.9
Cash Flow Hedges [Member] | Foreign Exchange Forward Contracts [Member]    
Derivative Instruments Gain Loss [Line Items]    
Amount of Gain / (Loss) Recognized in AOCI 43.4 11.1
Amount of Gain / (Loss) Reclassified from AOCI $ 22.0 $ 23.1
Derivative Instrument, Gain (Loss) Reclassified from AOCI into Income, Effective Portion, Statement of Income or Comprehensive Income [Extensible Enumeration] Cost of Goods and Services Sold Cost of Goods and Services Sold
Cash Flow Hedges [Member] | Forward Starting Interest Rate Swaps [Member]    
Derivative Instruments Gain Loss [Line Items]    
Amount of Gain / (Loss) Reclassified from AOCI $ (0.2) $ (0.2)
Derivative Instrument, Gain (Loss) Reclassified from AOCI into Income, Effective Portion, Statement of Income or Comprehensive Income [Extensible Enumeration] Interest Income (Expense), Net Interest Income (Expense), Net
XML 68 R61.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Derivative Instruments and Hedging Activities - Effects of Fair Value, Cash Flow and Net Investment Hedge Accounting on Condensed Consolidated Statements of Earnings (Detail) - USD ($)
$ in Millions
 3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Derivative Instruments Gain Loss [Line Items]    
Gain on net investment hedging relationships $ 70.5 $ (23.7)
Cash Flow Hedges [Member]    
Derivative Instruments Gain Loss [Line Items]    
Gain (loss) on cash flow hedging relationships 21.8 22.9
Cost of Products Sold [Member]    
Derivative Instruments Gain Loss [Line Items]    
Total amounts of income and expense line items presented in the statements of earnings in which the effects of fair value, cash flow and net investment hedges are recorded 512.3 500.8
Interest Expense [Member]    
Derivative Instruments Gain Loss [Line Items]    
Total amounts of income and expense line items presented in the statements of earnings in which the effects of fair value, cash flow and net investment hedges are recorded $ (50.7) $ (48.2)
Interest Rate Swap [Member] | Cash Flow Hedges [Member]    
Derivative Instruments Gain Loss [Line Items]    
Derivative Instrument, Gain (Loss) Reclassified from AOCI into Income, Effective Portion, Statement of Income or Comprehensive Income [Extensible Enumeration] Interest Income (Expense), Net Interest Income (Expense), Net
Interest Rate Swap [Member] | Interest Expense [Member]    
Derivative Instruments Gain Loss [Line Items]    
Gain (loss) on fair value hedging relationships $ (10.6) $ (8.2)
Foreign Exchange Forward [Member] | Cash Flow Hedges [Member]    
Derivative Instruments Gain Loss [Line Items]    
Gain (loss) on cash flow hedging relationships $ 22.0 $ 23.1
Derivative Instrument, Gain (Loss) Reclassified from AOCI into Income, Effective Portion, Statement of Income or Comprehensive Income [Extensible Enumeration] Cost of Goods and Services Sold Cost of Goods and Services Sold
Forward Starting Interest Rate Swaps [Member] | Cash Flow Hedges [Member]    
Derivative Instruments Gain Loss [Line Items]    
Gain (loss) on cash flow hedging relationships $ (0.2) $ (0.2)
Derivative Instrument, Gain (Loss) Reclassified from AOCI into Income, Effective Portion, Statement of Income or Comprehensive Income [Extensible Enumeration] Interest Income (Expense), Net Interest Income (Expense), Net
Cross Currency Interest Rate Contract [Member]    
Derivative Instruments Gain Loss [Line Items]    
Gain on net investment hedging relationships $ 46.1 $ (4.5)
Cross Currency Interest Rate Contract [Member] | Interest Expense [Member] | Net Investment Hedging [Member]    
Derivative Instruments Gain Loss [Line Items]    
Gain on net investment hedging relationships $ 8.2 $ 9.0
XML 69 R62.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Derivative Instruments and Hedging Activities - Derivative Instruments Not Designated as Hedging Instruments (Detail) - USD ($)
$ in Millions
 3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Derivatives Not Designated as Hedges [Member] | Foreign Exchange Forward Contracts [Member] | Other income (expense), net [Member]    
Derivative Instruments Gain Loss [Line Items]    
Gains/(losses) from derivative instruments not designated as hedging instruments $ 8.4 $ (3.6)
XML 70 R63.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Derivative Instruments and Hedging Activities - Fair Value of Derivative Instruments on Gross Basis (Detail) - USD ($)
$ in Millions
Mar. 31, 2024
Dec. 31, 2023
Derivatives Designated as Hedges [Member]    
Derivatives, Fair Value [Line Items]    
Derivative Assets $ 114.8 $ 81.0
Derivative Liabilities 222.4 237.7
Derivatives Not Designated as Hedges [Member]    
Derivatives, Fair Value [Line Items]    
Derivative Liabilities 2.8 2.4
Foreign Exchange Forward Contracts [Member] | Derivatives Not Designated as Hedges [Member]    
Derivatives, Fair Value [Line Items]    
Derivative Assets 3.7 1.2
Foreign Exchange Forward Contracts [Member] | Other Current Assets [Member] | Derivatives Designated as Hedges [Member]    
Derivatives, Fair Value [Line Items]    
Derivative Assets 66.3 58.4
Foreign Exchange Forward Contracts [Member] | Other Current Assets [Member] | Derivatives Not Designated as Hedges [Member]    
Derivatives, Fair Value [Line Items]    
Derivative Assets 3.7 1.2
Foreign Exchange Forward Contracts [Member] | Other Assets [Member] | Derivatives Designated as Hedges [Member]    
Derivatives, Fair Value [Line Items]    
Derivative Assets 21.2 17.2
Foreign Exchange Forward Contracts [Member] | Other Current Liabilities [Member] | Derivatives Designated as Hedges [Member]    
Derivatives, Fair Value [Line Items]    
Derivative Liabilities 8.5 13.9
Foreign Exchange Forward Contracts [Member] | Other Current Liabilities [Member] | Derivatives Not Designated as Hedges [Member]    
Derivatives, Fair Value [Line Items]    
Derivative Liabilities 2.8 2.4
Foreign Exchange Forward Contracts [Member] | Other Long-term Liabilities [Member] | Derivatives Designated as Hedges [Member]    
Derivatives, Fair Value [Line Items]    
Derivative Liabilities 6.3 11.0
Cross-currency Interest Rate Swaps [Member] | Other Current Assets [Member] | Derivatives Designated as Hedges [Member]    
Derivatives, Fair Value [Line Items]    
Derivative Assets 0.0 0.0
Cross-currency Interest Rate Swaps [Member] | Other Assets [Member] | Derivatives Designated as Hedges [Member]    
Derivatives, Fair Value [Line Items]    
Derivative Assets 27.3 5.4
Cross-currency Interest Rate Swaps [Member] | Other Current Liabilities [Member] | Derivatives Designated as Hedges [Member]    
Derivatives, Fair Value [Line Items]    
Derivative Liabilities 35.0 33.3
Cross-currency Interest Rate Swaps [Member] | Other Long-term Liabilities [Member] | Derivatives Designated as Hedges [Member]    
Derivatives, Fair Value [Line Items]    
Derivative Liabilities 8.8 34.8
Interest Rate Swap [Member] | Other Long-term Liabilities [Member] | Derivatives Designated as Hedges [Member]    
Derivatives, Fair Value [Line Items]    
Derivative Liabilities $ 163.8 $ 144.7
XML 71 R64.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Derivative Instruments and Hedging Activities - Schedule of Effects of Master Netting Agreements on Condensed Consolidated Balance Sheets (Detail) - USD ($)
$ in Millions
Mar. 31, 2024
Dec. 31, 2023
Derivatives Not Designated as Hedges [Member]    
Derivative Instruments and Hedging Activities Disclosures [Line Items]    
Gross Amount $ 2.8 $ 2.4
Offset 1.3 0.8
Net Amount in Balance Sheet $ 1.5 $ 1.6
Derivative Liability, Statement of Financial Position [Extensible Enumeration] Other Liabilities, Current Other Liabilities, Current
Foreign Exchange Forward [Member] | Derivatives Not Designated as Hedges [Member]    
Derivative Instruments and Hedging Activities Disclosures [Line Items]    
Gross Amount $ 3.7 $ 1.2
Offset 1.3 0.8
Net Amount in Balance Sheet $ 2.4 $ 0.4
Derivative Asset, Statement of Financial Position [Extensible Enumeration] Assets, Current Assets, Current
Cash Flow Hedges [Member]    
Derivative Instruments and Hedging Activities Disclosures [Line Items]    
Gross Amount $ 66.3 $ 58.4
Offset 8.4 13.0
Net Amount in Balance Sheet $ 57.9 $ 45.4
Derivative Asset, Statement of Financial Position [Extensible Enumeration] Assets, Current Assets, Current
Gross Amount $ 8.5 $ 13.9
Offset 8.4 13.0
Net Amount in Balance Sheet $ 0.1 $ 0.9
Derivative Liability, Statement of Financial Position [Extensible Enumeration] Other Liabilities, Current Other Liabilities, Current
Cash Flow Hedges [Member]    
Derivative Instruments and Hedging Activities Disclosures [Line Items]    
Gross Amount $ 21.2 $ 17.2
Offset 4.7 8.2
Net Amount in Balance Sheet $ 16.5 $ 9.0
Derivative Asset, Statement of Financial Position [Extensible Enumeration] Other Assets, Noncurrent Other Assets, Noncurrent
Gross Amount $ 6.3 $ 11.0
Offset 4.7 8.2
Net Amount in Balance Sheet $ 1.6 $ 2.8
Derivative Liability, Statement of Financial Position [Extensible Enumeration] Other Liabilities, Noncurrent Other Liabilities, Noncurrent
Other Current Assets [Member] | Foreign Exchange Forward [Member] | Derivatives Not Designated as Hedges [Member]    
Derivative Instruments and Hedging Activities Disclosures [Line Items]    
Gross Amount $ 3.7 $ 1.2
Other Current Liabilities [Member] | Foreign Exchange Forward [Member] | Derivatives Not Designated as Hedges [Member]    
Derivative Instruments and Hedging Activities Disclosures [Line Items]    
Gross Amount $ 2.8 $ 2.4
XML 72 R65.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Derivative Instruments and Hedging Activities - Net Investment Hedge Gains (Losses) Recognized on Condensed Consolidated Statements of Comprehensive Income (Detail) - USD ($)
$ in Millions
 3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Derivative Instruments Gain Loss [Line Items]    
Amount of Gain (Loss) Recognized in AOCI $ 70.5 $ (23.7)
Euro Notes [Member]    
Derivative Instruments Gain Loss [Line Items]    
Amount of Gain (Loss) Recognized in AOCI 24.4 (19.2)
Cross-currency Interest Rate Swaps [Member]    
Derivative Instruments Gain Loss [Line Items]    
Amount of Gain (Loss) Recognized in AOCI $ 46.1 $ (4.5)
XML 73 R66.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Income Taxes - Additional Information (Detail) - USD ($)
$ in Millions
 3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Income Taxes Disclosure [Line Items]    
Decrease in unrecognized tax benefits within the next twelve months $ 270  
Increase in unrecognized tax benefits within the next twelve months 20  
Amount of potential additional income tax expense related to an IRS notice of proposed adjustment subject to interest and penalties. $ 370  
Effective tax rate 19.70% 18.90%
U.S. corporate income tax rate 21.00%  
XML 74 R67.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Earnings Per Share - Reconciliation of Weighted Average Shares for Basic and Diluted Shares Computations (Detail) - shares
shares in Millions
 3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Earnings Per Share [Abstract]    
Weighted average shares outstanding for basic net earnings per share 205.2 209.4
Effect of dilutive stock options and other equity awards 1.0 1.0
Weighted average shares outstanding for diluted net earnings per share 206.2 210.4
XML 75 R68.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Earnings Per Share - Additional Information (Detail) - shares
shares in Millions
 3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Earnings Per Share [Abstract]    
Options to purchase shares of common stock not included in the computation of diluted earnings per share 1.6 2.0
XML 76 R69.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Segment Information - Additional Information (Detail)
 3 Months Ended
Mar. 31, 2024
Segment
Segment Reporting [Abstract]  
Number of operating segments 3
XML 77 R70.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Segment Information - Summary of Net Sales and Operating Profit by Segment (Detail) - USD ($)
$ in Millions
 3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Net Sales And Operating Profit Information [Line Items]    
Net Sales $ 1,889.2 $ 1,831.0
Operating Profit 265.9 327.3
Intangible asset amortization (142.1) (133.4)
Americas [Member]    
Net Sales And Operating Profit Information [Line Items]    
Net Sales 1,186.5 1,141.3
Operating Profit 639.3 608.9
Corporate Items [Member]    
Net Sales And Operating Profit Information [Line Items]    
Operating Profit (477.6) (387.9)
Operating Segments [Member] | EMEA [Member]    
Net Sales And Operating Profit Information [Line Items]    
Net Sales 444.8 425.6
Operating Profit 153.0 149.5
Operating Segments [Member] | Asia Pacific [Member]    
Net Sales And Operating Profit Information [Line Items]    
Net Sales 258.0 264.1
Operating Profit $ 93.3 $ 90.2
XML 78 R71.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Commitments and Contingencies - Additional Information (Detail) - USD ($)
 3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Dec. 31, 2023
Loss Contingencies [Line Items]      
Net Litigation Related Charges $ 1,000,000 $ 3,300,000  
Accrued litigation liabilities 226,500,000   $ 244,100,000
Other Contingencies [Member]      
Loss Contingencies [Line Items]      
Loss Contingency Minimum 0    
Loss Contingency, Range of Possible Loss, Portion Not Accrued $ 405,000,000    
EXCEL 79 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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how.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 81 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 83 FilingSummary.xml IDEA: XBRL DOCUMENT 3.24.1.u1 html 295 288 1 false 109 0 false 8 false false R1.htm 100000 - Document - Document and Entity Information Sheet http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DocumentDocumentAndEntityInformation Document and Entity Information Cover 1 false false R2.htm 100010 - Statement - Condensed Consolidated Statements of Earnings (unaudited) Sheet http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfEarningsUnaudited Condensed Consolidated Statements of Earnings (unaudited) Statements 2 false false R3.htm 100020 - Statement - Condensed Consolidated Statements of Comprehensive Income (unaudited) Sheet http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfComprehensiveIncomeUnaudited Condensed Consolidated Statements of Comprehensive Income (unaudited) Statements 3 false false R4.htm 100030 - Statement - Condensed Consolidated Balance Sheets (unaudited) Sheet http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited Condensed Consolidated Balance Sheets (unaudited) Statements 4 false false R5.htm 100040 - Statement - Condensed Consolidated Balance Sheets (unaudited) (Parenthetical) Sheet http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnauditedParenthetical Condensed Consolidated Balance Sheets (unaudited) (Parenthetical) Statements 5 false false R6.htm 100050 - Statement - Condensed Consolidated Statements of Stockholders' Equity (unaudited) Sheet http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfStockholdersEquityUnaudited Condensed Consolidated Statements of Stockholders' Equity (unaudited) Statements 6 false false R7.htm 100060 - Statement - Condensed Consolidated Statements of Stockholders' Equity (Parenthetical) (unaudited) Sheet http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfStockholdersEquityParentheticalUnaudited Condensed Consolidated Statements of Stockholders' Equity (Parenthetical) (unaudited) Statements 7 false false R8.htm 100070 - Statement - Condensed Consolidated Statements of Cash Flows (unaudited) Sheet http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited Condensed Consolidated Statements of Cash Flows (unaudited) Statements 8 false false R9.htm 995410 - Disclosure - Pay vs Performance Disclosure Sheet http://xbrl.sec.gov/ecd/role/PvpDisclosure Pay vs Performance Disclosure Notes 9 false false R10.htm 995445 - Disclosure - Insider Trading Arrangements Sheet http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements Insider Trading Arrangements Notes 10 false false R11.htm 995455 - Disclosure - Basis of Presentation Sheet http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureBasisOfPresentation Basis of Presentation Notes 11 false false R12.htm 995475 - Disclosure - Significant Accounting Policies Sheet http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureSignificantAccountingPolicies Significant Accounting Policies Notes 12 false false R13.htm 995485 - Disclosure - Revenue Sheet http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureRevenue Revenue Notes 13 false false R14.htm 995495 - Disclosure - Restructuring Sheet http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureRestructuring Restructuring Notes 14 false false R15.htm 995505 - Disclosure - Inventories Sheet http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureInventories Inventories Notes 15 false false R16.htm 995515 - Disclosure - Property, Plant and Equipment Sheet http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosurePropertyPlantAndEquipment Property, Plant and Equipment Notes 16 false false R17.htm 995525 - Disclosure - Acquisitions Sheet http://www.zimmerbiomet.com/20240331/taxonomy/role/DisclosureAcquisitions Acquisitions Notes 17 false false R18.htm 995535 - Disclosure - Debt Sheet http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDebt Debt Notes 18 false false R19.htm 995545 - Disclosure - Accumulated Other Comprehensive Income Sheet http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureAccumulatedOtherComprehensiveIncome Accumulated Other Comprehensive Income Notes 19 false false R20.htm 995555 - Disclosure - Fair Value Measurement of Assets and Liabilities Sheet http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureFairValueMeasurementOfAssetsAndLiabilities Fair Value Measurement of Assets and Liabilities Notes 20 false false R21.htm 995565 - Disclosure - Derivative Instruments and Hedging Activities Sheet http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivities Derivative Instruments and Hedging Activities Notes 21 false false R22.htm 995575 - Disclosure - Income Taxes Sheet http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureIncomeTaxes Income Taxes Notes 22 false false R23.htm 995585 - Disclosure - Earnings Per Share Sheet http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureEarningsPerShare Earnings Per Share Notes 23 false false R24.htm 995595 - Disclosure - Segment Information Sheet http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureSegmentInformation Segment Information Notes 24 false false R25.htm 995605 - Disclosure - Commitments and Contingencies Sheet http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureCommitmentsAndContingencies Commitments and Contingencies Notes 25 false false R26.htm 995615 - Disclosure - Significant Accounting Policies (Policies) Sheet http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureSignificantAccountingPoliciesPolicies Significant Accounting Policies (Policies) Policies http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureSignificantAccountingPolicies 26 false false R27.htm 995635 - Disclosure - Revenue (Tables) Sheet http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureRevenueTables Revenue (Tables) Tables http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureRevenue 27 false false R28.htm 995645 - Disclosure - Restructuring (Tables) Sheet http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureRestructuringTables Restructuring (Tables) Tables http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureRestructuring 28 false false R29.htm 995655 - Disclosure - Inventories (Tables) Sheet http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureInventoriesTables Inventories (Tables) Tables http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureInventories 29 false false R30.htm 995665 - Disclosure - Property, Plant and Equipment (Tables) Sheet http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosurePropertyPlantAndEquipmentTables Property, Plant and Equipment (Tables) Tables http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosurePropertyPlantAndEquipment 30 false false R31.htm 995675 - Disclosure - Acquisitions (Tables) Sheet http://www.zimmerbiomet.com/20240331/taxonomy/role/DisclosureAcquisitionsTables Acquisitions (Tables) Tables http://www.zimmerbiomet.com/20240331/taxonomy/role/DisclosureAcquisitions 31 false false R32.htm 995685 - Disclosure - Debt (Tables) Sheet http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDebtTables Debt (Tables) Tables http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDebt 32 false false R33.htm 995695 - Disclosure - Accumulated Other Comprehensive Income (Tables) Sheet http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureAccumulatedOtherComprehensiveIncomeTables Accumulated Other Comprehensive Income (Tables) Tables http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureAccumulatedOtherComprehensiveIncome 33 false false R34.htm 995705 - Disclosure - Fair Value Measurement of Assets and Liabilities (Tables) Sheet http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureFairValueMeasurementOfAssetsAndLiabilitiesTables Fair Value Measurement of Assets and Liabilities (Tables) Tables http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureFairValueMeasurementOfAssetsAndLiabilities 34 false false R35.htm 995715 - Disclosure - Derivative Instruments and Hedging Activities (Tables) Sheet http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesTables Derivative Instruments and Hedging Activities (Tables) Tables http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivities 35 false false R36.htm 995725 - Disclosure - Earnings Per Share (Tables) Sheet http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureEarningsPerShareTables Earnings Per Share (Tables) Tables http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureEarningsPerShare 36 false false R37.htm 995735 - Disclosure - Segment Information (Tables) Sheet http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureSegmentInformationTables Segment Information (Tables) Tables http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureSegmentInformation 37 false false R38.htm 995755 - Disclosure - Discontinued Operations and Related ZimVie Matters - Additional Information (Details) Sheet http://www.zimmerbiomet.com/20240331/taxonomy/role/DisclosureDiscontinuedOperationsAndRelatedZimvieMattersAdditionalInformationDetails Discontinued Operations and Related ZimVie Matters - Additional Information (Details) Details 38 false false R39.htm 995795 - Disclosure - Revenue - Schedule of Net Sales by Geography (Detail) Sheet http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureRevenueScheduleOfNetSalesByGeographyDetail Revenue - Schedule of Net Sales by Geography (Detail) Details 39 false false R40.htm 995805 - Disclosure - Revenue - Schedule of Net Sales by Product Category (Detail) Sheet http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureRevenueScheduleOfNetSalesByProductCategoryDetail Revenue - Schedule of Net Sales by Product Category (Detail) Details 40 false false R41.htm 995815 - Disclosure - Restructuring - Additional Information (Detail) Sheet http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureRestructuringAdditionalInformationDetail Restructuring - Additional Information (Detail) Details 41 false false R42.htm 995825 - Disclosure - Restructuring - Summary of Liabilities Recognized Related to Restructuring Plan (Detail) Sheet http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureRestructuringSummaryOfLiabilitiesRecognizedRelatedToRestructuringPlanDetail Restructuring - Summary of Liabilities Recognized Related to Restructuring Plan (Detail) Details 42 false false R43.htm 995835 - Disclosure - Restructuring - Summary of Location on Condensed Consolidated Statement of Earnings and Type of Cost for Restructuring Plan (Detail) Sheet http://www.zimmerbiomet.com/20240331/taxonomy/role/DisclosureRestructuringSummaryOfLocationOnCondensedConsolidatedStatementOfEarningsAndTypeOfCostForRestructuringPlanDetail Restructuring - Summary of Location on Condensed Consolidated Statement of Earnings and Type of Cost for Restructuring Plan (Detail) Details 43 false false R44.htm 995845 - Disclosure - Inventories - Summary of Inventories (Detail) Sheet http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureInventoriesSummaryOfInventoriesDetail Inventories - Summary of Inventories (Detail) Details 44 false false R45.htm 995855 - Disclosure - Property, Plant and Equipment - Summary of Property, Plant and Equipment (Detail) Sheet http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosurePropertyPlantAndEquipmentSummaryOfPropertyPlantAndEquipmentDetail Property, Plant and Equipment - Summary of Property, Plant and Equipment (Detail) Details 45 false false R46.htm 995865 - Disclosure - Property, Plant and Equipment - Additional Information (Detail) Sheet http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosurePropertyPlantAndEquipmentAdditionalInformationDetail Property, Plant and Equipment - Additional Information (Detail) Details 46 false false R47.htm 995875 - Disclosure - Acquisitions - Additional Information (Detail) Sheet http://www.zimmerbiomet.com/20240331/taxonomy/role/DisclosureAcquisitionsAdditionalInformationDetail Acquisitions - Additional Information (Detail) Details 47 false false R48.htm 995885 - Disclosure - Acquisitions - Summary of Estimates of Fair Value of Assets Acquired and Liabilities Assumed (Details) Sheet http://www.zimmerbiomet.com/20240331/taxonomy/role/DisclosureAcquisitionsSummaryOfEstimatesOfFairValueOfAssetsAcquiredAndLiabilitiesAssumedDetails Acquisitions - Summary of Estimates of Fair Value of Assets Acquired and Liabilities Assumed (Details) Details 48 false false R49.htm 995895 - Disclosure - Debt - Summary of Debt Instruments (Detail) Sheet http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDebtSummaryOfDebtInstrumentsDetail Debt - Summary of Debt Instruments (Detail) Details 49 false false R50.htm 995905 - Disclosure - Debt - Summary of Debt Instruments (Parenthetical) (Detail) Sheet http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDebtSummaryOfDebtInstrumentsParentheticalDetail Debt - Summary of Debt Instruments (Parenthetical) (Detail) Details 50 false false R51.htm 995925 - Disclosure - Debt - Additional Information (Detail) Sheet http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDebtAdditionalInformationDetail Debt - Additional Information (Detail) Details 51 false false R52.htm 995935 - Disclosure - Accumulated Other Comprehensive Income - Changes in Components of Accumulated Other Comprehensive Income, Net of Tax (Detail) Sheet http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureAccumulatedOtherComprehensiveIncomeChangesInComponentsOfAccumulatedOtherComprehensiveIncomeNetOfTaxDetail Accumulated Other Comprehensive Income - Changes in Components of Accumulated Other Comprehensive Income, Net of Tax (Detail) Details 52 false false R53.htm 995945 - Disclosure - Accumulated Other Comprehensive Income - Reclassification Adjustments from Accumulated Other Comprehensive Income (Detail) Sheet http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureAccumulatedOtherComprehensiveIncomeReclassificationAdjustmentsFromAccumulatedOtherComprehensiveIncomeDetail Accumulated Other Comprehensive Income - Reclassification Adjustments from Accumulated Other Comprehensive Income (Detail) Details 53 false false R54.htm 995955 - Disclosure - Accumulated Other Comprehensive Income - Tax Effects on Each Component of Accumulated Other Comprehensive Income Recognized in Statements of Comprehensive Income (Detail) Sheet http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureAccumulatedOtherComprehensiveIncomeTaxEffectsOnEachComponentOfAccumulatedOtherComprehensiveIncomeRecognizedInStatementsOfComprehensiveIncomeDetail Accumulated Other Comprehensive Income - Tax Effects on Each Component of Accumulated Other Comprehensive Income Recognized in Statements of Comprehensive Income (Detail) Details 54 false false R55.htm 995965 - Disclosure - Fair Value Measurement of Assets and Liabilities - Schedule of Fair Value Measurement of Asset and Liabilities (Detail) Sheet http://www.zimmerbiomet.com/20240331/taxonomy/role/DisclosureFairValueMeasurementOfAssetsAndLiabilitiesScheduleOfFairValueMeasurementOfAssetAndLiabilitiesDetail Fair Value Measurement of Assets and Liabilities - Schedule of Fair Value Measurement of Asset and Liabilities (Detail) Details 55 false false R56.htm 995975 - Disclosure - Fair Value Measurement of Assets and Liabilities - Additional Information (Details) Sheet http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureFairValueMeasurementOfAssetsAndLiabilitiesAdditionalInformationDetails Fair Value Measurement of Assets and Liabilities - Additional Information (Details) Details 56 false false R57.htm 995985 - Disclosure - Fair Value Measurement of Assets and Liabilities - Schedule of Fair Value Liabilities Measured on Recurring Basis (Detail) Sheet http://www.zimmerbiomet.com/20240331/taxonomy/role/DisclosureFairValueMeasurementOfAssetsAndLiabilitiesScheduleOfFairValueLiabilitiesMeasuredOnRecurringBasisDetail Fair Value Measurement of Assets and Liabilities - Schedule of Fair Value Liabilities Measured on Recurring Basis (Detail) Details 57 false false R58.htm 995995 - Disclosure - Derivative Instruments and Hedging Activities - Schedule of Amounts Recorded On Balance Sheet Related To Cumulative Basis Adjustments For Fair Value Hedges (Detail) Sheet http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesScheduleOfAmountsRecordedOnBalanceSheetRelatedToCumulativeBasisAdjustmentsForFairValueHedgesDetail Derivative Instruments and Hedging Activities - Schedule of Amounts Recorded On Balance Sheet Related To Cumulative Basis Adjustments For Fair Value Hedges (Detail) Details 58 false false R59.htm 996005 - Disclosure - Derivative Instruments and Hedging Activities - Additional Information (Detail) Sheet http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesAdditionalInformationDetail Derivative Instruments and Hedging Activities - Additional Information (Detail) Details 59 false false R60.htm 996015 - Disclosure - Derivative Instruments and Hedging Activities - Gross Unrealized Losses from Derivative Instruments (Detail) Sheet http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesGrossUnrealizedLossesFromDerivativeInstrumentsDetail Derivative Instruments and Hedging Activities - Gross Unrealized Losses from Derivative Instruments (Detail) Details 60 false false R61.htm 996025 - Disclosure - Derivative Instruments and Hedging Activities - Effects of Fair Value, Cash Flow and Net Investment Hedge Accounting on Condensed Consolidated Statements of Earnings (Detail) Sheet http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesEffectsOfFairValueCashFlowAndNetInvestmentHedgeAccountingOnCondensedConsolidatedStatementsOfEarningsDetail Derivative Instruments and Hedging Activities - Effects of Fair Value, Cash Flow and Net Investment Hedge Accounting on Condensed Consolidated Statements of Earnings (Detail) Details 61 false false R62.htm 996035 - Disclosure - Derivative Instruments and Hedging Activities - Derivative Instruments Not Designated as Hedging Instruments (Detail) Sheet http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsDetail Derivative Instruments and Hedging Activities - Derivative Instruments Not Designated as Hedging Instruments (Detail) Details 62 false false R63.htm 996045 - Disclosure - Derivative Instruments and Hedging Activities - Fair Value of Derivative Instruments on Gross Basis (Detail) Sheet http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesFairValueOfDerivativeInstrumentsOnGrossBasisDetail Derivative Instruments and Hedging Activities - Fair Value of Derivative Instruments on Gross Basis (Detail) Details 63 false false R64.htm 996055 - Disclosure - Derivative Instruments and Hedging Activities - Schedule of Effects of Master Netting Agreements on Condensed Consolidated Balance Sheets (Detail) Sheet http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesScheduleOfEffectsOfMasterNettingAgreementsOnCondensedConsolidatedBalanceSheetsDetail Derivative Instruments and Hedging Activities - Schedule of Effects of Master Netting Agreements on Condensed Consolidated Balance Sheets (Detail) Details 64 false false R65.htm 996065 - Disclosure - Derivative Instruments and Hedging Activities - Net Investment Hedge Gains (Losses) Recognized on Condensed Consolidated Statements of Comprehensive Income (Detail) Sheet http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesNetInvestmentHedgeGainsLossesRecognizedOnCondensedConsolidatedStatementsOfComprehensiveIncomeDetail Derivative Instruments and Hedging Activities - Net Investment Hedge Gains (Losses) Recognized on Condensed Consolidated Statements of Comprehensive Income (Detail) Details 65 false false R66.htm 996075 - Disclosure - Income Taxes - Additional Information (Detail) Sheet http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetail Income Taxes - Additional Information (Detail) Details 66 false false R67.htm 996085 - Disclosure - Earnings Per Share - Reconciliation of Weighted Average Shares for Basic and Diluted Shares Computations (Detail) Sheet http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureEarningsPerShareReconciliationOfWeightedAverageSharesForBasicAndDilutedSharesComputationsDetail Earnings Per Share - Reconciliation of Weighted Average Shares for Basic and Diluted Shares Computations (Detail) Details 67 false false R68.htm 996095 - Disclosure - Earnings Per Share - Additional Information (Detail) Sheet http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureEarningsPerShareAdditionalInformationDetail Earnings Per Share - Additional Information (Detail) Details 68 false false R69.htm 996105 - Disclosure - Segment Information - Additional Information (Detail) Sheet http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureSegmentInformationAdditionalInformationDetail Segment Information - Additional Information (Detail) Details 69 false false R70.htm 996115 - Disclosure - Segment Information - Summary of Net Sales and Operating Profit by Segment (Detail) Sheet http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureSegmentInformationSummaryOfNetSalesAndOperatingProfitBySegmentDetail Segment Information - Summary of Net Sales and Operating Profit by Segment (Detail) Details 70 false false R71.htm 996125 - Disclosure - Commitments and Contingencies - Additional Information (Detail) Sheet http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetail Commitments and Contingencies - Additional Information (Detail) Details 71 false false All Reports Book All Reports [ix-0514-Hidden-Fact-Eligible-For-Transform] WARN: 1 fact(s) appearing in ix:hidden were eligible for transformation: dei:DocumentTransitionReport - zbh-20240331.htm 8 zbh-20240331.htm zbh-20240331.xsd http://fasb.org/us-gaap/2023 http://xbrl.sec.gov/dei/2023 http://xbrl.sec.gov/ecd/2023 false false JSON 86 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "zbh-20240331.htm": { "nsprefix": "zbh", "nsuri": "http://www.zimmerbiomet.com/20240331", "dts": { "inline": { "local": [ "zbh-20240331.htm" ] }, "schema": { "local": [ "zbh-20240331.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd", "https://xbrl.sec.gov/country/2023/country-2023.xsd", "https://xbrl.sec.gov/currency/2023/currency-2023.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd", "https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd", "https://xbrl.sec.gov/ecd/2023/ecd-sub-2023.xsd" ] } }, "keyStandard": 262, "keyCustom": 26, "axisStandard": 29, "axisCustom": 0, "memberStandard": 49, "memberCustom": 57, "hidden": { "total": 64, "http://fasb.org/us-gaap/2023": 59, "http://xbrl.sec.gov/dei/2023": 5 }, "contextCount": 295, "entityCount": 1, "segmentCount": 109, "elementCount": 740, "unitCount": 8, "baseTaxonomies": { "http://fasb.org/us-gaap/2023": 833, "http://xbrl.sec.gov/dei/2023": 35, "http://xbrl.sec.gov/ecd/2023": 4 }, "report": { "R1": { "role": "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DocumentDocumentAndEntityInformation", "longName": "100000 - Document - Document and Entity Information", "shortName": "Document and Entity Information", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "C_0d3f46dd-32ef-48ee-b8c4-df5490602382", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "p", "body", "html" ], "reportCount": 1, "baseRef": "zbh-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_0d3f46dd-32ef-48ee-b8c4-df5490602382", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "p", "body", "html" ], "reportCount": 1, "baseRef": "zbh-20240331.htm", "first": true, "unique": true } }, "R2": { "role": "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfEarningsUnaudited", "longName": "100010 - Statement - Condensed Consolidated Statements of Earnings (unaudited)", "shortName": "Condensed Consolidated Statements of Earnings (unaudited)", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "2", "firstAnchor": { "contextRef": "C_0d3f46dd-32ef-48ee-b8c4-df5490602382", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "zbh-20240331.htm", "first": true }, "uniqueAnchor": { "contextRef": "C_0d3f46dd-32ef-48ee-b8c4-df5490602382", "name": "us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "zbh-20240331.htm", "unique": true } }, "R3": { "role": "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfComprehensiveIncomeUnaudited", "longName": "100020 - Statement - Condensed Consolidated Statements of Comprehensive Income (unaudited)", "shortName": "Condensed Consolidated Statements of Comprehensive Income (unaudited)", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "3", "firstAnchor": { "contextRef": "C_0d3f46dd-32ef-48ee-b8c4-df5490602382", "name": "us-gaap:NetIncomeLoss", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "zbh-20240331.htm", "first": true }, "uniqueAnchor": { "contextRef": "C_0d3f46dd-32ef-48ee-b8c4-df5490602382", "name": "us-gaap:ComprehensiveIncomeNetOfTax", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "zbh-20240331.htm", "unique": true } }, "R4": { "role": "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited", "longName": "100030 - Statement - Condensed Consolidated Balance Sheets (unaudited)", "shortName": "Condensed Consolidated Balance Sheets (unaudited)", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "4", "firstAnchor": { "contextRef": "C_3359f745-8562-4f05-9743-e62f46e5b4fd", "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "zbh-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_3359f745-8562-4f05-9743-e62f46e5b4fd", "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "zbh-20240331.htm", "first": true, "unique": true } }, "R5": { "role": "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnauditedParenthetical", "longName": "100040 - Statement - Condensed Consolidated Balance Sheets (unaudited) (Parenthetical)", "shortName": "Condensed Consolidated Balance Sheets (unaudited) (Parenthetical)", "isDefault": "false", "groupType": "statement", "subGroupType": "parenthetical", "menuCat": "Statements", "order": "5", "firstAnchor": { "contextRef": "C_3359f745-8562-4f05-9743-e62f46e5b4fd", "name": "us-gaap:CommonStockParOrStatedValuePerShare", "unitRef": "U_UnitedStatesOfAmericaDollarsShare", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "zbh-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_3359f745-8562-4f05-9743-e62f46e5b4fd", "name": "us-gaap:CommonStockParOrStatedValuePerShare", "unitRef": "U_UnitedStatesOfAmericaDollarsShare", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "zbh-20240331.htm", "first": true, "unique": true } }, "R6": { "role": "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfStockholdersEquityUnaudited", "longName": "100050 - Statement - Condensed Consolidated Statements of Stockholders' Equity (unaudited)", "shortName": "Condensed Consolidated Statements of Stockholders' Equity (unaudited)", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "6", "firstAnchor": { "contextRef": "C_efd299ab-3898-44d0-9f6c-243063cd3814", "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "zbh-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_efd299ab-3898-44d0-9f6c-243063cd3814", "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "zbh-20240331.htm", "first": true, "unique": true } }, "R7": { "role": "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfStockholdersEquityParentheticalUnaudited", "longName": "100060 - Statement - Condensed Consolidated Statements of Stockholders' Equity (Parenthetical) (unaudited)", "shortName": "Condensed Consolidated Statements of Stockholders' Equity (Parenthetical) (unaudited)", "isDefault": "false", "groupType": "statement", "subGroupType": "parenthetical", "menuCat": "Statements", "order": "7", "firstAnchor": { "contextRef": "C_0d3f46dd-32ef-48ee-b8c4-df5490602382", "name": "us-gaap:CommonStockDividendsPerShareDeclared", "unitRef": "U_UnitedStatesOfAmericaDollarsShare", "xsiNil": "false", "lang": null, "decimals": "2", "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "zbh-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_0d3f46dd-32ef-48ee-b8c4-df5490602382", "name": "us-gaap:CommonStockDividendsPerShareDeclared", "unitRef": "U_UnitedStatesOfAmericaDollarsShare", "xsiNil": "false", "lang": null, "decimals": "2", "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "zbh-20240331.htm", "first": true, "unique": true } }, "R8": { "role": "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited", "longName": "100070 - Statement - Condensed Consolidated Statements of Cash Flows (unaudited)", "shortName": "Condensed Consolidated Statements of Cash Flows (unaudited)", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "8", "firstAnchor": { "contextRef": "C_0d3f46dd-32ef-48ee-b8c4-df5490602382", "name": "us-gaap:ProfitLoss", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "zbh-20240331.htm", "first": true }, "uniqueAnchor": { "contextRef": "C_0d3f46dd-32ef-48ee-b8c4-df5490602382", "name": "us-gaap:DepreciationDepletionAndAmortization", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "zbh-20240331.htm", "unique": true } }, "R9": { "role": "http://xbrl.sec.gov/ecd/role/PvpDisclosure", "longName": "995410 - Disclosure - Pay vs Performance Disclosure", "shortName": "Pay vs Performance Disclosure", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "9", "firstAnchor": { "contextRef": "C_0d3f46dd-32ef-48ee-b8c4-df5490602382", "name": "us-gaap:NetIncomeLoss", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "zbh-20240331.htm", "first": true }, "uniqueAnchor": null }, "R10": { "role": "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements", "longName": "995445 - Disclosure - Insider Trading Arrangements", "shortName": "Insider Trading Arrangements", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "10", "firstAnchor": { "contextRef": "C_0d3f46dd-32ef-48ee-b8c4-df5490602382", "name": "ecd:Rule10b51ArrAdoptedFlag", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "p", "body", "html" ], "reportCount": 1, "baseRef": "zbh-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_0d3f46dd-32ef-48ee-b8c4-df5490602382", "name": "ecd:Rule10b51ArrAdoptedFlag", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "p", "body", "html" ], "reportCount": 1, "baseRef": "zbh-20240331.htm", "first": true, "unique": true } }, "R11": { "role": "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureBasisOfPresentation", "longName": "995455 - Disclosure - Basis of Presentation", "shortName": "Basis of Presentation", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "11", "firstAnchor": { "contextRef": "C_0d3f46dd-32ef-48ee-b8c4-df5490602382", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "zbh-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_0d3f46dd-32ef-48ee-b8c4-df5490602382", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "zbh-20240331.htm", "first": true, "unique": true } }, "R12": { "role": "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureSignificantAccountingPolicies", "longName": "995475 - Disclosure - Significant Accounting Policies", "shortName": "Significant Accounting Policies", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "12", "firstAnchor": { "contextRef": "C_0d3f46dd-32ef-48ee-b8c4-df5490602382", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "zbh-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_0d3f46dd-32ef-48ee-b8c4-df5490602382", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "zbh-20240331.htm", "first": true, "unique": true } }, "R13": { "role": "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureRevenue", "longName": "995485 - Disclosure - Revenue", "shortName": "Revenue", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "13", "firstAnchor": { "contextRef": "C_0d3f46dd-32ef-48ee-b8c4-df5490602382", "name": "us-gaap:RevenueFromContractWithCustomerTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "zbh-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_0d3f46dd-32ef-48ee-b8c4-df5490602382", "name": "us-gaap:RevenueFromContractWithCustomerTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "zbh-20240331.htm", "first": true, "unique": true } }, "R14": { "role": "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureRestructuring", "longName": "995495 - Disclosure - Restructuring", "shortName": "Restructuring", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "14", "firstAnchor": { "contextRef": "C_0d3f46dd-32ef-48ee-b8c4-df5490602382", "name": "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "zbh-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_0d3f46dd-32ef-48ee-b8c4-df5490602382", "name": "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "zbh-20240331.htm", "first": true, "unique": true } }, "R15": { "role": "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureInventories", "longName": "995505 - Disclosure - Inventories", "shortName": "Inventories", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "15", "firstAnchor": { "contextRef": "C_0d3f46dd-32ef-48ee-b8c4-df5490602382", "name": "us-gaap:InventoryDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "zbh-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_0d3f46dd-32ef-48ee-b8c4-df5490602382", "name": "us-gaap:InventoryDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "zbh-20240331.htm", "first": true, "unique": true } }, "R16": { "role": "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosurePropertyPlantAndEquipment", "longName": "995515 - Disclosure - Property, Plant and Equipment", "shortName": "Property, Plant and Equipment", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "16", "firstAnchor": { "contextRef": "C_0d3f46dd-32ef-48ee-b8c4-df5490602382", "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "zbh-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_0d3f46dd-32ef-48ee-b8c4-df5490602382", "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "zbh-20240331.htm", "first": true, "unique": true } }, "R17": { "role": "http://www.zimmerbiomet.com/20240331/taxonomy/role/DisclosureAcquisitions", "longName": "995525 - Disclosure - Acquisitions", "shortName": "Acquisitions", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "17", "firstAnchor": { "contextRef": "C_0d3f46dd-32ef-48ee-b8c4-df5490602382", "name": "us-gaap:BusinessCombinationDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "zbh-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_0d3f46dd-32ef-48ee-b8c4-df5490602382", "name": "us-gaap:BusinessCombinationDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "zbh-20240331.htm", "first": true, "unique": true } }, "R18": { "role": "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDebt", "longName": "995535 - Disclosure - Debt", "shortName": "Debt", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "18", "firstAnchor": { "contextRef": "C_0d3f46dd-32ef-48ee-b8c4-df5490602382", "name": "us-gaap:DebtDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "p", "body", "html" ], "reportCount": 1, "baseRef": "zbh-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_0d3f46dd-32ef-48ee-b8c4-df5490602382", "name": "us-gaap:DebtDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "p", "body", "html" ], "reportCount": 1, "baseRef": "zbh-20240331.htm", "first": true, "unique": true } }, "R19": { "role": "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureAccumulatedOtherComprehensiveIncome", "longName": "995545 - Disclosure - Accumulated Other Comprehensive Income", "shortName": "Accumulated Other Comprehensive Income", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "19", "firstAnchor": { "contextRef": "C_0d3f46dd-32ef-48ee-b8c4-df5490602382", "name": "us-gaap:ComprehensiveIncomeNoteTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "zbh-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_0d3f46dd-32ef-48ee-b8c4-df5490602382", "name": "us-gaap:ComprehensiveIncomeNoteTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "zbh-20240331.htm", "first": true, "unique": true } }, "R20": { "role": "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureFairValueMeasurementOfAssetsAndLiabilities", "longName": "995555 - Disclosure - Fair Value Measurement of Assets and Liabilities", "shortName": "Fair Value Measurement of Assets and Liabilities", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "20", "firstAnchor": { "contextRef": "C_0d3f46dd-32ef-48ee-b8c4-df5490602382", "name": "us-gaap:FairValueDisclosuresTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "zbh-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_0d3f46dd-32ef-48ee-b8c4-df5490602382", "name": "us-gaap:FairValueDisclosuresTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "zbh-20240331.htm", "first": true, "unique": true } }, "R21": { "role": "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivities", "longName": "995565 - Disclosure - Derivative Instruments and Hedging Activities", "shortName": "Derivative Instruments and Hedging Activities", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "21", "firstAnchor": { "contextRef": "C_0d3f46dd-32ef-48ee-b8c4-df5490602382", "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "zbh-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_0d3f46dd-32ef-48ee-b8c4-df5490602382", "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "zbh-20240331.htm", "first": true, "unique": true } }, "R22": { "role": "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureIncomeTaxes", "longName": "995575 - Disclosure - Income Taxes", "shortName": "Income Taxes", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "22", "firstAnchor": { "contextRef": "C_0d3f46dd-32ef-48ee-b8c4-df5490602382", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "zbh-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_0d3f46dd-32ef-48ee-b8c4-df5490602382", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "zbh-20240331.htm", "first": true, "unique": true } }, "R23": { "role": "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureEarningsPerShare", "longName": "995585 - Disclosure - Earnings Per Share", "shortName": "Earnings Per Share", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "23", "firstAnchor": { "contextRef": "C_0d3f46dd-32ef-48ee-b8c4-df5490602382", "name": "us-gaap:EarningsPerShareTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "zbh-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_0d3f46dd-32ef-48ee-b8c4-df5490602382", "name": "us-gaap:EarningsPerShareTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "zbh-20240331.htm", "first": true, "unique": true } }, "R24": { "role": "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureSegmentInformation", "longName": "995595 - Disclosure - Segment Information", "shortName": "Segment Information", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "24", "firstAnchor": { "contextRef": "C_0d3f46dd-32ef-48ee-b8c4-df5490602382", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "zbh-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_0d3f46dd-32ef-48ee-b8c4-df5490602382", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "zbh-20240331.htm", "first": true, "unique": true } }, "R25": { "role": "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureCommitmentsAndContingencies", "longName": "995605 - Disclosure - Commitments and Contingencies", "shortName": "Commitments and Contingencies", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "25", "firstAnchor": { "contextRef": "C_0d3f46dd-32ef-48ee-b8c4-df5490602382", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "zbh-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_0d3f46dd-32ef-48ee-b8c4-df5490602382", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "zbh-20240331.htm", "first": true, "unique": true } }, "R26": { "role": "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureSignificantAccountingPoliciesPolicies", "longName": "995615 - Disclosure - Significant Accounting Policies (Policies)", "shortName": "Significant Accounting Policies (Policies)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "policies", "menuCat": "Policies", "order": "26", "firstAnchor": { "contextRef": "C_0d3f46dd-32ef-48ee-b8c4-df5490602382", "name": "us-gaap:UseOfEstimates", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "us-gaap:SignificantAccountingPoliciesTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "zbh-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_0d3f46dd-32ef-48ee-b8c4-df5490602382", "name": "us-gaap:UseOfEstimates", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "us-gaap:SignificantAccountingPoliciesTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "zbh-20240331.htm", "first": true, "unique": true } }, "R27": { "role": "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureRevenueTables", "longName": "995635 - Disclosure - Revenue (Tables)", "shortName": "Revenue (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "27", "firstAnchor": { "contextRef": "C_0d3f46dd-32ef-48ee-b8c4-df5490602382", "name": "us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "us-gaap:RevenueFromContractWithCustomerTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "zbh-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_0d3f46dd-32ef-48ee-b8c4-df5490602382", "name": "us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "us-gaap:RevenueFromContractWithCustomerTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "zbh-20240331.htm", "first": true, "unique": true } }, "R28": { "role": "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureRestructuringTables", "longName": "995645 - Disclosure - Restructuring (Tables)", "shortName": "Restructuring (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "28", "firstAnchor": { "contextRef": "C_0d3f46dd-32ef-48ee-b8c4-df5490602382", "name": "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "p", "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "zbh-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_0d3f46dd-32ef-48ee-b8c4-df5490602382", "name": "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "p", "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "zbh-20240331.htm", "first": true, "unique": true } }, "R29": { "role": "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureInventoriesTables", "longName": "995655 - Disclosure - Inventories (Tables)", "shortName": "Inventories (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "29", "firstAnchor": { "contextRef": "C_0d3f46dd-32ef-48ee-b8c4-df5490602382", "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "us-gaap:InventoryDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "zbh-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_0d3f46dd-32ef-48ee-b8c4-df5490602382", "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "us-gaap:InventoryDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "zbh-20240331.htm", "first": true, "unique": true } }, "R30": { "role": "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosurePropertyPlantAndEquipmentTables", "longName": "995665 - Disclosure - Property, Plant and Equipment (Tables)", "shortName": "Property, Plant and Equipment (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "30", "firstAnchor": { "contextRef": "C_0d3f46dd-32ef-48ee-b8c4-df5490602382", "name": "us-gaap:PropertyPlantAndEquipmentTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "zbh-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_0d3f46dd-32ef-48ee-b8c4-df5490602382", "name": "us-gaap:PropertyPlantAndEquipmentTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "zbh-20240331.htm", "first": true, "unique": true } }, "R31": { "role": "http://www.zimmerbiomet.com/20240331/taxonomy/role/DisclosureAcquisitionsTables", "longName": "995675 - Disclosure - Acquisitions (Tables)", "shortName": "Acquisitions (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "31", "firstAnchor": { "contextRef": "C_55447fdb-9d01-4328-a0c5-8356cbb91dc8", "name": "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "us-gaap:BusinessCombinationDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "zbh-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_55447fdb-9d01-4328-a0c5-8356cbb91dc8", "name": "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "us-gaap:BusinessCombinationDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "zbh-20240331.htm", "first": true, "unique": true } }, "R32": { "role": "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDebtTables", "longName": "995685 - Disclosure - Debt (Tables)", "shortName": "Debt (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "32", "firstAnchor": { "contextRef": "C_0d3f46dd-32ef-48ee-b8c4-df5490602382", "name": "us-gaap:ScheduleOfDebtTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "zbh-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_0d3f46dd-32ef-48ee-b8c4-df5490602382", "name": "us-gaap:ScheduleOfDebtTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "zbh-20240331.htm", "first": true, "unique": true } }, "R33": { "role": "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureAccumulatedOtherComprehensiveIncomeTables", "longName": "995695 - Disclosure - Accumulated Other Comprehensive Income (Tables)", "shortName": "Accumulated Other Comprehensive Income (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "33", "firstAnchor": { "contextRef": "C_0d3f46dd-32ef-48ee-b8c4-df5490602382", "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "us-gaap:ComprehensiveIncomeNoteTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "zbh-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_0d3f46dd-32ef-48ee-b8c4-df5490602382", "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "us-gaap:ComprehensiveIncomeNoteTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "zbh-20240331.htm", "first": true, "unique": true } }, "R34": { "role": "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureFairValueMeasurementOfAssetsAndLiabilitiesTables", "longName": "995705 - Disclosure - Fair Value Measurement of Assets and Liabilities (Tables)", "shortName": "Fair Value Measurement of Assets and Liabilities (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "34", "firstAnchor": { "contextRef": "C_0d3f46dd-32ef-48ee-b8c4-df5490602382", "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "us-gaap:FairValueDisclosuresTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "zbh-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_0d3f46dd-32ef-48ee-b8c4-df5490602382", "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "us-gaap:FairValueDisclosuresTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "zbh-20240331.htm", "first": true, "unique": true } }, "R35": { "role": "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesTables", "longName": "995715 - Disclosure - Derivative Instruments and Hedging Activities (Tables)", "shortName": "Derivative Instruments and Hedging Activities (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "35", "firstAnchor": { "contextRef": "C_0d3f46dd-32ef-48ee-b8c4-df5490602382", "name": "us-gaap:ScheduleOfFairValueHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "zbh-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_0d3f46dd-32ef-48ee-b8c4-df5490602382", "name": "us-gaap:ScheduleOfFairValueHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "zbh-20240331.htm", "first": true, "unique": true } }, "R36": { "role": "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureEarningsPerShareTables", "longName": "995725 - Disclosure - Earnings Per Share (Tables)", "shortName": "Earnings Per Share (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "36", "firstAnchor": { "contextRef": "C_0d3f46dd-32ef-48ee-b8c4-df5490602382", "name": "us-gaap:ScheduleOfWeightedAverageNumberOfSharesTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "us-gaap:EarningsPerShareTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "zbh-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_0d3f46dd-32ef-48ee-b8c4-df5490602382", "name": "us-gaap:ScheduleOfWeightedAverageNumberOfSharesTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "us-gaap:EarningsPerShareTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "zbh-20240331.htm", "first": true, "unique": true } }, "R37": { "role": "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureSegmentInformationTables", "longName": "995735 - Disclosure - Segment Information (Tables)", "shortName": "Segment Information (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "37", "firstAnchor": { "contextRef": "C_0d3f46dd-32ef-48ee-b8c4-df5490602382", "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "us-gaap:SegmentReportingDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "zbh-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_0d3f46dd-32ef-48ee-b8c4-df5490602382", "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "us-gaap:SegmentReportingDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "zbh-20240331.htm", "first": true, "unique": true } }, "R38": { "role": "http://www.zimmerbiomet.com/20240331/taxonomy/role/DisclosureDiscontinuedOperationsAndRelatedZimvieMattersAdditionalInformationDetails", "longName": "995755 - Disclosure - Discontinued Operations and Related ZimVie Matters - Additional Information (Details)", "shortName": "Discontinued Operations and Related ZimVie Matters - Additional Information (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "38", "firstAnchor": { "contextRef": "C_3359f745-8562-4f05-9743-e62f46e5b4fd", "name": "us-gaap:DebtInstrumentFaceAmount", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "p", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "zbh-20240331.htm", "first": true }, "uniqueAnchor": null }, "R39": { "role": "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureRevenueScheduleOfNetSalesByGeographyDetail", "longName": "995795 - Disclosure - Revenue - Schedule of Net Sales by Geography (Detail)", "shortName": "Revenue - Schedule of Net Sales by Geography (Detail)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "39", "firstAnchor": { "contextRef": "C_0d3f46dd-32ef-48ee-b8c4-df5490602382", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "zbh-20240331.htm", "first": true }, "uniqueAnchor": { "contextRef": "C_88cb51fb-b91f-4bcc-b417-2f4341122888", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock", "div", "us-gaap:RevenueFromContractWithCustomerTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "zbh-20240331.htm", "unique": true } }, "R40": { "role": "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureRevenueScheduleOfNetSalesByProductCategoryDetail", "longName": "995805 - Disclosure - Revenue - Schedule of Net Sales by Product Category (Detail)", "shortName": "Revenue - Schedule of Net Sales by Product Category (Detail)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "40", "firstAnchor": { "contextRef": "C_0d3f46dd-32ef-48ee-b8c4-df5490602382", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "zbh-20240331.htm", "first": true }, "uniqueAnchor": { "contextRef": "C_35e2319b-ec43-4a5b-b7f6-c828e141f8bc", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock", "div", "us-gaap:RevenueFromContractWithCustomerTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "zbh-20240331.htm", "unique": true } }, "R41": { "role": "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureRestructuringAdditionalInformationDetail", "longName": "995815 - Disclosure - Restructuring - Additional Information (Detail)", "shortName": "Restructuring - Additional Information (Detail)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "41", "firstAnchor": { "contextRef": "C_c9962ffb-b245-4ce4-939a-f0f31d30336e", "name": "us-gaap:RestructuringAndRelatedCostExpectedCost1", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "span", "p", "td", "tr", "table", "ix:continuation", "div", "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "zbh-20240331.htm", "first": true }, "uniqueAnchor": null }, "R42": { "role": "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureRestructuringSummaryOfLiabilitiesRecognizedRelatedToRestructuringPlanDetail", "longName": "995825 - Disclosure - Restructuring - Summary of Liabilities Recognized Related to Restructuring Plan (Detail)", "shortName": "Restructuring - Summary of Liabilities Recognized Related to Restructuring Plan (Detail)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "42", "firstAnchor": { "contextRef": "C_e8bbbfb2-1a7b-4134-8865-c703fcc42b99", "name": "us-gaap:RestructuringReserve", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "span", "p", "td", "tr", "table", "ix:continuation", "div", "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "zbh-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_e8bbbfb2-1a7b-4134-8865-c703fcc42b99", "name": "us-gaap:RestructuringReserve", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "span", "p", "td", "tr", "table", "ix:continuation", "div", "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "zbh-20240331.htm", "first": true, "unique": true } }, "R43": { "role": "http://www.zimmerbiomet.com/20240331/taxonomy/role/DisclosureRestructuringSummaryOfLocationOnCondensedConsolidatedStatementOfEarningsAndTypeOfCostForRestructuringPlanDetail", "longName": "995835 - Disclosure - Restructuring - Summary of Location on Condensed Consolidated Statement of Earnings and Type of Cost for Restructuring Plan (Detail)", "shortName": "Restructuring - Summary of Location on Condensed Consolidated Statement of Earnings and Type of Cost for Restructuring Plan (Detail)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "43", "firstAnchor": { "contextRef": "C_0d3f46dd-32ef-48ee-b8c4-df5490602382", "name": "us-gaap:CostOfGoodsAndServicesSold", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "zbh-20240331.htm", "first": true }, "uniqueAnchor": { "contextRef": "C_246a03d3-a777-4974-b8c5-697f834462f5", "name": "us-gaap:CostOfGoodsAndServicesSold", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock", "div", "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "zbh-20240331.htm", "unique": true } }, "R44": { "role": "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureInventoriesSummaryOfInventoriesDetail", "longName": "995845 - Disclosure - Inventories - Summary of Inventories (Detail)", "shortName": "Inventories - Summary of Inventories (Detail)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "44", "firstAnchor": { "contextRef": "C_3359f745-8562-4f05-9743-e62f46e5b4fd", "name": "us-gaap:InventoryFinishedGoodsNetOfReserves", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "div", "us-gaap:InventoryDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "zbh-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_3359f745-8562-4f05-9743-e62f46e5b4fd", "name": "us-gaap:InventoryFinishedGoodsNetOfReserves", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "div", "us-gaap:InventoryDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "zbh-20240331.htm", "first": true, "unique": true } }, "R45": { "role": "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosurePropertyPlantAndEquipmentSummaryOfPropertyPlantAndEquipmentDetail", "longName": "995855 - Disclosure - Property, Plant and Equipment - Summary of Property, Plant and Equipment (Detail)", "shortName": "Property, Plant and Equipment - Summary of Property, Plant and Equipment (Detail)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "45", "firstAnchor": { "contextRef": "C_3359f745-8562-4f05-9743-e62f46e5b4fd", "name": "us-gaap:PropertyPlantAndEquipmentGross", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:PropertyPlantAndEquipmentTextBlock", "div", "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "zbh-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_3359f745-8562-4f05-9743-e62f46e5b4fd", "name": "us-gaap:PropertyPlantAndEquipmentGross", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:PropertyPlantAndEquipmentTextBlock", "div", "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "zbh-20240331.htm", "first": true, "unique": true } }, "R46": { "role": "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosurePropertyPlantAndEquipmentAdditionalInformationDetail", "longName": "995865 - Disclosure - Property, Plant and Equipment - Additional Information (Detail)", "shortName": "Property, Plant and Equipment - Additional Information (Detail)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "46", "firstAnchor": { "contextRef": "C_0d3f46dd-32ef-48ee-b8c4-df5490602382", "name": "us-gaap:CapitalExpendituresIncurredButNotYetPaid", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "span", "p", "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "zbh-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_0d3f46dd-32ef-48ee-b8c4-df5490602382", "name": "us-gaap:CapitalExpendituresIncurredButNotYetPaid", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "span", "p", "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "zbh-20240331.htm", "first": true, "unique": true } }, "R47": { "role": "http://www.zimmerbiomet.com/20240331/taxonomy/role/DisclosureAcquisitionsAdditionalInformationDetail", "longName": "995875 - Disclosure - Acquisitions - Additional Information (Detail)", "shortName": "Acquisitions - Additional Information (Detail)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "47", "firstAnchor": { "contextRef": "C_0d3f46dd-32ef-48ee-b8c4-df5490602382", "name": "us-gaap:PaymentsOfMergerRelatedCostsFinancingActivities", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "zbh-20240331.htm", "first": true }, "uniqueAnchor": { "contextRef": "C_bff6948c-7748-430a-86e5-c6de21dd736d", "name": "us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "p", "us-gaap:BusinessCombinationDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "zbh-20240331.htm", "unique": true } }, "R48": { "role": "http://www.zimmerbiomet.com/20240331/taxonomy/role/DisclosureAcquisitionsSummaryOfEstimatesOfFairValueOfAssetsAcquiredAndLiabilitiesAssumedDetails", "longName": "995885 - Disclosure - Acquisitions - Summary of Estimates of Fair Value of Assets Acquired and Liabilities Assumed (Details)", "shortName": "Acquisitions - Summary of Estimates of Fair Value of Assets Acquired and Liabilities Assumed (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "48", "firstAnchor": { "contextRef": "C_3359f745-8562-4f05-9743-e62f46e5b4fd", "name": "us-gaap:Goodwill", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "zbh-20240331.htm", "first": true }, "uniqueAnchor": { "contextRef": "C_844ac33b-16ea-4101-8729-2639c1f4790a", "name": "us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock", "div", "us-gaap:BusinessCombinationDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "zbh-20240331.htm", "unique": true } }, "R49": { "role": "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDebtSummaryOfDebtInstrumentsDetail", "longName": "995895 - Disclosure - Debt - Summary of Debt Instruments (Detail)", "shortName": "Debt - Summary of Debt Instruments (Detail)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "49", "firstAnchor": { "contextRef": "C_3359f745-8562-4f05-9743-e62f46e5b4fd", "name": "us-gaap:LongTermDebtCurrent", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "zbh-20240331.htm", "first": true }, "uniqueAnchor": { "contextRef": "C_3359f745-8562-4f05-9743-e62f46e5b4fd", "name": "zbh:LongDebtHedgedByInterestRateSwap", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfDebtTableTextBlock", "div", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "zbh-20240331.htm", "unique": true } }, "R50": { "role": "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDebtSummaryOfDebtInstrumentsParentheticalDetail", "longName": "995905 - Disclosure - Debt - Summary of Debt Instruments (Parenthetical) (Detail)", "shortName": "Debt - Summary of Debt Instruments (Parenthetical) (Detail)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "parenthetical", "menuCat": "Details", "order": "50", "firstAnchor": { "contextRef": "C_ab09c1a3-ba0b-44b5-92fd-89269241af0c", "name": "us-gaap:DebtInstrumentInterestRateStatedPercentage", "unitRef": "U_pure", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfDebtTableTextBlock", "div", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "zbh-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_ab09c1a3-ba0b-44b5-92fd-89269241af0c", "name": "us-gaap:DebtInstrumentInterestRateStatedPercentage", "unitRef": "U_pure", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfDebtTableTextBlock", "div", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "zbh-20240331.htm", "first": true, "unique": true } }, "R51": { "role": "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDebtAdditionalInformationDetail", "longName": "995925 - Disclosure - Debt - Additional Information (Detail)", "shortName": "Debt - Additional Information (Detail)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "51", "firstAnchor": { "contextRef": "C_3359f745-8562-4f05-9743-e62f46e5b4fd", "name": "us-gaap:DebtLongtermAndShorttermCombinedAmount", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-8", "ancestors": [ "span", "p", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "zbh-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_3359f745-8562-4f05-9743-e62f46e5b4fd", "name": "us-gaap:DebtLongtermAndShorttermCombinedAmount", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-8", "ancestors": [ "span", "p", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "zbh-20240331.htm", "first": true, "unique": true } }, "R52": { "role": "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureAccumulatedOtherComprehensiveIncomeChangesInComponentsOfAccumulatedOtherComprehensiveIncomeNetOfTaxDetail", "longName": "995935 - Disclosure - Accumulated Other Comprehensive Income - Changes in Components of Accumulated Other Comprehensive Income, Net of Tax (Detail)", "shortName": "Accumulated Other Comprehensive Income - Changes in Components of Accumulated Other Comprehensive Income, Net of Tax (Detail)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "52", "firstAnchor": { "contextRef": "C_73ec43dd-f1ea-4bc2-b55f-7a8f6d9f63e1", "name": "us-gaap:StockholdersEquity", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "zbh-20240331.htm", "first": true }, "uniqueAnchor": { "contextRef": "C_0d3f46dd-32ef-48ee-b8c4-df5490602382", "name": "us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "div", "us-gaap:ComprehensiveIncomeNoteTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "zbh-20240331.htm", "unique": true } }, "R53": { "role": "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureAccumulatedOtherComprehensiveIncomeReclassificationAdjustmentsFromAccumulatedOtherComprehensiveIncomeDetail", "longName": "995945 - Disclosure - Accumulated Other Comprehensive Income - Reclassification Adjustments from Accumulated Other Comprehensive Income (Detail)", "shortName": "Accumulated Other Comprehensive Income - Reclassification Adjustments from Accumulated Other Comprehensive Income (Detail)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "53", "firstAnchor": { "contextRef": "C_0d3f46dd-32ef-48ee-b8c4-df5490602382", "name": "us-gaap:CostOfGoodsAndServicesSold", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "zbh-20240331.htm", "first": true }, "uniqueAnchor": { "contextRef": "C_9851973d-5ddb-4365-ace2-8ff323bd18b5", "name": "us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock", "div", "us-gaap:ComprehensiveIncomeNoteTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "zbh-20240331.htm", "unique": true } }, "R54": { "role": "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureAccumulatedOtherComprehensiveIncomeTaxEffectsOnEachComponentOfAccumulatedOtherComprehensiveIncomeRecognizedInStatementsOfComprehensiveIncomeDetail", "longName": "995955 - Disclosure - Accumulated Other Comprehensive Income - Tax Effects on Each Component of Accumulated Other Comprehensive Income Recognized in Statements of Comprehensive Income (Detail)", "shortName": "Accumulated Other Comprehensive Income - Tax Effects on Each Component of Accumulated Other Comprehensive Income Recognized in Statements of Comprehensive Income (Detail)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "54", "firstAnchor": { "contextRef": "C_0d3f46dd-32ef-48ee-b8c4-df5490602382", "name": "us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfComprehensiveIncomeLossTableTextBlock", "div", "us-gaap:ComprehensiveIncomeNoteTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "zbh-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_0d3f46dd-32ef-48ee-b8c4-df5490602382", "name": "us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfComprehensiveIncomeLossTableTextBlock", "div", "us-gaap:ComprehensiveIncomeNoteTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "zbh-20240331.htm", "first": true, "unique": true } }, "R55": { "role": "http://www.zimmerbiomet.com/20240331/taxonomy/role/DisclosureFairValueMeasurementOfAssetsAndLiabilitiesScheduleOfFairValueMeasurementOfAssetAndLiabilitiesDetail", "longName": "995965 - Disclosure - Fair Value Measurement of Assets and Liabilities - Schedule of Fair Value Measurement of Asset and Liabilities (Detail)", "shortName": "Fair Value Measurement of Assets and Liabilities - Schedule of Fair Value Measurement of Asset and Liabilities (Detail)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "55", "firstAnchor": { "contextRef": "C_53b7495d-db74-4264-a34e-7eb7f752f679", "name": "us-gaap:DerivativeLiabilities", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:OffsettingAssetsTableTextBlock", "div", "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "zbh-20240331.htm", "first": true }, "uniqueAnchor": { "contextRef": "C_5ae1d9ab-7c39-4092-8618-bda47d7e920b", "name": "us-gaap:AssetsFairValueDisclosure", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "div", "us-gaap:FairValueDisclosuresTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "zbh-20240331.htm", "unique": true } }, "R56": { "role": "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureFairValueMeasurementOfAssetsAndLiabilitiesAdditionalInformationDetails", "longName": "995975 - Disclosure - Fair Value Measurement of Assets and Liabilities - Additional Information (Details)", "shortName": "Fair Value Measurement of Assets and Liabilities - Additional Information (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "56", "firstAnchor": { "contextRef": "C_0d3f46dd-32ef-48ee-b8c4-df5490602382", "name": "us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "zbh-20240331.htm", "first": true }, "uniqueAnchor": { "contextRef": "C_c244ddec-ef28-4214-b9fd-184339338c1f", "name": "zbh:NumberOfSharesIssuedForContingentConsiderationLiability", "unitRef": "U_shares", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "span", "p", "us-gaap:FairValueDisclosuresTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "zbh-20240331.htm", "unique": true } }, "R57": { "role": "http://www.zimmerbiomet.com/20240331/taxonomy/role/DisclosureFairValueMeasurementOfAssetsAndLiabilitiesScheduleOfFairValueLiabilitiesMeasuredOnRecurringBasisDetail", "longName": "995985 - Disclosure - Fair Value Measurement of Assets and Liabilities - Schedule of Fair Value Liabilities Measured on Recurring Basis (Detail)", "shortName": "Fair Value Measurement of Assets and Liabilities - Schedule of Fair Value Liabilities Measured on Recurring Basis (Detail)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "57", "firstAnchor": { "contextRef": "C_73aed2b9-aa86-4e0d-9a48-868842621d40", "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock", "div", "us-gaap:FairValueDisclosuresTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "zbh-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_73aed2b9-aa86-4e0d-9a48-868842621d40", "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock", "div", "us-gaap:FairValueDisclosuresTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "zbh-20240331.htm", "first": true, "unique": true } }, "R58": { "role": "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesScheduleOfAmountsRecordedOnBalanceSheetRelatedToCumulativeBasisAdjustmentsForFairValueHedgesDetail", "longName": "995995 - Disclosure - Derivative Instruments and Hedging Activities - Schedule of Amounts Recorded On Balance Sheet Related To Cumulative Basis Adjustments For Fair Value Hedges (Detail)", "shortName": "Derivative Instruments and Hedging Activities - Schedule of Amounts Recorded On Balance Sheet Related To Cumulative Basis Adjustments For Fair Value Hedges (Detail)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "58", "firstAnchor": { "contextRef": "C_8f2d1f03-121a-47ef-9b58-d08b106196f9", "name": "us-gaap:LongTermDebt", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfFairValueHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock", "div", "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "zbh-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_8f2d1f03-121a-47ef-9b58-d08b106196f9", "name": "us-gaap:LongTermDebt", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfFairValueHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock", "div", "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "zbh-20240331.htm", "first": true, "unique": true } }, "R59": { "role": "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesAdditionalInformationDetail", "longName": "996005 - Disclosure - Derivative Instruments and Hedging Activities - Additional Information (Detail)", "shortName": "Derivative Instruments and Hedging Activities - Additional Information (Detail)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "59", "firstAnchor": { "contextRef": "C_3359f745-8562-4f05-9743-e62f46e5b4fd", "name": "zbh:ForwardStartingInterestRateSwapCashFlowHedgeRemainingToBeAmortized", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "span", "p", "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "zbh-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_3359f745-8562-4f05-9743-e62f46e5b4fd", "name": "zbh:ForwardStartingInterestRateSwapCashFlowHedgeRemainingToBeAmortized", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "span", "p", "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "zbh-20240331.htm", "first": true, "unique": true } }, "R60": { "role": "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesGrossUnrealizedLossesFromDerivativeInstrumentsDetail", "longName": "996015 - Disclosure - Derivative Instruments and Hedging Activities - Gross Unrealized Losses from Derivative Instruments (Detail)", "shortName": "Derivative Instruments and Hedging Activities - Gross Unrealized Losses from Derivative Instruments (Detail)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "60", "firstAnchor": { "contextRef": "C_0d3f46dd-32ef-48ee-b8c4-df5490602382", "name": "us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfComprehensiveIncomeLossTableTextBlock", "div", "us-gaap:ComprehensiveIncomeNoteTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "zbh-20240331.htm", "first": true }, "uniqueAnchor": { "contextRef": "C_1a8a36b4-58c7-4f4d-9055-33302c0d3819", "name": "us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "div", "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "zbh-20240331.htm", "unique": true } }, "R61": { "role": "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesEffectsOfFairValueCashFlowAndNetInvestmentHedgeAccountingOnCondensedConsolidatedStatementsOfEarningsDetail", "longName": "996025 - Disclosure - Derivative Instruments and Hedging Activities - Effects of Fair Value, Cash Flow and Net Investment Hedge Accounting on Condensed Consolidated Statements of Earnings (Detail)", "shortName": "Derivative Instruments and Hedging Activities - Effects of Fair Value, Cash Flow and Net Investment Hedge Accounting on Condensed Consolidated Statements of Earnings (Detail)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "61", "firstAnchor": { "contextRef": "C_0d3f46dd-32ef-48ee-b8c4-df5490602382", "name": "us-gaap:TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfNetInvestmentHedgesStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock", "div", "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "zbh-20240331.htm", "first": true }, "uniqueAnchor": { "contextRef": "C_bade59f1-ba89-4f47-bfc0-5339cccc5231", "name": "zbh:DerivativeIncomeExpenseEffectsOfFairValueCashFlowAndNetInvestmentHedges", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock", "div", "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "zbh-20240331.htm", "unique": true } }, "R62": { "role": "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsDetail", "longName": "996035 - Disclosure - Derivative Instruments and Hedging Activities - Derivative Instruments Not Designated as Hedging Instruments (Detail)", "shortName": "Derivative Instruments and Hedging Activities - Derivative Instruments Not Designated as Hedging Instruments (Detail)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "62", "firstAnchor": { "contextRef": "C_b0202f40-dda0-44c1-bfd8-be1f0b147485", "name": "us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock", "div", "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "zbh-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_b0202f40-dda0-44c1-bfd8-be1f0b147485", "name": "us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock", "div", "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "zbh-20240331.htm", "first": true, "unique": true } }, "R63": { "role": "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesFairValueOfDerivativeInstrumentsOnGrossBasisDetail", "longName": "996045 - Disclosure - Derivative Instruments and Hedging Activities - Fair Value of Derivative Instruments on Gross Basis (Detail)", "shortName": "Derivative Instruments and Hedging Activities - Fair Value of Derivative Instruments on Gross Basis (Detail)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "63", "firstAnchor": { "contextRef": "C_d7b04b21-86cf-4a03-bcde-c6b5f80da876", "name": "us-gaap:DerivativeFairValueOfDerivativeAsset", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "span", "p", "td", "tr", "table", "ix:continuation", "div", "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "zbh-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_d7b04b21-86cf-4a03-bcde-c6b5f80da876", "name": "us-gaap:DerivativeFairValueOfDerivativeAsset", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "span", "p", "td", "tr", "table", "ix:continuation", "div", "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "zbh-20240331.htm", "first": true, "unique": true } }, "R64": { "role": "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesScheduleOfEffectsOfMasterNettingAgreementsOnCondensedConsolidatedBalanceSheetsDetail", "longName": "996055 - Disclosure - Derivative Instruments and Hedging Activities - Schedule of Effects of Master Netting Agreements on Condensed Consolidated Balance Sheets (Detail)", "shortName": "Derivative Instruments and Hedging Activities - Schedule of Effects of Master Netting Agreements on Condensed Consolidated Balance Sheets (Detail)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "64", "firstAnchor": { "contextRef": "C_53b7495d-db74-4264-a34e-7eb7f752f679", "name": "us-gaap:DerivativeFairValueOfDerivativeLiability", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:OffsettingAssetsTableTextBlock", "div", "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "zbh-20240331.htm", "first": true }, "uniqueAnchor": { "contextRef": "C_53b7495d-db74-4264-a34e-7eb7f752f679", "name": "zbh:LiabilityDerivativesOffset", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:OffsettingAssetsTableTextBlock", "div", "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "zbh-20240331.htm", "unique": true } }, "R65": { "role": "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesNetInvestmentHedgeGainsLossesRecognizedOnCondensedConsolidatedStatementsOfComprehensiveIncomeDetail", "longName": "996065 - Disclosure - Derivative Instruments and Hedging Activities - Net Investment Hedge Gains (Losses) Recognized on Condensed Consolidated Statements of Comprehensive Income (Detail)", "shortName": "Derivative Instruments and Hedging Activities - Net Investment Hedge Gains (Losses) Recognized on Condensed Consolidated Statements of Comprehensive Income (Detail)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "65", "firstAnchor": { "contextRef": "C_0d3f46dd-32ef-48ee-b8c4-df5490602382", "name": "us-gaap:TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfNetInvestmentHedgesStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock", "div", "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "zbh-20240331.htm", "first": true }, "uniqueAnchor": { "contextRef": "C_c2874160-f670-496b-bdef-4103c1a93867", "name": "us-gaap:TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfNetInvestmentHedgesStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock", "div", "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "zbh-20240331.htm", "unique": true } }, "R66": { "role": "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetail", "longName": "996075 - Disclosure - Income Taxes - Additional Information (Detail)", "shortName": "Income Taxes - Additional Information (Detail)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "66", "firstAnchor": { "contextRef": "C_3359f745-8562-4f05-9743-e62f46e5b4fd", "name": "us-gaap:DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-6", "ancestors": [ "span", "p", "us-gaap:IncomeTaxDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "zbh-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_3359f745-8562-4f05-9743-e62f46e5b4fd", "name": "us-gaap:DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-6", "ancestors": [ "span", "p", "us-gaap:IncomeTaxDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "zbh-20240331.htm", "first": true, "unique": true } }, "R67": { "role": "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureEarningsPerShareReconciliationOfWeightedAverageSharesForBasicAndDilutedSharesComputationsDetail", "longName": "996085 - Disclosure - Earnings Per Share - Reconciliation of Weighted Average Shares for Basic and Diluted Shares Computations (Detail)", "shortName": "Earnings Per Share - Reconciliation of Weighted Average Shares for Basic and Diluted Shares Computations (Detail)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "67", "firstAnchor": { "contextRef": "C_0d3f46dd-32ef-48ee-b8c4-df5490602382", "name": "us-gaap:WeightedAverageNumberOfSharesOutstandingBasic", "unitRef": "U_shares", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "zbh-20240331.htm", "first": true }, "uniqueAnchor": { "contextRef": "C_0d3f46dd-32ef-48ee-b8c4-df5490602382", "name": "us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements", "unitRef": "U_shares", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfWeightedAverageNumberOfSharesTableTextBlock", "div", "us-gaap:EarningsPerShareTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "zbh-20240331.htm", "unique": true } }, "R68": { "role": "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureEarningsPerShareAdditionalInformationDetail", "longName": "996095 - Disclosure - Earnings Per Share - Additional Information (Detail)", "shortName": "Earnings Per Share - Additional Information (Detail)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "68", "firstAnchor": { "contextRef": "C_0d3f46dd-32ef-48ee-b8c4-df5490602382", "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "unitRef": "U_shares", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "span", "p", "us-gaap:EarningsPerShareTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "zbh-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_0d3f46dd-32ef-48ee-b8c4-df5490602382", "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "unitRef": "U_shares", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "span", "p", "us-gaap:EarningsPerShareTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "zbh-20240331.htm", "first": true, "unique": true } }, "R69": { "role": "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureSegmentInformationAdditionalInformationDetail", "longName": "996105 - Disclosure - Segment Information - Additional Information (Detail)", "shortName": "Segment Information - Additional Information (Detail)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "69", "firstAnchor": { "contextRef": "C_0d3f46dd-32ef-48ee-b8c4-df5490602382", "name": "us-gaap:NumberOfOperatingSegments", "unitRef": "U_Segment", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "p", "us-gaap:SegmentReportingDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "zbh-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_0d3f46dd-32ef-48ee-b8c4-df5490602382", "name": "us-gaap:NumberOfOperatingSegments", "unitRef": "U_Segment", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "p", "us-gaap:SegmentReportingDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "zbh-20240331.htm", "first": true, "unique": true } }, "R70": { "role": "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureSegmentInformationSummaryOfNetSalesAndOperatingProfitBySegmentDetail", "longName": "996115 - Disclosure - Segment Information - Summary of Net Sales and Operating Profit by Segment (Detail)", "shortName": "Segment Information - Summary of Net Sales and Operating Profit by Segment (Detail)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "70", "firstAnchor": { "contextRef": "C_0d3f46dd-32ef-48ee-b8c4-df5490602382", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "zbh-20240331.htm", "first": true }, "uniqueAnchor": { "contextRef": "C_858458db-7549-406c-9d50-f239f6a34fa9", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "div", "us-gaap:SegmentReportingDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "zbh-20240331.htm", "unique": true } }, "R71": { "role": "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetail", "longName": "996125 - Disclosure - Commitments and Contingencies - Additional Information (Detail)", "shortName": "Commitments and Contingencies - Additional Information (Detail)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "71", "firstAnchor": { "contextRef": "C_0d3f46dd-32ef-48ee-b8c4-df5490602382", "name": "us-gaap:LitigationSettlementExpense", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "span", "p", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "zbh-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_0d3f46dd-32ef-48ee-b8c4-df5490602382", "name": "us-gaap:LitigationSettlementExpense", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "span", "p", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "zbh-20240331.htm", "first": true, "unique": true } } }, "tag": { "us-gaap_AccountingPoliciesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccountingPoliciesAbstract", "lang": { "en-us": { "role": { "label": "Accounting Policies [Abstract]" } } }, "auth_ref": [] }, "us-gaap_AccountsPayableCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccountsPayableCurrent", "crdr": "credit", "calculation": { "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 0.0 } }, "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited" ], "lang": { "en-us": { "role": { "label": "Accounts Payable, Current", "terseLabel": "Accounts payable", "totalLabel": "Accounts Payable, Current, Total", "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)." } } }, "auth_ref": [ "r46", "r789" ] }, "us-gaap_AccountsReceivableNetCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccountsReceivableNetCurrent", "crdr": "debit", "calculation": { "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/DisclosureDiscontinuedOperationsAndRelatedZimvieMattersAdditionalInformationDetails", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited" ], "lang": { "en-us": { "role": { "label": "Accounts Receivable, after Allowance for Credit Loss, Current", "terseLabel": "Accounts receivable, less allowance for credit losses", "totalLabel": "Accounts Receivable, after Allowance for Credit Loss, Current, Total", "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current." } } }, "auth_ref": [ "r355", "r356" ] }, "us-gaap_AccruedIncomeTaxesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccruedIncomeTaxesCurrent", "crdr": "credit", "calculation": { "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited" ], "lang": { "en-us": { "role": { "label": "Accrued Income Taxes, Current", "terseLabel": "Income taxes payable", "documentation": "Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all currently due domestic and foreign income tax obligations." } } }, "auth_ref": [ "r164", "r217" ] }, "us-gaap_AccruedIncomeTaxesNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccruedIncomeTaxesNoncurrent", "crdr": "credit", "calculation": { "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited" ], "lang": { "en-us": { "role": { "label": "Accrued Income Taxes, Noncurrent", "terseLabel": "Long-term income tax payable", "documentation": "Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all domestic and foreign income tax obligations due beyond one year or the operating cycle, whichever is longer. Alternate captions include income taxes payable, noncurrent." } } }, "auth_ref": [ "r165", "r217" ] }, "us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccumulatedDefinedBenefitPlansAdjustmentMember", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureAccumulatedOtherComprehensiveIncomeChangesInComponentsOfAccumulatedOtherComprehensiveIncomeNetOfTaxDetail", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureAccumulatedOtherComprehensiveIncomeReclassificationAdjustmentsFromAccumulatedOtherComprehensiveIncomeDetail" ], "lang": { "en-us": { "role": { "label": "Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member]", "terseLabel": "Defined Benefit Plan Items [Member]", "documentation": "Accumulated other comprehensive (income) loss related to defined benefit plans attributable to the parent." } } }, "auth_ref": [ "r13", "r29", "r60", "r897", "r898", "r899" ] }, "zbh_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditAndUnrecognizedActuarialGainLossMember": { "xbrltype": "domainItemType", "nsuri": "http://www.zimmerbiomet.com/20240331", "localname": "AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditAndUnrecognizedActuarialGainLossMember", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureAccumulatedOtherComprehensiveIncomeReclassificationAdjustmentsFromAccumulatedOtherComprehensiveIncomeDetail" ], "lang": { "en-us": { "role": { "documentation": "Accumulated defined benefit plans adjustment net prior service cost credit and unrecognized actuarial gain loss.", "label": "Accumulated Defined Benefit Plans Adjustment Net Prior Service Cost Credit And Unrecognized Actuarial Gain Loss [Member]", "terseLabel": "Prior Service Cost and Unrecognized Actuarial Gain Loss [Member]" } } }, "auth_ref": [] }, "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment", "crdr": "credit", "calculation": { "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosurePropertyPlantAndEquipmentSummaryOfPropertyPlantAndEquipmentDetail": { "parentTag": "us-gaap_PropertyPlantAndEquipmentNet", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosurePropertyPlantAndEquipmentSummaryOfPropertyPlantAndEquipmentDetail" ], "lang": { "en-us": { "role": { "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment", "negatedLabel": "Accumulated depreciation", "totalLabel": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment, Total", "periodStartLabel": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment, Beginning Balance", "periodEndLabel": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment, Ending Balance", "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services." } } }, "auth_ref": [ "r90", "r247", "r595" ] }, "us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccumulatedGainLossNetCashFlowHedgeParentMember", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureAccumulatedOtherComprehensiveIncomeReclassificationAdjustmentsFromAccumulatedOtherComprehensiveIncomeDetail" ], "lang": { "en-us": { "role": { "label": "Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent [Member]", "terseLabel": "Cash Flow Hedges [Member]", "documentation": "Accumulated other comprehensive income (loss) from gain (loss) of derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness, attributable to parent." } } }, "auth_ref": [ "r268", "r277", "r278", "r518", "r761", "r897" ] }, "us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureAccumulatedOtherComprehensiveIncomeReclassificationAdjustmentsFromAccumulatedOtherComprehensiveIncomeDetail" ], "lang": { "en-us": { "role": { "label": "Accumulated Net Gain (Loss) from Cash Flow Hedges Attributable to Parent [Member]", "terseLabel": "Defined Benefit Plan Items [Member]", "documentation": "Accumulated other comprehensive income (loss) resulting from gain (loss) from derivative instruments designated and qualifying as the effective portion of cash flow hedges, attributable to the parent." } } }, "auth_ref": [ "r12", "r60", "r518" ] }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax", "crdr": "credit", "calculation": { "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited" ], "lang": { "en-us": { "role": { "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax", "terseLabel": "Accumulated other comprehensive loss", "totalLabel": "Accumulated Other Comprehensive Income (Loss), Net of Tax, Total", "documentation": "Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source." } } }, "auth_ref": [ "r59", "r60", "r180", "r258", "r591", "r617", "r621" ] }, "us-gaap_AccumulatedOtherComprehensiveIncomeMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccumulatedOtherComprehensiveIncomeMember", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureAccumulatedOtherComprehensiveIncomeChangesInComponentsOfAccumulatedOtherComprehensiveIncomeNetOfTaxDetail", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfStockholdersEquityUnaudited" ], "lang": { "en-us": { "role": { "label": "AOCI Attributable to Parent [Member]", "terseLabel": "Accumulated Other Comprehensive (Loss) Income [Member]", "verboseLabel": "Total AOCI [Member]", "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners." } } }, "auth_ref": [ "r8", "r29", "r60", "r531", "r534", "r571", "r612", "r613", "r897", "r898", "r899", "r907", "r908", "r909" ] }, "us-gaap_AccumulatedTranslationAdjustmentMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccumulatedTranslationAdjustmentMember", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureAccumulatedOtherComprehensiveIncomeChangesInComponentsOfAccumulatedOtherComprehensiveIncomeNetOfTaxDetail" ], "lang": { "en-us": { "role": { "label": "Accumulated Foreign Currency Adjustment Attributable to Parent [Member]", "terseLabel": "Foreign Currency Translation [Member]", "documentation": "Accumulated other comprehensive income (loss) resulting from foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to the parent." } } }, "auth_ref": [ "r10", "r29", "r60", "r277", "r278", "r562", "r563", "r564", "r565", "r567", "r897" ] }, "us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/DisclosureAcquisitionsAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Weighted average amortization period of intangible assets", "label": "Acquired Finite-Lived Intangible Assets, Weighted Average Useful Life", "documentation": "Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r196" ] }, "zbh_AcquisitionIntegrationDivestitureAndRelatedDiscontinuedOperation": { "xbrltype": "monetaryItemType", "nsuri": "http://www.zimmerbiomet.com/20240331", "localname": "AcquisitionIntegrationDivestitureAndRelatedDiscontinuedOperation", "crdr": "debit", "calculation": { "http://www.zimmerbiomet.com/20240331/taxonomy/role/DisclosureDiscontinuedOperationsAndRelatedZimvieMattersSummaryOfDetailsOfLossFromDiscontinuedOperationsIncludedInCondensedConsolidatedState": { "parentTag": "us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax", "weight": -1.0, "order": 6.0 } }, "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/DisclosureDiscontinuedOperationsAndRelatedZimvieMattersSummaryOfDetailsOfLossFromDiscontinuedOperationsIncludedInCondensedConsolidatedState" ], "lang": { "en-us": { "role": { "documentation": "Acquisition, integration, divestiture and related discontinued operation.", "label": "Acquisition Integration Divestiture And Related Discontinued Operation", "terseLabel": "Acquisition, integration, divestiture and related" } } }, "auth_ref": [] }, "zbh_AcquisitionIntegrationDivestitureAndRelatedExpenses": { "xbrltype": "monetaryItemType", "nsuri": "http://www.zimmerbiomet.com/20240331", "localname": "AcquisitionIntegrationDivestitureAndRelatedExpenses", "crdr": "debit", "calculation": { "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfEarningsUnaudited": { "parentTag": "us-gaap_CostsAndExpenses", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfEarningsUnaudited" ], "lang": { "en-us": { "role": { "documentation": "Acquisition integration divestiture and related expenses", "label": "Acquisition Integration Divestiture And Related Expenses", "terseLabel": "Acquisition, integration, divestiture and related" } } }, "auth_ref": [] }, "ecd_Additional402vDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "Additional402vDisclosureTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Additional 402(v) Disclosure [Text Block]", "terseLabel": "Additional 402(v) Disclosure" } } }, "auth_ref": [ "r842" ] }, "us-gaap_AdditionalPaidInCapitalCommonStock": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdditionalPaidInCapitalCommonStock", "crdr": "credit", "calculation": { "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited" ], "lang": { "en-us": { "role": { "label": "Additional Paid in Capital, Common Stock", "terseLabel": "Paid-in capital", "periodStartLabel": "Additional Paid in Capital, Common Stock, Beginning Balance", "periodEndLabel": "Additional Paid in Capital, Common Stock, Ending Balance", "documentation": "Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital." } } }, "auth_ref": [ "r168" ] }, "us-gaap_AdditionalPaidInCapitalMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdditionalPaidInCapitalMember", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfStockholdersEquityUnaudited" ], "lang": { "en-us": { "role": { "label": "Additional Paid-in Capital [Member]", "terseLabel": "Paid-in Capital [Member]", "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders." } } }, "auth_ref": [ "r484", "r485", "r486", "r634", "r907", "r908", "r909", "r938", "r959" ] }, "zbh_AdditionsToInstruments": { "xbrltype": "monetaryItemType", "nsuri": "http://www.zimmerbiomet.com/20240331", "localname": "AdditionsToInstruments", "crdr": "credit", "calculation": { "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0, "order": 0.0 } }, "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "documentation": "Additions to instruments, which are hand-held devices used by surgeons during total joint replacement and other surgical procedures.", "label": "Additions To Instruments", "negatedLabel": "Additions to instruments" } } }, "auth_ref": [] }, "ecd_AdjToCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AdjToCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Adjustment to Compensation Amount", "terseLabel": "Adjustment to Compensation, Amount" } } }, "auth_ref": [ "r848" ] }, "ecd_AdjToCompAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AdjToCompAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Adjustment to Compensation [Axis]", "terseLabel": "Adjustment to Compensation:" } } }, "auth_ref": [ "r848" ] }, "ecd_AdjToNonPeoNeoCompFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AdjToNonPeoNeoCompFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Adjustment to Non-PEO NEO Compensation Footnote [Text Block]", "terseLabel": "Adjustment to Non-PEO NEO Compensation Footnote" } } }, "auth_ref": [ "r848" ] }, "ecd_AdjToPeoCompFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AdjToPeoCompFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Adjustment To PEO Compensation, Footnote [Text Block]", "terseLabel": "Adjustment To PEO Compensation, Footnote" } } }, "auth_ref": [ "r848" ] }, "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Adjustments to reconcile net earnings to cash provided by operating activities:", "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]" } } }, "auth_ref": [] }, "ecd_AggtErrCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AggtErrCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Aggregate Erroneous Compensation Amount", "terseLabel": "Aggregate Erroneous Compensation Amount" } } }, "auth_ref": [ "r813", "r824", "r834", "r859" ] }, "ecd_AggtErrCompNotYetDeterminedTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AggtErrCompNotYetDeterminedTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Aggregate Erroneous Compensation Not Yet Determined [Text Block]", "terseLabel": "Aggregate Erroneous Compensation Not Yet Determined" } } }, "auth_ref": [ "r816", "r827", "r837", "r862" ] }, "ecd_AllAdjToCompMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AllAdjToCompMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "All Adjustments to Compensation [Member]", "terseLabel": "All Adjustments to Compensation" } } }, "auth_ref": [ "r848" ] }, "currency_AllCurrenciesDomain": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/currency/2023", "localname": "AllCurrenciesDomain", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "All Currencies [Domain]", "terseLabel": "All Currencies" } } }, "auth_ref": [] }, "ecd_AllExecutiveCategoriesMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AllExecutiveCategoriesMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "All Executive Categories [Member]", "terseLabel": "All Executive Categories" } } }, "auth_ref": [ "r855" ] }, "ecd_AllIndividualsMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AllIndividualsMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure", "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure", "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements", "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "All Individuals [Member]", "terseLabel": "All Individuals" } } }, "auth_ref": [ "r820", "r828", "r838", "r855", "r863", "r867", "r875" ] }, "ecd_AllTradingArrangementsMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AllTradingArrangementsMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "All Trading Arrangements [Member]", "terseLabel": "All Trading Arrangements" } } }, "auth_ref": [ "r873" ] }, "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentFlag", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Amendment Flag", "verboseLabel": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "srt_AmericasMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "AmericasMember", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureSegmentInformationSummaryOfNetSalesAndOperatingProfitBySegmentDetail" ], "lang": { "en-us": { "role": { "label": "Americas [Member]" } } }, "auth_ref": [ "r961", "r962", "r963", "r964" ] }, "us-gaap_AmortizationOfIntangibleAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AmortizationOfIntangibleAssets", "crdr": "debit", "calculation": { "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfEarningsUnaudited": { "parentTag": "us-gaap_CostsAndExpenses", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureSegmentInformationSummaryOfNetSalesAndOperatingProfitBySegmentDetail", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfEarningsUnaudited" ], "lang": { "en-us": { "role": { "label": "Amortization of Intangible Assets", "terseLabel": "Intangible asset amortization", "negatedLabel": "Intangible asset amortization", "totalLabel": "Amortization of Intangible Assets, Total", "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method." } } }, "auth_ref": [ "r22", "r85", "r89" ] }, "zbh_AmountOfPotentialAdditionalIncomeTaxExpensesRelatedToIRSNoticeOfProposedAdjustmentSubjectToInterestAndPenalties": { "xbrltype": "monetaryItemType", "nsuri": "http://www.zimmerbiomet.com/20240331", "localname": "AmountOfPotentialAdditionalIncomeTaxExpensesRelatedToIRSNoticeOfProposedAdjustmentSubjectToInterestAndPenalties", "crdr": "credit", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "documentation": "Amount of potential additional income tax expenses related to IRS notice of proposed adjustment subject to interest and penalties.", "label": "Amount Of Potential Additional Income Tax Expenses Related To I R S Notice Of Proposed Adjustment Subject To Interest And Penalties", "terseLabel": "Amount of potential additional income tax expense related to an IRS notice of proposed adjustment subject to interest and penalties." } } }, "auth_ref": [] }, "zbh_AmountsReclassifiedOutOfAccumulatedOtherComprehensiveIncomeLossAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.zimmerbiomet.com/20240331", "localname": "AmountsReclassifiedOutOfAccumulatedOtherComprehensiveIncomeLossAbstract", "lang": { "en-us": { "role": { "documentation": "Amounts Reclassified Out Of Accumulated Other Comprehensive Income Loss [Abstract]", "label": "Amounts Reclassified Out Of Accumulated Other Comprehensive Income Loss [Abstract]" } } }, "auth_ref": [] }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureEarningsPerShareAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount", "terseLabel": "Options to purchase shares of common stock not included in the computation of diluted earnings per share", "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented." } } }, "auth_ref": [ "r321" ] }, "us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AociLossCashFlowHedgeCumulativeGainLossAfterTax", "crdr": "credit", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "AOCI, Cash Flow Hedge, Cumulative Gain (Loss), after Tax", "terseLabel": "Fair value of outstanding derivative instruments, unrealized gain net of taxes deferred in accumulated other comprehensive income", "documentation": "Amount, after tax, of accumulated gain (loss) on derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness." } } }, "auth_ref": [ "r266" ] }, "zbh_AprilAcquisitionMember": { "xbrltype": "domainItemType", "nsuri": "http://www.zimmerbiomet.com/20240331", "localname": "AprilAcquisitionMember", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/DisclosureAcquisitionsAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "April Acquisition [Member]", "documentation": "April acquisition." } } }, "auth_ref": [] }, "us-gaap_ArrangementsAndNonarrangementTransactionsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ArrangementsAndNonarrangementTransactionsMember", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/DisclosureDiscontinuedOperationsAndRelatedZimvieMattersAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Domain]", "documentation": "Collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations." } } }, "auth_ref": [ "r512" ] }, "srt_AsiaPacificMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "AsiaPacificMember", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureSegmentInformationSummaryOfNetSalesAndOperatingProfitBySegmentDetail" ], "lang": { "en-us": { "role": { "label": "Asia Pacific [Member]" } } }, "auth_ref": [ "r961", "r962", "r963", "r964" ] }, "us-gaap_Assets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "Assets", "crdr": "debit", "calculation": { "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited" ], "lang": { "en-us": { "role": { "label": "Assets", "totalLabel": "Total Assets", "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events." } } }, "auth_ref": [ "r215", "r250", "r288", "r332", "r340", "r346", "r357", "r389", "r390", "r392", "r393", "r394", "r396", "r398", "r400", "r401", "r514", "r519", "r551", "r586", "r680", "r789", "r804", "r926", "r927", "r945" ] }, "us-gaap_AssetsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetsAbstract", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited" ], "lang": { "en-us": { "role": { "label": "Assets [Abstract]", "terseLabel": "ASSETS" } } }, "auth_ref": [] }, "us-gaap_AssetsCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetsCurrent", "crdr": "debit", "calculation": { "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 0.0 } }, "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited" ], "lang": { "en-us": { "role": { "label": "Assets, Current", "totalLabel": "Total Current Assets", "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events." } } }, "auth_ref": [ "r243", "r260", "r288", "r357", "r389", "r390", "r392", "r393", "r394", "r396", "r398", "r400", "r401", "r514", "r519", "r551", "r789", "r926", "r927", "r945" ] }, "us-gaap_AssetsCurrentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetsCurrentAbstract", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited" ], "lang": { "en-us": { "role": { "label": "Assets, Current [Abstract]", "terseLabel": "Current Assets:" } } }, "auth_ref": [] }, "us-gaap_AssetsFairValueDisclosure": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetsFairValueDisclosure", "crdr": "debit", "calculation": { "http://www.zimmerbiomet.com/20240331/taxonomy/role/DisclosureFairValueMeasurementOfAssetsAndLiabilitiesScheduleOfFairValueMeasurementOfAssetAndLiabilitiesDetail": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/DisclosureFairValueMeasurementOfAssetsAndLiabilitiesScheduleOfFairValueMeasurementOfAssetAndLiabilitiesDetail" ], "lang": { "en-us": { "role": { "label": "Assets, Fair Value Disclosure", "totalLabel": "Total Assets", "documentation": "Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events." } } }, "auth_ref": [ "r134" ] }, "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent", "crdr": "debit", "calculation": { "http://www.zimmerbiomet.com/20240331/taxonomy/role/DisclosureDiscontinuedOperationsAndRelatedZimvieMattersSummaryOfDetailsOfAssetsAndLiabilitiesOfDiscontinuedOperationDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/DisclosureDiscontinuedOperationsAndRelatedZimvieMattersSummaryOfDetailsOfAssetsAndLiabilitiesOfDiscontinuedOperationDetails" ], "lang": { "en-us": { "role": { "label": "Disposal Group, Including Discontinued Operation, Assets, Current", "terseLabel": "Current assets of discontinued operations", "totalLabel": "Total Current Assets of Discontinued Operations", "documentation": "Amount classified as assets attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r7", "r145", "r158", "r199", "r201", "r241", "r242" ] }, "ecd_AwardExrcPrice": { "xbrltype": "perShareItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardExrcPrice", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Exercise Price", "terseLabel": "Exercise Price" } } }, "auth_ref": [ "r870" ] }, "ecd_AwardGrantDateFairValue": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardGrantDateFairValue", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Grant Date Fair Value", "terseLabel": "Fair Value as of Grant Date" } } }, "auth_ref": [ "r871" ] }, "ecd_AwardTmgDiscLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardTmgDiscLineItems", "lang": { "en-us": { "role": { "label": "Award Timing Disclosures [Line Items]", "terseLabel": "Award Timing Disclosures" } } }, "auth_ref": [ "r866" ] }, "ecd_AwardTmgHowMnpiCnsdrdTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardTmgHowMnpiCnsdrdTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Timing, How MNPI Considered [Text Block]", "terseLabel": "Award Timing, How MNPI Considered" } } }, "auth_ref": [ "r866" ] }, "ecd_AwardTmgMethodTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardTmgMethodTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Timing Method [Text Block]", "terseLabel": "Award Timing Method" } } }, "auth_ref": [ "r866" ] }, "ecd_AwardTmgMnpiCnsdrdFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardTmgMnpiCnsdrdFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Timing MNPI Considered [Flag]", "terseLabel": "Award Timing MNPI Considered" } } }, "auth_ref": [ "r866" ] }, "ecd_AwardTmgMnpiDiscTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardTmgMnpiDiscTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Timing MNPI Disclosure [Text Block]", "terseLabel": "Award Timing MNPI Disclosure" } } }, "auth_ref": [ "r866" ] }, "ecd_AwardTmgPredtrmndFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardTmgPredtrmndFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Timing Predetermined [Flag]", "terseLabel": "Award Timing Predetermined" } } }, "auth_ref": [ "r866" ] }, "us-gaap_AwardTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AwardTypeAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Type [Axis]", "terseLabel": "Award Type", "documentation": "Information by type of award under share-based payment arrangement." } } }, "auth_ref": [ "r458", "r459", "r460", "r461", "r462", "r463", "r464", "r465", "r466", "r467", "r468", "r469", "r470", "r471", "r472", "r473", "r474", "r475", "r476", "r477", "r478", "r479", "r480", "r481", "r482", "r483" ] }, "ecd_AwardUndrlygSecuritiesAmt": { "xbrltype": "decimalItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardUndrlygSecuritiesAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Underlying Securities Amount", "terseLabel": "Underlying Securities" } } }, "auth_ref": [ "r869" ] }, "ecd_AwardsCloseToMnpiDiscIndName": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardsCloseToMnpiDiscIndName", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Awards Close in Time to MNPI Disclosures, Individual Name", "terseLabel": "Name" } } }, "auth_ref": [ "r868" ] }, "ecd_AwardsCloseToMnpiDiscTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardsCloseToMnpiDiscTable", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Awards Close in Time to MNPI Disclosures [Table]", "terseLabel": "Awards Close in Time to MNPI Disclosures" } } }, "auth_ref": [ "r867" ] }, "ecd_AwardsCloseToMnpiDiscTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardsCloseToMnpiDiscTableTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Awards Close in Time to MNPI Disclosures [Table Text Block]", "terseLabel": "Awards Close in Time to MNPI Disclosures, Table" } } }, "auth_ref": [ "r867" ] }, "us-gaap_BalanceSheetLocationAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BalanceSheetLocationAxis", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesFairValueOfDerivativeInstrumentsOnGrossBasisDetail", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesScheduleOfEffectsOfMasterNettingAgreementsOnCondensedConsolidatedBalanceSheetsDetail" ], "lang": { "en-us": { "role": { "label": "Balance Sheet Location [Axis]", "terseLabel": "Balance Sheet Location", "documentation": "Information by location on balance sheet (statement of financial position)." } } }, "auth_ref": [] }, "us-gaap_BalanceSheetLocationDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BalanceSheetLocationDomain", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesFairValueOfDerivativeInstrumentsOnGrossBasisDetail", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesScheduleOfEffectsOfMasterNettingAgreementsOnCondensedConsolidatedBalanceSheetsDetail" ], "lang": { "en-us": { "role": { "label": "Balance Sheet Location [Domain]", "terseLabel": "Balance Sheet Location", "documentation": "Location in the balance sheet (statement of financial position)." } } }, "auth_ref": [ "r119", "r124" ] }, "zbh_BuildingsAndEquipmentMember": { "xbrltype": "domainItemType", "nsuri": "http://www.zimmerbiomet.com/20240331", "localname": "BuildingsAndEquipmentMember", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosurePropertyPlantAndEquipmentSummaryOfPropertyPlantAndEquipmentDetail" ], "lang": { "en-us": { "role": { "documentation": "Buildings and equipment.", "label": "Buildings And Equipment [Member]", "terseLabel": "Buildings And Equipment [Member]" } } }, "auth_ref": [] }, "us-gaap_BusinessAcquisitionAcquireeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessAcquisitionAcquireeDomain", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/DisclosureAcquisitionsAdditionalInformationDetail", "http://www.zimmerbiomet.com/20240331/taxonomy/role/DisclosureAcquisitionsSummaryOfEstimatesOfFairValueOfAssetsAcquiredAndLiabilitiesAssumedDetails", "http://www.zimmerbiomet.com/20240331/taxonomy/role/DisclosureAcquisitionsTables", "http://www.zimmerbiomet.com/20240331/taxonomy/role/DisclosureFairValueMeasurementOfAssetsAndLiabilitiesScheduleOfFairValueLiabilitiesMeasuredOnRecurringBasisDetail", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureFairValueMeasurementOfAssetsAndLiabilitiesAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Business Acquisition, Acquiree [Domain]", "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree." } } }, "auth_ref": [ "r507", "r783", "r784" ] }, "us-gaap_BusinessAcquisitionAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessAcquisitionAxis", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/DisclosureAcquisitionsAdditionalInformationDetail", "http://www.zimmerbiomet.com/20240331/taxonomy/role/DisclosureAcquisitionsSummaryOfEstimatesOfFairValueOfAssetsAcquiredAndLiabilitiesAssumedDetails", "http://www.zimmerbiomet.com/20240331/taxonomy/role/DisclosureAcquisitionsTables", "http://www.zimmerbiomet.com/20240331/taxonomy/role/DisclosureFairValueMeasurementOfAssetsAndLiabilitiesScheduleOfFairValueLiabilitiesMeasuredOnRecurringBasisDetail", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureFairValueMeasurementOfAssetsAndLiabilitiesAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Business Acquisition [Axis]", "documentation": "Information by business combination or series of individually immaterial business combinations." } } }, "auth_ref": [ "r105", "r106", "r507", "r783", "r784" ] }, "us-gaap_BusinessAcquisitionEffectiveDateOfAcquisition1": { "xbrltype": "dateItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessAcquisitionEffectiveDateOfAcquisition1", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/DisclosureAcquisitionsAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "verboseLabel": "Acquisition date", "terseLabel": "Acquisition Date for Second Quarter Acquisition", "label": "Business Acquisition, Effective Date of Acquisition", "documentation": "Date when the acquirer obtains control of the acquiree, in YYYY-MM-DD format." } } }, "auth_ref": [ "r1", "r2", "r32" ] }, "us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned", "crdr": "credit", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/DisclosureAcquisitionsAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Business Acquisition, Equity Interest Issued or Issuable, Value Assigned", "verboseLabel": "Issuance of common stock for acquisition, valued", "documentation": "Value of equity interests (such as common shares, preferred shares, or partnership interest) issued or issuable to acquire the entity." } } }, "auth_ref": [ "r211" ] }, "us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/DisclosureAcquisitionsAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Business Acquisition, Equity Interest Issued or Issuable, Number of Shares", "verboseLabel": "Issuance of common stock for acquisition", "documentation": "Number of shares of equity interests issued or issuable to acquire entity." } } }, "auth_ref": [ "r211" ] }, "us-gaap_BusinessAcquisitionLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessAcquisitionLineItems", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/DisclosureAcquisitionsAdditionalInformationDetail", "http://www.zimmerbiomet.com/20240331/taxonomy/role/DisclosureAcquisitionsSummaryOfEstimatesOfFairValueOfAssetsAcquiredAndLiabilitiesAssumedDetails", "http://www.zimmerbiomet.com/20240331/taxonomy/role/DisclosureAcquisitionsTables" ], "lang": { "en-us": { "role": { "label": "Business Acquisition [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r507" ] }, "zbh_BusinessAndSignificantAccountingPoliciesLineItems": { "xbrltype": "stringItemType", "nsuri": "http://www.zimmerbiomet.com/20240331", "localname": "BusinessAndSignificantAccountingPoliciesLineItems", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureSignificantAccountingPoliciesAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "documentation": "Business And Significant Accounting Policies [Line Items]", "label": "Business And Significant Accounting Policies [Line Items]", "terseLabel": "Business And Significant Accounting Policies [Line Items]" } } }, "auth_ref": [] }, "zbh_BusinessAndSignificantAccountingPoliciesTable": { "xbrltype": "stringItemType", "nsuri": "http://www.zimmerbiomet.com/20240331", "localname": "BusinessAndSignificantAccountingPoliciesTable", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureSignificantAccountingPoliciesAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "documentation": "Business And Significant Accounting Policies [Table]", "label": "Business And Significant Accounting Policies [Table]", "terseLabel": "Business And Significant Accounting Policies [Table]" } } }, "auth_ref": [] }, "zbh_BusinessCombinationCommonStockSharesRepurchased": { "xbrltype": "sharesItemType", "nsuri": "http://www.zimmerbiomet.com/20240331", "localname": "BusinessCombinationCommonStockSharesRepurchased", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/DisclosureAcquisitionsAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "verboseLabel": "Shares of common stock repurchased", "documentation": "Business combination common stock shares repurchased.", "label": "Business Combination Common Stock Shares Repurchased", "terseLabel": "Business combination, shares of common stock repurchased" } } }, "auth_ref": [] }, "us-gaap_BusinessCombinationConsiderationTransferred1": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessCombinationConsiderationTransferred1", "crdr": "credit", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/DisclosureAcquisitionsAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "verboseLabel": "Total consideration transferred at the acquisition dates", "totalLabel": "Business Combination, Consideration Transferred, Total", "label": "Business Combination, Consideration Transferred", "documentation": "Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer." } } }, "auth_ref": [ "r3", "r4", "r25" ] }, "us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessCombinationConsiderationTransferredLiabilitiesIncurred", "crdr": "credit", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/DisclosureAcquisitionsAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Business Combination, Consideration Transferred, Liabilities Incurred", "terseLabel": "Deferred business combination payments", "documentation": "Amount of liabilities incurred by the acquirer as part of consideration transferred in a business combination." } } }, "auth_ref": [ "r3", "r4", "r111", "r510" ] }, "us-gaap_BusinessCombinationContingentConsiderationLiability": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessCombinationContingentConsiderationLiability", "crdr": "credit", "calculation": { "http://www.zimmerbiomet.com/20240331/taxonomy/role/DisclosureFairValueMeasurementOfAssetsAndLiabilitiesScheduleOfFairValueMeasurementOfAssetAndLiabilitiesDetail": { "parentTag": "us-gaap_FinancialLiabilitiesFairValueDisclosure", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/DisclosureFairValueMeasurementOfAssetsAndLiabilitiesScheduleOfFairValueMeasurementOfAssetAndLiabilitiesDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Contingent consideration related to acquisitions", "label": "Business Combination, Contingent Consideration, Liability", "totalLabel": "Business Combination, Contingent Consideration, Liability, Total", "verboseLabel": "New contingent payments related to the Embody acquisition", "documentation": "Amount of liability recognized arising from contingent consideration in a business combination." } } }, "auth_ref": [ "r5", "r112", "r511" ] }, "us-gaap_BusinessCombinationDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessCombinationDisclosureTextBlock", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/DisclosureAcquisitions" ], "lang": { "en-us": { "role": { "label": "Business Combination Disclosure [Text Block]", "terseLabel": "Acquisitions", "documentation": "The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable)." } } }, "auth_ref": [ "r208", "r508" ] }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets", "crdr": "debit", "calculation": { "http://www.zimmerbiomet.com/20240331/taxonomy/role/DisclosureAcquisitionsSummaryOfEstimatesOfFairValueOfAssetsAcquiredAndLiabilitiesAssumedDetails": { "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet", "weight": 1.0, "order": 0.0 } }, "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/DisclosureAcquisitionsSummaryOfEstimatesOfFairValueOfAssetsAcquiredAndLiabilitiesAssumedDetails" ], "lang": { "en-us": { "role": { "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets", "totalLabel": "Total assets acquired", "documentation": "Amount of assets acquired at the acquisition date." } } }, "auth_ref": [ "r108" ] }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability", "crdr": "credit", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/DisclosureAcquisitionsAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Business combination contingent consideration payments", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Contingent Liability", "verboseLabel": "Contingent consideration", "documentation": "The amount of liability arising from an inherited contingency (as defined) which has been recognized as of the acquisition date." } } }, "auth_ref": [ "r107", "r108" ] }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets", "crdr": "debit", "calculation": { "http://www.zimmerbiomet.com/20240331/taxonomy/role/DisclosureAcquisitionsSummaryOfEstimatesOfFairValueOfAssetsAcquiredAndLiabilitiesAssumedDetails": { "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/DisclosureAcquisitionsSummaryOfEstimatesOfFairValueOfAssetsAcquiredAndLiabilitiesAssumedDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Total", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets", "terseLabel": "Current assets", "documentation": "Amount of assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer, acquired at the acquisition date." } } }, "auth_ref": [ "r108" ] }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities", "crdr": "credit", "calculation": { "http://www.zimmerbiomet.com/20240331/taxonomy/role/DisclosureAcquisitionsSummaryOfEstimatesOfFairValueOfAssetsAcquiredAndLiabilitiesAssumedDetails": { "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities", "weight": 1.0, "order": 0.0 } }, "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/DisclosureAcquisitionsSummaryOfEstimatesOfFairValueOfAssetsAcquiredAndLiabilitiesAssumedDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Total", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities", "terseLabel": "Current liabilities", "documentation": "Amount of liabilities due within one year or within the normal operating cycle, if longer, assumed at the acquisition date." } } }, "auth_ref": [ "r108" ] }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities", "crdr": "credit", "calculation": { "http://www.zimmerbiomet.com/20240331/taxonomy/role/DisclosureAcquisitionsSummaryOfEstimatesOfFairValueOfAssetsAcquiredAndLiabilitiesAssumedDetails": { "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/DisclosureAcquisitionsSummaryOfEstimatesOfFairValueOfAssetsAcquiredAndLiabilitiesAssumedDetails" ], "lang": { "en-us": { "role": { "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities", "verboseLabel": "Deferred income taxes", "documentation": "Amount of deferred tax liability attributable to taxable temporary differences assumed at the acquisition date." } } }, "auth_ref": [ "r108" ] }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets", "crdr": "debit", "calculation": { "http://www.zimmerbiomet.com/20240331/taxonomy/role/DisclosureAcquisitionsSummaryOfEstimatesOfFairValueOfAssetsAcquiredAndLiabilitiesAssumedDetails": { "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/DisclosureAcquisitionsSummaryOfEstimatesOfFairValueOfAssetsAcquiredAndLiabilitiesAssumedDetails" ], "lang": { "en-us": { "role": { "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Indefinite-Lived Intangible Assets", "verboseLabel": "Intangible assets not subject to amortization", "documentation": "Amount of assets, excluding financial assets and goodwill, that lack physical substance, having a projected indefinite period of benefit, acquired at the acquisition date." } } }, "auth_ref": [ "r108" ] }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles", "crdr": "debit", "calculation": { "http://www.zimmerbiomet.com/20240331/taxonomy/role/DisclosureAcquisitionsSummaryOfEstimatesOfFairValueOfAssetsAcquiredAndLiabilitiesAssumedDetails": { "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets", "weight": 1.0, "order": 0.0 } }, "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/DisclosureAcquisitionsAdditionalInformationDetail", "http://www.zimmerbiomet.com/20240331/taxonomy/role/DisclosureAcquisitionsSummaryOfEstimatesOfFairValueOfAssetsAcquiredAndLiabilitiesAssumedDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "IPR&D", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles", "terseLabel": "Intangible assets subject to amortization", "documentation": "The amount of identifiable intangible assets recognized as of the acquisition date." } } }, "auth_ref": [ "r107", "r108" ] }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities", "crdr": "credit", "calculation": { "http://www.zimmerbiomet.com/20240331/taxonomy/role/DisclosureAcquisitionsSummaryOfEstimatesOfFairValueOfAssetsAcquiredAndLiabilitiesAssumedDetails": { "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/DisclosureAcquisitionsSummaryOfEstimatesOfFairValueOfAssetsAcquiredAndLiabilitiesAssumedDetails" ], "lang": { "en-us": { "role": { "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities", "totalLabel": "Total liabilities assumed", "documentation": "Amount of liabilities assumed at the acquisition date." } } }, "auth_ref": [ "r108" ] }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets", "crdr": "debit", "calculation": { "http://www.zimmerbiomet.com/20240331/taxonomy/role/DisclosureAcquisitionsSummaryOfEstimatesOfFairValueOfAssetsAcquiredAndLiabilitiesAssumedDetails": { "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/DisclosureAcquisitionsSummaryOfEstimatesOfFairValueOfAssetsAcquiredAndLiabilitiesAssumedDetails" ], "lang": { "en-us": { "role": { "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Noncurrent Assets", "terseLabel": "Other assets", "documentation": "Amount of other assets expected to be realized or consumed after one year or the normal operating cycle, if longer, acquired at the acquisition date." } } }, "auth_ref": [ "r108" ] }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet", "crdr": "debit", "calculation": { "http://www.zimmerbiomet.com/20240331/taxonomy/role/DisclosureAcquisitionsSummaryOfEstimatesOfFairValueOfAssetsAcquiredAndLiabilitiesAssumedDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/DisclosureAcquisitionsSummaryOfEstimatesOfFairValueOfAssetsAcquiredAndLiabilitiesAssumedDetails" ], "lang": { "en-us": { "role": { "label": "Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net", "totalLabel": "Net assets acquired", "documentation": "Amount recognized for assets, including goodwill, in excess of (less than) the aggregate liabilities assumed." } } }, "auth_ref": [ "r108" ] }, "zbh_BusinessCombinationSharesOfCommonStockRepurchased": { "xbrltype": "monetaryItemType", "nsuri": "http://www.zimmerbiomet.com/20240331", "localname": "BusinessCombinationSharesOfCommonStockRepurchased", "crdr": "credit", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/DisclosureAcquisitionsAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "documentation": "Business combination, shares of common stock repurchased.", "label": "Business Combination, Shares of Common Stock Repurchased", "terseLabel": "Business combination, shares of common stock repurchased" } } }, "auth_ref": [] }, "us-gaap_BusinessCombinationsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessCombinationsAbstract", "lang": { "en-us": { "role": { "label": "Business Combinations [Abstract]" } } }, "auth_ref": [] }, "currency_CHF": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/currency/2023", "localname": "CHF", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Switzerland, Francs", "terseLabel": "Swiss Francs [Member]" } } }, "auth_ref": [] }, "us-gaap_CapitalExpendituresIncurredButNotYetPaid": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CapitalExpendituresIncurredButNotYetPaid", "crdr": "credit", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosurePropertyPlantAndEquipmentAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Capital Expenditures Incurred but Not yet Paid", "terseLabel": "Property plant and equipment included in accounts payable", "documentation": "Future cash outflow to pay for purchases of fixed assets that have occurred." } } }, "auth_ref": [ "r68", "r69", "r70" ] }, "zbh_CarryingAmountOfHedgedLiabilitiesMember": { "xbrltype": "domainItemType", "nsuri": "http://www.zimmerbiomet.com/20240331", "localname": "CarryingAmountOfHedgedLiabilitiesMember", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesScheduleOfAmountsRecordedOnBalanceSheetRelatedToCumulativeBasisAdjustmentsForFairValueHedgesDetail" ], "lang": { "en-us": { "role": { "documentation": "Carrying amount of hedged liabilities.", "label": "Carrying Amount Of Hedged Liabilities [Member]", "terseLabel": "Carrying Amount of Hedged Liabilities [Member]" } } }, "auth_ref": [] }, "us-gaap_Cash": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "Cash", "crdr": "debit", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDebtAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Cash", "terseLabel": "Cash on hand from dividend", "periodStartLabel": "Cash, Beginning Balance", "periodEndLabel": "Cash, Ending Balance", "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation." } } }, "auth_ref": [ "r226", "r589", "r645", "r675", "r789", "r804", "r895" ] }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashAndCashEquivalentsAtCarryingValue", "crdr": "debit", "calculation": { "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 0.0 } }, "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited" ], "lang": { "en-us": { "role": { "label": "Cash and Cash Equivalents, at Carrying Value", "terseLabel": "Cash and cash equivalents", "totalLabel": "Cash and Cash Equivalents, at Carrying Value, Total", "periodStartLabel": "Cash and Cash Equivalents, at Carrying Value, Beginning Balance", "periodEndLabel": "Cash and Cash Equivalents, at Carrying Value, Ending Balance", "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation." } } }, "auth_ref": [ "r67", "r245", "r753" ] }, "us-gaap_CashAndCashEquivalentsAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashAndCashEquivalentsAxis", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDebtAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Cash and Cash Equivalents [Axis]", "documentation": "Information by type of cash and cash equivalent balance." } } }, "auth_ref": [ "r245" ] }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations", "crdr": "debit", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "periodStartLabel": "Cash and cash equivalents, beginning of year", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations", "totalLabel": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations, Total", "periodEndLabel": "Cash and cash equivalents, end of period", "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r67", "r190", "r285" ] }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "crdr": "debit", "calculation": { "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect", "totalLabel": "Change in cash and cash equivalents", "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r6", "r190" ] }, "zbh_CashFlowHedgesOneMember": { "xbrltype": "domainItemType", "nsuri": "http://www.zimmerbiomet.com/20240331", "localname": "CashFlowHedgesOneMember", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesScheduleOfEffectsOfMasterNettingAgreementsOnCondensedConsolidatedBalanceSheetsDetail" ], "lang": { "en-us": { "role": { "documentation": "Cash flow hedges.", "label": "Cash flow hedges one [member]", "terseLabel": "Cash Flow Hedges [Member]" } } }, "auth_ref": [] }, "us-gaap_CashFlowHedgingMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashFlowHedgingMember", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureAccumulatedOtherComprehensiveIncomeChangesInComponentsOfAccumulatedOtherComprehensiveIncomeNetOfTaxDetail", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesAdditionalInformationDetail", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesEffectsOfFairValueCashFlowAndNetInvestmentHedgeAccountingOnCondensedConsolidatedStatementsOfEarningsDetail", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesGrossUnrealizedLossesFromDerivativeInstrumentsDetail", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesScheduleOfEffectsOfMasterNettingAgreementsOnCondensedConsolidatedBalanceSheetsDetail" ], "lang": { "en-us": { "role": { "label": "Cash Flow Hedging [Member]", "terseLabel": "Cash Flow Hedges [Member]", "documentation": "Hedge of the exposure to variability in the cash flows of a recognized asset or liability, or of a forecasted transaction, that is attributable to a particular risk." } } }, "auth_ref": [ "r116" ] }, "us-gaap_CashMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashMember", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDebtAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Cash [Member]", "label": "Cash [Member]", "documentation": "Currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits." } } }, "auth_ref": [ "r245" ] }, "ecd_ChangedPeerGroupFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ChangedPeerGroupFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Changed Peer Group, Footnote [Text Block]", "terseLabel": "Changed Peer Group, Footnote" } } }, "auth_ref": [ "r846" ] }, "zbh_ChangesInEstimatesRelatedToContingentPaymentLiabilitiesIncludedInDiscontinuedOperations": { "xbrltype": "monetaryItemType", "nsuri": "http://www.zimmerbiomet.com/20240331", "localname": "ChangesInEstimatesRelatedToContingentPaymentLiabilitiesIncludedInDiscontinuedOperations", "crdr": "credit", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureFairValueMeasurementOfAssetsAndLiabilitiesAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "documentation": "Changes in estimates related to contingent payment liabilities included in discontinued operations.", "label": "Changes In Estimates Related To Contingent Payment Liabilities Included In Discontinued Operations", "terseLabel": "Changes in estimates related to contingent payment liabilities included in discontinued operations" } } }, "auth_ref": [] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CityAreaCode", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "City Area Code", "terseLabel": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "us-gaap_ClassOfStockDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ClassOfStockDomain", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Class of Stock [Domain]", "terseLabel": "Class of Stock", "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock." } } }, "auth_ref": [ "r238", "r255", "r256", "r257", "r288", "r311", "r315", "r318", "r320", "r326", "r327", "r357", "r389", "r392", "r393", "r394", "r400", "r401", "r432", "r433", "r434", "r435", "r436", "r551", "r626", "r627", "r628", "r629", "r634", "r635", "r636", "r637", "r638", "r639", "r640", "r641", "r642", "r643", "r644", "r646", "r667", "r689", "r708", "r731", "r732", "r733", "r734", "r735", "r882", "r904", "r910" ] }, "ecd_CoSelectedMeasureAmt": { "xbrltype": "decimalItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "CoSelectedMeasureAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Company Selected Measure Amount", "terseLabel": "Company Selected Measure Amount" } } }, "auth_ref": [ "r847" ] }, "ecd_CoSelectedMeasureName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "CoSelectedMeasureName", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Company Selected Measure Name", "terseLabel": "Company Selected Measure Name" } } }, "auth_ref": [ "r847" ] }, "us-gaap_CommitmentsAndContingencies": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommitmentsAndContingencies", "crdr": "credit", "calculation": { "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited": { "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Commitments and Contingencies (Note 15)", "label": "Commitments and Contingencies", "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur." } } }, "auth_ref": [ "r55", "r141", "r588", "r666" ] }, "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommitmentsAndContingenciesDisclosureAbstract", "lang": { "en-us": { "role": { "label": "Commitments and Contingencies Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommitmentsAndContingenciesDisclosureTextBlock", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureCommitmentsAndContingencies" ], "lang": { "en-us": { "role": { "label": "Commitments and Contingencies Disclosure [Text Block]", "terseLabel": "Commitments and Contingencies", "documentation": "The entire disclosure for commitments and contingencies." } } }, "auth_ref": [ "r203", "r381", "r382", "r738", "r919" ] }, "us-gaap_CommonStockDividendsPerShareDeclared": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockDividendsPerShareDeclared", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfStockholdersEquityParentheticalUnaudited" ], "lang": { "en-us": { "role": { "label": "Common Stock, Dividends, Per Share, Declared", "terseLabel": "Cash dividend declared per share", "documentation": "Aggregate dividends declared during the period for each share of common stock outstanding." } } }, "auth_ref": [ "r207" ] }, "us-gaap_CommonStockMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockMember", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/DisclosureAcquisitionsAdditionalInformationDetail", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureBasisOfPresentationAdditionalInformationDetails", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureFairValueMeasurementOfAssetsAndLiabilitiesAdditionalInformationDetails", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DocumentDocumentAndEntityInformation", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfStockholdersEquityUnaudited" ], "lang": { "en-us": { "role": { "label": "Common Stock [Member]", "terseLabel": "Common Stock [Member]", "documentation": "Stock that is subordinate to all other stock of the issuer." } } }, "auth_ref": [ "r792", "r793", "r794", "r796", "r797", "r798", "r801", "r907", "r908", "r938", "r957", "r959" ] }, "us-gaap_CommonStockParOrStatedValuePerShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockParOrStatedValuePerShare", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnauditedParenthetical" ], "lang": { "en-us": { "role": { "label": "Common Stock, Par or Stated Value Per Share", "terseLabel": "Common stock, par value", "documentation": "Face amount or stated value per share of common stock." } } }, "auth_ref": [ "r167" ] }, "us-gaap_CommonStockSharesAuthorized": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockSharesAuthorized", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnauditedParenthetical" ], "lang": { "en-us": { "role": { "label": "Common Stock, Shares Authorized", "terseLabel": "Common stock, shares authorized", "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws." } } }, "auth_ref": [ "r167", "r667" ] }, "zbh_CommonStockSharesForwardExchangeAgreement": { "xbrltype": "sharesItemType", "nsuri": "http://www.zimmerbiomet.com/20240331", "localname": "CommonStockSharesForwardExchangeAgreement", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/DisclosureDiscontinuedOperationsAndRelatedZimvieMattersAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Common Stock Shares Forward Exchange Agreement", "documentation": "Common stock shares forward exchange agreement." } } }, "auth_ref": [] }, "us-gaap_CommonStockSharesIssued": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockSharesIssued", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnauditedParenthetical" ], "lang": { "en-us": { "role": { "label": "Common Stock, Shares, Issued", "terseLabel": "Common stock, shares issued", "totalLabel": "Common Stock, Shares, Issued, Total", "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury." } } }, "auth_ref": [ "r167" ] }, "us-gaap_CommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockSharesOutstanding", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfStockholdersEquityUnaudited" ], "lang": { "en-us": { "role": { "label": "Common Stock, Shares, Outstanding", "periodEndLabel": "Balance, shares", "periodStartLabel": "Balance, shares", "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation." } } }, "auth_ref": [ "r30", "r167", "r667", "r686", "r959", "r960" ] }, "us-gaap_CommonStockValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockValue", "crdr": "credit", "calculation": { "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 0.0 } }, "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Common stock, $0.01 par value, one billion shares authorized, 317.2 million shares as of March 31, 2024 (316.2 million as of December 31, 2023) issued", "label": "Common Stock, Value, Issued", "totalLabel": "Common Stock, Value, Issued, Total", "periodStartLabel": "Common Stock, Value, Issued, Beginning Balance", "periodEndLabel": "Common Stock, Value, Issued, Ending Balance", "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity." } } }, "auth_ref": [ "r167", "r590", "r789" ] }, "ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "CompActuallyPaidVsCoSelectedMeasureTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Compensation Actually Paid vs. Company Selected Measure [Text Block]", "terseLabel": "Compensation Actually Paid vs. Company Selected Measure" } } }, "auth_ref": [ "r852" ] }, "ecd_CompActuallyPaidVsNetIncomeTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "CompActuallyPaidVsNetIncomeTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Compensation Actually Paid vs. Net Income [Text Block]", "terseLabel": "Compensation Actually Paid vs. Net Income" } } }, "auth_ref": [ "r851" ] }, "ecd_CompActuallyPaidVsOtherMeasureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "CompActuallyPaidVsOtherMeasureTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Compensation Actually Paid vs. Other Measure [Text Block]", "terseLabel": "Compensation Actually Paid vs. Other Measure" } } }, "auth_ref": [ "r853" ] }, "ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "CompActuallyPaidVsTotalShareholderRtnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Compensation Actually Paid vs. Total Shareholder Return [Text Block]", "terseLabel": "Compensation Actually Paid vs. Total Shareholder Return" } } }, "auth_ref": [ "r850" ] }, "us-gaap_ComprehensiveIncomeNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ComprehensiveIncomeNetOfTax", "crdr": "credit", "calculation": { "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfComprehensiveIncomeUnaudited": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfComprehensiveIncomeUnaudited" ], "lang": { "en-us": { "role": { "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent", "totalLabel": "Comprehensive Income Attributable to Zimmer Biomet Holdings, Inc.", "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners." } } }, "auth_ref": [ "r61", "r273", "r275", "r280", "r582", "r602" ] }, "us-gaap_ComprehensiveIncomeNoteTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ComprehensiveIncomeNoteTextBlock", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureAccumulatedOtherComprehensiveIncome" ], "lang": { "en-us": { "role": { "label": "Comprehensive Income (Loss) Note [Text Block]", "terseLabel": "Accumulated Other Comprehensive Income", "documentation": "The entire disclosure for comprehensive income, which includes, but is not limited to, 1) the amount of income tax expense or benefit allocated to each component of other comprehensive income, including reclassification adjustments, 2) the reclassification adjustments for each classification of other comprehensive income and 3) the ending accumulated balances for each component of comprehensive income." } } }, "auth_ref": [ "r178", "r279", "r581", "r601" ] }, "zbh_ConsolidatedEBITDARatio": { "xbrltype": "percentItemType", "nsuri": "http://www.zimmerbiomet.com/20240331", "localname": "ConsolidatedEBITDARatio", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDebtAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "documentation": "Consolidated EBITDA ratio.", "label": "Consolidated E B I T D A Ratio", "terseLabel": "Consolidated EBITDA ratio" } } }, "auth_ref": [] }, "zbh_ConsolidatedEBITDARatioThereafter": { "xbrltype": "percentItemType", "nsuri": "http://www.zimmerbiomet.com/20240331", "localname": "ConsolidatedEBITDARatioThereafter", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDebtAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "documentation": "Consolidated EBITDA ratio thereafter.", "label": "Consolidated E B I T D A Ratio Thereafter", "terseLabel": "Consolidated EBITDA ratio thereafter" } } }, "auth_ref": [] }, "srt_ConsolidationItemsAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ConsolidationItemsAxis", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureSegmentInformationSummaryOfNetSalesAndOperatingProfitBySegmentDetail" ], "lang": { "en-us": { "role": { "label": "Consolidation Items [Axis]", "terseLabel": "Consolidation Items" } } }, "auth_ref": [ "r290", "r334", "r338", "r339", "r340", "r341", "r342", "r344", "r348", "r389", "r390", "r391", "r392", "r394", "r395", "r397", "r399", "r400", "r926", "r927" ] }, "srt_ConsolidationItemsDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ConsolidationItemsDomain", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureSegmentInformationSummaryOfNetSalesAndOperatingProfitBySegmentDetail" ], "lang": { "en-us": { "role": { "label": "Consolidation Items [Domain]", "terseLabel": "Consolidation Items" } } }, "auth_ref": [ "r290", "r334", "r338", "r339", "r340", "r341", "r342", "r344", "r348", "r389", "r390", "r391", "r392", "r394", "r395", "r397", "r399", "r400", "r926", "r927" ] }, "us-gaap_ConstructionInProgressMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConstructionInProgressMember", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosurePropertyPlantAndEquipmentSummaryOfPropertyPlantAndEquipmentDetail" ], "lang": { "en-us": { "role": { "label": "Construction in Progress [Member]", "terseLabel": "Construction in Progress [Member]", "documentation": "Structure or a modification to a structure under construction. Includes recently completed structures or modifications to structures that have not been placed into service." } } }, "auth_ref": [] }, "zbh_ContractTermination1Member": { "xbrltype": "domainItemType", "nsuri": "http://www.zimmerbiomet.com/20240331", "localname": "ContractTermination1Member", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/DisclosureRestructuringSummaryOfLocationOnCondensedConsolidatedStatementOfEarningsAndTypeOfCostForRestructuringPlanDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Contract Termination [Member]", "label": "Contract Termination1 [Member]", "documentation": "Contract termination." } } }, "auth_ref": [] }, "us-gaap_ContractTerminationMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ContractTerminationMember", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureRestructuringSummaryOfLiabilitiesRecognizedRelatedToRestructuringPlanDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Contract Termination [Member]", "label": "Contract Termination [Member]", "documentation": "Termination of a contract associated with exit from or disposal of business activities or restructurings pursuant to a plan." } } }, "auth_ref": [ "r768", "r769", "r770", "r771" ] }, "zbh_CorporateItemsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.zimmerbiomet.com/20240331", "localname": "CorporateItemsMember", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureSegmentInformationSummaryOfNetSalesAndOperatingProfitBySegmentDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Corporate Items [Member]", "label": "Corporate Items [Member]", "documentation": "Corporate items." } } }, "auth_ref": [] }, "us-gaap_CostOfGoodsAndServicesSold": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CostOfGoodsAndServicesSold", "crdr": "debit", "calculation": { "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfEarningsUnaudited": { "parentTag": "us-gaap_CostsAndExpenses", "weight": 1.0, "order": 0.0 }, "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureAccumulatedOtherComprehensiveIncomeReclassificationAdjustmentsFromAccumulatedOtherComprehensiveIncomeDetail": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": -1.0, "order": 0.0 } }, "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/DisclosureRestructuringSummaryOfLocationOnCondensedConsolidatedStatementOfEarningsAndTypeOfCostForRestructuringPlanDetail", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureAccumulatedOtherComprehensiveIncomeReclassificationAdjustmentsFromAccumulatedOtherComprehensiveIncomeDetail", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfEarningsUnaudited" ], "lang": { "en-us": { "role": { "label": "Cost of Goods and Services Sold", "terseLabel": "Cost of products sold, excluding intangible asset amortization", "verboseLabel": "Cost of products sold", "totalLabel": "Cost of Goods and Services Sold, Total", "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities." } } }, "auth_ref": [ "r185", "r577" ] }, "us-gaap_CostOfSalesMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CostOfSalesMember", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesAdditionalInformationDetail", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesEffectsOfFairValueCashFlowAndNetInvestmentHedgeAccountingOnCondensedConsolidatedStatementsOfEarningsDetail", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesGrossUnrealizedLossesFromDerivativeInstrumentsDetail" ], "lang": { "en-us": { "role": { "label": "Cost of Sales [Member]", "terseLabel": "Cost of Products Sold [Member]", "documentation": "Primary financial statement caption encompassing cost of sales." } } }, "auth_ref": [] }, "us-gaap_CostsAndExpenses": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CostsAndExpenses", "crdr": "debit", "calculation": { "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfEarningsUnaudited": { "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0, "order": 0.0 } }, "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfEarningsUnaudited" ], "lang": { "en-us": { "role": { "label": "Costs and Expenses", "totalLabel": "Operating expenses", "documentation": "Total costs of sales and operating expenses for the period." } } }, "auth_ref": [ "r184" ] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "label": "Cover [Abstract]", "documentation": "Cover page." } } }, "auth_ref": [] }, "us-gaap_CreditFacilityAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CreditFacilityAxis", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/DisclosureDiscontinuedOperationsAndRelatedZimvieMattersAdditionalInformationDetails", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDebtAdditionalInformationDetail", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDebtSummaryOfDebtInstrumentsDetail" ], "lang": { "en-us": { "role": { "label": "Credit Facility [Axis]", "terseLabel": "Credit Facility", "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing." } } }, "auth_ref": [] }, "us-gaap_CreditFacilityDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CreditFacilityDomain", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/DisclosureDiscontinuedOperationsAndRelatedZimvieMattersAdditionalInformationDetails", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDebtAdditionalInformationDetail", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDebtSummaryOfDebtInstrumentsDetail" ], "lang": { "en-us": { "role": { "label": "Credit Facility [Domain]", "terseLabel": "Credit Facility", "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing." } } }, "auth_ref": [] }, "zbh_CrossCurrencyInterestRateContractMaturedMember": { "xbrltype": "domainItemType", "nsuri": "http://www.zimmerbiomet.com/20240331", "localname": "CrossCurrencyInterestRateContractMaturedMember", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "documentation": "Cross Currency Interest Rate Contract Matured [Member].", "label": "Cross Currency Interest Rate Contract Matured [Member]", "terseLabel": "Cross-Currency Interest Rate Swaps Matured [Member]" } } }, "auth_ref": [] }, "us-gaap_CrossCurrencyInterestRateContractMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CrossCurrencyInterestRateContractMember", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/DisclosureFairValueMeasurementOfAssetsAndLiabilitiesScheduleOfFairValueMeasurementOfAssetAndLiabilitiesDetail", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesAdditionalInformationDetail", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesEffectsOfFairValueCashFlowAndNetInvestmentHedgeAccountingOnCondensedConsolidatedStatementsOfEarningsDetail", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesFairValueOfDerivativeInstrumentsOnGrossBasisDetail", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesNetInvestmentHedgeGainsLossesRecognizedOnCondensedConsolidatedStatementsOfComprehensiveIncomeDetail" ], "lang": { "en-us": { "role": { "label": "Cross Currency Interest Rate Contract [Member]", "terseLabel": "Cross-currency Interest Rate Swaps [Member]", "documentation": "Derivative instrument whose primary underlying risk is tied to interest rates and foreign exchange rates." } } }, "auth_ref": [ "r931", "r937" ] }, "zbh_CrossCurrencyInterestRateContractTerminatedMember": { "xbrltype": "domainItemType", "nsuri": "http://www.zimmerbiomet.com/20240331", "localname": "CrossCurrencyInterestRateContractTerminatedMember", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Cross Currency Interest Rate Swap Terminated [Member]", "label": "Cross Currency Interest Rate Contract Terminated Member", "documentation": "Cross currency interest rate contract terminated." } } }, "auth_ref": [] }, "zbh_CumulativeFairValueHedgingAdjustmentCarryingAmountOfHedgedLiabilitiesMember": { "xbrltype": "domainItemType", "nsuri": "http://www.zimmerbiomet.com/20240331", "localname": "CumulativeFairValueHedgingAdjustmentCarryingAmountOfHedgedLiabilitiesMember", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesScheduleOfAmountsRecordedOnBalanceSheetRelatedToCumulativeBasisAdjustmentsForFairValueHedgesDetail" ], "lang": { "en-us": { "role": { "documentation": "Cumulative fair value hedging adjustment carrying amount of hedged liabilities.", "label": "Cumulative Fair Value Hedging Adjustment Carrying Amount Of Hedged Liabilities [Member]", "terseLabel": "Cumulative Amount of Fair Value Hedging Adjustment Included in Carrying Amount of Hedged Liabilities [Member]" } } }, "auth_ref": [] }, "srt_CurrencyAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "CurrencyAxis", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Currency [Axis]", "terseLabel": "Currency" } } }, "auth_ref": [ "r944" ] }, "dei_CurrentFiscalYearEndDate": { "xbrltype": "gMonthDayItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CurrentFiscalYearEndDate", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Current Fiscal Year End Date", "terseLabel": "Current Fiscal Year End Date", "documentation": "End date of current fiscal year in the format --MM-DD." } } }, "auth_ref": [] }, "us-gaap_CustomerRelationshipsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CustomerRelationshipsMember", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/DisclosureAcquisitionsAdditionalInformationDetail", "http://www.zimmerbiomet.com/20240331/taxonomy/role/DisclosureAcquisitionsSummaryOfEstimatesOfFairValueOfAssetsAcquiredAndLiabilitiesAssumedDetails" ], "lang": { "en-us": { "role": { "label": "Customer Relationships [Member]", "documentation": "Customer relationship that exists between an entity and its customer, for example, but not limited to, tenant relationships." } } }, "auth_ref": [ "r110" ] }, "us-gaap_DebtCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtCurrent", "crdr": "credit", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDebtAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Debt, Current", "verboseLabel": "Term loan", "totalLabel": "Debt, Current, Total", "documentation": "Amount of debt and lease obligation, classified as current." } } }, "auth_ref": [ "r253" ] }, "us-gaap_DebtDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtDisclosureAbstract", "lang": { "en-us": { "role": { "label": "Debt Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_DebtDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtDisclosureTextBlock", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDebt" ], "lang": { "en-us": { "role": { "label": "Debt Disclosure [Text Block]", "terseLabel": "Debt", "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants." } } }, "auth_ref": [ "r204", "r287", "r402", "r408", "r409", "r410", "r411", "r412", "r413", "r418", "r425", "r426", "r428" ] }, "us-gaap_DebtInstrumentAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentAxis", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/DisclosureDiscontinuedOperationsAndRelatedZimvieMattersAdditionalInformationDetails", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDebtAdditionalInformationDetail", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDebtSummaryOfDebtInstrumentsDetail", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDebtSummaryOfDebtInstrumentsParentheticalDetail", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Debt Instrument [Axis]", "terseLabel": "Debt Instrument", "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities." } } }, "auth_ref": [ "r42", "r163", "r164", "r216", "r218", "r290", "r403", "r404", "r405", "r406", "r407", "r409", "r414", "r415", "r416", "r417", "r419", "r420", "r421", "r422", "r423", "r424", "r568", "r772", "r773", "r774", "r775", "r776", "r905" ] }, "us-gaap_DebtInstrumentCarryingAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentCarryingAmount", "crdr": "credit", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/DisclosureDiscontinuedOperationsAndRelatedZimvieMattersAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Long-Term Debt, Gross", "terseLabel": "Outstanding principal balance", "documentation": "Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt." } } }, "auth_ref": [ "r42", "r218", "r429" ] }, "us-gaap_DebtInstrumentFaceAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentFaceAmount", "crdr": "credit", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/DisclosureDiscontinuedOperationsAndRelatedZimvieMattersAdditionalInformationDetails", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDebtAdditionalInformationDetail", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDebtSummaryOfDebtInstrumentsDetail" ], "lang": { "en-us": { "role": { "verboseLabel": "Aggregate principal amount", "label": "Aggregate principal amount", "terseLabel": "Senior Notes due", "documentation": "Face (par) amount of debt instrument at time of issuance." } } }, "auth_ref": [ "r138", "r140", "r403", "r568", "r773", "r774" ] }, "us-gaap_DebtInstrumentInterestRateStatedPercentage": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentInterestRateStatedPercentage", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/DisclosureDiscontinuedOperationsAndRelatedZimvieMattersAdditionalInformationDetails", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDebtAdditionalInformationDetail", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDebtSummaryOfDebtInstrumentsParentheticalDetail" ], "lang": { "en-us": { "role": { "label": "Debt Instrument, Interest Rate, Stated Percentage", "terseLabel": "Interest rate", "documentation": "Contractual interest rate for funds borrowed, under the debt agreement." } } }, "auth_ref": [ "r52", "r404" ] }, "us-gaap_DebtInstrumentLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentLineItems", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDebtAdditionalInformationDetail", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDebtSummaryOfDebtInstrumentsDetail", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDebtSummaryOfDebtInstrumentsParentheticalDetail" ], "lang": { "en-us": { "role": { "label": "Debt Instrument [Line Items]", "terseLabel": "Debt Instrument [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r290", "r403", "r404", "r405", "r406", "r407", "r409", "r414", "r415", "r416", "r417", "r419", "r420", "r421", "r422", "r423", "r424", "r427", "r568", "r772", "r773", "r774", "r775", "r776", "r905" ] }, "us-gaap_DebtInstrumentMaturityDate": { "xbrltype": "dateItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentMaturityDate", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDebtAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Debt Instrument, Maturity Date", "verboseLabel": "Maturity date of debt instrument", "documentation": "Date when the debt instrument is scheduled to be fully repaid, in YYYY-MM-DD format." } } }, "auth_ref": [ "r236", "r772", "r939" ] }, "us-gaap_DebtInstrumentNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentNameDomain", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/DisclosureDiscontinuedOperationsAndRelatedZimvieMattersAdditionalInformationDetails", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDebtAdditionalInformationDetail", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDebtSummaryOfDebtInstrumentsDetail", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDebtSummaryOfDebtInstrumentsParentheticalDetail", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Debt Instrument, Name [Domain]", "terseLabel": "Debt Instrument, Name", "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities." } } }, "auth_ref": [ "r53", "r290", "r403", "r404", "r405", "r406", "r407", "r409", "r414", "r415", "r416", "r417", "r419", "r420", "r421", "r422", "r423", "r424", "r568", "r772", "r773", "r774", "r775", "r776", "r905" ] }, "us-gaap_DebtInstrumentRedemptionPeriodAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentRedemptionPeriodAxis", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDebtAdditionalInformationDetail", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDebtSummaryOfDebtInstrumentsDetail", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDebtSummaryOfDebtInstrumentsParentheticalDetail", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Debt Instrument, Redemption, Period [Axis]", "terseLabel": "Debt Instrument, Redemption, Period", "documentation": "Information about timing of debt redemption features under terms of the debt agreement." } } }, "auth_ref": [ "r36" ] }, "us-gaap_DebtInstrumentRedemptionPeriodDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentRedemptionPeriodDomain", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDebtAdditionalInformationDetail", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDebtSummaryOfDebtInstrumentsDetail", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDebtSummaryOfDebtInstrumentsParentheticalDetail", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Debt Instrument, Redemption, Period [Domain]", "terseLabel": "Debt Instrument, Redemption, Period", "documentation": "Period as defined under terms of the debt agreement for debt redemption features." } } }, "auth_ref": [ "r36" ] }, "us-gaap_DebtInstrumentTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentTable", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDebtAdditionalInformationDetail", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDebtSummaryOfDebtInstrumentsDetail", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDebtSummaryOfDebtInstrumentsParentheticalDetail" ], "lang": { "en-us": { "role": { "label": "Schedule of Long-Term Debt Instruments [Table]", "terseLabel": "Debt Instrument [Table]", "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer." } } }, "auth_ref": [ "r53", "r98", "r99", "r137", "r138", "r140", "r142", "r205", "r206", "r290", "r403", "r404", "r405", "r406", "r407", "r409", "r414", "r415", "r416", "r417", "r419", "r420", "r421", "r422", "r423", "r424", "r427", "r568", "r772", "r773", "r774", "r775", "r776", "r905" ] }, "us-gaap_DebtInstrumentTerm": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentTerm", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDebtAdditionalInformationDetail", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Debt Instrument, Term", "verboseLabel": "Hedged senior notes maturity period", "label": "Debt instrument, term", "documentation": "Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [] }, "us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet", "crdr": "debit", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDebtAdditionalInformationDetail", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDebtSummaryOfDebtInstrumentsDetail" ], "lang": { "en-us": { "role": { "label": "Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net", "terseLabel": "Debt discount and issuance costs", "negatedLabel": "Debt discount and issuance costs", "totalLabel": "Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net, Total", "documentation": "Amount of unamortized debt discount (premium) and debt issuance costs." } } }, "auth_ref": [ "r139", "r414", "r430", "r773", "r774" ] }, "us-gaap_DebtLongtermAndShorttermCombinedAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtLongtermAndShorttermCombinedAmount", "crdr": "credit", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDebtAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Debt, Long-Term and Short-Term, Combined Amount", "terseLabel": "Debt, long-term and short-term, combined amount", "totalLabel": "Debt, Long-term and Short-term, Combined Amount, Total", "documentation": "Represents the aggregate of total long-term debt, including current maturities and short-term debt." } } }, "auth_ref": [] }, "us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible", "crdr": "debit", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Decrease in Unrecognized Tax Benefits is Reasonably Possible", "terseLabel": "Decrease in unrecognized tax benefits within the next twelve months", "documentation": "Amount of decrease reasonably possible in the next twelve months for the unrecognized tax benefit." } } }, "auth_ref": [ "r104" ] }, "us-gaap_DeferredIncomeTaxLiabilitiesNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredIncomeTaxLiabilitiesNet", "crdr": "credit", "calculation": { "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited" ], "lang": { "en-us": { "role": { "label": "Deferred Income Tax Liabilities, Net", "terseLabel": "Deferred income taxes, net", "totalLabel": "Deferred Income Tax Liabilities, Net, Total", "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting." } } }, "auth_ref": [ "r488", "r489", "r587" ] }, "zbh_DeferredPaymentsTimeframe": { "xbrltype": "durationItemType", "nsuri": "http://www.zimmerbiomet.com/20240331", "localname": "DeferredPaymentsTimeframe", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/DisclosureAcquisitionsAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "documentation": "Deferred payments timeframe.", "label": "Deferred Payments Timeframe", "terseLabel": "Deferred payments timeframe" } } }, "auth_ref": [] }, "us-gaap_DepreciationDepletionAndAmortization": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DepreciationDepletionAndAmortization", "crdr": "debit", "calculation": { "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "label": "Depreciation, Depletion and Amortization", "terseLabel": "Depreciation and amortization", "totalLabel": "Depreciation, Depletion and Amortization, Total", "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets." } } }, "auth_ref": [ "r22", "r335" ] }, "us-gaap_DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration": { "xbrltype": "enumerationSetItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/DisclosureFairValueMeasurementOfAssetsAndLiabilitiesScheduleOfFairValueMeasurementOfAssetAndLiabilitiesDetail", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesScheduleOfEffectsOfMasterNettingAgreementsOnCondensedConsolidatedBalanceSheetsDetail" ], "lang": { "en-us": { "role": { "label": "Derivative Asset, Statement of Financial Position [Extensible Enumeration]", "documentation": "Indicates line item in statement of financial position that includes derivative asset." } } }, "auth_ref": [ "r521" ] }, "us-gaap_DerivativeAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeAssets", "crdr": "debit", "calculation": { "http://www.zimmerbiomet.com/20240331/taxonomy/role/DisclosureFairValueMeasurementOfAssetsAndLiabilitiesScheduleOfFairValueMeasurementOfAssetAndLiabilitiesDetail": { "parentTag": "us-gaap_AssetsFairValueDisclosure", "weight": 1.0, "order": 0.0 }, "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesScheduleOfEffectsOfMasterNettingAgreementsOnCondensedConsolidatedBalanceSheetsDetail": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/DisclosureDiscontinuedOperationsAndRelatedZimvieMattersAdditionalInformationDetails", "http://www.zimmerbiomet.com/20240331/taxonomy/role/DisclosureFairValueMeasurementOfAssetsAndLiabilitiesScheduleOfFairValueMeasurementOfAssetAndLiabilitiesDetail", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesScheduleOfEffectsOfMasterNettingAgreementsOnCondensedConsolidatedBalanceSheetsDetail" ], "lang": { "en-us": { "role": { "verboseLabel": "Fair value of forward exchange agreement", "label": "Derivative Asset", "terseLabel": "Derivatives, current and long-term", "totalLabel": "Net Amount in Balance Sheet", "documentation": "Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets not subject to a master netting arrangement and not elected to be offset." } } }, "auth_ref": [ "r262", "r264", "r550", "r647", "r648", "r649", "r650", "r651", "r653", "r654", "r655", "r656", "r657", "r673", "r674", "r718", "r721", "r725", "r726", "r727", "r728", "r760", "r794", "r958" ] }, "us-gaap_DerivativeContractTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeContractTypeDomain", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/DisclosureDiscontinuedOperationsAndRelatedZimvieMattersAdditionalInformationDetails", "http://www.zimmerbiomet.com/20240331/taxonomy/role/DisclosureFairValueMeasurementOfAssetsAndLiabilitiesScheduleOfFairValueMeasurementOfAssetAndLiabilitiesDetail", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureAccumulatedOtherComprehensiveIncomeReclassificationAdjustmentsFromAccumulatedOtherComprehensiveIncomeDetail", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesAdditionalInformationDetail", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsDetail", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesEffectsOfFairValueCashFlowAndNetInvestmentHedgeAccountingOnCondensedConsolidatedStatementsOfEarningsDetail", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesFairValueOfDerivativeInstrumentsOnGrossBasisDetail", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesGrossUnrealizedLossesFromDerivativeInstrumentsDetail", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesNetInvestmentHedgeGainsLossesRecognizedOnCondensedConsolidatedStatementsOfComprehensiveIncomeDetail", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesScheduleOfAmountsRecordedOnBalanceSheetRelatedToCumulativeBasisAdjustmentsForFairValueHedgesDetail", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesScheduleOfEffectsOfMasterNettingAgreementsOnCondensedConsolidatedBalanceSheetsDetail" ], "lang": { "en-us": { "role": { "label": "Derivative Contract [Domain]", "terseLabel": "Derivative Contract", "documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset." } } }, "auth_ref": [ "r655", "r657", "r672", "r673", "r674", "r676", "r677", "r678", "r679", "r681", "r682", "r683", "r684", "r695", "r696", "r697", "r698", "r701", "r702", "r703", "r704", "r718", "r719", "r725", "r727", "r792", "r794" ] }, "us-gaap_DerivativeFairValueOfDerivativeAsset": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeFairValueOfDerivativeAsset", "crdr": "debit", "calculation": { "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesScheduleOfEffectsOfMasterNettingAgreementsOnCondensedConsolidatedBalanceSheetsDetail": { "parentTag": "us-gaap_DerivativeAssets", "weight": 1.0, "order": 0.0 } }, "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesFairValueOfDerivativeInstrumentsOnGrossBasisDetail", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesScheduleOfEffectsOfMasterNettingAgreementsOnCondensedConsolidatedBalanceSheetsDetail" ], "lang": { "en-us": { "role": { "label": "Derivative Asset, Subject to Master Netting Arrangement, before Offset", "terseLabel": "Derivative Assets", "verboseLabel": "Gross Amount", "totalLabel": "Derivative Asset, Fair Value, Gross Asset, Total", "documentation": "Fair value, before effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets elected not to be offset. Excludes assets not subject to a master netting arrangement." } } }, "auth_ref": [ "r39", "r122", "r177", "r261", "r760" ] }, "us-gaap_DerivativeFairValueOfDerivativeLiability": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeFairValueOfDerivativeLiability", "crdr": "credit", "calculation": { "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesScheduleOfEffectsOfMasterNettingAgreementsOnCondensedConsolidatedBalanceSheetsDetail": { "parentTag": "us-gaap_DerivativeLiabilities", "weight": 1.0, "order": 0.0 } }, "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesFairValueOfDerivativeInstrumentsOnGrossBasisDetail", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesScheduleOfEffectsOfMasterNettingAgreementsOnCondensedConsolidatedBalanceSheetsDetail" ], "lang": { "en-us": { "role": { "label": "Derivative Liability, Subject to Master Netting Arrangement, before Offset", "terseLabel": "Derivative Liabilities", "verboseLabel": "Gross Amount", "totalLabel": "Derivative Liability, Fair Value, Gross Liability, Total", "documentation": "Fair value, before effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities elected not to be offset. Excludes liabilities not subject to a master netting arrangement." } } }, "auth_ref": [ "r39", "r122", "r177", "r261", "r760" ] }, "zbh_DerivativeIncomeExpenseEffectsOfCashFlowHedges": { "xbrltype": "monetaryItemType", "nsuri": "http://www.zimmerbiomet.com/20240331", "localname": "DerivativeIncomeExpenseEffectsOfCashFlowHedges", "crdr": "credit", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesEffectsOfFairValueCashFlowAndNetInvestmentHedgeAccountingOnCondensedConsolidatedStatementsOfEarningsDetail" ], "lang": { "en-us": { "role": { "documentation": "Derivative income expense effects of cash flow hedges.", "label": "Derivative Income Expense Effects Of Cash Flow Hedges", "terseLabel": "Total amounts of income and expense line items presented in the statements of earnings in which the effects of fair value, cash flow and net investment hedges are recorded" } } }, "auth_ref": [] }, "zbh_DerivativeIncomeExpenseEffectsOfFairValueCashFlowAndNetInvestmentHedges": { "xbrltype": "monetaryItemType", "nsuri": "http://www.zimmerbiomet.com/20240331", "localname": "DerivativeIncomeExpenseEffectsOfFairValueCashFlowAndNetInvestmentHedges", "crdr": "credit", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesEffectsOfFairValueCashFlowAndNetInvestmentHedgeAccountingOnCondensedConsolidatedStatementsOfEarningsDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Total amounts of income and expense line items presented in the statements of earnings in which the effects of fair value, cash flow and net investment hedges are recorded", "label": "Derivative Income Expense Effects Of Fair Value Cash Flow And Net Investment Hedges", "documentation": "Derivative income expense effects of fair value, cash flow and net investment hedges." } } }, "auth_ref": [] }, "us-gaap_DerivativeInstrumentGainLossReclassifiedFromAociIntoIncomeEffectivePortionStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration": { "xbrltype": "enumerationSetItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeInstrumentGainLossReclassifiedFromAociIntoIncomeEffectivePortionStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsDetail", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesEffectsOfFairValueCashFlowAndNetInvestmentHedgeAccountingOnCondensedConsolidatedStatementsOfEarningsDetail", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesGrossUnrealizedLossesFromDerivativeInstrumentsDetail" ], "lang": { "en-us": { "role": { "label": "Derivative Instrument, Gain (Loss) Reclassified from AOCI into Income, Effective Portion, Statement of Income or Comprehensive Income [Extensible Enumeration]", "documentation": "Indicates line item in statement of income or comprehensive income that includes gain (loss) from effective portion of derivative instrument reclassified from accumulated other comprehensive income (AOCI) into income." } } }, "auth_ref": [ "r525" ] }, "us-gaap_DerivativeInstrumentRiskAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeInstrumentRiskAxis", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/DisclosureDiscontinuedOperationsAndRelatedZimvieMattersAdditionalInformationDetails", "http://www.zimmerbiomet.com/20240331/taxonomy/role/DisclosureFairValueMeasurementOfAssetsAndLiabilitiesScheduleOfFairValueMeasurementOfAssetAndLiabilitiesDetail", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureAccumulatedOtherComprehensiveIncomeReclassificationAdjustmentsFromAccumulatedOtherComprehensiveIncomeDetail", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesAdditionalInformationDetail", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsDetail", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesEffectsOfFairValueCashFlowAndNetInvestmentHedgeAccountingOnCondensedConsolidatedStatementsOfEarningsDetail", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesFairValueOfDerivativeInstrumentsOnGrossBasisDetail", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesGrossUnrealizedLossesFromDerivativeInstrumentsDetail", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesNetInvestmentHedgeGainsLossesRecognizedOnCondensedConsolidatedStatementsOfComprehensiveIncomeDetail", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesScheduleOfAmountsRecordedOnBalanceSheetRelatedToCumulativeBasisAdjustmentsForFairValueHedgesDetail", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesScheduleOfEffectsOfMasterNettingAgreementsOnCondensedConsolidatedBalanceSheetsDetail" ], "lang": { "en-us": { "role": { "label": "Derivative Instrument [Axis]", "terseLabel": "Derivative Instrument", "documentation": "Information by type of derivative contract." } } }, "auth_ref": [ "r120", "r123", "r125", "r130", "r655", "r657", "r672", "r673", "r674", "r676", "r677", "r678", "r679", "r681", "r682", "r683", "r684", "r695", "r696", "r697", "r698", "r701", "r702", "r703", "r704", "r718", "r719", "r725", "r727", "r760", "r792", "r794" ] }, "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract", "lang": { "en-us": { "role": { "label": "Derivative Instruments and Hedging Activities Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivities" ], "lang": { "en-us": { "role": { "label": "Derivative Instruments and Hedging Activities Disclosure [Text Block]", "terseLabel": "Derivative Instruments and Hedging Activities", "documentation": "The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts." } } }, "auth_ref": [ "r214", "r528", "r536" ] }, "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesScheduleOfEffectsOfMasterNettingAgreementsOnCondensedConsolidatedBalanceSheetsDetail" ], "lang": { "en-us": { "role": { "label": "Derivative Instruments and Hedging Activities Disclosures [Line Items]", "terseLabel": "Derivative Instruments and Hedging Activities Disclosures [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesScheduleOfEffectsOfMasterNettingAgreementsOnCondensedConsolidatedBalanceSheetsDetail" ], "lang": { "en-us": { "role": { "label": "Derivative Instruments and Hedging Activities Disclosures [Table]", "terseLabel": "Derivative Instruments And Hedging Activities Disclosures [Table]", "documentation": "Disclosure of information about derivatives and hedging activities." } } }, "auth_ref": [] }, "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipAxis", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureAccumulatedOtherComprehensiveIncomeChangesInComponentsOfAccumulatedOtherComprehensiveIncomeNetOfTaxDetail", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesAdditionalInformationDetail", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesEffectsOfFairValueCashFlowAndNetInvestmentHedgeAccountingOnCondensedConsolidatedStatementsOfEarningsDetail", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesGrossUnrealizedLossesFromDerivativeInstrumentsDetail", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesScheduleOfEffectsOfMasterNettingAgreementsOnCondensedConsolidatedBalanceSheetsDetail" ], "lang": { "en-us": { "role": { "label": "Hedging Relationship [Axis]", "terseLabel": "Hedging Relationship", "documentation": "Information by type of hedging relationship." } } }, "auth_ref": [ "r31", "r120", "r125" ] }, "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesAdditionalInformationDetail", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsDetail", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesEffectsOfFairValueCashFlowAndNetInvestmentHedgeAccountingOnCondensedConsolidatedStatementsOfEarningsDetail", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesGrossUnrealizedLossesFromDerivativeInstrumentsDetail", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesNetInvestmentHedgeGainsLossesRecognizedOnCondensedConsolidatedStatementsOfComprehensiveIncomeDetail", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesScheduleOfAmountsRecordedOnBalanceSheetRelatedToCumulativeBasisAdjustmentsForFairValueHedgesDetail" ], "lang": { "en-us": { "role": { "label": "Derivative Instruments, Gain (Loss) [Table]", "terseLabel": "Derivative Instruments Gain Loss By Hedging Relationship By Income Statement Location By Derivative Instrument Risk [Table]", "documentation": "Disclosure of information about the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments." } } }, "auth_ref": [ "r31", "r120", "r125", "r130", "r131", "r132", "r526" ] }, "us-gaap_DerivativeInstrumentsGainLossLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeInstrumentsGainLossLineItems", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesAdditionalInformationDetail", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsDetail", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesEffectsOfFairValueCashFlowAndNetInvestmentHedgeAccountingOnCondensedConsolidatedStatementsOfEarningsDetail", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesGrossUnrealizedLossesFromDerivativeInstrumentsDetail", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesNetInvestmentHedgeGainsLossesRecognizedOnCondensedConsolidatedStatementsOfComprehensiveIncomeDetail", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesScheduleOfAmountsRecordedOnBalanceSheetRelatedToCumulativeBasisAdjustmentsForFairValueHedgesDetail" ], "lang": { "en-us": { "role": { "label": "Derivative Instruments, Gain (Loss) [Line Items]", "terseLabel": "Derivative Instruments Gain Loss [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r526" ] }, "us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet", "crdr": "credit", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesEffectsOfFairValueCashFlowAndNetInvestmentHedgeAccountingOnCondensedConsolidatedStatementsOfEarningsDetail", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesGrossUnrealizedLossesFromDerivativeInstrumentsDetail" ], "lang": { "en-us": { "role": { "label": "Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net", "terseLabel": "Amount of Gain / (Loss) Reclassified from AOCI", "verboseLabel": "Gain (loss) on cash flow hedging relationships", "totalLabel": "Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net, Total", "documentation": "The effective portion of net gain (loss) reclassified from accumulated other comprehensive income into income on derivative instruments designated and qualifying as hedging instruments." } } }, "auth_ref": [ "r38", "r128" ] }, "us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet", "crdr": "credit", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsDetail" ], "lang": { "en-us": { "role": { "label": "Derivative Instruments Not Designated as Hedging Instruments, Gain (Loss), Net", "terseLabel": "Gains/(losses) from derivative instruments not designated as hedging instruments", "totalLabel": "Derivative Instruments Not Designated as Hedging Instruments, Gain (Loss), Net, Total", "documentation": "Amount of realized and unrealized gain (loss) of derivative instruments not designated or qualifying as hedging instruments." } } }, "auth_ref": [ "r129", "r891" ] }, "us-gaap_DerivativeLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeLiabilities", "crdr": "credit", "calculation": { "http://www.zimmerbiomet.com/20240331/taxonomy/role/DisclosureFairValueMeasurementOfAssetsAndLiabilitiesScheduleOfFairValueMeasurementOfAssetAndLiabilitiesDetail": { "parentTag": "us-gaap_FinancialLiabilitiesFairValueDisclosure", "weight": 1.0, "order": 0.0 }, "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesScheduleOfEffectsOfMasterNettingAgreementsOnCondensedConsolidatedBalanceSheetsDetail": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/DisclosureFairValueMeasurementOfAssetsAndLiabilitiesScheduleOfFairValueMeasurementOfAssetAndLiabilitiesDetail", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesScheduleOfEffectsOfMasterNettingAgreementsOnCondensedConsolidatedBalanceSheetsDetail" ], "lang": { "en-us": { "role": { "label": "Derivative Liability", "terseLabel": "Derivatives, current and long-term", "totalLabel": "Net Amount in Balance Sheet", "documentation": "Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset." } } }, "auth_ref": [ "r262", "r264", "r550", "r647", "r648", "r649", "r650", "r653", "r654", "r655", "r656", "r657", "r681", "r683", "r684", "r719", "r720", "r721", "r725", "r726", "r727", "r728", "r760", "r958" ] }, "us-gaap_DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration": { "xbrltype": "enumerationSetItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/DisclosureFairValueMeasurementOfAssetsAndLiabilitiesScheduleOfFairValueMeasurementOfAssetAndLiabilitiesDetail", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesScheduleOfEffectsOfMasterNettingAgreementsOnCondensedConsolidatedBalanceSheetsDetail" ], "lang": { "en-us": { "role": { "label": "Derivative Liability, Statement of Financial Position [Extensible Enumeration]", "documentation": "Indicates line item in statement of financial position that includes derivative liability." } } }, "auth_ref": [ "r521" ] }, "us-gaap_DerivativeNotionalAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeNotionalAmount", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Derivative, Notional Amount", "terseLabel": "Derivative notional amount, Total", "documentation": "Nominal or face amount used to calculate payment on derivative." } } }, "auth_ref": [ "r935", "r936" ] }, "zbh_DerivativeOffset": { "xbrltype": "monetaryItemType", "nsuri": "http://www.zimmerbiomet.com/20240331", "localname": "DerivativeOffset", "crdr": "credit", "calculation": { "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesScheduleOfEffectsOfMasterNettingAgreementsOnCondensedConsolidatedBalanceSheetsDetail": { "parentTag": "us-gaap_DerivativeAssets", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesScheduleOfEffectsOfMasterNettingAgreementsOnCondensedConsolidatedBalanceSheetsDetail" ], "lang": { "en-us": { "role": { "documentation": "The effect of master netting arrangements in offsetting derivative instrument assets and liabilities.", "label": "Derivative Offset", "verboseLabel": "Offset" } } }, "auth_ref": [] }, "us-gaap_DerivativesFairValueLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativesFairValueLineItems", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesFairValueOfDerivativeInstrumentsOnGrossBasisDetail" ], "lang": { "en-us": { "role": { "label": "Derivatives, Fair Value [Line Items]", "terseLabel": "Derivatives, Fair Value [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_DesignatedAsHedgingInstrumentMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DesignatedAsHedgingInstrumentMember", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/DisclosureFairValueMeasurementOfAssetsAndLiabilitiesScheduleOfFairValueMeasurementOfAssetAndLiabilitiesDetail", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesFairValueOfDerivativeInstrumentsOnGrossBasisDetail" ], "lang": { "en-us": { "role": { "label": "Designated as Hedging Instrument [Member]", "terseLabel": "Derivatives Designated as Hedges [Member]", "documentation": "Derivative instrument designated as hedging instrument under Generally Accepted Accounting Principles (GAAP)." } } }, "auth_ref": [ "r31" ] }, "us-gaap_DevelopedTechnologyRightsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DevelopedTechnologyRightsMember", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/DisclosureAcquisitionsAdditionalInformationDetail", "http://www.zimmerbiomet.com/20240331/taxonomy/role/DisclosureAcquisitionsSummaryOfEstimatesOfFairValueOfAssetsAcquiredAndLiabilitiesAssumedDetails" ], "lang": { "en-us": { "role": { "label": "Developed Technology Rights [Member]", "terseLabel": "Technology [Member]", "documentation": "Rights to developed technology, which can include the right to develop, use, market, sell, or offer for sale products, compounds, or intellectual property." } } }, "auth_ref": [ "r210" ] }, "us-gaap_DisaggregationOfRevenueAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DisaggregationOfRevenueAbstract", "lang": { "en-us": { "role": { "label": "Disaggregation of Revenue [Abstract]" } } }, "auth_ref": [] }, "zbh_DiscontinuedInterestRateSwapsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.zimmerbiomet.com/20240331", "localname": "DiscontinuedInterestRateSwapsMember", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesEffectsOfFairValueCashFlowAndNetInvestmentHedgeAccountingOnCondensedConsolidatedStatementsOfEarningsDetail" ], "lang": { "en-us": { "role": { "documentation": "Discontinued interest rate swaps.", "label": "Discontinued Interest Rate Swaps [Member]", "terseLabel": "Discontinued Interest Rate Swaps [Member]" } } }, "auth_ref": [] }, "zbh_DiscontinuedOperationAmortizationOfIntangibleAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://www.zimmerbiomet.com/20240331", "localname": "DiscontinuedOperationAmortizationOfIntangibleAssets", "crdr": "debit", "calculation": { "http://www.zimmerbiomet.com/20240331/taxonomy/role/DisclosureDiscontinuedOperationsAndRelatedZimvieMattersSummaryOfDetailsOfLossFromDiscontinuedOperationsIncludedInCondensedConsolidatedState": { "parentTag": "us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/DisclosureDiscontinuedOperationsAndRelatedZimvieMattersSummaryOfDetailsOfLossFromDiscontinuedOperationsIncludedInCondensedConsolidatedState" ], "lang": { "en-us": { "role": { "documentation": "Discontinued operation amortization of intangible assets.", "label": "Discontinued Operation Amortization Of Intangible Assets", "terseLabel": "Intangible asset amortization" } } }, "auth_ref": [] }, "us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax", "crdr": "credit", "calculation": { "http://www.zimmerbiomet.com/20240331/taxonomy/role/DisclosureDiscontinuedOperationsAndRelatedZimvieMattersSummaryOfDetailsOfLossFromDiscontinuedOperationsIncludedInCondensedConsolidatedState": { "parentTag": "us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax", "weight": 1.0, "order": 0.0 } }, "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/DisclosureDiscontinuedOperationsAndRelatedZimvieMattersSummaryOfDetailsOfLossFromDiscontinuedOperationsIncludedInCondensedConsolidatedState" ], "lang": { "en-us": { "role": { "totalLabel": "Loss from discontinued operations before income taxes", "label": "Discontinued Operation, Income (Loss) from Discontinued Operation, before Income Tax", "documentation": "Amount before tax of income (loss) from a discontinued operation. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal." } } }, "auth_ref": [ "r146", "r147", "r148", "r149", "r150", "r156", "r182", "r955" ] }, "zbh_DiscontinuedOperationResearchAndDevelopment": { "xbrltype": "monetaryItemType", "nsuri": "http://www.zimmerbiomet.com/20240331", "localname": "DiscontinuedOperationResearchAndDevelopment", "crdr": "debit", "calculation": { "http://www.zimmerbiomet.com/20240331/taxonomy/role/DisclosureDiscontinuedOperationsAndRelatedZimvieMattersSummaryOfDetailsOfLossFromDiscontinuedOperationsIncludedInCondensedConsolidatedState": { "parentTag": "us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax", "weight": -1.0, "order": 3.0 } }, "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/DisclosureDiscontinuedOperationsAndRelatedZimvieMattersSummaryOfDetailsOfLossFromDiscontinuedOperationsIncludedInCondensedConsolidatedState" ], "lang": { "en-us": { "role": { "documentation": "Discontinued operation research and development.", "label": "Discontinued Operation Research And Development", "terseLabel": "Research and development" } } }, "auth_ref": [] }, "zbh_DiscontinuedOperationRestructuringAndOtherCostReductionInitiatives": { "xbrltype": "monetaryItemType", "nsuri": "http://www.zimmerbiomet.com/20240331", "localname": "DiscontinuedOperationRestructuringAndOtherCostReductionInitiatives", "crdr": "debit", "calculation": { "http://www.zimmerbiomet.com/20240331/taxonomy/role/DisclosureDiscontinuedOperationsAndRelatedZimvieMattersSummaryOfDetailsOfLossFromDiscontinuedOperationsIncludedInCondensedConsolidatedState": { "parentTag": "us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax", "weight": -1.0, "order": 5.0 } }, "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/DisclosureDiscontinuedOperationsAndRelatedZimvieMattersSummaryOfDetailsOfLossFromDiscontinuedOperationsIncludedInCondensedConsolidatedState" ], "lang": { "en-us": { "role": { "documentation": "Discontinued operation, restructuring and other cost reduction initiatives.", "label": "Discontinued Operation Restructuring And Other Cost Reduction Initiatives", "terseLabel": "Restructuring and other cost reduction initiatives" } } }, "auth_ref": [] }, "us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DiscontinuedOperationTaxEffectOfDiscontinuedOperation", "crdr": "debit", "calculation": { "http://www.zimmerbiomet.com/20240331/taxonomy/role/DisclosureDiscontinuedOperationsAndRelatedZimvieMattersSummaryOfDetailsOfLossFromDiscontinuedOperationsIncludedInCondensedConsolidatedState": { "parentTag": "us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/DisclosureDiscontinuedOperationsAndRelatedZimvieMattersSummaryOfDetailsOfLossFromDiscontinuedOperationsIncludedInCondensedConsolidatedState" ], "lang": { "en-us": { "role": { "verboseLabel": "Benefit for income taxes from discontinued operations", "label": "Discontinued Operation, Tax Effect of Discontinued Operation", "terseLabel": "(Benefit) Provision for income taxes from discontinued operations", "totalLabel": "Discontinued Operation, Tax Effect of Discontinued Operation, Total", "documentation": "Amount of tax expense (benefit) related to a discontinued operation. Includes, but is not limited to, tax expense (benefit) related to income (loss) from operations during the phase-out period, tax expense (benefit) related to gain (loss) on disposal, tax expense (benefit) related to gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and tax expense (benefit) related to adjustments of a prior period gain (loss) on disposal." } } }, "auth_ref": [ "r147", "r148", "r149", "r150", "r156", "r160", "r490", "r498", "r502" ] }, "us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DiscontinuedOperationsAndDisposalGroupsAbstract", "lang": { "en-us": { "role": { "label": "Discontinued Operations and Disposal Groups [Abstract]" } } }, "auth_ref": [] }, "us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet", "crdr": "debit", "calculation": { "http://www.zimmerbiomet.com/20240331/taxonomy/role/DisclosureDiscontinuedOperationsAndRelatedZimvieMattersSummaryOfDetailsOfAssetsAndLiabilitiesOfDiscontinuedOperationDetails": { "parentTag": "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/DisclosureDiscontinuedOperationsAndRelatedZimvieMattersSummaryOfDetailsOfAssetsAndLiabilitiesOfDiscontinuedOperationDetails" ], "lang": { "en-us": { "role": { "label": "Disposal Group, Including Discontinued Operation, Accounts, Notes and Loans Receivable, Net", "terseLabel": "Accounts receivable, less allowance for credit losses", "documentation": "Amount classified as accounts, notes and loans receivable attributable to disposal group held for sale or disposed of." } } }, "auth_ref": [ "r7", "r145", "r158", "r201" ] }, "us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DisposalGroupIncludingDiscontinuedOperationAccountsPayableCurrent", "crdr": "credit", "calculation": { "http://www.zimmerbiomet.com/20240331/taxonomy/role/DisclosureDiscontinuedOperationsAndRelatedZimvieMattersSummaryOfDetailsOfAssetsAndLiabilitiesOfDiscontinuedOperationDetails": { "parentTag": "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent", "weight": 1.0, "order": 0.0 } }, "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/DisclosureDiscontinuedOperationsAndRelatedZimvieMattersSummaryOfDetailsOfAssetsAndLiabilitiesOfDiscontinuedOperationDetails" ], "lang": { "en-us": { "role": { "label": "Disposal Group, Including Discontinued Operation, Accounts Payable, Current", "terseLabel": "Accounts payable", "documentation": "Amount classified as accounts payable attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r7", "r145", "r158", "r199", "r201" ] }, "us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedIncomeTaxesPayable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DisposalGroupIncludingDiscontinuedOperationAccruedIncomeTaxesPayable", "crdr": "credit", "calculation": { "http://www.zimmerbiomet.com/20240331/taxonomy/role/DisclosureDiscontinuedOperationsAndRelatedZimvieMattersSummaryOfDetailsOfAssetsAndLiabilitiesOfDiscontinuedOperationDetails": { "parentTag": "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/DisclosureDiscontinuedOperationsAndRelatedZimvieMattersSummaryOfDetailsOfAssetsAndLiabilitiesOfDiscontinuedOperationDetails" ], "lang": { "en-us": { "role": { "label": "Disposal Group, Including Discontinued Operation, Accrued Income Tax Payable, Current", "terseLabel": "Income taxes payable", "documentation": "Amount classified as income tax obligations attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r7", "r145", "r158", "r199", "r201" ] }, "us-gaap_DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent", "crdr": "debit", "calculation": { "http://www.zimmerbiomet.com/20240331/taxonomy/role/DisclosureDiscontinuedOperationsAndRelatedZimvieMattersSummaryOfDetailsOfAssetsAndLiabilitiesOfDiscontinuedOperationDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/DisclosureDiscontinuedOperationsAndRelatedZimvieMattersSummaryOfDetailsOfAssetsAndLiabilitiesOfDiscontinuedOperationDetails" ], "lang": { "en-us": { "role": { "label": "Disposal Group, Including Discontinued Operation, Assets, Noncurrent", "terseLabel": "Noncurrent assets of discontinued operations", "totalLabel": "Total Noncurrent Assets of Discontinued Operations", "documentation": "Amount classified as assets attributable to disposal group held for sale or disposed of, expected to be disposed of after one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r7", "r15", "r145", "r158", "r201", "r241", "r242" ] }, "us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents", "crdr": "debit", "calculation": { "http://www.zimmerbiomet.com/20240331/taxonomy/role/DisclosureDiscontinuedOperationsAndRelatedZimvieMattersSummaryOfDetailsOfAssetsAndLiabilitiesOfDiscontinuedOperationDetails": { "parentTag": "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent", "weight": 1.0, "order": 0.0 } }, "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/DisclosureDiscontinuedOperationsAndRelatedZimvieMattersSummaryOfDetailsOfAssetsAndLiabilitiesOfDiscontinuedOperationDetails" ], "lang": { "en-us": { "role": { "label": "Disposal Group, Including Discontinued Operation, Cash and Cash Equivalents", "terseLabel": "Cash and cash equivalents", "documentation": "Amount classified as cash and cash equivalents attributable to disposal group held for sale or disposed of." } } }, "auth_ref": [ "r7", "r145", "r158", "r201" ] }, "us-gaap_DisposalGroupIncludingDiscontinuedOperationClassifiedBalanceSheetDisclosuresAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DisposalGroupIncludingDiscontinuedOperationClassifiedBalanceSheetDisclosuresAbstract", "lang": { "en-us": { "role": { "label": "Disposal Group, Including Discontinued Operation, Classified Balance Sheet Disclosures [Abstract]" } } }, "auth_ref": [] }, "us-gaap_DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold", "crdr": "debit", "calculation": { "http://www.zimmerbiomet.com/20240331/taxonomy/role/DisclosureDiscontinuedOperationsAndRelatedZimvieMattersSummaryOfDetailsOfLossFromDiscontinuedOperationsIncludedInCondensedConsolidatedState": { "parentTag": "us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/DisclosureDiscontinuedOperationsAndRelatedZimvieMattersSummaryOfDetailsOfLossFromDiscontinuedOperationsIncludedInCondensedConsolidatedState" ], "lang": { "en-us": { "role": { "label": "Disposal Group, Including Discontinued Operation, Costs of Goods Sold", "terseLabel": "Cost of products sold, excluding intangible asset amortization", "documentation": "Amount of costs of goods sold attributable to disposal group, including, but not limited to, discontinued operation." } } }, "auth_ref": [ "r157", "r242" ] }, "us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredTaxLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DisposalGroupIncludingDiscontinuedOperationDeferredTaxLiabilities", "crdr": "credit", "calculation": { "http://www.zimmerbiomet.com/20240331/taxonomy/role/DisclosureDiscontinuedOperationsAndRelatedZimvieMattersSummaryOfDetailsOfAssetsAndLiabilitiesOfDiscontinuedOperationDetails": { "parentTag": "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent", "weight": 1.0, "order": 0.0 } }, "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/DisclosureDiscontinuedOperationsAndRelatedZimvieMattersSummaryOfDetailsOfAssetsAndLiabilitiesOfDiscontinuedOperationDetails" ], "lang": { "en-us": { "role": { "label": "Disposal Group, Including Discontinued Operation, Deferred Tax Liabilities", "terseLabel": "Deferred income taxes, net", "documentation": "Amount classified as deferred tax liabilities attributable to disposal group held for sale or disposed of." } } }, "auth_ref": [ "r7", "r145", "r158", "r201" ] }, "us-gaap_DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense", "crdr": "debit", "calculation": { "http://www.zimmerbiomet.com/20240331/taxonomy/role/DisclosureDiscontinuedOperationsAndRelatedZimvieMattersSummaryOfDetailsOfLossFromDiscontinuedOperationsIncludedInCondensedConsolidatedState": { "parentTag": "us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax", "weight": -1.0, "order": 4.0 } }, "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/DisclosureDiscontinuedOperationsAndRelatedZimvieMattersSummaryOfDetailsOfLossFromDiscontinuedOperationsIncludedInCondensedConsolidatedState" ], "lang": { "en-us": { "role": { "label": "Disposal Group, Including Discontinued Operation, General and Administrative Expense", "terseLabel": "Selling, general and administrative", "documentation": "Amount of general and administrative expense attributable to disposal group, including, but not limited to, discontinued operation." } } }, "auth_ref": [ "r157" ] }, "us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwillNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DisposalGroupIncludingDiscontinuedOperationGoodwillNoncurrent", "crdr": "debit", "calculation": { "http://www.zimmerbiomet.com/20240331/taxonomy/role/DisclosureDiscontinuedOperationsAndRelatedZimvieMattersSummaryOfDetailsOfAssetsAndLiabilitiesOfDiscontinuedOperationDetails": { "parentTag": "us-gaap_DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/DisclosureDiscontinuedOperationsAndRelatedZimvieMattersSummaryOfDetailsOfAssetsAndLiabilitiesOfDiscontinuedOperationDetails" ], "lang": { "en-us": { "role": { "label": "Disposal Group, Including Discontinued Operation, Goodwill, Noncurrent", "terseLabel": "Goodwill", "documentation": "Amount classified as goodwill attributable to disposal group held for sale or disposed of, expected to be disposed of after one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r7", "r15", "r145", "r158", "r201" ] }, "us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsNoncurrent", "crdr": "debit", "calculation": { "http://www.zimmerbiomet.com/20240331/taxonomy/role/DisclosureDiscontinuedOperationsAndRelatedZimvieMattersSummaryOfDetailsOfAssetsAndLiabilitiesOfDiscontinuedOperationDetails": { "parentTag": "us-gaap_DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/DisclosureDiscontinuedOperationsAndRelatedZimvieMattersSummaryOfDetailsOfAssetsAndLiabilitiesOfDiscontinuedOperationDetails" ], "lang": { "en-us": { "role": { "label": "Disposal Group, Including Discontinued Operation, Intangible Assets, Noncurrent", "terseLabel": "Intangible assets, net", "documentation": "Amount classified as intangible assets, excluding goodwill, attributable to disposal group held for sale or disposed of, expected to be disposed of beyond one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r7", "r15", "r145", "r158", "r201" ] }, "us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DisposalGroupIncludingDiscontinuedOperationInventoryCurrent", "crdr": "debit", "calculation": { "http://www.zimmerbiomet.com/20240331/taxonomy/role/DisclosureDiscontinuedOperationsAndRelatedZimvieMattersSummaryOfDetailsOfAssetsAndLiabilitiesOfDiscontinuedOperationDetails": { "parentTag": "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/DisclosureDiscontinuedOperationsAndRelatedZimvieMattersSummaryOfDetailsOfAssetsAndLiabilitiesOfDiscontinuedOperationDetails" ], "lang": { "en-us": { "role": { "label": "Disposal Group, Including Discontinued Operation, Inventory, Current", "terseLabel": "Inventories", "documentation": "Amount classified as inventory attributable to disposal group, expected to be disposed of within one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r7", "r145", "r158", "r199", "r201" ] }, "us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities", "crdr": "credit", "calculation": { "http://www.zimmerbiomet.com/20240331/taxonomy/role/DisclosureDiscontinuedOperationsAndRelatedZimvieMattersSummaryOfDetailsOfAssetsAndLiabilitiesOfDiscontinuedOperationDetails": { "parentTag": "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/DisclosureDiscontinuedOperationsAndRelatedZimvieMattersSummaryOfDetailsOfAssetsAndLiabilitiesOfDiscontinuedOperationDetails" ], "lang": { "en-us": { "role": { "label": "Disposal Group, Including Discontinued Operation, Other Liabilities, Current", "terseLabel": "Other current liabilities", "documentation": "Amount classified as other liabilities attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r7", "r145", "r158", "r199", "r201" ] }, "zbh_DisposalGroupIncludingDiscontinuedOperationOtherExpenseIncome": { "xbrltype": "monetaryItemType", "nsuri": "http://www.zimmerbiomet.com/20240331", "localname": "DisposalGroupIncludingDiscontinuedOperationOtherExpenseIncome", "crdr": "debit", "calculation": { "http://www.zimmerbiomet.com/20240331/taxonomy/role/DisclosureDiscontinuedOperationsAndRelatedZimvieMattersSummaryOfDetailsOfLossFromDiscontinuedOperationsIncludedInCondensedConsolidatedState": { "parentTag": "us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax", "weight": -1.0, "order": 7.0 } }, "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/DisclosureDiscontinuedOperationsAndRelatedZimvieMattersSummaryOfDetailsOfLossFromDiscontinuedOperationsIncludedInCondensedConsolidatedState" ], "lang": { "en-us": { "role": { "verboseLabel": "Other expense, net", "documentation": "Disposal group including discontinued operation other expense (income).", "label": "Disposal Group Including Discontinued Operation Other Expense Income", "terseLabel": "Other (income) expense, net" } } }, "auth_ref": [] }, "us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssets", "crdr": "debit", "calculation": { "http://www.zimmerbiomet.com/20240331/taxonomy/role/DisclosureDiscontinuedOperationsAndRelatedZimvieMattersSummaryOfDetailsOfAssetsAndLiabilitiesOfDiscontinuedOperationDetails": { "parentTag": "us-gaap_DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/DisclosureDiscontinuedOperationsAndRelatedZimvieMattersSummaryOfDetailsOfAssetsAndLiabilitiesOfDiscontinuedOperationDetails" ], "lang": { "en-us": { "role": { "label": "Disposal Group, Including Discontinued Operation, Other Assets, Noncurrent", "terseLabel": "Other assets", "documentation": "Amount classified as other assets attributable to disposal group held for sale or disposed of, expected to be disposed of after one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r7", "r15", "r145", "r158", "r201" ] }, "us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentLiabilities", "crdr": "credit", "calculation": { "http://www.zimmerbiomet.com/20240331/taxonomy/role/DisclosureDiscontinuedOperationsAndRelatedZimvieMattersSummaryOfDetailsOfAssetsAndLiabilitiesOfDiscontinuedOperationDetails": { "parentTag": "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/DisclosureDiscontinuedOperationsAndRelatedZimvieMattersSummaryOfDetailsOfAssetsAndLiabilitiesOfDiscontinuedOperationDetails" ], "lang": { "en-us": { "role": { "label": "Disposal Group, Including Discontinued Operation, Other Liabilities, Noncurrent", "terseLabel": "Other long-term liabilities", "documentation": "Amount classified as other liabilities attributable to disposal group held for sale or disposed of, expected to be disposed of beyond one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r7", "r15", "r145", "r158", "r201" ] }, "us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent", "crdr": "debit", "calculation": { "http://www.zimmerbiomet.com/20240331/taxonomy/role/DisclosureDiscontinuedOperationsAndRelatedZimvieMattersSummaryOfDetailsOfAssetsAndLiabilitiesOfDiscontinuedOperationDetails": { "parentTag": "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/DisclosureDiscontinuedOperationsAndRelatedZimvieMattersSummaryOfDetailsOfAssetsAndLiabilitiesOfDiscontinuedOperationDetails" ], "lang": { "en-us": { "role": { "label": "Disposal Group, Including Discontinued Operation, Prepaid and Other Assets, Current", "terseLabel": "Prepaid expenses and other current assets", "documentation": "Amount classified as prepaid and other assets attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r7", "r145", "r158", "r199", "r201" ] }, "us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentNoncurrent", "crdr": "debit", "calculation": { "http://www.zimmerbiomet.com/20240331/taxonomy/role/DisclosureDiscontinuedOperationsAndRelatedZimvieMattersSummaryOfDetailsOfAssetsAndLiabilitiesOfDiscontinuedOperationDetails": { "parentTag": "us-gaap_DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent", "weight": 1.0, "order": 0.0 } }, "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/DisclosureDiscontinuedOperationsAndRelatedZimvieMattersSummaryOfDetailsOfAssetsAndLiabilitiesOfDiscontinuedOperationDetails" ], "lang": { "en-us": { "role": { "label": "Disposal Group, Including Discontinued Operation, Property, Plant and Equipment, Noncurrent", "terseLabel": "Property, plant and equipment, net", "documentation": "Amount classified as property, plant and equipment attributable to disposal group held for sale or disposed of, expected to be disposed of after one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r7", "r15", "r145", "r158", "r201" ] }, "us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DisposalGroupIncludingDiscontinuedOperationRevenue", "crdr": "credit", "calculation": { "http://www.zimmerbiomet.com/20240331/taxonomy/role/DisclosureDiscontinuedOperationsAndRelatedZimvieMattersSummaryOfDetailsOfLossFromDiscontinuedOperationsIncludedInCondensedConsolidatedState": { "parentTag": "us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax", "weight": 1.0, "order": 0.0 } }, "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/DisclosureDiscontinuedOperationsAndRelatedZimvieMattersSummaryOfDetailsOfLossFromDiscontinuedOperationsIncludedInCondensedConsolidatedState" ], "lang": { "en-us": { "role": { "label": "Disposal Group, Including Discontinued Operation, Revenue", "terseLabel": "Net Sales", "documentation": "Amount of revenue attributable to disposal group, including, but not limited to, discontinued operation." } } }, "auth_ref": [ "r157", "r242" ] }, "us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/DisclosureDiscontinuedOperationsAndRelatedZimvieMatters1" ], "lang": { "en-us": { "role": { "label": "Disposal Groups, Including Discontinued Operations, Disclosure [Text Block]", "terseLabel": "Discontinued Operations and Related ZimVie Matters", "documentation": "The entire disclosure related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component." } } }, "auth_ref": [ "r144", "r198" ] }, "zbh_DividendPaidOnSeparation": { "xbrltype": "monetaryItemType", "nsuri": "http://www.zimmerbiomet.com/20240331", "localname": "DividendPaidOnSeparation", "crdr": "credit", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/DisclosureDiscontinuedOperationsAndRelatedZimvieMattersAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "documentation": "Dividend paid on separation.", "label": "Dividend Paid On Separation", "terseLabel": "Dividend paid on separation" } } }, "auth_ref": [] }, "us-gaap_DividendsCommonStockCash": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DividendsCommonStockCash", "crdr": "debit", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfStockholdersEquityUnaudited" ], "lang": { "en-us": { "role": { "label": "Dividends, Common Stock, Cash", "negatedLabel": "Cash dividends declared", "documentation": "Amount of paid and unpaid common stock dividends declared with the form of settlement in cash." } } }, "auth_ref": [ "r207" ] }, "dei_DocumentFiscalPeriodFocus": { "xbrltype": "fiscalPeriodItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalPeriodFocus", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Period Focus", "terseLabel": "Document Fiscal Period Focus", "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY." } } }, "auth_ref": [] }, "dei_DocumentFiscalYearFocus": { "xbrltype": "gYearItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalYearFocus", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Year Focus", "terseLabel": "Document Fiscal Year Focus", "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006." } } }, "auth_ref": [] }, "dei_DocumentInformationLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentInformationLineItems", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Information [Line Items]", "terseLabel": "Document Information [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "dei_DocumentInformationTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentInformationTable", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Information [Table]", "terseLabel": "Document Information [Table]", "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package." } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodEndDate", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Period End Date", "terseLabel": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_DocumentQuarterlyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentQuarterlyReport", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Quarterly Report", "terseLabel": "Document Quarterly Report", "documentation": "Boolean flag that is true only for a form used as an quarterly report." } } }, "auth_ref": [ "r808" ] }, "dei_DocumentTransitionReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentTransitionReport", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Transition Report", "terseLabel": "Document Transition Report", "documentation": "Boolean flag that is true only for a form used as a transition report." } } }, "auth_ref": [ "r841" ] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentType", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Type", "terseLabel": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "us-gaap_EMEAMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EMEAMember", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureSegmentInformationSummaryOfNetSalesAndOperatingProfitBySegmentDetail" ], "lang": { "en-us": { "role": { "label": "EMEA [Member]", "documentation": "Regions of Europe, Middle East and Africa." } } }, "auth_ref": [ "r961", "r962", "r963", "r964" ] }, "us-gaap_EarningsPerShareAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerShareAbstract", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfEarningsUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Earnings Per Common Share", "label": "Earnings Per Share [Abstract]" } } }, "auth_ref": [] }, "us-gaap_EarningsPerShareBasic": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerShareBasic", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfEarningsUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Basic", "label": "Earnings Per Share, Basic", "totalLabel": "Net Earnings Per Common Share - Basic", "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period." } } }, "auth_ref": [ "r281", "r296", "r297", "r299", "r300", "r302", "r308", "r311", "r318", "r319", "r320", "r324", "r539", "r540", "r583", "r603", "r762" ] }, "us-gaap_EarningsPerShareDiluted": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerShareDiluted", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfEarningsUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Diluted", "label": "Earnings Per Share, Diluted", "totalLabel": "Net Earnings Per Common Share - Diluted", "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period." } } }, "auth_ref": [ "r281", "r296", "r297", "r299", "r300", "r302", "r311", "r318", "r319", "r320", "r324", "r539", "r540", "r583", "r603", "r762" ] }, "us-gaap_EarningsPerShareTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerShareTextBlock", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureEarningsPerShare" ], "lang": { "en-us": { "role": { "label": "Earnings Per Share [Text Block]", "terseLabel": "Earnings Per Share", "documentation": "The entire disclosure for earnings per share." } } }, "auth_ref": [ "r307", "r321", "r322", "r323" ] }, "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations", "crdr": "debit", "calculation": { "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0, "order": 0.0 } }, "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "label": "Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations", "terseLabel": "Effect of exchange rates on cash and cash equivalents", "totalLabel": "Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations, Total", "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r941" ] }, "us-gaap_EffectOnFutureEarningsOffsetAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EffectOnFutureEarningsOffsetAmount", "crdr": "debit", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureRestructuringAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Effect on Future Earnings, Offset Amount", "terseLabel": "Reduction in annual pre-tax operating expenses", "documentation": "The amount that will be offset against future earnings by anticipated increases or decreases in other expenses or revenues." } } }, "auth_ref": [ "r94" ] }, "us-gaap_EffectiveIncomeTaxRateContinuingOperations": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EffectiveIncomeTaxRateContinuingOperations", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Effective Income Tax Rate Reconciliation, Percent", "terseLabel": "Effective tax rate", "totalLabel": "Effective Income Tax Rate Reconciliation, Percent, Total", "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations." } } }, "auth_ref": [ "r491" ] }, "us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent", "terseLabel": "U.S. corporate income tax rate", "documentation": "Percentage of domestic federal statutory tax rate applicable to pretax income (loss)." } } }, "auth_ref": [ "r289", "r491", "r499" ] }, "us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Percent", "terseLabel": "Minimum tax rate", "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the income tax rates." } } }, "auth_ref": [ "r499", "r934" ] }, "zbh_EmbodyIncMember": { "xbrltype": "domainItemType", "nsuri": "http://www.zimmerbiomet.com/20240331", "localname": "EmbodyIncMember", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/DisclosureAcquisitionsAdditionalInformationDetail", "http://www.zimmerbiomet.com/20240331/taxonomy/role/DisclosureFairValueMeasurementOfAssetsAndLiabilitiesScheduleOfFairValueLiabilitiesMeasuredOnRecurringBasisDetail", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureFairValueMeasurementOfAssetsAndLiabilitiesAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "documentation": "Embody, Inc. member.", "label": "Embody, Inc. [Member]", "verboseLabel": "Embody, Inc." } } }, "auth_ref": [] }, "us-gaap_EmployeeStockOptionMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EmployeeStockOptionMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Employee Stock Option [Member]", "terseLabel": "Employee Stock Option", "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time." } } }, "auth_ref": [] }, "zbh_EmployeeTerminationBenefitsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.zimmerbiomet.com/20240331", "localname": "EmployeeTerminationBenefitsMember", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/DisclosureRestructuringSummaryOfLocationOnCondensedConsolidatedStatementOfEarningsAndTypeOfCostForRestructuringPlanDetail", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureRestructuringSummaryOfLiabilitiesRecognizedRelatedToRestructuringPlanDetail" ], "lang": { "en-us": { "role": { "documentation": "Employee termination benefits.", "label": "Employee Termination Benefits [Member]", "terseLabel": "Employee Termination Benefits [Member]" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine1", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line One", "terseLabel": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCityOrTown", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, City or Town", "terseLabel": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_EntityAddressCountry": { "xbrltype": "countryCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCountry", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, Country", "terseLabel": "Entity Address, Country", "documentation": "ISO 3166-1 alpha-2 country code." } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, Postal Zip Code", "terseLabel": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, State or Province", "terseLabel": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCentralIndexKey", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r806" ] }, "dei_EntityCommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCommonStockSharesOutstanding", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Common Stock, Shares Outstanding", "terseLabel": "Entity Common Stock, Shares Outstanding", "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument." } } }, "auth_ref": [] }, "dei_EntityCurrentReportingStatus": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCurrentReportingStatus", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Current Reporting Status", "terseLabel": "Entity Current Reporting Status", "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [] }, "dei_EntityDomain": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityDomain", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDebtAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Entity [Domain]", "terseLabel": "Entity", "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains." } } }, "auth_ref": [] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r806" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFileNumber", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Securities Act File Number", "terseLabel": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_EntityFilerCategory": { "xbrltype": "filerCategoryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFilerCategory", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Filer Category", "terseLabel": "Entity Filer Category", "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [ "r806" ] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Incorporation, State or Country Code", "terseLabel": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_EntityInteractiveDataCurrent": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityInteractiveDataCurrent", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Interactive Data Current", "terseLabel": "Entity Interactive Data Current", "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)." } } }, "auth_ref": [ "r880" ] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityRegistrantName", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r806" ] }, "dei_EntityShellCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityShellCompany", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Shell Company", "terseLabel": "Entity Shell Company", "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act." } } }, "auth_ref": [ "r806" ] }, "dei_EntitySmallBusiness": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntitySmallBusiness", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Small Business", "terseLabel": "Entity Small Business", "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)." } } }, "auth_ref": [ "r806" ] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Tax Identification Number", "terseLabel": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r806" ] }, "us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EntityWideInformationRevenueFromExternalCustomerLineItems", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureRevenueScheduleOfNetSalesByProductCategoryDetail" ], "lang": { "en-us": { "role": { "label": "Revenue from External Customer [Line Items]", "terseLabel": "Entity Wide Information Revenue From External Customer [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_EquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EquityAbstract", "lang": { "en-us": { "role": { "label": "Equity [Abstract]" } } }, "auth_ref": [] }, "us-gaap_EquityComponentDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EquityComponentDomain", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureAccumulatedOtherComprehensiveIncomeChangesInComponentsOfAccumulatedOtherComprehensiveIncomeNetOfTaxDetail", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureAccumulatedOtherComprehensiveIncomeReclassificationAdjustmentsFromAccumulatedOtherComprehensiveIncomeDetail", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureBasisOfPresentationAdditionalInformationDetails", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureFairValueMeasurementOfAssetsAndLiabilitiesAdditionalInformationDetails", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfStockholdersEquityUnaudited" ], "lang": { "en-us": { "role": { "label": "Equity Component [Domain]", "terseLabel": "Equity Component", "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc." } } }, "auth_ref": [ "r30", "r239", "r276", "r277", "r278", "r291", "r292", "r293", "r295", "r303", "r305", "r325", "r358", "r361", "r437", "r484", "r485", "r486", "r495", "r496", "r530", "r531", "r532", "r533", "r534", "r535", "r538", "r560", "r562", "r563", "r564", "r565", "r567", "r571", "r612", "r613", "r614", "r634", "r708" ] }, "us-gaap_EquityInterestIssuedOrIssuableByTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EquityInterestIssuedOrIssuableByTypeAxis", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/DisclosureAcquisitionsAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Equity Interest Type [Axis]", "documentation": "Information by type of equity interests that are issued or issuable in a business combination." } } }, "auth_ref": [] }, "us-gaap_EquityInterestIssuedOrIssuableTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EquityInterestIssuedOrIssuableTypeDomain", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/DisclosureAcquisitionsAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Equity Interest Issued or Issuable, Type [Domain]", "documentation": "Name of equity interest issued or issuable to acquire an entity in a business combination." } } }, "auth_ref": [ "r211" ] }, "zbh_EquityMethodInvestmentsAndCostMethodInvestmentsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.zimmerbiomet.com/20240331", "localname": "EquityMethodInvestmentsAndCostMethodInvestmentsAbstract", "lang": { "en-us": { "role": { "documentation": "Equity Method Investments And Cost Method Investments [Abstract]", "label": "Equity Method Investments And Cost Method Investments [Abstract]" } } }, "auth_ref": [] }, "us-gaap_EquitySecuritiesFvNi": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EquitySecuritiesFvNi", "crdr": "debit", "calculation": { "http://www.zimmerbiomet.com/20240331/taxonomy/role/DisclosureFairValueMeasurementOfAssetsAndLiabilitiesScheduleOfFairValueMeasurementOfAssetAndLiabilitiesDetail": { "parentTag": "us-gaap_AssetsFairValueDisclosure", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/DisclosureFairValueMeasurementOfAssetsAndLiabilitiesScheduleOfFairValueMeasurementOfAssetAndLiabilitiesDetail" ], "lang": { "en-us": { "role": { "label": "Equity Securities, FV-NI, Current", "terseLabel": "Investment in ZimVie", "documentation": "Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI), classified as current." } } }, "auth_ref": [ "r251", "r549", "r755" ] }, "ecd_EquityValuationAssumptionDifferenceFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "EquityValuationAssumptionDifferenceFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Equity Valuation Assumption Difference, Footnote [Text Block]", "terseLabel": "Equity Valuation Assumption Difference, Footnote" } } }, "auth_ref": [ "r849" ] }, "ecd_ErrCompAnalysisTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ErrCompAnalysisTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Erroneous Compensation Analysis [Text Block]", "terseLabel": "Erroneous Compensation Analysis" } } }, "auth_ref": [ "r813", "r824", "r834", "r859" ] }, "ecd_ErrCompRecoveryTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ErrCompRecoveryTable", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Erroneously Awarded Compensation Recovery [Table]", "terseLabel": "Erroneously Awarded Compensation Recovery" } } }, "auth_ref": [ "r810", "r821", "r831", "r856" ] }, "zbh_ErrorCorrectionsAndPriorPeriodAdjustmentsAccountsReceivableAndEquity": { "xbrltype": "monetaryItemType", "nsuri": "http://www.zimmerbiomet.com/20240331", "localname": "ErrorCorrectionsAndPriorPeriodAdjustmentsAccountsReceivableAndEquity", "crdr": "debit", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/DisclosureDiscontinuedOperationsAndRelatedZimvieMattersAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Impact on accounts receivable", "label": "Error Corrections And Prior Period Adjustments Accounts Receivable and Equity", "documentation": "Error corrections and prior period adjustments accounts receivable and equity." } } }, "auth_ref": [] }, "zbh_ErrorCorrectionsAndPriorPeriodAdjustmentsRetainedEarningsAccumulatedDeficit": { "xbrltype": "monetaryItemType", "nsuri": "http://www.zimmerbiomet.com/20240331", "localname": "ErrorCorrectionsAndPriorPeriodAdjustmentsRetainedEarningsAccumulatedDeficit", "crdr": "credit", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/DisclosureDiscontinuedOperationsAndRelatedZimvieMattersAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Impact on retained earnings", "label": "Error Corrections And Prior Period Adjustments Retained Earnings Accumulated Deficit", "documentation": "Error Corrections And Prior Period Adjustments Retained Earnings Accumulated Deficit" } } }, "auth_ref": [] }, "zbh_EuroNotesMember": { "xbrltype": "domainItemType", "nsuri": "http://www.zimmerbiomet.com/20240331", "localname": "EuroNotesMember", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDebtAdditionalInformationDetail", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDebtSummaryOfDebtInstrumentsDetail", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDebtSummaryOfDebtInstrumentsParentheticalDetail", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesNetInvestmentHedgeGainsLossesRecognizedOnCondensedConsolidatedStatementsOfComprehensiveIncomeDetail" ], "lang": { "en-us": { "role": { "documentation": "Euro notes.", "label": "Euro Notes [Member]", "terseLabel": "Euro Notes [Member]" } } }, "auth_ref": [] }, "ecd_ExecutiveCategoryAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ExecutiveCategoryAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Executive Category [Axis]", "terseLabel": "Executive Category:" } } }, "auth_ref": [ "r855" ] }, "us-gaap_ExtinguishmentOfDebtAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ExtinguishmentOfDebtAxis", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesScheduleOfAmountsRecordedOnBalanceSheetRelatedToCumulativeBasisAdjustmentsForFairValueHedgesDetail" ], "lang": { "en-us": { "role": { "label": "Extinguishment of Debt [Axis]", "terseLabel": "Extinguishment of Debt", "documentation": "Information pertaining to the debt extinguished including the amount of gain (loss), the income tax effect on the gain (loss), and the amount of gain (loss), net or the related income tax, by debt instrument." } } }, "auth_ref": [ "r97" ] }, "us-gaap_ExtinguishmentOfDebtTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ExtinguishmentOfDebtTypeDomain", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesScheduleOfAmountsRecordedOnBalanceSheetRelatedToCumulativeBasisAdjustmentsForFairValueHedgesDetail" ], "lang": { "en-us": { "role": { "label": "Extinguishment of Debt, Type [Domain]", "terseLabel": "Extinguishment of Debt, Type", "documentation": "Type of debt extinguished." } } }, "auth_ref": [ "r97" ] }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/DisclosureFairValueMeasurementOfAssetsAndLiabilitiesScheduleOfFairValueLiabilitiesMeasuredOnRecurringBasisDetail", "http://www.zimmerbiomet.com/20240331/taxonomy/role/DisclosureFairValueMeasurementOfAssetsAndLiabilitiesScheduleOfFairValueMeasurementOfAssetAndLiabilitiesDetail", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureFairValueMeasurementOfAssetsAndLiabilitiesAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]", "terseLabel": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r542", "r543", "r547" ] }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/DisclosureFairValueMeasurementOfAssetsAndLiabilitiesScheduleOfFairValueLiabilitiesMeasuredOnRecurringBasisDetail", "http://www.zimmerbiomet.com/20240331/taxonomy/role/DisclosureFairValueMeasurementOfAssetsAndLiabilitiesScheduleOfFairValueMeasurementOfAssetAndLiabilitiesDetail", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureFairValueMeasurementOfAssetsAndLiabilitiesAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Fair Value, Recurring and Nonrecurring [Table]", "terseLabel": "Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Table]", "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis." } } }, "auth_ref": [ "r542", "r543", "r547" ] }, "us-gaap_FairValueByFairValueHierarchyLevelAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueByFairValueHierarchyLevelAxis", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/DisclosureFairValueMeasurementOfAssetsAndLiabilitiesScheduleOfFairValueLiabilitiesMeasuredOnRecurringBasisDetail", "http://www.zimmerbiomet.com/20240331/taxonomy/role/DisclosureFairValueMeasurementOfAssetsAndLiabilitiesScheduleOfFairValueMeasurementOfAssetAndLiabilitiesDetail" ], "lang": { "en-us": { "role": { "label": "Fair Value Hierarchy and NAV [Axis]", "terseLabel": "Fair Value Hierarchy and NAV", "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient." } } }, "auth_ref": [ "r416", "r450", "r451", "r452", "r453", "r454", "r455", "r543", "r572", "r573", "r574", "r773", "r774", "r780", "r781", "r782" ] }, "us-gaap_FairValueByMeasurementFrequencyAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueByMeasurementFrequencyAxis", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/DisclosureFairValueMeasurementOfAssetsAndLiabilitiesScheduleOfFairValueLiabilitiesMeasuredOnRecurringBasisDetail", "http://www.zimmerbiomet.com/20240331/taxonomy/role/DisclosureFairValueMeasurementOfAssetsAndLiabilitiesScheduleOfFairValueMeasurementOfAssetAndLiabilitiesDetail" ], "lang": { "en-us": { "role": { "label": "Measurement Frequency [Axis]", "terseLabel": "Fair Value, Measurements, Recurring [Member]", "documentation": "Information by measurement frequency." } } }, "auth_ref": [ "r542", "r543", "r544", "r545", "r548" ] }, "us-gaap_FairValueDisclosuresAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueDisclosuresAbstract", "lang": { "en-us": { "role": { "label": "Fair Value Disclosures [Abstract]" } } }, "auth_ref": [] }, "us-gaap_FairValueDisclosuresTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueDisclosuresTextBlock", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureFairValueMeasurementOfAssetsAndLiabilities" ], "lang": { "en-us": { "role": { "label": "Fair Value Disclosures [Text Block]", "terseLabel": "Fair Value Measurement of Assets and Liabilities", "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information." } } }, "auth_ref": [ "r541" ] }, "us-gaap_FairValueInputsLevel1Member": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueInputsLevel1Member", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/DisclosureFairValueMeasurementOfAssetsAndLiabilitiesScheduleOfFairValueMeasurementOfAssetAndLiabilitiesDetail" ], "lang": { "en-us": { "role": { "label": "Fair Value, Inputs, Level 1 [Member]", "terseLabel": "Fair Value Measurements at Reporting Date Using: Quoted Prices in Active Markets for Identical Assets (Level 1) [Member]", "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date." } } }, "auth_ref": [ "r416", "r450", "r455", "r543", "r572", "r780", "r781", "r782" ] }, "us-gaap_FairValueInputsLevel2Member": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueInputsLevel2Member", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/DisclosureFairValueMeasurementOfAssetsAndLiabilitiesScheduleOfFairValueMeasurementOfAssetAndLiabilitiesDetail" ], "lang": { "en-us": { "role": { "label": "Fair Value, Inputs, Level 2 [Member]", "terseLabel": "Fair Value Measurements at Reporting Date Using: Significant Other Observable Inputs (Level 2) [Member]", "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets." } } }, "auth_ref": [ "r416", "r450", "r455", "r543", "r573", "r773", "r774", "r780", "r781", "r782" ] }, "us-gaap_FairValueInputsLevel3Member": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueInputsLevel3Member", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/DisclosureFairValueMeasurementOfAssetsAndLiabilitiesScheduleOfFairValueLiabilitiesMeasuredOnRecurringBasisDetail", "http://www.zimmerbiomet.com/20240331/taxonomy/role/DisclosureFairValueMeasurementOfAssetsAndLiabilitiesScheduleOfFairValueMeasurementOfAssetAndLiabilitiesDetail" ], "lang": { "en-us": { "role": { "label": "Fair Value, Inputs, Level 3 [Member]", "terseLabel": "Fair Value Measurements at Reporting Date Using: Significant Unobservable Inputs (Level 3) [Member]", "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing." } } }, "auth_ref": [ "r416", "r450", "r451", "r452", "r453", "r454", "r455", "r543", "r574", "r773", "r774", "r780", "r781", "r782" ] }, "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureFairValueMeasurementOfAssetsAndLiabilitiesTables" ], "lang": { "en-us": { "role": { "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]", "terseLabel": "Fair Value Liabilities Measured on Recurring Basis", "documentation": "Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability." } } }, "auth_ref": [ "r33", "r136" ] }, "us-gaap_FairValueMeasurementFrequencyDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueMeasurementFrequencyDomain", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/DisclosureFairValueMeasurementOfAssetsAndLiabilitiesScheduleOfFairValueLiabilitiesMeasuredOnRecurringBasisDetail", "http://www.zimmerbiomet.com/20240331/taxonomy/role/DisclosureFairValueMeasurementOfAssetsAndLiabilitiesScheduleOfFairValueMeasurementOfAssetAndLiabilitiesDetail" ], "lang": { "en-us": { "role": { "label": "Measurement Frequency [Domain]", "terseLabel": "Measurement Frequency", "documentation": "Measurement frequency." } } }, "auth_ref": [] }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings", "crdr": "credit", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/DisclosureFairValueMeasurementOfAssetsAndLiabilitiesScheduleOfFairValueLiabilitiesMeasuredOnRecurringBasisDetail" ], "lang": { "en-us": { "role": { "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings", "terseLabel": "Change in estimates", "documentation": "Amount of gain (loss) recognized in income from liability measured at fair value on recurring basis using unobservable input (level 3)." } } }, "auth_ref": [ "r546" ] }, "zbh_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIncreaseDecreaseForeignCurrency": { "xbrltype": "monetaryItemType", "nsuri": "http://www.zimmerbiomet.com/20240331", "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIncreaseDecreaseForeignCurrency", "crdr": "credit", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/DisclosureFairValueMeasurementOfAssetsAndLiabilitiesScheduleOfFairValueLiabilitiesMeasuredOnRecurringBasisDetail" ], "lang": { "en-us": { "role": { "documentation": "Fair value measurement with unobservable inputs reconciliation recurring basis liability increase decrease foreign currency.", "label": "Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Increase Decrease Foreign Currency", "terseLabel": "Foreign currency impact" } } }, "auth_ref": [] }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases", "crdr": "credit", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/DisclosureFairValueMeasurementOfAssetsAndLiabilitiesScheduleOfFairValueLiabilitiesMeasuredOnRecurringBasisDetail" ], "lang": { "en-us": { "role": { "verboseLabel": "New contingent consideration related to the 2023 acquisitions", "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Purchases", "documentation": "Amount of purchases of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing." } } }, "auth_ref": [ "r135" ] }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements", "crdr": "debit", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/DisclosureFairValueMeasurementOfAssetsAndLiabilitiesScheduleOfFairValueLiabilitiesMeasuredOnRecurringBasisDetail" ], "lang": { "en-us": { "role": { "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements", "terseLabel": "Settlements", "documentation": "Amount of settlements of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing." } } }, "auth_ref": [ "r135" ] }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue", "crdr": "credit", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/DisclosureFairValueMeasurementOfAssetsAndLiabilitiesScheduleOfFairValueLiabilitiesMeasuredOnRecurringBasisDetail" ], "lang": { "en-us": { "role": { "periodEndLabel": "Ending balance March 31, 2024", "periodStartLabel": "Beginning balance December 31, 2023", "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value", "documentation": "Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing." } } }, "auth_ref": [ "r33" ] }, "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueMeasurementsFairValueHierarchyDomain", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/DisclosureFairValueMeasurementOfAssetsAndLiabilitiesScheduleOfFairValueLiabilitiesMeasuredOnRecurringBasisDetail", "http://www.zimmerbiomet.com/20240331/taxonomy/role/DisclosureFairValueMeasurementOfAssetsAndLiabilitiesScheduleOfFairValueMeasurementOfAssetAndLiabilitiesDetail" ], "lang": { "en-us": { "role": { "label": "Fair Value Hierarchy and NAV [Domain]", "terseLabel": "Fair Value Hierarchy and NAV", "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value." } } }, "auth_ref": [ "r416", "r450", "r451", "r452", "r453", "r454", "r455", "r572", "r573", "r574", "r773", "r774", "r780", "r781", "r782" ] }, "us-gaap_FairValueMeasurementsRecurringMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueMeasurementsRecurringMember", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/DisclosureFairValueMeasurementOfAssetsAndLiabilitiesScheduleOfFairValueLiabilitiesMeasuredOnRecurringBasisDetail", "http://www.zimmerbiomet.com/20240331/taxonomy/role/DisclosureFairValueMeasurementOfAssetsAndLiabilitiesScheduleOfFairValueMeasurementOfAssetAndLiabilitiesDetail" ], "lang": { "en-us": { "role": { "label": "Fair Value, Recurring [Member]", "terseLabel": "Fair Value, Measurements, Recurring [Member]", "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value." } } }, "auth_ref": [ "r541", "r548" ] }, "zbh_FairValueOfOutstandingDerivativeInstrumentsNetUnrealizedGainLossDeferredInOtherComprehensiveIncome": { "xbrltype": "monetaryItemType", "nsuri": "http://www.zimmerbiomet.com/20240331", "localname": "FairValueOfOutstandingDerivativeInstrumentsNetUnrealizedGainLossDeferredInOtherComprehensiveIncome", "crdr": "credit", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "documentation": "Accumulated change, before taxes, in accumulated gains and losses from derivative instruments designated and qualifying as the effective portion of cash flow hedges.", "label": "Fair Value Of Outstanding Derivative Instruments Net Unrealized Gain Loss Deferred In Other Comprehensive Income", "terseLabel": "Fair value of outstanding derivative instruments, net unrealized gain deferred in accumulated other comprehensive income" } } }, "auth_ref": [] }, "zbh_FairValueOfOutstandingDerivativeInstrumentsUnrealizedGainLossNetOfTaxesExpectedToBeReclassifiedToEarnings": { "xbrltype": "monetaryItemType", "nsuri": "http://www.zimmerbiomet.com/20240331", "localname": "FairValueOfOutstandingDerivativeInstrumentsUnrealizedGainLossNetOfTaxesExpectedToBeReclassifiedToEarnings", "crdr": "credit", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "documentation": "The estimated net amount of unrealized gains or losses on foreign currency cash flow hedges at the reporting date expected to be reclassified to earnings within the next 12 months, after taxes.", "label": "Fair Value Of Outstanding Derivative Instruments Unrealized Gain Loss Net Of Taxes Expected To Be Reclassified To Earnings", "terseLabel": "Fair value of outstanding derivative instruments, gain (loss), net of taxes expected to be reclassified to earnings" } } }, "auth_ref": [] }, "us-gaap_FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList": { "xbrltype": "enumerationSetItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/DisclosureFairValueMeasurementOfAssetsAndLiabilitiesScheduleOfFairValueLiabilitiesMeasuredOnRecurringBasisDetail" ], "lang": { "en-us": { "role": { "label": "Fair Value, Liability, Recurring Basis, Unobservable Input Reconciliation, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]", "documentation": "Indicates line item in statement in which net income is reported that includes gain (loss) from liability measured at fair value using unobservable input (level 3)." } } }, "auth_ref": [ "r546" ] }, "us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesFairValueOfDerivativeInstrumentsOnGrossBasisDetail" ], "lang": { "en-us": { "role": { "label": "Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]", "terseLabel": "Fair Values Derivatives Balance Sheet Location By Derivative Contract Type By Hedging Designation [Table]", "documentation": "Schedule that discloses the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position." } } }, "auth_ref": [ "r119", "r121", "r131" ] }, "us-gaap_FinancialLiabilitiesFairValueDisclosure": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FinancialLiabilitiesFairValueDisclosure", "crdr": "credit", "calculation": { "http://www.zimmerbiomet.com/20240331/taxonomy/role/DisclosureFairValueMeasurementOfAssetsAndLiabilitiesScheduleOfFairValueMeasurementOfAssetAndLiabilitiesDetail": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/DisclosureFairValueMeasurementOfAssetsAndLiabilitiesScheduleOfFairValueMeasurementOfAssetAndLiabilitiesDetail" ], "lang": { "en-us": { "role": { "label": "Financial Liabilities Fair Value Disclosure", "totalLabel": "Total Liabilities", "documentation": "Fair value of financial obligations, including, but not limited to, debt instruments, derivative liabilities, federal funds purchased and sold under agreements to repurchase, securities loaned or sold under agreements to repurchase, financial instruments sold not yet purchased, guarantees, line of credit, loans and notes payable, servicing liability, and trading liabilities." } } }, "auth_ref": [] }, "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/DisclosureAcquisitionsAdditionalInformationDetail", "http://www.zimmerbiomet.com/20240331/taxonomy/role/DisclosureAcquisitionsSummaryOfEstimatesOfFairValueOfAssetsAcquiredAndLiabilitiesAssumedDetails" ], "lang": { "en-us": { "role": { "label": "Finite-Lived Intangible Assets by Major Class [Axis]", "documentation": "Information by major type or class of finite-lived intangible assets." } } }, "auth_ref": [ "r364", "r365", "r366", "r367", "r578", "r579" ] }, "us-gaap_FiniteLivedIntangibleAssetsGross": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsGross", "crdr": "debit", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/DisclosureAcquisitionsAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Intangible assets subject to amortization", "label": "Finite-Lived Intangible Assets, Gross", "totalLabel": "Finite-Lived Intangible Assets, Gross, Total", "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life." } } }, "auth_ref": [ "r197", "r579" ] }, "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/DisclosureAcquisitionsAdditionalInformationDetail", "http://www.zimmerbiomet.com/20240331/taxonomy/role/DisclosureAcquisitionsSummaryOfEstimatesOfFairValueOfAssetsAcquiredAndLiabilitiesAssumedDetails" ], "lang": { "en-us": { "role": { "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]", "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company." } } }, "auth_ref": [ "r86", "r88" ] }, "zbh_FivePointSevenFiveZeroPercentageMember": { "xbrltype": "domainItemType", "nsuri": "http://www.zimmerbiomet.com/20240331", "localname": "FivePointSevenFiveZeroPercentageMember", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDebtSummaryOfDebtInstrumentsDetail", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDebtSummaryOfDebtInstrumentsParentheticalDetail" ], "lang": { "en-us": { "role": { "documentation": "Five Point Seven Five Zero Percentage [Member]", "label": "Five Point Seven Five Zero Percentage [Member]", "terseLabel": "5.750% [Member]" } } }, "auth_ref": [] }, "zbh_FivePointThreeFiveZeroPercentageMember": { "xbrltype": "domainItemType", "nsuri": "http://www.zimmerbiomet.com/20240331", "localname": "FivePointThreeFiveZeroPercentageMember", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDebtSummaryOfDebtInstrumentsDetail", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDebtSummaryOfDebtInstrumentsParentheticalDetail" ], "lang": { "en-us": { "role": { "terseLabel": "5.350% [Member]", "label": "Five Point Three Five Zero Percentage [Member]", "documentation": "Five point three five zero percentage." } } }, "auth_ref": [] }, "zbh_FiveYearCreditAgreementMember": { "xbrltype": "domainItemType", "nsuri": "http://www.zimmerbiomet.com/20240331", "localname": "FiveYearCreditAgreementMember", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDebtSummaryOfDebtInstrumentsDetail" ], "lang": { "en-us": { "role": { "documentation": "Five year credit agreement.", "label": "Five Year Credit Agreement [Member]", "terseLabel": "Five-Year Credit Agreement [Member]" } } }, "auth_ref": [] }, "zbh_FiveYearRevolvingFacilityMember": { "xbrltype": "domainItemType", "nsuri": "http://www.zimmerbiomet.com/20240331", "localname": "FiveYearRevolvingFacilityMember", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDebtAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "documentation": "Five year revolving facility member.", "label": "Five Year Revolving Facility [Member]", "terseLabel": "Five Year Revolving Facility" } } }, "auth_ref": [] }, "zbh_FloatingRateNotesMember": { "xbrltype": "domainItemType", "nsuri": "http://www.zimmerbiomet.com/20240331", "localname": "FloatingRateNotesMember", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDebtAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "documentation": "Floating rate notes.", "label": "Floating Rate Notes [Member]", "terseLabel": "Floating Rate Notes [Member]" } } }, "auth_ref": [] }, "us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months", "crdr": "credit", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Foreign Currency Cash Flow Hedge Gain (Loss) to be Reclassified During Next 12 Months", "terseLabel": "Fair value of outstanding derivative instruments, gain, expected to be reclassified to earnings", "documentation": "The estimated net amount of unrealized gains or losses on foreign currency cash flow hedges at the reporting date expected to be reclassified to earnings within the next 12 months." } } }, "auth_ref": [ "r133" ] }, "us-gaap_ForeignCurrencyTransactionGainLossBeforeTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ForeignCurrencyTransactionGainLossBeforeTax", "crdr": "credit", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Gain (Loss), Foreign Currency Transaction, before Tax", "terseLabel": "Gains (losses) on derivatives", "totalLabel": "Foreign Currency Transaction Gain (Loss), before Tax, Total", "documentation": "Amount, before tax, of realized and unrealized gain (loss) from foreign currency transaction." } } }, "auth_ref": [ "r552", "r554", "r556", "r558", "r705" ] }, "us-gaap_ForeignExchangeContractMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ForeignExchangeContractMember", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Foreign Exchange Contract [Member]", "terseLabel": "Foreign Exchange Contract [Member]", "documentation": "Derivative instrument whose primary underlying risk is tied to foreign exchange rates." } } }, "auth_ref": [ "r760", "r780", "r788" ] }, "us-gaap_ForeignExchangeForwardMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ForeignExchangeForwardMember", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/DisclosureFairValueMeasurementOfAssetsAndLiabilitiesScheduleOfFairValueMeasurementOfAssetAndLiabilitiesDetail", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureAccumulatedOtherComprehensiveIncomeReclassificationAdjustmentsFromAccumulatedOtherComprehensiveIncomeDetail", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsDetail", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesEffectsOfFairValueCashFlowAndNetInvestmentHedgeAccountingOnCondensedConsolidatedStatementsOfEarningsDetail", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesFairValueOfDerivativeInstrumentsOnGrossBasisDetail", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesGrossUnrealizedLossesFromDerivativeInstrumentsDetail", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesScheduleOfEffectsOfMasterNettingAgreementsOnCondensedConsolidatedBalanceSheetsDetail" ], "lang": { "en-us": { "role": { "label": "Foreign Exchange Forward [Member]", "terseLabel": "Foreign Exchange Forward Contracts [Member]", "documentation": "Foreign exchange forward traded on an exchange (examples include but are not limited to the International Securities Exchange, Philadelphia Stock Exchange, or the Chicago Mercantile Exchange) for options or future contracts to buy or sell a certain currency, at a specified date, at a fixed exercise exchange rate." } } }, "auth_ref": [ "r673", "r678", "r683", "r697", "r703", "r723", "r724", "r725", "r794" ] }, "ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Forgone Recovery due to Disqualification of Tax Benefits, Amount", "terseLabel": "Forgone Recovery due to Disqualification of Tax Benefits, Amount" } } }, "auth_ref": [ "r817", "r828", "r838", "r863" ] }, "ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ForgoneRecoveryDueToExpenseOfEnforcementAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Forgone Recovery due to Expense of Enforcement, Amount", "terseLabel": "Forgone Recovery due to Expense of Enforcement, Amount" } } }, "auth_ref": [ "r817", "r828", "r838", "r863" ] }, "ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ForgoneRecoveryDueToViolationOfHomeCountryLawAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Forgone Recovery due to Violation of Home Country Law, Amount", "terseLabel": "Forgone Recovery due to Violation of Home Country Law, Amount" } } }, "auth_ref": [ "r817", "r828", "r838", "r863" ] }, "ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ForgoneRecoveryExplanationOfImpracticabilityTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Forgone Recovery, Explanation of Impracticability [Text Block]", "terseLabel": "Forgone Recovery, Explanation of Impracticability" } } }, "auth_ref": [ "r817", "r828", "r838", "r863" ] }, "ecd_ForgoneRecoveryIndName": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ForgoneRecoveryIndName", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Forgone Recovery, Individual Name", "terseLabel": "Name" } } }, "auth_ref": [ "r817", "r828", "r838", "r863" ] }, "zbh_ForwardExchangeAgreementMember": { "xbrltype": "domainItemType", "nsuri": "http://www.zimmerbiomet.com/20240331", "localname": "ForwardExchangeAgreementMember", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/DisclosureDiscontinuedOperationsAndRelatedZimvieMattersAdditionalInformationDetails", "http://www.zimmerbiomet.com/20240331/taxonomy/role/DisclosureFairValueMeasurementOfAssetsAndLiabilitiesScheduleOfFairValueMeasurementOfAssetAndLiabilitiesDetail", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsDetail", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesFairValueOfDerivativeInstrumentsOnGrossBasisDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Forward Exchange Agreement [Member]", "label": "Forward Exchange Agreement [Member]", "documentation": "Forward Exchange Agreement.", "verboseLabel": "Forward Exchange Agreement" } } }, "auth_ref": [] }, "zbh_ForwardStartingInterestRateSwapCashFlowHedgeRemainingToBeAmortized": { "xbrltype": "monetaryItemType", "nsuri": "http://www.zimmerbiomet.com/20240331", "localname": "ForwardStartingInterestRateSwapCashFlowHedgeRemainingToBeAmortized", "crdr": "debit", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "documentation": "Forward starting interest rate swap cash flow hedge remaining to be amortized.", "label": "Forward Starting Interest Rate Swap Cash Flow Hedge Remaining To Be Amortized", "terseLabel": "Forward starting interest rate swap cash flow hedge to be amortized" } } }, "auth_ref": [] }, "zbh_ForwardStartingInterestRateSwapsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.zimmerbiomet.com/20240331", "localname": "ForwardStartingInterestRateSwapsMember", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureAccumulatedOtherComprehensiveIncomeReclassificationAdjustmentsFromAccumulatedOtherComprehensiveIncomeDetail", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesEffectsOfFairValueCashFlowAndNetInvestmentHedgeAccountingOnCondensedConsolidatedStatementsOfEarningsDetail", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesGrossUnrealizedLossesFromDerivativeInstrumentsDetail" ], "lang": { "en-us": { "role": { "documentation": "Forward starting interest rate swaps.", "label": "Forward Starting Interest Rate Swaps [Member]", "terseLabel": "Forward Starting Interest Rate Swaps [Member]" } } }, "auth_ref": [] }, "zbh_FourPointFourFiveZeroPercentageMember": { "xbrltype": "domainItemType", "nsuri": "http://www.zimmerbiomet.com/20240331", "localname": "FourPointFourFiveZeroPercentageMember", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDebtSummaryOfDebtInstrumentsDetail", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDebtSummaryOfDebtInstrumentsParentheticalDetail", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "documentation": "Four Point Four Five Zero Percentage [Member]", "label": "Four Point Four Five Zero Percentage [Member]", "terseLabel": "4.450% [Member]" } } }, "auth_ref": [] }, "zbh_FourPointTwoFiveZeroPercentageMember": { "xbrltype": "domainItemType", "nsuri": "http://www.zimmerbiomet.com/20240331", "localname": "FourPointTwoFiveZeroPercentageMember", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDebtSummaryOfDebtInstrumentsDetail", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDebtSummaryOfDebtInstrumentsParentheticalDetail" ], "lang": { "en-us": { "role": { "documentation": "Four Point Two Five Zero Percentage [Member]", "label": "Four Point Two Five Zero Percentage [Member]", "terseLabel": "4.250% [Member]" } } }, "auth_ref": [] }, "us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GainLossOnFairValueHedgesRecognizedInEarnings", "crdr": "credit", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesEffectsOfFairValueCashFlowAndNetInvestmentHedgeAccountingOnCondensedConsolidatedStatementsOfEarningsDetail" ], "lang": { "en-us": { "role": { "label": "Gain (Loss) on Fair Value Hedges Recognized in Earnings", "terseLabel": "Gain (loss) on fair value hedging relationships", "totalLabel": "Gain (Loss) on Fair Value Hedges Recognized in Earnings, Total", "documentation": "Total amount of gain (loss) derived from fair value hedges recognized in earnings in the period." } } }, "auth_ref": [ "r126" ] }, "us-gaap_GainLossOnInvestments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GainLossOnInvestments", "crdr": "credit", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/DisclosureDiscontinuedOperationsAndRelatedZimvieMattersAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "(Gain) loss on investment in ZimVie Inc.", "label": "Gain (Loss) on Investments", "totalLabel": "Gain (Loss) on Investments, Total", "verboseLabel": "Gain (loss) on investment in ZimVie", "documentation": "Amount of realized and unrealized gain (loss) on investment." } } }, "auth_ref": [ "r187", "r881" ] }, "us-gaap_GainLossRelatedToLitigationSettlement": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GainLossRelatedToLitigationSettlement", "crdr": "credit", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Net Litigation Related Gain (Charges)", "label": "Gain (Loss) Related to Litigation Settlement", "documentation": "Amount of gain (loss) recognized in settlement of litigation and insurance claims. Excludes claims within an insurance entity's normal claims settlement process." } } }, "auth_ref": [ "r920" ] }, "us-gaap_Goodwill": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "Goodwill", "crdr": "debit", "calculation": { "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 2.0 }, "http://www.zimmerbiomet.com/20240331/taxonomy/role/DisclosureAcquisitionsSummaryOfEstimatesOfFairValueOfAssetsAcquiredAndLiabilitiesAssumedDetails": { "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/DisclosureAcquisitionsSummaryOfEstimatesOfFairValueOfAssetsAcquiredAndLiabilitiesAssumedDetails", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited" ], "lang": { "en-us": { "role": { "label": "Goodwill", "terseLabel": "Goodwill", "totalLabel": "Goodwill, Total", "periodStartLabel": "Goodwill, Beginning Balance", "periodEndLabel": "Goodwill, Ending Balance", "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized." } } }, "auth_ref": [ "r248", "r363", "r580", "r767", "r789", "r914", "r915" ] }, "us-gaap_GoodwillAndIntangibleAssetImpairment": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GoodwillAndIntangibleAssetImpairment", "crdr": "debit", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureSegmentInformationSummaryOfNetSalesAndOperatingProfitBySegmentDetail" ], "lang": { "en-us": { "role": { "totalLabel": "Goodwill and Intangible Asset Impairment, Total", "label": "Goodwill and Intangible Asset Impairment", "terseLabel": "Intangible asset impairment", "negatedLabel": "Intangible asset impairment", "documentation": "Total loss recognized during the period from the impairment of goodwill plus the loss recognized in the period resulting from the impairment of the carrying amount of intangible assets, other than goodwill." } } }, "auth_ref": [] }, "us-gaap_HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease", "crdr": "credit", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesScheduleOfAmountsRecordedOnBalanceSheetRelatedToCumulativeBasisAdjustmentsForFairValueHedgesDetail" ], "lang": { "en-us": { "role": { "label": "Hedged Liability, Fair Value Hedge, Cumulative Increase (Decrease)", "terseLabel": "Long-term debt", "documentation": "Amount of cumulative increase (decrease) in fair value of hedged liability in fair value hedge, attributable to hedged risk." } } }, "auth_ref": [ "r527" ] }, "us-gaap_HedgingDesignationAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "HedgingDesignationAxis", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/DisclosureFairValueMeasurementOfAssetsAndLiabilitiesScheduleOfFairValueMeasurementOfAssetAndLiabilitiesDetail", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesAdditionalInformationDetail", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsDetail", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesFairValueOfDerivativeInstrumentsOnGrossBasisDetail", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesScheduleOfEffectsOfMasterNettingAgreementsOnCondensedConsolidatedBalanceSheetsDetail" ], "lang": { "en-us": { "role": { "label": "Hedging Designation [Axis]", "terseLabel": "Hedging Designation", "documentation": "Information by designation of purpose of derivative instrument." } } }, "auth_ref": [ "r31", "r526" ] }, "us-gaap_HedgingDesignationDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "HedgingDesignationDomain", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/DisclosureFairValueMeasurementOfAssetsAndLiabilitiesScheduleOfFairValueMeasurementOfAssetAndLiabilitiesDetail", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesAdditionalInformationDetail", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsDetail", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesFairValueOfDerivativeInstrumentsOnGrossBasisDetail", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesScheduleOfEffectsOfMasterNettingAgreementsOnCondensedConsolidatedBalanceSheetsDetail" ], "lang": { "en-us": { "role": { "label": "Hedging Designation [Domain]", "terseLabel": "Hedging Designation", "documentation": "Designation of purpose of derivative instrument." } } }, "auth_ref": [ "r31" ] }, "us-gaap_HedgingRelationshipDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "HedgingRelationshipDomain", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureAccumulatedOtherComprehensiveIncomeChangesInComponentsOfAccumulatedOtherComprehensiveIncomeNetOfTaxDetail", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesAdditionalInformationDetail", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesEffectsOfFairValueCashFlowAndNetInvestmentHedgeAccountingOnCondensedConsolidatedStatementsOfEarningsDetail", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesGrossUnrealizedLossesFromDerivativeInstrumentsDetail", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesScheduleOfEffectsOfMasterNettingAgreementsOnCondensedConsolidatedBalanceSheetsDetail" ], "lang": { "en-us": { "role": { "label": "Hedging Relationship [Domain]", "terseLabel": "Hedging Relationship", "documentation": "Nature or intent of a hedge." } } }, "auth_ref": [ "r31" ] }, "zbh_HipsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.zimmerbiomet.com/20240331", "localname": "HipsMember", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureRevenueScheduleOfNetSalesByProductCategoryDetail" ], "lang": { "en-us": { "role": { "documentation": "Hips.", "label": "Hips [Member]", "terseLabel": "Hips [Member]" } } }, "auth_ref": [] }, "zbh_IPRDAndReclassified": { "xbrltype": "monetaryItemType", "nsuri": "http://www.zimmerbiomet.com/20240331", "localname": "IPRDAndReclassified", "crdr": "debit", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/DisclosureAcquisitionsAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "terseLabel": "IPR&D", "label": "I P R & D and Reclassified", "documentation": "IPR&D and reclassified." } } }, "auth_ref": [] }, "us-gaap_InProcessResearchAndDevelopmentMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InProcessResearchAndDevelopmentMember", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/DisclosureAcquisitionsAdditionalInformationDetail", "http://www.zimmerbiomet.com/20240331/taxonomy/role/DisclosureAcquisitionsSummaryOfEstimatesOfFairValueOfAssetsAcquiredAndLiabilitiesAssumedDetails" ], "lang": { "en-us": { "role": { "label": "In Process Research and Development [Member]", "verboseLabel": "In-process Research and Development (IPR&D) [Member]", "documentation": "In process investigation of new knowledge useful in developing new product or service or new process or technique or improvement to existing product or process, and translation of knowledge into plan or design for new product or process or for improvement to existing product or process." } } }, "auth_ref": [] }, "us-gaap_IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity", "crdr": "debit", "calculation": { "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfEarningsUnaudited": { "parentTag": "us-gaap_NetIncomeLoss", "weight": -1.0, "order": 0.0 } }, "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfEarningsUnaudited" ], "lang": { "en-us": { "role": { "label": "Income (Loss) from Continuing Operations, Net of Tax, Attributable to Noncontrolling Interest", "terseLabel": "Less: Net earnings attributable to noncontrolling interest", "documentation": "Amount after tax of income (loss) from continuing operations attributable to the noncontrolling interest." } } }, "auth_ref": [ "r113", "r213" ] }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "crdr": "credit", "calculation": { "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureAccumulatedOtherComprehensiveIncomeReclassificationAdjustmentsFromAccumulatedOtherComprehensiveIncomeDetail": { "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic", "weight": 1.0, "order": 0.0 }, "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfEarningsUnaudited": { "parentTag": "us-gaap_ProfitLoss", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureAccumulatedOtherComprehensiveIncomeReclassificationAdjustmentsFromAccumulatedOtherComprehensiveIncomeDetail", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfEarningsUnaudited" ], "lang": { "en-us": { "role": { "totalLabel": "Earnings before income taxes", "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest", "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest." } } }, "auth_ref": [ "r0", "r181", "r221", "r332", "r339", "r345", "r348", "r584", "r597", "r764" ] }, "us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeLossFromDiscontinuedOperationsNetOfTax", "crdr": "credit", "calculation": { "http://www.zimmerbiomet.com/20240331/taxonomy/role/DisclosureDiscontinuedOperationsAndRelatedZimvieMattersSummaryOfDetailsOfLossFromDiscontinuedOperationsIncludedInCondensedConsolidatedState": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/DisclosureDiscontinuedOperationsAndRelatedZimvieMattersSummaryOfDetailsOfLossFromDiscontinuedOperationsIncludedInCondensedConsolidatedState" ], "lang": { "en-us": { "role": { "totalLabel": "Loss from discontinued operations, net of tax", "label": "Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest", "documentation": "Amount after tax of income (loss) from a discontinued operation including the portion attributable to the noncontrolling interest. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal." } } }, "auth_ref": [ "r146", "r147", "r148", "r149", "r150", "r160", "r242", "r504", "r598" ] }, "us-gaap_IncomeStatementAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeStatementAbstract", "lang": { "en-us": { "role": { "label": "Income Statement [Abstract]" } } }, "auth_ref": [] }, "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/DisclosureDiscontinuedOperationsAndRelatedZimvieMattersAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]", "terseLabel": "Income Statement Balance Sheet And Additional Disclosures By Disposal Groups Including Discontinued Operations [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/DisclosureDiscontinuedOperationsAndRelatedZimvieMattersAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Disposal Groups, Including Discontinued Operations [Table]", "terseLabel": "Income Statement Balance Sheet And Additional Disclosures By Disposal Groups Including Discontinued Operations [Table]", "documentation": "Disclosure of information about a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component." } } }, "auth_ref": [ "r24", "r35", "r43", "r145", "r151", "r152", "r153", "r154", "r155", "r159", "r161", "r162", "r202" ] }, "us-gaap_IncomeStatementLocationAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeStatementLocationAxis", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesAdditionalInformationDetail", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsDetail", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesEffectsOfFairValueCashFlowAndNetInvestmentHedgeAccountingOnCondensedConsolidatedStatementsOfEarningsDetail", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesGrossUnrealizedLossesFromDerivativeInstrumentsDetail" ], "lang": { "en-us": { "role": { "label": "Income Statement Location [Axis]", "terseLabel": "Income Statement Location", "documentation": "Information by location in the income statement." } } }, "auth_ref": [ "r368", "r373", "r692" ] }, "us-gaap_IncomeStatementLocationDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeStatementLocationDomain", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesAdditionalInformationDetail", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsDetail", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesEffectsOfFairValueCashFlowAndNetInvestmentHedgeAccountingOnCondensedConsolidatedStatementsOfEarningsDetail", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesGrossUnrealizedLossesFromDerivativeInstrumentsDetail" ], "lang": { "en-us": { "role": { "label": "Income Statement Location [Domain]", "terseLabel": "Income Statement Location", "documentation": "Location in the income statement." } } }, "auth_ref": [ "r373", "r692" ] }, "us-gaap_IncomeTaxAuthorityAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxAuthorityAxis", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Income Tax Authority [Axis]", "documentation": "Information by tax jurisdiction." } } }, "auth_ref": [ "r27" ] }, "us-gaap_IncomeTaxAuthorityDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxAuthorityDomain", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Income Tax Authority [Domain]", "documentation": "Agency, division or body classification that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes." } } }, "auth_ref": [] }, "us-gaap_IncomeTaxDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxDisclosureAbstract", "lang": { "en-us": { "role": { "label": "Income Tax Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_IncomeTaxDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxDisclosureTextBlock", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureIncomeTaxes" ], "lang": { "en-us": { "role": { "label": "Income Tax Disclosure [Text Block]", "terseLabel": "Income Taxes", "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information." } } }, "auth_ref": [ "r289", "r487", "r492", "r493", "r494", "r497", "r500", "r505", "r506", "r631" ] }, "us-gaap_IncomeTaxExpenseBenefit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxExpenseBenefit", "crdr": "debit", "calculation": { "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfEarningsUnaudited": { "parentTag": "us-gaap_ProfitLoss", "weight": -1.0, "order": 0.0 }, "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureAccumulatedOtherComprehensiveIncomeReclassificationAdjustmentsFromAccumulatedOtherComprehensiveIncomeDetail2": { "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic", "weight": -1.0, "order": 1.0 }, "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureAccumulatedOtherComprehensiveIncomeReclassificationAdjustmentsFromAccumulatedOtherComprehensiveIncomeDetail": { "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureAccumulatedOtherComprehensiveIncomeReclassificationAdjustmentsFromAccumulatedOtherComprehensiveIncomeDetail", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfEarningsUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Provision for income taxes", "verboseLabel": "Tax benefit related to Swiss Agreement", "label": "Provision (benefit) for income taxes", "totalLabel": "Income Tax Expense (Benefit), Total", "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations." } } }, "auth_ref": [ "r225", "r235", "r304", "r305", "r336", "r490", "r498", "r604" ] }, "zbh_IncomeTaxesDisclosureLineItems": { "xbrltype": "stringItemType", "nsuri": "http://www.zimmerbiomet.com/20240331", "localname": "IncomeTaxesDisclosureLineItems", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Income Taxes Disclosure [Line Items]", "label": "Income Taxes Disclosure [Line Items]", "documentation": "Income Taxes Disclosure [Line Items]" } } }, "auth_ref": [] }, "zbh_IncomeTaxesDisclosureTable": { "xbrltype": "stringItemType", "nsuri": "http://www.zimmerbiomet.com/20240331", "localname": "IncomeTaxesDisclosureTable", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Income Taxes Disclosure [Table]", "label": "Income Taxes Disclosure [Table]", "documentation": "Income Taxes Disclosure [Table]" } } }, "auth_ref": [] }, "us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities", "crdr": "debit", "calculation": { "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "label": "Increase (Decrease) in Accounts Payable and Accrued Liabilities", "terseLabel": "Accounts payable and accrued liabilities", "totalLabel": "Increase (Decrease) in Accounts Payable and Accrued Liabilities, Total", "documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid." } } }, "auth_ref": [ "r21" ] }, "us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInAccruedIncomeTaxesPayable", "crdr": "debit", "calculation": { "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "label": "Increase (Decrease) in Income Taxes Payable", "terseLabel": "Income taxes", "documentation": "The increase (decrease) during the period in the amount due for taxes based on the reporting entity's earnings or attributable to the entity's income earning process (business presence) within a given jurisdiction." } } }, "auth_ref": [ "r21" ] }, "us-gaap_IncreaseDecreaseInInventories": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInInventories", "crdr": "credit", "calculation": { "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 5.0 } }, "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "label": "Increase (Decrease) in Inventories", "negatedLabel": "Inventories", "totalLabel": "Increase (Decrease) in Inventories, Total", "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities." } } }, "auth_ref": [ "r21" ] }, "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInOperatingCapitalAbstract", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "label": "Increase (Decrease) in Operating Capital [Abstract]", "terseLabel": "Changes in operating assets and liabilities, net of acquired assets and liabilities" } } }, "auth_ref": [] }, "us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInOtherOperatingCapitalNet", "crdr": "credit", "calculation": { "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 7.0 } }, "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "label": "Increase (Decrease) in Other Operating Assets and Liabilities, Net", "negatedLabel": "Other assets and liabilities", "totalLabel": "Increase (Decrease) in Other Operating Assets and Liabilities, Net, Total", "documentation": "Amount of increase (decrease) in operating assets after deduction of operating liabilities classified as other." } } }, "auth_ref": [ "r21" ] }, "us-gaap_IncreaseDecreaseInReceivables": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInReceivables", "crdr": "credit", "calculation": { "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 4.0 } }, "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "label": "Increase (Decrease) in Receivables", "negatedLabel": "Receivables", "totalLabel": "Increase (Decrease) in Receivables, Total", "documentation": "The increase (decrease) during the reporting period in the total amount due within one year (or one operating cycle) from all parties, associated with underlying transactions that are classified as operating activities." } } }, "auth_ref": [ "r21" ] }, "us-gaap_IncreaseInUnrecognizedTaxBenefitsIsReasonablyPossible": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseInUnrecognizedTaxBenefitsIsReasonablyPossible", "crdr": "credit", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Increase in Unrecognized Tax Benefits is Reasonably Possible", "terseLabel": "Increase in unrecognized tax benefits within the next twelve months", "documentation": "Amount of increase reasonably possible in the next twelve months for the unrecognized tax benefit." } } }, "auth_ref": [ "r104" ] }, "us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncrementalCommonSharesAttributableToShareBasedPaymentArrangements", "calculation": { "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureEarningsPerShareReconciliationOfWeightedAverageSharesForBasicAndDilutedSharesComputationsDetail": { "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureEarningsPerShareReconciliationOfWeightedAverageSharesForBasicAndDilutedSharesComputationsDetail" ], "lang": { "en-us": { "role": { "label": "Incremental Common Shares Attributable to Dilutive Effect of Share-Based Payment Arrangements", "terseLabel": "Effect of dilutive stock options and other equity awards", "totalLabel": "Incremental Common Shares Attributable to Share-based Payment Arrangements, Total", "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method." } } }, "auth_ref": [ "r312", "r313", "r314", "r320", "r457" ] }, "zbh_IncrementalFeatureLineOfCredit": { "xbrltype": "monetaryItemType", "nsuri": "http://www.zimmerbiomet.com/20240331", "localname": "IncrementalFeatureLineOfCredit", "crdr": "credit", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDebtAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "documentation": "Incremental feature line of credit.", "label": "Incremental Feature Line Of Credit", "terseLabel": "Uncommitted incremental feature" } } }, "auth_ref": [] }, "ecd_IndividualAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "IndividualAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure", "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure", "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements", "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Individual [Axis]", "terseLabel": "Individual:" } } }, "auth_ref": [ "r820", "r828", "r838", "r855", "r863", "r867", "r875" ] }, "ecd_InsiderTradingArrLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "InsiderTradingArrLineItems", "lang": { "en-us": { "role": { "label": "Insider Trading Arrangements [Line Items]", "terseLabel": "Insider Trading Arrangements:" } } }, "auth_ref": [ "r873" ] }, "ecd_InsiderTradingPoliciesProcLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "InsiderTradingPoliciesProcLineItems", "lang": { "en-us": { "role": { "label": "Insider Trading Policies and Procedures [Line Items]", "terseLabel": "Insider Trading Policies and Procedures:" } } }, "auth_ref": [ "r809", "r879" ] }, "ecd_InsiderTrdPoliciesProcAdoptedFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "InsiderTrdPoliciesProcAdoptedFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" ], "lang": { "en-us": { "role": { "label": "Insider Trading Policies and Procedures Adopted [Flag]", "terseLabel": "Insider Trading Policies and Procedures Adopted" } } }, "auth_ref": [ "r809", "r879" ] }, "ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "InsiderTrdPoliciesProcNotAdoptedTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" ], "lang": { "en-us": { "role": { "label": "Insider Trading Policies and Procedures Not Adopted [Text Block]", "terseLabel": "Insider Trading Policies and Procedures Not Adopted" } } }, "auth_ref": [ "r809", "r879" ] }, "zbh_InstrumentsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.zimmerbiomet.com/20240331", "localname": "InstrumentsMember", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosurePropertyPlantAndEquipmentSummaryOfPropertyPlantAndEquipmentDetail" ], "lang": { "en-us": { "role": { "documentation": "Instruments.", "label": "Instruments [Member]", "terseLabel": "Instruments [Member]" } } }, "auth_ref": [] }, "us-gaap_IntangibleAssetsNetExcludingGoodwill": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IntangibleAssetsNetExcludingGoodwill", "crdr": "debit", "calculation": { "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited" ], "lang": { "en-us": { "role": { "label": "Intangible Assets, Net (Excluding Goodwill)", "terseLabel": "Intangible assets, net", "totalLabel": "Intangible Assets, Net (Excluding Goodwill), Total", "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges." } } }, "auth_ref": [ "r84", "r87" ] }, "us-gaap_IntellectualPropertyMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IntellectualPropertyMember", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/DisclosureAcquisitionsAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Intellectual Property [Member]", "documentation": "Intangible asset arising from original creative thought. Include, but is not limited to, trademarks, patents, and copyrights." } } }, "auth_ref": [ "r41" ] }, "us-gaap_InterestExpenseMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InterestExpenseMember", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesAdditionalInformationDetail", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesEffectsOfFairValueCashFlowAndNetInvestmentHedgeAccountingOnCondensedConsolidatedStatementsOfEarningsDetail" ], "lang": { "en-us": { "role": { "label": "Interest Expense [Member]", "terseLabel": "Interest Expense [Member]", "documentation": "Primary financial statement caption encompassing interest expense." } } }, "auth_ref": [ "r38" ] }, "zbh_InterestExpenseNetMember": { "xbrltype": "domainItemType", "nsuri": "http://www.zimmerbiomet.com/20240331", "localname": "InterestExpenseNetMember", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesGrossUnrealizedLossesFromDerivativeInstrumentsDetail" ], "lang": { "en-us": { "role": { "documentation": "Interest expense net.", "label": "Interest Expense Net [Member]", "terseLabel": "Interest Expense [Member]" } } }, "auth_ref": [] }, "us-gaap_InterestIncomeExpenseNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InterestIncomeExpenseNet", "crdr": "credit", "calculation": { "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureAccumulatedOtherComprehensiveIncomeReclassificationAdjustmentsFromAccumulatedOtherComprehensiveIncomeDetail": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0, "order": 1.0 }, "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfEarningsUnaudited": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureAccumulatedOtherComprehensiveIncomeReclassificationAdjustmentsFromAccumulatedOtherComprehensiveIncomeDetail", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfEarningsUnaudited" ], "lang": { "en-us": { "role": { "label": "Interest Income (Expense), Net", "terseLabel": "Interest expense, net", "totalLabel": "Interest Income (Expense), Net, Total", "documentation": "The net amount of operating interest income (expense)." } } }, "auth_ref": [ "r223" ] }, "us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet", "crdr": "credit", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Interest Rate Cash Flow Hedge Gain (Loss) to be Reclassified During Next 12 Months, Net", "terseLabel": "Fair value of outstanding derivative instruments, loss, expected to be reclassified to earnings", "documentation": "The estimated net amount of unrealized gains or losses on interest rate cash flow hedges as of the balance sheet date expected to be reclassified to earnings within the next twelve months." } } }, "auth_ref": [ "r133" ] }, "us-gaap_InterestRateSwapMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InterestRateSwapMember", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/DisclosureFairValueMeasurementOfAssetsAndLiabilitiesScheduleOfFairValueMeasurementOfAssetAndLiabilitiesDetail", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesEffectsOfFairValueCashFlowAndNetInvestmentHedgeAccountingOnCondensedConsolidatedStatementsOfEarningsDetail", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesFairValueOfDerivativeInstrumentsOnGrossBasisDetail" ], "lang": { "en-us": { "role": { "label": "Interest Rate Swap [Member]", "terseLabel": "Interest Rate Swap [Member]", "verboseLabel": "Interest Rate Swaps [Member]", "documentation": "Forward based contracts in which two parties agree to swap periodic payments that are fixed at the outset of the swap contract with variable payments based on a market interest rate (index rate) over a specified period." } } }, "auth_ref": [ "r750", "r799", "r800" ] }, "zbh_InterestRateSwapsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.zimmerbiomet.com/20240331", "localname": "InterestRateSwapsMember", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesEffectsOfFairValueCashFlowAndNetInvestmentHedgeAccountingOnCondensedConsolidatedStatementsOfEarningsDetail" ], "lang": { "en-us": { "role": { "documentation": "Interest rate swaps.", "label": "Interest Rate Swaps [Member]", "terseLabel": "Interest Rate Swaps [Member]" } } }, "auth_ref": [] }, "us-gaap_InventoryDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InventoryDisclosureAbstract", "lang": { "en-us": { "role": { "label": "Inventory Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_InventoryDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InventoryDisclosureTextBlock", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureInventories" ], "lang": { "en-us": { "role": { "label": "Inventory Disclosure [Text Block]", "terseLabel": "Inventories", "documentation": "The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory." } } }, "auth_ref": [ "r362" ] }, "us-gaap_InventoryFinishedGoodsNetOfReserves": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InventoryFinishedGoodsNetOfReserves", "crdr": "debit", "calculation": { "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureInventoriesSummaryOfInventoriesDetail": { "parentTag": "us-gaap_InventoryNet", "weight": 1.0, "order": 0.0 } }, "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureInventoriesSummaryOfInventoriesDetail" ], "lang": { "en-us": { "role": { "label": "Inventory, Finished Goods, Net of Reserves", "terseLabel": "Finished goods", "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale." } } }, "auth_ref": [ "r195", "r757" ] }, "us-gaap_InventoryNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InventoryNet", "crdr": "debit", "calculation": { "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 2.0 }, "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureInventoriesSummaryOfInventoriesDetail": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureInventoriesSummaryOfInventoriesDetail", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited" ], "lang": { "en-us": { "role": { "label": "Inventory, Net", "terseLabel": "Inventories", "totalLabel": "Inventories", "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer." } } }, "auth_ref": [ "r259", "r754", "r789" ] }, "us-gaap_InventoryRawMaterialsNetOfReserves": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InventoryRawMaterialsNetOfReserves", "crdr": "debit", "calculation": { "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureInventoriesSummaryOfInventoriesDetail": { "parentTag": "us-gaap_InventoryNet", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureInventoriesSummaryOfInventoriesDetail" ], "lang": { "en-us": { "role": { "label": "Inventory, Raw Materials, Net of Reserves", "terseLabel": "Raw materials", "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of unprocessed items to be consumed in the manufacturing or production process." } } }, "auth_ref": [ "r195", "r759" ] }, "us-gaap_InventoryWorkInProcessNetOfReserves": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InventoryWorkInProcessNetOfReserves", "crdr": "debit", "calculation": { "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureInventoriesSummaryOfInventoriesDetail": { "parentTag": "us-gaap_InventoryNet", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureInventoriesSummaryOfInventoriesDetail" ], "lang": { "en-us": { "role": { "label": "Inventory, Work in Process, Net of Reserves", "terseLabel": "Work in progress", "documentation": "Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing." } } }, "auth_ref": [ "r195", "r758" ] }, "zbh_JaceMember": { "xbrltype": "domainItemType", "nsuri": "http://www.zimmerbiomet.com/20240331", "localname": "JaceMember", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/DisclosureAcquisitionsAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "documentation": "Jace Medical, LLC.", "label": "Jace [Member]", "terseLabel": "Jace [Member]" } } }, "auth_ref": [] }, "zbh_JapanTermLoanAAndJapanTermLoanBMember": { "xbrltype": "domainItemType", "nsuri": "http://www.zimmerbiomet.com/20240331", "localname": "JapanTermLoanAAndJapanTermLoanBMember", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDebtAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "documentation": "Japan Term Loan A and Japan Term Loan B.", "label": "Japan Term Loan A And Japan Term Loan B [Member]", "terseLabel": "Japan Term Loan A and Japan Term Loan B [Member]" } } }, "auth_ref": [] }, "zbh_JapanTermLoanAMember": { "xbrltype": "domainItemType", "nsuri": "http://www.zimmerbiomet.com/20240331", "localname": "JapanTermLoanAMember", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDebtAdditionalInformationDetail", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDebtSummaryOfDebtInstrumentsDetail" ], "lang": { "en-us": { "role": { "documentation": "Japan Term Loan A.", "label": "Japan Term Loan A [Member]", "terseLabel": "Japan Term Loan A [Member]" } } }, "auth_ref": [] }, "zbh_JapanTermLoanBMember": { "xbrltype": "domainItemType", "nsuri": "http://www.zimmerbiomet.com/20240331", "localname": "JapanTermLoanBMember", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDebtAdditionalInformationDetail", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDebtSummaryOfDebtInstrumentsDetail" ], "lang": { "en-us": { "role": { "documentation": "Japan Term Loan B.", "label": "Japan Term Loan B [Member]", "terseLabel": "Japan Term Loan B [Member]" } } }, "auth_ref": [] }, "zbh_KneesMember": { "xbrltype": "domainItemType", "nsuri": "http://www.zimmerbiomet.com/20240331", "localname": "KneesMember", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureRevenueScheduleOfNetSalesByProductCategoryDetail" ], "lang": { "en-us": { "role": { "documentation": "Knees.", "label": "Knees [Member]", "terseLabel": "Knees [Member]" } } }, "auth_ref": [] }, "us-gaap_LandMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LandMember", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosurePropertyPlantAndEquipmentSummaryOfPropertyPlantAndEquipmentDetail" ], "lang": { "en-us": { "role": { "label": "Land [Member]", "terseLabel": "Land [Member]", "documentation": "Part of earth's surface not covered by water." } } }, "auth_ref": [ "r930" ] }, "dei_LegalEntityAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LegalEntityAxis", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDebtAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Legal Entity [Axis]", "terseLabel": "Legal Entity", "documentation": "The set of legal entities associated with a report." } } }, "auth_ref": [] }, "us-gaap_Liabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "Liabilities", "crdr": "credit", "calculation": { "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited": { "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0, "order": 0.0 } }, "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited" ], "lang": { "en-us": { "role": { "label": "Liabilities", "totalLabel": "Total Liabilities", "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future." } } }, "auth_ref": [ "r49", "r288", "r357", "r389", "r390", "r392", "r393", "r394", "r396", "r398", "r400", "r401", "r515", "r519", "r520", "r551", "r665", "r763", "r804", "r926", "r945", "r946" ] }, "us-gaap_LiabilitiesAndStockholdersEquity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesAndStockholdersEquity", "crdr": "credit", "calculation": { "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited" ], "lang": { "en-us": { "role": { "label": "Liabilities and Equity", "totalLabel": "Total Liabilities and Stockholders' Equity", "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any." } } }, "auth_ref": [ "r172", "r220", "r594", "r789", "r906", "r912", "r940" ] }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesAndStockholdersEquityAbstract", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited" ], "lang": { "en-us": { "role": { "label": "Liabilities and Equity [Abstract]", "terseLabel": "LIABILITIES AND STOCKHOLDERS' EQUITY" } } }, "auth_ref": [] }, "us-gaap_LiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesCurrent", "crdr": "credit", "calculation": { "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 0.0 } }, "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited" ], "lang": { "en-us": { "role": { "label": "Liabilities, Current", "totalLabel": "Total Current Liabilities", "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer." } } }, "auth_ref": [ "r51", "r244", "r288", "r357", "r389", "r390", "r392", "r393", "r394", "r396", "r398", "r400", "r401", "r515", "r519", "r520", "r551", "r789", "r926", "r945", "r946" ] }, "us-gaap_LiabilitiesCurrentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesCurrentAbstract", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited" ], "lang": { "en-us": { "role": { "label": "Liabilities, Current [Abstract]", "terseLabel": "Current Liabilities:" } } }, "auth_ref": [] }, "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent", "crdr": "credit", "calculation": { "http://www.zimmerbiomet.com/20240331/taxonomy/role/DisclosureDiscontinuedOperationsAndRelatedZimvieMattersSummaryOfDetailsOfAssetsAndLiabilitiesOfDiscontinuedOperationDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/DisclosureDiscontinuedOperationsAndRelatedZimvieMattersSummaryOfDetailsOfAssetsAndLiabilitiesOfDiscontinuedOperationDetails" ], "lang": { "en-us": { "role": { "label": "Disposal Group, Including Discontinued Operation, Liabilities, Current", "terseLabel": "Current liabilities of discontinued operations", "totalLabel": "Total Current Liabilities of Discontinued Operations", "documentation": "Amount classified as liabilities attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r7", "r145", "r158", "r199", "r201", "r241", "r242" ] }, "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent", "crdr": "credit", "calculation": { "http://www.zimmerbiomet.com/20240331/taxonomy/role/DisclosureDiscontinuedOperationsAndRelatedZimvieMattersSummaryOfDetailsOfAssetsAndLiabilitiesOfDiscontinuedOperationDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/DisclosureDiscontinuedOperationsAndRelatedZimvieMattersSummaryOfDetailsOfAssetsAndLiabilitiesOfDiscontinuedOperationDetails" ], "lang": { "en-us": { "role": { "label": "Disposal Group, Including Discontinued Operation, Liabilities, Noncurrent", "terseLabel": "Noncurrent liabilities of discontinued operations", "totalLabel": "Total Noncurrent Liabilities of Discontinued Operations", "documentation": "Amount classified as liabilities attributable to disposal group held for sale or disposed of, expected to be disposed of beyond one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r7", "r15", "r145", "r158", "r201", "r241", "r242" ] }, "zbh_LiabilityDerivativesOffset": { "xbrltype": "monetaryItemType", "nsuri": "http://www.zimmerbiomet.com/20240331", "localname": "LiabilityDerivativesOffset", "crdr": "debit", "calculation": { "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesScheduleOfEffectsOfMasterNettingAgreementsOnCondensedConsolidatedBalanceSheetsDetail": { "parentTag": "us-gaap_DerivativeLiabilities", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesScheduleOfEffectsOfMasterNettingAgreementsOnCondensedConsolidatedBalanceSheetsDetail" ], "lang": { "en-us": { "role": { "documentation": "Liability Derivatives Offset", "label": "Liability Derivatives Offset", "verboseLabel": "Offset" } } }, "auth_ref": [] }, "us-gaap_LineOfCredit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LineOfCredit", "crdr": "credit", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDebtAdditionalInformationDetail", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDebtSummaryOfDebtInstrumentsDetail" ], "lang": { "en-us": { "role": { "label": "Long-Term Line of Credit", "terseLabel": "Outstanding borrowings", "totalLabel": "Long-term Line of Credit, Total", "verboseLabel": "Uncommitted Credit Facility", "documentation": "The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement." } } }, "auth_ref": [ "r42", "r218", "r954" ] }, "us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LineOfCreditFacilityFairValueOfAmountOutstanding", "crdr": "credit", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDebtAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Line of Credit Facility, Fair Value of Amount Outstanding", "terseLabel": "Line of credit fair value", "documentation": "Fair value of the amount outstanding under the credit facility." } } }, "auth_ref": [ "r550" ] }, "zbh_LineOfCreditFacilityMaturityDescription": { "xbrltype": "stringItemType", "nsuri": "http://www.zimmerbiomet.com/20240331", "localname": "LineOfCreditFacilityMaturityDescription", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDebtAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "documentation": "Line of credit facility maturity description.", "label": "Line of Credit Facility Maturity Description", "terseLabel": "Line of credit facility maturity description" } } }, "auth_ref": [] }, "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LineOfCreditFacilityMaximumBorrowingCapacity", "crdr": "credit", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/DisclosureDiscontinuedOperationsAndRelatedZimvieMattersAdditionalInformationDetails", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDebtAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Debt instrument", "verboseLabel": "ZimVie revolving credit agreement", "label": "Uncommitted credit facility", "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility." } } }, "auth_ref": [ "r47" ] }, "us-gaap_LitigationReserve": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LitigationReserve", "crdr": "credit", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Estimated Litigation Liability", "terseLabel": "Accrued litigation liabilities", "documentation": "Aggregate carrying amount of the estimated litigation liability for known or estimated probable loss from litigation, which may include attorneys' fees and other litigation costs." } } }, "auth_ref": [ "r55", "r920" ] }, "us-gaap_LitigationSettlementExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LitigationSettlementExpense", "crdr": "debit", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Litigation Settlement, Expense", "terseLabel": "Net Litigation Related Charges", "documentation": "Amount of litigation expense, including but not limited to legal, forensic, accounting, and investigative fees." } } }, "auth_ref": [] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LocalPhoneNumber", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Local Phone Number", "terseLabel": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "zbh_LongDebtHedgedByInterestRateSwap": { "xbrltype": "monetaryItemType", "nsuri": "http://www.zimmerbiomet.com/20240331", "localname": "LongDebtHedgedByInterestRateSwap", "crdr": "credit", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDebtSummaryOfDebtInstrumentsDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Adjustment related to interest rate swaps", "label": "Long Debt Hedged By Interest Rate Swap", "documentation": "Change in fair value of debt hedged by interest rate swaps." } } }, "auth_ref": [] }, "us-gaap_LongTermDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LongTermDebt", "crdr": "credit", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesScheduleOfAmountsRecordedOnBalanceSheetRelatedToCumulativeBasisAdjustmentsForFairValueHedgesDetail" ], "lang": { "en-us": { "role": { "label": "Long-Term Debt", "terseLabel": "Long-term debt", "totalLabel": "Long-term Debt, Total", "documentation": "Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation." } } }, "auth_ref": [ "r42", "r218", "r415", "r431", "r773", "r774", "r954" ] }, "us-gaap_LongTermDebtByCurrentAndNoncurrentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LongTermDebtByCurrentAndNoncurrentAbstract", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDebtSummaryOfDebtInstrumentsDetail" ], "lang": { "en-us": { "role": { "label": "Long-Term Debt, by Current and Noncurrent [Abstract]", "terseLabel": "Long-term debt" } } }, "auth_ref": [] }, "us-gaap_LongTermDebtCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LongTermDebtCurrent", "crdr": "credit", "calculation": { "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDebtSummaryOfDebtInstrumentsDetail", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited" ], "lang": { "en-us": { "role": { "label": "Long-Term Debt, Current Maturities", "terseLabel": "Current portion of long-term debt", "totalLabel": "Long-term Debt, Current Maturities, Total", "verboseLabel": "Total current portion of long-term debt", "documentation": "Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as current. Excludes lease obligation." } } }, "auth_ref": [ "r252" ] }, "us-gaap_LongTermDebtCurrentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LongTermDebtCurrentAbstract", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDebtSummaryOfDebtInstrumentsDetail" ], "lang": { "en-us": { "role": { "label": "Long-Term Debt, Current Maturities [Abstract]", "terseLabel": "Current portion of long-term debt" } } }, "auth_ref": [] }, "us-gaap_LongTermDebtFairValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LongTermDebtFairValue", "crdr": "credit", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDebtAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Long-Term Debt, Fair Value", "terseLabel": "Estimated fair value", "documentation": "The fair value amount of long-term debt whether such amount is presented as a separate caption or as a parenthetical disclosure. Additionally, this element may be used in connection with the fair value disclosures required in the footnote disclosures to the financial statements. The element may be used in both the balance sheet and disclosure in the same submission." } } }, "auth_ref": [] }, "zbh_LongTermDebtFairValueAdjustments": { "xbrltype": "monetaryItemType", "nsuri": "http://www.zimmerbiomet.com/20240331", "localname": "LongTermDebtFairValueAdjustments", "crdr": "debit", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDebtAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "documentation": "Long term debt fair value adjustments.", "label": "Long Term Debt Fair Value Adjustments", "terseLabel": "Other debt and fair value adjustments, total" } } }, "auth_ref": [] }, "us-gaap_LongTermDebtNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LongTermDebtNoncurrent", "crdr": "credit", "calculation": { "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDebtSummaryOfDebtInstrumentsDetail", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited" ], "lang": { "en-us": { "role": { "label": "Long-Term Debt, Excluding Current Maturities", "terseLabel": "Long-term debt", "totalLabel": "Total long-term debt", "documentation": "Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation." } } }, "auth_ref": [ "r254" ] }, "zbh_LongTermDebtNoncurrentMember": { "xbrltype": "domainItemType", "nsuri": "http://www.zimmerbiomet.com/20240331", "localname": "LongTermDebtNoncurrentMember", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesScheduleOfAmountsRecordedOnBalanceSheetRelatedToCumulativeBasisAdjustmentsForFairValueHedgesDetail" ], "lang": { "en-us": { "role": { "documentation": "Long term debt Noncurrent.", "label": "Long Term Debt Noncurrent [Member]", "terseLabel": "Long Term Debt Noncurrent [Member]" } } }, "auth_ref": [] }, "us-gaap_LongtermDebtTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LongtermDebtTypeAxis", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDebtAdditionalInformationDetail", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDebtSummaryOfDebtInstrumentsDetail", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDebtSummaryOfDebtInstrumentsParentheticalDetail", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Long-Term Debt, Type [Axis]", "terseLabel": "Long-term Debt, Type", "documentation": "Information by type of long-term debt." } } }, "auth_ref": [ "r53" ] }, "us-gaap_LongtermDebtTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LongtermDebtTypeDomain", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDebtAdditionalInformationDetail", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDebtSummaryOfDebtInstrumentsDetail", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDebtSummaryOfDebtInstrumentsParentheticalDetail", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Long-Term Debt, Type [Domain]", "terseLabel": "Long-term Debt, Type", "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer." } } }, "auth_ref": [ "r53", "r96" ] }, "us-gaap_LossContingenciesByNatureOfContingencyAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LossContingenciesByNatureOfContingencyAxis", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Loss Contingency Nature [Axis]", "terseLabel": "Loss Contingency Nature", "documentation": "Information by type of existing condition, situation, or set of circumstances involving uncertainty as to possible loss to an enterprise that will ultimately be resolved when one or more future events occur or fail to occur." } } }, "auth_ref": [ "r383", "r384", "r385", "r388", "r921", "r923" ] }, "us-gaap_LossContingenciesLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LossContingenciesLineItems", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Loss Contingencies [Line Items]", "terseLabel": "Loss Contingencies [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r383", "r384", "r385", "r388", "r921", "r923" ] }, "us-gaap_LossContingenciesTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LossContingenciesTable", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Loss Contingencies [Table]", "terseLabel": "Loss Contingencies [Table]", "documentation": "Discloses the specific components (such as the nature, name, and date) of the loss contingency and gives an estimate of the possible loss or range of loss, or states that a reasonable estimate cannot be made. Excludes environmental contingencies, warranties and unconditional purchase obligations." } } }, "auth_ref": [ "r383", "r384", "r385", "r388", "r921", "r923" ] }, "us-gaap_LossContingencyAccrualAtCarryingValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LossContingencyAccrualAtCarryingValue", "crdr": "credit", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Loss Contingency Accrual", "terseLabel": "Loss Contingency Accrual", "periodStartLabel": "Loss Contingency Accrual, Beginning Balance", "periodEndLabel": "Loss Contingency Accrual, Ending Balance", "documentation": "Amount of loss contingency liability." } } }, "auth_ref": [ "r383", "r883" ] }, "zbh_LossContingencyMinimum": { "xbrltype": "monetaryItemType", "nsuri": "http://www.zimmerbiomet.com/20240331", "localname": "LossContingencyMinimum", "crdr": "credit", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Loss Contingency Minimum", "label": "Loss Contingency Minimum", "documentation": "Loss contingency minimum." } } }, "auth_ref": [] }, "us-gaap_LossContingencyNatureDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LossContingencyNatureDomain", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Loss Contingency, Nature [Domain]", "terseLabel": "Loss Contingency, Nature", "documentation": "An existing condition, situation, or set of circumstances involving uncertainty as to possible loss to an enterprise that will ultimately be resolved when one or more future events occur or fail to occur. Resolution of the uncertainty may confirm the incurrence of a loss or impairment of an asset or the incurrence of a liability." } } }, "auth_ref": [ "r383", "r384", "r385", "r388", "r921", "r923" ] }, "us-gaap_LossContingencyRangeOfPossibleLossPortionNotAccrued": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LossContingencyRangeOfPossibleLossPortionNotAccrued", "crdr": "debit", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Loss Contingency, Range of Possible Loss, Portion Not Accrued", "terseLabel": "Loss Contingency, Range of Possible Loss, Portion Not Accrued", "documentation": "The difference between the maximum amount of estimated loss and the amount recorded as of the balance sheet date." } } }, "auth_ref": [ "r922", "r924" ] }, "us-gaap_MaterialReconcilingItemsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "MaterialReconcilingItemsMember", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureSegmentInformationSummaryOfNetSalesAndOperatingProfitBySegmentDetail" ], "lang": { "en-us": { "role": { "label": "Segment Reconciling Items [Member]", "terseLabel": "Segment Reconciling Items", "documentation": "Items used in reconciling reportable segments' amounts to consolidated amount. Excludes corporate-level activity." } } }, "auth_ref": [ "r81" ] }, "us-gaap_MaturitiesOfSeniorDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "MaturitiesOfSeniorDebt", "crdr": "credit", "calculation": { "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "label": "Maturities of Senior Debt", "negatedLabel": "Redemption of senior notes", "documentation": "The cash outflow for the settlement of long-term borrowing, with the highest claim on the assets of the entity in case of bankruptcy or liquidation, as it matures." } } }, "auth_ref": [ "r66" ] }, "us-gaap_MaximumLengthOfTimeForeignCurrencyCashFlowHedge": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "MaximumLengthOfTimeForeignCurrencyCashFlowHedge", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Maximum Length of Time, Foreign Currency Cash Flow Hedge", "terseLabel": "Expected months of hedging of inter company sales of inventory to minimize the effects of foreign exchange rate movements", "documentation": "Maximum period of time the entity is hedging its exposure to variability in future cash flows for forecasted transactions, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Excludes forecasted transactions related to payment of variable interest on existing financial instruments." } } }, "auth_ref": [ "r26" ] }, "srt_MaximumMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "MaximumMember", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/DisclosureAcquisitionsAdditionalInformationDetail", "http://www.zimmerbiomet.com/20240331/taxonomy/role/DisclosureDiscontinuedOperationsAndRelatedZimvieMattersAdditionalInformationDetails", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDebtAdditionalInformationDetail", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesAdditionalInformationDetail", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureRestructuringAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Maximum [Member]", "terseLabel": "Maximum" } } }, "auth_ref": [ "r384", "r385", "r386", "r387", "r456", "r576", "r611", "r656", "r657", "r711", "r713", "r715", "r716", "r729", "r748", "r749", "r765", "r777", "r785", "r791", "r928", "r947", "r948", "r949", "r950", "r951", "r952" ] }, "ecd_MeasureAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "MeasureAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Measure [Axis]", "terseLabel": "Measure:" } } }, "auth_ref": [ "r847" ] }, "ecd_MeasureName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "MeasureName", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Measure Name", "terseLabel": "Name" } } }, "auth_ref": [ "r847" ] }, "srt_MinimumMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "MinimumMember", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/DisclosureDiscontinuedOperationsAndRelatedZimvieMattersAdditionalInformationDetails", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDebtAdditionalInformationDetail", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesAdditionalInformationDetail", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureRestructuringAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Minimum [Member]", "terseLabel": "Minimum [Member]", "verboseLabel": "Minimum [Member]" } } }, "auth_ref": [ "r384", "r385", "r386", "r387", "r456", "r576", "r611", "r656", "r657", "r711", "r713", "r715", "r716", "r729", "r748", "r749", "r765", "r777", "r785", "r791", "r928", "r947", "r948", "r949", "r950", "r951", "r952" ] }, "us-gaap_MinorityInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "MinorityInterest", "crdr": "credit", "calculation": { "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited": { "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited" ], "lang": { "en-us": { "role": { "label": "Equity, Attributable to Noncontrolling Interest", "terseLabel": "Noncontrolling interest", "totalLabel": "Stockholders' Equity Attributable to Noncontrolling Interest, Total", "periodStartLabel": "Stockholders' Equity Attributable to Noncontrolling Interest, Beginning Balance", "periodEndLabel": "Stockholders' Equity Attributable to Noncontrolling Interest, Ending Balance", "documentation": "Amount of equity (deficit) attributable to noncontrolling interest. Excludes temporary equity." } } }, "auth_ref": [ "r58", "r219", "r288", "r357", "r389", "r392", "r393", "r394", "r400", "r401", "r551", "r593", "r669" ] }, "ecd_MnpiDiscTimedForCompValFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "MnpiDiscTimedForCompValFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "MNPI Disclosure Timed for Compensation Value [Flag]", "terseLabel": "MNPI Disclosure Timed for Compensation Value" } } }, "auth_ref": [ "r866" ] }, "ecd_MtrlTermsOfTrdArrTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "MtrlTermsOfTrdArrTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Material Terms of Trading Arrangement [Text Block]", "terseLabel": "Material Terms of Trading Arrangement" } } }, "auth_ref": [ "r874" ] }, "zbh_MultiCurrencyRevolvingFacilityMember": { "xbrltype": "domainItemType", "nsuri": "http://www.zimmerbiomet.com/20240331", "localname": "MultiCurrencyRevolvingFacilityMember", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDebtAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "documentation": "Multi Currency Revolving Facility [Member]", "label": "Multi Currency Revolving Facility [Member]", "terseLabel": "Multicurrency Revolving Facility [Member]" } } }, "auth_ref": [] }, "ecd_NamedExecutiveOfficersFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NamedExecutiveOfficersFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Named Executive Officers, Footnote [Text Block]", "terseLabel": "Named Executive Officers, Footnote" } } }, "auth_ref": [ "r848" ] }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInFinancingActivities", "crdr": "debit", "calculation": { "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "totalLabel": "Net cash used in financing activities", "label": "Net Cash Provided by (Used in) Financing Activities", "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit." } } }, "auth_ref": [ "r284" ] }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Cash flows provided by (used in) financing activities:", "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]" } } }, "auth_ref": [] }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInInvestingActivities", "crdr": "debit", "calculation": { "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "totalLabel": "Net cash used in investing activities", "label": "Net Cash Provided by (Used in) Investing Activities", "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets." } } }, "auth_ref": [ "r284" ] }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Cash flows provided by (used in) investing activities:", "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]" } } }, "auth_ref": [] }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInOperatingActivities", "calculation": { "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "totalLabel": "Net cash provided by operating activities", "label": "Net Cash Provided by (Used in) Operating Activities", "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities." } } }, "auth_ref": [ "r190", "r191", "r192" ] }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Cash flows provided by (used in) operating activities:", "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]" } } }, "auth_ref": [] }, "us-gaap_NetIncomeLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetIncomeLoss", "crdr": "credit", "calculation": { "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfComprehensiveIncomeUnaudited": { "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": 1.0, "order": 2.0 }, "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfEarningsUnaudited": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfComprehensiveIncomeUnaudited", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfEarningsUnaudited", "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Net Income (Loss)", "terseLabel": "Net Income (Loss)", "verboseLabel": "Net earnings", "totalLabel": "Net Earnings of Zimmer Biomet Holdings, Inc.", "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent." } } }, "auth_ref": [ "r183", "r192", "r222", "r242", "r271", "r274", "r278", "r288", "r294", "r296", "r297", "r299", "r300", "r304", "r305", "r316", "r332", "r339", "r345", "r348", "r357", "r389", "r390", "r392", "r393", "r394", "r396", "r398", "r400", "r401", "r540", "r551", "r600", "r688", "r706", "r707", "r764", "r802", "r926" ] }, "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetIncomeLossAvailableToCommonStockholdersBasic", "crdr": "credit", "calculation": { "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureAccumulatedOtherComprehensiveIncomeReclassificationAdjustmentsFromAccumulatedOtherComprehensiveIncomeDetail2": { "parentTag": null, "weight": null, "order": null, "root": true }, "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureAccumulatedOtherComprehensiveIncomeReclassificationAdjustmentsFromAccumulatedOtherComprehensiveIncomeDetail": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureAccumulatedOtherComprehensiveIncomeReclassificationAdjustmentsFromAccumulatedOtherComprehensiveIncomeDetail" ], "lang": { "en-us": { "role": { "label": "Net Income (Loss) Available to Common Stockholders, Basic", "totalLabel": "Net of tax", "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders." } } }, "auth_ref": [ "r282", "r296", "r297", "r299", "r300", "r308", "r309", "r317", "r320", "r332", "r339", "r345", "r348", "r764" ] }, "zbh_NetInvestmentHedgeGainAtMaturity": { "xbrltype": "monetaryItemType", "nsuri": "http://www.zimmerbiomet.com/20240331", "localname": "NetInvestmentHedgeGainAtMaturity", "crdr": "credit", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "documentation": "Net investment hedge gain at maturity.", "label": "Net Investment Hedge Gain At Maturity", "terseLabel": "Net investment hedge gain at maturity" } } }, "auth_ref": [] }, "zbh_NetInvestmentHedgeGainLossAtMaturity": { "xbrltype": "monetaryItemType", "nsuri": "http://www.zimmerbiomet.com/20240331", "localname": "NetInvestmentHedgeGainLossAtMaturity", "crdr": "debit", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "documentation": "Net investment hedge gain/loss at maturity that remains in AOCI.", "label": "Net Investment Hedge Gain Loss At Maturity", "terseLabel": "Net investment hedge gain/loss at maturity" } } }, "auth_ref": [] }, "zbh_NetInvestmentHedgeGainLossAtTermination": { "xbrltype": "monetaryItemType", "nsuri": "http://www.zimmerbiomet.com/20240331", "localname": "NetInvestmentHedgeGainLossAtTermination", "crdr": "credit", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Net investment hedge gain /loss at termination", "label": "Net Investment Hedge Gain Loss At Termination", "documentation": "Net investment hedge gain loss at termination." } } }, "auth_ref": [] }, "zbh_NetInvestmentHedgeLossAtMaturity": { "xbrltype": "monetaryItemType", "nsuri": "http://www.zimmerbiomet.com/20240331", "localname": "NetInvestmentHedgeLossAtMaturity", "crdr": "debit", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "documentation": "Net investment hedge loss at maturity.", "label": "Net Investment Hedge Loss at Maturity", "terseLabel": "Net investment hedge loss at maturity" } } }, "auth_ref": [] }, "us-gaap_NetInvestmentHedgingMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetInvestmentHedgingMember", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesEffectsOfFairValueCashFlowAndNetInvestmentHedgeAccountingOnCondensedConsolidatedStatementsOfEarningsDetail" ], "lang": { "en-us": { "role": { "label": "Net Investment Hedging [Member]", "terseLabel": "Net Investment Hedging [Member]", "documentation": "Hedges of a net investment in a foreign operation." } } }, "auth_ref": [ "r117" ] }, "zbh_NetSalesAndOperatingProfitInformationLineItems": { "xbrltype": "stringItemType", "nsuri": "http://www.zimmerbiomet.com/20240331", "localname": "NetSalesAndOperatingProfitInformationLineItems", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureSegmentInformationSummaryOfNetSalesAndOperatingProfitBySegmentDetail" ], "lang": { "en-us": { "role": { "documentation": "Net sales and operating profit information.", "label": "Net Sales And Operating Profit Information [Line Items]", "terseLabel": "Net Sales And Operating Profit Information [Line Items]" } } }, "auth_ref": [] }, "zbh_NetSalesAndOperatingProfitInformationTable": { "xbrltype": "stringItemType", "nsuri": "http://www.zimmerbiomet.com/20240331", "localname": "NetSalesAndOperatingProfitInformationTable", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureSegmentInformationSummaryOfNetSalesAndOperatingProfitBySegmentDetail" ], "lang": { "en-us": { "role": { "documentation": "Net sales and operating profit information.", "label": "Net Sales And Operating Profit Information [Table]", "terseLabel": "Net Sales And Operating Profit Information [Table]" } } }, "auth_ref": [] }, "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "New Accounting Pronouncements, Policy [Policy Text Block]", "terseLabel": "Accounting Pronouncements Not Yet Adopted", "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact." } } }, "auth_ref": [] }, "ecd_NonGaapMeasureDescriptionTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonGaapMeasureDescriptionTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Non-GAAP Measure Description [Text Block]", "terseLabel": "Non-GAAP Measure Description" } } }, "auth_ref": [ "r847" ] }, "ecd_NonNeosMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonNeosMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Non-NEOs [Member]", "terseLabel": "Non-NEOs" } } }, "auth_ref": [ "r817", "r828", "r838", "r855", "r863" ] }, "ecd_NonPeoNeoAvgCompActuallyPaidAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonPeoNeoAvgCompActuallyPaidAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Non-PEO NEO Average Compensation Actually Paid Amount", "terseLabel": "Non-PEO NEO Average Compensation Actually Paid Amount" } } }, "auth_ref": [ "r845" ] }, "ecd_NonPeoNeoAvgTotalCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonPeoNeoAvgTotalCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Non-PEO NEO Average Total Compensation Amount", "terseLabel": "Non-PEO NEO Average Total Compensation Amount" } } }, "auth_ref": [ "r844" ] }, "ecd_NonPeoNeoMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonPeoNeoMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Non-PEO NEO [Member]", "terseLabel": "Non-PEO NEO" } } }, "auth_ref": [ "r855" ] }, "zbh_NonRule10B51ArrAmendedFlag": { "xbrltype": "booleanItemType", "nsuri": "http://www.zimmerbiomet.com/20240331", "localname": "NonRule10B51ArrAmendedFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Non-Rule 10b5-1 Arrangement Amended", "label": "Non-Rule 10b5-1 Arr Amended [Flag]", "documentation": "Non-Rule 10b5-1 arr amended." } } }, "auth_ref": [] }, "ecd_NonRule10b51ArrAdoptedFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonRule10b51ArrAdoptedFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Non-Rule 10b5-1 Arrangement Adopted [Flag]", "terseLabel": "Non-Rule 10b5-1 Arrangement Adopted" } } }, "auth_ref": [ "r874" ] }, "ecd_NonRule10b51ArrTrmntdFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonRule10b51ArrTrmntdFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Non-Rule 10b5-1 Arrangement Terminated [Flag]", "terseLabel": "Non-Rule 10b5-1 Arrangement Terminated" } } }, "auth_ref": [ "r874" ] }, "us-gaap_NoncontrollingInterestMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NoncontrollingInterestMember", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfStockholdersEquityUnaudited" ], "lang": { "en-us": { "role": { "label": "Noncontrolling Interest [Member]", "terseLabel": "Noncontrolling Interest [Member]", "documentation": "This element represents that portion of equity (net assets) in a subsidiary not attributable, directly or indirectly, to the parent. A noncontrolling interest is sometimes called a minority interest." } } }, "auth_ref": [ "r113", "r437", "r907", "r908", "r909", "r959" ] }, "us-gaap_NondesignatedMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NondesignatedMember", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/DisclosureFairValueMeasurementOfAssetsAndLiabilitiesScheduleOfFairValueMeasurementOfAssetAndLiabilitiesDetail", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesAdditionalInformationDetail", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsDetail", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesFairValueOfDerivativeInstrumentsOnGrossBasisDetail", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesScheduleOfEffectsOfMasterNettingAgreementsOnCondensedConsolidatedBalanceSheetsDetail" ], "lang": { "en-us": { "role": { "label": "Not Designated as Hedging Instrument [Member]", "terseLabel": "Derivatives Not Designated as Hedges [Member]", "documentation": "Derivative instrument not designated as hedging instrument under Generally Accepted Accounting Principles (GAAP)." } } }, "auth_ref": [ "r31" ] }, "zbh_NovemberTwoThousandTwentyThreeAcquisitionMember": { "xbrltype": "domainItemType", "nsuri": "http://www.zimmerbiomet.com/20240331", "localname": "NovemberTwoThousandTwentyThreeAcquisitionMember", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/DisclosureAcquisitionsAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "terseLabel": "November 2023 acquisition [Member]", "label": "November Two Thousand Twenty Three Acquisition [Member]", "documentation": "November two thousand twenty three acquisition." } } }, "auth_ref": [] }, "us-gaap_NumberOfOperatingSegments": { "xbrltype": "integerItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NumberOfOperatingSegments", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureSegmentInformationAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Number of Operating Segments", "terseLabel": "Number of operating segments", "documentation": "Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues." } } }, "auth_ref": [ "r911" ] }, "zbh_NumberOfSharesIssuedForContingentConsiderationLiability": { "xbrltype": "sharesItemType", "nsuri": "http://www.zimmerbiomet.com/20240331", "localname": "NumberOfSharesIssuedForContingentConsiderationLiability", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureFairValueMeasurementOfAssetsAndLiabilitiesAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Issuance of common stock for contingent consideration liability", "label": "Number Of Shares Issued For Contingent Consideration Liability", "documentation": "Number of shares issued for contingent consideration liability." } } }, "auth_ref": [] }, "zbh_NumberOfUnregisteredCommonSharesRetainedInSpinoff": { "xbrltype": "sharesItemType", "nsuri": "http://www.zimmerbiomet.com/20240331", "localname": "NumberOfUnregisteredCommonSharesRetainedInSpinoff", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureFairValueMeasurementOfAssetsAndLiabilitiesAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of unregistered common shares retained in spinoff", "label": "Number of Unregistered Common Shares Retained in Spinoff", "documentation": "Number of Unregistered Common Shares Retained in Spinoff" } } }, "auth_ref": [] }, "zbh_OctoberTwoThousandTwentyThreeAcquisitionMember": { "xbrltype": "domainItemType", "nsuri": "http://www.zimmerbiomet.com/20240331", "localname": "OctoberTwoThousandTwentyThreeAcquisitionMember", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/DisclosureAcquisitionsAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "terseLabel": "October 2023 acquisition [Member]", "label": "October Two Thousand Twenty Three Acquisition [Member]", "documentation": "October two thousand twenty three acquisition." } } }, "auth_ref": [] }, "us-gaap_OffsettingAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OffsettingAbstract", "lang": { "en-us": { "role": { "label": "Offsetting [Abstract]" } } }, "auth_ref": [] }, "us-gaap_OffsettingAssetsTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OffsettingAssetsTableTextBlock", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesTables" ], "lang": { "en-us": { "role": { "label": "Offsetting Assets [Table Text Block]", "terseLabel": "Schedule of Effects of Master Netting Agreements on Condensed Consolidated Balance Sheets", "documentation": "Tabular disclosure of derivative and other financial assets that are subject to offsetting, including master netting arrangements." } } }, "auth_ref": [ "r176", "r263" ] }, "zbh_OnePointFourFiveZeroPercentageMember": { "xbrltype": "domainItemType", "nsuri": "http://www.zimmerbiomet.com/20240331", "localname": "OnePointFourFiveZeroPercentageMember", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDebtSummaryOfDebtInstrumentsDetail", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDebtSummaryOfDebtInstrumentsParentheticalDetail" ], "lang": { "en-us": { "role": { "documentation": "One Point Four Five Zero Percentage [Member]", "label": "One Point Four Five Zero Percentage [Member]", "terseLabel": "1.450% [Member]" } } }, "auth_ref": [] }, "zbh_OnePointFourOneFourPercentageMember": { "xbrltype": "domainItemType", "nsuri": "http://www.zimmerbiomet.com/20240331", "localname": "OnePointFourOneFourPercentageMember", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDebtAdditionalInformationDetail", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDebtSummaryOfDebtInstrumentsDetail", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDebtSummaryOfDebtInstrumentsParentheticalDetail" ], "lang": { "en-us": { "role": { "documentation": "One point four one four percentage.", "label": "One Point Four One Four Percentage [Member]", "terseLabel": "1.414% [Member]" } } }, "auth_ref": [] }, "zbh_OnePointOneSixFourPercentageMember": { "xbrltype": "domainItemType", "nsuri": "http://www.zimmerbiomet.com/20240331", "localname": "OnePointOneSixFourPercentageMember", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDebtSummaryOfDebtInstrumentsDetail", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDebtSummaryOfDebtInstrumentsParentheticalDetail" ], "lang": { "en-us": { "role": { "documentation": "One Point Six Four Percentage [Member]", "label": "One Point One Six Four Percentage [Member]", "terseLabel": "1.164% [Member]" } } }, "auth_ref": [] }, "zbh_OnePointOneSixFourPercentageNotesDueTwoThousandTwentySevenMember": { "xbrltype": "domainItemType", "nsuri": "http://www.zimmerbiomet.com/20240331", "localname": "OnePointOneSixFourPercentageNotesDueTwoThousandTwentySevenMember", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "documentation": "One point one six four percentage notes due two thousand twenty seven member.", "label": "One Point One Six Four Percentage Notes Due Two Thousand Twenty Seven [Member]", "terseLabel": "1.164% Notes due 2027 [Member]" } } }, "auth_ref": [] }, "us-gaap_OperatingIncomeLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingIncomeLoss", "crdr": "credit", "calculation": { "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfEarningsUnaudited": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0, "order": 0.0 } }, "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureSegmentInformationSummaryOfNetSalesAndOperatingProfitBySegmentDetail", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfEarningsUnaudited" ], "lang": { "en-us": { "role": { "label": "Operating Income (Loss)", "terseLabel": "Operating Profit", "totalLabel": "Operating Profit", "documentation": "The net result for the period of deducting operating expenses from operating revenues." } } }, "auth_ref": [ "r332", "r339", "r345", "r348", "r764" ] }, "us-gaap_OperatingSegmentsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingSegmentsMember", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureSegmentInformationSummaryOfNetSalesAndOperatingProfitBySegmentDetail" ], "lang": { "en-us": { "role": { "label": "Operating Segments [Member]", "terseLabel": "Operating Segments", "documentation": "Identifies components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity." } } }, "auth_ref": [ "r338", "r339", "r340", "r341", "r342", "r348" ] }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract", "lang": { "en-us": { "role": { "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]" } } }, "auth_ref": [] }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureBasisOfPresentation" ], "lang": { "en-us": { "role": { "label": "Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]", "terseLabel": "Basis of Presentation", "documentation": "The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure." } } }, "auth_ref": [ "r143", "r212", "r622", "r623" ] }, "us-gaap_OtherAssetsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherAssetsMember", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesFairValueOfDerivativeInstrumentsOnGrossBasisDetail", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesScheduleOfEffectsOfMasterNettingAgreementsOnCondensedConsolidatedBalanceSheetsDetail" ], "lang": { "en-us": { "role": { "label": "Other Assets [Member]", "terseLabel": "Other Assets [Member]", "documentation": "Primary financial statement caption encompassing other assets." } } }, "auth_ref": [ "r119", "r131" ] }, "us-gaap_OtherAssetsNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherAssetsNoncurrent", "crdr": "debit", "calculation": { "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited" ], "lang": { "en-us": { "role": { "label": "Other Assets, Noncurrent", "terseLabel": "Other assets", "totalLabel": "Other Assets, Noncurrent, Total", "documentation": "Amount of noncurrent assets classified as other." } } }, "auth_ref": [ "r249" ] }, "us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax", "crdr": "credit", "calculation": { "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfComprehensiveIncomeUnaudited": { "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent", "weight": 1.0, "order": 0.0 }, "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureAccumulatedOtherComprehensiveIncomeTaxEffectsOnEachComponentOfAccumulatedOtherComprehensiveIncomeRecognizedInStatementsOfComprehensiveIncomeDetail": { "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax", "weight": 1.0, "order": 0.0 } }, "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureAccumulatedOtherComprehensiveIncomeTaxEffectsOnEachComponentOfAccumulatedOtherComprehensiveIncomeRecognizedInStatementsOfComprehensiveIncomeDetail", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfComprehensiveIncomeUnaudited" ], "lang": { "en-us": { "role": { "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss) Arising During Period, Net of Tax", "terseLabel": "Foreign currency cumulative translation adjustments, net of tax", "documentation": "Amount after tax, before reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature." } } }, "auth_ref": [ "r11", "r180", "r553", "r555", "r559" ] }, "us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax", "crdr": "debit", "calculation": { "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureAccumulatedOtherComprehensiveIncomeTaxEffectsOnEachComponentOfAccumulatedOtherComprehensiveIncomeRecognizedInStatementsOfComprehensiveIncomeDetail": { "parentTag": "us-gaap_OtherComprehensiveIncomeLossTax", "weight": 1.0, "order": 0.0 } }, "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureAccumulatedOtherComprehensiveIncomeTaxEffectsOnEachComponentOfAccumulatedOtherComprehensiveIncomeRecognizedInStatementsOfComprehensiveIncomeDetail" ], "lang": { "en-us": { "role": { "label": "OCI, Foreign Currency Transaction and Translation Gain (Loss), Arising During Period, Tax", "terseLabel": "Foreign currency cumulative translation adjustments, tax", "documentation": "Amount of tax expense (benefit), before reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature." } } }, "auth_ref": [ "r9", "r16", "r553", "r557", "r566" ] }, "us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax", "crdr": "credit", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureAccumulatedOtherComprehensiveIncomeChangesInComponentsOfAccumulatedOtherComprehensiveIncomeNetOfTaxDetail" ], "lang": { "en-us": { "role": { "label": "Other Comprehensive Income (Loss), before Reclassifications, Net of Tax", "terseLabel": "AOCI before reclassifications", "documentation": "Amount after tax, before reclassification adjustments of other comprehensive income (loss)." } } }, "auth_ref": [ "r40", "r60", "r277", "r560", "r563", "r567", "r897" ] }, "us-gaap_OtherComprehensiveIncomeLossBeforeTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeLossBeforeTax", "crdr": "credit", "calculation": { "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureAccumulatedOtherComprehensiveIncomeTaxEffectsOnEachComponentOfAccumulatedOtherComprehensiveIncomeRecognizedInStatementsOfComprehensiveIncomeDetail": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureAccumulatedOtherComprehensiveIncomeTaxEffectsOnEachComponentOfAccumulatedOtherComprehensiveIncomeRecognizedInStatementsOfComprehensiveIncomeDetail" ], "lang": { "en-us": { "role": { "totalLabel": "Total Other Comprehensive Income (Loss)", "label": "Other Comprehensive Income (Loss), before Tax", "documentation": "Amount before tax, after reclassification adjustments of other comprehensive income (loss)." } } }, "auth_ref": [ "r279", "r560", "r561", "r567", "r581", "r601", "r897", "r898" ] }, "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax", "crdr": "credit", "calculation": { "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfComprehensiveIncomeUnaudited": { "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent", "weight": 1.0, "order": 1.0 }, "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureAccumulatedOtherComprehensiveIncomeTaxEffectsOnEachComponentOfAccumulatedOtherComprehensiveIncomeRecognizedInStatementsOfComprehensiveIncomeDetail": { "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureAccumulatedOtherComprehensiveIncomeTaxEffectsOnEachComponentOfAccumulatedOtherComprehensiveIncomeRecognizedInStatementsOfComprehensiveIncomeDetail", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfComprehensiveIncomeUnaudited" ], "lang": { "en-us": { "role": { "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, after Tax", "terseLabel": "Unrealized cash flow hedge gains, net of tax", "documentation": "Amount, after tax and before reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness." } } }, "auth_ref": [ "r265", "r266" ] }, "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax", "crdr": "credit", "calculation": { "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureAccumulatedOtherComprehensiveIncomeTaxEffectsOnEachComponentOfAccumulatedOtherComprehensiveIncomeRecognizedInStatementsOfComprehensiveIncomeDetail": { "parentTag": "us-gaap_OtherComprehensiveIncomeLossBeforeTax", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureAccumulatedOtherComprehensiveIncomeTaxEffectsOnEachComponentOfAccumulatedOtherComprehensiveIncomeRecognizedInStatementsOfComprehensiveIncomeDetail", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesGrossUnrealizedLossesFromDerivativeInstrumentsDetail" ], "lang": { "en-us": { "role": { "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax", "verboseLabel": "Amount of Gain / (Loss) Recognized in AOCI", "terseLabel": "Unrealized cash flow hedge gains, before tax", "documentation": "Amount, before tax and reclassification, of gain (loss) from derivative instrument designated and qualifying cash flow hedge included in assessment of hedge effectiveness." } } }, "auth_ref": [ "r265", "r266", "r522", "r523", "r529" ] }, "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax", "crdr": "debit", "calculation": { "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureAccumulatedOtherComprehensiveIncomeTaxEffectsOnEachComponentOfAccumulatedOtherComprehensiveIncomeRecognizedInStatementsOfComprehensiveIncomeDetail": { "parentTag": "us-gaap_OtherComprehensiveIncomeLossTax", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureAccumulatedOtherComprehensiveIncomeTaxEffectsOnEachComponentOfAccumulatedOtherComprehensiveIncomeRecognizedInStatementsOfComprehensiveIncomeDetail" ], "lang": { "en-us": { "role": { "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, Tax", "terseLabel": "Unrealized cash flow hedge gains, tax", "documentation": "Amount, before reclassification, of tax expense (benefit) for gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness." } } }, "auth_ref": [ "r267" ] }, "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax", "crdr": "debit", "calculation": { "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfComprehensiveIncomeUnaudited": { "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent", "weight": -1.0, "order": 2.0 }, "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureAccumulatedOtherComprehensiveIncomeTaxEffectsOnEachComponentOfAccumulatedOtherComprehensiveIncomeRecognizedInStatementsOfComprehensiveIncomeDetail": { "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureAccumulatedOtherComprehensiveIncomeTaxEffectsOnEachComponentOfAccumulatedOtherComprehensiveIncomeRecognizedInStatementsOfComprehensiveIncomeDetail", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfComprehensiveIncomeUnaudited" ], "lang": { "en-us": { "role": { "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, after Tax", "negatedLabel": "Reclassification adjustments on hedges, net of tax", "negatedTerseLabel": "Reclassification adjustments on cash flow hedges, net of tax", "documentation": "Amount, after tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness." } } }, "auth_ref": [ "r266", "r269" ] }, "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax", "crdr": "debit", "calculation": { "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureAccumulatedOtherComprehensiveIncomeTaxEffectsOnEachComponentOfAccumulatedOtherComprehensiveIncomeRecognizedInStatementsOfComprehensiveIncomeDetail": { "parentTag": "us-gaap_OtherComprehensiveIncomeLossBeforeTax", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureAccumulatedOtherComprehensiveIncomeTaxEffectsOnEachComponentOfAccumulatedOtherComprehensiveIncomeRecognizedInStatementsOfComprehensiveIncomeDetail" ], "lang": { "en-us": { "role": { "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, before Tax", "negatedLabel": "Reclassification adjustments on cash flow hedges, before tax", "documentation": "Amount, before tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness." } } }, "auth_ref": [ "r232", "r266", "r269" ] }, "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax", "crdr": "credit", "calculation": { "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureAccumulatedOtherComprehensiveIncomeTaxEffectsOnEachComponentOfAccumulatedOtherComprehensiveIncomeRecognizedInStatementsOfComprehensiveIncomeDetail": { "parentTag": "us-gaap_OtherComprehensiveIncomeLossTax", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureAccumulatedOtherComprehensiveIncomeTaxEffectsOnEachComponentOfAccumulatedOtherComprehensiveIncomeRecognizedInStatementsOfComprehensiveIncomeDetail" ], "lang": { "en-us": { "role": { "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, Tax", "negatedLabel": "Reclassification adjustments on cash flow hedges, tax", "documentation": "Amount of tax expense (benefit) for reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness." } } }, "auth_ref": [ "r267" ] }, "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax", "crdr": "credit", "calculation": { "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureAccumulatedOtherComprehensiveIncomeTaxEffectsOnEachComponentOfAccumulatedOtherComprehensiveIncomeRecognizedInStatementsOfComprehensiveIncomeDetail": { "parentTag": "us-gaap_OtherComprehensiveIncomeLossBeforeTax", "weight": 1.0, "order": 0.0 } }, "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureAccumulatedOtherComprehensiveIncomeTaxEffectsOnEachComponentOfAccumulatedOtherComprehensiveIncomeRecognizedInStatementsOfComprehensiveIncomeDetail" ], "lang": { "en-us": { "role": { "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, before Tax", "terseLabel": "Foreign currency cumulative translation adjustments, before tax", "totalLabel": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, before Tax, Total", "documentation": "Amount before tax, after reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature." } } }, "auth_ref": [ "r9", "r180" ] }, "zbh_OtherComprehensiveIncomeLossLineItems": { "xbrltype": "stringItemType", "nsuri": "http://www.zimmerbiomet.com/20240331", "localname": "OtherComprehensiveIncomeLossLineItems", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureAccumulatedOtherComprehensiveIncomeChangesInComponentsOfAccumulatedOtherComprehensiveIncomeNetOfTaxDetail", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureAccumulatedOtherComprehensiveIncomeReclassificationAdjustmentsFromAccumulatedOtherComprehensiveIncomeDetail" ], "lang": { "en-us": { "role": { "documentation": "Other comprehensive income (loss).", "label": "Other Comprehensive Income Loss [Line Items]", "terseLabel": "Other Comprehensive Income Loss [Line Items]" } } }, "auth_ref": [] }, "us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax", "crdr": "debit", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfStockholdersEquityUnaudited" ], "lang": { "en-us": { "role": { "label": "Other Comprehensive Income (Loss), Net Investment Hedge, Gain (Loss), Reclassification, before Tax", "terseLabel": "Reclassifications of net investment hedges", "documentation": "Amount, before tax, of reclassification from accumulated other comprehensive income (AOCI) for gain (loss) from derivative designated and qualifying as net investment hedge." } } }, "auth_ref": [ "r524" ] }, "us-gaap_OtherComprehensiveIncomeLossNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeLossNetOfTax", "crdr": "credit", "calculation": { "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureAccumulatedOtherComprehensiveIncomeTaxEffectsOnEachComponentOfAccumulatedOtherComprehensiveIncomeRecognizedInStatementsOfComprehensiveIncomeDetail": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureAccumulatedOtherComprehensiveIncomeTaxEffectsOnEachComponentOfAccumulatedOtherComprehensiveIncomeRecognizedInStatementsOfComprehensiveIncomeDetail" ], "lang": { "en-us": { "role": { "negatedTotalLabel": "Total Other Comprehensive Income (Loss)", "label": "Other Comprehensive Income (Loss), Net of Tax", "totalLabel": "Total Other Comprehensive Income (Loss)", "documentation": "Amount after tax and reclassification adjustments of other comprehensive income (loss)." } } }, "auth_ref": [ "r30", "r40", "r272", "r275", "r279", "r560", "r561", "r567", "r581", "r601", "r897", "r898" ] }, "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfComprehensiveIncomeUnaudited" ], "lang": { "en-us": { "role": { "label": "Other Comprehensive Income (Loss), Net of Tax [Abstract]", "terseLabel": "Other Comprehensive Income (Loss):" } } }, "auth_ref": [] }, "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent", "crdr": "credit", "calculation": { "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfComprehensiveIncomeUnaudited": { "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": 1.0, "order": 0.0 } }, "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfComprehensiveIncomeUnaudited", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfStockholdersEquityUnaudited" ], "lang": { "en-us": { "role": { "totalLabel": "Total Other Comprehensive (Loss) Income", "terseLabel": "Other comprehensive income (loss)", "label": "Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent", "verboseLabel": "Other comprehensive loss", "documentation": "Amount after tax of other comprehensive income (loss) attributable to parent entity." } } }, "auth_ref": [ "r20", "r28", "r213", "r272", "r275" ] }, "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax", "crdr": "debit", "calculation": { "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfComprehensiveIncomeUnaudited": { "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent", "weight": -1.0, "order": 3.0 }, "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureAccumulatedOtherComprehensiveIncomeTaxEffectsOnEachComponentOfAccumulatedOtherComprehensiveIncomeRecognizedInStatementsOfComprehensiveIncomeDetail": { "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax", "weight": -1.0, "order": 3.0 } }, "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureAccumulatedOtherComprehensiveIncomeTaxEffectsOnEachComponentOfAccumulatedOtherComprehensiveIncomeRecognizedInStatementsOfComprehensiveIncomeDetail", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfComprehensiveIncomeUnaudited" ], "lang": { "en-us": { "role": { "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax", "negatedLabel": "Adjustments to prior service cost and unrecognized actuarial assumptions, net of tax", "totalLabel": "Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax, Total", "documentation": "Amount, after tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan." } } }, "auth_ref": [ "r14", "r180" ] }, "us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansBeforeTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansBeforeTax", "crdr": "credit", "calculation": { "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureAccumulatedOtherComprehensiveIncomeTaxEffectsOnEachComponentOfAccumulatedOtherComprehensiveIncomeRecognizedInStatementsOfComprehensiveIncomeDetail": { "parentTag": "us-gaap_OtherComprehensiveIncomeLossBeforeTax", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureAccumulatedOtherComprehensiveIncomeTaxEffectsOnEachComponentOfAccumulatedOtherComprehensiveIncomeRecognizedInStatementsOfComprehensiveIncomeDetail" ], "lang": { "en-us": { "role": { "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, Reclassification Adjustment from AOCI, before Tax", "terseLabel": "Adjustments to prior service cost and unrecognized actuarial assumptions, before tax", "totalLabel": "Other Comprehensive (Income) Loss, Defined Benefit Plan, Reclassification Adjustment from AOCI, before Tax, Total", "documentation": "Amount, before tax, of reclassification adjustment from accumulated other comprehensive (income) loss for net period benefit cost (credit) of defined benefit plan." } } }, "auth_ref": [ "r18", "r180", "r270", "r932" ] }, "us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansTax", "crdr": "debit", "calculation": { "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureAccumulatedOtherComprehensiveIncomeTaxEffectsOnEachComponentOfAccumulatedOtherComprehensiveIncomeRecognizedInStatementsOfComprehensiveIncomeDetail": { "parentTag": "us-gaap_OtherComprehensiveIncomeLossTax", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureAccumulatedOtherComprehensiveIncomeTaxEffectsOnEachComponentOfAccumulatedOtherComprehensiveIncomeRecognizedInStatementsOfComprehensiveIncomeDetail" ], "lang": { "en-us": { "role": { "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, Reclassification Adjustment from AOCI, Tax", "terseLabel": "Adjustments to prior service cost and unrecognized actuarial assumptions, tax", "totalLabel": "Other Comprehensive (Income) Loss, Defined Benefit Plan, Reclassification Adjustment from AOCI, Tax, Total", "documentation": "Amount of tax (expense) benefit for reclassification adjustment from accumulated other comprehensive (income) loss of defined benefit plan." } } }, "auth_ref": [ "r16", "r213" ] }, "zbh_OtherComprehensiveIncomeLossTable": { "xbrltype": "stringItemType", "nsuri": "http://www.zimmerbiomet.com/20240331", "localname": "OtherComprehensiveIncomeLossTable", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureAccumulatedOtherComprehensiveIncomeChangesInComponentsOfAccumulatedOtherComprehensiveIncomeNetOfTaxDetail", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureAccumulatedOtherComprehensiveIncomeReclassificationAdjustmentsFromAccumulatedOtherComprehensiveIncomeDetail" ], "lang": { "en-us": { "role": { "documentation": "Other Comprehensive Income Loss [Table]", "label": "Other Comprehensive Income Loss [Table]", "terseLabel": "Other Comprehensive Income Loss [Table]" } } }, "auth_ref": [] }, "us-gaap_OtherComprehensiveIncomeLossTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeLossTax", "crdr": "debit", "calculation": { "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureAccumulatedOtherComprehensiveIncomeTaxEffectsOnEachComponentOfAccumulatedOtherComprehensiveIncomeRecognizedInStatementsOfComprehensiveIncomeDetail": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureAccumulatedOtherComprehensiveIncomeTaxEffectsOnEachComponentOfAccumulatedOtherComprehensiveIncomeRecognizedInStatementsOfComprehensiveIncomeDetail" ], "lang": { "en-us": { "role": { "totalLabel": "Total Other Comprehensive Income (Loss), tax", "label": "Other Comprehensive Income (Loss), Tax", "documentation": "Amount of tax expense (benefit) allocated to other comprehensive income (loss)." } } }, "auth_ref": [ "r16", "r276", "r279", "r490", "r501", "r503", "r560", "r564", "r567", "r581", "r601" ] }, "zbh_OtherContingenciesMember": { "xbrltype": "domainItemType", "nsuri": "http://www.zimmerbiomet.com/20240331", "localname": "OtherContingenciesMember", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "documentation": "Other Contingencies.", "label": "Other Contingencies [Member]", "terseLabel": "Other Contingencies [Member]" } } }, "auth_ref": [] }, "us-gaap_OtherCurrentAssetsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherCurrentAssetsMember", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesFairValueOfDerivativeInstrumentsOnGrossBasisDetail", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesScheduleOfEffectsOfMasterNettingAgreementsOnCondensedConsolidatedBalanceSheetsDetail" ], "lang": { "en-us": { "role": { "label": "Other Current Assets [Member]", "terseLabel": "Other Current Assets [Member]", "documentation": "Primary financial statement caption encompassing other current assets." } } }, "auth_ref": [ "r119", "r131" ] }, "us-gaap_OtherCurrentLiabilitiesMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherCurrentLiabilitiesMember", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesFairValueOfDerivativeInstrumentsOnGrossBasisDetail", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesScheduleOfEffectsOfMasterNettingAgreementsOnCondensedConsolidatedBalanceSheetsDetail" ], "lang": { "en-us": { "role": { "label": "Other Current Liabilities [Member]", "terseLabel": "Other Current Liabilities [Member]", "documentation": "Primary financial statement caption encompassing other current liabilities." } } }, "auth_ref": [] }, "zbh_OtherExpenseIncomeNetPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.zimmerbiomet.com/20240331", "localname": "OtherExpenseIncomeNetPolicyTextBlock", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "documentation": "Other expense (income) net.", "label": "Other Expense Income Net Policy [Text Block]", "terseLabel": "Other Expense (Income), Net" } } }, "auth_ref": [] }, "us-gaap_OtherIntangibleAssetsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherIntangibleAssetsMember", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/DisclosureAcquisitionsSummaryOfEstimatesOfFairValueOfAssetsAcquiredAndLiabilitiesAssumedDetails" ], "lang": { "en-us": { "role": { "label": "Other Intangible Assets [Member]", "documentation": "Intangible assets classified as other." } } }, "auth_ref": [] }, "us-gaap_OtherLiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherLiabilitiesCurrent", "crdr": "credit", "calculation": { "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited" ], "lang": { "en-us": { "role": { "label": "Other Liabilities, Current", "terseLabel": "Other current liabilities", "totalLabel": "Other Liabilities, Current, Total", "documentation": "Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r50", "r789" ] }, "us-gaap_OtherLiabilitiesMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherLiabilitiesMember", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesFairValueOfDerivativeInstrumentsOnGrossBasisDetail", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesScheduleOfEffectsOfMasterNettingAgreementsOnCondensedConsolidatedBalanceSheetsDetail" ], "lang": { "en-us": { "role": { "label": "Other Liabilities [Member]", "terseLabel": "Other Long-term Liabilities [Member]", "documentation": "Primary financial statement caption encompassing other liabilities." } } }, "auth_ref": [ "r119", "r131" ] }, "us-gaap_OtherLiabilitiesNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherLiabilitiesNoncurrent", "crdr": "credit", "calculation": { "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited" ], "lang": { "en-us": { "role": { "label": "Other Liabilities, Noncurrent", "terseLabel": "Other long-term liabilities", "totalLabel": "Other Liabilities, Noncurrent, Total", "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r54" ] }, "us-gaap_OtherNonoperatingIncomeExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherNonoperatingIncomeExpense", "crdr": "credit", "calculation": { "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureAccumulatedOtherComprehensiveIncomeReclassificationAdjustmentsFromAccumulatedOtherComprehensiveIncomeDetail2": { "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic", "weight": 1.0, "order": 0.0 }, "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfEarningsUnaudited": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0, "order": 1.0 }, "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureAccumulatedOtherComprehensiveIncomeReclassificationAdjustmentsFromAccumulatedOtherComprehensiveIncomeDetail": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureAccumulatedOtherComprehensiveIncomeReclassificationAdjustmentsFromAccumulatedOtherComprehensiveIncomeDetail", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfEarningsUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Other (expense) income, net", "label": "Other Nonoperating Income (Expense)", "totalLabel": "Other Nonoperating Income (Expense), Total", "verboseLabel": "Other income (expense), net", "documentation": "Amount of income (expense) related to nonoperating activities, classified as other." } } }, "auth_ref": [ "r188" ] }, "us-gaap_OtherNonoperatingIncomeExpenseMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherNonoperatingIncomeExpenseMember", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsDetail" ], "lang": { "en-us": { "role": { "label": "Other Nonoperating Income (Expense) [Member]", "terseLabel": "Other (expense) income, net [Member]", "verboseLabel": "Other income (expense), net [Member]", "documentation": "Primary financial statement caption encompassing other nonoperating income (expense)." } } }, "auth_ref": [] }, "ecd_OtherPerfMeasureAmt": { "xbrltype": "decimalItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "OtherPerfMeasureAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Other Performance Measure, Amount", "terseLabel": "Other Performance Measure, Amount" } } }, "auth_ref": [ "r847" ] }, "zbh_OtherProductCategoryMember": { "xbrltype": "domainItemType", "nsuri": "http://www.zimmerbiomet.com/20240331", "localname": "OtherProductCategoryMember", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureRevenueScheduleOfNetSalesByProductCategoryDetail" ], "lang": { "en-us": { "role": { "documentation": "Other product category.", "label": "Other Product Category [Member]", "terseLabel": "Other [Member]" } } }, "auth_ref": [] }, "us-gaap_OtherRestructuringMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherRestructuringMember", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/DisclosureRestructuringSummaryOfLocationOnCondensedConsolidatedStatementOfEarningsAndTypeOfCostForRestructuringPlanDetail", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureRestructuringSummaryOfLiabilitiesRecognizedRelatedToRestructuringPlanDetail" ], "lang": { "en-us": { "role": { "label": "Other Restructuring [Member]", "terseLabel": "Other Restructuring [Member]", "documentation": "Restructuring and related activities classified as other." } } }, "auth_ref": [ "r768", "r769", "r770", "r771" ] }, "zbh_OthersCountriesMember": { "xbrltype": "domainItemType", "nsuri": "http://www.zimmerbiomet.com/20240331", "localname": "OthersCountriesMember", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureRevenueScheduleOfNetSalesByGeographyDetail" ], "lang": { "en-us": { "role": { "documentation": "Others countries.", "label": "Others Countries [Member]", "terseLabel": "International [Member]" } } }, "auth_ref": [] }, "ecd_OutstandingAggtErrCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "OutstandingAggtErrCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Outstanding Aggregate Erroneous Compensation Amount", "terseLabel": "Outstanding Aggregate Erroneous Compensation Amount" } } }, "auth_ref": [ "r815", "r826", "r836", "r861" ] }, "zbh_OutstandingCommonSharesRetained": { "xbrltype": "sharesItemType", "nsuri": "http://www.zimmerbiomet.com/20240331", "localname": "OutstandingCommonSharesRetained", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/DisclosureDiscontinuedOperationsAndRelatedZimvieMattersAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Outstanding common shares retained", "documentation": "Outstanding common shares retained" } } }, "auth_ref": [] }, "ecd_OutstandingRecoveryCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "OutstandingRecoveryCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Outstanding Recovery Compensation Amount", "terseLabel": "Compensation Amount" } } }, "auth_ref": [ "r818", "r829", "r839", "r864" ] }, "ecd_OutstandingRecoveryIndName": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "OutstandingRecoveryIndName", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Outstanding Recovery, Individual Name", "terseLabel": "Name" } } }, "auth_ref": [ "r818", "r829", "r839", "r864" ] }, "ecd_PayVsPerformanceDisclosureLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PayVsPerformanceDisclosureLineItems", "lang": { "en-us": { "role": { "label": "Pay vs Performance Disclosure [Line Items]", "terseLabel": "Pay vs Performance Disclosure" } } }, "auth_ref": [ "r843" ] }, "us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentForContingentConsiderationLiabilityFinancingActivities", "crdr": "credit", "calculation": { "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0, "order": 6.0 } }, "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureFairValueMeasurementOfAssetsAndLiabilitiesAdditionalInformationDetails", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Business combination contingent consideration payments", "label": "Payment for Contingent Consideration Liability, Financing Activities", "negatedLabel": "Business combination contingent consideration payments", "documentation": "Amount of cash outflow, not made soon after acquisition date of business combination, to settle contingent consideration liability up to amount recognized at acquisition date, including, but not limited to, measurement period adjustment and less amount paid soon after acquisition date." } } }, "auth_ref": [ "r19" ] }, "us-gaap_PaymentsForProceedsFromHedgeInvestingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsForProceedsFromHedgeInvestingActivities", "crdr": "credit", "calculation": { "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "label": "Payments for (Proceeds from) Hedge, Investing Activities", "negatedLabel": "Net investment hedge settlements", "totalLabel": "Payments for (Proceeds from) Hedge, Investing Activities, Total", "documentation": "The cash outflow or inflow for a financial contract that meets the hedge criteria as either a cash flow hedge, fair value hedge, or hedge of a net investment in a foreign operation." } } }, "auth_ref": [] }, "us-gaap_PaymentsForProceedsFromOtherInvestingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsForProceedsFromOtherInvestingActivities", "crdr": "credit", "calculation": { "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0, "order": 5.0 } }, "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "label": "Payments for (Proceeds from) Other Investing Activities", "negatedLabel": "Other investing activities", "documentation": "Amount of cash (inflow) outflow from investing activities classified as other." } } }, "auth_ref": [ "r884", "r900" ] }, "us-gaap_PaymentsForRepurchaseOfCommonStock": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsForRepurchaseOfCommonStock", "crdr": "credit", "calculation": { "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0, "order": 8.0 } }, "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "label": "Payments for Repurchase of Common Stock", "negatedLabel": "Repurchase of common stock", "documentation": "The cash outflow to reacquire common stock during the period." } } }, "auth_ref": [ "r65" ] }, "us-gaap_PaymentsForRestructuring": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsForRestructuring", "crdr": "credit", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureRestructuringSummaryOfLiabilitiesRecognizedRelatedToRestructuringPlanDetail" ], "lang": { "en-us": { "role": { "label": "Payments for Restructuring", "negatedLabel": "Cash payments", "documentation": "Amount of cash payments made as the result of exit or disposal activities. Excludes payments associated with a discontinued operation or an asset retirement obligation." } } }, "auth_ref": [ "r372", "r903" ] }, "us-gaap_PaymentsOfDividendsCommonStock": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsOfDividendsCommonStock", "crdr": "credit", "calculation": { "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0, "order": 4.0 } }, "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "label": "Payments of Ordinary Dividends, Common Stock", "negatedLabel": "Dividends paid to stockholders", "documentation": "Amount of cash outflow in the form of ordinary dividends to common shareholders of the parent entity." } } }, "auth_ref": [ "r65" ] }, "us-gaap_PaymentsOfMergerRelatedCostsFinancingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsOfMergerRelatedCostsFinancingActivities", "crdr": "credit", "calculation": { "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0, "order": 7.0 } }, "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/DisclosureAcquisitionsAdditionalInformationDetail", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Deferred business combination payments made", "negatedLabel": "Deferred business combination payments", "label": "Payments of Merger Related Costs, Financing Activities", "documentation": "The cash outflow for financing costs associated with business combinations." } } }, "auth_ref": [ "r64" ] }, "us-gaap_PaymentsToAcquireBusinessTwoNetOfCashAcquired": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsToAcquireBusinessTwoNetOfCashAcquired", "crdr": "credit", "calculation": { "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0, "order": 4.0 } }, "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "label": "Payments to Acquire Business Two, Net of Cash Acquired", "terseLabel": "Business combination investments, net of acquired cash", "negatedLabel": "Business combination investments, net of acquired cash", "documentation": "The cash outflow associated with a second acquisition of a business, net of the cash acquired from the purchase." } } }, "auth_ref": [ "r900" ] }, "us-gaap_PaymentsToAcquireBusinessesGross": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsToAcquireBusinessesGross", "crdr": "credit", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/DisclosureAcquisitionsAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Payments to Acquire Businesses, Gross", "terseLabel": "Cash payments to acquire businesses", "verboseLabel": "Initial cash consideration", "documentation": "The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price." } } }, "auth_ref": [ "r62", "r509" ] }, "us-gaap_PaymentsToAcquireIntangibleAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsToAcquireIntangibleAssets", "crdr": "credit", "calculation": { "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0, "order": 3.0 } }, "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "negatedLabel": "Acquisition of intellectual property rights", "label": "Payments to Acquire Intangible Assets", "documentation": "The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill." } } }, "auth_ref": [ "r189" ] }, "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsToAcquirePropertyPlantAndEquipment", "crdr": "credit", "calculation": { "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "label": "Payments to Acquire Property, Plant, and Equipment", "negatedLabel": "Additions to other property, plant and equipment", "totalLabel": "Payments to Acquire Property, Plant, and Equipment, Total", "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets." } } }, "auth_ref": [ "r189" ] }, "ecd_PeerGroupIssuersFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PeerGroupIssuersFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Peer Group Issuers, Footnote [Text Block]", "terseLabel": "Peer Group Issuers, Footnote" } } }, "auth_ref": [ "r846" ] }, "ecd_PeerGroupTotalShareholderRtnAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PeerGroupTotalShareholderRtnAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Peer Group Total Shareholder Return Amount", "terseLabel": "Peer Group Total Shareholder Return Amount" } } }, "auth_ref": [ "r846" ] }, "ecd_PeoActuallyPaidCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PeoActuallyPaidCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "PEO Actually Paid Compensation Amount", "terseLabel": "PEO Actually Paid Compensation Amount" } } }, "auth_ref": [ "r845" ] }, "ecd_PeoMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PeoMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "PEO [Member]", "terseLabel": "PEO" } } }, "auth_ref": [ "r855" ] }, "ecd_PeoName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PeoName", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "PEO Name", "terseLabel": "PEO Name" } } }, "auth_ref": [ "r848" ] }, "ecd_PeoTotalCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PeoTotalCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "PEO Total Compensation Amount", "terseLabel": "PEO Total Compensation Amount" } } }, "auth_ref": [ "r844" ] }, "zbh_PercentageOfDebtDesignatedAsNetInvestmentHedges": { "xbrltype": "percentItemType", "nsuri": "http://www.zimmerbiomet.com/20240331", "localname": "PercentageOfDebtDesignatedAsNetInvestmentHedges", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "documentation": "Percentage of debt designated as net investment hedges.", "label": "Percentage Of Debt Designated As Net Investment Hedges", "terseLabel": "Percentage of debt designated as net investment hedges" } } }, "auth_ref": [] }, "zbh_PercentageOfOutstandingCommonSharesRetained": { "xbrltype": "percentItemType", "nsuri": "http://www.zimmerbiomet.com/20240331", "localname": "PercentageOfOutstandingCommonSharesRetained", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/DisclosureDiscontinuedOperationsAndRelatedZimvieMattersAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "documentation": "Percentage of outstanding common shares retained.", "label": "Percentage Of Outstanding Common Shares Retained", "terseLabel": "Percentage of outstanding common shares retained" } } }, "auth_ref": [] }, "zbh_PercentageOfOutstandingCommonStockDistributed": { "xbrltype": "percentItemType", "nsuri": "http://www.zimmerbiomet.com/20240331", "localname": "PercentageOfOutstandingCommonStockDistributed", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/DisclosureDiscontinuedOperationsAndRelatedZimvieMattersAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "documentation": "Percentage of outstanding common stock distributed.", "label": "Percentage Of Outstanding Common Stock Distributed", "terseLabel": "Percentage of outstanding common stock distributed" } } }, "auth_ref": [] }, "zbh_PillarTwoMinimumTaxRate": { "xbrltype": "percentItemType", "nsuri": "http://www.zimmerbiomet.com/20240331", "localname": "PillarTwoMinimumTaxRate", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "documentation": "Pillar two minimum tax rate.", "label": "Pillar Two Minimum Tax Rate", "terseLabel": "Pillar two minimum tax rate" } } }, "auth_ref": [] }, "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PrepaidExpenseAndOtherAssetsCurrent", "crdr": "debit", "calculation": { "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited" ], "lang": { "en-us": { "role": { "label": "Prepaid Expense and Other Assets, Current", "terseLabel": "Prepaid expenses and other current assets", "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r896" ] }, "us-gaap_PrepaidTaxes": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PrepaidTaxes", "crdr": "debit", "calculation": { "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Prepaid taxes", "label": "Prepaid Taxes", "documentation": "Amount of asset related to consideration paid in advance for income and other taxes that provide economic benefits within a future period of one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r756", "r766", "r913" ] }, "us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions", "crdr": "debit", "calculation": { "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "label": "Proceeds, Issuance of Shares, Share-Based Payment Arrangement, Including Option Exercised", "terseLabel": "Proceeds from employee stock compensation plans", "totalLabel": "Proceeds, Issuance of Shares, Share-based Payment Arrangement, Including Option Exercised, Total", "documentation": "Amount of cash inflow from issuance of shares under share-based payment arrangement. Includes, but is not limited to, option exercised." } } }, "auth_ref": [ "r17", "r34" ] }, "us-gaap_ProceedsFromLinesOfCredit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromLinesOfCredit", "crdr": "debit", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDebtAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Net proceeds from revolving facilities", "label": "Proceeds from Lines of Credit", "totalLabel": "Proceeds from Lines of Credit, Total", "verboseLabel": "Proceeds from revolving facility", "documentation": "Amount of cash inflow from contractual arrangement with the lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements." } } }, "auth_ref": [ "r63", "r905" ] }, "us-gaap_ProceedsFromOtherDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromOtherDebt", "crdr": "debit", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/DisclosureDiscontinuedOperationsAndRelatedZimvieMattersAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Proceeds from Other Debt", "terseLabel": "ZimVie term loan credit agreement", "documentation": "Amount of cash inflow from debt classified as other." } } }, "auth_ref": [ "r63" ] }, "us-gaap_ProceedsFromPaymentsForOtherFinancingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromPaymentsForOtherFinancingActivities", "crdr": "debit", "calculation": { "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0, "order": 9.0 } }, "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "label": "Proceeds from (Payments for) Other Financing Activities", "terseLabel": "Other financing activities", "documentation": "Amount of cash inflow (outflow) from financing activities classified as other." } } }, "auth_ref": [ "r885", "r901" ] }, "us-gaap_ProceedsFromRepaymentsOfLinesOfCredit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromRepaymentsOfLinesOfCredit", "crdr": "debit", "calculation": { "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0, "order": 0.0 } }, "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Net proceeds from revolving facilities", "label": "Proceeds from (Repayments of) Lines of Credit", "documentation": "The net cash inflow or cash outflow from a contractual arrangement with the lender, including letter of credit, standby letter of credit and revolving credit arrangements, under which borrowings can be made up to a specific amount at any point in time with either short term or long term maturity that is collateralized (backed by pledge, mortgage or other lien in the entity's assets)." } } }, "auth_ref": [] }, "srt_ProductOrServiceAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ProductOrServiceAxis", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureRevenueScheduleOfNetSalesByProductCategoryDetail" ], "lang": { "en-us": { "role": { "label": "Product and Service [Axis]", "terseLabel": "Product and Service" } } }, "auth_ref": [ "r350", "r577", "r605", "r606", "r607", "r608", "r609", "r610", "r751", "r778", "r790", "r892", "r924", "r925", "r929", "r956" ] }, "srt_ProductsAndServicesDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ProductsAndServicesDomain", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureRevenueScheduleOfNetSalesByProductCategoryDetail" ], "lang": { "en-us": { "role": { "label": "Product and Service [Domain]", "terseLabel": "Product and Service" } } }, "auth_ref": [ "r350", "r577", "r605", "r606", "r607", "r608", "r609", "r610", "r751", "r778", "r790", "r892", "r924", "r925", "r929", "r956" ] }, "us-gaap_ProfitLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProfitLoss", "crdr": "credit", "calculation": { "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 0.0 }, "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfEarningsUnaudited": { "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfEarningsUnaudited", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfStockholdersEquityUnaudited" ], "lang": { "en-us": { "role": { "totalLabel": "Net Earnings", "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest", "terseLabel": "Net earnings", "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest." } } }, "auth_ref": [ "r242", "r271", "r274", "r283", "r288", "r294", "r304", "r305", "r332", "r339", "r345", "r348", "r357", "r389", "r390", "r392", "r393", "r394", "r396", "r398", "r400", "r401", "r513", "r516", "r517", "r540", "r551", "r584", "r599", "r633", "r688", "r706", "r707", "r764", "r786", "r787", "r803", "r899", "r926" ] }, "us-gaap_PropertyPlantAndEquipmentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentAbstract", "lang": { "en-us": { "role": { "label": "Property, Plant and Equipment [Abstract]" } } }, "auth_ref": [] }, "us-gaap_PropertyPlantAndEquipmentByTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentByTypeAxis", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosurePropertyPlantAndEquipmentSummaryOfPropertyPlantAndEquipmentDetail" ], "lang": { "en-us": { "role": { "label": "Long-Lived Tangible Asset [Axis]", "terseLabel": "Long-Lived Tangible Asset", "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale." } } }, "auth_ref": [ "r23" ] }, "us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentDisclosureTextBlock", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosurePropertyPlantAndEquipment" ], "lang": { "en-us": { "role": { "label": "Property, Plant and Equipment Disclosure [Text Block]", "terseLabel": "Property, Plant and Equipment", "documentation": "The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections." } } }, "auth_ref": [ "r198", "r229", "r233", "r234" ] }, "us-gaap_PropertyPlantAndEquipmentGross": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentGross", "crdr": "debit", "calculation": { "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosurePropertyPlantAndEquipmentSummaryOfPropertyPlantAndEquipmentDetail": { "parentTag": "us-gaap_PropertyPlantAndEquipmentNet", "weight": 1.0, "order": 0.0 } }, "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosurePropertyPlantAndEquipmentSummaryOfPropertyPlantAndEquipmentDetail" ], "lang": { "en-us": { "role": { "label": "Property, Plant and Equipment, Gross", "terseLabel": "Property, plant and equipment, Gross", "totalLabel": "Property, Plant and Equipment, Gross, Total", "periodStartLabel": "Property, Plant and Equipment, Gross, Beginning Balance", "periodEndLabel": "Property, Plant and Equipment, Gross, Ending Balance", "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures." } } }, "auth_ref": [ "r200", "r246", "r596" ] }, "us-gaap_PropertyPlantAndEquipmentLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentLineItems", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosurePropertyPlantAndEquipmentSummaryOfPropertyPlantAndEquipmentDetail" ], "lang": { "en-us": { "role": { "label": "Property, Plant and Equipment [Line Items]", "terseLabel": "Property, Plant and Equipment [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_PropertyPlantAndEquipmentNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentNet", "crdr": "debit", "calculation": { "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 1.0 }, "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosurePropertyPlantAndEquipmentSummaryOfPropertyPlantAndEquipmentDetail": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosurePropertyPlantAndEquipmentSummaryOfPropertyPlantAndEquipmentDetail", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited" ], "lang": { "en-us": { "role": { "label": "Property, Plant and Equipment, Net", "terseLabel": "Property, plant and equipment, net", "totalLabel": "Property, plant and equipment, net", "periodStartLabel": "Property, Plant and Equipment, Net, Beginning Balance", "periodEndLabel": "Property, Plant and Equipment, Net, Ending Balance", "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures." } } }, "auth_ref": [ "r23", "r585", "r596", "r789" ] }, "us-gaap_PropertyPlantAndEquipmentTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentTextBlock", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosurePropertyPlantAndEquipmentTables" ], "lang": { "en-us": { "role": { "label": "Property, Plant and Equipment [Table Text Block]", "terseLabel": "Summary of Property, Plant and Equipment", "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation." } } }, "auth_ref": [ "r23" ] }, "us-gaap_PropertyPlantAndEquipmentTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentTypeDomain", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosurePropertyPlantAndEquipmentSummaryOfPropertyPlantAndEquipmentDetail" ], "lang": { "en-us": { "role": { "label": "Long-Lived Tangible Asset [Domain]", "terseLabel": "Long-Lived Tangible Asset", "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software." } } }, "auth_ref": [ "r200" ] }, "ecd_PvpTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PvpTable", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Pay vs Performance Disclosure [Table]", "terseLabel": "Pay vs Performance Disclosure" } } }, "auth_ref": [ "r843" ] }, "ecd_PvpTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PvpTableTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Pay vs Performance [Table Text Block]", "terseLabel": "Pay vs Performance Disclosure, Table" } } }, "auth_ref": [ "r843" ] }, "srt_RangeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "RangeAxis", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/DisclosureAcquisitionsAdditionalInformationDetail", "http://www.zimmerbiomet.com/20240331/taxonomy/role/DisclosureDiscontinuedOperationsAndRelatedZimvieMattersAdditionalInformationDetails", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDebtAdditionalInformationDetail", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesAdditionalInformationDetail", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureRestructuringAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Statistical Measurement [Axis]", "terseLabel": "Statistical Measurement" } } }, "auth_ref": [ "r384", "r385", "r386", "r387", "r449", "r456", "r480", "r481", "r482", "r575", "r576", "r611", "r656", "r657", "r711", "r713", "r715", "r716", "r729", "r748", "r749", "r765", "r777", "r785", "r791", "r794", "r916", "r928", "r948", "r949", "r950", "r951", "r952" ] }, "srt_RangeMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "RangeMember", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/DisclosureAcquisitionsAdditionalInformationDetail", "http://www.zimmerbiomet.com/20240331/taxonomy/role/DisclosureDiscontinuedOperationsAndRelatedZimvieMattersAdditionalInformationDetails", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDebtAdditionalInformationDetail", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesAdditionalInformationDetail", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureRestructuringAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Statistical Measurement [Domain]", "terseLabel": "Statistical Measurement" } } }, "auth_ref": [ "r384", "r385", "r386", "r387", "r449", "r456", "r480", "r481", "r482", "r575", "r576", "r611", "r656", "r657", "r711", "r713", "r715", "r716", "r729", "r748", "r749", "r765", "r777", "r785", "r791", "r794", "r916", "r928", "r948", "r949", "r950", "r951", "r952" ] }, "us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax", "crdr": "debit", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureAccumulatedOtherComprehensiveIncomeChangesInComponentsOfAccumulatedOtherComprehensiveIncomeNetOfTaxDetail" ], "lang": { "en-us": { "role": { "label": "Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax", "terseLabel": "Reclassifications to statements of earnings", "negatedLabel": "Reclassifications to statements of earnings", "documentation": "Amount after tax of reclassification adjustments of other comprehensive income (loss)." } } }, "auth_ref": [ "r40", "r60", "r277", "r560", "r565", "r567", "r897" ] }, "us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureAccumulatedOtherComprehensiveIncomeReclassificationAdjustmentsFromAccumulatedOtherComprehensiveIncomeDetail" ], "lang": { "en-us": { "role": { "label": "Reclassification out of Accumulated Other Comprehensive Income [Axis]", "terseLabel": "Reclassification out of Accumulated Other Comprehensive Income", "documentation": "Information by item reclassified out of accumulated other comprehensive income (loss)." } } }, "auth_ref": [ "r278" ] }, "us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureAccumulatedOtherComprehensiveIncomeReclassificationAdjustmentsFromAccumulatedOtherComprehensiveIncomeDetail" ], "lang": { "en-us": { "role": { "label": "Reclassification out of Accumulated Other Comprehensive Income [Domain]", "terseLabel": "Reclassification out of Accumulated Other Comprehensive Income", "documentation": "Item reclassified out of accumulated other comprehensive income (loss)." } } }, "auth_ref": [ "r278" ] }, "us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureAccumulatedOtherComprehensiveIncomeReclassificationAdjustmentsFromAccumulatedOtherComprehensiveIncomeDetail" ], "lang": { "en-us": { "role": { "label": "Reclassification out of Accumulated Other Comprehensive Income [Member]", "terseLabel": "Reclassification out of Accumulated Other Comprehensive Income [Member]", "documentation": "Identifies item reclassified out of accumulated other comprehensive income (loss)." } } }, "auth_ref": [ "r278" ] }, "us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureAccumulatedOtherComprehensiveIncomeTables" ], "lang": { "en-us": { "role": { "label": "Reclassification out of Accumulated Other Comprehensive Income [Table Text Block]", "terseLabel": "Reclassification Adjustments from Accumulated Other Comprehensive Income", "documentation": "Tabular disclosure of information about items reclassified out of accumulated other comprehensive income (loss)." } } }, "auth_ref": [] }, "ecd_RecoveryOfErrCompDisclosureLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "RecoveryOfErrCompDisclosureLineItems", "lang": { "en-us": { "role": { "label": "Recovery of Erroneously Awarded Compensation Disclosure [Line Items]", "terseLabel": "Recovery of Erroneously Awarded Compensation Disclosure" } } }, "auth_ref": [ "r810", "r821", "r831", "r856" ] }, "us-gaap_RepaymentsOfDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RepaymentsOfDebt", "crdr": "credit", "calculation": { "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0, "order": 3.0 } }, "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "negatedLabel": "Payment on term loan", "label": "Repayments of Debt", "documentation": "Amount of cash outflow for short-term and long-term debt. Excludes payment of lease obligation." } } }, "auth_ref": [ "r902" ] }, "us-gaap_RepaymentsOfLongTermDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RepaymentsOfLongTermDebt", "crdr": "credit", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDebtAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Repayments of Long-Term Debt", "terseLabel": "Redemption of outstanding principal amount", "totalLabel": "Repayments of Long-term Debt, Total", "documentation": "The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer." } } }, "auth_ref": [ "r66", "r629" ] }, "us-gaap_RepaymentsOfShortTermDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RepaymentsOfShortTermDebt", "crdr": "credit", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/DisclosureDiscontinuedOperationsAndRelatedZimvieMattersAdditionalInformationDetails", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDebtAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "totalLabel": "Repayments of Short-Term Debt, Total", "label": "Repayments of Short-Term Debt", "verboseLabel": "Payments to settle debt", "terseLabel": "Redemption of outstanding principal amount", "documentation": "The cash outflow for a borrowing having initial term of repayment within one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r66" ] }, "us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost", "crdr": "debit", "calculation": { "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfEarningsUnaudited": { "parentTag": "us-gaap_CostsAndExpenses", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfEarningsUnaudited" ], "lang": { "en-us": { "role": { "label": "Research and Development Expense (Excluding Acquired in Process Cost)", "terseLabel": "Research and development", "documentation": "The costs incurred in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, excluding in-process research and development acquired in a business combination consummated during the period. Excludes software research and development, which has a separate concept." } } }, "auth_ref": [ "r933" ] }, "srt_RestatementAdjustmentMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "RestatementAdjustmentMember", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/DisclosureDiscontinuedOperationsAndRelatedZimvieMattersAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Restatement Adjustment", "label": "Revision of Prior Period, Adjustment [Member]", "terseLabel": "Adjustment" } } }, "auth_ref": [ "r291", "r292", "r293", "r302", "r303", "r324", "r538", "r539", "r886", "r887", "r888", "r889", "r890", "r893", "r894" ] }, "srt_RestatementAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "RestatementAxis", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/DisclosureDiscontinuedOperationsAndRelatedZimvieMattersAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Revision of Prior Period [Axis]" } } }, "auth_ref": [ "r240", "r291", "r292", "r293", "r294", "r295", "r296", "r297", "r298", "r299", "r301", "r302", "r303", "r304", "r305", "r306", "r324", "r359", "r360", "r496", "r537", "r538", "r539", "r540", "r569", "r570", "r571", "r612", "r613", "r614", "r615", "r616", "r617", "r618", "r619", "r620", "r621", "r624" ] }, "ecd_RestatementDateAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "RestatementDateAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Restatement Determination Date [Axis]", "terseLabel": "Restatement Determination Date:" } } }, "auth_ref": [ "r811", "r822", "r832", "r857" ] }, "ecd_RestatementDeterminationDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "RestatementDeterminationDate", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Restatement Determination Date", "terseLabel": "Restatement Determination Date" } } }, "auth_ref": [ "r812", "r823", "r833", "r858" ] }, "ecd_RestatementDoesNotRequireRecoveryTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "RestatementDoesNotRequireRecoveryTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Restatement Does Not Require Recovery [Text Block]", "terseLabel": "Restatement does not require Recovery" } } }, "auth_ref": [ "r819", "r830", "r840", "r865" ] }, "srt_RestatementDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "RestatementDomain", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/DisclosureDiscontinuedOperationsAndRelatedZimvieMattersAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Revision of Prior Period [Domain]" } } }, "auth_ref": [ "r240", "r291", "r292", "r293", "r294", "r295", "r296", "r297", "r298", "r299", "r301", "r302", "r303", "r304", "r305", "r306", "r324", "r359", "r360", "r496", "r537", "r538", "r539", "r540", "r569", "r570", "r571", "r612", "r613", "r614", "r615", "r616", "r617", "r618", "r619", "r620", "r621", "r624" ] }, "us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDebtAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Cash and Cash Equivalents [Domain]", "documentation": "Type of cash and cash equivalent. Cash is currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r245" ] }, "zbh_RestructuringAndOtherCostReductionInitiatives": { "xbrltype": "monetaryItemType", "nsuri": "http://www.zimmerbiomet.com/20240331", "localname": "RestructuringAndOtherCostReductionInitiatives", "crdr": "debit", "calculation": { "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfEarningsUnaudited": { "parentTag": "us-gaap_CostsAndExpenses", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/DisclosureRestructuringSummaryOfLocationOnCondensedConsolidatedStatementOfEarningsAndTypeOfCostForRestructuringPlanDetail", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfEarningsUnaudited" ], "lang": { "en-us": { "role": { "documentation": "Restructuring and other cost reduction initiatives .", "label": "Restructuring And Other Cost Reduction Initiatives", "terseLabel": "Restructuring and other cost reduction initiatives" } } }, "auth_ref": [] }, "us-gaap_RestructuringAndRelatedActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RestructuringAndRelatedActivitiesAbstract", "lang": { "en-us": { "role": { "label": "Restructuring and Related Activities [Abstract]" } } }, "auth_ref": [] }, "us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RestructuringAndRelatedActivitiesDisclosureTextBlock", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureRestructuring" ], "lang": { "en-us": { "role": { "label": "Restructuring and Related Activities Disclosure [Text Block]", "terseLabel": "Restructuring", "documentation": "The entire disclosure for restructuring and related activities. Description of restructuring activities such as exit and disposal activities, include facts and circumstances leading to the plan, the expected plan completion date, the major types of costs associated with the plan activities, total expected costs, the accrual balance at the end of the period, and the periods over which the remaining accrual will be settled." } } }, "auth_ref": [ "r369", "r370", "r372", "r375", "r380" ] }, "us-gaap_RestructuringAndRelatedCostCostIncurredToDate1": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RestructuringAndRelatedCostCostIncurredToDate1", "crdr": "debit", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureRestructuringSummaryOfLiabilitiesRecognizedRelatedToRestructuringPlanDetail" ], "lang": { "en-us": { "role": { "label": "Restructuring and Related Cost, Cost Incurred to Date", "verboseLabel": "Expense incurred since the start of the Restructuring Plan", "documentation": "Amount of costs incurred to date for the specified restructuring cost." } } }, "auth_ref": [ "r371", "r374", "r377", "r379" ] }, "us-gaap_RestructuringAndRelatedCostExpectedCost1": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RestructuringAndRelatedCostExpectedCost1", "crdr": "debit", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureRestructuringAdditionalInformationDetail", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureRestructuringSummaryOfLiabilitiesRecognizedRelatedToRestructuringPlanDetail" ], "lang": { "en-us": { "role": { "label": "Restructuring and Related Cost, Expected Cost", "terseLabel": "Pre-tax restructuring charges", "verboseLabel": "Expense estimated to be recognized for the Restructuring Plan", "totalLabel": "Restructuring and Related Cost, Expected Cost, Total", "documentation": "Amount expected to be recognized in earnings for the specified restructuring cost." } } }, "auth_ref": [ "r371", "r374", "r377", "r379" ] }, "us-gaap_RestructuringAndRelatedCostIncurredCost": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RestructuringAndRelatedCostIncurredCost", "crdr": "debit", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/DisclosureRestructuringSummaryOfLocationOnCondensedConsolidatedStatementOfEarningsAndTypeOfCostForRestructuringPlanDetail", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureRestructuringSummaryOfLiabilitiesRecognizedRelatedToRestructuringPlanDetail" ], "lang": { "en-us": { "role": { "label": "Restructuring and Related Cost, Incurred Cost", "terseLabel": "Expenses", "totalLabel": "Restructuring and Related Costs, Incurred Cost, Total", "verboseLabel": "Total", "documentation": "Discloses the amount charged against the accrued restructuring reserves, or earnings if not previously accrued, during the period for the specified type of restructuring cost." } } }, "auth_ref": [ "r371", "r374", "r377", "r379" ] }, "us-gaap_RestructuringCostAndReserveAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RestructuringCostAndReserveAxis", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/DisclosureRestructuringSummaryOfLocationOnCondensedConsolidatedStatementOfEarningsAndTypeOfCostForRestructuringPlanDetail", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureBasisOfPresentationAdditionalInformationDetails", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureFairValueMeasurementOfAssetsAndLiabilitiesAdditionalInformationDetails", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureRestructuringSummaryOfLiabilitiesRecognizedRelatedToRestructuringPlanDetail", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureSignificantAccountingPoliciesAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Restructuring Type [Axis]", "terseLabel": "Restructuring Type", "documentation": "Information by type of restructuring cost." } } }, "auth_ref": [ "r371", "r372", "r377", "r378" ] }, "us-gaap_RestructuringCostAndReserveLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RestructuringCostAndReserveLineItems", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/DisclosureRestructuringSummaryOfLocationOnCondensedConsolidatedStatementOfEarningsAndTypeOfCostForRestructuringPlanDetail", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureRestructuringAdditionalInformationDetail", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureRestructuringSummaryOfLiabilitiesRecognizedRelatedToRestructuringPlanDetail" ], "lang": { "en-us": { "role": { "label": "Restructuring Cost and Reserve [Line Items]", "terseLabel": "Restructuring Cost And Reserve [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r371", "r372", "r373", "r374", "r377", "r378", "r379" ] }, "us-gaap_RestructuringPlanAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RestructuringPlanAxis", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/DisclosureRestructuringSummaryOfLocationOnCondensedConsolidatedStatementOfEarningsAndTypeOfCostForRestructuringPlanDetail", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureRestructuringAdditionalInformationDetail", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureRestructuringSummaryOfLiabilitiesRecognizedRelatedToRestructuringPlanDetail" ], "lang": { "en-us": { "role": { "label": "Restructuring Plan [Axis]", "terseLabel": "Restructuring Plan", "documentation": "Information by individual restructuring plan." } } }, "auth_ref": [] }, "us-gaap_RestructuringPlanDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RestructuringPlanDomain", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/DisclosureRestructuringSummaryOfLocationOnCondensedConsolidatedStatementOfEarningsAndTypeOfCostForRestructuringPlanDetail", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureRestructuringAdditionalInformationDetail", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureRestructuringSummaryOfLiabilitiesRecognizedRelatedToRestructuringPlanDetail" ], "lang": { "en-us": { "role": { "label": "Restructuring Plan [Domain]", "terseLabel": "Restructuring Plan", "documentation": "Identification of the individual restructuring plans." } } }, "auth_ref": [] }, "zbh_RestructuringProgramBenefitsRealizedPeriod": { "xbrltype": "gYearItemType", "nsuri": "http://www.zimmerbiomet.com/20240331", "localname": "RestructuringProgramBenefitsRealizedPeriod", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureRestructuringAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "documentation": "Restructuring program benefits realized period..", "label": "Restructuring Program Benefits Realized Period", "terseLabel": "Restructuring program benefits realized period" } } }, "auth_ref": [] }, "us-gaap_RestructuringReserve": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RestructuringReserve", "crdr": "credit", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureRestructuringSummaryOfLiabilitiesRecognizedRelatedToRestructuringPlanDetail" ], "lang": { "en-us": { "role": { "label": "Restructuring Reserve", "periodEndLabel": "Ending Balance", "periodStartLabel": "Beginning Balance", "totalLabel": "Restructuring Reserve, Total", "documentation": "Carrying amount (including both current and noncurrent portions of the accrual) as of the balance sheet date pertaining to a specified type of cost associated with exit from or disposal of business activities or restructuring pursuant to a duly authorized plan." } } }, "auth_ref": [ "r372", "r376" ] }, "us-gaap_RestructuringReserveSettledWithoutCash2": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RestructuringReserveSettledWithoutCash2", "crdr": "debit", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureRestructuringSummaryOfLiabilitiesRecognizedRelatedToRestructuringPlanDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Non-cash activity", "label": "Restructuring Reserve, Settled without Cash", "documentation": "Amount of decrease in the reserve for full or partial settlement through consideration other than cash." } } }, "auth_ref": [ "r372", "r378" ] }, "us-gaap_RestructuringReserveTranslationAdjustment": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RestructuringReserveTranslationAdjustment", "crdr": "credit", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureRestructuringSummaryOfLiabilitiesRecognizedRelatedToRestructuringPlanDetail" ], "lang": { "en-us": { "role": { "label": "Restructuring Reserve, Foreign Currency Translation Gain (Loss)", "terseLabel": "Foreign currency exchange rate changes", "documentation": "Amount of foreign currency translation gain (loss) which decreases (increases) the restructuring reserve." } } }, "auth_ref": [ "r917", "r918" ] }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RetainedEarningsAccumulatedDeficit", "crdr": "credit", "calculation": { "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/DisclosureDiscontinuedOperationsAndRelatedZimvieMattersAdditionalInformationDetails", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited" ], "lang": { "en-us": { "role": { "label": "Retained Earnings (Accumulated Deficit)", "terseLabel": "Retained earnings", "totalLabel": "Retained Earnings (Accumulated Deficit), Total", "periodStartLabel": "Retained Earnings (Accumulated Deficit), Beginning Balance", "periodEndLabel": "Retained Earnings (Accumulated Deficit), Ending Balance", "documentation": "Amount of accumulated undistributed earnings (deficit)." } } }, "auth_ref": [ "r169", "r207", "r592", "r616", "r621", "r630", "r668", "r789" ] }, "us-gaap_RetainedEarningsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RetainedEarningsMember", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfStockholdersEquityUnaudited" ], "lang": { "en-us": { "role": { "label": "Retained Earnings [Member]", "terseLabel": "Retained Earnings [Member]", "documentation": "Accumulated undistributed earnings (deficit)." } } }, "auth_ref": [ "r239", "r291", "r292", "r293", "r295", "r303", "r305", "r358", "r361", "r484", "r485", "r486", "r495", "r496", "r530", "r532", "r533", "r535", "r538", "r612", "r614", "r634", "r959" ] }, "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RevenueFromContractWithCustomerExcludingAssessedTax", "crdr": "credit", "calculation": { "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfEarningsUnaudited": { "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureRevenueScheduleOfNetSalesByGeographyDetail", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureRevenueScheduleOfNetSalesByProductCategoryDetail", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureSegmentInformationSummaryOfNetSalesAndOperatingProfitBySegmentDetail", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfEarningsUnaudited" ], "lang": { "en-us": { "role": { "label": "Revenue from Contract with Customer, Excluding Assessed Tax", "terseLabel": "Net Sales", "totalLabel": "Revenue from Contract with Customer, Excluding Assessed Tax, Total", "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise." } } }, "auth_ref": [ "r333", "r334", "r338", "r343", "r344", "r350", "r352", "r354", "r446", "r447", "r577" ] }, "us-gaap_RevenueFromContractWithCustomerTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RevenueFromContractWithCustomerTextBlock", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureRevenue" ], "lang": { "en-us": { "role": { "label": "Revenue from Contract with Customer [Text Block]", "terseLabel": "Revenue", "documentation": "The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts." } } }, "auth_ref": [ "r237", "r438", "r439", "r440", "r441", "r442", "r443", "r444", "r445", "r448" ] }, "us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RevenueFromExternalCustomersByGeographicAreasTableTextBlock", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureRevenueTables" ], "lang": { "en-us": { "role": { "label": "Revenue from External Customers by Geographic Areas [Table Text Block]", "terseLabel": "Schedule of Net Sales by Geography", "documentation": "Tabular disclosure of revenue from external customers by geographic areas attributed to the entity's country of domicile and to foreign countries from which the entity derives revenue." } } }, "auth_ref": [ "r37" ] }, "us-gaap_RevenueRecognitionAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RevenueRecognitionAbstract", "lang": { "en-us": { "role": { "label": "Revenue Recognition [Abstract]" } } }, "auth_ref": [] }, "us-gaap_RevolvingCreditFacilityMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RevolvingCreditFacilityMember", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/DisclosureDiscontinuedOperationsAndRelatedZimvieMattersAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Revolving Credit Facility [Member]", "terseLabel": "Revolving Loans", "documentation": "Arrangement in which loan proceeds can continuously be obtained following repayments, but the total amount borrowed cannot exceed a specified maximum amount." } } }, "auth_ref": [] }, "zbh_Rule10B51ArrAmendedFlag": { "xbrltype": "booleanItemType", "nsuri": "http://www.zimmerbiomet.com/20240331", "localname": "Rule10B51ArrAmendedFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Rule 10b5-1 Arrangement Amended", "label": "Rule 10b5-1 Arr Amended Flag", "documentation": "Rule 10b5-1 arr amended flag." } } }, "auth_ref": [] }, "ecd_Rule10b51ArrAdoptedFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "Rule10b51ArrAdoptedFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Rule 10b5-1 Arrangement Adopted [Flag]", "terseLabel": "Rule 10b5-1 Arrangement Adopted" } } }, "auth_ref": [ "r874" ] }, "ecd_Rule10b51ArrTrmntdFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "Rule10b51ArrTrmntdFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Rule 10b5-1 Arrangement Terminated [Flag]", "terseLabel": "Rule 10b5-1 Arrangement Terminated" } } }, "auth_ref": [ "r874" ] }, "zbh_SETMember": { "xbrltype": "domainItemType", "nsuri": "http://www.zimmerbiomet.com/20240331", "localname": "SETMember", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureRevenueScheduleOfNetSalesByProductCategoryDetail" ], "lang": { "en-us": { "role": { "documentation": "SET.", "label": "S E T [Member]", "terseLabel": "S.E.T [Member]" } } }, "auth_ref": [] }, "zbh_SalesInformationLineItems": { "xbrltype": "stringItemType", "nsuri": "http://www.zimmerbiomet.com/20240331", "localname": "SalesInformationLineItems", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureRevenueScheduleOfNetSalesByGeographyDetail" ], "lang": { "en-us": { "role": { "documentation": "Sales Information [Line Items]", "label": "Sales Information [Line Items]", "terseLabel": "Sales Information [Line Items]" } } }, "auth_ref": [] }, "zbh_SalesInformationTable": { "xbrltype": "stringItemType", "nsuri": "http://www.zimmerbiomet.com/20240331", "localname": "SalesInformationTable", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureRevenueScheduleOfNetSalesByGeographyDetail" ], "lang": { "en-us": { "role": { "documentation": "Sales Information [Table]", "label": "Sales Information [Table]", "terseLabel": "Sales Information [Table]" } } }, "auth_ref": [] }, "us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureAccumulatedOtherComprehensiveIncomeTables" ], "lang": { "en-us": { "role": { "label": "Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]", "terseLabel": "Changes in Components of Accumulated Other Comprehensive Income, Net of Tax", "documentation": "Tabular disclosure of the components of accumulated other comprehensive income (loss)." } } }, "auth_ref": [ "r60", "r942", "r943" ] }, "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTable", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/DisclosureAcquisitionsAdditionalInformationDetail", "http://www.zimmerbiomet.com/20240331/taxonomy/role/DisclosureAcquisitionsSummaryOfEstimatesOfFairValueOfAssetsAcquiredAndLiabilitiesAssumedDetails", "http://www.zimmerbiomet.com/20240331/taxonomy/role/DisclosureAcquisitionsTables" ], "lang": { "en-us": { "role": { "label": "Schedule of Business Acquisitions, by Acquisition [Table]", "documentation": "Schedule reflecting each material business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities." } } }, "auth_ref": [ "r105", "r106", "r507" ] }, "us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesTables" ], "lang": { "en-us": { "role": { "label": "Schedule of Cash Flow Hedges Included in Accumulated Other Comprehensive Income (Loss) [Table Text Block]", "terseLabel": "Gross Unrealized Losses from Derivative Instruments", "documentation": "Tabular disclosure of gain (loss) on derivative and nonderivative instruments designated and qualifying as cash flow hedge recorded in accumulated other comprehensive income (AOCI) and reclassified into earnings." } } }, "auth_ref": [ "r128" ] }, "us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfComprehensiveIncomeLossTableTextBlock", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureAccumulatedOtherComprehensiveIncomeTables" ], "lang": { "en-us": { "role": { "label": "Comprehensive Income (Loss) [Table Text Block]", "terseLabel": "Tax Effects on Each Component of Accumulated Other Comprehensive Income Recognized in Statements of Comprehensive Income", "documentation": "Tabular disclosure of components of comprehensive income (loss). Includes, but is not limited to, foreign currency translation adjustments, foreign currency transactions designated as economic hedges of a net investment in foreign entity, gain (loss) and prior service cost (credit) for pension plans and other postretirement benefit plans." } } }, "auth_ref": [ "r179" ] }, "us-gaap_ScheduleOfDebtTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfDebtTableTextBlock", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDebtTables" ], "lang": { "en-us": { "role": { "label": "Schedule of Debt [Table Text Block]", "terseLabel": "Summary of Debt Instruments", "documentation": "Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation." } } }, "auth_ref": [] }, "us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesTables" ], "lang": { "en-us": { "role": { "label": "Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block]", "terseLabel": "Fair Value of Derivative Instruments on Gross Basis", "documentation": "Tabular disclosure of the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position." } } }, "auth_ref": [ "r121" ] }, "us-gaap_ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesTables" ], "lang": { "en-us": { "role": { "label": "Schedule of Derivatives Instruments Statements of Financial Performance and Financial Position, Location [Table Text Block]", "terseLabel": "Effects of Fair Value, Cash Flow and Net Investment Hedge Accounting on Consolidated Statements of Earnings", "documentation": "Tabular disclosure of derivative instruments (including nonderivative instruments that are designated and qualify as hedging instruments) of (a) the location and amount of gains and losses reported in the statement of financial performance and (b) the location and fair value amounts of the instruments reported in the statement of financial position." } } }, "auth_ref": [ "r118" ] }, "us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/DisclosureDiscontinuedOperationsAndRelatedZimvieMattersTables" ], "lang": { "en-us": { "role": { "terseLabel": "Summary of Details of Loss from Discontinued operation", "label": "Disposal Groups, Including Discontinued Operations [Table Text Block]", "documentation": "Tabular disclosure of information related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component." } } }, "auth_ref": [ "r24", "r35", "r43", "r145", "r151", "r152", "r153", "r154", "r155", "r159", "r161", "r162", "r202" ] }, "us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureRevenueScheduleOfNetSalesByProductCategoryDetail" ], "lang": { "en-us": { "role": { "label": "Revenue from External Customers by Products and Services [Table]", "terseLabel": "Schedule Of Entity Wide Information Revenue From External Customers By Products And Services [Table]", "documentation": "Tabular presentation of the description and amount of revenues from a product or service, or a group of similar products or similar services, reported from external customers during the period, if the information is not provided as part of the reportable operating segment information." } } }, "auth_ref": [ "r82" ] }, "us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureRevenueTables" ], "lang": { "en-us": { "role": { "label": "Revenue from External Customers by Products and Services [Table Text Block]", "terseLabel": "Schedule of Net Sales by Product Category", "documentation": "Tabular disclosure of entity-wide revenues from external customers for each product or service or each group of similar products or services if the information is not provided as part of the reportable operating segment information." } } }, "auth_ref": [ "r82" ] }, "us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureSegmentInformationTables" ], "lang": { "en-us": { "role": { "label": "Schedule of Error Corrections and Prior Period Adjustments [Table Text Block]", "terseLabel": "Summary of Changes in Segment Operating Profit", "documentation": "Tabular disclosure of prior period adjustments to previously issued financial statements including (1) the effect of the correction on each financial statement line item and any per-share amounts affected for each prior period presented (2) the cumulative effect of the change on retained earnings or other appropriate components of equity or net assets in the statement of financial position, as of the beginning of the earliest period presented, and (3) the effect of the prior period adjustments (both gross and net of applicable income tax) on the net income of each prior period presented in the entity's annual report for the year in which the adjustments are made." } } }, "auth_ref": [ "r71", "r72", "r73" ] }, "us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureFairValueMeasurementOfAssetsAndLiabilitiesTables" ], "lang": { "en-us": { "role": { "label": "Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]", "terseLabel": "Fair Value Measurement of Asset and Liabilities", "documentation": "Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3)." } } }, "auth_ref": [ "r542", "r543" ] }, "us-gaap_ScheduleOfFairValueHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfFairValueHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesTables" ], "lang": { "en-us": { "role": { "label": "Schedule of Fair Value Hedging Instruments, Statements of Financial Performance and Financial Position, Location [Table Text Block]", "terseLabel": "Schedule of Amounts Recorded On Balance Sheet Related To Cumulative Basis Adjustments For Fair Value Hedges", "documentation": "Tabular disclosure for fair value hedging instruments of (a) the location and amount of gains and losses reported in the statement of financial performance and (b) the location and fair value amounts of the instruments reported in the statement of financial position." } } }, "auth_ref": [ "r126" ] }, "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfInventoryCurrentTableTextBlock", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureInventoriesTables" ], "lang": { "en-us": { "role": { "label": "Schedule of Inventory, Current [Table Text Block]", "terseLabel": "Summary of Inventories", "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process." } } }, "auth_ref": [ "r44", "r173", "r174", "r175" ] }, "us-gaap_ScheduleOfNetInvestmentHedgesStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfNetInvestmentHedgesStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesTables" ], "lang": { "en-us": { "role": { "label": "Schedule of Net Investment Hedges, Statements of Financial Performance and Financial Position, Location [Table Text Block]", "terseLabel": "Net Investment Hedge Gains Recognized on Condensed Consolidated Statements of Comprehensive Income", "documentation": "Tabular disclosure for net investment hedges of (a) the location and amount of gains and losses reported in the statement of financial performance and (b) the location and fair value amounts of the instruments reported in the statement of financial position." } } }, "auth_ref": [ "r127" ] }, "us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesTables" ], "lang": { "en-us": { "role": { "label": "Derivatives Not Designated as Hedging Instruments [Table Text Block]", "terseLabel": "Derivative Instruments Not Designated as Hedging Instruments", "documentation": "Tabular disclosure of derivative instrument not designated or qualifying as hedging instrument." } } }, "auth_ref": [ "r129", "r891" ] }, "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfPropertyPlantAndEquipmentTable", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosurePropertyPlantAndEquipmentSummaryOfPropertyPlantAndEquipmentDetail" ], "lang": { "en-us": { "role": { "label": "Property, Plant and Equipment [Table]", "terseLabel": "Schedule Of Property Plant And Equipment [Table]", "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation." } } }, "auth_ref": [ "r23" ] }, "us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/DisclosureAcquisitionsTables" ], "lang": { "en-us": { "role": { "terseLabel": "Summary of Estimates of Fair Value of Assets Acquired and Liabilities Assumed", "label": "Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]", "documentation": "Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree." } } }, "auth_ref": [ "r209" ] }, "us-gaap_ScheduleOfRestructuringAndRelatedCostsTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfRestructuringAndRelatedCostsTable", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/DisclosureRestructuringSummaryOfLocationOnCondensedConsolidatedStatementOfEarningsAndTypeOfCostForRestructuringPlanDetail", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureRestructuringAdditionalInformationDetail", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureRestructuringSummaryOfLiabilitiesRecognizedRelatedToRestructuringPlanDetail" ], "lang": { "en-us": { "role": { "label": "Schedule of Restructuring and Related Costs [Table]", "terseLabel": "Schedule Of Restructuring And Related Costs [Table]", "documentation": "Table presenting the description of the restructuring costs, such as the expected cost; the costs incurred during the period; the cumulative costs incurred as of the balance sheet date; the income statement caption within which the restructuring charges recognized for the period are included; and the amount of and periodic changes to an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost by type of restructuring." } } }, "auth_ref": [ "r371", "r372", "r373", "r374", "r377", "r378", "r379" ] }, "us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfRestructuringAndRelatedCostsTextBlock", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureRestructuringTables" ], "lang": { "en-us": { "role": { "label": "Restructuring and Related Costs [Table Text Block]", "terseLabel": "Summary of Liabilities Recognized Related to Restructuring Plan", "documentation": "Tabular disclosure of costs incurred for restructuring including, but not limited to, exit and disposal activities, remediation, implementation, integration, asset impairment, and charges against earnings from the write-down of assets." } } }, "auth_ref": [ "r91", "r93", "r94" ] }, "us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfRestructuringReserveByTypeOfCostTextBlock", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureRestructuringTables" ], "lang": { "en-us": { "role": { "label": "Schedule of Restructuring Reserve by Type of Cost [Table Text Block]", "terseLabel": "Summary of Location on Condensed Consolidated Statement of Earnings and Type of Cost for Restructuring Plan", "documentation": "Tabular disclosure of an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost. This element may also include a description of any reversal and other adjustment made during the period to the amount of an accrued liability for restructuring activities. This element may be used to encapsulate the roll forward presentations of an entity's restructuring reserve by type of cost and in total, and explanation of changes that occurred in the period." } } }, "auth_ref": [ "r92", "r95" ] }, "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureSegmentInformationTables" ], "lang": { "en-us": { "role": { "label": "Schedule of Segment Reporting Information, by Segment [Table Text Block]", "terseLabel": "Summary of Net sales and Operating Profit by Segment", "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss." } } }, "auth_ref": [ "r78", "r79", "r80", "r83" ] }, "us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfWeightedAverageNumberOfSharesTableTextBlock", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureEarningsPerShareTables" ], "lang": { "en-us": { "role": { "label": "Schedule of Weighted Average Number of Shares [Table Text Block]", "terseLabel": "Reconciliation of Weighted Average Shares for Basic and Diluted Shares Computations", "documentation": "Tabular disclosure of the weighted average number of shares used in calculating basic net earnings per share (or unit) and diluted earnings per share (or unit)." } } }, "auth_ref": [ "r74" ] }, "us-gaap_SecuredDebtMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SecuredDebtMember", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/DisclosureDiscontinuedOperationsAndRelatedZimvieMattersAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Secured Debt [Member]", "terseLabel": "Term Loan", "documentation": "Collateralized debt obligation backed by, for example, but not limited to, pledge, mortgage or other lien on the entity's assets." } } }, "auth_ref": [] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12bTitle", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Title of 12(b) Security", "terseLabel": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r805" ] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityExchangeName", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Security Exchange Name", "terseLabel": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r807" ] }, "srt_SegmentGeographicalDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "SegmentGeographicalDomain", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureRevenueScheduleOfNetSalesByGeographyDetail", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureSegmentInformationSummaryOfNetSalesAndOperatingProfitBySegmentDetail" ], "lang": { "en-us": { "role": { "label": "Geographical [Domain]", "terseLabel": "Geographical" } } }, "auth_ref": [ "r352", "r353", "r649", "r652", "r654", "r712", "r714", "r717", "r730", "r739", "r740", "r741", "r742", "r743", "r744", "r745", "r746", "r747", "r752", "r779", "r794", "r929", "r956" ] }, "us-gaap_SegmentReportingAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SegmentReportingAbstract", "lang": { "en-us": { "role": { "label": "Segment Reporting [Abstract]" } } }, "auth_ref": [] }, "us-gaap_SegmentReportingDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SegmentReportingDisclosureTextBlock", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureSegmentInformation" ], "lang": { "en-us": { "role": { "label": "Segment Reporting Disclosure [Text Block]", "terseLabel": "Segment Information", "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments." } } }, "auth_ref": [ "r328", "r329", "r330", "r331", "r332", "r337", "r342", "r346", "r347", "r348", "r349", "r350", "r351", "r354" ] }, "us-gaap_SellingGeneralAndAdministrativeExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SellingGeneralAndAdministrativeExpense", "crdr": "debit", "calculation": { "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfEarningsUnaudited": { "parentTag": "us-gaap_CostsAndExpenses", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfEarningsUnaudited" ], "lang": { "en-us": { "role": { "label": "Selling, General and Administrative Expense", "terseLabel": "Selling, general and administrative", "totalLabel": "Selling, General and Administrative Expense, Total", "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc." } } }, "auth_ref": [ "r186" ] }, "us-gaap_SeniorNotesMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SeniorNotesMember", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDebtAdditionalInformationDetail", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDebtSummaryOfDebtInstrumentsDetail", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDebtSummaryOfDebtInstrumentsParentheticalDetail", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Senior Notes [Member]", "terseLabel": "Senior Notes [Member]", "documentation": "Bond that takes priority over other debt securities sold by the issuer. In the event the issuer goes bankrupt, senior debt holders receive priority for (must receive) repayment prior to (relative to) junior and unsecured (general) creditors." } } }, "auth_ref": [] }, "zbh_September2020CreditAgreementMember": { "xbrltype": "domainItemType", "nsuri": "http://www.zimmerbiomet.com/20240331", "localname": "September2020CreditAgreementMember", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDebtAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "documentation": "September 2020 credit agreement", "label": "September2020 Credit Agreement [Member]", "terseLabel": "September 2020 Credit Agreement [Member]" } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensation", "crdr": "debit", "calculation": { "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "label": "Share-Based Payment Arrangement, Noncash Expense", "terseLabel": "Share-based compensation", "totalLabel": "Share-based Payment Arrangement, Noncash Expense, Total", "documentation": "Amount of noncash expense for share-based payment arrangement." } } }, "auth_ref": [ "r21" ] }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "All Award Types", "terseLabel": "All Award Types", "documentation": "Award under share-based payment arrangement." } } }, "auth_ref": [ "r458", "r459", "r460", "r461", "r462", "r463", "r464", "r465", "r466", "r467", "r468", "r469", "r470", "r471", "r472", "r473", "r474", "r475", "r476", "r477", "r478", "r479", "r480", "r481", "r482", "r483" ] }, "zbh_SharesPledgedAsCollateral": { "xbrltype": "sharesItemType", "nsuri": "http://www.zimmerbiomet.com/20240331", "localname": "SharesPledgedAsCollateral", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/DisclosureDiscontinuedOperationsAndRelatedZimvieMattersAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Shares pledged as collateral", "documentation": "Shares pledged as collateral." } } }, "auth_ref": [] }, "us-gaap_ShortTermBankLoansAndNotesPayable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShortTermBankLoansAndNotesPayable", "crdr": "credit", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDebtSummaryOfDebtInstrumentsDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Short-Term Term Loan", "label": "Short-Term Bank Loans and Notes Payable", "documentation": "Amount of borrowings from a bank classified as other, maturing within one year or operating cycle, if longer." } } }, "auth_ref": [ "r45", "r662", "r953" ] }, "us-gaap_ShortTermBorrowingsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShortTermBorrowingsAbstract", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDebtSummaryOfDebtInstrumentsDetail" ], "lang": { "en-us": { "role": { "label": "Short-Term Debt [Abstract]" } } }, "auth_ref": [] }, "us-gaap_ShortTermDebtTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShortTermDebtTypeAxis", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDebtAdditionalInformationDetail", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDebtSummaryOfDebtInstrumentsDetail" ], "lang": { "en-us": { "role": { "label": "Short-Term Debt, Type [Axis]", "documentation": "Information by type of short-term debt arrangement." } } }, "auth_ref": [ "r48" ] }, "us-gaap_ShortTermDebtTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShortTermDebtTypeDomain", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDebtAdditionalInformationDetail", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDebtSummaryOfDebtInstrumentsDetail" ], "lang": { "en-us": { "role": { "label": "Short-Term Debt, Type [Domain]", "documentation": "Type of short-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing." } } }, "auth_ref": [ "r46" ] }, "zbh_ShortTermTermLoanAndForwardExchangeAgreementMember": { "xbrltype": "domainItemType", "nsuri": "http://www.zimmerbiomet.com/20240331", "localname": "ShortTermTermLoanAndForwardExchangeAgreementMember", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/DisclosureDiscontinuedOperationsAndRelatedZimvieMattersAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Short-Term Term Loan and Forward Exchange Agreement [Member]", "documentation": "Short-term term loan and forward exchange agreement.", "verboseLabel": "Short Term Term Loan And Forward Exchange Agreement" } } }, "auth_ref": [] }, "zbh_ShortTermTermLoanMember": { "xbrltype": "domainItemType", "nsuri": "http://www.zimmerbiomet.com/20240331", "localname": "ShortTermTermLoanMember", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/DisclosureDiscontinuedOperationsAndRelatedZimvieMattersAdditionalInformationDetails", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDebtAdditionalInformationDetail", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDebtSummaryOfDebtInstrumentsDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Short-Term Term Loan [Member]", "verboseLabel": "Short-Term Term Loan", "label": "Short-Term Term Loan [Member]", "documentation": "Short-term term loan." } } }, "auth_ref": [] }, "us-gaap_SignificantAccountingPoliciesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SignificantAccountingPoliciesTextBlock", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureSignificantAccountingPolicies" ], "lang": { "en-us": { "role": { "label": "Significant Accounting Policies [Text Block]", "terseLabel": "Significant Accounting Policies", "documentation": "The entire disclosure for all significant accounting policies of the reporting entity." } } }, "auth_ref": [ "r193", "r286" ] }, "us-gaap_SoftwareAndSoftwareDevelopmentCostsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SoftwareAndSoftwareDevelopmentCostsMember", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosurePropertyPlantAndEquipmentSummaryOfPropertyPlantAndEquipmentDetail" ], "lang": { "en-us": { "role": { "label": "Software and Software Development Costs [Member]", "terseLabel": "Capitalized Software Costs [Member]", "documentation": "Purchased software applications and internally developed software for sale, licensing or long-term internal use." } } }, "auth_ref": [] }, "zbh_SpinOffPercentageRetained": { "xbrltype": "percentItemType", "nsuri": "http://www.zimmerbiomet.com/20240331", "localname": "SpinOffPercentageRetained", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureFairValueMeasurementOfAssetsAndLiabilitiesAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "documentation": "Spin off percentage retained.", "label": "Spin Off Percentage Retained", "verboseLabel": "Spin-off percentage retained" } } }, "auth_ref": [] }, "us-gaap_SpinoffMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SpinoffMember", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureBasisOfPresentationAdditionalInformationDetails", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureFairValueMeasurementOfAssetsAndLiabilitiesAdditionalInformationDetails", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureSignificantAccountingPoliciesAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Spinoff [Member]", "terseLabel": "Spinoff [Member]", "verboseLabel": "Spinoff [Member]", "documentation": "Creation of an independent entity from an existing entity through divestiture, for example, but not limited to, sale or distribution of new shares." } } }, "auth_ref": [] }, "us-gaap_StatementClassOfStockAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementClassOfStockAxis", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Class of Stock [Axis]", "terseLabel": "Class of Stock", "documentation": "Information by the different classes of stock of the entity." } } }, "auth_ref": [ "r238", "r255", "r256", "r257", "r288", "r311", "r315", "r318", "r320", "r326", "r327", "r357", "r389", "r392", "r393", "r394", "r400", "r401", "r432", "r433", "r434", "r435", "r436", "r551", "r626", "r627", "r628", "r629", "r634", "r635", "r636", "r637", "r638", "r639", "r640", "r641", "r642", "r643", "r644", "r646", "r667", "r689", "r708", "r731", "r732", "r733", "r734", "r735", "r882", "r904", "r910" ] }, "us-gaap_StatementEquityComponentsAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementEquityComponentsAxis", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureAccumulatedOtherComprehensiveIncomeChangesInComponentsOfAccumulatedOtherComprehensiveIncomeNetOfTaxDetail", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureAccumulatedOtherComprehensiveIncomeReclassificationAdjustmentsFromAccumulatedOtherComprehensiveIncomeDetail", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureBasisOfPresentationAdditionalInformationDetails", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureFairValueMeasurementOfAssetsAndLiabilitiesAdditionalInformationDetails", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfStockholdersEquityUnaudited" ], "lang": { "en-us": { "role": { "label": "Equity Components [Axis]", "terseLabel": "Equity Components", "documentation": "Information by component of equity." } } }, "auth_ref": [ "r30", "r57", "r239", "r276", "r277", "r278", "r291", "r292", "r293", "r295", "r303", "r305", "r325", "r358", "r361", "r437", "r484", "r485", "r486", "r495", "r496", "r530", "r531", "r532", "r533", "r534", "r535", "r538", "r560", "r562", "r563", "r564", "r565", "r567", "r571", "r612", "r613", "r614", "r634", "r708" ] }, "srt_StatementGeographicalAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "StatementGeographicalAxis", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureRevenueScheduleOfNetSalesByGeographyDetail", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureSegmentInformationSummaryOfNetSalesAndOperatingProfitBySegmentDetail" ], "lang": { "en-us": { "role": { "label": "Geographical [Axis]", "terseLabel": "Geographical" } } }, "auth_ref": [ "r352", "r353", "r649", "r652", "r654", "r712", "r714", "r717", "r730", "r737", "r739", "r740", "r741", "r742", "r743", "r744", "r745", "r746", "r747", "r752", "r779", "r794", "r929", "r956" ] }, "us-gaap_StatementLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementLineItems", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureBasisOfPresentationAdditionalInformationDetails", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfStockholdersEquityUnaudited" ], "lang": { "en-us": { "role": { "label": "Statement [Line Items]", "terseLabel": "Statement [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r291", "r292", "r293", "r325", "r577", "r625", "r646", "r658", "r659", "r660", "r661", "r663", "r664", "r667", "r670", "r671", "r672", "r673", "r674", "r676", "r677", "r678", "r679", "r681", "r682", "r683", "r684", "r685", "r687", "r690", "r691", "r693", "r694", "r695", "r696", "r697", "r698", "r699", "r700", "r701", "r702", "r703", "r704", "r708", "r795" ] }, "us-gaap_StatementOfCashFlowsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementOfCashFlowsAbstract", "lang": { "en-us": { "role": { "label": "Statement of Cash Flows [Abstract]" } } }, "auth_ref": [] }, "us-gaap_StatementOfFinancialPositionAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementOfFinancialPositionAbstract", "lang": { "en-us": { "role": { "label": "Statement of Financial Position [Abstract]" } } }, "auth_ref": [] }, "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract", "lang": { "en-us": { "role": { "label": "Statement of Comprehensive Income [Abstract]" } } }, "auth_ref": [] }, "us-gaap_StatementOfStockholdersEquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementOfStockholdersEquityAbstract", "lang": { "en-us": { "role": { "label": "Statement of Stockholders' Equity [Abstract]" } } }, "auth_ref": [] }, "us-gaap_StatementTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementTable", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureBasisOfPresentationAdditionalInformationDetails", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfStockholdersEquityUnaudited" ], "lang": { "en-us": { "role": { "label": "Statement [Table]", "terseLabel": "Statement [Table]", "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed." } } }, "auth_ref": [ "r291", "r292", "r293", "r325", "r577", "r625", "r646", "r658", "r659", "r660", "r661", "r663", "r664", "r667", "r670", "r671", "r672", "r673", "r674", "r676", "r677", "r678", "r679", "r681", "r682", "r683", "r684", "r685", "r687", "r690", "r691", "r693", "r694", "r695", "r696", "r697", "r698", "r699", "r700", "r701", "r702", "r703", "r704", "r708", "r795" ] }, "zbh_SternalClosureCompanyMember": { "xbrltype": "domainItemType", "nsuri": "http://www.zimmerbiomet.com/20240331", "localname": "SternalClosureCompanyMember", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/DisclosureAcquisitionsAdditionalInformationDetail", "http://www.zimmerbiomet.com/20240331/taxonomy/role/DisclosureAcquisitionsSummaryOfEstimatesOfFairValueOfAssetsAcquiredAndLiabilitiesAssumedDetails", "http://www.zimmerbiomet.com/20240331/taxonomy/role/DisclosureAcquisitionsTables" ], "lang": { "en-us": { "role": { "documentation": "Sternal closure company.", "label": "Sternal Closure Company [Member]", "verboseLabel": "Sternal Closure Company [Member]", "terseLabel": "Sternal closure company [Member]" } } }, "auth_ref": [] }, "ecd_StkPrcOrTsrEstimationMethodTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "StkPrcOrTsrEstimationMethodTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Stock Price or TSR Estimation Method [Text Block]", "terseLabel": "Stock Price or TSR Estimation Method" } } }, "auth_ref": [ "r814", "r825", "r835", "r860" ] }, "us-gaap_StockAppreciationRightsSARSMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockAppreciationRightsSARSMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Stock Appreciation Rights (SARs) [Member]", "terseLabel": "Stock Appreciation Rights (SARs)", "documentation": "Right to receive cash or shares equal to appreciation of predetermined number of grantor's shares during predetermined time period." } } }, "auth_ref": [] }, "us-gaap_StockIssued1": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockIssued1", "crdr": "credit", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/DisclosureDiscontinuedOperationsAndRelatedZimvieMattersAdditionalInformationDetails", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureFairValueMeasurementOfAssetsAndLiabilitiesAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Issuance of common stock for contingent consideration liability, valued", "label": "Stock Issued", "verboseLabel": "Noncash financing activity", "documentation": "The fair value of stock issued in noncash financing activities." } } }, "auth_ref": [ "r68", "r69", "r70" ] }, "us-gaap_StockIssuedDuringPeriodSharesAcquisitions": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockIssuedDuringPeriodSharesAcquisitions", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfStockholdersEquityUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Embody, Inc. acquisition consideration, shares", "label": "Stock Issued During Period, Shares, Acquisitions", "documentation": "Number of shares of stock issued during the period pursuant to acquisitions." } } }, "auth_ref": [ "r166", "r167", "r207" ] }, "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockIssuedDuringPeriodSharesShareBasedCompensation", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfStockholdersEquityUnaudited" ], "lang": { "en-us": { "role": { "label": "Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture", "terseLabel": "Stock compensation plans, shares", "totalLabel": "Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture, Total", "documentation": "Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP)." } } }, "auth_ref": [ "r30", "r166", "r167", "r207" ] }, "us-gaap_StockIssuedDuringPeriodValueAcquisitions": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockIssuedDuringPeriodValueAcquisitions", "crdr": "credit", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfStockholdersEquityUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Embody, Inc. acquisition consideration", "label": "Stock Issued During Period, Value, Acquisitions", "documentation": "Value of stock issued pursuant to acquisitions during the period." } } }, "auth_ref": [ "r30", "r57", "r207" ] }, "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockIssuedDuringPeriodValueShareBasedCompensation", "crdr": "credit", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfStockholdersEquityUnaudited" ], "lang": { "en-us": { "role": { "label": "Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture", "terseLabel": "Stock compensation plans", "totalLabel": "Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture, Total", "documentation": "Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP)." } } }, "auth_ref": [ "r103", "r166", "r167", "r207" ] }, "zbh_StockPriceAtTheAcquisitionDate": { "xbrltype": "perShareItemType", "nsuri": "http://www.zimmerbiomet.com/20240331", "localname": "StockPriceAtTheAcquisitionDate", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/DisclosureAcquisitionsAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "verboseLabel": "Fair value of common stock at the settlement date", "documentation": "Stock price at the acquisition date.", "label": "Stock Price at the Acquisition Date", "terseLabel": "Fair value of common stock at the acquisition date" } } }, "auth_ref": [] }, "zbh_StockPriceAtTheSettlementDate": { "xbrltype": "perShareItemType", "nsuri": "http://www.zimmerbiomet.com/20240331", "localname": "StockPriceAtTheSettlementDate", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureFairValueMeasurementOfAssetsAndLiabilitiesAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair value of common stock at the settlement date", "label": "Stock Price At The Settlement Date", "documentation": "Stock price at the settlement date." } } }, "auth_ref": [] }, "us-gaap_StockRepurchasedDuringPeriodShares": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockRepurchasedDuringPeriodShares", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureFairValueMeasurementOfAssetsAndLiabilitiesAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Shares of common stock repurchased", "label": "Stock Repurchased During Period, Shares", "documentation": "Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock." } } }, "auth_ref": [ "r30", "r166", "r167", "r207", "r629", "r708", "r734" ] }, "us-gaap_StockholdersEquity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockholdersEquity", "crdr": "credit", "calculation": { "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited": { "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0, "order": 0.0 } }, "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureAccumulatedOtherComprehensiveIncomeChangesInComponentsOfAccumulatedOtherComprehensiveIncomeNetOfTaxDetail", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited" ], "lang": { "en-us": { "role": { "label": "Equity, Attributable to Parent", "periodEndLabel": "Stockholders equity, ending balance", "periodStartLabel": "Stockholders equity, beginning balance", "totalLabel": "Total Zimmer Biomet Holdings, Inc. stockholders' equity", "documentation": "Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest." } } }, "auth_ref": [ "r167", "r170", "r171", "r194", "r669", "r686", "r709", "r710", "r789", "r804", "r906", "r912", "r940", "r959" ] }, "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "crdr": "credit", "calculation": { "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited": { "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfStockholdersEquityUnaudited" ], "lang": { "en-us": { "role": { "label": "Equity, Including Portion Attributable to Noncontrolling Interest", "periodEndLabel": "Balance", "periodStartLabel": "Balance", "totalLabel": "Total Stockholders' Equity", "documentation": "Amount of equity (deficit) attributable to parent and noncontrolling interest. Excludes temporary equity." } } }, "auth_ref": [ "r113", "r114", "r115", "r239", "r240", "r277", "r291", "r292", "r293", "r295", "r303", "r358", "r361", "r437", "r484", "r485", "r486", "r495", "r496", "r530", "r531", "r532", "r533", "r534", "r535", "r538", "r560", "r562", "r567", "r571", "r613", "r614", "r632", "r669", "r686", "r709", "r710", "r736", "r803", "r906", "r912", "r940", "r959" ] }, "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited" ], "lang": { "en-us": { "role": { "label": "Equity, Including Portion Attributable to Noncontrolling Interest [Abstract]", "terseLabel": "Stockholders' Equity:" } } }, "auth_ref": [] }, "us-gaap_StockholdersEquityNoteSpinoffTransaction": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockholdersEquityNoteSpinoffTransaction", "crdr": "credit", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfStockholdersEquityUnaudited" ], "lang": { "en-us": { "role": { "label": "Stockholders' Equity Note, Spinoff Transaction", "terseLabel": "Spinoff of ZimVie Inc.", "documentation": "The change in equity as a result of a spin-off transaction (a regular or reverse spin-off) which is based on the recorded amounts." } } }, "auth_ref": [ "r102" ] }, "zbh_StockholdersEquitySpinOffPercentage": { "xbrltype": "percentItemType", "nsuri": "http://www.zimmerbiomet.com/20240331", "localname": "StockholdersEquitySpinOffPercentage", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureBasisOfPresentationAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "documentation": "Stockholders equity spin off percentage.", "label": "Stockholders Equity Spin Off Percentage", "terseLabel": "Spin-off percentage" } } }, "auth_ref": [] }, "us-gaap_SwissFederalTaxAdministrationFTAMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SwissFederalTaxAdministrationFTAMember", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Tax Reform and AHV Financing [Member]", "label": "Swiss Federal Tax Administration (FTA) [Member]", "documentation": "Designated tax department of the government of Switzerland." } } }, "auth_ref": [] }, "ecd_TabularListTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TabularListTableTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Tabular List [Table Text Block]", "terseLabel": "Tabular List, Table" } } }, "auth_ref": [ "r854" ] }, "zbh_ThreePointFiveFiveZeroPercentageMember": { "xbrltype": "domainItemType", "nsuri": "http://www.zimmerbiomet.com/20240331", "localname": "ThreePointFiveFiveZeroPercentageMember", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDebtSummaryOfDebtInstrumentsDetail", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDebtSummaryOfDebtInstrumentsParentheticalDetail" ], "lang": { "en-us": { "role": { "documentation": "Three Point Five Five Zero Percentage [Member]", "label": "Three Point Five Five Zero Percentage [Member]", "terseLabel": "3.550% [Member]" } } }, "auth_ref": [] }, "zbh_ThreePointOneFiveZeroPercentageMember": { "xbrltype": "domainItemType", "nsuri": "http://www.zimmerbiomet.com/20240331", "localname": "ThreePointOneFiveZeroPercentageMember", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDebtSummaryOfDebtInstrumentsDetail", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDebtSummaryOfDebtInstrumentsParentheticalDetail" ], "lang": { "en-us": { "role": { "documentation": "Three Point One Five Zero Percentage [Member]", "label": "Three Point One Five Zero Percentage [Member]", "terseLabel": "3.150% [Member]" } } }, "auth_ref": [] }, "zbh_ThreePointOneFiveZeroPercentageSeniorNotesDue2022Member": { "xbrltype": "domainItemType", "nsuri": "http://www.zimmerbiomet.com/20240331", "localname": "ThreePointOneFiveZeroPercentageSeniorNotesDue2022Member", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/DisclosureDiscontinuedOperationsAndRelatedZimvieMattersAdditionalInformationDetails", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDebtAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "documentation": "3.150% Senior notes due 2022.", "label": "Three Point One Five Zero Percentage Senior Notes Due2022 [Member]", "terseLabel": "3.150% Senior Notes Due 2022" } } }, "auth_ref": [] }, "zbh_ThreePointSevenZeroPercentageMember": { "xbrltype": "domainItemType", "nsuri": "http://www.zimmerbiomet.com/20240331", "localname": "ThreePointSevenZeroPercentageMember", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDebtSummaryOfDebtInstrumentsDetail", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDebtSummaryOfDebtInstrumentsParentheticalDetail" ], "lang": { "en-us": { "role": { "documentation": "Three point seven zero percentage.", "label": "Three Point Seven Zero Percentage [Member]", "verboseLabel": "3.700% Senior Notes due 2023", "terseLabel": "3.700% [Member]" } } }, "auth_ref": [] }, "zbh_ThreePointSevenZeroPercentageSeniorNotesDue2023Member": { "xbrltype": "domainItemType", "nsuri": "http://www.zimmerbiomet.com/20240331", "localname": "ThreePointSevenZeroPercentageSeniorNotesDue2023Member", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDebtAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "documentation": "Three Point seven zero Percentage Senior Notes Due 2023.", "label": "Three Point seven zero Percentage Senior Notes Due 2023 [Member]", "terseLabel": "3.700% Senior Notes due 2023" } } }, "auth_ref": [] }, "zbh_ThreePointZeroFiveZeroPercentageMember": { "xbrltype": "domainItemType", "nsuri": "http://www.zimmerbiomet.com/20240331", "localname": "ThreePointZeroFiveZeroPercentageMember", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDebtSummaryOfDebtInstrumentsDetail", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDebtSummaryOfDebtInstrumentsParentheticalDetail" ], "lang": { "en-us": { "role": { "documentation": "Three point zero five zero percentage member.", "label": "Three Point Zero Five Zero Percentage [Member]", "terseLabel": "3.050% [Member]" } } }, "auth_ref": [] }, "ecd_TotalShareholderRtnAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TotalShareholderRtnAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Total Shareholder Return Amount", "terseLabel": "Total Shareholder Return Amount" } } }, "auth_ref": [ "r846" ] }, "ecd_TotalShareholderRtnVsPeerGroupTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TotalShareholderRtnVsPeerGroupTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Total Shareholder Return Vs Peer Group [Text Block]", "terseLabel": "Total Shareholder Return Vs Peer Group" } } }, "auth_ref": [ "r853" ] }, "us-gaap_TrademarksAndTradeNamesMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TrademarksAndTradeNamesMember", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/DisclosureAcquisitionsAdditionalInformationDetail", "http://www.zimmerbiomet.com/20240331/taxonomy/role/DisclosureAcquisitionsSummaryOfEstimatesOfFairValueOfAssetsAcquiredAndLiabilitiesAssumedDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Trademarks And Trade Names [Member]", "label": "Trademarks and Trade Names [Member]", "documentation": "Rights acquired through registration of a trademark to gain or protect exclusive use of a business name, symbol or other device or style, or rights either acquired through registration of a business name to gain or protect exclusive use thereof." } } }, "auth_ref": [ "r109" ] }, "ecd_TradingArrAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TradingArrAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Trading Arrangement [Axis]", "terseLabel": "Trading Arrangement:" } } }, "auth_ref": [ "r873" ] }, "ecd_TradingArrByIndTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TradingArrByIndTable", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Trading Arrangements, by Individual [Table]", "terseLabel": "Trading Arrangements, by Individual" } } }, "auth_ref": [ "r875" ] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "TradingSymbol", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Trading Symbol", "terseLabel": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "us-gaap_TransferOfInvestments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TransferOfInvestments", "crdr": "credit", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/DisclosureDiscontinuedOperationsAndRelatedZimvieMattersAdditionalInformationDetails", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDebtAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Transfer from Investments", "terseLabel": "Noncash financing activity", "documentation": "Value of investments transferred from the entity's investments in noncash transactions." } } }, "auth_ref": [ "r68", "r69", "r70" ] }, "us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax", "crdr": "credit", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesEffectsOfFairValueCashFlowAndNetInvestmentHedgeAccountingOnCondensedConsolidatedStatementsOfEarningsDetail", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesNetInvestmentHedgeGainsLossesRecognizedOnCondensedConsolidatedStatementsOfComprehensiveIncomeDetail" ], "lang": { "en-us": { "role": { "verboseLabel": "Amount of Gain (Loss) Recognized in AOCI", "label": "Gain (Loss) on Derivative Used in Net Investment Hedge, after Tax", "terseLabel": "Gain on net investment hedging relationships", "documentation": "Amount, after tax, of reclassification from accumulated other comprehensive income (AOCI) of gain (loss) from increase (decrease) in fair value of net investment hedge." } } }, "auth_ref": [ "r224", "r524" ] }, "ecd_TrdArrAdoptionDate": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TrdArrAdoptionDate", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Trading Arrangement Adoption Date", "terseLabel": "Adoption Date" } } }, "auth_ref": [ "r876" ] }, "ecd_TrdArrDuration": { "xbrltype": "durationItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TrdArrDuration", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Trading Arrangement Duration", "terseLabel": "Arrangement Duration" } } }, "auth_ref": [ "r877" ] }, "ecd_TrdArrIndName": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TrdArrIndName", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Trading Arrangement, Individual Name", "terseLabel": "Name" } } }, "auth_ref": [ "r875" ] }, "ecd_TrdArrIndTitle": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TrdArrIndTitle", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Trading Arrangement, Individual Title", "terseLabel": "Title" } } }, "auth_ref": [ "r875" ] }, "ecd_TrdArrSecuritiesAggAvailAmt": { "xbrltype": "sharesItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TrdArrSecuritiesAggAvailAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Trading Arrangement, Securities Aggregate Available Amount", "terseLabel": "Aggregate Available" } } }, "auth_ref": [ "r878" ] }, "ecd_TrdArrTerminationDate": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TrdArrTerminationDate", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Trading Arrangement Termination Date", "terseLabel": "Termination Date" } } }, "auth_ref": [ "r876" ] }, "us-gaap_TreasuryStockCommonMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TreasuryStockCommonMember", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfStockholdersEquityUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Treasury Shares [Member]", "label": "Treasury Stock, Common [Member]", "documentation": "Previously issued common shares repurchased by the issuing entity and held in treasury." } } }, "auth_ref": [ "r100" ] }, "us-gaap_TreasuryStockCommonShares": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TreasuryStockCommonShares", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnauditedParenthetical" ], "lang": { "en-us": { "role": { "terseLabel": "Treasury stock, shares", "label": "Treasury Stock, Common, Shares", "documentation": "Number of previously issued common shares repurchased by the issuing entity and held in treasury." } } }, "auth_ref": [ "r100" ] }, "us-gaap_TreasuryStockSharesAcquired": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TreasuryStockSharesAcquired", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureFairValueMeasurementOfAssetsAndLiabilitiesAdditionalInformationDetails", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfStockholdersEquityUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Shares of common stock repurchased", "label": "Treasury Stock, Shares, Acquired", "negatedLabel": "Share repurchases, Shares", "documentation": "Number of shares that have been repurchased during the period and are being held in treasury." } } }, "auth_ref": [ "r30", "r167", "r207" ] }, "us-gaap_TreasuryStockValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TreasuryStockValue", "crdr": "debit", "calculation": { "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited": { "parentTag": "us-gaap_StockholdersEquity", "weight": -1.0, "order": 4.0 } }, "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited" ], "lang": { "en-us": { "role": { "negatedLabel": "Treasury stock, 111.5 million shares as of March 31, 2024 (110.6 million as of December 31, 2023)", "label": "Treasury Stock, Value", "totalLabel": "Treasury Stock, Value, Total", "periodStartLabel": "Treasury Stock, Value, Beginning Balance", "periodEndLabel": "Treasury Stock, Value, Ending Balance", "terseLabel": "Treasury stock, 106.9 million shares (104.8 million shares in 2022)", "documentation": "The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury." } } }, "auth_ref": [ "r56", "r100", "r101" ] }, "us-gaap_TreasuryStockValueAcquiredCostMethod": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TreasuryStockValueAcquiredCostMethod", "crdr": "debit", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfStockholdersEquityUnaudited" ], "lang": { "en-us": { "role": { "label": "Treasury Stock, Value, Acquired, Cost Method", "negatedLabel": "Share repurchases", "documentation": "Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method." } } }, "auth_ref": [ "r30", "r100", "r207" ] }, "zbh_TwoPointFourTwoFivePercentageMember": { "xbrltype": "domainItemType", "nsuri": "http://www.zimmerbiomet.com/20240331", "localname": "TwoPointFourTwoFivePercentageMember", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDebtSummaryOfDebtInstrumentsDetail", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDebtSummaryOfDebtInstrumentsParentheticalDetail" ], "lang": { "en-us": { "role": { "documentation": "Two point four two five percentage.", "label": "Two Point Four Two Five Percentage [Member]", "terseLabel": "2.425% [Member]" } } }, "auth_ref": [] }, "zbh_TwoPointFourTwoFivePercentageNotesDueTwoThousandTwentySixMember": { "xbrltype": "domainItemType", "nsuri": "http://www.zimmerbiomet.com/20240331", "localname": "TwoPointFourTwoFivePercentageNotesDueTwoThousandTwentySixMember", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "documentation": "Two point four two five percentage notes due two thousand twenty six.", "label": "Two Point Four Two Five Percentage Notes Due Two Thousand Twenty Six [Member]", "terseLabel": "2.425% Notes due 2026 [Member]" } } }, "auth_ref": [] }, "zbh_TwoPointSixZeroPercentageMember": { "xbrltype": "domainItemType", "nsuri": "http://www.zimmerbiomet.com/20240331", "localname": "TwoPointSixZeroPercentageMember", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDebtSummaryOfDebtInstrumentsDetail", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDebtSummaryOfDebtInstrumentsParentheticalDetail" ], "lang": { "en-us": { "role": { "documentation": "Two point six zero percentage.", "label": "Two Point Six Zero Percentage [Member]", "terseLabel": "2.600% [Member]" } } }, "auth_ref": [] }, "zbh_TwoThousandAndTwentyTwoFiveYearCreditAgreementMember": { "xbrltype": "domainItemType", "nsuri": "http://www.zimmerbiomet.com/20240331", "localname": "TwoThousandAndTwentyTwoFiveYearCreditAgreementMember", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDebtSummaryOfDebtInstrumentsDetail" ], "lang": { "en-us": { "role": { "documentation": "Two thousand and twenty two five-year credit agreement member.", "label": "Two Thousand and Twenty Two Five-Year Credit Agreement [Member]", "terseLabel": "2022 Five-Year Credit Agreement [Member]" } } }, "auth_ref": [] }, "zbh_TwoThousandFortyFiveMember": { "xbrltype": "domainItemType", "nsuri": "http://www.zimmerbiomet.com/20240331", "localname": "TwoThousandFortyFiveMember", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDebtSummaryOfDebtInstrumentsDetail", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDebtSummaryOfDebtInstrumentsParentheticalDetail", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "documentation": "Two Thousand Forty Five [Member]", "label": "Two Thousand Forty Five [Member]", "terseLabel": "Due in 2045 [Member]" } } }, "auth_ref": [] }, "zbh_TwoThousandNineteenCreditAgreementMember": { "xbrltype": "domainItemType", "nsuri": "http://www.zimmerbiomet.com/20240331", "localname": "TwoThousandNineteenCreditAgreementMember", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDebtAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "documentation": "Two Thousand Nineteen Credit Agreement", "label": "Two Thousand Nineteen Credit Agreement [Member]", "terseLabel": "2019 Credit Agreement [Member]" } } }, "auth_ref": [] }, "zbh_TwoThousandNineteenRestructuringPlanMember": { "xbrltype": "domainItemType", "nsuri": "http://www.zimmerbiomet.com/20240331", "localname": "TwoThousandNineteenRestructuringPlanMember", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/DisclosureRestructuringSummaryOfLocationOnCondensedConsolidatedStatementOfEarningsAndTypeOfCostForRestructuringPlanDetail", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureRestructuringAdditionalInformationDetail", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureRestructuringSummaryOfLiabilitiesRecognizedRelatedToRestructuringPlanDetail" ], "lang": { "en-us": { "role": { "documentation": "Two thousand nineteen restructuring plan.", "label": "Two Thousand Nineteen Restructuring Plan [Member]", "terseLabel": "2019 Restructuring Plan [Member]" } } }, "auth_ref": [] }, "zbh_TwoThousandThirtyFiveMember": { "xbrltype": "domainItemType", "nsuri": "http://www.zimmerbiomet.com/20240331", "localname": "TwoThousandThirtyFiveMember", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDebtSummaryOfDebtInstrumentsDetail", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDebtSummaryOfDebtInstrumentsParentheticalDetail" ], "lang": { "en-us": { "role": { "documentation": "Two Thousand Thirty Five [Member]", "label": "Two Thousand Thirty Five [Member]", "terseLabel": "Due in 2035 [Member]" } } }, "auth_ref": [] }, "zbh_TwoThousandThirtyMember": { "xbrltype": "domainItemType", "nsuri": "http://www.zimmerbiomet.com/20240331", "localname": "TwoThousandThirtyMember", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDebtSummaryOfDebtInstrumentsDetail", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDebtSummaryOfDebtInstrumentsParentheticalDetail" ], "lang": { "en-us": { "role": { "documentation": "Two thousand thirty member.", "label": "Two Thousand Thirty [Member]", "terseLabel": "Due in 2030 [Member]" } } }, "auth_ref": [] }, "zbh_TwoThousandThirtyNineMember": { "xbrltype": "domainItemType", "nsuri": "http://www.zimmerbiomet.com/20240331", "localname": "TwoThousandThirtyNineMember", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDebtSummaryOfDebtInstrumentsDetail", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDebtSummaryOfDebtInstrumentsParentheticalDetail" ], "lang": { "en-us": { "role": { "documentation": "Two Thousand Thirty Nine [Member]", "label": "Two Thousand Thirty Nine [Member]", "terseLabel": "Due in 2039 [Member]" } } }, "auth_ref": [] }, "zbh_TwoThousandThirtyOneMember": { "xbrltype": "domainItemType", "nsuri": "http://www.zimmerbiomet.com/20240331", "localname": "TwoThousandThirtyOneMember", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDebtSummaryOfDebtInstrumentsDetail", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDebtSummaryOfDebtInstrumentsParentheticalDetail" ], "lang": { "en-us": { "role": { "documentation": "Two thousand thirty one.", "label": "Two Thousand Thirty One [Member]", "terseLabel": "Due in 2031 [Member]" } } }, "auth_ref": [] }, "zbh_TwoThousandTwentyEightMember": { "xbrltype": "domainItemType", "nsuri": "http://www.zimmerbiomet.com/20240331", "localname": "TwoThousandTwentyEightMember", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDebtSummaryOfDebtInstrumentsDetail", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDebtSummaryOfDebtInstrumentsParentheticalDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Due in 2028 [Member]", "label": "Two Thousand Twenty Eight [Member]", "documentation": "Two thousand twenty eight." } } }, "auth_ref": [] }, "zbh_TwoThousandTwentyFiveMember": { "xbrltype": "domainItemType", "nsuri": "http://www.zimmerbiomet.com/20240331", "localname": "TwoThousandTwentyFiveMember", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDebtSummaryOfDebtInstrumentsDetail", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDebtSummaryOfDebtInstrumentsParentheticalDetail" ], "lang": { "en-us": { "role": { "documentation": "Two Thousand Twenty Five [Member]", "label": "Two Thousand Twenty Five [Member]", "terseLabel": "Due in 2025 [Member]" } } }, "auth_ref": [] }, "zbh_TwoThousandTwentyFourMember": { "xbrltype": "domainItemType", "nsuri": "http://www.zimmerbiomet.com/20240331", "localname": "TwoThousandTwentyFourMember", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDebtSummaryOfDebtInstrumentsDetail", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDebtSummaryOfDebtInstrumentsParentheticalDetail" ], "lang": { "en-us": { "role": { "documentation": "Two thousand twenty four.", "label": "Two Thousand Twenty Four [Member]", "terseLabel": "Due in 2024 [Member]" } } }, "auth_ref": [] }, "zbh_TwoThousandTwentyOneFiveYearCreditAgreementMember": { "xbrltype": "domainItemType", "nsuri": "http://www.zimmerbiomet.com/20240331", "localname": "TwoThousandTwentyOneFiveYearCreditAgreementMember", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDebtAdditionalInformationDetail", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDebtSummaryOfDebtInstrumentsDetail" ], "lang": { "en-us": { "role": { "documentation": "Two Thousand Twenty One Five-Year Credit Agreement [Member].", "label": "Two Thousand Twenty One Five Year Credit Agreement [Member]", "terseLabel": "2021 Five-Year Credit Agreement [Member]" } } }, "auth_ref": [] }, "zbh_TwoThousandTwentyOneMember": { "xbrltype": "domainItemType", "nsuri": "http://www.zimmerbiomet.com/20240331", "localname": "TwoThousandTwentyOneMember", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDebtAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "documentation": "Two Thousand Twenty One [Member]", "label": "Two Thousand Twenty One [Member]", "terseLabel": "Due in 2021 [Member]" } } }, "auth_ref": [] }, "zbh_TwoThousandTwentyOneRestructuringPlanMember": { "xbrltype": "domainItemType", "nsuri": "http://www.zimmerbiomet.com/20240331", "localname": "TwoThousandTwentyOneRestructuringPlanMember", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureRestructuringAdditionalInformationDetail", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureRestructuringSummaryOfLiabilitiesRecognizedRelatedToRestructuringPlanDetail" ], "lang": { "en-us": { "role": { "documentation": "Two thousand twenty one restructuring plan.", "label": "Two Thousand Twenty One Restructuring Plan [Member]", "terseLabel": "2021 Restructuring Plan [Member]" } } }, "auth_ref": [] }, "zbh_TwoThousandTwentyOneThreeSixtyFourDayRevolvingCreditAgreementMember": { "xbrltype": "domainItemType", "nsuri": "http://www.zimmerbiomet.com/20240331", "localname": "TwoThousandTwentyOneThreeSixtyFourDayRevolvingCreditAgreementMember", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDebtAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "documentation": "Two thousand twenty one three sixty four day-revolving credit agreement member.", "label": "Two Thousand Twenty One Three Sixty Four Day Revolving Credit Agreement [Member]", "terseLabel": "2021 364-Day Revolving Credit Agreement [Member]" } } }, "auth_ref": [] }, "zbh_TwoThousandTwentySevenMember": { "xbrltype": "domainItemType", "nsuri": "http://www.zimmerbiomet.com/20240331", "localname": "TwoThousandTwentySevenMember", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDebtSummaryOfDebtInstrumentsDetail", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDebtSummaryOfDebtInstrumentsParentheticalDetail" ], "lang": { "en-us": { "role": { "documentation": "Two thousand twenty seven.", "label": "Two Thousand Twenty Seven [Member]", "terseLabel": "Due in 2027 [Member]" } } }, "auth_ref": [] }, "zbh_TwoThousandTwentySixMember": { "xbrltype": "domainItemType", "nsuri": "http://www.zimmerbiomet.com/20240331", "localname": "TwoThousandTwentySixMember", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDebtSummaryOfDebtInstrumentsDetail", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDebtSummaryOfDebtInstrumentsParentheticalDetail" ], "lang": { "en-us": { "role": { "documentation": "Two thousand twenty six.", "label": "Two Thousand Twenty Six [Member]", "terseLabel": "Due in 2026 [Member]" } } }, "auth_ref": [] }, "zbh_TwoThousandTwentyThreeAcquisitionsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.zimmerbiomet.com/20240331", "localname": "TwoThousandTwentyThreeAcquisitionsMember", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/DisclosureAcquisitionsAdditionalInformationDetail", "http://www.zimmerbiomet.com/20240331/taxonomy/role/DisclosureAcquisitionsSummaryOfEstimatesOfFairValueOfAssetsAcquiredAndLiabilitiesAssumedDetails", "http://www.zimmerbiomet.com/20240331/taxonomy/role/DisclosureAcquisitionsTables" ], "lang": { "en-us": { "role": { "terseLabel": "2023 Acquisitions [Member]", "label": "Two Thousand Twenty Three Acquisitions Member", "documentation": "2023 acquisition." } } }, "auth_ref": [] }, "zbh_TwoThousandTwentyThreeFiveYearCreditAgreementMember": { "xbrltype": "domainItemType", "nsuri": "http://www.zimmerbiomet.com/20240331", "localname": "TwoThousandTwentyThreeFiveYearCreditAgreementMember", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDebtAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "terseLabel": "2023 Five-Year Credit Agreement [Member]", "label": "Two Thousand Twenty Three Five Year Credit Agreement [Member]", "documentation": "Two Thousand Twenty Three Five Year Credit Agreement." } } }, "auth_ref": [] }, "zbh_TwoThousandTwentyThreeFiveYearRevolvingFacilityMember": { "xbrltype": "domainItemType", "nsuri": "http://www.zimmerbiomet.com/20240331", "localname": "TwoThousandTwentyThreeFiveYearRevolvingFacilityMember", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDebtAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "documentation": "Two thousand twenty three five year revolving facility.", "label": "Two Thousand Twenty Three Five Year Revolving Facility [Member]", "terseLabel": "2023 Five-Year Revolving Facility" } } }, "auth_ref": [] }, "zbh_TwoThousandTwentyThreeMember": { "xbrltype": "domainItemType", "nsuri": "http://www.zimmerbiomet.com/20240331", "localname": "TwoThousandTwentyThreeMember", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDebtAdditionalInformationDetail", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDebtSummaryOfDebtInstrumentsDetail", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDebtSummaryOfDebtInstrumentsParentheticalDetail" ], "lang": { "en-us": { "role": { "documentation": "Two thousand twenty three.", "label": "Two Thousand Twenty Three [Member]", "terseLabel": "Due in 2023 [Member]", "verboseLabel": "Due in 2023 [Member]" } } }, "auth_ref": [] }, "zbh_TwoThousandTwentyThreeRestructuringPlanMember": { "xbrltype": "domainItemType", "nsuri": "http://www.zimmerbiomet.com/20240331", "localname": "TwoThousandTwentyThreeRestructuringPlanMember", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureRestructuringAdditionalInformationDetail", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureRestructuringSummaryOfLiabilitiesRecognizedRelatedToRestructuringPlanDetail" ], "lang": { "en-us": { "role": { "terseLabel": "2023 Restructuring Plan [Member]", "label": "Two Thousand Twenty Three Restructuring Plan [Member]", "documentation": "Two thousand twenty three restructuring plan." } } }, "auth_ref": [] }, "zbh_TwoThousandTwentyThreeThreeSixtyFourDayRevolvingCreditAgreementMember": { "xbrltype": "domainItemType", "nsuri": "http://www.zimmerbiomet.com/20240331", "localname": "TwoThousandTwentyThreeThreeSixtyFourDayRevolvingCreditAgreementMember", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDebtAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "terseLabel": "2023 364-Day Revolving Credit Agreement [Member]", "label": "Two Thousand Twenty Three Three Sixty Four Day Revolving Credit Agreement [Member]", "documentation": "Two Thousand Twenty Three Three Sixty Four Day Revolving Credit Agreement ." } } }, "auth_ref": [] }, "zbh_TwoThousandTwentyTwoFiveYearCreditAgreementMember": { "xbrltype": "domainItemType", "nsuri": "http://www.zimmerbiomet.com/20240331", "localname": "TwoThousandTwentyTwoFiveYearCreditAgreementMember", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDebtAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "terseLabel": "2022 Five-Year Credit Agreement [Member]", "label": "Two Thousand Twenty Two Five-Year Credit Agreement [Member]", "documentation": "Two thousand twenty two five-year credit agreement." } } }, "auth_ref": [] }, "zbh_TwoThousandTwentyTwoFiveYearRevolvingFacilityMember": { "xbrltype": "domainItemType", "nsuri": "http://www.zimmerbiomet.com/20240331", "localname": "TwoThousandTwentyTwoFiveYearRevolvingFacilityMember", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDebtAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "documentation": "2022 five-year revolving facility member.", "label": "Two Thousand Twenty Two Five-Year Revolving Facility [Member]", "terseLabel": "2022 Five-Year Revolving Facility" } } }, "auth_ref": [] }, "zbh_TwoThousandTwentyTwoMember": { "xbrltype": "domainItemType", "nsuri": "http://www.zimmerbiomet.com/20240331", "localname": "TwoThousandTwentyTwoMember", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDebtAdditionalInformationDetail", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDebtSummaryOfDebtInstrumentsDetail", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDebtSummaryOfDebtInstrumentsParentheticalDetail" ], "lang": { "en-us": { "role": { "documentation": "Two Thousand Twenty Two [Member]", "label": "Two Thousand Twenty Two [Member]", "terseLabel": "Due in 2022 [Member]" } } }, "auth_ref": [] }, "zbh_TwoThousandTwentyTwoThreeSixtyFourDayRevolvingCreditAgreementMember": { "xbrltype": "domainItemType", "nsuri": "http://www.zimmerbiomet.com/20240331", "localname": "TwoThousandTwentyTwoThreeSixtyFourDayRevolvingCreditAgreementMember", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDebtAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "terseLabel": "2022 364-Day Revolving Credit Agreement [Member]", "label": "Two thousand twenty two three sixty four-day revolving credit agreement member", "documentation": "Two thousand twenty two three sixty four-day revolving credit agreement." } } }, "auth_ref": [] }, "us-gaap_TypeOfArrangementAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TypeOfArrangementAxis", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/DisclosureDiscontinuedOperationsAndRelatedZimvieMattersAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]", "documentation": "Information by collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations." } } }, "auth_ref": [ "r512" ] }, "us-gaap_TypeOfCostGoodOrServiceExtensibleList": { "xbrltype": "enumerationSetItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TypeOfCostGoodOrServiceExtensibleList", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/DisclosureRestructuringSummaryOfLocationOnCondensedConsolidatedStatementOfEarningsAndTypeOfCostForRestructuringPlanDetail", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureAccumulatedOtherComprehensiveIncomeReclassificationAdjustmentsFromAccumulatedOtherComprehensiveIncomeDetail", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfEarningsUnaudited" ], "lang": { "en-us": { "role": { "label": "Cost, Product and Service [Extensible Enumeration]", "terseLabel": "Type of Cost, Good or Service [Extensible List]", "documentation": "Indicates type of cost from product sold and service rendered." } } }, "auth_ref": [ "r930" ] }, "us-gaap_TypeOfRestructuringDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TypeOfRestructuringDomain", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/DisclosureRestructuringSummaryOfLocationOnCondensedConsolidatedStatementOfEarningsAndTypeOfCostForRestructuringPlanDetail", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureBasisOfPresentationAdditionalInformationDetails", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureFairValueMeasurementOfAssetsAndLiabilitiesAdditionalInformationDetails", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureRestructuringSummaryOfLiabilitiesRecognizedRelatedToRestructuringPlanDetail", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureSignificantAccountingPoliciesAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Type of Restructuring [Domain]", "terseLabel": "Type of Restructuring", "documentation": "Identification of the types of restructuring costs." } } }, "auth_ref": [ "r371", "r372", "r377", "r378" ] }, "us-gaap_TypeOfRevenueExtensibleList": { "xbrltype": "enumerationSetItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TypeOfRevenueExtensibleList", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfEarningsUnaudited" ], "lang": { "en-us": { "role": { "label": "Revenue, Product and Service [Extensible Enumeration]", "terseLabel": "Type of Revenue [Extensible List]", "documentation": "Indicates type of revenue from product and service. Includes, but is not limited to, revenue from contract with customer and other sources." } } }, "auth_ref": [] }, "country_US": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/country/2023", "localname": "US", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureRevenueScheduleOfNetSalesByGeographyDetail" ], "lang": { "en-us": { "role": { "label": "UNITED STATES", "terseLabel": "US [Member]" } } }, "auth_ref": [] }, "currency_USD": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/currency/2023", "localname": "USD", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "United States of America, Dollars", "terseLabel": "U.S. Dollars [Member]" } } }, "auth_ref": [] }, "zbh_UncommittedCreditFacilityMember": { "xbrltype": "domainItemType", "nsuri": "http://www.zimmerbiomet.com/20240331", "localname": "UncommittedCreditFacilityMember", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDebtAdditionalInformationDetail", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDebtSummaryOfDebtInstrumentsDetail" ], "lang": { "en-us": { "role": { "documentation": "Uncommitted credit facility.", "label": "Uncommitted Credit Facility [Member]" } } }, "auth_ref": [] }, "ecd_UndrlygSecurityMktPriceChngPct": { "xbrltype": "pureItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "UndrlygSecurityMktPriceChngPct", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Underlying Security Market Price Change, Percent", "terseLabel": "Underlying Security Market Price Change" } } }, "auth_ref": [ "r872" ] }, "us-gaap_UnrealizedGainLossOnDerivatives": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "UnrealizedGainLossOnDerivatives", "crdr": "credit", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/DisclosureDiscontinuedOperationsAndRelatedZimvieMattersAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Unrealized gain", "label": "Unrealized Gain (Loss) on Derivatives", "documentation": "The net change in the difference between the fair value and the carrying value, or in the comparative fair values, of derivative instruments, including options, swaps, futures, and forward contracts, held at each balance sheet date, that was included in earnings for the period." } } }, "auth_ref": [ "r22", "r701", "r702", "r703", "r704", "r722" ] }, "us-gaap_UnsecuredLongTermDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "UnsecuredLongTermDebt", "crdr": "credit", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDebtAdditionalInformationDetail", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDebtSummaryOfDebtInstrumentsDetail" ], "lang": { "en-us": { "role": { "label": "Unsecured Long-Term Debt, Noncurrent", "terseLabel": "Term loan", "verboseLabel": "Term loan", "documentation": "Carrying value as of the balance sheet date of uncollateralized debt obligation (with maturities initially due after one year or beyond the operating cycle if longer), excluding current portion." } } }, "auth_ref": [ "r53" ] }, "us-gaap_UseOfEstimates": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "UseOfEstimates", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Use of Estimates, Policy [Policy Text Block]", "terseLabel": "Use of Estimates", "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles." } } }, "auth_ref": [ "r75", "r76", "r77", "r227", "r228", "r230", "r231" ] }, "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "WeightedAverageNumberOfDilutedSharesOutstanding", "calculation": { "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureEarningsPerShareReconciliationOfWeightedAverageSharesForBasicAndDilutedSharesComputationsDetail": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureEarningsPerShareReconciliationOfWeightedAverageSharesForBasicAndDilutedSharesComputationsDetail", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfEarningsUnaudited" ], "lang": { "en-us": { "role": { "label": "Weighted Average Number of Shares Outstanding, Diluted", "terseLabel": "Diluted", "totalLabel": "Weighted average shares outstanding for diluted net earnings per share", "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period." } } }, "auth_ref": [ "r310", "r320" ] }, "us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "WeightedAverageNumberOfSharesOutstandingAbstract", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfEarningsUnaudited" ], "lang": { "en-us": { "role": { "label": "Weighted Average Number of Shares Outstanding, Diluted [Abstract]", "terseLabel": "Weighted Average Common Shares Outstanding" } } }, "auth_ref": [] }, "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "WeightedAverageNumberOfSharesOutstandingBasic", "calculation": { "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureEarningsPerShareReconciliationOfWeightedAverageSharesForBasicAndDilutedSharesComputationsDetail": { "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding", "weight": 1.0, "order": 0.0 } }, "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureEarningsPerShareReconciliationOfWeightedAverageSharesForBasicAndDilutedSharesComputationsDetail", "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfEarningsUnaudited" ], "lang": { "en-us": { "role": { "label": "Weighted Average Number of Shares Outstanding, Basic", "terseLabel": "Basic", "verboseLabel": "Weighted average shares outstanding for basic net earnings per share", "totalLabel": "Weighted Average Number of Shares Outstanding, Basic, Total", "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period." } } }, "auth_ref": [ "r308", "r320" ] }, "zbh_ZimVieTermLoanMaximumBorrowingCapacity": { "xbrltype": "monetaryItemType", "nsuri": "http://www.zimmerbiomet.com/20240331", "localname": "ZimVieTermLoanMaximumBorrowingCapacity", "crdr": "credit", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/DisclosureDiscontinuedOperationsAndRelatedZimvieMattersAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "documentation": "ZimVie term loan maximum borrowing capacity.", "label": "Zim Vie Term Loan Maximum Borrowing Capacity", "terseLabel": "ZimVie term loan credit agreement" } } }, "auth_ref": [] }, "zbh_ZimVieToZimmerBiometMember": { "xbrltype": "domainItemType", "nsuri": "http://www.zimmerbiomet.com/20240331", "localname": "ZimVieToZimmerBiometMember", "presentation": [ "http://www.zimmerbiomet.com/20240331/taxonomy/role/Role_DisclosureDebtAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "documentation": "ZimVie to Zimmer Biomet.", "label": "Zim Vie To Zimmer Biomet [Member]", "terseLabel": "ZimVie to Zimmer Biomet" } } }, "auth_ref": [] } } } }, "std_ref": { "r0": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "25", "Paragraph": "1", "SubTopic": "20", "Topic": "940", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481913/940-20-25-1" }, "r1": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "25", "Paragraph": "6", "SubTopic": "10", "Topic": "805", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479405/805-10-25-6" }, "r2": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "25", "Paragraph": "7", "SubTopic": "10", "Topic": "805", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479405/805-10-25-7" }, "r3": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "30", "Paragraph": "7", "SubTopic": "30", "Topic": "805", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479637/805-30-30-7" }, "r4": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "30", "Paragraph": "8", "SubTopic": "30", "Topic": "805", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479637/805-30-30-8" }, "r5": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "1", "Subparagraph": "(b)", "SubTopic": "30", "Topic": "805", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479613/805-30-35-1" }, "r6": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "SubTopic": "230", "Topic": "830", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481877/830-230-45-1" }, "r7": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10", "SubTopic": "20", "Topic": "205", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483475/205-20-45-10" }, "r8": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "SubTopic": "10", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A" }, "r9": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A" }, "r10": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "Subparagraph": "(a),(b),(c)", "SubTopic": "10", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A" }, "r11": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "Subparagraph": "(a-c)", "SubTopic": "10", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A" }, "r12": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "Subparagraph": "(d)", "SubTopic": "10", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A" }, "r13": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "Subparagraph": "(i),(j),(k)", "SubTopic": "10", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A" }, "r14": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "Subparagraph": "(i-k)", "SubTopic": "10", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A" }, "r15": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "11", "SubTopic": "10", "Topic": "360", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482130/360-10-45-11" }, "r16": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "12", "SubTopic": "10", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-12" }, "r17": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "14", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-14" }, "r18": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "15", "SubTopic": "10", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-15" }, "r19": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "15", "Subparagraph": "(f)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15" }, "r20": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "SubTopic": "10", "Topic": "810", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-20" }, "r21": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r22": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(b)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r23": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "SubTopic": "10", "Topic": "360", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1" }, "r24": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "SubTopic": "20", "Topic": "205", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-1" }, "r25": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "SubTopic": "30", "Topic": "805", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479581/805-30-50-1" }, "r26": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "SubTopic": "30", "Topic": "815", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480870/815-30-50-1" }, "r27": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15", "Subparagraph": "(e)", "SubTopic": "10", "Topic": "740", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-15" }, "r28": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(c)(3)", "SubTopic": "10", "Topic": "810", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A" }, "r29": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(c),(3)", "SubTopic": "10", "Topic": "810", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A" }, "r30": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "SubTopic": "10", "Topic": "505", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2" }, "r31": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "SubTopic": "10", "Topic": "815", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-2" }, "r32": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "SubTopic": "10", "Topic": "805", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479328/805-10-50-2" }, "r33": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "SubTopic": "10", "Topic": "820", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r34": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2A", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "718", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2A" }, "r35": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "SubTopic": "10", "Topic": "360", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-3" }, "r36": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "e", "SubTopic": "470", "Topic": "942", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480848/942-470-50-3" }, "r37": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "41", "Subparagraph": "a", "SubTopic": "10", "Topic": "280", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41" }, "r38": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4D", "Subparagraph": "(b)", "SubTopic": "10", "Topic": "815", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4D" }, "r39": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4D", "Subparagraph": "(c)(2)", "SubTopic": "20", "Topic": "860", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4D" }, "r40": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "15", "SubTopic": "10", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482739/220-10-55-15" }, "r41": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "44", "SubTopic": "20", "Topic": "805", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479876/805-20-55-44" }, "r42": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(22))", "SubTopic": "10", "Topic": "210", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r43": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "205", "SubTopic": "20", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-3" }, "r44": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483489/210-10-50-1" }, "r45": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.19(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r46": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.19(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r47": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.19(b),22(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r48": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.19)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r49": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.19-26)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r50": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.20)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r51": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.21)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r52": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.22(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r53": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.22)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r54": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.24)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r55": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.25)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r56": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.29,30)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r57": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.29-31)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r58": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.31)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r59": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "220", "SubTopic": "10", "Section": "45", "Paragraph": "14", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-14" }, "r60": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "220", "SubTopic": "10", "Section": "45", "Paragraph": "14A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-14A" }, "r61": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "220", "SubTopic": "10", "Section": "45", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-5" }, "r62": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "13", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13" }, "r63": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "14", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-14" }, "r64": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15" }, "r65": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "15", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15" }, "r66": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "15", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15" }, "r67": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-4" }, "r68": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-3" }, "r69": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-4" }, "r70": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-5" }, "r71": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "250", "SubTopic": "10", "Section": "50", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7" }, "r72": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "250", "SubTopic": "10", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-8" }, "r73": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "250", "SubTopic": "10", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-9" }, "r74": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "260", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1" }, "r75": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-4" }, "r76": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-8" }, "r77": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-9" }, "r78": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "280", "SubTopic": "10", "Section": "50", "Paragraph": "22", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r79": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "280", "SubTopic": "10", "Section": "50", "Paragraph": "25", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-25" }, "r80": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "280", "SubTopic": "10", "Section": "50", "Paragraph": "30", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r81": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "280", "SubTopic": "10", "Section": "50", "Paragraph": "31", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-31" }, "r82": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "280", "SubTopic": "10", "Section": "50", "Paragraph": "40", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-40" }, "r83": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "20", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r84": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "30", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482686/350-30-45-1" }, "r85": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "30", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482686/350-30-45-2" }, "r86": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "30", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1" }, "r87": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "30", "Section": "50", "Paragraph": "2", "Subparagraph": "((a)(1),(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r88": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "30", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r89": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "30", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r90": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "360", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1" }, "r91": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "420", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1" }, "r92": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "420", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1" }, "r93": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "420", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB TOPIC 5.P.3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479823/420-10-S99-1" }, "r94": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "420", "SubTopic": "10", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB TOPIC 5.P.4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479823/420-10-S99-2" }, "r95": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "420", "SubTopic": "10", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 5.P.4(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479823/420-10-S99-2" }, "r96": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "470", "SubTopic": "10", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481544/470-10-50-5" }, "r97": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "470", "SubTopic": "50", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481244/470-50-50-1" }, "r98": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-3" }, "r99": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-8" }, "r100": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "30", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481549/505-30-45-1" }, "r101": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "30", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481520/505-30-50-4" }, "r102": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "60", "Section": "25", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481423/505-60-25-2" }, "r103": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r104": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "740", "SubTopic": "10", "Section": "50", "Paragraph": "15", "Subparagraph": "(d)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-15" }, "r105": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479328/805-10-50-2" }, "r106": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479328/805-10-50-3" }, "r107": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "10", "Section": "55", "Paragraph": "37", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479303/805-10-55-37" }, "r108": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "20", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479907/805-20-50-1" }, "r109": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "20", "Section": "55", "Paragraph": "14", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479876/805-20-55-14" }, "r110": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "20", "Section": "55", "Paragraph": "20", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479876/805-20-55-20" }, "r111": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "30", "Section": "25", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479668/805-30-25-5" }, "r112": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "30", "Section": "25", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479668/805-30-25-6" }, "r113": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "45", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-15" }, "r114": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "45", "Paragraph": "16", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-16" }, "r115": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "55", "Paragraph": "4I", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4I" }, "r116": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-2" }, "r117": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-2" }, "r118": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4A" }, "r119": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4A" }, "r120": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4A", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4A" }, "r121": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4B", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4B" }, "r122": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4B", "Subparagraph": "(a),(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4B" }, "r123": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4B", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4B" }, "r124": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4B" }, "r125": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4C", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4C" }, "r126": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4C", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4C" }, "r127": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4C", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4C" }, "r128": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4C", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4C" }, "r129": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4C", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4C" }, "r130": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4D", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4D" }, "r131": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "55", "Paragraph": "182", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480401/815-10-55-182" }, "r132": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "25", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480238/815-25-50-1" }, "r133": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "30", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480870/815-30-50-1" }, "r134": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "820", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r135": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "820", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r136": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "820", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-3" }, "r137": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "835", "SubTopic": "30", "Section": "45", "Paragraph": "1A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-1A" }, "r138": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "835", "SubTopic": "30", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-2" }, "r139": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "835", "SubTopic": "30", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-3" }, "r140": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "835", "SubTopic": "30", "Section": "55", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482949/835-30-55-8" }, "r141": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "942", "SubTopic": "210", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03.17)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r142": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "942", "SubTopic": "470", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480848/942-470-50-3" }, "r143": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//205/tableOfContent" }, "r144": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//205-20/tableOfContent" }, "r145": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483475/205-20-45-11" }, "r146": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483475/205-20-45-3" }, "r147": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483475/205-20-45-3A" }, "r148": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3B", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483475/205-20-45-3B" }, "r149": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483475/205-20-45-4" }, "r150": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-1" }, "r151": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-3A" }, "r152": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-4A" }, "r153": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4B", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-4B" }, "r154": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-5A" }, "r155": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5B", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-5B" }, "r156": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-5B" }, "r157": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5B", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-5B" }, "r158": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5B", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-5B" }, "r159": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5C", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-5C" }, "r160": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5C", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-5C" }, "r161": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5D", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-5D" }, "r162": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-7" }, "r163": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r164": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(20))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r165": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(24))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r166": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(28))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r167": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(29))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r168": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r169": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r170": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r171": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(31))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r172": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(32))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r173": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r174": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r175": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r176": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483466/210-20-50-3" }, "r177": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483444/210-20-55-7" }, "r178": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//220/tableOfContent" }, "r179": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Paragraph": "1", "Section": "45", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1" }, "r180": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-11" }, "r181": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(10))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r182": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(14))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r183": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(20))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r184": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r185": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.2(a),(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r186": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r187": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.7(c),9(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r188": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.9)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r189": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "13", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13" }, "r190": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24" }, "r191": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25" }, "r192": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r193": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "235", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//235/tableOfContent" }, "r194": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 4.E)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480418/310-10-S99-2" }, "r195": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "330", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 5.BB)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480581/330-10-S99-2" }, "r196": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1" }, "r197": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r198": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "360", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//360/tableOfContent" }, "r199": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482130/360-10-45-9" }, "r200": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1" }, "r201": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-3" }, "r202": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-3A" }, "r203": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "440", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//440/tableOfContent" }, "r204": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "470", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//470/tableOfContent" }, "r205": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-6" }, "r206": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-7" }, "r207": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.3-04)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1" }, "r208": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "805", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//805/tableOfContent" }, "r209": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Paragraph": "1", "Section": "50", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479907/805-20-50-1" }, "r210": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "38", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479876/805-20-55-38" }, "r211": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "805", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479581/805-30-50-1" }, "r212": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "810", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//810/tableOfContent" }, "r213": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "19", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-19" }, "r214": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "815", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//815/tableOfContent" }, "r215": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(11))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r216": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(13))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r217": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(15)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r218": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(16))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r219": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r220": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r221": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(15))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r222": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r223": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04.10)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r224": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "Subparagraph": "(b)", "SubTopic": "10", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A" }, "r225": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Subparagraph": "(a)", "SubTopic": "20", "Topic": "740", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482659/740-20-45-2" }, "r226": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "SubTopic": "210", "Topic": "946", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480555/946-210-45-20" }, "r227": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1" }, "r228": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1" }, "r229": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "SubTopic": "360", "Topic": "958", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480321/958-360-50-1" }, "r230": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-11" }, "r231": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-12" }, "r232": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4C", "Subparagraph": "(c)", "SubTopic": "10", "Topic": "815", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4C" }, "r233": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "SubTopic": "360", "Topic": "958", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480321/958-360-50-6" }, "r234": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "SubTopic": "360", "Topic": "958", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480321/958-360-50-7" }, "r235": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(h))", "SubTopic": "10", "Topic": "235", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r236": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.22(a)(2))", "SubTopic": "10", "Topic": "210", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r237": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Topic": "606", "Publisher": "FASB", "URI": "https://asc.fasb.org//606/tableOfContent" }, "r238": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "(a)", "Publisher": "SEC" }, "r239": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "105", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6" }, "r240": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "105", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6" }, "r241": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5C", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-5C" }, "r242": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-7" }, "r243": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1" }, "r244": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-5" }, "r245": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r246": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(13))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r247": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(14))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r248": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(15))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r249": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(17))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r250": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(18))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r251": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r252": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(20))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r253": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(21))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r254": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r255": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(27)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r256": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(28))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r257": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(29))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r258": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30)(a)(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r259": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r260": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r261": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483466/210-20-50-3" }, "r262": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483466/210-20-50-3" }, "r263": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483466/210-20-50-4" }, "r264": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483444/210-20-55-10" }, "r265": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A" }, "r266": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-11" }, "r267": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-12" }, "r268": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "14A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-14A" }, "r269": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-15" }, "r270": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "17A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-17A" }, "r271": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A" }, "r272": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1A", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A" }, "r273": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1A", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A" }, "r274": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1B" }, "r275": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1B", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1B" }, "r276": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-4" }, "r277": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-5" }, "r278": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-6" }, "r279": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(21))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r280": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(24))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r281": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(25))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r282": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5", "Subparagraph": "(SAB Topic 6.B)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-5" }, "r283": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-2" }, "r284": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24" }, "r285": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-8" }, "r286": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-1" }, "r287": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r288": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r289": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(h)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r290": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-04(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-3" }, "r291": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "23", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23" }, "r292": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24" }, "r293": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5" }, "r294": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1" }, "r295": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1" }, "r296": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11" }, "r297": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11" }, "r298": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-12" }, "r299": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-3" }, "r300": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-4" }, "r301": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7" }, "r302": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7" }, "r303": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7" }, "r304": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-8" }, "r305": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-9" }, "r306": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5", "Subparagraph": "(SAB Topic 11.M.Q2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480530/250-10-S99-5" }, "r307": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//260/tableOfContent" }, "r308": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-10" }, "r309": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-11" }, "r310": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "16", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-16" }, "r311": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-2" }, "r312": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "22", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-22" }, "r313": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "23", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-23" }, "r314": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-28A" }, "r315": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-3" }, "r316": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "60B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B" }, "r317": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "60B", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B" }, "r318": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "60B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B" }, "r319": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-7" }, "r320": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1" }, "r321": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1" }, "r322": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-2" }, "r323": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-3" }, "r324": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-15" }, "r325": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "272", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483014/272-10-45-1" }, "r326": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "272", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482987/272-10-50-1" }, "r327": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "272", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482987/272-10-50-3" }, "r328": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//280/tableOfContent" }, "r329": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-15" }, "r330": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "21", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-21" }, "r331": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "21", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-21" }, "r332": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r333": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r334": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r335": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r336": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r337": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "26", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-26" }, "r338": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r339": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r340": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r341": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r342": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "31", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-31" }, "r343": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r344": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r345": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r346": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r347": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r348": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r349": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "34", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-34" }, "r350": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "40", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-40" }, "r351": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "41", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41" }, "r352": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "41", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41" }, "r353": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "41", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41" }, "r354": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "42", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-42" }, "r355": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481990/310-10-45-2" }, "r356": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481990/310-10-45-9" }, "r357": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3" }, "r358": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "4", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4" }, "r359": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "4", "Subparagraph": "(e)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4" }, "r360": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "4", "Subparagraph": "(e)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4" }, "r361": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "5", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-5" }, "r362": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "330", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//330/tableOfContent" }, "r363": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482598/350-20-45-1" }, "r364": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1" }, "r365": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1" }, "r366": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r367": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r368": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-3" }, "r369": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//420/tableOfContent" }, "r370": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1" }, "r371": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1" }, "r372": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1" }, "r373": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1" }, "r374": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1" }, "r375": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1" }, "r376": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB TOPIC 5.P.4(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479823/420-10-S99-2" }, "r377": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 5.P.4(b)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479823/420-10-S99-2" }, "r378": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 5.P.4(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479823/420-10-S99-2" }, "r379": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 5.P.4(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479823/420-10-S99-2" }, "r380": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 5.P.4(e))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479823/420-10-S99-2" }, "r381": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "440", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482648/440-10-50-4" }, "r382": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "440", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482648/440-10-50-4" }, "r383": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-1" }, "r384": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-4" }, "r385": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-9" }, "r386": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 5.Y.Q2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1" }, "r387": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 5.Y.Q4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1" }, "r388": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "460", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482425/460-10-50-3" }, "r389": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r390": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r391": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(B))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r392": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r393": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r394": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r395": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r396": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r397": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r398": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r399": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(C))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r400": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r401": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r402": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r403": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r404": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r405": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r406": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r407": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r408": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r409": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r410": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r411": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1C", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1C" }, "r412": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1C", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1C" }, "r413": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1C", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1C" }, "r414": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1D", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D" }, "r415": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1D", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D" }, "r416": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1D", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D" }, "r417": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1E", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E" }, "r418": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1E", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E" }, "r419": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1E", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E" }, "r420": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1E", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E" }, "r421": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1F", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F" }, "r422": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1F", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F" }, "r423": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1F", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F" }, "r424": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1F", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F" }, "r425": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1I", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I" }, "r426": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1I", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I" }, "r427": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1I", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I" }, "r428": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1I", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I" }, "r429": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-4" }, "r430": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-4" }, "r431": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-4" }, "r432": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r433": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r434": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r435": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14" }, "r436": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2" }, "r437": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.3-04)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1" }, "r438": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-10" }, "r439": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-12" }, "r440": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-12" }, "r441": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-12" }, "r442": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-12" }, "r443": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-12" }, "r444": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-13" }, "r445": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-15" }, "r446": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-4" }, "r447": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-5" }, "r448": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-9" }, "r449": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r450": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r451": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r452": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(02)(A)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r453": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(02)(B)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r454": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(02)(C)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r455": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r456": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-5" }, "r457": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480454/718-10-45-1" }, "r458": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r459": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r460": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r461": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r462": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r463": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r464": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r465": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r466": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r467": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r468": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(04)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r469": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r470": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r471": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r472": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r473": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r474": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r475": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r476": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r477": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r478": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r479": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r480": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r481": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r482": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r483": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(v)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r484": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "15", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15" }, "r485": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "15", "Subparagraph": "(f)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15" }, "r486": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "15", "Subparagraph": "(f)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15" }, "r487": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//740/tableOfContent" }, "r488": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-4" }, "r489": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-6" }, "r490": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-10" }, "r491": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-12" }, "r492": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-14" }, "r493": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "17", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-17" }, "r494": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "21", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-21" }, "r495": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "8", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8" }, "r496": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "8", "Subparagraph": "(d)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8" }, "r497": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB TOPIC 6.I.5.Q1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1" }, "r498": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB TOPIC 6.I.7)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1" }, "r499": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 6.I.Fact.4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1" }, "r500": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 11.C)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-2" }, "r501": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "11", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482659/740-20-45-11" }, "r502": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482659/740-20-45-2" }, "r503": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482659/740-20-45-2" }, "r504": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "270", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482551/740-270-45-3" }, "r505": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "270", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482526/740-270-50-1" }, "r506": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482603/740-30-50-2" }, "r507": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479907/805-20-50-5" }, "r508": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479907/805-20-50-5" }, "r509": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479581/805-30-50-1" }, "r510": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479581/805-30-50-1" }, "r511": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479581/805-30-50-1" }, "r512": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "808", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479402/808-10-50-1" }, "r513": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "19", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-19" }, "r514": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25" }, "r515": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25" }, "r516": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A" }, "r517": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A" }, "r518": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(c)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A" }, "r519": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3" }, "r520": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3" }, "r521": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4A" }, "r522": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4A", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4A" }, "r523": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4C", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4C" }, "r524": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4CCC", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4CCC" }, "r525": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4D", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4D" }, "r526": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4E", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4E" }, "r527": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4EE", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4EE" }, "r528": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5C", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-5C" }, "r529": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480627/815-20-45-3" }, "r530": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r531": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r532": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r533": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r534": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r535": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(i)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r536": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480237/815-40-50-5" }, "r537": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r538": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r539": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r540": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r541": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r542": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r543": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r544": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(bbb)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r545": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(bbb)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r546": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r547": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-3" }, "r548": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-6A" }, "r549": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482736/825-10-45-1A" }, "r550": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-10" }, "r551": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28" }, "r552": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "17", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481839/830-10-45-17" }, "r553": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481839/830-10-45-9" }, "r554": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482014/830-20-35-1" }, "r555": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482014/830-20-35-3" }, "r556": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481956/830-20-45-1" }, "r557": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481956/830-20-45-5" }, "r558": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481926/830-20-50-1" }, "r559": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-12" }, "r560": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "17", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-17" }, "r561": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r562": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r563": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r564": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r565": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r566": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "21", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-21" }, "r567": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481674/830-30-50-1" }, "r568": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "835", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482900/835-30-50-1" }, "r569": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "5", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479832/842-10-65-5" }, "r570": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "848", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(a)(3)(iii)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2" }, "r571": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "848", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(a)(3)(iii)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2" }, "r572": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r573": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r574": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r575": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r576": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "910", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482546/910-10-50-6" }, "r577": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "924", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 11.L)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479941/924-10-S99-1" }, "r578": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "926", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483154/926-20-50-5" }, "r579": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "928", "SubTopic": "340", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483147/928-340-50-1" }, "r580": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(10)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r581": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r582": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(26))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r583": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(27))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r584": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-05(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479557/942-235-S99-1" }, "r585": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480842/942-360-50-1" }, "r586": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(12))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r587": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(15)(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r588": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r589": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r590": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r591": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r592": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r593": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(24))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r594": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(25))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r595": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(8)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r596": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(8))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r597": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(11))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r598": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(12))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r599": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(16))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r600": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(18))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r601": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r602": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r603": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r604": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r605": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column A))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2" }, "r606": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column B))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2" }, "r607": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column C))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2" }, "r608": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column D))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2" }, "r609": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column E))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2" }, "r610": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column F))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2" }, "r611": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7A", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-7A" }, "r612": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r613": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(f)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r614": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(f)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r615": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r616": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r617": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r618": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r619": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(2)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r620": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(h)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r621": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(h)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r622": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480424/946-10-50-1" }, "r623": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480424/946-10-50-2" }, "r624": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480424/946-10-50-3" }, "r625": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r626": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(i)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r627": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(i)(2)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r628": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(i)(2)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r629": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(i)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r630": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-11" }, "r631": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-13" }, "r632": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-3" }, "r633": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-3" }, "r634": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4" }, "r635": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-2" }, "r636": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "27", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-27" }, "r637": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7" }, "r638": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7" }, "r639": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7" }, "r640": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7" }, "r641": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7" }, "r642": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7" }, "r643": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7" }, "r644": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7" }, "r645": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "21", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480555/946-210-45-21" }, "r646": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480555/946-210-45-4" }, "r647": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1" }, "r648": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1" }, "r649": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1" }, "r650": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1" }, "r651": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-12" }, "r652": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-2" }, "r653": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r654": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r655": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r656": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r657": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r658": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r659": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r660": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r661": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r662": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(13)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r663": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(13)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r664": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(13)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r665": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(14))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r666": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(15))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r667": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(16)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r668": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(17))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r669": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r670": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(2)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r671": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(2)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r672": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r673": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r674": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r675": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r676": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r677": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r678": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r679": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(e))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r680": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(8))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r681": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r682": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r683": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r684": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(e))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r685": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.6-05(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2" }, "r686": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.6-05(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2" }, "r687": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-3" }, "r688": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-7" }, "r689": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483580/946-220-50-3" }, "r690": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r691": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r692": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(g)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r693": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r694": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r695": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r696": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r697": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r698": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r699": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r700": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r701": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r702": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r703": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r704": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r705": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r706": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r707": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(1)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r708": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(4)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r709": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r710": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r711": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r712": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column C)(Footnote 5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r713": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2" }, "r714": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-12A(Column C)(Footnote 4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2" }, "r715": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r716": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r717": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r718": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5", "Subparagraph": "(SX 210.12-13(Column A)(Footnote 3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5" }, "r719": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5", "Subparagraph": "(SX 210.12-13(Column G)(Footnote 8))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5" }, "r720": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5", "Subparagraph": "(SX 210.12-13(Column G))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5" }, "r721": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5A", "Subparagraph": "(SX 210.12-13A(Column E))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5A" }, "r722": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5A", "Subparagraph": "(SX 210.12-13A(Column F))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5A" }, "r723": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5B", "Subparagraph": "(SX 210.12-13B(Column A))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5B" }, "r724": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5B", "Subparagraph": "(SX 210.12-13B(Column B))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5B" }, "r725": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5B", "Subparagraph": "(SX 210.12-13B(Column E)(Footnote 4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5B" }, "r726": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5B", "Subparagraph": "(SX 210.12-13B(Column E))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5B" }, "r727": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5C", "Subparagraph": "(SX 210.12-13C(Column H)(Footnote 7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5C" }, "r728": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5C", "Subparagraph": "(SX 210.12-13C(Column H))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5C" }, "r729": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r730": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column F)(Footnote 7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r731": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-1" }, "r732": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2" }, "r733": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2" }, "r734": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2" }, "r735": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2" }, "r736": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-3" }, "r737": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "948", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-29(Footnote 4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479851/948-310-S99-1" }, "r738": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "954", "SubTopic": "440", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480327/954-440-50-1" }, "r739": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column B))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r740": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column C))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r741": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column D))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r742": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column E))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r743": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column F))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r744": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column G))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r745": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column H))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r746": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column I))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r747": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r748": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "976", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482856/976-310-50-1" }, "r749": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "978", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482707/978-310-50-1" }, "r750": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4D", "Subparagraph": "(a)(1)", "SubTopic": "10", "Topic": "815", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4D" }, "r751": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "13H", "Subparagraph": "(a)", "SubTopic": "40", "Topic": "944", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-13H" }, "r752": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "13H", "Subparagraph": "(b)", "SubTopic": "40", "Topic": "944", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-13H" }, "r753": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1" }, "r754": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1" }, "r755": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1" }, "r756": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(g)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1" }, "r757": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r758": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r759": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6)(a)(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r760": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "22", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483444/210-20-55-22" }, "r761": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482739/220-10-55-15" }, "r762": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "52", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-52" }, "r763": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r764": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "31", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-31" }, "r765": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "12A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481933/310-10-55-12A" }, "r766": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "340", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "05", "Paragraph": "5", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482955/340-10-05-5" }, "r767": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482548/350-20-55-24" }, "r768": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1" }, "r769": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1" }, "r770": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 5.P.4(b)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479823/420-10-S99-2" }, "r771": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 5.P.4(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479823/420-10-S99-2" }, "r772": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r773": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69B", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69B" }, "r774": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69C", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69C" }, "r775": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69E", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69E" }, "r776": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69F", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69F" }, "r777": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r778": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91" }, "r779": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91" }, "r780": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r781": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r782": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "17", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480482/715-20-55-17" }, "r783": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-11" }, "r784": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-6" }, "r785": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480547/715-80-55-8" }, "r786": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "4J", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4J" }, "r787": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "4K", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4K" }, "r788": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4D", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4D" }, "r789": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481372/852-10-55-10" }, "r790": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "944", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479401/944-30-55-2" }, "r791": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "29F", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-29F" }, "r792": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1" }, "r793": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r794": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480493/946-210-55-1" }, "r795": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480833/946-310-45-1" }, "r796": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r797": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2" }, "r798": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r799": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5C", "Subparagraph": "(SX 210.12-13C(Column A)(Footnote 1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5C" }, "r800": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5C", "Subparagraph": "(SX 210.12-13C(Column B)(Footnote 1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5C" }, "r801": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r802": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-10" }, "r803": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-11" }, "r804": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-12" }, "r805": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r806": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r807": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r808": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-Q", "Number": "240", "Section": "308", "Subsection": "a" }, "r809": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "16", "Subsection": "J", "Paragraph": "a" }, "r810": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1" }, "r811": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i" }, "r812": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "A" }, "r813": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "B" }, "r814": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "C" }, "r815": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "D" }, "r816": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "E" }, "r817": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "ii" }, "r818": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "iii" }, "r819": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "2" }, "r820": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Subsection": "F", "Paragraph": "1", "Subparagraph": "ii", "Section": "6" }, "r821": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a" }, "r822": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1" }, "r823": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "i" }, "r824": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "ii" }, "r825": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "iii" }, "r826": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "iv" }, "r827": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "v" }, "r828": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "2" }, "r829": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "3" }, "r830": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "b" }, "r831": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a" }, "r832": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1" }, "r833": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "i" }, "r834": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "ii" }, "r835": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "iii" }, "r836": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "iv" }, "r837": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "v" }, "r838": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "2" }, "r839": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "3" }, "r840": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "b" }, "r841": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Section": "13", "Subsection": "a-1" }, "r842": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v" }, "r843": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "1" }, "r844": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "ii" }, "r845": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iii" }, "r846": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iv" }, "r847": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "vi" }, "r848": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "3" }, "r849": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "4" }, "r850": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "5", "Subparagraph": "i" }, "r851": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "5", "Subparagraph": "ii" }, "r852": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "5", "Subparagraph": "iii" }, "r853": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "5", "Subparagraph": "iv" }, "r854": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "6" }, "r855": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "6", "Subparagraph": "i" }, "r856": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1" }, "r857": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i" }, "r858": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "A" }, "r859": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "B" }, "r860": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "C" }, "r861": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "D" }, "r862": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "E" }, "r863": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "ii" }, "r864": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "iii" }, "r865": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "2" }, "r866": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "1" }, "r867": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2" }, "r868": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "A" }, "r869": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "C" }, "r870": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "D" }, "r871": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "E" }, "r872": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "F" }, "r873": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a" }, "r874": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "1" }, "r875": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "2", "Subparagraph": "A" }, "r876": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "2", "Subparagraph": "B" }, "r877": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "2", "Subparagraph": "C" }, "r878": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "2", "Subparagraph": "D" }, "r879": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "b", "Paragraph": "1" }, "r880": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-T", "Number": "232", "Section": "405" }, "r881": { "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r882": { "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef", "Topic": "272", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483014/272-10-45-3" }, "r883": { "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-10" }, "r884": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "12", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-12" }, "r885": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "15", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15" }, "r886": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(2)", "SubTopic": "10", "Topic": "250", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1" }, "r887": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(3)", "SubTopic": "10", "Topic": "250", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1" }, "r888": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "250", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11" }, "r889": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(b)", "SubTopic": "10", "Topic": "250", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11" }, "r890": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "SubTopic": "10", "Topic": "250", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-3" }, "r891": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4CC", "SubTopic": "10", "Topic": "815", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4CC" }, "r892": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4H", "SubTopic": "40", "Topic": "944", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-4H" }, "r893": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "SubTopic": "10", "Topic": "250", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-8" }, "r894": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "SubTopic": "10", "Topic": "250", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-9" }, "r895": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r896": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r897": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-4" }, "r898": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-5" }, "r899": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-6" }, "r900": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13" }, "r901": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "14", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-14" }, "r902": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "15", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15" }, "r903": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "17", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-17" }, "r904": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r905": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(f))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r906": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r907": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "23", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23" }, "r908": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24" }, "r909": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5" }, "r910": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "55", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-55" }, "r911": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-18" }, "r912": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3" }, "r913": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "340", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483032/340-10-45-1" }, "r914": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r915": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r916": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "410", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481931/410-30-50-10" }, "r917": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1" }, "r918": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 5.P.4(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479823/420-10-S99-2" }, "r919": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "450", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//450/tableOfContent" }, "r920": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-1" }, "r921": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-4" }, "r922": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-4" }, "r923": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-9" }, "r924": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-9" }, "r925": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 5.Y.Q2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1" }, "r926": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r927": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r928": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r929": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-5" }, "r930": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91" }, "r931": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r932": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r933": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "730", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482916/730-10-50-1" }, "r934": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-12" }, "r935": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-1A" }, "r936": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-1B" }, "r937": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4D", "Subparagraph": "(a)(6)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4D" }, "r938": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r939": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(bbb)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r940": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28" }, "r941": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "830", "SubTopic": "230", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481877/830-230-45-1" }, "r942": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r943": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481674/830-30-50-1" }, "r944": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479424/830-30-S99-1" }, "r945": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7" }, "r946": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7" }, "r947": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r948": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r949": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r950": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4" }, "r951": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4" }, "r952": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4" }, "r953": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(16)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r954": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(16)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r955": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(12))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r956": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479432/944-30-50-2B" }, "r957": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4" }, "r958": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r959": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(4)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r960": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r961": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r962": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2" }, "r963": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r964": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" } } } ZIP 87 0000950170-24-052097-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0000950170-24-052097-xbrl.zip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�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end XML 89 zbh-20240331_htm.xml IDEA: XBRL DOCUMENT 0001136869 zbh:HipsMember 2023-01-01 2023-03-31 0001136869 zbh:UncommittedCreditFacilityMember 2023-12-31 0001136869 us-gaap:OtherCurrentAssetsMember us-gaap:ForeignExchangeForwardMember us-gaap:DesignatedAsHedgingInstrumentMember 2023-12-31 0001136869 zbh:ShortTermTermLoanMember 2023-01-01 2023-03-31 0001136869 us-gaap:LandMember 2024-03-31 0001136869 srt:MaximumMember us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember 2024-03-31 0001136869 us-gaap:ForeignExchangeForwardMember us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2023-01-01 2023-03-31 0001136869 zbh:FivePointThreeFiveZeroPercentageMember zbh:TwoThousandTwentyEightMember us-gaap:SeniorNotesMember 2023-12-31 0001136869 us-gaap:CostOfSalesMember 2023-01-01 2023-03-31 0001136869 zbh:ThreePointFiveFiveZeroPercentageMember zbh:TwoThousandThirtyMember us-gaap:SeniorNotesMember 2023-12-31 0001136869 us-gaap:CashFlowHedgingMember 2023-01-01 2023-03-31 0001136869 us-gaap:CostOfSalesMember 2024-03-31 0001136869 us-gaap:InterestRateSwapMember us-gaap:InterestExpenseMember 2023-01-01 2023-03-31 0001136869 zbh:CorporateItemsMember 2024-01-01 2024-03-31 0001136869 srt:MaximumMember zbh:AprilAcquisitionMember 2023-04-28 0001136869 2024-03-31 0001136869 country:US 2023-01-01 2023-03-31 0001136869 zbh:AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditAndUnrecognizedActuarialGainLossMember us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2024-01-01 2024-03-31 0001136869 us-gaap:ForeignExchangeForwardMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:DesignatedAsHedgingInstrumentMember 2023-12-31 0001136869 zbh:OthersCountriesMember 2024-01-01 2024-03-31 0001136869 zbh:OnePointFourFiveZeroPercentageMember zbh:TwoThousandTwentyFourMember us-gaap:SeniorNotesMember 2024-03-31 0001136869 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-03-31 0001136869 us-gaap:NondesignatedMember 2023-12-31 0001136869 zbh:EmbodyIncMember 2023-02-14 2023-02-14 0001136869 us-gaap:CashFlowHedgingMember 2023-12-31 0001136869 country:US 2024-01-01 2024-03-31 0001136869 us-gaap:CommonStockMember 2023-03-31 0001136869 zbh:FourPointFourFiveZeroPercentageMember zbh:TwoThousandFortyFiveMember us-gaap:SeniorNotesMember 2023-12-31 0001136869 srt:AmericasMember 2023-01-01 2023-03-31 0001136869 zbh:CashFlowHedgesOneMember 2023-12-31 0001136869 us-gaap:AdditionalPaidInCapitalMember 2023-03-31 0001136869 zbh:OnePointOneSixFourPercentageMember zbh:TwoThousandTwentySevenMember zbh:EuroNotesMember 2024-03-31 0001136869 us-gaap:OtherLiabilitiesMember us-gaap:InterestRateSwapMember us-gaap:DesignatedAsHedgingInstrumentMember 2023-12-31 0001136869 us-gaap:OtherRestructuringMember zbh:TwoThousandTwentyOneRestructuringPlanMember 2023-12-31 0001136869 us-gaap:FairValueMeasurementsRecurringMember 2024-03-31 0001136869 us-gaap:ForeignExchangeForwardMember us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2024-01-01 2024-03-31 0001136869 zbh:CumulativeFairValueHedgingAdjustmentCarryingAmountOfHedgedLiabilitiesMember zbh:LongTermDebtNoncurrentMember 2023-12-31 0001136869 us-gaap:CashFlowHedgingMember 2024-01-01 2024-03-31 0001136869 zbh:AprilAcquisitionMember 2023-04-28 2023-04-28 0001136869 zbh:EmployeeTerminationBenefitsMember zbh:TwoThousandTwentyThreeRestructuringPlanMember 2024-03-31 0001136869 us-gaap:OtherCurrentAssetsMember us-gaap:ForeignExchangeForwardMember us-gaap:NondesignatedMember 2024-03-31 0001136869 us-gaap:CustomerRelationshipsMember 2023-01-01 2023-12-31 0001136869 us-gaap:RetainedEarningsMember 2023-03-31 0001136869 zbh:CarryingAmountOfHedgedLiabilitiesMember 2023-12-31 0001136869 srt:MaximumMember zbh:OctoberTwoThousandTwentyThreeAcquisitionMember 2023-10-06 0001136869 us-gaap:OtherRestructuringMember zbh:TwoThousandTwentyOneRestructuringPlanMember 2024-03-31 0001136869 us-gaap:InterestRateSwapMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:DesignatedAsHedgingInstrumentMember 2024-03-31 0001136869 zbh:ThreePointZeroFiveZeroPercentageMember zbh:TwoThousandTwentySixMember us-gaap:SeniorNotesMember 2024-03-31 0001136869 zbh:TwoThousandTwentyThreeThreeSixtyFourDayRevolvingCreditAgreementMember 2024-01-01 2024-03-31 0001136869 us-gaap:TreasuryStockCommonMember 2023-01-01 2023-03-31 0001136869 zbh:EmbodyIncMember us-gaap:CommonStockMember 2023-02-14 2023-02-14 0001136869 srt:MaximumMember zbh:TwoThousandTwentyThreeFiveYearCreditAgreementMember 2024-03-31 0001136869 zbh:ThreePointSevenZeroPercentageSeniorNotesDue2023Member zbh:TwoThousandTwentyThreeMember us-gaap:SeniorNotesMember 2023-03-31 0001136869 srt:MinimumMember zbh:TwoThousandTwentyThreeThreeSixtyFourDayRevolvingCreditAgreementMember 2024-03-31 0001136869 zbh:TwoThousandTwentyTwoFiveYearCreditAgreementMember zbh:MultiCurrencyRevolvingFacilityMember 2022-08-19 2022-08-19 0001136869 us-gaap:CommonStockMember 2024-03-31 0001136869 us-gaap:OtherCurrentLiabilitiesMember us-gaap:ForeignExchangeForwardMember us-gaap:DesignatedAsHedgingInstrumentMember 2024-03-31 0001136869 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2023-01-01 2023-03-31 0001136869 zbh:OnePointFourFiveZeroPercentageMember zbh:TwoThousandTwentyFourMember us-gaap:SeniorNotesMember 2023-12-31 0001136869 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-01-01 2024-03-31 0001136869 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-12-31 0001136869 us-gaap:TreasuryStockCommonMember 2023-03-31 0001136869 zbh:EmployeeTerminationBenefitsMember zbh:TwoThousandTwentyOneRestructuringPlanMember 2023-12-31 0001136869 zbh:AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditAndUnrecognizedActuarialGainLossMember us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2023-01-01 2023-03-31 0001136869 zbh:EuroNotesMember 2023-01-01 2023-03-31 0001136869 zbh:OnePointOneSixFourPercentageNotesDueTwoThousandTwentySevenMember 2024-01-01 2024-03-31 0001136869 us-gaap:TrademarksAndTradeNamesMember 2023-01-01 2023-12-31 0001136869 us-gaap:InterestExpenseMember 2024-01-01 2024-03-31 0001136869 us-gaap:InterestRateSwapMember us-gaap:CashFlowHedgingMember 2023-01-01 2023-03-31 0001136869 zbh:EmbodyIncMember 2023-02-14 0001136869 us-gaap:OtherAssetsMember us-gaap:CrossCurrencyInterestRateContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2023-12-31 0001136869 us-gaap:RetainedEarningsMember 2023-01-01 2023-03-31 0001136869 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001136869 us-gaap:RetainedEarningsMember 2023-12-31 0001136869 us-gaap:ContractTerminationMember zbh:TwoThousandNineteenRestructuringPlanMember 2024-01-01 2024-03-31 0001136869 us-gaap:OtherAssetsMember us-gaap:CrossCurrencyInterestRateContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2024-03-31 0001136869 zbh:FourPointFourFiveZeroPercentageMember zbh:TwoThousandFortyFiveMember us-gaap:SeniorNotesMember 2024-01-01 2024-03-31 0001136869 zbh:TwoThousandTwentyThreeRestructuringPlanMember 2024-03-31 0001136869 zbh:TwoThousandTwentyThreeAcquisitionsMember us-gaap:TrademarksAndTradeNamesMember 2023-12-31 0001136869 us-gaap:NoncontrollingInterestMember 2024-01-01 2024-03-31 0001136869 zbh:ForwardStartingInterestRateSwapsMember us-gaap:CashFlowHedgingMember 2024-01-01 2024-03-31 0001136869 srt:MinimumMember zbh:TwoThousandTwentyTwoFiveYearCreditAgreementMember 2024-03-31 0001136869 us-gaap:ForeignExchangeForwardMember us-gaap:CashFlowHedgingMember 2023-01-01 2023-03-31 0001136869 zbh:UncommittedCreditFacilityMember 2023-08-28 0001136869 us-gaap:CashFlowHedgingMember 2024-03-31 0001136869 us-gaap:OtherRestructuringMember zbh:TwoThousandNineteenRestructuringPlanMember 2023-12-31 0001136869 us-gaap:CrossCurrencyInterestRateContractMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:DesignatedAsHedgingInstrumentMember 2023-12-31 0001136869 zbh:EmbodyIncMember us-gaap:CommonStockMember 2024-03-31 0001136869 zbh:TwoThousandTwentyThreeAcquisitionsMember 2024-01-01 2024-03-31 0001136869 us-gaap:OtherCurrentAssetsMember us-gaap:CrossCurrencyInterestRateContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2024-03-31 0001136869 zbh:TwoThousandTwentyThreeAcquisitionsMember us-gaap:DevelopedTechnologyRightsMember 2023-12-31 0001136869 us-gaap:CrossCurrencyInterestRateContractMember 2024-01-01 2024-03-31 0001136869 2022-12-31 0001136869 zbh:TwoPointFourTwoFivePercentageMember zbh:TwoThousandTwentySixMember zbh:EuroNotesMember 2023-12-31 0001136869 zbh:CorporateItemsMember 2023-01-01 2023-03-31 0001136869 zbh:TwoThousandTwentyOneRestructuringPlanMember 2024-03-31 0001136869 zbh:SETMember 2023-01-01 2023-03-31 0001136869 us-gaap:CrossCurrencyInterestRateContractMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:DesignatedAsHedgingInstrumentMember 2023-12-31 0001136869 zbh:FivePointThreeFiveZeroPercentageMember zbh:TwoThousandTwentyEightMember us-gaap:SeniorNotesMember 2024-03-31 0001136869 us-gaap:CommonStockMember 2023-01-01 2023-03-31 0001136869 zbh:ThreePointSevenZeroPercentageSeniorNotesDue2023Member zbh:TwoThousandTwentyThreeMember us-gaap:SeniorNotesMember 2023-01-01 2023-03-31 0001136869 us-gaap:FairValueMeasurementsRecurringMember 2023-12-31 0001136869 us-gaap:OperatingSegmentsMember srt:AsiaPacificMember 2023-01-01 2023-03-31 0001136869 zbh:FivePointSevenFiveZeroPercentageMember zbh:TwoThousandThirtyNineMember us-gaap:SeniorNotesMember 2024-03-31 0001136869 us-gaap:OperatingSegmentsMember us-gaap:EMEAMember 2024-01-01 2024-03-31 0001136869 zbh:TwoThousandTwentyThreeAcquisitionsMember us-gaap:InProcessResearchAndDevelopmentMember 2023-12-31 0001136869 2023-01-01 2023-12-31 0001136869 us-gaap:ForeignExchangeForwardMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:NondesignatedMember 2024-03-31 0001136869 zbh:OctoberTwoThousandTwentyThreeAcquisitionMember 2023-10-06 0001136869 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2023-12-31 0001136869 us-gaap:ConstructionInProgressMember 2023-12-31 0001136869 2023-03-31 0001136869 srt:MinimumMember zbh:TwoThousandTwentyThreeFiveYearCreditAgreementMember 2024-03-31 0001136869 zbh:KneesMember 2023-01-01 2023-03-31 0001136869 zbh:TwoThousandTwentyTwoFiveYearCreditAgreementMember zbh:MultiCurrencyRevolvingFacilityMember 2022-08-19 0001136869 us-gaap:ContractTerminationMember zbh:TwoThousandTwentyOneRestructuringPlanMember 2023-12-31 0001136869 us-gaap:OtherCurrentAssetsMember us-gaap:ForeignExchangeForwardMember us-gaap:NondesignatedMember 2023-12-31 0001136869 us-gaap:InterestExpenseMember 2024-03-31 0001136869 us-gaap:InterestRateSwapMember us-gaap:InterestExpenseMember 2024-01-01 2024-03-31 0001136869 zbh:UncommittedCreditFacilityMember 2024-03-31 0001136869 zbh:EuroNotesMember 2024-01-01 2024-03-31 0001136869 zbh:FourPointTwoFiveZeroPercentageMember zbh:TwoThousandThirtyFiveMember us-gaap:SeniorNotesMember 2024-03-31 0001136869 zbh:ThreePointFiveFiveZeroPercentageMember zbh:TwoThousandTwentyFiveMember us-gaap:SeniorNotesMember 2024-03-31 0001136869 us-gaap:AccumulatedTranslationAdjustmentMember 2024-01-01 2024-03-31 0001136869 us-gaap:OtherCurrentLiabilitiesMember us-gaap:ForeignExchangeForwardMember us-gaap:NondesignatedMember 2023-12-31 0001136869 us-gaap:CrossCurrencyInterestRateContractMember 2024-03-31 0001136869 zbh:TwoThousandTwentyOneRestructuringPlanMember 2024-01-01 2024-03-31 0001136869 zbh:TwoThousandNineteenRestructuringPlanMember 2019-12-31 0001136869 us-gaap:CommonStockMember 2023-12-31 0001136869 us-gaap:ForeignExchangeForwardMember us-gaap:CashFlowHedgingMember 2024-01-01 2024-03-31 0001136869 zbh:InstrumentsMember 2024-03-31 0001136869 us-gaap:InterestRateSwapMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:DesignatedAsHedgingInstrumentMember 2023-12-31 0001136869 zbh:EmployeeTerminationBenefitsMember zbh:TwoThousandTwentyOneRestructuringPlanMember 2024-03-31 0001136869 zbh:ForwardStartingInterestRateSwapsMember us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2023-01-01 2023-03-31 0001136869 us-gaap:CashMember zbh:ShortTermTermLoanMember 2023-01-01 2023-03-31 0001136869 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2024-01-01 2024-03-31 0001136869 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2024-01-01 2024-03-31 0001136869 zbh:TwoPointSixZeroPercentageMember zbh:TwoThousandThirtyOneMember us-gaap:SeniorNotesMember 2024-03-31 0001136869 zbh:FourPointTwoFiveZeroPercentageMember zbh:TwoThousandThirtyFiveMember us-gaap:SeniorNotesMember 2023-12-31 0001136869 us-gaap:DevelopedTechnologyRightsMember 2023-01-01 2023-12-31 0001136869 zbh:NovemberTwoThousandTwentyThreeAcquisitionMember 2023-11-15 2023-11-15 0001136869 zbh:HipsMember 2024-01-01 2024-03-31 0001136869 zbh:TwoThousandNineteenRestructuringPlanMember 2024-03-31 0001136869 us-gaap:OtherLiabilitiesMember us-gaap:CrossCurrencyInterestRateContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2023-12-31 0001136869 2024-04-22 0001136869 zbh:EmbodyIncMember us-gaap:CommonStockMember 2024-01-01 2024-03-31 0001136869 us-gaap:CommonStockMember 2024-01-01 2024-03-31 0001136869 zbh:OnePointOneSixFourPercentageMember zbh:TwoThousandTwentySevenMember zbh:EuroNotesMember 2023-12-31 0001136869 us-gaap:ForeignExchangeForwardMember us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2023-01-01 2023-03-31 0001136869 us-gaap:ContractTerminationMember zbh:TwoThousandTwentyThreeRestructuringPlanMember 2024-01-01 2024-03-31 0001136869 us-gaap:OperatingSegmentsMember srt:AsiaPacificMember 2024-01-01 2024-03-31 0001136869 zbh:TwoThousandTwentyThreeThreeSixtyFourDayRevolvingCreditAgreementMember 2024-03-31 0001136869 us-gaap:CostOfSalesMember 2024-01-01 2024-03-31 0001136869 2024-01-01 2024-03-31 0001136869 zbh:TwoPointFourTwoFivePercentageNotesDueTwoThousandTwentySixMember 2024-01-01 2024-03-31 0001136869 us-gaap:InterestRateSwapMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:DesignatedAsHedgingInstrumentMember 2023-12-31 0001136869 zbh:CrossCurrencyInterestRateContractMaturedMember 2023-01-01 2023-03-31 0001136869 us-gaap:TreasuryStockCommonMember 2022-12-31 0001136869 zbh:OthersCountriesMember 2023-01-01 2023-03-31 0001136869 srt:MaximumMember zbh:NovemberTwoThousandTwentyThreeAcquisitionMember 2023-11-15 0001136869 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2023-12-31 0001136869 2023-12-31 0001136869 zbh:EmbodyIncMember us-gaap:InProcessResearchAndDevelopmentMember 2023-03-31 0001136869 us-gaap:ForeignExchangeForwardMember us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2024-01-01 2024-03-31 0001136869 us-gaap:OtherAssetsMember us-gaap:ForeignExchangeForwardMember us-gaap:DesignatedAsHedgingInstrumentMember 2023-12-31 0001136869 us-gaap:OtherAssetsMember us-gaap:ForeignExchangeForwardMember us-gaap:DesignatedAsHedgingInstrumentMember 2024-03-31 0001136869 zbh:EmployeeTerminationBenefitsMember zbh:TwoThousandTwentyOneRestructuringPlanMember 2024-01-01 2024-03-31 0001136869 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2024-01-01 2024-03-31 0001136869 us-gaap:OtherLiabilitiesMember us-gaap:ForeignExchangeForwardMember us-gaap:DesignatedAsHedgingInstrumentMember 2023-12-31 0001136869 zbh:TwoThousandTwentyTwoThreeSixtyFourDayRevolvingCreditAgreementMember 2022-08-19 0001136869 zbh:BuildingsAndEquipmentMember 2023-12-31 0001136869 us-gaap:NoncontrollingInterestMember 2023-12-31 0001136869 zbh:TwoThousandNineteenRestructuringPlanMember 2024-01-01 2024-03-31 0001136869 zbh:FourPointFourFiveZeroPercentageMember zbh:TwoThousandFortyFiveMember us-gaap:SeniorNotesMember 2024-03-31 0001136869 us-gaap:OtherCurrentAssetsMember us-gaap:CrossCurrencyInterestRateContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2023-12-31 0001136869 zbh:EuroNotesMember 2024-03-31 0001136869 zbh:TwoThousandTwentyOneRestructuringPlanMember 2021-12-31 0001136869 zbh:TwoThousandTwentyOneRestructuringPlanMember 2023-12-31 0001136869 zbh:TwoPointSixZeroPercentageMember zbh:TwoThousandThirtyOneMember us-gaap:SeniorNotesMember 2023-12-31 0001136869 us-gaap:OtherCurrentLiabilitiesMember us-gaap:CrossCurrencyInterestRateContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2023-12-31 0001136869 zbh:CrossCurrencyInterestRateContractMaturedMember 2023-03-31 0001136869 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-03-31 0001136869 us-gaap:CommonStockMember 2022-12-31 0001136869 us-gaap:AccumulatedTranslationAdjustmentMember 2023-12-31 0001136869 us-gaap:ForeignExchangeForwardMember us-gaap:NondesignatedMember us-gaap:OtherNonoperatingIncomeExpenseMember 2023-01-01 2023-03-31 0001136869 us-gaap:OtherCurrentLiabilitiesMember us-gaap:ForeignExchangeForwardMember us-gaap:NondesignatedMember 2024-03-31 0001136869 us-gaap:OtherLiabilitiesMember us-gaap:ForeignExchangeForwardMember us-gaap:DesignatedAsHedgingInstrumentMember 2024-03-31 0001136869 us-gaap:CrossCurrencyInterestRateContractMember us-gaap:NetInvestmentHedgingMember us-gaap:InterestExpenseMember 2024-01-01 2024-03-31 0001136869 zbh:CumulativeFairValueHedgingAdjustmentCarryingAmountOfHedgedLiabilitiesMember zbh:LongTermDebtNoncurrentMember 2024-03-31 0001136869 us-gaap:NoncontrollingInterestMember 2022-12-31 0001136869 us-gaap:OtherLiabilitiesMember us-gaap:CrossCurrencyInterestRateContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2024-03-31 0001136869 zbh:OctoberTwoThousandTwentyThreeAcquisitionMember 2023-10-06 2023-10-06 0001136869 us-gaap:DesignatedAsHedgingInstrumentMember 2023-12-31 0001136869 us-gaap:NondesignatedMember 2024-03-31 0001136869 srt:MaximumMember zbh:EmbodyIncMember us-gaap:CommonStockMember 2023-02-14 0001136869 zbh:ThreePointZeroFiveZeroPercentageMember zbh:TwoThousandTwentySixMember us-gaap:SeniorNotesMember 2023-12-31 0001136869 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-01-01 2023-03-31 0001136869 zbh:TwoThousandTwentyThreeAcquisitionsMember us-gaap:CustomerRelationshipsMember 2023-12-31 0001136869 zbh:TwoThousandNineteenRestructuringPlanMember 2023-12-31 0001136869 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2024-03-31 0001136869 zbh:CarryingAmountOfHedgedLiabilitiesMember 2024-03-31 0001136869 us-gaap:SoftwareAndSoftwareDevelopmentCostsMember 2023-12-31 0001136869 zbh:TwoPointFourTwoFivePercentageMember zbh:TwoThousandTwentySixMember zbh:EuroNotesMember 2024-03-31 0001136869 us-gaap:ContractTerminationMember zbh:TwoThousandTwentyThreeRestructuringPlanMember 2024-03-31 0001136869 us-gaap:OtherCurrentLiabilitiesMember us-gaap:ForeignExchangeForwardMember us-gaap:DesignatedAsHedgingInstrumentMember 2023-12-31 0001136869 us-gaap:ForeignExchangeForwardMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:NondesignatedMember 2024-03-31 0001136869 us-gaap:OtherLiabilitiesMember us-gaap:InterestRateSwapMember us-gaap:DesignatedAsHedgingInstrumentMember 2024-03-31 0001136869 us-gaap:AdditionalPaidInCapitalMember 2023-12-31 0001136869 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2023-12-31 0001136869 us-gaap:ForeignExchangeForwardMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:NondesignatedMember 2023-12-31 0001136869 us-gaap:ContractTerminationMember zbh:TwoThousandTwentyOneRestructuringPlanMember 2024-01-01 2024-03-31 0001136869 zbh:OtherProductCategoryMember 2023-01-01 2023-03-31 0001136869 zbh:SETMember 2024-01-01 2024-03-31 0001136869 zbh:FivePointSevenFiveZeroPercentageMember zbh:TwoThousandThirtyNineMember us-gaap:SeniorNotesMember 2023-12-31 0001136869 us-gaap:LandMember 2023-12-31 0001136869 us-gaap:ContractTerminationMember zbh:TwoThousandTwentyOneRestructuringPlanMember 2024-03-31 0001136869 zbh:EmployeeTerminationBenefitsMember zbh:TwoThousandTwentyThreeRestructuringPlanMember 2023-12-31 0001136869 srt:AmericasMember 2024-01-01 2024-03-31 0001136869 us-gaap:AdditionalPaidInCapitalMember 2024-01-01 2024-03-31 0001136869 us-gaap:OtherRestructuringMember zbh:TwoThousandNineteenRestructuringPlanMember 2024-03-31 0001136869 us-gaap:ForeignExchangeForwardMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:DesignatedAsHedgingInstrumentMember 2024-03-31 0001136869 currency:CHF us-gaap:ForeignExchangeContractMember 2024-03-31 0001136869 srt:MinimumMember us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember 2024-03-31 0001136869 us-gaap:AccumulatedTranslationAdjustmentMember 2024-03-31 0001136869 us-gaap:OtherRestructuringMember zbh:TwoThousandTwentyThreeRestructuringPlanMember 2024-03-31 0001136869 us-gaap:ForeignExchangeForwardMember us-gaap:NondesignatedMember us-gaap:OtherNonoperatingIncomeExpenseMember 2024-01-01 2024-03-31 0001136869 zbh:OtherContingenciesMember 2024-03-31 0001136869 zbh:TwoThousandTwentyTwoFiveYearCreditAgreementMember 2023-07-07 0001136869 us-gaap:NoncontrollingInterestMember 2023-03-31 0001136869 zbh:TwoThousandTwentyThreeAcquisitionsMember 2023-12-31 0001136869 zbh:InstrumentsMember 2023-12-31 0001136869 zbh:CrossCurrencyInterestRateContractMaturedMember 2024-03-31 0001136869 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-03-31 0001136869 zbh:TwoThousandTwentyThreeRestructuringPlanMember 2024-01-01 2024-03-31 0001136869 us-gaap:InterestExpenseMember 2023-01-01 2023-03-31 0001136869 zbh:TwoThousandTwentyThreeRestructuringPlanMember 2023-12-31 0001136869 zbh:ThreePointFiveFiveZeroPercentageMember zbh:TwoThousandTwentyFiveMember us-gaap:SeniorNotesMember 2023-12-31 0001136869 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember 2024-01-01 2024-03-31 0001136869 us-gaap:SoftwareAndSoftwareDevelopmentCostsMember 2024-03-31 0001136869 us-gaap:ForeignExchangeForwardMember us-gaap:NondesignatedMember 2023-12-31 0001136869 us-gaap:ContractTerminationMember zbh:TwoThousandNineteenRestructuringPlanMember 2023-12-31 0001136869 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2024-01-01 2024-03-31 0001136869 zbh:TwoThousandTwentyThreeFiveYearCreditAgreementMember zbh:MultiCurrencyRevolvingFacilityMember 2023-07-07 0001136869 us-gaap:CrossCurrencyInterestRateContractMember us-gaap:NetInvestmentHedgingMember us-gaap:InterestExpenseMember 2023-01-01 2023-03-31 0001136869 us-gaap:OtherCurrentLiabilitiesMember us-gaap:CrossCurrencyInterestRateContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2024-03-31 0001136869 us-gaap:OperatingSegmentsMember us-gaap:EMEAMember 2023-01-01 2023-03-31 0001136869 us-gaap:OtherRestructuringMember zbh:TwoThousandTwentyOneRestructuringPlanMember 2024-01-01 2024-03-31 0001136869 us-gaap:InterestRateSwapMember us-gaap:CashFlowHedgingMember 2024-01-01 2024-03-31 0001136869 us-gaap:CrossCurrencyInterestRateContractMember 2023-01-01 2023-03-31 0001136869 us-gaap:ContractTerminationMember zbh:TwoThousandNineteenRestructuringPlanMember 2024-03-31 0001136869 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-12-31 0001136869 us-gaap:RetainedEarningsMember 2022-12-31 0001136869 us-gaap:ForeignExchangeForwardMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:DesignatedAsHedgingInstrumentMember 2023-12-31 0001136869 zbh:OtherProductCategoryMember 2024-01-01 2024-03-31 0001136869 zbh:NovemberTwoThousandTwentyThreeAcquisitionMember 2023-11-15 0001136869 us-gaap:OtherRestructuringMember zbh:TwoThousandTwentyThreeRestructuringPlanMember 2023-12-31 0001136869 us-gaap:NoncontrollingInterestMember 2023-01-01 2023-03-31 0001136869 zbh:KneesMember 2024-01-01 2024-03-31 0001136869 zbh:EmployeeTerminationBenefitsMember zbh:TwoThousandTwentyThreeRestructuringPlanMember 2024-01-01 2024-03-31 0001136869 zbh:TwoThousandTwentyThreeFiveYearCreditAgreementMember zbh:MultiCurrencyRevolvingFacilityMember 2023-07-07 2023-07-07 0001136869 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2024-03-31 0001136869 us-gaap:DesignatedAsHedgingInstrumentMember 2024-03-31 0001136869 us-gaap:TreasuryStockCommonMember 2024-03-31 0001136869 zbh:EmployeeTerminationBenefitsMember zbh:TwoThousandNineteenRestructuringPlanMember 2024-03-31 0001136869 us-gaap:OtherCurrentAssetsMember us-gaap:ForeignExchangeForwardMember us-gaap:DesignatedAsHedgingInstrumentMember 2024-03-31 0001136869 2023-01-01 2023-03-31 0001136869 zbh:ForwardStartingInterestRateSwapsMember us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2024-01-01 2024-03-31 0001136869 us-gaap:ForeignExchangeForwardMember us-gaap:NondesignatedMember 2024-03-31 0001136869 us-gaap:InterestRateSwapMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:DesignatedAsHedgingInstrumentMember 2024-03-31 0001136869 us-gaap:ForeignExchangeForwardMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:NondesignatedMember 2023-12-31 0001136869 srt:MaximumMember zbh:TwoThousandTwentyThreeThreeSixtyFourDayRevolvingCreditAgreementMember 2024-03-31 0001136869 zbh:BuildingsAndEquipmentMember 2024-03-31 0001136869 zbh:EmployeeTerminationBenefitsMember zbh:TwoThousandNineteenRestructuringPlanMember 2024-01-01 2024-03-31 0001136869 zbh:EmployeeTerminationBenefitsMember zbh:TwoThousandNineteenRestructuringPlanMember 2023-12-31 0001136869 us-gaap:RetainedEarningsMember 2024-03-31 0001136869 us-gaap:NoncontrollingInterestMember 2024-03-31 0001136869 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2024-03-31 0001136869 us-gaap:CrossCurrencyInterestRateContractMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:DesignatedAsHedgingInstrumentMember 2024-03-31 0001136869 zbh:CashFlowHedgesOneMember 2024-03-31 0001136869 us-gaap:RetainedEarningsMember 2024-01-01 2024-03-31 0001136869 us-gaap:CommonStockMember 2024-01-01 2024-03-31 0001136869 us-gaap:TreasuryStockCommonMember 2023-12-31 0001136869 us-gaap:AdditionalPaidInCapitalMember 2024-03-31 0001136869 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember 2023-01-01 2023-03-31 0001136869 us-gaap:OtherRestructuringMember zbh:TwoThousandTwentyThreeRestructuringPlanMember 2024-01-01 2024-03-31 0001136869 zbh:ThreePointFiveFiveZeroPercentageMember zbh:TwoThousandThirtyMember us-gaap:SeniorNotesMember 2024-03-31 0001136869 us-gaap:ForeignExchangeForwardMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:DesignatedAsHedgingInstrumentMember 2024-03-31 0001136869 zbh:ForwardStartingInterestRateSwapsMember us-gaap:CashFlowHedgingMember 2023-01-01 2023-03-31 0001136869 us-gaap:ConstructionInProgressMember 2024-03-31 0001136869 us-gaap:TreasuryStockCommonMember 2024-01-01 2024-03-31 0001136869 currency:USD us-gaap:ForeignExchangeContractMember 2024-03-31 0001136869 us-gaap:OtherRestructuringMember zbh:TwoThousandNineteenRestructuringPlanMember 2024-01-01 2024-03-31 0001136869 zbh:EmbodyIncMember us-gaap:CommonStockMember 2023-02-14 0001136869 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2023-01-01 2023-03-31 0001136869 us-gaap:CrossCurrencyInterestRateContractMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:DesignatedAsHedgingInstrumentMember 2024-03-31 iso4217:EUR iso4217:USD shares pure iso4217:JPY shares iso4217:CHF zbh:Segment iso4217:USD --12-31 false Q1 0001136869 false http://fasb.org/us-gaap/2023#ProductMember http://fasb.org/us-gaap/2023#ProductMember http://fasb.org/us-gaap/2023#ProductMember http://fasb.org/us-gaap/2023#ProductMember http://fasb.org/us-gaap/2023#ProductMember http://fasb.org/us-gaap/2023#ProductMember http://fasb.org/us-gaap/2023#ProductMember http://fasb.org/us-gaap/2023#ProductMember http://fasb.org/us-gaap/2023#AssetsCurrent http://fasb.org/us-gaap/2023#OtherAssetsNoncurrent http://fasb.org/us-gaap/2023#AssetsCurrent http://fasb.org/us-gaap/2023#OtherAssetsNoncurrent http://fasb.org/us-gaap/2023#AssetsCurrent http://fasb.org/us-gaap/2023#OtherAssetsNoncurrent http://fasb.org/us-gaap/2023#AssetsCurrent http://fasb.org/us-gaap/2023#OtherAssetsNoncurrent http://fasb.org/us-gaap/2023#AssetsCurrent http://fasb.org/us-gaap/2023#OtherAssetsNoncurrent http://fasb.org/us-gaap/2023#AssetsCurrent http://fasb.org/us-gaap/2023#OtherAssetsNoncurrent http://fasb.org/us-gaap/2023#OtherLiabilitiesCurrent http://fasb.org/us-gaap/2023#OtherLiabilitiesNoncurrent http://fasb.org/us-gaap/2023#OtherLiabilitiesCurrent http://fasb.org/us-gaap/2023#OtherLiabilitiesNoncurrent http://fasb.org/us-gaap/2023#OtherLiabilitiesCurrent http://fasb.org/us-gaap/2023#OtherLiabilitiesNoncurrent http://fasb.org/us-gaap/2023#OtherLiabilitiesCurrent http://fasb.org/us-gaap/2023#OtherLiabilitiesNoncurrent http://fasb.org/us-gaap/2023#OtherLiabilitiesCurrent http://fasb.org/us-gaap/2023#OtherLiabilitiesNoncurrent http://fasb.org/us-gaap/2023#OtherLiabilitiesCurrent http://fasb.org/us-gaap/2023#OtherLiabilitiesNoncurrent http://fasb.org/us-gaap/2023#OtherLiabilitiesCurrent http://fasb.org/us-gaap/2023#OtherLiabilitiesNoncurrent http://fasb.org/us-gaap/2023#OtherLiabilitiesCurrent http://fasb.org/us-gaap/2023#OtherLiabilitiesNoncurrent http://fasb.org/us-gaap/2023#AssetsCurrent http://fasb.org/us-gaap/2023#OtherAssetsNoncurrent http://fasb.org/us-gaap/2023#AssetsCurrent http://fasb.org/us-gaap/2023#OtherAssetsNoncurrent http://fasb.org/us-gaap/2023#AssetsCurrent http://fasb.org/us-gaap/2023#OtherAssetsNoncurrent http://fasb.org/us-gaap/2023#AssetsCurrent http://fasb.org/us-gaap/2023#OtherAssetsNoncurrent http://fasb.org/us-gaap/2023#AssetsCurrent http://fasb.org/us-gaap/2023#OtherAssetsNoncurrent http://fasb.org/us-gaap/2023#AssetsCurrent http://fasb.org/us-gaap/2023#OtherAssetsNoncurrent http://fasb.org/us-gaap/2023#OtherLiabilitiesCurrent http://fasb.org/us-gaap/2023#OtherLiabilitiesNoncurrent http://fasb.org/us-gaap/2023#OtherLiabilitiesCurrent http://fasb.org/us-gaap/2023#OtherLiabilitiesNoncurrent http://fasb.org/us-gaap/2023#OtherLiabilitiesCurrent http://fasb.org/us-gaap/2023#OtherLiabilitiesNoncurrent http://fasb.org/us-gaap/2023#OtherLiabilitiesCurrent http://fasb.org/us-gaap/2023#OtherLiabilitiesNoncurrent http://fasb.org/us-gaap/2023#OtherLiabilitiesCurrent http://fasb.org/us-gaap/2023#OtherLiabilitiesNoncurrent http://fasb.org/us-gaap/2023#OtherLiabilitiesCurrent http://fasb.org/us-gaap/2023#OtherLiabilitiesNoncurrent http://fasb.org/us-gaap/2023#OtherLiabilitiesCurrent http://fasb.org/us-gaap/2023#OtherLiabilitiesNoncurrent http://fasb.org/us-gaap/2023#OtherLiabilitiesCurrent http://fasb.org/us-gaap/2023#OtherLiabilitiesNoncurrent http://www.zimmerbiomet.com/20240331#AcquisitionIntegrationDivestitureAndRelatedExpenses http://fasb.org/us-gaap/2023#CostOfGoodsAndServicesSold http://fasb.org/us-gaap/2023#CostOfGoodsAndServicesSold http://fasb.org/us-gaap/2023#InterestIncomeExpenseNet http://fasb.org/us-gaap/2023#InterestIncomeExpenseNet http://fasb.org/us-gaap/2023#CostOfGoodsAndServicesSold http://fasb.org/us-gaap/2023#InterestIncomeExpenseNet http://fasb.org/us-gaap/2023#CostOfGoodsAndServicesSold http://fasb.org/us-gaap/2023#InterestIncomeExpenseNet http://fasb.org/us-gaap/2023#AssetsCurrent http://fasb.org/us-gaap/2023#AssetsCurrent http://fasb.org/us-gaap/2023#OtherAssetsNoncurrent http://fasb.org/us-gaap/2023#OtherAssetsNoncurrent http://fasb.org/us-gaap/2023#AssetsCurrent http://fasb.org/us-gaap/2023#AssetsCurrent http://fasb.org/us-gaap/2023#OtherLiabilitiesCurrent http://fasb.org/us-gaap/2023#OtherLiabilitiesCurrent http://fasb.org/us-gaap/2023#OtherLiabilitiesNoncurrent http://fasb.org/us-gaap/2023#OtherLiabilitiesNoncurrent http://fasb.org/us-gaap/2023#OtherLiabilitiesCurrent http://fasb.org/us-gaap/2023#OtherLiabilitiesCurrent 10-Q true 2024-03-31 2024 001-16407 ZIMMER BIOMET HOLDINGS, INC. DE 13-4151777 345 East Main Street Warsaw IN 46580 574 373-3333 Common Stock, $0.01 par value ZBH NYSE 2.425% Notes due 2026 ZBH 26 NYSE 1.164% Notes due 2027 ZBH 27 NYSE Yes Yes Large Accelerated Filer false false false 205728398 1889200000 1831000000 512300000 500800000 142100000 133400000 107900000 110400000 736200000 715900000 124400000 41800000 400000 1300000 1623300000 1503700000 265900000 327300000 -100000 7700000 -50700000 -48200000 215100000 286800000 42300000 54100000 172800000 232800000 400000 200000 172400000 232500000 0.84 1.11 0.84 1.11 205200000 209400000 206200000 210400000 172400000 232500000 -35800000 12400000 34700000 8800000 18000000 19000000 1100000 900000 -20200000 1300000 152200000 233800000 393000000 415800000 1446400000 1442400000 2388200000 2385200000 403800000 366100000 4631500000 4609500000 2090900000 2060400000 8791500000 8818500000 4734100000 4856400000 1204400000 1152100000 21452400000 21496900000 370300000 410600000 70300000 61200000 1386300000 1485700000 970000000 900000000 2797000000 2857400000 370400000 357600000 275800000 273700000 577000000 652100000 4826200000 4867900000 8846400000 9008700000 0.01 0.01 1000000000 1000000000 317200000 316200000 3200000 3200000 9945900000 9846100000 10509000000 10384500000 -211200000 -191000000 111500000 110600000 7648900000 7562300000 12598000000 12480500000 8100000 7700000 12606000000 12488100000 21452400000 21496900000 316200000 3200000 9846100000 10384500000 -191000000 -110600000 -7562300000 7700000 12488100000 172400000 400000 172800000 -20200000 -20200000 0.24 49300000 49300000 800000 76400000 1400000 1400000 79200000 200000 23400000 23400000 0.9 88000000 88000000 317200000 3200000 9945900000 10509000000 -211200000 -111500000 -7648900000 8100000 12606000000 313800000 3100000 9504400000 9559300000 -179300000 -104800000 -6867200000 6700000 12027000000 232500000 200000 232800000 1300000 1300000 0.24 50400000 50400000 500000 55400000 300000 300000 56000000 1100000 100000 134900000 135000000 2300000 2100000 241700000 244000000 315400000 3200000 9692400000 9741700000 -178000000 -106900000 -7108600000 6900000 12157600000 172800000 232800000 238600000 231800000 29000000.0 25000000 -8600000 21500000 22700000 -8600000 55300000 94200000 -119400000 -91800000 6400000 26000000.0 228000000 307700000 82000000.0 82800000 55100000 46700000 -10200000 -13400000 12500000 14000000 0 18900000 55600000 300000 -195000000 -149400000 70000000 210000000 0 86300000 0 33900000 49400000 50300000 56400000 36000000.0 1500000 9600000 1500000 0 113600000 267600000 -10500000 -5100000 -50100000 -206700000 -5700000 2900000 -22700000 -45500000 415800000 375700000 393000000.0 330200000 <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">1. Basis of Presentation</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The financial data presented herein is unaudited and should be read in conjunction with the consolidated financial statements and accompanying notes included in our Annual Report on Form 10-K for the year ended December 31, 2023.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">In our opinion, the accompanying unaudited condensed consolidated financial statements include all adjustments, consisting of only normal recurring adjustments, necessary for a fair statement of the financial position, results of operations and cash flows for the interim periods presented. The December 31, 2023 condensed consolidated balance sheet data was derived from audited financial statements, but does not include all disclosures required by accounting principles generally accepted in the United States of America (“GAAP”). Results for interim periods should not be considered indicative of results for the full year.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> Amounts reported in millions within this Quarterly Report on Form 10-Q are computed based on the actual amounts. As a result, the sum of the components may not equal the total amount reported in millions due to rounding. In addition, certain columns and rows within tables may not sum to the totals due to the use of rounded numbers. Percentages presented are calculated from the underlying unrounded amounts.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The words “we,” “us,” “our” and similar words, “Zimmer Biomet” and “the Company” refer to Zimmer Biomet Holdings, Inc. and its subsidiaries. “Zimmer Biomet Holdings” refers to the parent company only.</span></p> <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">2. Significant Accounting Policies</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Use of Estimates</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> - The accompanying unaudited condensed consolidated financial statements are prepared in conformity with GAAP, which requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. We have made our best estimates, as appropriate under GAAP, in the recognition of our assets and liabilities. Actual results could differ materially from these estimates.</span></p></div><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Accounting Pronouncements Not Yet Adopted </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">- In November 2023, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2023-07, Improvements to Reportable Segment Disclosures, which is an amendment to ASC Topic 280 - Segment Reporting. The ASU requires more detailed and disaggregated segment information, including the disclosure of significant segment expense categories and amounts for each reportable segment. The ASU also requires certain annual disclosures to also be made in interim periods. The ASU is effective for fiscal years beginning after December 15, 2023, and interim periods for fiscal years beginning after December 15, 2024. The guidance will be applied retrospectively unless retrospective adoption is impracticable. Early adoption of this ASU is permitted. We are currently evaluating the impact this ASU will have on our financial statements and disclosures.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">In December 2023, the FASB issued ASU 2023-09, Improvements to Income Tax Disclosures, which is an amendment to ASC Topic 740 - Income Taxes. The ASU improves the transparency of income tax disclosures by requiring greater disaggregated information about an entity’s effective tax rate reconciliation and requiring additional disclosures and disaggregation of income taxes, among other amendments to improve the effectiveness of income tax disclosures. The ASU is effective for fiscal years beginning after December 15, 2024. The guidance will be applied prospectively with an option to apply the guidance retrospectively. Early adoption of this ASU is permitted. We are currently evaluating the impact this ASU will have on our financial statements and disclosures.</span></p></div> <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Use of Estimates</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> - The accompanying unaudited condensed consolidated financial statements are prepared in conformity with GAAP, which requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. We have made our best estimates, as appropriate under GAAP, in the recognition of our assets and liabilities. Actual results could differ materially from these estimates.</span></p> <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Accounting Pronouncements Not Yet Adopted </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">- In November 2023, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2023-07, Improvements to Reportable Segment Disclosures, which is an amendment to ASC Topic 280 - Segment Reporting. The ASU requires more detailed and disaggregated segment information, including the disclosure of significant segment expense categories and amounts for each reportable segment. The ASU also requires certain annual disclosures to also be made in interim periods. The ASU is effective for fiscal years beginning after December 15, 2023, and interim periods for fiscal years beginning after December 15, 2024. The guidance will be applied retrospectively unless retrospective adoption is impracticable. Early adoption of this ASU is permitted. We are currently evaluating the impact this ASU will have on our financial statements and disclosures.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">In December 2023, the FASB issued ASU 2023-09, Improvements to Income Tax Disclosures, which is an amendment to ASC Topic 740 - Income Taxes. The ASU improves the transparency of income tax disclosures by requiring greater disaggregated information about an entity’s effective tax rate reconciliation and requiring additional disclosures and disaggregation of income taxes, among other amendments to improve the effectiveness of income tax disclosures. The ASU is effective for fiscal years beginning after December 15, 2024. The guidance will be applied prospectively with an option to apply the guidance retrospectively. Early adoption of this ASU is permitted. We are currently evaluating the impact this ASU will have on our financial statements and disclosures.</span></p> <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">3. Revenue</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="text-indent:5%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Net sales by geography are as follows (in millions):</span></p><p style="text-indent:5%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:45.42%;"></td> <td style="width:3.54%;"></td> <td style="width:1%;"></td> <td style="width:21.599999999999998%;"></td> <td style="width:1%;"></td> <td style="width:3.84%;"></td> <td style="width:1%;"></td> <td style="width:21.599999999999998%;"></td> <td style="width:1%;"></td> </tr> <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="6" style="vertical-align:middle;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Three Months Ended</span></p></td> <td style="vertical-align:middle;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="6" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">March 31,</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:middle;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2024</span></p></td> <td style="vertical-align:middle;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:middle;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2023</span></p></td> <td style="vertical-align:middle;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">United States</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1,099.2</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1,060.4</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">International</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">790.0</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">770.6</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Total</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1,889.2</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1,831.0</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> </table></div><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><div style="font-size:12pt;font-family:Times New Roman;"><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Net sales by product category are as follows (in millions):</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> </span></p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:45.42%;"></td> <td style="width:3.54%;"></td> <td style="width:1%;"></td> <td style="width:21.599999999999998%;"></td> <td style="width:1%;"></td> <td style="width:3.84%;"></td> <td style="width:1%;"></td> <td style="width:21.599999999999998%;"></td> <td style="width:1%;"></td> </tr> <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="6" style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Three Months Ended</span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="6" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">March 31,</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2024</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2023</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Knees</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">788.1</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">762.5</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Hips</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">491.2</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">492.8</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">S.E.T.</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">452.6</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">433.4</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Other</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">157.3</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">142.3</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Total</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1,889.2</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1,831.0</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> </table></div><p style="text-indent:5%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:5%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">S.E.T. includes sales from our Sports Medicine, Extremities, Trauma, Craniomaxillofacial and Thoracic ("CMFT") product categories. Other includes sales from our Technology, Surgical and Bone Cement product categories.</span></p><p style="text-indent:5%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:5%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">This net sales presentation differs from our reportable operating segments, which are based upon our senior management organizational structure and how we allocate resources toward achieving operating profit goals. Each of our reportable operating segments sells all the product categories noted above. Accordingly, the only difference from the presentation above and our reportable operating segments are the geographic groupings.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p> <p style="text-indent:5%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Net sales by geography are as follows (in millions):</span></p><p style="text-indent:5%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:45.42%;"></td> <td style="width:3.54%;"></td> <td style="width:1%;"></td> <td style="width:21.599999999999998%;"></td> <td style="width:1%;"></td> <td style="width:3.84%;"></td> <td style="width:1%;"></td> <td style="width:21.599999999999998%;"></td> <td style="width:1%;"></td> </tr> <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="6" style="vertical-align:middle;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Three Months Ended</span></p></td> <td style="vertical-align:middle;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="6" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">March 31,</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:middle;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2024</span></p></td> <td style="vertical-align:middle;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:middle;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2023</span></p></td> <td style="vertical-align:middle;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">United States</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1,099.2</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1,060.4</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">International</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">790.0</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">770.6</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Total</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1,889.2</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1,831.0</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> </table> 1099200000 1060400000 790000000.0 770600000 1889200000 1831000000 <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Net sales by product category are as follows (in millions):</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> </span></p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:45.42%;"></td> <td style="width:3.54%;"></td> <td style="width:1%;"></td> <td style="width:21.599999999999998%;"></td> <td style="width:1%;"></td> <td style="width:3.84%;"></td> <td style="width:1%;"></td> <td style="width:21.599999999999998%;"></td> <td style="width:1%;"></td> </tr> <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="6" style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Three Months Ended</span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="6" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">March 31,</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2024</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2023</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Knees</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">788.1</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">762.5</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Hips</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">491.2</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">492.8</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">S.E.T.</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">452.6</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">433.4</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Other</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">157.3</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">142.3</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Total</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1,889.2</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1,831.0</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> </table> 788100000 762500000 491200000 492800000 452600000 433400000 157300000 142300000 1889200000 1831000000 <p style="font-size:10pt;margin-top:8pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">4. Restructuring</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">In December 2023, our management approved a new global restructuring program (the “2023 Restructuring Plan”) intended to optimize our cost structure and drive greater efficiencies throughout the company. The 2023 Restructuring Plan is expected to result in total pre-tax restructuring charges of approximately</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">120</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million. </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The pre-tax restructuring charges consist of employee termination benefits; contract terminations for sales agents; and other charges, such as consulting fees.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> The expenses incurred under our 2023 Restructuring Plan are reported in our “Restructuring and other cost reduction initiatives” financial statement line item. The charges incurred in the three-month period ended March 31, 2024 were primarily the result of finalizing, obtaining approval and, where applicable, communicating certain restructuring plans. </span><span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The following table summarizes the liabilities recognized related to the 2023 Restructuring Plan (in millions):</span></span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:55.653%;"></td> <td style="width:1.621%;"></td> <td style="width:1%;"></td> <td style="width:7.465999999999999%;"></td> <td style="width:1%;"></td> <td style="width:1.621%;"></td> <td style="width:1%;"></td> <td style="width:7.465999999999999%;"></td> <td style="width:1%;"></td> <td style="width:1.621%;"></td> <td style="width:1%;"></td> <td style="width:7.465999999999999%;"></td> <td style="width:1%;"></td> <td style="width:1.621%;"></td> <td style="width:1%;"></td> <td style="width:7.465999999999999%;"></td> <td style="width:1%;"></td> </tr> <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Employee</span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Termination</span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Contract</span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Benefits</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Terminations</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Other</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Total</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Balance, December 31, 2023</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">9.2</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">-</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">5.0</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">14.2</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Expenses incurred in the three months ended March 31, 2024</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">71.0</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1.8</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">6.8</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">79.6</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Cash payments</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">23.5</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">-</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1.3</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">24.8</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Foreign currency exchange rate changes</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">0.4</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">-</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">-</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">0.4</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Non-cash activity</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">-</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">-</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1.2</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1.2</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Balance, March 31, 2024</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">56.3</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1.8</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">11.7</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">69.8</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;"> <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Expense incurred since the start of the 2023 Restructuring Plan</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">80.2</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1.8</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">10.4</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">92.4</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;"> <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Expense estimated to be recognized for the 2023 Restructuring Plan</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">90.0</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">10.0</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">20.0</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">120.0</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:5.067%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">In December 2021, our management approved a global restructuring program (the “2021 Restructuring Plan”) intended to further reduce costs and to reorganize our global operations in preparation for the spinoff of ZimVie. The 2021 Restructuring Plan is expected to result in total pre-tax restructuring charges of approximately</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">180</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> The pre-tax restructuring charges consist of employee termination benefits; contract terminations for sales agents; and other charges, such as consulting fees and project management expenses. The expenses incurred under our 2021 Restructuring Plan are reported in our “Restructuring and other cost reduction initiatives” financial statement line item. </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The following table summarizes the liabilities recognized related to the 2021 Restructuring Plan (in millions):</span></span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:55.653%;"></td> <td style="width:1.621%;"></td> <td style="width:1%;"></td> <td style="width:7.465999999999999%;"></td> <td style="width:1%;"></td> <td style="width:1.621%;"></td> <td style="width:1%;"></td> <td style="width:7.465999999999999%;"></td> <td style="width:1%;"></td> <td style="width:1.621%;"></td> <td style="width:1%;"></td> <td style="width:7.465999999999999%;"></td> <td style="width:1%;"></td> <td style="width:1.621%;"></td> <td style="width:1%;"></td> <td style="width:7.465999999999999%;"></td> <td style="width:1%;"></td> </tr> <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Employee</span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Termination</span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Contract</span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Benefits</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Terminations</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Other</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Total</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Balance, December 31, 2023</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">4.2</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">17.6</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2.9</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">24.7</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Expenses incurred in the three months ended March 31, 2024</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">0.4</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">-</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1.3</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">0.9</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Cash payments</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">0.8</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">7.3</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1.5</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">9.6</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Foreign currency exchange rate changes</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">0.1</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">0.4</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">-</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">0.5</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Balance, March 31, 2024</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2.9</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">9.9</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2.7</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">15.5</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"> <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Expense incurred since the start of the 2021 Restructuring Plan</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">58.7</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">73.8</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">37.5</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">170.0</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"> <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Expense estimated to be recognized for the 2021 Restructuring Plan</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">60.0</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">80.0</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">40.0</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">180.0</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> </table></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">In December 2019, our Board of Directors approved, and we initiated, a global restructuring program (the “2019 Restructuring Plan”) with an objective of reducing structural costs to allow us to further invest in higher priority growth opportunities. The 2019 Restructuring Plan is expected to result in total pre-tax restructuring charges of approximately </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">370</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million. </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> The pre-tax restructuring charges consist of employee termination benefits; contract terminations for facilities and sales agents; and other charges, such as consulting fees, project management expenses and relocation costs, including costs to close a manufacturing facility.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The following table summarizes the location on our condensed consolidated statement of earnings and type of cost for our 2019 Restructuring Plan (in millions):</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:42.72%;"></td> <td style="width:1.6%;"></td> <td style="width:1%;"></td> <td style="width:10.72%;"></td> <td style="width:1%;"></td> <td style="width:1.6%;"></td> <td style="width:1%;"></td> <td style="width:10.72%;"></td> <td style="width:1%;"></td> <td style="width:1.6%;"></td> <td style="width:1%;"></td> <td style="width:10.72%;"></td> <td style="width:1%;"></td> <td style="width:1.6%;"></td> <td style="width:1%;"></td> <td style="width:10.72%;"></td> <td style="width:1%;"></td> </tr> <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:Arial;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:Arial;min-width:fit-content;"> </span></p></td> <td colspan="14" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Three Months Ended March 31, 2024</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Employee</span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Termination</span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Contract</span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Benefits</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Terminations</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Other</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Total</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span><span style="-sec-ix-hidden:F_6dbbe914-c1b6-4801-a675-111e8ea7ba1f;"><span style="-sec-ix-hidden:F_7ca05962-43b6-4d08-aeee-cd6934ebb90c;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Cost of products</span></span></span></span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> sold, excluding intangible asset amortization</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">-</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">-</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">0.5</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">0.5</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Restructuring and other cost reduction initiatives</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">14.7</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">-</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1.8</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">16.5</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">14.7</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">-</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2.3</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">17.0</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> </table></div><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The following table summarizes the liabilities recognized related to the 2019 Restructuring Plan (in millions):</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:55.653%;"></td> <td style="width:1.621%;"></td> <td style="width:1%;"></td> <td style="width:7.465999999999999%;"></td> <td style="width:1%;"></td> <td style="width:1.621%;"></td> <td style="width:1%;"></td> <td style="width:7.465999999999999%;"></td> <td style="width:1%;"></td> <td style="width:1.621%;"></td> <td style="width:1%;"></td> <td style="width:7.465999999999999%;"></td> <td style="width:1%;"></td> <td style="width:1.621%;"></td> <td style="width:1%;"></td> <td style="width:7.465999999999999%;"></td> <td style="width:1%;"></td> </tr> <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Employee</span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Termination</span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Contract</span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Benefits</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Terminations</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Other</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Total</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Balance, December 31, 2023</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">43.8</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">5.6</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2.9</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">52.3</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Expenses incurred in the three months ended March 31, 2024</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">14.7</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">-</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2.3</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">17.0</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Cash payments</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">-</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">0.5</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">3.5</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">4.0</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Foreign currency exchange rate changes</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">0.5</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">-</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">-</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">0.5</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Balance, March 31, 2024</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">58.0</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">5.1</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1.7</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">64.8</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"> <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Expense incurred since the start of the 2019 Restructuring Plan</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">140.4</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">35.0</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">161.0</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">336.4</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"> <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Expense estimated to be recognized for the 2019 Restructuring Plan</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">155.0</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">35.0</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">180.0</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">370.0</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> </table></div><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">We </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">do not include restructuring charges in the operating profit of our reportable segments. We report the expenses for other cost reduction and optimization initiatives in our “Restructuring and other cost reduction initiatives” financial statement line item because</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">these </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">activities also have the goal of reducing costs across the organization. However, since the cost reduction initiative expenses are not considered restructuring, they have been excluded from the amounts presented in this note.</span></p> 120000000 <span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The following table summarizes the liabilities recognized related to the 2023 Restructuring Plan (in millions):</span><p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:55.653%;"></td> <td style="width:1.621%;"></td> <td style="width:1%;"></td> <td style="width:7.465999999999999%;"></td> <td style="width:1%;"></td> <td style="width:1.621%;"></td> <td style="width:1%;"></td> <td style="width:7.465999999999999%;"></td> <td style="width:1%;"></td> <td style="width:1.621%;"></td> <td style="width:1%;"></td> <td style="width:7.465999999999999%;"></td> <td style="width:1%;"></td> <td style="width:1.621%;"></td> <td style="width:1%;"></td> <td style="width:7.465999999999999%;"></td> <td style="width:1%;"></td> </tr> <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Employee</span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Termination</span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Contract</span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Benefits</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Terminations</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Other</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Total</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Balance, December 31, 2023</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">9.2</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">-</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">5.0</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">14.2</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Expenses incurred in the three months ended March 31, 2024</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">71.0</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1.8</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">6.8</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">79.6</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Cash payments</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">23.5</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">-</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1.3</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">24.8</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Foreign currency exchange rate changes</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">0.4</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">-</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">-</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">0.4</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Non-cash activity</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">-</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">-</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1.2</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1.2</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Balance, March 31, 2024</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">56.3</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1.8</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">11.7</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">69.8</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;"> <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Expense incurred since the start of the 2023 Restructuring Plan</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">80.2</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1.8</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">10.4</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">92.4</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;"> <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Expense estimated to be recognized for the 2023 Restructuring Plan</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">90.0</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">10.0</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">20.0</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">120.0</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The following table summarizes the liabilities recognized related to the 2021 Restructuring Plan (in millions):</span><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:55.653%;"></td> <td style="width:1.621%;"></td> <td style="width:1%;"></td> <td style="width:7.465999999999999%;"></td> <td style="width:1%;"></td> <td style="width:1.621%;"></td> <td style="width:1%;"></td> <td style="width:7.465999999999999%;"></td> <td style="width:1%;"></td> <td style="width:1.621%;"></td> <td style="width:1%;"></td> <td style="width:7.465999999999999%;"></td> <td style="width:1%;"></td> <td style="width:1.621%;"></td> <td style="width:1%;"></td> <td style="width:7.465999999999999%;"></td> <td style="width:1%;"></td> </tr> <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Employee</span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Termination</span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Contract</span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Benefits</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Terminations</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Other</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Total</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Balance, December 31, 2023</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">4.2</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">17.6</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2.9</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">24.7</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Expenses incurred in the three months ended March 31, 2024</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">0.4</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">-</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1.3</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">0.9</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Cash payments</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">0.8</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">7.3</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1.5</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">9.6</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Foreign currency exchange rate changes</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">0.1</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">0.4</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">-</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">0.5</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Balance, March 31, 2024</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2.9</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">9.9</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2.7</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">15.5</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"> <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Expense incurred since the start of the 2021 Restructuring Plan</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">58.7</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">73.8</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">37.5</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">170.0</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"> <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Expense estimated to be recognized for the 2021 Restructuring Plan</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">60.0</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">80.0</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">40.0</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">180.0</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> </table><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The following table summarizes the liabilities recognized related to the 2019 Restructuring Plan (in millions):</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:55.653%;"></td> <td style="width:1.621%;"></td> <td style="width:1%;"></td> <td style="width:7.465999999999999%;"></td> <td style="width:1%;"></td> <td style="width:1.621%;"></td> <td style="width:1%;"></td> <td style="width:7.465999999999999%;"></td> <td style="width:1%;"></td> <td style="width:1.621%;"></td> <td style="width:1%;"></td> <td style="width:7.465999999999999%;"></td> <td style="width:1%;"></td> <td style="width:1.621%;"></td> <td style="width:1%;"></td> <td style="width:7.465999999999999%;"></td> <td style="width:1%;"></td> </tr> <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Employee</span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Termination</span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Contract</span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Benefits</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Terminations</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Other</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Total</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Balance, December 31, 2023</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">43.8</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">5.6</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2.9</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">52.3</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Expenses incurred in the three months ended March 31, 2024</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">14.7</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">-</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2.3</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">17.0</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Cash payments</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">-</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">0.5</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">3.5</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">4.0</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Foreign currency exchange rate changes</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">0.5</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">-</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">-</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">0.5</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Balance, March 31, 2024</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">58.0</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">5.1</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1.7</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">64.8</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"> <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Expense incurred since the start of the 2019 Restructuring Plan</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">140.4</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">35.0</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">161.0</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">336.4</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"> <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Expense estimated to be recognized for the 2019 Restructuring Plan</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">155.0</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">35.0</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">180.0</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">370.0</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> </table> 9200000 5000000 14200000 71000000 1800000 6800000 79600000 23500000 1300000 24800000 -400000 -400000 1200000 1200000 56300000 1800000 11700000 69800000 80200000 1800000 10400000 92400000 90000000 10000000 20000000 120000000 180000000 4200000 17600000 2900000 24700000 -400000 1300000 900000 800000 7300000 1500000 9600000 -100000 -400000 -500000 2900000 9900000 2700000 15500000 58700000 73800000 37500000 170000000 60000000 80000000 40000000 180000000 370000000 <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The following table summarizes the location on our condensed consolidated statement of earnings and type of cost for our 2019 Restructuring Plan (in millions):</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:42.72%;"></td> <td style="width:1.6%;"></td> <td style="width:1%;"></td> <td style="width:10.72%;"></td> <td style="width:1%;"></td> <td style="width:1.6%;"></td> <td style="width:1%;"></td> <td style="width:10.72%;"></td> <td style="width:1%;"></td> <td style="width:1.6%;"></td> <td style="width:1%;"></td> <td style="width:10.72%;"></td> <td style="width:1%;"></td> <td style="width:1.6%;"></td> <td style="width:1%;"></td> <td style="width:10.72%;"></td> <td style="width:1%;"></td> </tr> <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:Arial;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:Arial;min-width:fit-content;"> </span></p></td> <td colspan="14" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Three Months Ended March 31, 2024</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Employee</span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Termination</span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Contract</span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Benefits</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Terminations</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Other</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Total</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span><span style="-sec-ix-hidden:F_6dbbe914-c1b6-4801-a675-111e8ea7ba1f;"><span style="-sec-ix-hidden:F_7ca05962-43b6-4d08-aeee-cd6934ebb90c;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Cost of products</span></span></span></span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> sold, excluding intangible asset amortization</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">-</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">-</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">0.5</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">0.5</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Restructuring and other cost reduction initiatives</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">14.7</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">-</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1.8</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">16.5</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">14.7</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">-</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2.3</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">17.0</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> </table> 500000 500000 14700000 1800000 16500000 14700000 2300000 17000000 43800000 5600000 2900000 52300000 14700000 2300000 17000000 500000 3500000 4000000 -500000 -500000 58000000.0 5100000 1700000 64800000 140400000 35000000 161000000 336400000 155000000 35000000 180000000 370000000 <p style="font-size:10pt;margin-top:8pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">5.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> </span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Inventories</span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:70.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:39.872%;"></td> <td style="width:2.799%;"></td> <td style="width:1%;"></td> <td style="width:25.255%;"></td> <td style="width:1%;"></td> <td style="width:2.799%;"></td> <td style="width:1%;"></td> <td style="width:25.275%;"></td> <td style="width:1%;"></td> </tr> <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;"> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">March 31,</span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">December 31,</span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;"> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:middle;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2024</span></p></td> <td style="vertical-align:middle;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:middle;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2023</span></p></td> <td style="vertical-align:middle;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;"> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="6" style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">(in millions)</span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Finished goods</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1,846.7</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1,831.2</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Work in progress</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">226.7</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">246.5</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Raw materials</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">314.8</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">307.5</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Inventories</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2,388.2</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2,385.2</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> </table></div> <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:70.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:39.872%;"></td> <td style="width:2.799%;"></td> <td style="width:1%;"></td> <td style="width:25.255%;"></td> <td style="width:1%;"></td> <td style="width:2.799%;"></td> <td style="width:1%;"></td> <td style="width:25.275%;"></td> <td style="width:1%;"></td> </tr> <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;"> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">March 31,</span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">December 31,</span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;"> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:middle;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2024</span></p></td> <td style="vertical-align:middle;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:middle;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2023</span></p></td> <td style="vertical-align:middle;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;"> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="6" style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">(in millions)</span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Finished goods</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1,846.7</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1,831.2</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Work in progress</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">226.7</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">246.5</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Raw materials</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">314.8</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">307.5</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Inventories</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2,388.2</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2,385.2</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> </table> 1846700000 1831200000 226700000 246500000 314800000 307500000 2388200000 2385200000 <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">6. Property, Plant and Equipment</span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:70.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:49.98%;"></td> <td style="width:2.2%;"></td> <td style="width:1%;"></td> <td style="width:20.8%;"></td> <td style="width:1%;"></td> <td style="width:2.2%;"></td> <td style="width:1%;"></td> <td style="width:20.82%;"></td> <td style="width:1%;"></td> </tr> <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;"> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">March 31,</span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">December 31,</span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;"> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2024</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2023</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;"> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="6" style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">(in millions)</span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Land</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">18.8</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">18.9</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Buildings and equipment</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2,254.1</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2,245.9</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Capitalized software costs</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">555.2</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">552.2</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Instruments</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">3,814.6</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">3,748.6</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Construction in progress</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">206.4</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">200.6</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">6,849.1</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">6,766.2</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Accumulated depreciation</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">4,758.2</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">4,705.8</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Property, plant and equipment, net</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2,090.9</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2,060.4</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> </table></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:4.173%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">We had $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">25.3</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">30.8</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million of property, plant and equipment included in accounts payable as of March 31, 2024 and December 31, 2023, respectively.</span></p> <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:70.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:49.98%;"></td> <td style="width:2.2%;"></td> <td style="width:1%;"></td> <td style="width:20.8%;"></td> <td style="width:1%;"></td> <td style="width:2.2%;"></td> <td style="width:1%;"></td> <td style="width:20.82%;"></td> <td style="width:1%;"></td> </tr> <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;"> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">March 31,</span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">December 31,</span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;"> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2024</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2023</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;"> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="6" style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">(in millions)</span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Land</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">18.8</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">18.9</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Buildings and equipment</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2,254.1</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2,245.9</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Capitalized software costs</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">555.2</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">552.2</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Instruments</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">3,814.6</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">3,748.6</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Construction in progress</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">206.4</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">200.6</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">6,849.1</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">6,766.2</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Accumulated depreciation</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">4,758.2</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">4,705.8</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Property, plant and equipment, net</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2,090.9</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2,060.4</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> </table> 18800000 18900000 2254100000 2245900000 555200000 552200000 3814600000 3748600000 206400000 200600000 6849100000 6766200000 4758200000 4705800000 2090900000 2060400000 25300000 30800000 <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">7. Acquisitions</span></p><p style="text-indent:4.173%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:4.173%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">On </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">February 14, 2023</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">, we completed the acquisition of all the outstanding shares of Embody, Inc. ("Embody"), a medical device company focused on soft tissue healing, that expands our portfolio for the sports medicine market. The initial consideration consisted of the issuance of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">1.1</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million shares of our common stock valued at $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">135.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">19.5</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million of cash for a total value of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">154.5</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million. The fair value of our common stock was determined to be $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">127.34</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> per share, which represented the average of our high and low stock prices on the acquisition date. The Embody acquisition includes additional consideration of up to $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">120.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million in fair value of our common shares and cash, subject to achieving a future regulatory milestone after closing and commercial milestones based on sales growth over a three-year period. We assigned a fair value of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">94.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million for this contingent consideration as of the acquisition date. The estimated fair value of the contingent consideration liability was calculated based on the probability of achieving the specified regulatory milestone and by simulating numerous potential outcomes for the commercial milestones and discounting to present value the estimated payments.</span></p><p style="text-indent:4.173%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:4.173%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">On </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">April 28, 2023</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">, we completed the acquisition of all the outstanding shares of a privately held orthopedics medical device company that expands our portfolio in the orthopedics market ("April 2023 acquisition"). The initial consideration consisted of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">15.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million of cash and includes consideration of up to $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">8.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million in cash, subject to achieving future regulatory milestones.</span></p><p style="text-indent:4.173%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:4.173%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">On </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">October 6, 2023</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">, we completed the acquisition of all the outstanding shares of a privately held orthopedics medical device company that provides us new surgical technology that can be used in procedures across multiple product categories (“October 2023 acquisition”). The initial consideration consisted of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">42.2</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million of cash and includes additional consideration of up to $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">33.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million in cash contingent upon achieving certain commercial milestones based on sales growth over a three-year period. We assigned a fair value of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">21.5</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million for this contingent consideration as of the acquisition date. The estimated fair value of the contingent liability was calculated based on the probability of achieving the commercial milestones and discounting to present value the estimated payments.</span></p><p style="text-indent:4.173%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:4.173%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">On </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">November 15, 2023</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">we completed the acquisition of a privately held technology company by acquiring certain assets, liabilities and employees of the technology company (“November 2023 acquisition”). The November 2023 acquisition expands our</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">technology </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">and data capabilities and solutions across multiple product categories to better serve our customers. The initial consideration consisted of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">60.7</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million of cash and includes additional consideration of up to $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">20.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million in cash contingent upon achieving a commercial milestone based on a certain sales target which must be achieved by December 31, 2025. We assigned a fair value of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">15.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million for this contingent consideration as of the acquisition date. The estimated fair value of the contingent liability was calculated based on the probability of achieving the commercial milestone and discounting to present value the estimated payment.</span></p><p style="text-indent:4.173%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:4.173%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">These acquisitions are collectively referred to in this report as the “2023 acquisitions”. Refer to Note 10 for information regarding the issuance of common stock and cash payments related to the contingent consideration liabilities that have occurred subsequent to the acquisition dates.</span></p><p style="text-indent:4.173%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:4.173%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The goodwill related to the 2023 acquisitions represents the excess of the consideration transferred over the fair value of the net assets acquired. The goodwill related to the 2023 acquisitions is generated from the operational synergies and cross-selling opportunities we expect to achieve from the technologies acquired. A portion of the goodwill is expected to be deductible for U.S. income tax purposes. The goodwill related to the Embody, the October 2023 and the November 2023 acquisitions is included in the Americas operating segment and the Americas Orthopedics reporting unit. The goodwill related to the April 2023 acquisition is included in the Asia Pacific operating segment and reporting unit. The goodwill related to the Embody acquisition was the only significant activity related to our consolidated goodwill balance in the three-month period ended March 31, 2023, other than changes related to foreign currency exchange rate translation adjustments. Foreign currency exchange translations adjustments were the only significant activity impacting goodwill for the three-month period ended March 31, 2024.</span></p><p style="text-indent:4.173%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:4.173%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> The purchase price allocation for the Embody acquisition was final as of March 31, 2024. The purchase price allocations for the other 2023 acquisitions are preliminary as of March 31, 2024. We need additional time to evaluate the tax attributes of those transactions, which may change the recognized tax assets and liabilities. There may be differences between the preliminary estimates of fair value and the final acquisition accounting. The final estimates of fair value are expected to be completed as soon as possible, but no later than one year after the respective acquisition dates.</span></p><p style="text-indent:4.173%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="text-indent:4.173%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The following table </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">summarizes the estimates of fair value of the assets acquired and liabilities assumed related to the 2023 acquisitions (in millions):</span></p><p style="text-indent:4.173%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:80.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:78.78%;"></td> <td style="width:2.62%;"></td> <td style="width:1%;"></td> <td style="width:16.599999999999998%;"></td> <td style="width:1%;"></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Current assets</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">13.1</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Intangible assets subject to amortization:</span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">   Technology</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">144.0</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">   Trademarks and trade names</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">3.5</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">   Customer relationships</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">40.1</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Intangible assets not subject to amortization:</span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">   In-process research and development (IPR&amp;D)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">36.3</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Goodwill</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">215.0</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Other assets</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">4.8</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Total assets acquired</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">456.8</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Current liabilities</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">8.2</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Deferred income taxes</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">37.7</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Total liabilities assumed</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="border-top:0.5pt solid #000000;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="border-top:0.5pt solid #000000;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">45.9</span></p></td> <td style="border-top:0.5pt solid #ffffff03;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Net assets acquired</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">410.9</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> </table></div><p style="text-indent:4.173%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:4.173%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The weighted average amortization periods selected for technology, customer relationships and trademarks and trade names were </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">15</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> years, </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">8 </span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">years and </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">13 </span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">years, respectively. Upon receiving regulatory approval subsequent to the Embody acquisition date, the $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">36.3</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million of IPR&amp;D was reclassified to a definite-lived intangible asset and began amortizing over the applicable estimated useful life.</span></p><p style="text-indent:4.173%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:4.173%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">In the three-month period ended March 31, 2024, there were no material adjustments to the preliminary values of the 2023 acquisitions.</span></p><p style="text-indent:4.173%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:4.173%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">We have not included pro forma information and certain other information under GAAP for these acquisitions because they did not have a material impact on our financial position or results of operations.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p> 2023-02-14 1100000 135000000 19500000 154500000 127.34 120000000 94000000 2023-04-28 15000000 8000000 2023-10-06 42200000 33000000 21500000 2023-11-15 60700000 20000000 15000000 <p style="text-indent:4.173%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The following table </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">summarizes the estimates of fair value of the assets acquired and liabilities assumed related to the 2023 acquisitions (in millions):</span></p><p style="text-indent:4.173%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:80.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:78.78%;"></td> <td style="width:2.62%;"></td> <td style="width:1%;"></td> <td style="width:16.599999999999998%;"></td> <td style="width:1%;"></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Current assets</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">13.1</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Intangible assets subject to amortization:</span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">   Technology</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">144.0</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">   Trademarks and trade names</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">3.5</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">   Customer relationships</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">40.1</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Intangible assets not subject to amortization:</span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">   In-process research and development (IPR&amp;D)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">36.3</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Goodwill</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">215.0</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Other assets</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">4.8</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Total assets acquired</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">456.8</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Current liabilities</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">8.2</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Deferred income taxes</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">37.7</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Total liabilities assumed</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="border-top:0.5pt solid #000000;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="border-top:0.5pt solid #000000;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">45.9</span></p></td> <td style="border-top:0.5pt solid #ffffff03;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Net assets acquired</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">410.9</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> </table> 13100000 144000000 3500000 40100000 36300000 215000000 4800000 456800000 8200000 37700000 45900000 410900000 P15Y P8Y P13Y 36300000 <span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">. Debt</span><div style="font-size:10pt;font-family:Times New Roman;"><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Our debt consisted of the following (in millions):</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:70.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:58.888%;"></td> <td style="width:2.02%;"></td> <td style="width:1%;"></td> <td style="width:16.456999999999997%;"></td> <td style="width:1%;"></td> <td style="width:2.18%;"></td> <td style="width:1%;"></td> <td style="width:16.456999999999997%;"></td> <td style="width:1%;"></td> </tr> <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;"> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">March 31,</span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">December 31,</span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;"> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2024</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2023</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;"> <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Current portion of long-term debt</span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Uncommitted Credit Facility</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">120.0</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">50.0</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1.450</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">% Senior Notes due 2024</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">850.0</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">850.0</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Total current portion of long-term debt</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">970.0</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">900.0</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;"> <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Long-term debt</span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">3.550</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">% Senior Notes due 2025</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">863.0</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">863.0</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">3.050</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">% Senior Notes due 2026</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">600.0</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">600.0</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">5.350</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">% Senior Notes due 2028</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">500.0</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">500.0</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">3.550</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">% Senior Notes due 2030</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">257.5</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">257.5</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2.600</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">% Senior Notes due 2031</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">750.0</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">750.0</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">4.250</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">% Senior Notes due 2035</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">253.4</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">253.4</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">5.750</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">% Senior Notes due 2039</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">317.8</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">317.8</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">4.450</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">% Senior Notes due 2045</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">395.4</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">395.4</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2.425</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">% Euro Notes due 2026</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">540.1</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">552.3</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1.164</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">% Euro Notes due 2027</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">540.1</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">552.3</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Debt discount and issuance costs</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">27.4</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">29.1</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Adjustment related to interest rate swaps</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">163.7</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">144.7</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Total long-term debt</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">4,826.2</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">4,867.9</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> </table></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">At March 31, 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">, our total current and non-current debt of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">5.8</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> billion consisted of</span><span style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">5.9</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> billion aggregate principal amount of our senior notes, which included €</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">1.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> billion Euro-denominated senior notes (“Euro Notes”), and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">120.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million of outstanding borrowings under the Uncommitted Credit Facility (defined below), partially offset by debt discount and issuance costs of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">27.4</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million and fair value adjustments related to interest rate swaps totaling</span><span style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">163.7</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million. </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">In the three-month period ended March 31, 2023, we redeemed $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">83.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million outstanding principal amount on a short-term term loan by paying $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">33.9</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million in cash and by transferring all our common shares we owned of a publicly traded company we previously spun-off. The transfer of the common shares as part of the settlement resulted in a $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">49.1</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million noncash financing activity. In the three-month period ended March 31, 2023 we also redeemed $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">86.3</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million outstanding principal amount of our </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">3.700</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">% Senior Notes due 2023.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">On August 28, 2023, we entered into an uncommitted facility letter (the "Uncommitted Credit Facility"), which provides that from time to time, we may request, and the lender in its absolute and sole discretion may provide, short-term loans. Borrowings under the Uncommitted Credit Facility may be used only for general corporate and working capital purposes. The Uncommitted Credit Facility provides that the aggregate principal amount of outstanding borrowings at any time shall not exceed $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">300.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million. Each borrowing under the Uncommitted Credit Facility will mature on the maturity date specified by the lender at the time of the advance, which will be no more than 90 days following the date of the advance. The Uncommitted Credit Facility and borrowings thereunder are unsecured. Borrowings under the Uncommitted Credit Facility bear interest at floating rates, based upon either an adjusted term secured overnight financing rate (“Term SOFR”) for the applicable interest period, the prime rate, or lender’s cost of funds, in each case, plus an applicable margin determined at the time of each borrowing. The Uncommitted Credit Facility includes customary affirmative and negative covenants and events of default for unsecured uncommitted financing arrangements. We were in compliance with all covenants under the Uncommitted Credit Facility as of March 31, 2024. As of March 31, 2024, there were outstanding borrowings of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">120.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million under the Uncommitted Credit Facility.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">On July 7, 2023, we entered into a new five-year revolving credit agreement (the “2023 Five-Year Credit Agreement”) and a new 364-day revolving credit agreement (the “2023 364-Day Revolving Credit Agreement”), as described below. Borrowings under these credit agreements will be used for general corporate purposes.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The 2023 Five-Year Credit Agreement contains a </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">five-year</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> unsecured revolving facility of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">1.5</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> billion (the “2023 Five-Year Revolving Facility”). The 2023 Five-Year Credit Agreement replaced the previous revolving credit agreement entered into on August 19, 2022 (the “2022 Five-Year Credit Agreement”), which contained a </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">five-year</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> unsecured revolving facility of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">1.5</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> billion (the “2022 Five-Year Revolving Facility”). There was approximately $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">520.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million in aggregate outstanding borrowings under the 2022 Five-Year Credit Agreement at the time it was terminated, which borrowings were repaid in full through borrowings under the 2023 Five-Year Credit Agreement on July 7, 2023 in the same amount and on the same interest rate and margin terms.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The 2023 Five-Year Credit Agreement will mature on </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">July 7, 2028</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">, with two one-year extensions exercisable at our discretion and subject to required lender consent. The 2023 Five-Year Credit Agreement also includes an uncommitted incremental feature allowing us to request an increase of the facility by an aggregate amount of up to $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">500.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Borrowings under the 2023 Five-Year Credit Agreement bear interest at floating rates, based upon either an adjusted Term SOFR for the applicable interest period or an alternate base rate, in each case, plus an applicable margin determined by reference to our senior unsecured long-term debt credit rating. We pay a facility fee on the aggregate amount of the 2023 Five-Year Revolving Facility at a rate determined by reference to our senior unsecured long-term debt credit rating. The 2023 Five-Year Credit Agreement contains customary affirmative and negative covenants and events of default for unsecured financing arrangements, including, among other things, limitations on consolidations, mergers, and sales of assets. The 2023 Five-Year Credit Agreement also requires us to maintain a consolidated indebtedness to consolidated EBITDA ratio of no greater than </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">4.5</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> to </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">1.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> as of the last day of any period of four consecutive fiscal quarters (with such ratio subject to increase to </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">5.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> to </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">1.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> for a period of time in connection with a qualified material acquisition and certain other restrictions). We were in compliance with all covenants under the 2023 Five-Year Credit Agreement as of March 31, 2024. As of March 31, 2024, there were no outstanding borrowings under the 2023 Five-Year Credit Agreement.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The 2023 364-Day Revolving Credit Agreement is an unsecured revolving credit facility in the principal amount of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">1.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> billion (the “2023 364-Day Revolving Facility”). The 2023 364-Day Revolving Credit Agreement replaced a credit agreement entered into on August 19, 2022, which was also a 364- day unsecured revolving credit facility of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">1.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> billion (the “2022 364-Day Revolving Facility”). There were </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">no</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> borrowings outstanding under the 2022 364-Day Revolving Facility when it was terminated.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The 2023 364-Day Revolving Facility will mature on </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">July 5, 2024</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">. Borrowings under the 2023 364-Day Revolving Credit Agreement bear interest at floating rates based upon either an adjusted Term SOFR for the applicable interest period or an alternate base rate, in each case, plus an applicable margin determined by reference to our senior unsecured long-term debt credit rating. We pay a facility fee on the aggregate amount of the 2023 364-Day Revolving Facility at a rate determined by reference to our senior unsecured long-term debt credit rating. The 2023 364-Day Revolving Credit Agreement contains customary affirmative and negative covenants and events of default for an unsecured financing arrangement including, among other things, limitations on consolidations, mergers, and sales of assets. The 2023 364-Day Revolving Credit Agreement also requires us to maintain a consolidated indebtedness to consolidated EBITDA ratio of no greater than </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">4.5</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> to </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">1.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> as of the last day of any period of four consecutive fiscal quarters (with such ratio subject to increase to </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">5.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> to </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">1.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> in connection with a qualified material acquisition and certain other restrictions). We were in compliance with all covenants under the 2023 364-Day Revolving Credit Agreement as of March 31, 2024. As of March 31, 2024, there were </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">no</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> outstanding borrowings under the 2023 364-Day Revolving Credit Agreement.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Borrowings under our revolving credit facilities have been executed with</span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> underlying notes that have maturities of three months or less</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">. At maturity of the underlying note, we elect to either repay the note, borrow the same amount, or some combination thereof. On our condensed consolidated statements of cash flows, we present the borrowings and repayments of these underlying notes as net cash inflows or outflows due to their short-term nature.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The estimated fair value of our senior notes, which includes our Euro notes, as of March 31, 2024, based on quoted prices for the specific securities from transactions in over-the-counter markets (Level 2), was </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">5,553.8</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million. </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The carrying value of the outstanding $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">120.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million principal balance of the Uncommitted Credit Facility approximates its fair value as it bears interest at short-term market rates.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p> <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Our debt consisted of the following (in millions):</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:70.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:58.888%;"></td> <td style="width:2.02%;"></td> <td style="width:1%;"></td> <td style="width:16.456999999999997%;"></td> <td style="width:1%;"></td> <td style="width:2.18%;"></td> <td style="width:1%;"></td> <td style="width:16.456999999999997%;"></td> <td style="width:1%;"></td> </tr> <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;"> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">March 31,</span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">December 31,</span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;"> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2024</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2023</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;"> <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Current portion of long-term debt</span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Uncommitted Credit Facility</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">120.0</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">50.0</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1.450</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">% Senior Notes due 2024</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">850.0</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">850.0</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Total current portion of long-term debt</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">970.0</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">900.0</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;"> <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Long-term debt</span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">3.550</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">% Senior Notes due 2025</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">863.0</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">863.0</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">3.050</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">% Senior Notes due 2026</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">600.0</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">600.0</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">5.350</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">% Senior Notes due 2028</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">500.0</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">500.0</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">3.550</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">% Senior Notes due 2030</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">257.5</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">257.5</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2.600</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">% Senior Notes due 2031</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">750.0</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">750.0</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">4.250</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">% Senior Notes due 2035</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">253.4</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">253.4</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">5.750</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">% Senior Notes due 2039</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">317.8</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">317.8</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">4.450</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">% Senior Notes due 2045</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">395.4</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">395.4</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2.425</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">% Euro Notes due 2026</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">540.1</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">552.3</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1.164</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">% Euro Notes due 2027</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">540.1</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">552.3</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Debt discount and issuance costs</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">27.4</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">29.1</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Adjustment related to interest rate swaps</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">163.7</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">144.7</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Total long-term debt</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">4,826.2</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">4,867.9</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> </table> 120000000 50000000 0.0145 0.0145 850000000 850000000 970000000 900000000 0.0355 0.0355 863000000 863000000 0.03050 0.03050 600000000 600000000 0.0535 0.0535 500000000 500000000 0.03550 0.03550 257500000 257500000 0.02600 0.02600 750000000 750000000 0.04250 0.04250 253400000 253400000 0.05750 0.05750 317800000 317800000 0.04450 0.04450 395400000 395400000 0.02425 0.02425 540100000 552300000 0.01164 0.01164 540100000 552300000 27400000 29100000 -163700000 -144700000 4826200000 4867900000 5800000000 5900000000 1000000000 120000000 27400000 163700000 83000000 33900000 49100000 86300000 0.037 300000000 120000000 P5Y 1500000000 P5Y 1500000000 520000000 2028-07-07 500000000 0.045 0.01 0.05 0.01 1000000000 1000000000 0 2024-07-05 0.045 0.01 0.05 0.01 0 underlying notes that have maturities of three months or less 5553800000 120000000 <p style="font-size:10pt;margin-top:8pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">9. Accumulated Other Comprehensive Income</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Accumulated other comprehensive income (loss) (“AOCI”) refers to certain gains and losses that under GAAP are included in comprehensive income but are excluded from net earnings as these amounts are initially recorded as an adjustment to stockholders’ equity. Amounts in AOCI may be reclassified to net earnings upon the occurrence of certain events.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Our AOCI is comprised of foreign currency translation adjustments, unrealized gains and losses on cash flow hedges and unrecognized prior service costs and gains and losses in actuarial assumptions related to our defined benefit plans. Foreign currency translation adjustments are reclassified to net earnings upon sale or upon a complete or substantially complete liquidation of an investment in a foreign entity. Unrealized gains and losses on cash flow hedges are reclassified to net earnings when the hedged item affects net earnings. Amounts related to defined benefit plans that are in AOCI are reclassified over the service periods of employees in the plan.</span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The following table shows the changes in the components of AOCI gains (losses), net of tax (in millions):</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:90.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:50.27%;"></td> <td style="width:1.22%;"></td> <td style="width:1%;"></td> <td style="width:9.162%;"></td> <td style="width:1%;"></td> <td style="width:1.22%;"></td> <td style="width:1%;"></td> <td style="width:9.162%;"></td> <td style="width:1%;"></td> <td style="width:1.22%;"></td> <td style="width:1%;"></td> <td style="width:9.162%;"></td> <td style="width:1%;"></td> <td style="width:1.42%;"></td> <td style="width:1%;"></td> <td style="width:9.162%;"></td> <td style="width:1%;"></td> </tr> <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;"> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Foreign</span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Cash</span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Defined</span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;"> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Currency</span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Flow</span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Benefit</span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Total</span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;"> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Translation</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Hedges</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Plan Items</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">AOCI</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Balance at December 31, 2023</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">159.4</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">63.3</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">94.9</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">191.0</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">AOCI before reclassifications</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">35.8</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">34.7</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">-</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1.1</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Reclassifications to statements of earnings</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">-</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">18.0</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1.1</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">19.1</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Balance at March 31, 2024</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">195.2</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">80.0</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">96.0</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">211.2</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> </tr> </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></div><div style="font-size:10pt;font-family:Times New Roman;"><p style="text-indent:4.533%;font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The following table shows the reclassification adjustments from AOCI (in millions):</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:41.92%;"></td> <td style="width:1.68%;"></td> <td style="width:1%;"></td> <td style="width:9.82%;"></td> <td style="width:1%;"></td> <td style="width:1.96%;"></td> <td style="width:1%;"></td> <td style="width:9.82%;"></td> <td style="width:1%;"></td> <td style="width:1.96%;"></td> <td style="width:28.84%;"></td> </tr> <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;"> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="8" style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Amount of Gain (Loss)</span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;"> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="8" style="vertical-align:middle;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Reclassified from AOCI</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="6" style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Three Months Ended</span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;"> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="6" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">March 31,</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Location on</span></p></td> </tr> <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;"> <td style="vertical-align:middle;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Component of AOCI</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2024</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2023</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Statements of Earnings</span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;"> <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-style:italic;min-width:fit-content;">Cash flow hedges</span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span><span style="-sec-ix-hidden:F_3bc01aa3-dea5-451a-8ffd-09ce349d6b32;"><span style="-sec-ix-hidden:F_ebfd7fc3-d546-45ea-ae92-9fa50c48508c;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Foreign</span></span></span></span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> exchange forward contracts</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">22.0</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">23.1</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Cost of products sold</span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Forward starting interest rate swaps</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">0.2</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">0.2</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Interest expense, net</span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">21.8</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">22.9</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Total before tax</span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">3.8</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">3.9</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Provision for income taxes</span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">18.0</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">19.0</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Net of tax</span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;"> <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-style:italic;min-width:fit-content;">Defined benefit plans</span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Prior service cost and unrecognized actuarial loss</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">0.8</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1.0</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Other (expense) income, net</span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">0.3</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">0.1</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Provision for income taxes</span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1.1</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">0.9</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Net of tax</span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Total reclassifications</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">19.1</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">19.9</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Net of tax</span></p></td> </tr> </table></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><div style="font-size:12pt;font-family:Times New Roman;"><p style="text-indent:4.533%;font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The following table shows the tax effects on each component of AOCI recognized in our condensed consolidated statements of comprehensive income (in millions):</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:60.948%;"></td> <td style="width:1.36%;"></td> <td style="width:1%;"></td> <td style="width:9.578000000000001%;"></td> <td style="width:1%;"></td> <td style="width:1.48%;"></td> <td style="width:1%;"></td> <td style="width:9.578000000000001%;"></td> <td style="width:1%;"></td> <td style="width:1.48%;"></td> <td style="width:1%;"></td> <td style="width:9.578000000000001%;"></td> <td style="width:1%;"></td> </tr> <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;"> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="10" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Three Months Ended March 31, 2024</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;"> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Before Tax</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Tax</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Net of Tax</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Foreign currency cumulative translation adjustments</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">19.2</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">16.6</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">35.8</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Unrealized cash flow hedge gains</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">43.4</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">8.7</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">34.7</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Reclassification adjustments on cash flow hedges</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">21.8</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">3.8</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">18.0</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Adjustments to prior service cost and unrecognized actuarial assumptions</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">0.8</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">0.3</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1.1</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Total Other Comprehensive Income (Loss)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1.6</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">21.8</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">20.2</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> </tr> </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> </span></p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:60.948%;"></td> <td style="width:1.36%;"></td> <td style="width:1%;"></td> <td style="width:9.578000000000001%;"></td> <td style="width:1%;"></td> <td style="width:1.48%;"></td> <td style="width:1%;"></td> <td style="width:9.578000000000001%;"></td> <td style="width:1%;"></td> <td style="width:1.48%;"></td> <td style="width:1%;"></td> <td style="width:9.578000000000001%;"></td> <td style="width:1%;"></td> </tr> <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;"> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="10" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Three Months Ended March 31, 2023</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;"> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Before Tax</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Tax</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Net of Tax</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Foreign currency cumulative translation adjustments</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">7.5</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">4.9</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">12.4</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Unrealized cash flow hedge gains</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">11.1</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2.3</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">8.8</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Reclassification adjustments on cash flow hedges</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">22.9</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">3.9</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">19.0</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Adjustments to prior service cost and unrecognized actuarial assumptions</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1.0</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">0.1</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">0.9</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Total Other Comprehensive Income (Loss)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">5.3</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">6.6</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1.3</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> </table></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p> <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The following table shows the changes in the components of AOCI gains (losses), net of tax (in millions):</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:90.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:50.27%;"></td> <td style="width:1.22%;"></td> <td style="width:1%;"></td> <td style="width:9.162%;"></td> <td style="width:1%;"></td> <td style="width:1.22%;"></td> <td style="width:1%;"></td> <td style="width:9.162%;"></td> <td style="width:1%;"></td> <td style="width:1.22%;"></td> <td style="width:1%;"></td> <td style="width:9.162%;"></td> <td style="width:1%;"></td> <td style="width:1.42%;"></td> <td style="width:1%;"></td> <td style="width:9.162%;"></td> <td style="width:1%;"></td> </tr> <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;"> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Foreign</span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Cash</span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Defined</span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;"> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Currency</span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Flow</span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Benefit</span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Total</span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;"> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Translation</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Hedges</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Plan Items</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">AOCI</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Balance at December 31, 2023</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">159.4</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">63.3</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">94.9</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">191.0</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">AOCI before reclassifications</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">35.8</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">34.7</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">-</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1.1</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Reclassifications to statements of earnings</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">-</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">18.0</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1.1</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">19.1</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Balance at March 31, 2024</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">195.2</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">80.0</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">96.0</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">211.2</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> </tr> </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p> -159400000 63300000 -94900000 -191000000.0 -35800000 34700000 -1100000 18000000 1100000 19100000 -195200000 80000000.0 -96000000.0 -211200000 <p style="text-indent:4.533%;font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The following table shows the reclassification adjustments from AOCI (in millions):</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:41.92%;"></td> <td style="width:1.68%;"></td> <td style="width:1%;"></td> <td style="width:9.82%;"></td> <td style="width:1%;"></td> <td style="width:1.96%;"></td> <td style="width:1%;"></td> <td style="width:9.82%;"></td> <td style="width:1%;"></td> <td style="width:1.96%;"></td> <td style="width:28.84%;"></td> </tr> <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;"> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="8" style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Amount of Gain (Loss)</span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;"> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="8" style="vertical-align:middle;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Reclassified from AOCI</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="6" style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Three Months Ended</span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;"> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="6" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">March 31,</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Location on</span></p></td> </tr> <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;"> <td style="vertical-align:middle;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Component of AOCI</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2024</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2023</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Statements of Earnings</span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;"> <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-style:italic;min-width:fit-content;">Cash flow hedges</span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span><span style="-sec-ix-hidden:F_3bc01aa3-dea5-451a-8ffd-09ce349d6b32;"><span style="-sec-ix-hidden:F_ebfd7fc3-d546-45ea-ae92-9fa50c48508c;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Foreign</span></span></span></span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> exchange forward contracts</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">22.0</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">23.1</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Cost of products sold</span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Forward starting interest rate swaps</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">0.2</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">0.2</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Interest expense, net</span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">21.8</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">22.9</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Total before tax</span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">3.8</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">3.9</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Provision for income taxes</span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">18.0</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">19.0</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Net of tax</span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;"> <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-style:italic;min-width:fit-content;">Defined benefit plans</span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Prior service cost and unrecognized actuarial loss</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">0.8</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1.0</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Other (expense) income, net</span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">0.3</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">0.1</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Provision for income taxes</span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1.1</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">0.9</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Net of tax</span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Total reclassifications</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">19.1</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">19.9</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Net of tax</span></p></td> </tr> </table> 22000000 23100000 -200000 -200000 21800000 22900000 3800000 3900000 18000000 19000000 800000 1000000 -300000 100000 1100000 900000 19100000 19900000 <p style="text-indent:4.533%;font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The following table shows the tax effects on each component of AOCI recognized in our condensed consolidated statements of comprehensive income (in millions):</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:60.948%;"></td> <td style="width:1.36%;"></td> <td style="width:1%;"></td> <td style="width:9.578000000000001%;"></td> <td style="width:1%;"></td> <td style="width:1.48%;"></td> <td style="width:1%;"></td> <td style="width:9.578000000000001%;"></td> <td style="width:1%;"></td> <td style="width:1.48%;"></td> <td style="width:1%;"></td> <td style="width:9.578000000000001%;"></td> <td style="width:1%;"></td> </tr> <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;"> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="10" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Three Months Ended March 31, 2024</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;"> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Before Tax</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Tax</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Net of Tax</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Foreign currency cumulative translation adjustments</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">19.2</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">16.6</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">35.8</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Unrealized cash flow hedge gains</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">43.4</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">8.7</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">34.7</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Reclassification adjustments on cash flow hedges</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">21.8</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">3.8</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">18.0</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Adjustments to prior service cost and unrecognized actuarial assumptions</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">0.8</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">0.3</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1.1</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Total Other Comprehensive Income (Loss)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1.6</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">21.8</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">20.2</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> </tr> </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> </span></p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:60.948%;"></td> <td style="width:1.36%;"></td> <td style="width:1%;"></td> <td style="width:9.578000000000001%;"></td> <td style="width:1%;"></td> <td style="width:1.48%;"></td> <td style="width:1%;"></td> <td style="width:9.578000000000001%;"></td> <td style="width:1%;"></td> <td style="width:1.48%;"></td> <td style="width:1%;"></td> <td style="width:9.578000000000001%;"></td> <td style="width:1%;"></td> </tr> <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;"> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="10" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Three Months Ended March 31, 2023</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;"> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Before Tax</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Tax</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Net of Tax</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Foreign currency cumulative translation adjustments</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">7.5</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">4.9</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">12.4</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Unrealized cash flow hedge gains</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">11.1</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2.3</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">8.8</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Reclassification adjustments on cash flow hedges</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">22.9</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">3.9</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">19.0</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Adjustments to prior service cost and unrecognized actuarial assumptions</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1.0</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">0.1</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">0.9</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Total Other Comprehensive Income (Loss)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">5.3</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">6.6</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1.3</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> </table> -19200000 16600000 -35800000 43400000 8700000 34700000 21800000 3800000 18000000.0 -800000 300000 1100000 1600000 21800000 -20200000 7500000 -4900000 12400000 11100000 2300000 8800000 22900000 3900000 19000000 -1000000 -100000 900000 -5300000 -6600000 1300000 <p style="font-size:10pt;margin-top:8pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">10. Fair Value Measurement of Assets and Liabilities</span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The following financial assets and liabilities are recorded at fair value on a recurring basis (in millions):</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:90.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:40.024%;"></td> <td style="width:1.479%;"></td> <td style="width:1%;"></td> <td style="width:11.515%;"></td> <td style="width:1%;"></td> <td style="width:1.479%;"></td> <td style="width:1%;"></td> <td style="width:11.515%;"></td> <td style="width:1%;"></td> <td style="width:1.479%;"></td> <td style="width:1%;"></td> <td style="width:11.515%;"></td> <td style="width:1%;"></td> <td style="width:1.479%;"></td> <td style="width:1%;"></td> <td style="width:11.515%;"></td> <td style="width:1%;"></td> </tr> <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="14" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">As of March 31, 2024</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="10" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Fair Value Measurements at Reporting Date Using:</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"> <td style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Description</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Recorded<br/>Balance</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Quoted Prices<br/>in Active<br/>Markets for<br/>Identical<br/>Assets <br/>(Level 1)</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Significant<br/>Other<br/>Observable<br/>Inputs <br/>(Level 2)</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Significant<br/>Unobservable<br/>Inputs<br/>(Level 3)</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;"> <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Assets</span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"> <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Derivatives designated as hedges, current and long-term</span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span><span style="-sec-ix-hidden:F_f5696f8b-e38f-4429-8f1a-8097552d28fb;"><span style="-sec-ix-hidden:F_d2d078df-d4a6-4b3c-af91-06779b08ed6d;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Foreign currency forward contracts</span></span></span></span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">74.4</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">-</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">74.4</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">-</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span><span style="-sec-ix-hidden:F_cda2d97a-da99-4d7b-a7e0-5af7316fcf45;"><span style="-sec-ix-hidden:F_be43eecd-83ac-439e-a8af-7b46e3dc30cd;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Cross-currency interest rate swaps</span></span></span></span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">27.3</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">-</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">27.3</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">-</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;"> <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Derivatives not designated as hedges, current and long-term</span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span><span style="-sec-ix-hidden:F_cf90e8bf-10bd-4362-84f7-7dc2c39daf87;"><span style="-sec-ix-hidden:F_ae48029b-7f01-4356-8626-8cae50a91a8d;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Foreign currency forward contracts</span></span></span></span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2.4</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">-</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2.4</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">-</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="text-indent:20pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Total Assets</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="border-top:0.5pt solid #000000;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="border-top:0.5pt solid #000000;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">104.1</span></p></td> <td style="border-top:0.5pt solid #ffffff03;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="border-top:0.5pt solid #000000;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="border-top:0.5pt solid #000000;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">-</span></p></td> <td style="border-top:0.5pt solid #ffffff03;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="border-top:0.5pt solid #000000;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="border-top:0.5pt solid #000000;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">104.1</span></p></td> <td style="border-top:0.5pt solid #ffffff03;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="border-top:0.5pt solid #000000;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="border-top:0.5pt solid #000000;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">-</span></p></td> <td style="border-top:0.5pt solid #ffffff03;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"> <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;"> <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Liabilities</span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"> <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Derivatives designated as hedges, current and long-term</span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span><span style="-sec-ix-hidden:F_bed31466-91c7-41c1-9848-b2d60fda396a;"><span style="-sec-ix-hidden:F_553c2821-9211-4d61-9871-8d4f9b77b26c;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Foreign currency forward contracts</span></span></span></span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1.7</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">-</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1.7</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">-</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span><span style="-sec-ix-hidden:F_cd1c8bed-702f-42e5-a396-4a00652dc1b6;"><span style="-sec-ix-hidden:F_11f70a5b-3e61-417d-8a45-93ae0f86d2a7;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Cross-currency interest rate swaps</span></span></span></span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">43.8</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">-</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">43.8</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">-</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span><span style="-sec-ix-hidden:F_e60c78d8-7dd9-4e4e-bf93-ffdefc88a8bb;"><span style="-sec-ix-hidden:F_c5eb6800-88b5-46a3-88b6-30803713c24b;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Interest rate swaps</span></span></span></span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">163.8</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">-</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">163.8</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">-</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"> <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Derivatives not designated as hedges, current and long-term</span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span><span style="-sec-ix-hidden:F_d3bbd046-16a3-4668-8420-8e9c29f66235;"><span style="-sec-ix-hidden:F_ff017bf3-c3af-4eeb-9466-c05863d98f40;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Foreign currency forward contracts</span></span></span></span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1.5</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">-</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1.5</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">-</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Contingent consideration related to acquisitions</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">115.2</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">-</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">-</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">115.2</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="text-indent:20pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Total Liabilities</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">326.0</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">-</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">210.8</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">115.2</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></span></p><div style="font-size:10pt;font-family:Times New Roman;"> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:90.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:40.024%;"></td> <td style="width:1.479%;"></td> <td style="width:1%;"></td> <td style="width:11.515%;"></td> <td style="width:1%;"></td> <td style="width:1.479%;"></td> <td style="width:1%;"></td> <td style="width:11.515%;"></td> <td style="width:1%;"></td> <td style="width:1.479%;"></td> <td style="width:1%;"></td> <td style="width:11.515%;"></td> <td style="width:1%;"></td> <td style="width:1.479%;"></td> <td style="width:1%;"></td> <td style="width:11.515%;"></td> <td style="width:1%;"></td> </tr> <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;"> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="14" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">As of December 31, 2023</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;"> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="10" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Fair Value Measurements at Reporting Date Using:</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"> <td style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Description</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Recorded<br/>Balance</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Quoted Prices<br/>in Active<br/>Markets for<br/>Identical<br/>Assets <br/>(Level 1)</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Significant<br/>Other<br/>Observable<br/>Inputs <br/>(Level 2)</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Significant<br/>Unobservable<br/>Inputs<br/>(Level 3)</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;"> <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Assets</span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"> <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Derivatives designated as hedges, current and long-term</span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span><span style="-sec-ix-hidden:F_bf741c4d-af19-4904-9cbb-dd3fe3a8357a;"><span style="-sec-ix-hidden:F_c662f4a4-06c8-49a6-b528-ddac66d5a120;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Foreign currency forward contracts</span></span></span></span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">54.4</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">-</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">54.4</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">-</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span><span style="-sec-ix-hidden:F_2c8c8475-86a8-4cf0-98eb-323267098f62;"><span style="-sec-ix-hidden:F_814a3620-f08e-44c2-96cb-16858dbac18a;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Cross-currency interest rate swaps</span></span></span></span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">5.4</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">-</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">5.4</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">-</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;"> <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Derivatives not designated as hedges, current and long-term</span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span><span style="-sec-ix-hidden:F_afbebbb7-7487-45ca-a8a0-b55cf69df1e5;"><span style="-sec-ix-hidden:F_36551e82-7dc2-4276-91cd-45988092df7f;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Foreign currency forward contracts</span></span></span></span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">0.4</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">-</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">0.4</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">-</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Total Assets</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="border-top:0.5pt solid #000000;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="border-top:0.5pt solid #000000;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">60.2</span></p></td> <td style="border-top:0.5pt solid #ffffff03;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="border-top:0.5pt solid #000000;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="border-top:0.5pt solid #000000;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">-</span></p></td> <td style="border-top:0.5pt solid #ffffff03;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="border-top:0.5pt solid #000000;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="border-top:0.5pt solid #000000;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">60.2</span></p></td> <td style="border-top:0.5pt solid #ffffff03;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="border-top:0.5pt solid #000000;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="border-top:0.5pt solid #000000;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">-</span></p></td> <td style="border-top:0.5pt solid #ffffff03;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"> <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;"> <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Liabilities</span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"> <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Derivatives designated as hedges, current and long-term</span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span><span style="-sec-ix-hidden:F_bfbc3cc5-8880-4f14-ab44-8bbe8334397a;"><span style="-sec-ix-hidden:F_3c2c1f06-0296-43ba-992c-2befbdc89511;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Foreign currency forward contracts</span></span></span></span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">3.7</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">-</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">3.7</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">-</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span><span style="-sec-ix-hidden:F_68670cce-2a64-417c-8c33-00c91da8acb7;"><span style="-sec-ix-hidden:F_f2610181-1772-4175-b6f5-07ffcc74af77;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Cross-currency interest rate swaps</span></span></span></span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">68.1</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">-</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">68.1</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">-</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span><span style="-sec-ix-hidden:F_8dae4002-681f-4621-9b14-82c09be405f3;"><span style="-sec-ix-hidden:F_6404dfb8-1c40-4ba5-89bd-c90c331fa7aa;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Interest rate swaps</span></span></span></span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">144.7</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">-</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">144.7</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">-</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"> <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Derivatives not designated as hedges, current and long-term</span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span><span style="-sec-ix-hidden:F_b0e1c0e1-501b-4c0d-b8dd-dd3d3566b926;"><span style="-sec-ix-hidden:F_010f90a4-aa3f-4056-8699-2c6de9ae13b4;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Foreign currency forward contracts</span></span></span></span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1.6</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">-</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1.6</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">-</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Contingent consideration related to acquisitions</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">141.7</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">-</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">-</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">141.7</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Total Liabilities</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">359.8</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">-</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">218.1</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">141.7</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> </table></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">We value our foreign currency forward contracts using a market approach based on foreign currency exchange rates obtained from active markets, and we perform ongoing assessments of counterparty credit risk.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">We value our interest rate swaps using a market approach based on publicly available market yield curves and the terms of our swaps, and we perform ongoing assessments of counterparty credit risk. The valuation of our cross-currency interest rate swaps also includes consideration of foreign currency exchange rates.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Contingent payments related to acquisitions consist of sales-based payments and regulatory milestones, and are valued using discounted cash flow techniques. The fair value of sales-based payments is based upon significant unobservable inputs such as probability-weighted future revenue estimates and simulating the numerous potential outcomes, and changes as revenue estimates increase or decrease. The fair value of the regulatory milestones is based on the probability of success in obtaining the specified regulatory approval.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Contingent payments related to the Embody acquisition are to be settled by issuance of our common stock and cash payments. The Embody acquisition is discussed in Note 7. During the three-month period ended March 31, 2024, we issued </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">0.2</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million shares of our common stock valued at $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">23.4</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million and paid $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">1.5</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million of cash for a commercial milestone related to the Embody acquisition. The fair value of common stock was determined to be $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">123.87</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> per share, which represented the average of our high and low stock prices on the settlement date. To minimize dilution from issuing shares for the milestone settlement, we repurchased </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">0.2</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million shares of our common stock in February of 2024.</span></p><div style="font-size:12pt;font-family:Times New Roman;"><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The following table provides a reconciliation of the beginning and ending balances of items measured at fair value on a recurring basis in the tables above that used significant unobservable inputs (Level 3) (in millions):</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> </span></p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:84.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:77.96%;"></td> <td style="width:3.08%;"></td> <td style="width:1%;"></td> <td style="width:16.959999999999997%;"></td> <td style="width:1%;"></td> </tr> <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;"> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Level 3 - Liabilities</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;"> <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Contingent payments related to acquisitions</span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Beginning balance December 31, 2023</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">141.7</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span><span style="-sec-ix-hidden:F_422ae5b2-f404-41f4-b4b4-52fe55f686b8;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Change in estimates</span></span></span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1.6</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Settlements</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">24.9</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Ending balance March 31, 2024</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="border-top:0.5pt solid #000000;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="border-top:0.5pt solid #000000;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">115.2</span></p></td> <td style="border-top:0.5pt solid #ffffff03;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></div><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Changes in estimates for contingent payments related to acquisitions are recognized in the Acquisition, integration, divestiture and related line item on our condensed consolidated statements of earnings.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p> <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The following financial assets and liabilities are recorded at fair value on a recurring basis (in millions):</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:90.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:40.024%;"></td> <td style="width:1.479%;"></td> <td style="width:1%;"></td> <td style="width:11.515%;"></td> <td style="width:1%;"></td> <td style="width:1.479%;"></td> <td style="width:1%;"></td> <td style="width:11.515%;"></td> <td style="width:1%;"></td> <td style="width:1.479%;"></td> <td style="width:1%;"></td> <td style="width:11.515%;"></td> <td style="width:1%;"></td> <td style="width:1.479%;"></td> <td style="width:1%;"></td> <td style="width:11.515%;"></td> <td style="width:1%;"></td> </tr> <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="14" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">As of March 31, 2024</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="10" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Fair Value Measurements at Reporting Date Using:</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"> <td style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Description</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Recorded<br/>Balance</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Quoted Prices<br/>in Active<br/>Markets for<br/>Identical<br/>Assets <br/>(Level 1)</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Significant<br/>Other<br/>Observable<br/>Inputs <br/>(Level 2)</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Significant<br/>Unobservable<br/>Inputs<br/>(Level 3)</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;"> <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Assets</span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"> <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Derivatives designated as hedges, current and long-term</span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span><span style="-sec-ix-hidden:F_f5696f8b-e38f-4429-8f1a-8097552d28fb;"><span style="-sec-ix-hidden:F_d2d078df-d4a6-4b3c-af91-06779b08ed6d;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Foreign currency forward contracts</span></span></span></span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">74.4</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">-</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">74.4</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">-</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span><span style="-sec-ix-hidden:F_cda2d97a-da99-4d7b-a7e0-5af7316fcf45;"><span style="-sec-ix-hidden:F_be43eecd-83ac-439e-a8af-7b46e3dc30cd;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Cross-currency interest rate swaps</span></span></span></span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">27.3</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">-</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">27.3</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">-</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;"> <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Derivatives not designated as hedges, current and long-term</span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span><span style="-sec-ix-hidden:F_cf90e8bf-10bd-4362-84f7-7dc2c39daf87;"><span style="-sec-ix-hidden:F_ae48029b-7f01-4356-8626-8cae50a91a8d;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Foreign currency forward contracts</span></span></span></span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2.4</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">-</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2.4</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">-</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="text-indent:20pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Total Assets</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="border-top:0.5pt solid #000000;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="border-top:0.5pt solid #000000;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">104.1</span></p></td> <td style="border-top:0.5pt solid #ffffff03;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="border-top:0.5pt solid #000000;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="border-top:0.5pt solid #000000;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">-</span></p></td> <td style="border-top:0.5pt solid #ffffff03;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="border-top:0.5pt solid #000000;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="border-top:0.5pt solid #000000;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">104.1</span></p></td> <td style="border-top:0.5pt solid #ffffff03;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="border-top:0.5pt solid #000000;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="border-top:0.5pt solid #000000;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">-</span></p></td> <td style="border-top:0.5pt solid #ffffff03;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"> <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;"> <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Liabilities</span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"> <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Derivatives designated as hedges, current and long-term</span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span><span style="-sec-ix-hidden:F_bed31466-91c7-41c1-9848-b2d60fda396a;"><span style="-sec-ix-hidden:F_553c2821-9211-4d61-9871-8d4f9b77b26c;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Foreign currency forward contracts</span></span></span></span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1.7</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">-</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1.7</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">-</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span><span style="-sec-ix-hidden:F_cd1c8bed-702f-42e5-a396-4a00652dc1b6;"><span style="-sec-ix-hidden:F_11f70a5b-3e61-417d-8a45-93ae0f86d2a7;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Cross-currency interest rate swaps</span></span></span></span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">43.8</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">-</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">43.8</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">-</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span><span style="-sec-ix-hidden:F_e60c78d8-7dd9-4e4e-bf93-ffdefc88a8bb;"><span style="-sec-ix-hidden:F_c5eb6800-88b5-46a3-88b6-30803713c24b;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Interest rate swaps</span></span></span></span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">163.8</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">-</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">163.8</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">-</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"> <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Derivatives not designated as hedges, current and long-term</span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span><span style="-sec-ix-hidden:F_d3bbd046-16a3-4668-8420-8e9c29f66235;"><span style="-sec-ix-hidden:F_ff017bf3-c3af-4eeb-9466-c05863d98f40;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Foreign currency forward contracts</span></span></span></span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1.5</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">-</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1.5</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">-</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Contingent consideration related to acquisitions</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">115.2</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">-</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">-</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">115.2</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="text-indent:20pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Total Liabilities</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">326.0</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">-</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">210.8</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">115.2</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:90.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:40.024%;"></td> <td style="width:1.479%;"></td> <td style="width:1%;"></td> <td style="width:11.515%;"></td> <td style="width:1%;"></td> <td style="width:1.479%;"></td> <td style="width:1%;"></td> <td style="width:11.515%;"></td> <td style="width:1%;"></td> <td style="width:1.479%;"></td> <td style="width:1%;"></td> <td style="width:11.515%;"></td> <td style="width:1%;"></td> <td style="width:1.479%;"></td> <td style="width:1%;"></td> <td style="width:11.515%;"></td> <td style="width:1%;"></td> </tr> <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;"> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="14" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">As of December 31, 2023</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;"> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="10" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Fair Value Measurements at Reporting Date Using:</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"> <td style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Description</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Recorded<br/>Balance</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Quoted Prices<br/>in Active<br/>Markets for<br/>Identical<br/>Assets <br/>(Level 1)</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Significant<br/>Other<br/>Observable<br/>Inputs <br/>(Level 2)</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Significant<br/>Unobservable<br/>Inputs<br/>(Level 3)</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;"> <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Assets</span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"> <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Derivatives designated as hedges, current and long-term</span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span><span style="-sec-ix-hidden:F_bf741c4d-af19-4904-9cbb-dd3fe3a8357a;"><span style="-sec-ix-hidden:F_c662f4a4-06c8-49a6-b528-ddac66d5a120;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Foreign currency forward contracts</span></span></span></span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">54.4</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">-</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">54.4</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">-</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span><span style="-sec-ix-hidden:F_2c8c8475-86a8-4cf0-98eb-323267098f62;"><span style="-sec-ix-hidden:F_814a3620-f08e-44c2-96cb-16858dbac18a;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Cross-currency interest rate swaps</span></span></span></span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">5.4</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">-</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">5.4</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">-</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;"> <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Derivatives not designated as hedges, current and long-term</span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span><span style="-sec-ix-hidden:F_afbebbb7-7487-45ca-a8a0-b55cf69df1e5;"><span style="-sec-ix-hidden:F_36551e82-7dc2-4276-91cd-45988092df7f;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Foreign currency forward contracts</span></span></span></span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">0.4</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">-</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">0.4</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">-</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Total Assets</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="border-top:0.5pt solid #000000;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="border-top:0.5pt solid #000000;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">60.2</span></p></td> <td style="border-top:0.5pt solid #ffffff03;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="border-top:0.5pt solid #000000;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="border-top:0.5pt solid #000000;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">-</span></p></td> <td style="border-top:0.5pt solid #ffffff03;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="border-top:0.5pt solid #000000;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="border-top:0.5pt solid #000000;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">60.2</span></p></td> <td style="border-top:0.5pt solid #ffffff03;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="border-top:0.5pt solid #000000;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="border-top:0.5pt solid #000000;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">-</span></p></td> <td style="border-top:0.5pt solid #ffffff03;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"> <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;"> <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Liabilities</span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"> <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Derivatives designated as hedges, current and long-term</span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span><span style="-sec-ix-hidden:F_bfbc3cc5-8880-4f14-ab44-8bbe8334397a;"><span style="-sec-ix-hidden:F_3c2c1f06-0296-43ba-992c-2befbdc89511;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Foreign currency forward contracts</span></span></span></span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">3.7</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">-</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">3.7</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">-</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span><span style="-sec-ix-hidden:F_68670cce-2a64-417c-8c33-00c91da8acb7;"><span style="-sec-ix-hidden:F_f2610181-1772-4175-b6f5-07ffcc74af77;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Cross-currency interest rate swaps</span></span></span></span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">68.1</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">-</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">68.1</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">-</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span><span style="-sec-ix-hidden:F_8dae4002-681f-4621-9b14-82c09be405f3;"><span style="-sec-ix-hidden:F_6404dfb8-1c40-4ba5-89bd-c90c331fa7aa;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Interest rate swaps</span></span></span></span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">144.7</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">-</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">144.7</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">-</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"> <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Derivatives not designated as hedges, current and long-term</span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span><span style="-sec-ix-hidden:F_b0e1c0e1-501b-4c0d-b8dd-dd3d3566b926;"><span style="-sec-ix-hidden:F_010f90a4-aa3f-4056-8699-2c6de9ae13b4;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Foreign currency forward contracts</span></span></span></span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1.6</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">-</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1.6</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">-</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Contingent consideration related to acquisitions</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">141.7</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">-</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">-</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">141.7</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Total Liabilities</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">359.8</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">-</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">218.1</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">141.7</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> </table> 74400000 74400000 27300000 27300000 2400000 2400000 104100000 104100000 1700000 1700000 43800000 43800000 163800000 163800000 1500000 1500000 115200000 115200000 326000000.0 210800000 115200000 54400000 54400000 5400000 5400000 400000 400000 60200000 60200000 3700000 3700000 68100000 68100000 144700000 144700000 1600000 1600000 141700000 141700000 359800000 218100000 141700000 200000 23400000 1500000 123.87 200000 <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The following table provides a reconciliation of the beginning and ending balances of items measured at fair value on a recurring basis in the tables above that used significant unobservable inputs (Level 3) (in millions):</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> </span></p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:84.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:77.96%;"></td> <td style="width:3.08%;"></td> <td style="width:1%;"></td> <td style="width:16.959999999999997%;"></td> <td style="width:1%;"></td> </tr> <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;"> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Level 3 - Liabilities</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;"> <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Contingent payments related to acquisitions</span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Beginning balance December 31, 2023</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">141.7</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span><span style="-sec-ix-hidden:F_422ae5b2-f404-41f4-b4b4-52fe55f686b8;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Change in estimates</span></span></span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1.6</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Settlements</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">24.9</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Ending balance March 31, 2024</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="border-top:0.5pt solid #000000;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="border-top:0.5pt solid #000000;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">115.2</span></p></td> <td style="border-top:0.5pt solid #ffffff03;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p> 141700000 -1600000 -24900000 115200000 <p style="font-size:10pt;margin-top:8pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">11. Derivative Instruments and Hedging Activities</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">We are exposed to certain market risks relating to our ongoing business operations, including foreign currency exchange rate risk, commodity price risk, interest rate risk and credit risk. We manage our exposure to these and other market risks through regular operating and financing activities. Currently, the only risks that we manage through the use of derivative instruments are interest rate risk and foreign currency exchange rate risk.</span></p><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Interest Rate Risk</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Derivatives Designated as Fair Value Hedges</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">We currently use fixed-to-variable interest rate swaps to manage our exposure to interest rate risk from our cash investments and debt portfolio. These derivative instruments are designated as fair value hedges under GAAP. Changes in the fair value of the derivative instrument are recorded in current earnings and are offset by gains or losses on the underlying debt instrument.</span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">As of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">March 31, 2024 and December 31, 2023, the following amounts were recorded on our condensed consolidated balance sheets related to cumulative basis adjustments for fair value hedges (in millions):</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:26.28%;"></td> <td style="width:1.48%;"></td> <td style="width:1%;"></td> <td style="width:14.58%;"></td> <td style="width:1%;"></td> <td style="width:1.48%;"></td> <td style="width:1%;"></td> <td style="width:14.58%;"></td> <td style="width:1%;"></td> <td style="width:1.48%;"></td> <td style="width:1.48%;"></td> <td style="width:1%;"></td> <td style="width:14.58%;"></td> <td style="width:1%;"></td> <td style="width:1.48%;"></td> <td style="width:1%;"></td> <td style="width:14.58%;"></td> <td style="width:1%;"></td> </tr> <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="6" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Carrying Amount of the Hedged Liabilities</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="6" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Cumulative Amount of Fair Value Hedging Adjustment Included in the Carrying Amount of the Hedged Liabilities</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"> <td style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Balance Sheet Line Item</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">March 31, 2024</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">December 31, 2023</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">March 31, 2024</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">December 31, 2023</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Long-term debt</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">832.3</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">851.3</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">163.7</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">144.7</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> </tr> </table></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Derivatives Designated as Cash Flow Hedges</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">In 2014, we entered into forward starting interest rate swaps that were designated as cash flow hedges of our </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">thirty-year</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> tranche of senior notes due 2045 we expected to issue in 2015. The forward starting interest rate swaps mitigated the risk of changes in interest rates prior to the completion of the notes offering. The interest rate swaps were settled, and the remaining loss to be recognized at </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">March 31, 2024 was </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">23.7</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million, which will be recognized using the effective interest rate method over the remaining maturity period of the hedged notes.</span></p><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Foreign Currency Exchange Rate Risk</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">We operate on a global basis and are exposed to the risk that our financial condition, results of operations and cash flows could be adversely affected by changes in foreign currency exchange rates. To reduce the potential effects of foreign currency exchange rate movements on net earnings, we enter into derivative financial instruments in the form of foreign currency exchange forward contracts with major financial institutions. We also designated our Euro Notes as net investment hedges of investments in foreign subsidiaries. We are primarily exposed to foreign currency exchange rate risk with respect to transactions and net assets denominated in Euros, Swiss Francs, Japanese Yen, British Pounds, Chinese Renmimbi, Canadian Dollars, Australian Dollars, Korean Won, Swedish Krona, Czech Koruna, Thai Baht, Taiwan Dollars, South African Rand, Russian Rubles, Indian Rupees, Turkish Lira, Polish Zloty, Danish Krone, and Norwegian Krone. We do not use derivative financial instruments for trading or speculative purposes.</span></p><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Derivatives Designated as Net Investment Hedges</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">We are exposed to the impact of foreign exchange rate fluctuations in the investments in our wholly-owned foreign subsidiaries that are denominated in currencies other than the U.S. Dollar. In order to mitigate the volatility in foreign exchange rates, we issued Euro Notes in December 2016 and November 2019 and designated </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">100</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> percent of the Euro Notes to hedge our net investment in certain wholly-owned foreign subsidiaries that have a functional currency of the Euro. All changes in the fair value of a hedging instrument designated as a net investment hedge are recorded as a component of AOCI in the condensed consolidated balance sheets.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">At March 31, 2024, we had receive-fixed-rate, pay-fixed-rate cross-currency interest swaps with notional amounts outstanding of Euro </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">700</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million, Japanese Yen </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">54.1</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> billion and Swiss Franc </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">125</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million. These transactions further hedge our net investment in certain wholly-owned foreign subsidiaries that have a functional currency of Euro, Japanese Yen and Swiss Franc. All changes in the fair value of a derivative instrument designated as a net investment hedge are recorded as a component of AOCI in the condensed consolidated balance sheets. The portion of this change related to the excluded component will be amortized into earnings over the life of the derivative while the remainder will be recorded in AOCI until the hedged net investment is sold or substantially liquidated. We recognize the excluded component in interest expense, net on our condensed consolidated statements of earnings. The net cash received related to the receive-fixed-rate, pay-fixed-rate component of the cross-currency interest rate swaps is reflected in investing cash flows in our condensed consolidated statements of cash flows. In the three-month period ended March 31, 2023, Euro </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">100</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">and Swiss Franc </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">50</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million of these cross-currency interest rate swaps matured at a gain of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">6.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million and loss of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">3.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million, respectively. The settlement of these gains and losses with the counterparties is reflected in investing cash flows in our condensed consolidated statements of cash flows and will remain in AOCI on our condensed consolidated balance sheet until the hedged net investment is sold or substantially liquidated. </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">No</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> cross-currency interest rate swaps matured in the three-month period ended March 31, 2024.</span></p><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Derivatives Designated as Cash Flow Hedges</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Our revenues are generated in various currencies throughout the world. However, a significant amount of our inventory is produced in U.S. Dollars. Therefore, movements in foreign currency exchange rates may have different proportional effects on our revenues compared to our cost of products sold. To minimize the effects of foreign currency exchange rate movements on cash flows, we hedge intercompany sales of inventory expected to occur within the next </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">30</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> months with foreign currency exchange forward contracts. We designate these derivative instruments as cash flow hedges.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">We perform quarterly assessments of hedge effectiveness by verifying and documenting the critical terms of the hedge instrument and confirming that forecasted transactions have not changed significantly. We also assess on a quarterly basis whether there have been adverse developments regarding the risk of a counterparty default. For derivatives which qualify as hedges of future cash flows, the gains and losses are temporarily recorded in AOCI and then recognized in cost of products sold when the hedged item affects net earnings. On our condensed consolidated statements of cash flows, the settlements of these cash flow hedges are recognized in operating cash flows.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">For foreign currency exchange forward contracts and options outstanding at March 31, 2024, we had obligations to purchase U.S. Dollars and sell Euros, Japanese Yen, British Pounds, Canadian Dollars, Australian Dollars, Korean Won, Swedish Krona, Czech Koruna, Thai Baht, Taiwan Dollars, South African Rand, Indian Rupees, Polish Zloty, Danish Krone, and Norwegian Krone and obligations to purchase Swiss Francs and sell U.S. Dollars. These derivatives mature at dates ranging from April 2024 through August 2026. As of March 31, 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">, the notional amounts of outstanding forward contracts and options entered into with third parties to purchase U.S. Dollars were $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">1,526.7</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million. As of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">March 31, 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">, the notional amounts of outstanding forward contracts and options entered into with third parties to purchase Swiss Francs were $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">435.4</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million.</span></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Derivatives Not Designated as Hedging Instruments</span></p><p style="text-indent:5%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">We enter into foreign currency forward exchange contracts with terms of one to three months to manage currency exposures for monetary assets and liabilities denominated in a currency other than an entity’s functional currency. As a result, any foreign currency remeasurement gains/losses recognized in earnings are generally offset with gains/losses on the foreign currency forward exchange contracts in the same reporting period. The net amount of these offsetting gains/losses is recorded in other (expense) income, net. Any outstanding contracts are recorded on the balance sheet at fair value as of the end of the reporting period. The notional amounts of these contracts are typically in a range of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">1.25</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> billion to $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">1.75</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> billion per quarter.</span></p><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Income Statement Presentation</span></p><p style="font-size:10pt;margin-top:8pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Derivatives Designated as Cash Flow Hedges</span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Derivative instruments designated as cash flow hedges had the following effects, before taxes, on AOCI and net earnings on our condensed consolidated statements of earnings, condensed consolidated statements of comprehensive income and condensed consolidated balance sheets (in millions):</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:23.591%;"></td> <td style="width:1.679%;"></td> <td style="width:1%;"></td> <td style="width:7.776999999999999%;"></td> <td style="width:1%;"></td> <td style="width:1.679%;"></td> <td style="width:1%;"></td> <td style="width:7.776999999999999%;"></td> <td style="width:1%;"></td> <td style="width:1.679%;"></td> <td style="width:28.908%;"></td> <td style="width:1.679%;"></td> <td style="width:1%;"></td> <td style="width:7.776999999999999%;"></td> <td style="width:1%;"></td> <td style="width:1.679%;"></td> <td style="width:1%;"></td> <td style="width:7.776999999999999%;"></td> <td style="width:1%;"></td> </tr> <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="6" style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Amount of Gain</span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="6" style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Amount of Gain (Loss)</span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="6" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Recognized in AOCI</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="6" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Reclassified from AOCI</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="6" style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Three Months Ended</span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="6" style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Three Months Ended</span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="6" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">March 31,</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Location on</span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="6" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">March 31,</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"> <td style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Derivative Instrument</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2024</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2023</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Statements of Earnings</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2024</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2023</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Foreign exchange<br/>   forward contracts</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">43.4</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">11.1</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span><span style="-sec-ix-hidden:F_92b5ddaf-fd21-44d3-926b-1e7570574fbc;"><span style="-sec-ix-hidden:F_5361be90-571e-4f02-9349-d075b51bfbf9;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Cost of products sold</span></span></span></span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">22.0</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">23.1</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Forward starting<br/>   interest rate swaps</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">-</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">-</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span><span style="-sec-ix-hidden:F_b2cfd198-996f-4f6d-8879-d9905e2f6f23;"><span style="-sec-ix-hidden:F_b61d1f4b-42f1-42cc-90ad-5622976efc92;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Interest expense, net</span></span></span></span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">0.2</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">0.2</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">43.4</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">11.1</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">21.8</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">22.9</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></div><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The fair value of outstanding derivative instruments designated as cash flow hedges and recorded on our condensed consolidated balance sheet at March 31, 2024, together with settled derivatives where the hedged item has not yet affected earnings, was a net unrealized gain of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">93.1</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million, or </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">79.9</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million after taxes, which is deferred in AOCI. A gain of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">75.2</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million, or </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">62.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million after taxes, is expected to be reclassified to earnings in cost of products sold and a loss of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">0.7</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million, or </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">0.5</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million after taxes, is expected to be reclassified to earnings in interest expense, net over the next twelve months.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The following table presents the effect of fair value, cash flow and net investment hedge accounting on our condensed consolidated statements of earnings (in millions):</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:55.26%;"></td> <td style="width:1.66%;"></td> <td style="width:1%;"></td> <td style="width:7.84%;"></td> <td style="width:1%;"></td> <td style="width:1.24%;"></td> <td style="width:1%;"></td> <td style="width:7.84%;"></td> <td style="width:1%;"></td> <td style="width:1.24%;"></td> <td style="width:1%;"></td> <td style="width:7.84%;"></td> <td style="width:1%;"></td> <td style="width:1.24%;"></td> <td style="width:1%;"></td> <td style="width:7.84%;"></td> <td style="width:1%;"></td> </tr> <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="14" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Location and Amount of Gain/(Loss) Recognized in Income on Fair Value, Cash Flow and Net Investment Hedging Relationships</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="6" style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Three Months Ended</span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="6" style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Three Months Ended</span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="6" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">March 31, 2024</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="6" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">March 31, 2023</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="font-size:8pt;"><span style="-sec-ix-hidden:F_4b4a5e37-a370-4411-b2f8-6ed594bc9065;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Cost of</span></span></span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="font-size:8pt;"><span style="-sec-ix-hidden:F_d2e66eac-3663-4409-8c6b-2c4838a59bf0;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Interest</span></span></span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="font-size:8pt;"><span style="-sec-ix-hidden:F_c99c4bac-4bcc-4c47-a48f-000678e2fe5c;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Cost of</span></span></span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="font-size:8pt;"><span style="-sec-ix-hidden:F_a854c6ae-1d31-438e-a809-53b98cd9bae1;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Interest</span></span></span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Products</span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Expense,</span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Products</span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Expense,</span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Sold</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Net</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Sold</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Net</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Total amounts of income and expense line items presented in the statements of earnings in which the effects of fair value, cash flow and net investment hedges are recorded</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;color:#000000;white-space:pre-wrap;min-width:fit-content;">512.3</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:8pt;min-width:fit-content;">(</span><span style="font-size:8pt;color:#000000;white-space:pre-wrap;min-width:fit-content;">50.7</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;color:#000000;white-space:pre-wrap;min-width:fit-content;">500.8</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:8pt;min-width:fit-content;">(</span><span style="font-size:8pt;color:#000000;white-space:pre-wrap;min-width:fit-content;">48.2</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> </tr> <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"> <td colspan="4" style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">        The effects of fair value, cash flow and net investment hedging:</span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;"> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">             Gain (loss) on fair value hedging <br/>                  relationships</span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">                       Interest rate swaps</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">-</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:8pt;min-width:fit-content;">(</span><span style="font-size:8pt;color:#000000;white-space:pre-wrap;min-width:fit-content;">10.6</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">-</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:8pt;min-width:fit-content;">(</span><span style="font-size:8pt;color:#000000;white-space:pre-wrap;min-width:fit-content;">8.2</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> </tr> <tr style="height:8pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;"> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">             Gain (loss) on cash flow hedging <br/>                  relationships</span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">                       Foreign exchange forward contracts</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;color:#000000;white-space:pre-wrap;min-width:fit-content;">22.0</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">-</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;color:#000000;white-space:pre-wrap;min-width:fit-content;">23.1</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">-</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">                       Forward starting interest rate swaps</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">-</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:8pt;min-width:fit-content;">(</span><span style="font-size:8pt;color:#000000;white-space:pre-wrap;min-width:fit-content;">0.2</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">-</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:8pt;min-width:fit-content;">(</span><span style="font-size:8pt;color:#000000;white-space:pre-wrap;min-width:fit-content;">0.2</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> </tr> <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">             Gain on net investment hedging <br/>                  relationships</span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">                       Cross-currency interest rate swaps</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">-</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;color:#000000;white-space:pre-wrap;min-width:fit-content;">8.2</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">-</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;color:#000000;white-space:pre-wrap;min-width:fit-content;">9.0</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> </table></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Derivatives Not Designated as Hedging Instruments</span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The following gains / (losses) from these derivative instruments were recognized on our condensed consolidated statements of earnings (in millions):</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:41.128%;"></td> <td style="width:1.98%;"></td> <td style="width:29.606%;"></td> <td style="width:1.8%;"></td> <td style="width:1%;"></td> <td style="width:9.842%;"></td> <td style="width:1%;"></td> <td style="width:1.8%;"></td> <td style="width:1%;"></td> <td style="width:9.842%;"></td> <td style="width:1%;"></td> </tr> <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="6" style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Three Months Ended</span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Location on</span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="6" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">March 31,</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"> <td style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Derivative Instrument</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Statements of Earnings</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2024</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2023</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Foreign exchange forward contracts</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Other (expense) income, net</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">8.4</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">3.6</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> </tr> </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></div><p style="text-indent:4.533%;font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">These gains / (losses) do not reflect offsetting losses of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">12.2</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million in the three-month period ended March 31, 2024, and offsetting gains of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">0.4</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> in the three-month period ended March 31, 2023, recognized in other income (expense), net as a result of foreign currency remeasurement of monetary assets and liabilities denominated in a currency other than an entity’s functional currency.</span></p><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Balance Sheet Presentation</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">As of March 31, 2024 and December 31, 2023</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">, all derivatives designated as fair value hedges, cash flow hedges and net investment hedges are recorded at fair value on our condensed consolidated balance sheets. On our condensed consolidated balance sheets, we recognize individual forward contracts with the same counterparty on a net asset/liability basis if we have a master netting agreement with the counterparty. Under these master netting agreements, we are able to settle derivative instrument assets and liabilities with the same counterparty in a single transaction, instead of settling each derivative instrument separately. We have master netting agreements with substantially all of our counterparties. </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The fair value of derivative instruments on a gross basis is as follows (in millions):</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:35.134%;"></td> <td style="width:1.18%;"></td> <td style="width:21.269%;"></td> <td style="width:1.18%;"></td> <td style="width:1%;"></td> <td style="width:6.803000000000001%;"></td> <td style="width:1%;"></td> <td style="width:1.18%;"></td> <td style="width:21.269%;"></td> <td style="width:1.18%;"></td> <td style="width:1%;"></td> <td style="width:6.803000000000001%;"></td> <td style="width:1%;"></td> </tr> <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="4" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">As of March 31, 2024</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="4" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">As of December 31, 2023</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Balance</span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Balance</span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Sheet</span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Fair</span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Sheet</span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Fair</span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Location</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Value</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Location</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Value</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;"> <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-style:italic;min-width:fit-content;">Asset Derivatives Designated as Hedges</span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="text-indent:20pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Foreign exchange forward contracts</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Other current assets</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">66.3</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Other current assets</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">58.4</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="text-indent:20pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Cross-currency interest rate swaps</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Other current assets</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">-</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Other current assets</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">-</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="text-indent:20pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Foreign exchange forward contracts</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Other assets</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">21.2</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Other assets</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">17.2</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="text-indent:20pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Cross-currency interest rate swaps</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Other assets</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">27.3</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Other assets</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">5.4</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Total asset derivatives</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">114.8</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">81.0</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;"> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"> <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-style:italic;min-width:fit-content;">Asset Derivatives Not Designated as Hedges</span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="text-indent:20pt;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Foreign exchange forward contracts</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Other current assets</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">3.7</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Other current assets</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1.2</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"> <td style="text-indent:20pt;vertical-align:top;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;"> <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-style:italic;min-width:fit-content;">Liability Derivatives Designated as Hedges</span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="text-indent:20pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Foreign exchange forward contracts</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Other current liabilities</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">8.5</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Other current liabilities</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">13.9</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="text-indent:20pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Cross-currency interest rate swaps</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Other current liabilities</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">35.0</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Other current liabilities</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">33.3</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="text-indent:20pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Foreign exchange forward contracts</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Other long-term liabilities</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">6.3</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Other long-term liabilities</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">11.0</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="text-indent:20pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Cross-currency interest rate swaps</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Other long-term liabilities</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">8.8</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Other long-term liabilities</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">34.8</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="text-indent:20pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Interest rate swaps</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Other long-term liabilities</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">163.8</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Other long-term liabilities</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">144.7</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Total liability derivatives</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">222.4</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">237.7</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"> <td style="text-indent:20pt;vertical-align:top;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;"> <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-style:italic;min-width:fit-content;">Liability Derivatives Not Designated as Hedges</span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="text-indent:20pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Foreign exchange forward contracts</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Other current liabilities</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2.8</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Other current liabilities</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2.4</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> </table></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="text-indent:4.533%;font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The table below presents the effects of our master netting agreements on our condensed consolidated balance sheets (in millions):</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:22.655%;"></td> <td style="width:1.12%;"></td> <td style="width:19.956%;"></td> <td style="width:1.12%;"></td> <td style="width:1%;"></td> <td style="width:6.259%;"></td> <td style="width:1%;"></td> <td style="width:1.12%;"></td> <td style="width:1%;"></td> <td style="width:6.259%;"></td> <td style="width:1%;"></td> <td style="width:1.12%;"></td> <td style="width:1%;"></td> <td style="width:6.259%;"></td> <td style="width:1%;"></td> <td style="width:1.12%;"></td> <td style="width:1%;"></td> <td style="width:6.259%;"></td> <td style="width:1%;"></td> <td style="width:1.12%;"></td> <td style="width:1%;"></td> <td style="width:6.259%;"></td> <td style="width:1%;"></td> <td style="width:1.12%;"></td> <td style="width:1%;"></td> <td style="width:6.259%;"></td> <td style="width:1%;"></td> </tr> <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="10" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">As of March 31, 2024</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="10" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">As of December 31, 2023</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"> <td style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Description</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Location</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Gross<br/>Amount</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Offset</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Net Amount in<br/>Balance Sheet</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Gross<br/>Amount</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Offset</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Net Amount in<br/>Balance Sheet</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;"> <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-style:italic;min-width:fit-content;">Asset Derivatives</span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Cash flow hedges</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span><span style="-sec-ix-hidden:F_1f71d066-e8d1-47c3-b1c8-0e7eb7e649c6;"><span style="-sec-ix-hidden:F_cc591cf8-ea2f-462f-8d3e-332e0016324e;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Other current assets</span></span></span></span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">66.3</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">8.4</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">57.9</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">58.4</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">13.0</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">45.4</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Cash flow hedges</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span><span style="-sec-ix-hidden:F_bf07857d-2fd5-46f1-a15e-8849a24f6028;"><span style="-sec-ix-hidden:F_359f6c98-0041-4df7-80fc-ebf673ce9e8a;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Other assets</span></span></span></span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">21.2</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">4.7</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">16.5</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">17.2</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">8.2</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">9.0</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Derivatives Not Designated as Hedges</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span><span style="-sec-ix-hidden:F_4ce826d2-2f19-4a87-810f-0fab7d2e8237;"><span style="-sec-ix-hidden:F_37b4da1d-a0ca-4431-87b9-07b36d7126da;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Other current assets</span></span></span></span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">3.7</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1.3</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2.4</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1.2</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">0.8</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">0.4</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"> <td style="text-indent:10pt;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;"> <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-style:italic;min-width:fit-content;">Liability Derivatives</span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Cash flow hedges</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span><span style="-sec-ix-hidden:F_170af71a-e1d1-4814-a0d7-010c46331a58;"><span style="-sec-ix-hidden:F_2b074a4d-4e56-491d-a6e8-dfa1a93871dc;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Other current liabilities</span></span></span></span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">8.5</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">8.4</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">0.1</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">13.9</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">13.0</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">0.9</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Cash flow hedges</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span><span style="-sec-ix-hidden:F_a39ff77f-420e-4413-8b1a-7915c755ccf6;"><span style="-sec-ix-hidden:F_dc348431-4a20-4740-89fe-ca43fb1686e4;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Other long-term liabilities</span></span></span></span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">6.3</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">4.7</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1.6</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">11.0</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">8.2</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2.8</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Derivatives Not Designated as Hedges</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span><span style="-sec-ix-hidden:F_4dd80ba7-e83c-4475-9a42-ef6abe7434c4;"><span style="-sec-ix-hidden:F_00ab5103-0784-4736-9184-a256329d3398;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Other current liabilities</span></span></span></span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2.8</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1.3</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1.5</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2.4</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">0.8</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1.6</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> </table></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The following net investment hedge gains (losses) were recognized on our condensed consolidated statements of comprehensive income (in millions):</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:90.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:70.234%;"></td> <td style="width:1.98%;"></td> <td style="width:1%;"></td> <td style="width:10.902000000000001%;"></td> <td style="width:1%;"></td> <td style="width:1.98%;"></td> <td style="width:1%;"></td> <td style="width:10.902000000000001%;"></td> <td style="width:1%;"></td> </tr> <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="6" style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Amount of Gain (Loss)</span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="6" style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Recognized in AOCI</span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="6" style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Three Months Ended</span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="6" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">March 31,</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"> <td style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Derivative Instrument</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2024</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2023</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Euro Notes</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">24.4</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">19.2</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Cross-currency interest rate swaps</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">46.1</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">4.5</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">70.5</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">23.7</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> </tr> </table></div> <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">As of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">March 31, 2024 and December 31, 2023, the following amounts were recorded on our condensed consolidated balance sheets related to cumulative basis adjustments for fair value hedges (in millions):</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:26.28%;"></td> <td style="width:1.48%;"></td> <td style="width:1%;"></td> <td style="width:14.58%;"></td> <td style="width:1%;"></td> <td style="width:1.48%;"></td> <td style="width:1%;"></td> <td style="width:14.58%;"></td> <td style="width:1%;"></td> <td style="width:1.48%;"></td> <td style="width:1.48%;"></td> <td style="width:1%;"></td> <td style="width:14.58%;"></td> <td style="width:1%;"></td> <td style="width:1.48%;"></td> <td style="width:1%;"></td> <td style="width:14.58%;"></td> <td style="width:1%;"></td> </tr> <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="6" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Carrying Amount of the Hedged Liabilities</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="6" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Cumulative Amount of Fair Value Hedging Adjustment Included in the Carrying Amount of the Hedged Liabilities</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"> <td style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Balance Sheet Line Item</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">March 31, 2024</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">December 31, 2023</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">March 31, 2024</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">December 31, 2023</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Long-term debt</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">832.3</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">851.3</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">163.7</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">144.7</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> </tr> </table> 832300000 851300000 -163700000 -144700000 P30Y 23700000 1 700000000 54100000000 125000000 100000000 50000000 6000000 3000000 0 P30M 1526700000 435400000 1250000000 1750000000 <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Derivative instruments designated as cash flow hedges had the following effects, before taxes, on AOCI and net earnings on our condensed consolidated statements of earnings, condensed consolidated statements of comprehensive income and condensed consolidated balance sheets (in millions):</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:23.591%;"></td> <td style="width:1.679%;"></td> <td style="width:1%;"></td> <td style="width:7.776999999999999%;"></td> <td style="width:1%;"></td> <td style="width:1.679%;"></td> <td style="width:1%;"></td> <td style="width:7.776999999999999%;"></td> <td style="width:1%;"></td> <td style="width:1.679%;"></td> <td style="width:28.908%;"></td> <td style="width:1.679%;"></td> <td style="width:1%;"></td> <td style="width:7.776999999999999%;"></td> <td style="width:1%;"></td> <td style="width:1.679%;"></td> <td style="width:1%;"></td> <td style="width:7.776999999999999%;"></td> <td style="width:1%;"></td> </tr> <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="6" style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Amount of Gain</span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="6" style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Amount of Gain (Loss)</span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="6" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Recognized in AOCI</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="6" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Reclassified from AOCI</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="6" style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Three Months Ended</span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="6" style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Three Months Ended</span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="6" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">March 31,</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Location on</span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="6" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">March 31,</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"> <td style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Derivative Instrument</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2024</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2023</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Statements of Earnings</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2024</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2023</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Foreign exchange<br/>   forward contracts</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">43.4</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">11.1</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span><span style="-sec-ix-hidden:F_92b5ddaf-fd21-44d3-926b-1e7570574fbc;"><span style="-sec-ix-hidden:F_5361be90-571e-4f02-9349-d075b51bfbf9;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Cost of products sold</span></span></span></span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">22.0</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">23.1</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Forward starting<br/>   interest rate swaps</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">-</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">-</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span><span style="-sec-ix-hidden:F_b2cfd198-996f-4f6d-8879-d9905e2f6f23;"><span style="-sec-ix-hidden:F_b61d1f4b-42f1-42cc-90ad-5622976efc92;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Interest expense, net</span></span></span></span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">0.2</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">0.2</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">43.4</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">11.1</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">21.8</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">22.9</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p> 43400000 11100000 22000000 23100000 -200000 -200000 43400000 11100000 21800000 22900000 93100000 79900000 75200000 62000000 -700000 -500000 <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The following table presents the effect of fair value, cash flow and net investment hedge accounting on our condensed consolidated statements of earnings (in millions):</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:55.26%;"></td> <td style="width:1.66%;"></td> <td style="width:1%;"></td> <td style="width:7.84%;"></td> <td style="width:1%;"></td> <td style="width:1.24%;"></td> <td style="width:1%;"></td> <td style="width:7.84%;"></td> <td style="width:1%;"></td> <td style="width:1.24%;"></td> <td style="width:1%;"></td> <td style="width:7.84%;"></td> <td style="width:1%;"></td> <td style="width:1.24%;"></td> <td style="width:1%;"></td> <td style="width:7.84%;"></td> <td style="width:1%;"></td> </tr> <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="14" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Location and Amount of Gain/(Loss) Recognized in Income on Fair Value, Cash Flow and Net Investment Hedging Relationships</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="6" style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Three Months Ended</span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="6" style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Three Months Ended</span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="6" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">March 31, 2024</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="6" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">March 31, 2023</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="font-size:8pt;"><span style="-sec-ix-hidden:F_4b4a5e37-a370-4411-b2f8-6ed594bc9065;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Cost of</span></span></span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="font-size:8pt;"><span style="-sec-ix-hidden:F_d2e66eac-3663-4409-8c6b-2c4838a59bf0;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Interest</span></span></span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="font-size:8pt;"><span style="-sec-ix-hidden:F_c99c4bac-4bcc-4c47-a48f-000678e2fe5c;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Cost of</span></span></span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="font-size:8pt;"><span style="-sec-ix-hidden:F_a854c6ae-1d31-438e-a809-53b98cd9bae1;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Interest</span></span></span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Products</span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Expense,</span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Products</span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Expense,</span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Sold</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Net</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Sold</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Net</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Total amounts of income and expense line items presented in the statements of earnings in which the effects of fair value, cash flow and net investment hedges are recorded</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;color:#000000;white-space:pre-wrap;min-width:fit-content;">512.3</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:8pt;min-width:fit-content;">(</span><span style="font-size:8pt;color:#000000;white-space:pre-wrap;min-width:fit-content;">50.7</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;color:#000000;white-space:pre-wrap;min-width:fit-content;">500.8</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:8pt;min-width:fit-content;">(</span><span style="font-size:8pt;color:#000000;white-space:pre-wrap;min-width:fit-content;">48.2</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> </tr> <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"> <td colspan="4" style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">        The effects of fair value, cash flow and net investment hedging:</span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;"> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">             Gain (loss) on fair value hedging <br/>                  relationships</span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">                       Interest rate swaps</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">-</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:8pt;min-width:fit-content;">(</span><span style="font-size:8pt;color:#000000;white-space:pre-wrap;min-width:fit-content;">10.6</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">-</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:8pt;min-width:fit-content;">(</span><span style="font-size:8pt;color:#000000;white-space:pre-wrap;min-width:fit-content;">8.2</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> </tr> <tr style="height:8pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;"> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">             Gain (loss) on cash flow hedging <br/>                  relationships</span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">                       Foreign exchange forward contracts</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;color:#000000;white-space:pre-wrap;min-width:fit-content;">22.0</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">-</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;color:#000000;white-space:pre-wrap;min-width:fit-content;">23.1</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">-</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">                       Forward starting interest rate swaps</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">-</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:8pt;min-width:fit-content;">(</span><span style="font-size:8pt;color:#000000;white-space:pre-wrap;min-width:fit-content;">0.2</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">-</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:8pt;min-width:fit-content;">(</span><span style="font-size:8pt;color:#000000;white-space:pre-wrap;min-width:fit-content;">0.2</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> </tr> <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">             Gain on net investment hedging <br/>                  relationships</span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">                       Cross-currency interest rate swaps</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">-</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;color:#000000;white-space:pre-wrap;min-width:fit-content;">8.2</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">-</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;color:#000000;white-space:pre-wrap;min-width:fit-content;">9.0</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> </table> 512300000 -50700000 500800000 -48200000 -10600000 -8200000 22000000 23100000 -200000 -200000 8200000 9000000 <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The following gains / (losses) from these derivative instruments were recognized on our condensed consolidated statements of earnings (in millions):</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:41.128%;"></td> <td style="width:1.98%;"></td> <td style="width:29.606%;"></td> <td style="width:1.8%;"></td> <td style="width:1%;"></td> <td style="width:9.842%;"></td> <td style="width:1%;"></td> <td style="width:1.8%;"></td> <td style="width:1%;"></td> <td style="width:9.842%;"></td> <td style="width:1%;"></td> </tr> <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="6" style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Three Months Ended</span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Location on</span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="6" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">March 31,</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"> <td style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Derivative Instrument</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Statements of Earnings</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2024</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2023</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Foreign exchange forward contracts</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Other (expense) income, net</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">8.4</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">3.6</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> </tr> </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p> 8400000 -3600000 -12200000 400000 <span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The fair value of derivative instruments on a gross basis is as follows (in millions):</span><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:35.134%;"></td> <td style="width:1.18%;"></td> <td style="width:21.269%;"></td> <td style="width:1.18%;"></td> <td style="width:1%;"></td> <td style="width:6.803000000000001%;"></td> <td style="width:1%;"></td> <td style="width:1.18%;"></td> <td style="width:21.269%;"></td> <td style="width:1.18%;"></td> <td style="width:1%;"></td> <td style="width:6.803000000000001%;"></td> <td style="width:1%;"></td> </tr> <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="4" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">As of March 31, 2024</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="4" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">As of December 31, 2023</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Balance</span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Balance</span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Sheet</span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Fair</span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Sheet</span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Fair</span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Location</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Value</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Location</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Value</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;"> <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-style:italic;min-width:fit-content;">Asset Derivatives Designated as Hedges</span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="text-indent:20pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Foreign exchange forward contracts</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Other current assets</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">66.3</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Other current assets</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">58.4</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="text-indent:20pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Cross-currency interest rate swaps</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Other current assets</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">-</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Other current assets</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">-</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="text-indent:20pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Foreign exchange forward contracts</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Other assets</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">21.2</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Other assets</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">17.2</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="text-indent:20pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Cross-currency interest rate swaps</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Other assets</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">27.3</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Other assets</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">5.4</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Total asset derivatives</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">114.8</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">81.0</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;"> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"> <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-style:italic;min-width:fit-content;">Asset Derivatives Not Designated as Hedges</span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="text-indent:20pt;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Foreign exchange forward contracts</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Other current assets</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">3.7</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Other current assets</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1.2</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"> <td style="text-indent:20pt;vertical-align:top;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;"> <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-style:italic;min-width:fit-content;">Liability Derivatives Designated as Hedges</span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="text-indent:20pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Foreign exchange forward contracts</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Other current liabilities</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">8.5</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Other current liabilities</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">13.9</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="text-indent:20pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Cross-currency interest rate swaps</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Other current liabilities</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">35.0</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Other current liabilities</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">33.3</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="text-indent:20pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Foreign exchange forward contracts</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Other long-term liabilities</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">6.3</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Other long-term liabilities</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">11.0</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="text-indent:20pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Cross-currency interest rate swaps</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Other long-term liabilities</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">8.8</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Other long-term liabilities</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">34.8</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="text-indent:20pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Interest rate swaps</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Other long-term liabilities</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">163.8</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Other long-term liabilities</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">144.7</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Total liability derivatives</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">222.4</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">237.7</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"> <td style="text-indent:20pt;vertical-align:top;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;"> <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-style:italic;min-width:fit-content;">Liability Derivatives Not Designated as Hedges</span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="text-indent:20pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Foreign exchange forward contracts</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Other current liabilities</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2.8</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Other current liabilities</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2.4</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> </table> 66300000 58400000 0 0 21200000 17200000 27300000 5400000 114800000 81000000 3700000 1200000 8500000 13900000 35000000 33300000 6300000 11000000 8800000 34800000 163800000 144700000 222400000 237700000 2800000 2400000 <p style="text-indent:4.533%;font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The table below presents the effects of our master netting agreements on our condensed consolidated balance sheets (in millions):</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:22.655%;"></td> <td style="width:1.12%;"></td> <td style="width:19.956%;"></td> <td style="width:1.12%;"></td> <td style="width:1%;"></td> <td style="width:6.259%;"></td> <td style="width:1%;"></td> <td style="width:1.12%;"></td> <td style="width:1%;"></td> <td style="width:6.259%;"></td> <td style="width:1%;"></td> <td style="width:1.12%;"></td> <td style="width:1%;"></td> <td style="width:6.259%;"></td> <td style="width:1%;"></td> <td style="width:1.12%;"></td> <td style="width:1%;"></td> <td style="width:6.259%;"></td> <td style="width:1%;"></td> <td style="width:1.12%;"></td> <td style="width:1%;"></td> <td style="width:6.259%;"></td> <td style="width:1%;"></td> <td style="width:1.12%;"></td> <td style="width:1%;"></td> <td style="width:6.259%;"></td> <td style="width:1%;"></td> </tr> <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="10" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">As of March 31, 2024</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="10" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">As of December 31, 2023</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"> <td style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Description</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Location</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Gross<br/>Amount</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Offset</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Net Amount in<br/>Balance Sheet</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Gross<br/>Amount</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Offset</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Net Amount in<br/>Balance Sheet</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;"> <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-style:italic;min-width:fit-content;">Asset Derivatives</span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Cash flow hedges</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span><span style="-sec-ix-hidden:F_1f71d066-e8d1-47c3-b1c8-0e7eb7e649c6;"><span style="-sec-ix-hidden:F_cc591cf8-ea2f-462f-8d3e-332e0016324e;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Other current assets</span></span></span></span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">66.3</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">8.4</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">57.9</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">58.4</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">13.0</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">45.4</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Cash flow hedges</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span><span style="-sec-ix-hidden:F_bf07857d-2fd5-46f1-a15e-8849a24f6028;"><span style="-sec-ix-hidden:F_359f6c98-0041-4df7-80fc-ebf673ce9e8a;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Other assets</span></span></span></span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">21.2</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">4.7</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">16.5</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">17.2</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">8.2</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">9.0</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Derivatives Not Designated as Hedges</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span><span style="-sec-ix-hidden:F_4ce826d2-2f19-4a87-810f-0fab7d2e8237;"><span style="-sec-ix-hidden:F_37b4da1d-a0ca-4431-87b9-07b36d7126da;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Other current assets</span></span></span></span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">3.7</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1.3</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2.4</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1.2</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">0.8</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">0.4</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"> <td style="text-indent:10pt;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;"> <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-style:italic;min-width:fit-content;">Liability Derivatives</span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Cash flow hedges</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span><span style="-sec-ix-hidden:F_170af71a-e1d1-4814-a0d7-010c46331a58;"><span style="-sec-ix-hidden:F_2b074a4d-4e56-491d-a6e8-dfa1a93871dc;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Other current liabilities</span></span></span></span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">8.5</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">8.4</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">0.1</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">13.9</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">13.0</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">0.9</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Cash flow hedges</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span><span style="-sec-ix-hidden:F_a39ff77f-420e-4413-8b1a-7915c755ccf6;"><span style="-sec-ix-hidden:F_dc348431-4a20-4740-89fe-ca43fb1686e4;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Other long-term liabilities</span></span></span></span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">6.3</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">4.7</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1.6</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">11.0</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">8.2</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2.8</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Derivatives Not Designated as Hedges</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span><span style="-sec-ix-hidden:F_4dd80ba7-e83c-4475-9a42-ef6abe7434c4;"><span style="-sec-ix-hidden:F_00ab5103-0784-4736-9184-a256329d3398;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Other current liabilities</span></span></span></span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2.8</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1.3</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1.5</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2.4</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">0.8</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1.6</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> </table> 66300000 8400000 57900000 58400000 13000000 45400000 21200000 4700000 16500000 17200000 8200000 9000000 3700000 1300000 2400000 1200000 800000 400000 8500000 8400000 100000 13900000 13000000 900000 6300000 4700000 1600000 11000000 8200000 2800000 2800000 1300000 1500000 2400000 800000 1600000 <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The following net investment hedge gains (losses) were recognized on our condensed consolidated statements of comprehensive income (in millions):</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:90.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:70.234%;"></td> <td style="width:1.98%;"></td> <td style="width:1%;"></td> <td style="width:10.902000000000001%;"></td> <td style="width:1%;"></td> <td style="width:1.98%;"></td> <td style="width:1%;"></td> <td style="width:10.902000000000001%;"></td> <td style="width:1%;"></td> </tr> <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="6" style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Amount of Gain (Loss)</span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="6" style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Recognized in AOCI</span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="6" style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Three Months Ended</span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="6" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">March 31,</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"> <td style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Derivative Instrument</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2024</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2023</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Euro Notes</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">24.4</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">19.2</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Cross-currency interest rate swaps</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">46.1</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">4.5</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">70.5</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">23.7</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> </tr> </table> 24400000 -19200000 46100000 -4500000 70500000 -23700000 <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">12. Income Taxes</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:5%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">We operate on a global basis and are subject to numerous and complex tax laws and regulations. Additionally, tax laws continue to undergo rapid changes in both application and interpretation by various countries, including state aid interpretations and initiatives led by the Organisation for Economic Cooperation and Development ("OECD"). Our income tax filings are subject to examinations by taxing authorities throughout the world. Income tax audits may require an extended period of time to reach resolution and may result in significant income tax adjustments when interpretation of tax laws or allocation of company profits is disputed. Although ultimate timing is uncertain, the net amount of tax liability for unrecognized tax benefits may change within the next twelve months due to changes in audit status, expiration of statutes of limitations, settlements of tax assessments and other events. Management’s best estimate of such change is within the range of a $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">270</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million decrease to a $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">20</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million increase.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">We are under continuous audit by the IRS and have disputes with the IRS and other foreign taxing authorities in the jurisdictions where we operate. In addition, some jurisdictions in which we operate require payment of disputed taxes to petition a court or taxing authority, or we may elect to make such payments prior to final resolution. We record any prepayments as income tax receivables when we believe our position is more likely than not to be upheld. We assess our position on these disputes at each reporting period. During the course of these audits and disputes, we receive proposed adjustments from taxing authorities that may be material. Therefore, there is a possibility that an adverse outcome in these audits or disputes could have a material effect on our results of operations and financial condition. Our U.S. federal income tax returns have been audited through 2019.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:4.173%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The IRS has proposed adjustments for tax years 2010-2012, primarily related to reallocating profits between certain U.S. and foreign subsidiaries, which remain unsettled. We have disputed these adjustments and intend to continue to vigorously defend our positions as we pursue resolution through the administrative process with the IRS Independent Office of Appeals.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:4.173%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The IRS has proposed adjustments for tax years 2013-2015, primarily related to transfer pricing involving our cost sharing agreement between the U.S. and Switzerland affiliated companies and the reallocation of profits between certain of our U.S. and foreign subsidiaries. This includes a proposed increase to our U.S. federal taxable income, which would result in additional tax expense related to 2013 of approximately $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">370</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million, subject to interest and penalties. We strongly believe that the position of the IRS, with regard to this matter, is inconsistent with the applicable U.S. Treasury Regulations governing our cost sharing agreement. We intend to vigorously contest the adjustment, and we will pursue all available administrative and, if necessary, judicial remedies. If we pursue judicial remedies in the U.S. Tax Court for years 2013-2015, a number of years will likely elapse before such matters are finally resolved. No payment of any amount related to this matter is required to be made, if at all, until all applicable proceedings have been completed.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:4.173%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The IRS has proposed adjustments for tax years 2016-2019, primarily related to the U.S. taxation of foreign earnings and profits, which could result in additional material tax expense if we are unsuccessful in defending our position. We disagree with the proposed adjustments and intend to continue to vigorously contest the adjustments. We do not expect a final resolution of these issues in the next 12 months. No payment of any amount related to his matter is required to be made, if at all, until all applicable proceedings have been completed.</span></p><p style="text-indent:4.133%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">In the three-month period ended March 31, 2024, our effective tax rate (“ETR”) was </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">19.7</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> percent compared to </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">18.9</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> percent for the three-month period ended March 31, 2023. The </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">19.7</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> percent and </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">18.9</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> percent ETR in the three-month periods ended March 31, 2024 and 2023, respectively, were primarily driven by our mix of earnings between U.S. and foreign locations. Absent discrete tax events, we expect our future ETR will be lower than the U.S. corporate income tax rate of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">21.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> percent due to our mix of earnings between U.S. and foreign locations, which generally have lower corporate income tax rates. Our ETR in future periods could also potentially be impacted by: changes in our mix of pre-tax earnings; changes in tax rates, tax laws or their interpretation; including the European Union adoption of Pillar Two proposals which began to take effect in 2024; the outcome of various federal, state and foreign audits, appeals, and litigation; and the expiration of certain statutes of limitations. Currently, we cannot reasonably estimate the impact of these items on our financial results.</span></p> 270000000 20000000 370000000 0.197 0.189 0.197 0.189 0.21 <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">13. Earnings Per Share</span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The following is a reconciliation of weighted average shares for the basic and diluted shares computations (in millions):</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:90.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:63.32%;"></td> <td style="width:2%;"></td> <td style="width:1%;"></td> <td style="width:14.34%;"></td> <td style="width:1%;"></td> <td style="width:2%;"></td> <td style="width:1%;"></td> <td style="width:14.34%;"></td> <td style="width:1%;"></td> </tr> <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="6" style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Three Months Ended</span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="6" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">March 31,</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2024</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2023</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Weighted average shares outstanding for basic net earnings per share</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">205.2</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">209.4</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Effect of dilutive stock options and other equity awards</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1.0</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1.0</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Weighted average shares outstanding for diluted net earnings per share</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">206.2</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">210.4</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> </table></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">During the three-month periods ended March 31, 2024 and 2023, an average of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">1.6</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million options and </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">2.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million options, respectively, to purchase shares of common stock were not included in the computation of diluted earnings per share because the effect would have been antidilutive.</span></p> <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The following is a reconciliation of weighted average shares for the basic and diluted shares computations (in millions):</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:90.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:63.32%;"></td> <td style="width:2%;"></td> <td style="width:1%;"></td> <td style="width:14.34%;"></td> <td style="width:1%;"></td> <td style="width:2%;"></td> <td style="width:1%;"></td> <td style="width:14.34%;"></td> <td style="width:1%;"></td> </tr> <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="6" style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Three Months Ended</span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="6" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">March 31,</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2024</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2023</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Weighted average shares outstanding for basic net earnings per share</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">205.2</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">209.4</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Effect of dilutive stock options and other equity awards</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1.0</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1.0</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Weighted average shares outstanding for diluted net earnings per share</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">206.2</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">210.4</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> </table> 205200000 209400000 1000000 1000000.0 206200000 210400000 1600000 2000000 <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">14. Segment Information</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">We design, manufacture and market orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; craniomaxillofacial and thoracic products (“CMFT”); surgical products; and a suite of integrated digital and robotic technologies that leverage data, data analytics and artificial intelligence. Our chief operating decision maker (“CODM”) allocates resources to achieve our operating profit goals through </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">three</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> operating segments. These operating segments, which also constitute our reportable segments, are Americas; EMEA; and Asia Pacific.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:5%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Our CODM evaluates performance based upon segment operating profit exclusive of operating expenses and income pertaining to intangible asset amortization, certain inventory and manufacturing-related charges, restructuring and other cost reduction initiatives, acquisition, integration, divestiture and related, litigation, certain European Union Medical Device Regulation (“EU MDR”) expenses, other charges and corporate functions (collectively referred to as “Corporate items”). Corporate functions include finance, corporate legal, information technology, human resources and other corporate departments as well as stock-based compensation and certain operations, distribution, quality assurance, regulatory assurance, research and development ("R&amp;D") and marketing expenses. Intercompany transactions have been eliminated from segment operating profit.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Our Americas operating segment is comprised principally of the U.S. and includes other North, Central and South American markets. Our EMEA operating segment is comprised principally of Europe and includes the Middle East and African markets. Our Asia Pacific operating segment is comprised principally of Japan, China and Australia and includes other Asian and Pacific markets. The Americas, EMEA and Asia Pacific operating segments include the commercial operations as well as regional headquarter expenses to operate in those markets. Our operating segments do not include many centralized, product category expenses such as R&amp;D and global marketing that benefit all regions.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">In the three-month period ended March 31, 2024, the segment operating profit measures our CODM reviews were revised. Certain product category headquarter costs, primarily R&amp;D and marketing, that were previously in our Americas operating segment are now included in Corporate items. In addition, certain support function costs from our operating segments are now included in Corporate items. We have reclassified these product category headquarter and support function expenses in the prior period to conform to the current period presentation.</span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="text-indent:5%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Net sales and operating profit by segment are as follows (in millions):</span></p><p style="text-indent:5%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p> <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;"> <tr style="visibility:collapse;"> <td style="width:50.38%;"></td> <td style="width:1.22%;"></td> <td style="width:1%;"></td> <td style="width:9.184000000000001%;"></td> <td style="width:1%;"></td> <td style="width:1.22%;"></td> <td style="width:1%;"></td> <td style="width:9.184000000000001%;"></td> <td style="width:1%;"></td> <td style="width:1.22%;"></td> <td style="width:1%;"></td> <td style="width:9.184000000000001%;"></td> <td style="width:1%;"></td> <td style="width:1.22%;"></td> <td style="width:1%;"></td> <td style="width:9.184000000000001%;"></td> <td style="width:1%;"></td> </tr> <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="6" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Net Sales</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="6" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Operating Profit</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="6" style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Three Months Ended</span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="6" style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Three Months Ended</span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="6" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">March 31,</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="6" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">March 31,</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2024</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2023</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2024</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2023</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Americas</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1,186.5</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1,141.3</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">639.3</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">608.9</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">EMEA</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">444.8</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">425.6</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">153.0</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">149.5</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Asia Pacific</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">258.0</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">264.1</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">93.3</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">90.2</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Total</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1,889.2</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1,831.0</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Corporate items</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">477.6</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">387.9</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Intangible asset amortization</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">142.1</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">133.4</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Operating profit</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="border-top:0.5pt solid #000000;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="border-top:0.5pt solid #000000;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">265.9</span></p></td> <td style="border-top:0.5pt solid #ffffff03;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="border-top:0.5pt solid #000000;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="border-top:0.5pt solid #000000;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">327.3</span></p></td> <td style="border-top:0.5pt solid #ffffff03;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> </table></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p> 3 <p style="text-indent:5%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Net sales and operating profit by segment are as follows (in millions):</span></p><p style="text-indent:5%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p> <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;"> <tr style="visibility:collapse;"> <td style="width:50.38%;"></td> <td style="width:1.22%;"></td> <td style="width:1%;"></td> <td style="width:9.184000000000001%;"></td> <td style="width:1%;"></td> <td style="width:1.22%;"></td> <td style="width:1%;"></td> <td style="width:9.184000000000001%;"></td> <td style="width:1%;"></td> <td style="width:1.22%;"></td> <td style="width:1%;"></td> <td style="width:9.184000000000001%;"></td> <td style="width:1%;"></td> <td style="width:1.22%;"></td> <td style="width:1%;"></td> <td style="width:9.184000000000001%;"></td> <td style="width:1%;"></td> </tr> <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="6" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Net Sales</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="6" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Operating Profit</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="6" style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Three Months Ended</span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="6" style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Three Months Ended</span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="6" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">March 31,</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="6" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">March 31,</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2024</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2023</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2024</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2023</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Americas</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1,186.5</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1,141.3</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">639.3</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">608.9</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">EMEA</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">444.8</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">425.6</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">153.0</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">149.5</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Asia Pacific</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">258.0</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">264.1</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">93.3</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">90.2</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Total</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1,889.2</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1,831.0</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Corporate items</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">477.6</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">387.9</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Intangible asset amortization</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">142.1</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">133.4</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Operating profit</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="border-top:0.5pt solid #000000;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="border-top:0.5pt solid #000000;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">265.9</span></p></td> <td style="border-top:0.5pt solid #ffffff03;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="border-top:0.5pt solid #000000;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="border-top:0.5pt solid #000000;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">327.3</span></p></td> <td style="border-top:0.5pt solid #ffffff03;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> </table> 1186500000 1141300000 639300000 608900000 444800000 425600000 153000000 149500000 258000000 264100000 93300000 90200000 1889200000 1831000000 -477600000 -387900000 142100000 133400000 265900000 327300000 <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">15. Commitments and Contingencies</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">From time to time, we are involved in various legal proceedings, including product liability, intellectual property, stockholder matters, tax disputes, commercial disputes, employment matters, whistleblower and </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">qui tam</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> claims and investigations, governmental proceedings and investigations, and other legal matters that arise in the normal course of our business, including those described below. On a quarterly and annual basis, we review relevant information with respect to loss contingencies and update our accruals, disclosures and estimates of reasonably possible losses or ranges of loss based on such reviews. We establish liabilities for loss contingencies on an undiscounted basis when it is probable that a loss has been incurred and the amount of the loss can be reasonably estimated. If the reasonable estimate of a known or probable loss is a range, and no amount within the range is a better estimate than any other, the minimum amount of the range is accrued. For matters where a loss is believed to be reasonably possible, but not probable, or if no reasonable estimate of known or probable loss is available, no accrual has been made.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">When determining the estimated loss or range of loss, significant judgment is required. Estimates of probable losses resulting from litigation and other contingencies are inherently difficult to predict, particularly when the matters are in early procedural stages with incomplete facts or legal discovery, involve unsubstantiated or indeterminate claims for damages, and/or potentially involve penalties, fines or punitive damages. In addition to the matters described herein, we remain subject to the risk of future governmental, regulatory and legal actions. Governmental and regulatory actions may lead to product recalls, injunctions and other restrictions on our operations and monetary sanctions, which may include substantial civil or criminal penalties. Actions involving intellectual property could result in a loss of patent protection or the ability to market products, which could lead to significant sales reductions or cost increases, or otherwise materially affect the results of our operations.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">We recognize litigation-related charges and gains in Selling, general and administrative expense on our condensed consolidated statement of earnings. During the three-month periods ended March 31, 2024 and 2023, we recognized $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">1.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">3.3</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million, respectively, of net litigation-related charges. At March 31, 2024 and December 31, 2023, accrued litigation liabilities were $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">226.5</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">244.1</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million, respectively. These litigation-related charges and accrued liabilities reflect all of our litigation-related contingencies and not just the matters discussed below. The ultimate cost of litigation could be materially different than the amount of the current estimates and accruals and could have a material adverse impact on our financial condition and results of operations.</span></p><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Litigation</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Durom Cup-related claims</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">: On July 22, 2008, we temporarily suspended marketing and distribution of the Durom Cup in the U.S. Subsequently, a number of product liability lawsuits were filed against us in various U.S. and foreign jurisdictions. The plaintiffs seek damages for personal injury, and they generally allege that the Durom Cup contains defects that result in complications and revision of the device. We have settled the majority of these claims in the U.S., but other lawsuits are pending in various foreign jurisdictions and additional claims may be asserted in the future. The majority of claims outside the U.S. are pending in Germany, Netherlands and Italy.</span><span style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">We rely on significant estimates in determining the provisions for Durom Cup-related claims, including our estimate of the number of claims that we will receive and the average amount we will pay per claim. The actual number of claims and the actual amount we pay per claim may differ from our estimates. For various reasons, we cannot reasonably estimate the possible loss or range of loss that may result from Durom Cup-related claims in excess of the losses we have accrued. Although we are vigorously defending these lawsuits, their ultimate resolution is uncertain. We accrued a litigation-related charge in this matter based on an estimate of the reasonably possible loss, as discussed above.</span></p><p style="text-indent:5%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Zimmer M/L Taper, M/L Taper with Kinectiv Technology, and Versys Femoral Head-related claims (“Metal Reaction” claims): </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">We are a defendant in a number of product liability lawsuits relating to our M/L Taper and M/L Taper with Kinectiv Technology hip stems, and Versys Femoral Head implants. The plaintiffs seek damages for personal injury, alleging that defects in the products lead to corrosion at the head/stem junction resulting in, among other things, pain, inflammation and revision surgery.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:5%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The majority of the cases are consolidated in an MDL that was created on October 3, 2018 in the U.S. District Court for the Southern District of New York (</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">In Re: Zimmer M/L Taper Hip Prosthesis or M/L Taper Hip Prosthesis with Kinectiv Technology and Versys Femoral Head Products Liability Litigation</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">). Most of the cases in the MDL have been resolved. Other related cases are pending in various state and federal courts and in courts in Canada, and additional claims may be asserted in the future. Although we are vigorously defending these lawsuits, their ultimate resolution is uncertain. We accrued a litigation-related charge in this matter based on an estimate of the reasonably possible loss, as discussed above.</span></p><p style="text-indent:5%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Biomet metal-on-metal hip implant claims</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">: Biomet is a defendant in a number of product liability lawsuits relating to metal-on-metal hip implants, most of which involve the M2a-Magnum hip system. Cases were originally consolidated in an MDL in the U.S. District Court for the Northern District of Indiana </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">(In Re: Biomet M2a Magnum Hip Implant Product Liability Litigation)</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">, but the majority of the claims in the U.S. have been settled. Trials may still occur in the future, and although each case will be tried on its particular facts, a verdict and subsequent final judgment for the plaintiff in one or more of these cases could have a substantial impact on our potential liability. Lawsuits are pending in various foreign jurisdictions and additional claims are expected to be asserted. We continue to refine our estimates of the potential liability to resolve the remaining claims and lawsuits. Although we are vigorously</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">defending these lawsuits, their ultimate resolution is uncertain. We accrued a litigation-related charge in this matter based on an estimate of the reasonably possible loss, as discussed above.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Other Contingencies</span></p><p style="text-indent:5.067%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Contractual obligations:</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> We have entered into development, distribution and other contractual arrangements that may result in future payments dependent upon various events such as the achievement of certain product R&amp;D milestones, sales milestones, or, at our discretion, maintenance of exclusive rights to distribute a product. Since there is uncertainty on the timing or whether such payments will have to be made, they have not been recognized on our condensed consolidated balance sheets. These estimated payments could range from $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> to approximately </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">405</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million.</span></p> 1000000 3300000 226500000 244100000 0 405000000 false false false false false false